sample_id,temperature,variation_id,label,source_text,variation_text,delta_score_2gram,delta_entropy_2gram,delta_variance_2gram,delta_score_3gram,delta_entropy_3gram,delta_variance_3gram,delta_score_4gram,delta_entropy_4gram,delta_variance_4gram,delta_score_5gram,delta_entropy_5gram,delta_variance_5gram
0,0.1,1,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Does losing consciousness indicate neuropsychological decline following a concussion? The study's findings question the significance of LOC in forecasting long-term neuropsychological impairments. While LOC is commonly considered a marker of concussion severity, our results imply that other elements might be more crucial in cognitive recovery.",2.6054570009253947e-07,0.19793819929384737,0.0181755829903978,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
0,0.1,2,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Is loss of consciousness a predictor of neuropsychological impairments after a concussion? This study's outcomes challenge the role of LOC as a reliable indicator of long-term neuropsychological deficits. Although LOC is frequently used to gauge concussion severity, our data suggest other factors may be more influential in cognitive recovery.",1.6580180914979784e-07,0.11092682230421813,0.0181755829903978,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
0,0.1,3,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Can loss of consciousness predict neuropsychological deficits post-concussion? The findings from this research cast doubt on LOC's value as a predictor of lasting neuropsychological issues. Despite LOC being a common marker for concussion severity, our study indicates that other variables could be more important in cognitive recovery.",2.1317375462116866e-07,0.15348643672301465,0.0181755829903978,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
0,0.1,4,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Does loss of consciousness forecast neuropsychological decline after a concussion? The study results question the relevance of LOC as a predictor of long-term neuropsychological deficits. Even though LOC is often used to assess concussion severity, our findings suggest other factors may have a greater impact on cognitive recovery.",1.8948778188548325e-07,0.1319802315020513,0.0181755829903978,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
0,0.1,5,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Is loss of consciousness an indicator of neuropsychological decline following concussion? The research findings undermine the importance of LOC as a predictor of enduring neuropsychological deficits. While LOC is typically used as a severity marker, our results point to other factors playing a more significant role in cognitive recovery.",1.6580180914979784e-07,0.13980795482754882,0.002648319227800483,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
0,0.1,6,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Does experiencing loss of consciousness predict neuropsychological impairments after a concussion? The study's conclusions cast doubt on LOC's predictive value for long-term neuropsychological deficits. Although LOC is commonly regarded as a marker of concussion severity, our findings highlight the potential importance of other factors in cognitive recovery.",2.1317375462116866e-07,0.15348643672301465,0.0181755829903978,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
0,0.1,7,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Can loss of consciousness serve as a predictor for neuropsychological deficits after concussion? The results from this study question the significance of LOC in predicting long-term neuropsychological impairments. Despite LOC being a frequent marker of concussion severity, our data suggest other factors may be more critical in cognitive recovery.",1.6580180914979784e-07,0.11092682230421813,0.0181755829903978,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
0,0.1,8,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Is loss of consciousness a reliable predictor of neuropsychological decline post-concussion? The study's findings challenge the importance of LOC as an indicator of lasting neuropsychological deficits. Although LOC is often used to measure concussion severity, our results imply that other factors might play a more vital role in cognitive recovery.",1.4211583641411244e-07,0.09030753510148237,0.0181755829903978,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
0,0.1,9,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Does loss of consciousness predict long-term neuropsychological deficits after concussion? The findings from this study cast doubt on the role of LOC as a predictor of neuropsychological impairments. While LOC is commonly used as a marker of concussion severity, our research suggests other factors may be more influential in cognitive recovery.",1.1842986367842703e-07,0.09783071500636176,0.0018160871470449327,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
0,0.1,10,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of long-term neuropsychological deficits. Although LOC is often used as a marker of concussion severity, our findings suggest that other factors may play a more significant role in cognitive recovery. 
","Is loss of consciousness a key predictor of neuropsychological impairments following concussion? The study results question the importance of LOC in forecasting long-term neuropsychological deficits. Although LOC is frequently used as a severity marker, our findings indicate that other factors could be more significant in cognitive recovery.",2.1317375462116866e-07,0.15348643672301465,0.0181755829903978,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
1,0.1,1,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is transgastric endoscopic splenectomy achievable? The procedure seems technically feasible in a porcine model, involving spleen access via the stomach for minimally invasive removal, showing promising results and potential advantages over traditional laparoscopic methods.",2.605457000925387e-07,0.2561753824263291,0.02271498107084911,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
1,0.1,2,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Can transgastric endoscopic splenectomy be performed? In a porcine model, this technique appears feasible, using stomach access to remove the spleen minimally invasively, with encouraging outcomes suggesting benefits compared to conventional laparoscopic surgery.",2.84231672828224e-07,0.2869470410930828,0.02271498107084911,0.0217611175773825,0.32721291120841567,0.0,0.021729618491434434,0.33647223662121295,0.0,2.8423167282822487e-07,0.3462762367178347,0.0
1,0.1,3,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is it possible to perform transgastric endoscopic splenectomy? The porcine model indicates technical feasibility, where the spleen is accessed through the stomach for minimally invasive extraction, showing promising results and potential improvements over standard laparoscopic surgery.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
1,0.1,4,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Does transgastric endoscopic splenectomy work? Evidence from a porcine model shows it is technically feasible, involving spleen removal through the stomach, offering a minimally invasive approach with promising results and possible advantages over traditional laparoscopy.",2.3685972735685343e-07,0.2263224192766473,0.02271498107084911,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
1,0.1,5,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Can transgastric endoscopic splenectomy be done? The procedure is technically feasible in a porcine model, accessing the spleen via the stomach for minimally invasive removal, with promising findings suggesting benefits over conventional laparoscopic surgery.",2.605457000925387e-07,0.2561753824263291,0.02271498107084911,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
1,0.1,6,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is transgastric endoscopic splenectomy a viable option? In a porcine model, it appears technically feasible by accessing the spleen through the stomach, enabling minimally invasive removal and showing promising results compared to traditional laparoscopic techniques.",2.3685972735685343e-07,0.2263224192766473,0.02271498107084911,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
1,0.1,7,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is it feasible to perform transgastric endoscopic splenectomy? The porcine model study suggests technical feasibility, using stomach access for spleen removal in a minimally invasive manner, with encouraging outcomes and potential advantages over laparoscopic surgery.",2.3685972735685343e-07,0.2263224192766473,0.02271498107084911,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
1,0.1,8,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Can the spleen be removed via transgastric endoscopic splenectomy? This novel approach is technically feasible in a porcine model, involving stomach access for minimally invasive removal, demonstrating promising results and potential benefits over traditional laparoscopy.",2.3685972735685343e-07,0.2263224192766473,0.02271498107084911,0.01813426464781874,0.26469255422708216,0.0,0.018108015409528687,0.2719337154836414,0.0,2.3685972735685406e-07,0.27958486221916123,0.0
1,0.1,9,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is transgastric endoscopic splenectomy possible? The porcine model indicates it is technically feasible, allowing spleen removal through the stomach in a minimally invasive way, with promising results and potential improvements over standard laparoscopic surgery.",2.605457000925387e-07,0.2561753824263291,0.02271498107084911,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
1,0.1,10,ai,"Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. This novel approach involves accessing the spleen through the stomach, allowing for minimally invasive removal. The study demonstrates promising results, suggesting potential benefits over traditional laparoscopic surgery. 
","Is transgastric endoscopic splenectomy achievable? The study in a porcine model shows technical feasibility by accessing the spleen through the stomach, enabling minimally invasive removal and suggesting potential benefits compared to traditional laparoscopic methods.",2.605457000925387e-07,0.2561753824263291,0.02271498107084911,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
2,0.1,1,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Does blood pressure vary in treated hypertensive patients based on whether a physician or a nurse takes the measurement? Systolic blood pressure recorded by physicians was significantly lower (p < 0.001) than that recorded by nurses in a study involving 200 patients, attributed to the physician's perceived authority causing a ""white coat"" effect.",1.8948778188548325e-07,0.14148924309649402,0.029376456599286553,0.014507411718254981,0.14571181118139354,0.0,0.014486412327622933,0.14842000511827358,0.0,1.8948778188548325e-07,0.15123096972392336,0.0
2,0.1,2,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","In treated hypertensive patients, does blood pressure differ when measured by a physician compared to a nurse? A study of 200 patients found systolic BP measured by physicians to be significantly lower (p < 0.001) than measurements taken by nurses, due to the ""white coat"" effect linked to the physician's authority.",2.3685972735685406e-07,0.18284271680534525,0.027845901043731004,0.018134264647818726,0.1857171457950919,0.0,0.018108015409528666,0.18924199963852795,0.0,2.3685972735685406e-07,0.19290366612449228,0.0
2,0.1,3,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Is there a difference in blood pressure readings in treated hypertensive patients depending on whether a nurse or a physician measures it? Research on 200 patients showed systolic BP was significantly lower (p < 0.001) when measured by physicians, attributed to the ""white coat"" effect from the physician's perceived authority.",2.6054570009253947e-07,0.14759364967806832,0.06777645659928656,0.0199476911126006,0.20633643299782767,0.0,0.019918816950481533,0.2102954088363611,0.0,2.6054570009253947e-07,0.21440987134545564,0.0
2,0.1,4,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Does the blood pressure of treated hypertensive patients change based on whether a nurse or physician measures it? In a study of 200 patients, systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses, explained by the ""white coat"" effect due to physician authority.",2.6054570009253947e-07,0.1758853713335764,0.04737715104373101,0.0199476911126006,0.20633643299782767,0.0,0.019918816950481533,0.2102954088363611,0.0,2.6054570009253947e-07,0.21440987134545564,0.0
2,0.1,5,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","For treated hypertensive patients, does blood pressure differ when measured by a nurse versus a physician? A study with 200 patients revealed that systolic BP readings by physicians were significantly lower (p < 0.001) than those by nurses, attributed to the ""white coat"" effect from the physician's perceived authority.",2.8423167282822487e-07,0.16821293688080408,0.06777645659928656,0.02176111757738247,0.22738984219566083,0.0,0.0217296184914344,0.23180161405732447,0.0,2.8423167282822487e-07,0.23638877806423064,0.0
2,0.1,6,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","In treated hypertensive patients, is there a difference in blood pressure readings depending on whether a physician or nurse takes the measurement? A study of 200 patients found systolic BP measured by physicians to be significantly lower (p < 0.001) than that measured by nurses, due to the ""white coat"" effect linked to physician authority.",1.4211583641411244e-07,0.07610201902293667,0.04926453064699038,0.010880558788691236,0.10724553035359774,0.0,0.0108648092457172,0.10919929196499112,0.0,1.4211583641411244e-07,0.11122563511022499,0.0
2,0.1,7,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Does blood pressure in treated hypertensive patients vary depending on whether a nurse or physician measures it? Research involving 200 patients showed systolic BP was significantly lower (p < 0.001) when measured by physicians, attributed to the ""white coat"" effect caused by the physician's perceived authority.",3.552895910352811e-07,0.2327514580183756,0.06777645659928656,0.02720139697172809,0.2933478099874569,0.0,0.027162023114293,0.2992428948528567,0.0,3.552895910352811e-07,0.3053816495511823,0.0
2,0.1,8,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Is there a variation in blood pressure readings in treated hypertensive patients based on whether a physician or nurse performs the measurement? A study of 200 patients found that systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses, due to the ""white coat"" effect from the physician's authority.",1.4211583641411244e-07,0.07610201902293667,0.04926453064699038,0.010880558788691236,0.10724553035359774,0.0,0.0108648092457172,0.10919929196499112,0.0,1.4211583641411244e-07,0.11122563511022499,0.0
2,0.1,9,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","Does the measurement of blood pressure in treated hypertensive patients differ when taken by a physician versus a nurse? In a study of 200 patients, systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses, attributed to the ""white coat"" effect linked to the physician's perceived authority.",1.8948778188548325e-07,0.14148924309649402,0.02937645659928656,0.014507411718254981,0.14571181118139354,0.0,0.014486412327622933,0.14842000511827358,0.0,1.8948778188548325e-07,0.15123096972392336,0.0
2,0.1,10,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? 

Answer: Systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses in a study of 200 patients. The difference was attributed to the perceived authority of the physician, leading to a ""white coat"" effect. 
","For treated hypertensive patients, does blood pressure change depending on whether it is measured by a nurse or a physician? A study of 200 patients showed that systolic BP measured by physicians was significantly lower (p < 0.001) than that measured by nurses, explained by the ""white coat"" effect due to the physician's perceived authority.",1.4211583641411244e-07,0.11146391726153748,0.007667330382961968,0.010880558788691236,0.10724553035359774,0.0,0.0108648092457172,0.10919929196499112,0.0,1.4211583641411244e-07,0.11122563511022499,0.0
3,0.1,1,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are we overlooking any prognostic indicators? Answer: We present for the first time that ESLD etiology serves as a prognostic factor for survival. Renal function, measured by serum creatinine, and urinary sodium levels below 5 mEq/l at diagnosis were linked to outcomes.",4.737194547137081e-08,0.04445176257083272,0.0,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
3,0.1,2,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: could there be missing prognostic factors? Answer: We identify ESLD etiology as a novel prognostic factor for survival. Renal function, indicated by serum creatinine, and urinary Na under 5 mEq/l at diagnosis correlated with prognosis.",2.1317375462116834e-07,0.21772348384486895,0.0,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
3,0.1,3,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are some prognostic factors being missed? Answer: For the first time, we report ESLD etiology as a survival prognostic factor. Renal function (serum creatinine) and urinary sodium less than 5 mEq/l at diagnosis were associated with prognosis.",1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
3,0.1,4,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: might we be missing prognostic factors? Answer: We reveal ESLD etiology as a prognostic factor for survival for the first time. Renal function, expressed by serum creatinine, and urinary Na below 5 mEq/l at diagnosis were found to be linked.",9.474389094274162e-08,0.09097177820572666,0.0,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
3,0.1,5,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are there overlooked prognostic factors? Answer: We report ESLD etiology as a prognostic factor for survival for the first time. Renal function (serum creatinine) and urinary sodium under 5 mEq/l at diagnosis were associated with outcomes.,1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
3,0.1,6,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: could some prognostic factors be missing? Answer: We demonstrate for the first time that ESLD etiology is a prognostic factor for survival. Renal function, measured by serum creatinine, and urinary Na less than 5 mEq/l at diagnosis were related to prognosis.",7.105791820705622e-08,0.06744128079553224,0.0,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
3,0.1,7,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are we missing key prognostic factors? Answer: We report ESLD etiology as a survival prognostic factor for the first time. Renal function (serum creatinine) and urinary sodium below 5 mEq/l at diagnosis were found to be associated.,1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
3,0.1,8,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are some prognostic factors overlooked? Answer: For the first time, we identify ESLD etiology as a prognostic factor for survival. Renal function, expressed as serum creatinine, and urinary Na under 5 mEq/l at diagnosis were linked to prognosis.",1.4211583641411244e-07,0.13976194237515838,0.0,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
3,0.1,9,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: might some prognostic factors be missed? Answer: We present ESLD etiology as a prognostic factor for survival for the first time. Renal function (serum creatinine) and urinary sodium less than 5 mEq/l at diagnosis were associated with outcomes.,1.4211583641411244e-07,0.13976194237515838,0.0,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
3,0.1,10,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are we neglecting prognostic factors? Answer: We report for the first time that ESLD etiology is a prognostic factor for survival. Renal function, indicated by serum creatinine, and urinary Na below 5 mEq/l at diagnosis were found to be related.",9.474389094274162e-08,0.09097177820572666,0.0,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
4,0.1,1,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Is Aripiprazole a novel risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The review indicated that aripiprazole may trigger pathological gambling, an impulse control disorder also seen with other atypical antipsychotics. Additional research is necessary to clarify the risk factors and mechanisms behind this effect.",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
4,0.1,2,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Could Aripiprazole be a new risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed alongside existing case reports. The review revealed that aripiprazole can cause pathological gambling, an impulse control disorder noted with other atypical antipsychotics. More studies are required to fully understand the underlying risk factors and mechanisms.",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
4,0.1,3,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Aripiprazole: is it a new risk factor for pathological gambling? Answer: Adverse drug reactions were examined in relation to other published case reports. The review demonstrated that aripiprazole may induce pathological gambling, an impulse control disorder observed with other atypical antipsychotics. Further investigation is needed to comprehend the risk factors and mechanisms involved.",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
4,0.1,4,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Does Aripiprazole represent a new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated against previously reported cases. The review found that aripiprazole can lead to pathological gambling, an impulse control disorder also associated with other atypical antipsychotics. Further research is essential to understand the risk factors and mechanisms at play.",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
4,0.1,5,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Is Aripiprazole a potential new risk factor for pathological gambling? Answer: Adverse drug reactions were reviewed alongside other case reports. The findings showed that aripiprazole might cause pathological gambling, an impulse control disorder seen with other atypical antipsychotics. More research is needed to fully elucidate the risk factors and mechanisms.",1.4211583641411244e-07,0.08857342885843433,0.017851239669421492,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
4,0.1,6,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Aripiprazole as a new risk factor for pathological gambling? Answer: Adverse drug reactions were compared with other documented case reports. The review suggested that aripiprazole can provoke pathological gambling, an impulse control disorder observed with other atypical antipsychotics. Additional studies are required to better understand the risk factors and mechanisms involved.",1.1842986367842703e-07,0.09595304393715409,0.001748760330578504,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
4,0.1,7,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Could Aripiprazole be linked as a new risk factor for pathological gambling? Answer: Adverse drug reactions were contrasted with previously published case reports. The review indicated that aripiprazole may induce pathological gambling, an impulse control disorder also reported with other atypical antipsychotics. Further research is necessary to clarify the underlying risk factors and mechanisms.",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
4,0.1,8,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Is there a new risk factor for pathological gambling in Aripiprazole? Answer: Adverse drug reactions were assessed in comparison with other case reports. The review showed that aripiprazole can trigger pathological gambling, an impulse control disorder noted with other atypical antipsychotics. More investigation is needed to fully understand the risk factors and mechanisms.",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
4,0.1,9,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Aripiprazole: a novel risk factor for pathological gambling? Answer: Adverse drug reactions were reviewed alongside existing case reports. The analysis revealed that aripiprazole might cause pathological gambling, an impulse control disorder also seen with other atypical antipsychotics. Further studies are required to elucidate the risk factors and mechanisms.",1.8948778188548325e-07,0.1293954233786887,0.017851239669421492,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
4,0.1,10,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? 
Answer: Adverse drug reactions were confronted with other already published case reports. The review showed that aripiprazole can induce pathological gambling, an impulse control disorder that has been observed with other atypical antipsychotics. Further research is needed to fully understand the risk factors and mechanisms underlying this phenomenon. 
","Question: Is Aripiprazole associated with a new risk factor for pathological gambling? Answer: Adverse drug reactions were examined in the context of other published case reports. The review found that aripiprazole can induce pathological gambling, an impulse control disorder observed with other atypical antipsychotics. Additional research is needed to fully understand the risk factors and mechanisms.",2.3685972735685406e-08,0.006736750945891323,0.017851239669421492,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
5,0.1,1,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Does the ultra high risk (UHR) criteria for psychosis indicate varying levels of risk for developing psychosis? Our findings suggest yes. Individuals classified as UHR due to attenuated psychotic symptoms showed a notably greater risk of progressing to psychosis than those identified by genetic risk or functional decline. This underscores the need for thorough evaluations of UHR individuals, taking into account multiple risk factors.",2.3685972735685406e-07,0.09035371361494082,0.04102040816326531,0.018134264647818782,0.13027764562207889,0.013886133703630227,0.01810801540952868,0.15180601286800588,0.0,2.3685972735685406e-07,0.15415067982725894,0.0
5,0.1,2,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
",Are there different degrees of risk for psychosis transition within the ultra high risk (UHR) criteria? Our research indicates that there are. People who meet UHR criteria because of attenuated psychotic symptoms have a significantly higher chance of transitioning to psychosis than those identified through genetic risk or functional decline. This emphasizes the importance of a detailed assessment for UHR individuals that includes various risk factors.,1.8948778188548325e-07,0.05910117011083926,0.04102040816326531,0.014507411718255037,0.09852894730749906,0.013886133703630227,0.014486412327622947,0.1195451506497811,0.0,1.8948778188548325e-07,0.1213608570042668,0.0
5,0.1,3,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Does the UHR criteria for psychosis reflect different risk levels for developing psychosis? According to our data, yes. Those meeting UHR criteria due to attenuated psychotic symptoms face a much higher risk of psychosis transition compared to individuals meeting criteria based on genetic risk or functional decline. This finding highlights the necessity of comprehensive assessments for UHR individuals, considering multiple risk elements.",2.8423167282822487e-07,0.14534071290070472,0.024631519274376415,0.021761117577382527,0.16306746844507103,0.013886133703630227,0.021729618491434413,0.18514243313559753,0.0,2.8423167282822487e-07,0.18805223150293937,0.0
5,0.1,4,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
",Is there variability in the risk of psychosis transition among individuals meeting ultra high risk (UHR) criteria? Our data suggest so. Individuals identified as UHR through attenuated psychotic symptoms have a significantly elevated risk of developing psychosis relative to those identified by genetic risk or functional decline. This points to the importance of thorough evaluations that consider multiple risk factors for UHR individuals.,2.6054570009253947e-07,0.12871364143106057,0.024895710501346466,0.019947691112600655,0.1465381664938601,0.013886133703630227,0.019918816950481547,0.16833531481921682,0.0,2.6054570009253947e-07,0.17095779814363965,0.0
5,0.1,5,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Are different levels of risk for psychosis transition present within the ultra high risk (UHR) criteria? Our findings indicate yes. Those who meet UHR criteria based on attenuated psychotic symptoms exhibit a substantially higher risk of transitioning to psychosis than those meeting criteria due to genetic risk or functional decline. This stresses the importance of comprehensive assessments for UHR individuals, incorporating various risk factors.",2.3685972735685406e-07,0.09035371361494082,0.04102040816326531,0.018134264647818782,0.13027764562207889,0.013886133703630227,0.01810801540952868,0.15180601286800588,0.0,2.3685972735685406e-07,0.15415067982725894,0.0
5,0.1,6,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Does the ultra high risk (UHR) classification for psychosis include varying risks of transition? Our data affirm this. Individuals meeting UHR criteria through attenuated psychotic symptoms have a significantly greater risk of psychosis onset compared to those identified by genetic risk or functional decline. This highlights the need for a broad assessment approach for UHR individuals, considering multiple risk factors.",3.316036182995957e-07,0.15595099610075724,0.04102040816326531,0.025387970506946272,0.19696902012075146,0.013886133703630227,0.025351221573340146,0.21962860920676608,0.0,3.316036182995957e-07,0.22314355131420882,0.0
5,0.1,7,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Are there distinct risk levels for psychosis transition within the ultra high risk (UHR) criteria? Our research shows that there are. People meeting UHR criteria due to attenuated psychotic symptoms have a markedly higher risk of developing psychosis than those meeting criteria based on genetic risk or functional decline. This finding underscores the importance of comprehensive evaluations for UHR individuals, taking multiple risk factors into account.",1.8948778188548325e-07,0.05910117011083926,0.04102040816326531,0.014507411718255037,0.09852894730749906,0.013886133703630227,0.014486412327622947,0.1195451506497811,0.0,1.8948778188548325e-07,0.1213608570042668,0.0
5,0.1,8,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Does the ultra high risk (UHR) criteria for psychosis imply different transition risks? Our data suggest yes. Individuals classified as UHR by attenuated psychotic symptoms have a significantly increased risk of psychosis transition compared to those identified through genetic risk or functional decline. This highlights the importance of thorough assessments for UHR individuals, considering various risk factors.",4.026615365066519e-07,0.20813674927132642,0.04102040816326531,0.03082824990129189,0.2500788454346994,0.013886133703630227,0.030783626196198746,0.27369583047704094,0.0,4.026615365066519e-07,0.2782033284972374,0.0
5,0.1,9,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Is there a difference in risk levels for psychosis transition among those meeting ultra high risk (UHR) criteria? Our findings suggest so. Individuals meeting UHR criteria based on attenuated psychotic symptoms show a significantly higher risk of transitioning to psychosis than those meeting criteria due to genetic risk or functional decline. This emphasizes the need for comprehensive assessments of UHR individuals, incorporating multiple risk factors.",2.1317375462116866e-07,0.09626620603930114,0.025399344923154453,0.01632083818303691,0.11427730427563532,0.013886133703630227,0.016297213868575813,0.13554549199622468,0.0,2.1317375462116866e-07,0.137621377876048,0.0
5,0.1,10,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? 
Answer: Our data suggest that there are. We found that individuals meeting UHR criteria based on attenuated psychotic symptoms had a significantly higher risk of transition to psychosis compared to those meeting criteria based on genetic risk or functional decline. This finding highlights the importance of a comprehensive assessment for UHR individuals, considering multiple risk factors. 
","Do the ultra high risk (UHR) criteria for psychosis indicate varying risks of transition? Our data indicate that they do. Individuals meeting UHR criteria through attenuated psychotic symptoms have a significantly greater risk of developing psychosis compared to those identified by genetic risk or functional decline. This finding highlights the importance of a thorough assessment approach for UHR individuals, considering multiple risk factors.",2.6054570009253947e-07,0.10635405496138439,0.04102040816326531,0.019947691112600655,0.1465381664938601,0.013886133703630227,0.019918816950481547,0.16833531481921682,0.0,2.6054570009253947e-07,0.17095779814363965,0.0
6,0.1,1,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: This inquiry explores the key issue of determining the best duration of acid suppression therapy for patients suffering from severe reflux oesophagitis. Identifying the ideal length of acid suppression needed to maximize healing is vital for enhancing treatment effectiveness and avoiding unnecessarily extended therapy.,4.737194547137081e-08,0.02445589808630011,0.02808308771678736,0.0036268529295637453,0.023393693977673102,0.029414349460514216,0.003621603081905733,0.05163295505101928,0.015380859375,4.737194547137081e-08,0.0307716586667528,0.0
6,0.1,2,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: This question addresses the important topic of finding the optimal acid suppression period for patients with severe reflux oesophagitis. Knowing the best duration for acid suppression to achieve maximum healing is critical for improving patient outcomes and preventing overly long treatment.,2.3685972735685406e-08,0.025598716665721,0.029683415611614986,0.0018134264647818726,0.026741447903147808,0.0302734375,0.0018108015409528666,0.0058234190197259394,0.015380859375,2.3685972735685406e-08,0.015748356968136257,0.0
6,0.1,3,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: This question investigates the essential aspect of optimizing the length of acid suppression therapy in patients with severe reflux oesophagitis. Understanding the optimal treatment duration is key to maximizing healing and reducing unnecessary prolonged medication use.,1.4211583641411244e-07,0.04869751311028381,0.058457643114487715,0.010880558788691236,0.07640616578905401,0.013611558729531743,0.0108648092457172,0.07552222043422674,0.015380859375,1.4211583641411244e-07,0.0984400728132524,0.0
6,0.1,4,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: This inquiry focuses on the critical issue of determining the most effective duration of acid suppression for patients with severe reflux oesophagitis. Establishing the optimal time frame is important for enhancing healing outcomes and minimizing excessive therapy.,1.1842986367842703e-07,0.07642306398212817,0.026997578438606673,0.009067132323909363,0.08222423195425677,0.002475772497127271,0.009054007704764333,0.08182000813651058,0.0012810193954682567,1.1842986367842703e-07,0.08134563945395268,0.0
6,0.1,5,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: This question explores the vital concern of how long acid suppression should be administered to patients with severe reflux oesophagitis to achieve the best healing results. Identifying the optimal duration is essential for improving treatment success and avoiding unnecessary extended therapy.,2.3685972735685406e-08,0.054531178860941054,0.07605892411753215,0.0018134264647818726,0.026741447903147808,0.0302734375,0.0018108015409528666,0.0058234190197259394,0.015380859375,2.3685972735685406e-08,0.015748356968136257,0.0
6,0.1,6,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
","Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: This question examines the important issue of the ideal length of acid suppression therapy for patients with severe reflux oesophagitis. Understanding the optimal treatment period is crucial for maximizing healing and preventing prolonged, unnecessary treatment.",1.6580180914979784e-07,0.06598435296374561,0.05791315513301807,0.012693985253473108,0.09360489268202254,0.013329323350178359,0.012675610786670066,0.09261665379352646,0.015380859375,1.6580180914979784e-07,0.11583181552512123,0.0
6,0.1,7,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: This question delves into the significant topic of determining the optimal duration of acid suppression in severe reflux oesophagitis cases. Knowing the best time frame for therapy is key to achieving maximal healing and reducing unnecessary prolonged treatment.,9.474389094274162e-08,0.014993721554438011,0.05949494770984127,0.0072537058591274906,0.042871023417073495,0.014148739838081157,0.007243206163811466,0.04218580016663509,0.015380859375,9.474389094274162e-08,0.06453852113757197,0.0
6,0.1,8,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: This inquiry addresses the essential question of how long acid suppression should be maintained for patients with severe reflux oesophagitis to ensure maximal healing. Identifying the optimal duration is important for improving outcomes and minimizing excessive therapy.,1.1842986367842703e-07,0.009344304573100537,0.07508215544969614,0.009067132323909363,0.036771957819178525,0.0302734375,0.009054007704764333,0.05871510211784603,0.015380859375,1.1842986367842703e-07,0.08134563945395268,0.0
6,0.1,9,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: This question investigates the critical aspect of optimizing acid suppression duration in patients with severe reflux oesophagitis. Understanding the ideal treatment length is vital for maximizing healing and avoiding unnecessary prolonged therapy.,2.3685972735685406e-07,0.09538878901782333,0.07366858780549254,0.018134264647818726,0.12229413125733934,0.0302734375,0.018108015409528666,0.14572647910747438,0.015380859375,2.3685972735685406e-07,0.16989903679539609,0.0
6,0.1,10,ai,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? 

Answer:This question delves into the crucial aspect of optimizing acid suppression therapy for patients with severe reflux oesophagitis.  Understanding the optimal duration of acid suppression for achieving maximal healing in these patients is essential for improving treatment outcomes and minimizing unnecessary prolonged therapy. 
",Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: This question focuses on the key issue of determining the optimal acid suppression period for patients with severe reflux oesophagitis. Knowing the best duration for therapy is essential for enhancing healing outcomes and preventing overly extended treatment.,1.1842986367842703e-07,0.009344304573100537,0.07508215544969614,0.009067132323909363,0.036771957819178525,0.0302734375,0.009054007704764333,0.05871510211784603,0.015380859375,1.1842986367842703e-07,0.08134563945395268,0.0
7,0.1,1,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it possible to predict discordance between TEOAE and AABR results in newborns? Given current screening methods, some degree of discordance between TEOAE and AABR outcomes may be unavoidable in certain types of hearing loss among seemingly healthy newborns whose mothers had prenatal care. This suggests that the limitations of using perinatal morbidities as criteria for targeted screening in these cases deserve more investigation.",1.8948778188548325e-07,0.09819355560487297,0.026888375066436557,0.014507411718254981,0.09674369687030548,0.029750067727680834,0.014486412327622933,0.09512967648611115,0.03274920999712727,1.8948778188548325e-07,0.119995937622007,0.016661878770468257
7,0.1,2,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can discordant results between TEOAE and AABR in newborns be anticipated? With the screening technologies available, discordance between TEOAE and AABR may be inevitable in some hearing loss categories among apparently healthy newborns whose mothers received prenatal care. Therefore, the potential shortcomings of relying on perinatal morbidities for targeted screening in such cases warrant further study.",0.0,0.025205352020361893,0.01805205057286282,0.0,0.025672117798516858,0.018470322568413872,0.0,0.02615649737962089,0.018860946745562133,0.0,0.0,0.0
7,0.1,3,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is discordance in TEOAE and AABR outcomes predictable in newborn infants? Considering current screening technologies, discordant TEOAE and AABR results may be unavoidable for certain types of hearing loss in apparently healthy newborns whose mothers had prenatal care. Hence, the limitations of using perinatal morbidities as a basis for targeted screening in these cases should be further explored.",4.737194547137081e-08,0.03748687923508642,0.0012705324385313826,0.0036268529295637453,0.0372845055208213,0.0006606862828746896,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
7,0.1,4,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can we predict when TEOAE and AABR results will be discordant in newborns? Given the screening tools available, some discordance between TEOAE and AABR outcomes may be inevitable in certain hearing loss categories among apparently healthy newborns whose mothers underwent prenatal care. This indicates that the potential limitations of perinatal morbidity-based targeted screening need further examination.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
7,0.1,5,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it feasible to predict discordance between TEOAE and AABR outcomes in newborns? With current screening technologies, discordant results between TEOAE and AABR may be unavoidable in some types of hearing loss among apparently healthy newborns whose mothers received prenatal care. Therefore, the limitations of using perinatal morbidities as a basis for targeted screening in these cases merit additional research.",9.474389094274162e-08,0.05012541892821387,0.014389675859663914,0.0072537058591274906,0.04932782794894042,0.01592684955790791,0.007243206163811466,0.04843840057857163,0.017538265306122455,9.474389094274162e-08,0.07410797215372167,0.0
7,0.1,6,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Are discordant TEOAE and AABR outcomes in newborns predictable? Given the available screening technologies, some discordance between TEOAE and AABR may be inevitable for certain hearing loss categories in apparently healthy newborns whose mothers had prenatal care. Thus, the potential limitations of perinatal morbidity-based targeted screening in such cases deserve further investigation.",9.474389094274162e-08,0.07946133321722204,0.0028384992665777056,0.0072537058591274906,0.07901481056001103,0.0014797441851465525,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
7,0.1,7,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it possible to foresee discordance in TEOAE and AABR results among newborns? Considering current screening technologies, discordant TEOAE and AABR outcomes may be unavoidable in some hearing loss categories among apparently healthy newborns whose mothers received prenatal care. This suggests that the limitations of targeted screening based on perinatal morbidities warrant further study.",4.737194547137081e-08,0.03894356239886809,0.0013659614719480281,0.0036268529295637453,0.03872771712894396,0.0007114496724635287,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
7,0.1,8,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can discordance between TEOAE and AABR outcomes in newborns be predicted? Given the screening technologies available, discordant results may be inevitable for certain hearing loss types among apparently healthy newborns whose mothers had prenatal care. Therefore, the potential limitations of using perinatal morbidities as a basis for targeted screening merit further research.",9.474389094274162e-08,0.02509684846742255,0.03631185475258099,0.0072537058591274906,0.051288923337613035,0.01851192595229618,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
7,0.1,9,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is predicting discordance in TEOAE and AABR outcomes in newborns achievable? With current screening technologies, some discordance between TEOAE and AABR may be unavoidable in certain hearing loss categories among apparently healthy newborns whose mothers received prenatal care. Hence, the limitations of perinatal morbidity-based targeted screening in these cases should be further examined.",7.105791820705622e-08,0.05899777649954663,0.0020881452474190224,0.005440279394345618,0.058668538416332794,0.001088074047703811,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
7,0.1,10,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can we anticipate discordance in TEOAE and AABR results in newborns? Given the available screening technologies, discordant TEOAE and AABR outcomes may be inevitable for some types of hearing loss among apparently healthy newborns whose mothers underwent prenatal care. This highlights the need to further investigate the limitations of targeted screening based on perinatal morbidities.",2.3685972735685406e-08,0.019282670224506138,0.0006703937681290656,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
8,0.1,1,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This article explores whether culture, attitudes, and faith have a role in recovery outcome measures, focusing on the cultural suitability of the RAQ in Australia and emphasizing the need for comprehensive, inclusive recovery metrics.",7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
8,0.1,2,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper examines the relevance of culture, attitudes, and faith in recovery outcome assessments, highlighting the cultural fit of the RAQ within Australian contexts and the necessity for robust, inclusive recovery measures.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.1,3,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This study addresses the question of incorporating culture, attitudes, and faith into recovery outcome measures, analyzing the RAQ's cultural appropriateness in Australia and calling for the creation of rigorous, inclusive recovery tools.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.1,4,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The discussion centers on the place of culture, attitudes, and faith in recovery outcome measures, evaluating the RAQ's suitability for Australian populations and advocating for the development of thorough, inclusive recovery assessments.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.1,5,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This research considers whether culture, attitudes, and faith should be included in recovery outcome measures, assessing the RAQ's cultural relevance in Australia and underscoring the importance of developing rigorous, inclusive recovery metrics.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.1,6,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The paper investigates the role of culture, attitudes, and faith in recovery outcome measures, focusing on the RAQ's cultural appropriateness in Australian settings and the need for comprehensive, inclusive recovery outcome tools.",1.184298636784265e-07,0.15574273021253981,0.004467120181405871,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.1,7,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This work explores the integration of culture, attitudes, and faith into recovery outcome measures, reviewing the RAQ's fit within Australian cultural contexts and highlighting the demand for rigorous, inclusive recovery measures.",1.421158364141118e-07,0.1438133800961805,0.02775510204081633,0.010880558788691277,0.18805223150294026,0.0,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
8,0.1,8,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The article discusses the significance of culture, attitudes, and faith in recovery outcome measures, examining the RAQ's cultural suitability in Australia and emphasizing the necessity for inclusive, rigorous recovery assessments.",1.658018091497971e-07,0.17771493177186226,0.02775510204081633,0.012693985253473157,0.22314355131420927,0.0,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
8,0.1,9,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This paper analyzes the inclusion of culture, attitudes, and faith in recovery outcome measures, considering the RAQ's cultural appropriateness in Australian environments and advocating for the development of inclusive, rigorous recovery tools.",1.184298636784265e-07,0.1110235572731888,0.02775510204081633,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
8,0.1,10,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The study evaluates the place of culture, attitudes, and faith in recovery outcome measures, focusing on the RAQ's cultural fit in Australia and the importance of creating rigorous, inclusive recovery outcome measures.",1.184298636784265e-07,0.15574273021253981,0.004467120181405871,0.009067132323909398,0.1541506798272585,0.0,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
9,0.1,1,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","This study explored whether diffusion-weighted echo-planar MR imaging (DW-EPI) can distinguish different histologic subtypes of primary parotid gland tumors, finding it may differentiate benign from malignant tumors, though more research is required to confirm its accuracy for specific subtypes.",7.10579182070562e-07,0.4596014547626712,0.0874089490114464,0.05440279394345618,0.511010864291821,0.05946082136558325,0.054324046228586,0.5641268835363786,0.0302734375,7.105791820705622e-07,0.6190392084062233,0.0
9,0.1,2,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","The research assessed the ability of diffusion-weighted echo-planar MR imaging (DW-EPI) to predict various histologic subtypes of primary parotid gland tumors, indicating potential to separate benign and malignant tumors but needing further validation for precise subtype identification.",7.579511275419326e-07,0.5136686760329474,0.0874089490114464,0.058029646873019924,0.5665807154466331,0.05946082136558325,0.05794564931049174,0.621285297376327,0.0302734375,7.57951127541933e-07,0.6778797084291566,0.0
9,0.1,3,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","Investigation into diffusion-weighted echo-planar MR imaging (DW-EPI) revealed it might help differentiate benign from malignant primary parotid gland tumors, though its effectiveness in predicting exact histologic subtypes remains to be fully established.",8.763809912203591e-07,0.6632004100039111,0.0874089490114464,0.06709677919692933,0.7207313952738916,0.05946082136558325,0.0669996570152561,0.7803499920060157,0.0302734375,8.7638099122036e-07,0.8421827597204325,0.0
9,0.1,4,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","This study evaluated diffusion-weighted echo-planar MR imaging (DW-EPI) for its capability to distinguish histologic subtypes of primary parotid gland tumors, suggesting it can separate benign and malignant tumors, but additional studies are necessary to verify its predictive accuracy for specific subtypes.",6.632072365991914e-07,0.4083081603751215,0.0874089490114464,0.050775941013892434,0.4583671308064021,0.05946082136558325,0.050702443146680265,0.5100596622661024,0.0302734375,6.632072365991914e-07,0.5634693572514111,0.0
9,0.1,5,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","Diffusion-weighted echo-planar MR imaging (DW-EPI) was studied for its potential to differentiate between histologic subtypes of primary parotid gland tumors, showing promise in distinguishing benign from malignant tumors, yet requiring further research to confirm its subtype prediction accuracy.",7.342651548062473e-07,0.4862697018448321,0.0874089490114464,0.05621622040823805,0.5384098384799363,0.05946082136558325,0.056134847769538865,0.5922977605030755,0.0302734375,7.342651548062476e-07,0.6480267452794748,0.0
9,0.1,6,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","The potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to classify different histologic subtypes of primary parotid gland tumors was investigated, with findings indicating it may differentiate benign and malignant tumors, but more research is needed for precise subtype prediction.",7.10579182070562e-07,0.4596014547626712,0.0874089490114464,0.05440279394345618,0.511010864291821,0.05946082136558325,0.054324046228586,0.5641268835363786,0.0302734375,7.105791820705622e-07,0.6190392084062233,0.0
9,0.1,7,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","This research focused on diffusion-weighted echo-planar MR imaging (DW-EPI) as a tool to predict histologic subtypes of primary parotid gland tumors, demonstrating possible discrimination between benign and malignant tumors, though further studies are needed to assess its accuracy for specific subtypes.",6.632072365991914e-07,0.4083081603751215,0.0874089490114464,0.050775941013892434,0.4583671308064021,0.05946082136558325,0.050702443146680265,0.5100596622661024,0.0302734375,6.632072365991914e-07,0.5634693572514111,0.0
9,0.1,8,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","The study examined whether diffusion-weighted echo-planar MR imaging (DW-EPI) can predict various histologic subtypes of primary parotid gland tumors, finding it potentially useful for distinguishing benign from malignant tumors but requiring additional research for subtype specificity.",7.816371002776179e-07,0.5418395529996443,0.0874089490114464,0.059843073337801804,0.5955682523198846,0.05946082136558325,0.05975645085144461,0.6511382605260088,0.0302734375,7.816371002776184e-07,0.7086513670959103,0.0
9,0.1,9,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","Diffusion-weighted echo-planar MR imaging (DW-EPI) was analyzed for its ability to differentiate histologic subtypes of primary parotid gland tumors, showing potential to separate benign and malignant tumors, but further investigation is necessary to confirm its accuracy in subtype prediction.",7.10579182070562e-07,0.4596014547626712,0.0874089490114464,0.05440279394345618,0.511010864291821,0.05946082136558325,0.054324046228586,0.5641268835363786,0.0302734375,7.105791820705622e-07,0.6190392084062233,0.0
9,0.1,10,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?

**Answer:**  epi.  This study investigated the potential of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate between various histological subtypes of primary parotid gland tumors. The results showed that DW-EPI could potentially discriminate between benign and malignant tumors, but further research is needed to determine its accuracy in predicting specific histological subtypes. 
","This study investigated the use of diffusion-weighted echo-planar MR imaging (DW-EPI) to differentiate histologic subtypes of primary parotid gland tumors, suggesting it may distinguish benign from malignant tumors, though more research is needed to validate its predictive accuracy for specific subtypes.",6.632072365991914e-07,0.4083081603751215,0.0874089490114464,0.050775941013892434,0.4583671308064021,0.05946082136558325,0.050702443146680265,0.5100596622661024,0.0302734375,6.632072365991914e-07,0.5634693572514111,0.0
10,0.1,1,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Is there a correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight infants during their first week?,1.4685303096124926e-06,1.2043372541865445,0.13995644559419418,0.11243244081647641,1.2572568239897675,0.05928537093414515,0.11226969553907784,1.340913486672699,0.024081694863587855,1.468530309612495e-06,1.3940809449161184,0.012193263222069812
10,0.1,2,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Does measuring end-tidal carbon dioxide reflect arterial carbon dioxide levels in extremely low birth weight newborns within the initial week of life?,1.515902255083863e-06,1.3010493817136792,0.1358448753462603,0.11605929374604018,1.3525670037940927,0.05928537093414515,0.11589129862098359,1.4409969452296805,0.024081694863587855,1.5159022550838656e-06,1.499441460573944,0.012193263222069812
10,0.1,3,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
","In extremely low birth weight infants, how well does end-tidal carbon dioxide measurement correspond to arterial carbon dioxide in the first week after birth?",1.4685303096124926e-06,1.2043372541865445,0.13995644559419418,0.11243244081647641,1.2572568239897675,0.05928537093414515,0.11226969553907784,1.340913486672699,0.024081694863587855,1.468530309612495e-06,1.3940809449161184,0.012193263222069812
10,0.1,4,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Is end-tidal carbon dioxide an accurate indicator of arterial carbon dioxide in extremely low birth weight infants during their first week?,1.5395882278195484e-06,1.35314024674292,0.13348337950138497,0.11787272021082205,1.4038602981816428,0.05928537093414515,0.11770210016193647,1.4950641664999558,0.024081694863587855,1.539588227819551e-06,1.5565998744138927,0.012193263222069812
10,0.1,5,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",What is the relationship between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants in their first week of life?,1.4685303096124926e-06,1.2043372541865445,0.13995644559419418,0.11243244081647641,1.2572568239897675,0.05928537093414515,0.11226969553907784,1.340913486672699,0.024081694863587855,1.468530309612495e-06,1.3940809449161184,0.012193263222069812
10,0.1,6,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Does end-tidal carbon dioxide measurement reliably correlate with arterial carbon dioxide in extremely low birth weight infants during their first week?,1.5395882278195484e-06,1.35314024674292,0.13348337950138497,0.11787272021082205,1.4038602981816428,0.05928537093414515,0.11770210016193647,1.4950641664999558,0.024081694863587855,1.539588227819551e-06,1.5565998744138927,0.012193263222069812
10,0.1,7,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",How closely does end-tidal carbon dioxide track arterial carbon dioxide in extremely low birth weight infants within the first week of life?,1.515902255083863e-06,1.3010493817136792,0.1358448753462603,0.11605929374604018,1.3525670037940927,0.05928537093414515,0.11589129862098359,1.4409969452296805,0.024081694863587855,1.5159022550838656e-06,1.499441460573944,0.012193263222069812
10,0.1,8,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Is there a consistent correlation between end-tidal and arterial carbon dioxide levels in extremely low birth weight infants during their first week?,1.515902255083863e-06,1.2350353645174943,0.18334487534626032,0.11605929374604018,1.3525670037940927,0.05928537093414515,0.11589129862098359,1.4409969452296805,0.024081694863587855,1.5159022550838656e-06,1.499441460573944,0.012193263222069812
10,0.1,9,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",Can end-tidal carbon dioxide be used as a proxy for arterial carbon dioxide in extremely low birth weight infants in the first week of life?,1.4448443368768072e-06,1.1592662369396312,0.14175697364493706,0.11061901435169454,1.2128050614189334,0.05928537093414515,0.11045889399812497,1.294393471037805,0.024081694863587855,1.4448443368768096e-06,1.3452907807466872,0.012193263222069812
10,0.1,10,ai,"Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? 

Answer: There is limited evidence on the correlation between end-tidal carbon dioxide (ETCO2) and arterial carbon dioxide (PaCO2) in extremely low birth weight (ELBW) infants. Studies have shown varying degrees of correlation, with some suggesting a strong association while others finding a weaker correlation. Further research is needed to determine the reliability of ETCO2 as a proxy for PaCO2 in this vulnerable population. 
",What evidence exists regarding the correlation between end-tidal and arterial carbon dioxide in extremely low birth weight infants during their first week?,1.515902255083863e-06,1.2350353645174943,0.18334487534626032,0.11605929374604018,1.3525670037940927,0.05928537093414515,0.11589129862098359,1.4409969452296805,0.024081694863587855,1.5159022550838656e-06,1.499441460573944,0.012193263222069812
11,0.1,1,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does having both major depression and alcohol use disorder during adolescence result in worse depression outcomes? Answer: The findings indicate that slightly elevated depression rates up to age 35 in the comorbid MD/AUD group were due to greater exposure to adverse childhood conditions within this group. Adolescent MD/AUD comorbidity is likely to be,1.4211583641411244e-07,0.08374901575834537,0.01694411414982164,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
11,0.1,2,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,"Question: In adolescents, does the coexistence of major depression and alcohol use disorder lead to poorer depression outcomes? Answer: Analysis shows that the marginally increased depression rates by age 35 in the comorbid MD/AUD group can be attributed to higher exposure to adverse childhood experiences among these individuals. Adolescent MD/AUD comorbidity is likely to be",1.1842986367842703e-07,0.06505688274619104,0.01694411414982164,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
11,0.1,3,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does comorbidity of major depression and alcohol use disorder in adolescence cause worse depression outcomes? Answer: Results suggest that the slightly higher depression rates up to age 35 in the comorbid MD/AUD group were explained by increased adverse childhood exposures in this group. Adolescent MD/AUD comorbidity is likely to be,2.1317375462116866e-07,0.14201792388232093,0.01694411414982164,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
11,0.1,4,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Are depression outcomes poorer in adolescents with both major depression and alcohol use disorder? Answer: The analyses suggest that the marginally elevated depression rates through age 35 in the comorbid MD/AUD group stem from greater exposure to adverse childhood circumstances among them. Adolescent MD/AUD comorbidity is likely to be,2.3685972735685406e-07,0.16222063119983954,0.01694411414982164,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
11,0.1,5,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does having major depression and alcohol use disorder together in adolescence lead to worse depression outcomes? Answer: Findings indicate that the slightly higher depression rates by age 35 in the comorbid MD/AUD group were due to increased adverse childhood experiences in this group. Adolescent MD/AUD comorbidity is likely to be,2.1317375462116866e-07,0.14201792388232093,0.01694411414982164,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
11,0.1,6,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,"Question: In adolescence, does the combination of major depression and alcohol use disorder result in poorer depression outcomes? Answer: The results show that marginally higher depression rates up to age 35 in the comorbid MD/AUD group were explained by greater exposure to adverse childhood conditions among these individuals. Adolescent MD/AUD comorbidity is likely to be",1.1842986367842703e-07,0.06505688274619104,0.01694411414982164,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
11,0.1,7,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does the presence of both major depression and alcohol use disorder in adolescence worsen depression outcomes? Answer: Analyses suggest that the slightly elevated depression rates through age 35 in the comorbid MD/AUD group were due to increased adverse childhood exposures within this group. Adolescent MD/AUD comorbidity is likely to be,2.1317375462116866e-07,0.14201792388232093,0.01694411414982164,0.016320838183036854,0.1686227124357922,0.0,0.0162972138685758,0.17185025692665912,0.0,2.1317375462116866e-07,0.17520408902509166,0.0
11,0.1,8,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Are depression outcomes negatively impacted by comorbid major depression and alcohol use disorder in adolescence? Answer: The findings suggest that marginally higher depression rates by age 35 in the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances among members of this group. Adolescent MD/AUD comorbidity is likely to be,1.4211583641411244e-07,0.08374901575834537,0.01694411414982164,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
11,0.1,9,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does comorbidity of major depression and alcohol use disorder during adolescence lead to poorer depression outcomes? Answer: Results indicate that the slightly higher depression rates up to age 35 in the comorbid MD/AUD group were due to greater exposure to adverse childhood experiences among these individuals. Adolescent MD/AUD comorbidity is likely to be,1.4211583641411244e-07,0.08374901575834537,0.01694411414982164,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
11,0.1,10,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Is depression outcome worse in adolescents with both major depression and alcohol use disorder? Answer: The analyses suggest that the marginally elevated depression rates through age 35 in the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances within this group. Adolescent MD/AUD comorbidity is likely to be,1.8948778188548325e-07,0.12221529658614116,0.01694411414982164,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
12,0.1,1,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Does having an optimistic perspective predict improved survival rates in advanced age?,9.474389094274137e-07,1.4795658751761551,0.039150354019158694,0.07253705859127504,1.581712025211702,0.019991670137442734,0.07243206163811484,1.6945957207744073,0.0,9.474389094274156e-07,1.7917594692280554,0.0
12,0.1,2,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Is a positive outlook linked to better longevity among the elderly?,9.711248821630991e-07,1.5748760549804803,0.039150354019158694,0.07435048505605693,1.687072540869528,0.019991670137442734,0.07424286317906771,1.8123787564307912,0.0,9.71124882163101e-07,1.9252908618525773,0.0
12,0.1,3,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Can optimism serve as a predictor for longer life spans in older adults?,9.237529366917283e-07,1.392554498186525,0.039150354019158694,0.07072363212649317,1.4864018454073769,0.019991670137442734,0.07062126009716196,1.5892352051165815,0.0,9.237529366917302e-07,1.6739764335716716,0.0
12,0.1,4,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Does maintaining optimism contribute to increased survival at older ages?,9.948108548987843e-07,1.6802365706383062,0.039150354019158694,0.0761639115208388,1.8048555765259118,0.019991670137442734,0.07605366472002059,1.945910149055313,0.0,9.948108548987862e-07,2.079441541679836,0.0
12,0.1,5,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Is there a correlation between optimism and enhanced longevity in senior populations?,9.474389094274137e-07,1.4795658751761551,0.039150354019158694,0.07253705859127504,1.581712025211702,0.019991670137442734,0.07243206163811484,1.6945957207744073,0.0,9.474389094274156e-07,1.7917594692280554,0.0
12,0.1,6,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Does an optimistic attitude forecast greater survival chances in advanced years?,9.711248821630991e-07,1.5748760549804803,0.039150354019158694,0.07435048505605693,1.687072540869528,0.019991670137442734,0.07424286317906771,1.8123787564307912,0.0,9.71124882163101e-07,1.9252908618525773,0.0
12,0.1,7,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Are older adults with a positive mindset more likely to live longer?,9.474389094274137e-07,1.4795658751761551,0.039150354019158694,0.07253705859127504,1.581712025211702,0.019991670137442734,0.07243206163811484,1.6945957207744073,0.0,9.474389094274156e-07,1.7917594692280554,0.0
12,0.1,8,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Does a hopeful outlook influence survival rates among the elderly?,9.948108548987843e-07,1.6802365706383062,0.039150354019158694,0.0761639115208388,1.8048555765259118,0.019991670137442734,0.07605366472002059,1.945910149055313,0.0,9.948108548987862e-07,2.079441541679836,0.0
12,0.1,9,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Is optimism a key factor in predicting longevity in older individuals?,9.711248821630991e-07,1.5748760549804803,0.039150354019158694,0.07435048505605693,1.687072540869528,0.019991670137442734,0.07424286317906771,1.8123787564307912,0.0,9.71124882163101e-07,1.9252908618525773,0.0
12,0.1,10,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? 
Answer: An optimistic outlook appears to be a significant predictor of longevity in older adults.  Studies show that those with a positive outlook tend to live longer, even after accounting for factors like health status and socioeconomic factors. 
",Can a positive mental outlook predict better survival outcomes in advanced age?,9.474389094274137e-07,1.4795658751761551,0.039150354019158694,0.07253705859127504,1.581712025211702,0.019991670137442734,0.07243206163811484,1.6945957207744073,0.0,9.474389094274156e-07,1.7917594692280554,0.0
13,0.1,1,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse maternal and neonatal outcomes? ACR independently predicts negative outcomes for both mother and newborn in suspected preeclampsia cases and may help assess risk.,1.4211583641411222e-07,0.04243666596083662,0.13296398891966765,0.010880558788691236,0.010914815685533874,0.11426592797783926,0.0108648092457172,0.0221226454348864,0.09418282548476452,1.4211583641411244e-07,0.05678783245002439,0.07271468144044323
13,0.1,2,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia serve as a prognostic indicator for adverse maternal and neonatal outcomes? ACR is an independent predictor of poor maternal and neonatal outcomes in suspected preeclampsia and could be valuable for risk assessment.,0.0,0.0945200700763551,0.06514721319093474,0.0,0.12895761498789637,0.09102329759235173,0.0,0.1320280343923712,0.09418282548476452,0.0,0.10143617276487005,0.07271468144044323
13,0.1,3,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia forecast adverse outcomes for mother and baby? ACR independently forecasts maternal and neonatal complications in suspected preeclampsia and may aid in risk evaluation.,2.3685972735685343e-07,0.06878896914938792,0.13296398891966765,0.01813426464781874,0.10349553549221158,0.11426592797783926,0.018108015409528687,0.13990568109127022,0.09418282548476452,2.3685972735685406e-07,0.1781486894542912,0.07271468144044323
13,0.1,4,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a reliable prognostic marker for maternal and neonatal adverse events? ACR independently predicts adverse maternal and neonatal outcomes in suspected preeclampsia and might be useful for risk stratification.,1.1842986367842692e-07,0.038225875414357624,0.05657510003077876,0.009067132323909363,0.0011016322119083988,0.08796936114073188,0.009054007704764333,0.0052763287532289205,0.09418282548476452,1.1842986367842703e-07,0.028616955483327544,0.07271468144044323
13,0.1,5,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict maternal and neonatal adverse outcomes? ACR is an independent prognostic factor for negative outcomes in both mother and newborn in suspected preeclampsia and may assist in risk assessment.,9.474389094274162e-08,0.09372996034838632,0.13296398891966765,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03194457583538979,0.09418282548476452,9.474389094274162e-08,0.0012179812952122226,0.07271468144044323
13,0.1,6,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia a prognostic factor for adverse maternal and neonatal outcomes? ACR independently predicts poor outcomes for mother and neonate in suspected preeclampsia and could be helpful in informing risk.,9.474389094274162e-08,0.05907260132038994,0.10798042547456574,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03194457583538979,0.09418282548476452,9.474389094274162e-08,0.0012179812952122226,0.07271468144044323
13,0.1,7,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic factor for maternal and neonatal adverse outcomes? ACR is an independent predictor of adverse maternal and neonatal events in suspected preeclampsia and may be useful for risk evaluation.,2.3685972735685406e-08,0.10157181443406404,0.08656303710527145,0.0018134264647818726,0.10465951272658458,0.0904705680730207,0.0018108015409528666,0.10793048281331119,0.09418282548476452,2.3685972735685406e-08,0.07674356017449835,0.07271468144044323
13,0.1,8,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia an independent prognostic factor for maternal and neonatal adverse outcomes? ACR independently forecasts negative outcomes for mother and baby in suspected preeclampsia and might aid in risk assessment.,1.1842986367842692e-07,0.03286614310461067,0.1073407202216067,0.009067132323909363,0.03758306276769474,0.11426592797783926,0.009054007704764333,0.0052763287532289205,0.09418282548476452,1.1842986367842703e-07,0.028616955483327544,0.07271468144044323
13,0.1,9,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia act as a prognostic indicator for adverse maternal and neonatal outcomes? ACR is an independent predictor of maternal and neonatal complications in suspected preeclampsia and may help guide risk assessment.,7.105791820705622e-08,0.050798457762178284,0.08431178642131132,0.005440279394345618,0.054218998127248064,0.08928236453273734,0.0054324046228586,0.05792006223864776,0.09418282548476452,7.105791820705622e-08,0.025450265786948645,0.07271468144044323
13,0.1,10,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a useful prognostic factor for maternal and neonatal adverse outcomes? ACR independently predicts adverse outcomes in mother and neonate in suspected preeclampsia and could be valuable for informing risk.,9.474389094274162e-08,0.05907260132038994,0.10798042547456574,0.0072537058591274906,0.06355854917095272,0.11426592797783926,0.007243206163811466,0.03194457583538979,0.09418282548476452,9.474389094274162e-08,0.0012179812952122226,0.07271468144044323
14,0.1,1,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Are Pap smears showing glandular cell abnormalities identified during rapid prescreening? Yes, such Pap smears are frequently marked as ""abnormal"" in rapid prescreening, prompting a detailed manual examination by a cytotechnologist to assess the significance of the abnormalities or the need for additional analysis.",7.105791820705622e-08,0.051003485144437644,0.08383648918619602,0.005440279394345618,0.023426752587707433,0.06632653061224489,0.0054324046228586,0.007604187163049225,0.045351473922902494,7.105791820705622e-08,0.04008125783265193,0.023242630385487524
14,0.1,2,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are commonly detected as ""abnormal"" in rapid prescreening, which leads to a thorough manual review by a cytotechnologist to evaluate the abnormalities' importance or necessity for further testing.",4.737194547137081e-08,0.04321902706520664,0.06172764564878104,0.0036268529295637453,0.014717846250927646,0.043083900226757364,0.003621603081905733,0.01649336441601079,0.045351473922902494,4.737194547137081e-08,0.01538864524228023,0.023242630385487524
14,0.1,3,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Can rapid prescreening catch glandular cell abnormalities in Pap smears? Yes, Pap smears exhibiting glandular cell abnormalities are typically flagged as ""abnormal"" during rapid prescreening, resulting in a manual review by a cytotechnologist to determine if the abnormalities are significant or require more investigation.",7.105791820705622e-08,0.01347532234951121,0.03770411957168354,0.005440279394345618,0.009580256010384147,0.04253117070742633,0.0054324046228586,0.007604187163049225,0.045351473922902494,7.105791820705622e-08,0.04008125783265193,0.023242630385487524
14,0.1,4,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Are glandular cell abnormalities in Pap smears identified through rapid prescreening? Pap smears with such abnormalities are often labeled ""abnormal"" in rapid prescreening, which then triggers a cytotechnologist to manually review the sample to decide if further examination is needed.",1.6580180914979774e-07,0.04994158993198994,0.08145585087362259,0.012693985253473108,0.07665670596927399,0.06632653061224489,0.012675610786670066,0.1102583412231315,0.045351473922902494,1.6580180914979784e-07,0.14544177349047782,0.023242630385487524
14,0.1,5,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are usually marked as ""abnormal"" during rapid prescreening, prompting a cytotechnologist to conduct a manual review to assess the abnormalities' significance or need for further study.",7.105791820705622e-08,0.01876408139746344,0.06067816775728733,0.005440279394345618,0.009580256010384147,0.04253117070742633,0.0054324046228586,0.007604187163049225,0.045351473922902494,7.105791820705622e-08,0.04008125783265193,0.023242630385487524
14,0.1,6,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Do Pap smears with glandular cell abnormalities get detected by rapid prescreening? These smears are often flagged as ""abnormal"" in rapid prescreening, leading to a manual review by a cytotechnologist to determine if the abnormalities warrant additional investigation.",2.1317375462116834e-07,0.06703931415792486,0.10707911957168353,0.016320838183036854,0.13072392723955018,0.06632653061224489,0.0162972138685758,0.16582819237794366,0.045351473922902494,2.1317375462116866e-07,0.20260018733042617,0.023242630385487524
14,0.1,7,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Are glandular cell abnormalities in Pap smears caught by rapid prescreening? Yes, such abnormalities are frequently identified as ""abnormal"" during rapid prescreening, which initiates a manual cytotechnologist review to evaluate their significance or the need for further analysis.",2.1317375462116834e-07,0.06703931415792486,0.10707911957168353,0.016320838183036854,0.13072392723955018,0.06632653061224489,0.0162972138685758,0.16582819237794366,0.045351473922902494,2.1317375462116866e-07,0.20260018733042617,0.023242630385487524
14,0.1,8,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Does rapid prescreening detect glandular cell abnormalities in Pap smears? Pap smears with these abnormalities are commonly flagged as ""abnormal"" in rapid prescreening, triggering a cytotechnologist to manually review the sample for significance or further testing requirements.",2.3685972735685364e-07,0.09443828834604018,0.10707911957168353,0.018134264647818726,0.15889480420624702,0.06632653061224489,0.018108015409528673,0.19481572925119517,0.045351473922902494,2.3685972735685406e-07,0.23245315048010795,0.023242630385487524
14,0.1,9,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Are Pap smears with glandular cell abnormalities recognized during rapid prescreening? They are often marked as ""abnormal"" in rapid prescreening, which leads to a cytotechnologist performing a manual review to decide if further investigation is necessary.",2.6054570009253894e-07,0.12260916531273702,0.10707911957168353,0.019947691112600606,0.18788234107949853,0.06632653061224489,0.019918816950481547,0.22466869240087695,0.045351473922902494,2.6054570009253947e-07,0.26322480914686164,0.023242630385487524
14,0.1,10,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? 
Answer: Pap smears with glandular cell abnormalities are often flagged as ""abnormal"" during rapid prescreening. This triggers further manual review by a cytotechnologist to determine if the abnormalities are significant or require further investigation. 
","Is the presence of glandular cell abnormalities in Pap smears identified by rapid prescreening? Such smears are typically flagged as ""abnormal"" during rapid prescreening, prompting a cytotechnologist to manually review the abnormalities to determine their significance or the need for additional examination.",1.1842986367842703e-07,0.035614839902157414,0.10707911957168353,0.009067132323909363,0.025363411581724282,0.06632653061224489,0.009054007704764333,0.05761460773771265,0.045351473922902494,1.1842986367842703e-07,0.09137455222020163,0.023242630385487524
15,0.1,1,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Do provider service networks lead to reduced costs compared to HMOs or primary care case management within Florida's Medicaid program? The Medicaid Managed Care Program in Florida has traditionally relied on HMOs and primary care case management as its primary service delivery methods. Although provider service networks (PSNs) have been considered, there is no definitive evidence yet regarding their cost-effectiveness relative to these established models. Additional studies are necessary to assess the financial impact of adopting PSNs in Florida's Medicaid program.",0.0,0.017328679513998857,0.012188500673232336,0.0,0.017548029887595185,0.012573376423514915,0.0,0.0,0.0,0.0,0.0,0.0
15,0.1,2,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Are expenditures lower with provider service networks than with HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Managed Care Program has mainly utilized HMOs and primary care case management for service delivery. Provider service networks (PSNs) have been investigated, but no conclusive data exists comparing their cost efficiency to current models. More research is required to evaluate the potential cost effects of implementing PSNs in Florida's Medicaid system.",2.1317375462116866e-07,0.1616178747349073,0.05590975017920123,0.01632083818303698,0.1299773115027092,0.006444077134986216,0.016297213868575813,0.12492054008752085,0.001671268896474492,2.1317375462116866e-07,0.12429771667757539,0.0
15,0.1,3,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Does the use of provider service networks reduce spending compared to HMOs or primary care case management in Florida's Medicaid program? Historically, Florida's Medicaid Managed Care Program has employed HMOs and primary care case management as its core service delivery frameworks. While provider service networks (PSNs) have been explored, there is no clear evidence yet on their cost-effectiveness relative to these models. Further investigation is needed to understand the cost implications of introducing PSNs in Florida's Medicaid program.",7.105791820705622e-08,0.06774646963420139,0.044789542101571336,0.0054402793943456595,0.04148525374188772,0.001980246913580258,0.0054324046228586,0.03993163333847427,0.0005125479853454618,7.105791820705622e-08,0.03974032864951482,0.0
15,0.1,4,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Are provider service networks associated with lower costs than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Managed Care Program in Florida has traditionally depended on HMOs and primary care case management as the main service delivery approaches. Provider service networks (PSNs) have been examined, but no definitive proof exists comparing their cost-effectiveness to these established models. Additional research is necessary to determine the financial impact of PSNs in Florida's Medicaid program.",1.1842986367842703e-07,0.07262523824410394,0.005648850612402848,0.009067132323909433,0.07012547004328074,0.003388662131519289,0.009054007704764333,0.06746671462543308,0.0008776371736328465,1.1842986367842703e-07,0.0671393028376297,0.0
15,0.1,5,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Do provider service networks result in decreased expenditures compared to HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Managed Care Program has historically used HMOs and primary care case management as its primary service delivery models. Although provider service networks (PSNs) have been considered, there is currently no conclusive evidence comparing their cost-effectiveness to existing models. More research is needed to clarify the potential cost implications of implementing PSNs in Florida's Medicaid program.",9.474389094274162e-08,0.08280310400960911,0.04652255303454818,0.007253705859127546,0.05570331864006395,0.0026751658621525995,0.007243206163811466,0.053604436438384084,0.0006926271886682073,9.474389094274162e-08,0.05334598070529406,0.0
15,0.1,6,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Is there a cost advantage to using provider service networks over HMOs or primary care case management in Florida's Medicaid program? The Medicaid Managed Care Program in Florida has primarily utilized HMOs and primary care case management for service delivery. Provider service networks (PSNs) have been explored, but no conclusive evidence exists regarding their cost-effectiveness compared to these models. Further study is required to assess the financial impact of PSNs in Florida's Medicaid program.",1.6580180914979784e-07,0.10319877292529878,0.008116313857626428,0.012693985253473206,0.09960596729613957,0.004874432910419085,0.012675610786670066,0.09578121771036496,0.0012632821723730786,1.6580180914979784e-07,0.09531017980432566,0.0
15,0.1,7,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Do provider service networks offer lower expenditures than HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Managed Care Program has traditionally relied on HMOs and primary care case management as the main service delivery methods. While provider service networks (PSNs) have been investigated, there is no definitive evidence comparing their cost-effectiveness to current models. Additional research is needed to evaluate the potential cost implications of PSNs in Florida's Medicaid program.",1.6580180914979784e-07,0.12935688943056434,0.052002784807034394,0.012693985253473206,0.09960596729613957,0.004874432910419085,0.012675610786670066,0.09578121771036496,0.0012632821723730786,1.6580180914979784e-07,0.09531017980432566,0.0
15,0.1,8,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Are expenditures reduced by provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as its primary service delivery frameworks. Provider service networks (PSNs) have been explored, but no conclusive data exists on their cost-effectiveness relative to these models. Further research is necessary to determine the financial impact of implementing PSNs in Florida's Medicaid program.",1.1842986367842703e-07,0.07262523824410394,0.005648850612402889,0.009067132323909433,0.07012547004328074,0.003388662131519289,0.009054007704764333,0.06746671462543308,0.0008776371736328465,1.1842986367842703e-07,0.0671393028376297,0.0
15,0.1,9,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Does the implementation of provider service networks lead to lower costs than HMOs or primary care case management in Florida's Medicaid program? Florida's Medicaid Managed Care Program has mainly employed HMOs and primary care case management as its core service delivery models. Although provider service networks (PSNs) have been considered, there is no conclusive evidence comparing their cost-effectiveness to existing models. More research is needed to understand the potential cost implications of PSNs in Florida's Medicaid program.",9.474389094274162e-08,0.08280310400960911,0.04652255303454815,0.007253705859127546,0.05570331864006395,0.0026751658621525995,0.007243206163811466,0.053604436438384084,0.0006926271886682073,9.474389094274162e-08,0.05334598070529406,0.0
15,0.1,10,ai,"Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Managed Care Program in Florida has historically used HMOs and primary care case management as the main service delivery models. While provider service networks (PSNs) have been explored, there is currently no conclusive evidence comparing their cost-effectiveness to existing models.  Further research is needed to determine the potential cost implications of implementing PSNs in Florida's Medicaid program. 
","Are provider service networks more cost-effective than HMOs or primary care case management in Florida's Medicaid program? The Medicaid Managed Care Program in Florida has traditionally used HMOs and primary care case management as the main service delivery approaches. Provider service networks (PSNs) have been explored, but no definitive evidence exists comparing their cost-effectiveness to these models. Further study is required to assess the financial impact of implementing PSNs in Florida's Medicaid program.",1.8948778188548325e-07,0.11883837750204762,0.009399234511176482,0.014507411718255092,0.11467694664264716,0.005648335437241643,0.014486412327622933,0.11024478516934888,0.001464363234917809,1.8948778188548325e-07,0.10969891725642178,0.0
16,0.1,1,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
",Is lumbar drainage an effective method for managing postoperative cerebrospinal fluid fistulas following spine surgery? Lumbar drainage appears to be both effective and safe for preventing and treating CSF fistulas after spine surgery. It reduces the risk of complications like pseudomeningocele and enhances patient recovery.,4.737194547137081e-08,0.015684784721507583,0.020673448681217014,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
16,0.1,2,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Does lumbar drainage effectively treat postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is considered a safe and effective approach to prevent and manage CSF fistulas post-spine surgery, lowering complications such as pseudomeningocele and improving outcomes.",2.3685972735685364e-07,0.2233569668559814,0.015633327711249794,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
16,0.1,3,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Is lumbar drainage a reliable treatment for cerebrospinal fluid fistulas after spine surgery? Evidence suggests lumbar drainage is both safe and effective in preventing and treating CSF fistulas, reducing complications like pseudomeningocele and benefiting patient outcomes.",2.6054570009253894e-07,0.2526280774426146,0.014841716949297964,0.019947691112600606,0.2803019651541576,0.0,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
16,0.1,4,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Can lumbar drainage effectively prevent and treat postoperative cerebrospinal fluid fistulas following spine surgery? Lumbar drainage has been shown to be a safe and effective method to manage CSF fistulas, decreasing risks of pseudomeningocele and improving patient prognosis.",2.1317375462116834e-07,0.19491723113549364,0.01638225691255996,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
16,0.1,5,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Is lumbar drainage effective in managing cerebrospinal fluid fistulas after spine surgery? Lumbar drainage seems to be a safe and effective technique for both preventing and treating CSF fistulas, minimizing complications such as pseudomeningocele and enhancing recovery.",2.3685972735685364e-07,0.2233569668559814,0.015633327711249794,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
16,0.1,6,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Does lumbar drainage provide effective treatment for postoperative CSF fistulas after spine surgery? Lumbar drainage is effective and safe in preventing and treating CSF fistulas, reducing the chance of complications like pseudomeningocele and improving patient outcomes.",2.6054570009253894e-07,0.2526280774426146,0.014841716949297964,0.019947691112600606,0.2803019651541576,0.0,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
16,0.1,7,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Is lumbar drainage a safe and effective option for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage appears to prevent and treat CSF fistulas effectively, lowering the risk of pseudomeningocele and improving patient recovery.",2.8423167282822424e-07,0.2827805675605046,0.014003673094582187,0.021761117577382486,0.3101549283038394,0.0,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
16,0.1,8,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","How effective is lumbar drainage for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is both safe and effective in managing CSF fistulas, decreasing complications such as pseudomeningocele and enhancing patient outcomes.",3.3160361829959484e-07,0.34595352459958795,0.012170947962263819,0.025387970506946245,0.3726752852851729,0.0,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
16,0.1,9,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","Is lumbar drainage beneficial in treating cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is considered an effective and safe method to prevent and treat CSF fistulas, reducing risks like pseudomeningocele and improving patient prognosis.",2.8423167282822424e-07,0.2827805675605046,0.014003673094582187,0.021761117577382486,0.3101549283038394,0.0,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
16,0.1,10,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? 
Answer: Lumbar drainage seems to be effective and safe both in preventing and treating CSF fistulas after spine surgery.  It can decrease the risk of complications such as pseudomeningocele formation and improve patient outcomes. 
","What is the effectiveness of lumbar drainage for postoperative cerebrospinal fluid fistulas following spine surgery? Lumbar drainage seems to be a safe and effective approach to prevent and treat CSF fistulas, minimizing complications such as pseudomeningocele and improving patient outcomes.",1.6580180914979774e-07,0.1403520917441563,0.01776516105400517,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
17,0.1,1,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Are higher depression rates in women explained by differences in symptom reporting? Men and women in this community sample showed similar depressive symptom patterns, indicating that gender differences in depression prevalence might not be just because women report symptoms more. More research is necessary to explore the biological, social, and psychological factors behind gender disparities in depression.",2.8423167282822487e-07,0.2189112708895289,0.017851239669421492,0.02176111757738247,0.19735943415849366,0.0,0.0217296184914344,0.20067069546214888,0.0,2.8423167282822487e-07,0.20409535634351572,0.0
17,0.1,2,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Do higher depression rates among women result from differential symptom reporting? In this community sample, men and women reported comparable depressive symptoms, suggesting that women's higher depression rates are not solely due to greater symptom reporting. Further studies are required to examine the biological, social, and psychological contributors to gender differences in depression.",3.789755637709665e-07,0.32158300048390753,0.03840000000000001,0.029014823436509962,0.3000492290415391,0.019599999999999992,0.028972824655245866,0.2776317365982788,0.0,3.789755637709665e-07,0.2825669717850099,0.0
17,0.1,3,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Is the higher prevalence of depression in women due to differences in how symptoms are reported? Men and women in this community sample exhibited similar depressive symptom patterns, implying that gender differences in depression rates are not only because women report symptoms more. Additional research is needed to investigate the biological, social, and psychological factors influencing gender disparities in depression.",2.1317375462116866e-07,0.1654667758656423,0.01694411414982164,0.016320838183036854,0.14424960884454574,0.0,0.0162972138685758,0.14660347419187403,0.0,2.1317375462116866e-07,0.14903557916048715,0.0
17,0.1,4,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Are women's higher depression rates explained by their symptom reporting habits? This community sample showed men and women reporting similar depressive symptoms, suggesting that gender differences in depression prevalence are not just due to women's greater symptom reporting. More research is needed to understand the biological, social, and psychological factors behind these gender differences.",3.552895910352811e-07,0.24921579162398766,0.0,0.02720139697172809,0.25344890080953686,0.0,0.027162023114293,0.257829109302099,0.0,3.552895910352811e-07,0.2623642644674913,0.0
17,0.1,5,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Could the higher depression rates in women be due to differences in symptom reporting? Men and women in this community sample reported similar depressive symptoms, indicating that gender differences in depression prevalence may not be solely from women's increased symptom reporting. Further research is essential to explore the biological, social, and psychological factors contributing to gender disparities in depression.",2.3685972735685406e-07,0.1829663215455497,0.017236072637734686,0.018134264647818726,0.16164135155641457,0.0,0.018108015409528666,0.16430305129127465,0.0,2.3685972735685406e-07,0.16705408466316563,0.0
17,0.1,6,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Is the greater prevalence of depression in women accounted for by how symptoms are reported? Men and women in this community sample showed similar patterns of depressive symptoms, suggesting that women's higher depression rates are not just because they report symptoms more. Additional research is needed to understand the complex biological, social, and psychological factors behind gender differences in depression.",2.1317375462116866e-07,0.14197026127038992,0.0,0.016320838183036854,0.14424960884454574,0.0,0.0162972138685758,0.14660347419187403,0.0,2.1317375462116866e-07,0.14903557916048715,0.0
17,0.1,7,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Are higher depression rates in women explained by differences in symptom reporting? Men and women in this community sample reported similar depressive symptoms, indicating that gender differences in depression prevalence may not be solely due to women's greater symptom reporting. Further research is required to explore the biological, social, and psychological factors contributing to gender disparities in depression.",2.6054570009253947e-07,0.20077739104541603,0.017538265306122455,0.0199476911126006,0.1793409286558152,0.0,0.019918816950481533,0.18232155679395312,0.0,2.6054570009253947e-07,0.1854032233313614,0.0
17,0.1,8,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Do women have higher depression rates because they report symptoms differently? Men and women in this community sample showed similar depressive symptom patterns, suggesting that gender differences in depression prevalence are not only due to women's greater willingness to report symptoms. More research is needed to understand the biological, social, and psychological factors behind these gender disparities.",2.8423167282822487e-07,0.1941560144409591,0.0,0.02176111757738247,0.19735943415849366,0.0,0.0217296184914344,0.20067069546214888,0.0,2.8423167282822487e-07,0.20409535634351572,0.0
17,0.1,9,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Is the increased rate of depression in women explained by differential symptom reporting? Men and women in this community sample reported similar depressive symptoms, implying that gender differences in depression prevalence are not solely due to women's greater symptom reporting. Further research is necessary to explore the biological, social, and psychological contributors to gender disparities in depression.",2.8423167282822487e-07,0.1941560144409591,0.0,0.02176111757738247,0.19735943415849366,0.0,0.0217296184914344,0.20067069546214888,0.0,2.8423167282822487e-07,0.20409535634351572,0.0
17,0.1,10,ai,"Question: Are higher rates of depression in women accounted for by differential symptom reporting? 
Answer: Men and women in this community sample reported similar patterns of depressive symptoms. This suggests that gender differences in depression prevalence may not be solely due to women's greater willingness to report symptoms. Further research is needed to understand the complex interplay of biological, social, and psychological factors contributing to gender disparities in depression. 
","Are women's higher depression rates due to differences in symptom reporting? Men and women in this community sample exhibited similar depressive symptom patterns, suggesting that gender differences in depression prevalence may not be just because women report symptoms more. Additional research is needed to understand the complex biological, social, and psychological factors influencing gender disparities in depression.",2.8423167282822487e-07,0.2189112708895289,0.017851239669421492,0.02176111757738247,0.19735943415849366,0.0,0.0217296184914344,0.20067069546214888,0.0,2.8423167282822487e-07,0.20409535634351572,0.0
18,0.1,1,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a link between crime and over-the-counter pharmacy syringe sales? Our research shows that OTC pharmacy syringe sales did not correlate with a rise in reported crime in Los Angeles communities from 2006 to 2008.,4.73719454713706e-08,0.10324992977309444,0.03180708532418292,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
18,0.1,2,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does crime relate to the sale of syringes over the counter at pharmacies? Findings indicate that OTC pharmacy syringe sales were not connected to increased crime reports in Los Angeles neighborhoods between 2006 and 2008.,2.36859727356853e-08,0.11387080321755416,0.06035379812695108,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
18,0.1,3,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales associated with crime? Our study found no association between OTC syringe sales and higher crime rates in Los Angeles localities during 2006-2008.,1.658018091497971e-07,0.20771219726635204,0.02195379812695107,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
18,0.1,4,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there an association between crime and OTC pharmacy syringe sales? The data reveal that OTC syringe sales at pharmacies did not lead to more reported crimes in Los Angeles communities from 2006 through 2008.,2.36859727356853e-08,0.11387080321755416,0.06035379812695108,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
18,0.1,5,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Do over-the-counter pharmacy syringe sales impact crime rates? Evidence from 2006-2008 in Los Angeles shows no increase in reported crime linked to OTC syringe sales.,2.131737546211677e-07,0.23443589105066254,0.06035379812695108,0.016320838183036916,0.33024168687057687,0.0,0.016297213868575862,0.3429447511268311,0.0,2.1317375462116866e-07,0.35667494393873334,0.0
18,0.1,6,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime connected to the sale of syringes over the counter in pharmacies? Our results demonstrate no increase in crime reports in Los Angeles areas during 2006-2008 due to OTC syringe sales.,4.73719454713706e-08,0.02149748308653887,0.06035379812695108,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
18,0.1,7,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are crime rates influenced by over-the-counter pharmacy syringe sales? The findings indicate no rise in reported crime in Los Angeles communities from 2006 to 2008 associated with OTC syringe sales.,9.47438909427412e-08,0.04519389141213459,0.06035379812695108,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,0.1,8,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a relationship between crime and OTC pharmacy syringe sales? Our analysis found no correlation between OTC syringe sales and increased crime in Los Angeles local communities during 2006-2008.,9.47438909427412e-08,0.04519389141213459,0.06035379812695108,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,0.1,9,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does the sale of syringes over the counter at pharmacies relate to crime? The study shows that OTC pharmacy syringe sales did not cause an increase in reported crime in Los Angeles from 2006 to 2008.,4.73719454713706e-08,0.14285834009080567,0.06035379812695108,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
18,0.1,10,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales linked to crime? Our findings confirm that OTC syringe sales were not associated with higher crime rates in Los Angeles communities between 2006 and 2008.,9.47438909427412e-08,0.09299714524385472,0.02591502261674699,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
19,0.1,1,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is specialized breast pathology evaluation essential for managing ductal carcinoma in situ? Expert breast pathology evaluation remains crucial in managing ductal carcinoma in situ (DCIS) because of the disease's heterogeneity and the need for precise subtyping to guide prognosis and treatment choices.,2.1317375462116866e-07,0.17343001610850228,0.016691120992995842,0.016320838183036854,0.1654543128031416,0.02621620112406349,0.0162972138685758,0.1565419764677376,0.036598953524161267,2.1317375462116866e-07,0.15357019257431448,0.04246913580246913
19,0.1,2,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
","Does the management of ductal carcinoma in situ require expert breast pathology assessment? Due to the diverse nature of ductal carcinoma in situ (DCIS) and the critical role of accurate subtyping in prognosis and treatment planning, expert breast pathology assessment is still necessary.",1.8948778188548325e-07,0.17831422817654907,0.0025990024637942144,0.014507411718254981,0.17203785348193845,0.004302395426473982,0.014486412327622933,0.16499287727995604,0.012360726377346885,1.8948778188548325e-07,0.16314071543054043,0.016845867104408177
19,0.1,3,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
","Is expert pathology review of breast tissue necessary for ductal carcinoma in situ management? Given the heterogeneity of ductal carcinoma in situ (DCIS) and the importance of precise subtyping for prognosis and therapy decisions, expert breast pathology assessment remains essential.",2.6054570009253936e-07,0.1610181765201686,0.05990099753620576,0.0199476911126006,0.1857383912182735,0.048254004693398585,0.019918816950481533,0.21110711585907493,0.03521604938271605,2.6054570009253947e-07,0.20763741384459067,0.04246913580246913
19,0.1,4,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is specialized breast pathology analysis required for the treatment of ductal carcinoma in situ? Expert breast pathology assessments are indispensable in managing ductal carcinoma in situ (DCIS) because of the disease's variability and the need for accurate subtyping to inform prognosis and treatment.,1.8948778188548325e-07,0.07929320238227167,0.06528396926533137,0.014507411718254981,0.07060168071706885,0.07634814049586772,0.014486412327622933,0.09567815922396194,0.06222222222222222,1.8948778188548325e-07,0.1275947061710565,0.04246913580246913
19,0.1,5,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
","Is expert breast pathology evaluation needed in the management of ductal carcinoma in situ? Due to the heterogeneous nature of ductal carcinoma in situ (DCIS) and the significance of accurate subtyping for prognosis and treatment, expert breast pathology evaluation continues to be necessary.",1.8948778188548325e-07,0.17831422817654907,0.002599002463794242,0.014507411718254981,0.17203785348193845,0.0043023954264739955,0.014486412327622933,0.16499287727995604,0.012360726377346885,1.8948778188548325e-07,0.1275947061710565,0.04246913580246913
19,0.1,6,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is expert breast pathology assessment vital for managing ductal carcinoma in situ? The heterogeneity of ductal carcinoma in situ (DCIS) and the critical importance of precise subtyping for prognosis and treatment decisions make expert breast pathology assessment necessary.,3.0791764556390996e-07,0.29436095805414864,0.004453948925094653,0.023574544042164344,0.2823672814703011,0.018078512396694182,0.023540420032387266,0.2688179621661959,0.03367550941945406,3.079176455639103e-07,0.264795827684539,0.04246913580246913
19,0.1,7,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
","Is expert breast pathology review required for the management of ductal carcinoma in situ? Because of the diverse characteristics of ductal carcinoma in situ (DCIS) and the essential role of accurate subtyping in prognosis and treatment, expert breast pathology review remains necessary.",2.1317375462116866e-07,0.2072420736967926,0.005750929901435997,0.016320838183036854,0.20011167183113887,0.001957708397102284,0.0162972138685758,0.19208798572722197,0.011090008927846784,2.1317375462116866e-07,0.15357019257431448,0.04246913580246913
19,0.1,8,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is expert pathology assessment of breast tissue essential for ductal carcinoma in situ management? Expert breast pathology assessment continues to be necessary due to the heterogeneity of ductal carcinoma in situ (DCIS) and the importance of accurate subtyping for prognosis and treatment decisions.,1.8948778188548325e-07,0.11230021098036413,0.04210706094033012,0.014507411718254981,0.10441373830535872,0.052070937997511384,0.014486412327622933,0.13033551825195833,0.0372386587771203,1.8948778188548325e-07,0.1275947061710565,0.04246913580246913
19,0.1,9,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is expert breast pathology evaluation necessary for the treatment of ductal carcinoma in situ? The management of ductal carcinoma in situ (DCIS) requires expert breast pathology evaluation because of the disease's heterogeneity and the need for precise subtyping to guide prognosis and treatment.,1.8948778188548325e-07,0.17831422817654907,0.002599002463794242,0.014507411718254981,0.17203785348193845,0.0043023954264739955,0.014486412327622933,0.16499287727995604,0.012360726377346885,1.8948778188548325e-07,0.1275947061710565,0.04246913580246913
19,0.1,10,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? 

Answer: Expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS) due to the heterogeneity of this disease and the importance of accurate subtyping for prognosis and treatment decisions. 
",Is specialized breast pathology assessment required for managing ductal carcinoma in situ? Expert breast pathology assessment remains essential in the management of ductal carcinoma in situ (DCIS) due to the disease's heterogeneity and the importance of accurate subtyping for prognosis and treatment decisions.,1.8948778188548325e-07,0.11230021098036413,0.042107060940330135,0.014507411718254981,0.10441373830535872,0.052070937997511384,0.014486412327622933,0.09567815922396194,0.06222222222222222,1.8948778188548325e-07,0.1275947061710565,0.04246913580246913
20,0.1,1,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there an initial night impact on sleep bruxism? The findings indicated no general first night effect on the severity of RMMA frequency in young, healthy individuals with SB. Clinically, a single night of sleep recording might suffice for patients with moderate to high frequency SB. Nonetheless, low RMMA frequency observed on the first night may require confirmation with a second night recording.",4.737194547137081e-08,0.11306130192202835,0.08754047545582547,0.0036268529295637453,0.10382596405334787,0.0507015306122449,0.003621603081905733,0.057803178591540494,0.017236072637734686,4.737194547137081e-08,0.03448617607116855,0.0
20,0.1,2,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the first night affect sleep bruxism? Results demonstrated no significant first night effect on RMMA frequency severity in young, healthy patients with SB. In practice, one night of sleep monitoring could be adequate for those with moderate to high frequency SB. However, if RMMA frequency is low on the first night, a second night recording might be necessary for confirmation.",0.0,0.07803552045207018,0.08594097329092715,0.0,0.07048954378575623,0.0507015306122449,0.0,0.023901626915860064,0.017236072637734686,0.0,0.0,0.0
20,0.1,3,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night effect on sleep bruxism? The study showed no overall first night impact on RMMA frequency severity in young, healthy SB patients. For clinical purposes, one night of sleep recording may be enough for patients with moderate to high SB frequency. Yet, low RMMA frequency on the first night should be verified by a second night recording.",0.0,0.06931471805599587,0.050853253992681494,0.0,0.07048954378575623,0.0507015306122449,0.0,0.023901626915860064,0.017236072637734686,0.0,0.0,0.0
20,0.1,4,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does sleep bruxism exhibit a first night effect? The results revealed no overall first night effect on the severity of RMMA frequency in young, healthy individuals with SB. Clinically, a single night of sleep recording may be sufficient for patients with moderate to high frequency SB. However, low RMMA frequency during the first night could be validated by a second night recording.",2.3685972735685406e-08,0.08712329083428783,0.052270959028787034,0.0018134264647818726,0.08729666210213693,0.0507015306122449,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
20,0.1,5,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there an effect of the first night on sleep bruxism? Findings showed no general first night effect on RMMA frequency severity in young, healthy SB patients. In clinical settings, one night of sleep recording might be adequate for moderate to high frequency SB patients. Still, low RMMA frequency on the first night may need confirmation through a second night recording.",0.0,0.023104906018664995,0.016794204672992585,0.0,0.046993029190503854,0.033757416462423265,0.0,0.023901626915860064,0.017236072637734686,0.0,0.0,0.0
20,0.1,6,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the initial night influence sleep bruxism? The data indicated no overall first night effect on RMMA frequency severity in young, healthy patients with SB. For clinical practice, one night of sleep recording may suffice for those with moderate to high frequency SB. However, low RMMA frequency on the first night might require a second night recording for confirmation.",4.737194547137081e-08,0.06564543300066328,0.10136369362559841,0.0036268529295637453,0.036003367714587675,0.0507015306122449,0.003621603081905733,0.011189692895409387,0.017236072637734686,4.737194547137081e-08,0.03571808260207909,0.0
20,0.1,7,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night impact on sleep bruxism? The study found no overall first night effect on the severity of RMMA frequency in young, healthy SB patients. Clinically, one night of sleep recording could be enough for patients with moderate to high frequency SB. Nevertheless, low RMMA frequency on the first night should be confirmed by a second night recording.",0.0,0.04620981203733132,0.03376165280927186,0.0,0.07048954378575623,0.0507015306122449,0.0,0.023901626915860064,0.017236072637734686,0.0,0.0,0.0
20,0.1,8,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the first night affect sleep bruxism severity? Results showed no general first night effect on RMMA frequency severity in young, healthy individuals with SB. In clinical practice, one night of sleep recording may be sufficient for moderate to high frequency SB patients. However, low RMMA frequency on the first night might need confirmation with a second night recording.",4.737194547137081e-08,0.00882065944886401,0.03017832647462282,0.0036268529295637453,0.011682414010730113,0.033163265306122444,0.003621603081905733,0.011189692895409387,0.017236072637734686,4.737194547137081e-08,0.03571808260207909,0.0
20,0.1,9,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Is there a first night effect on the severity of sleep bruxism? The findings revealed no overall first night effect on RMMA frequency in young, healthy SB patients. Clinically, one night of sleep recording may be adequate for patients with moderate to high frequency SB. Yet, low RMMA frequency on the first night could be confirmed by a second night recording.",0.0,0.023104906018664995,0.016564921394635473,0.0,0.023496514595251483,0.016844959359551777,0.0,0.0,0.0,0.0,0.0,0.0
20,0.1,10,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Does the first night influence sleep bruxism? The results showed no overall first night effect on the severity of RMMA frequency in young, healthy patients with SB. In clinical practice, one night of sleep recording may be sufficient for moderate to high frequency SB patients. However, low RMMA frequency observed on the first night might require confirmation by a second night recording.",2.3685972735685406e-08,0.041671016699209584,0.018774407911312685,0.0018134264647818726,0.06419175608347238,0.034039651841776646,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
21,0.1,1,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access major surgery in newborns cause less pain? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not result in lower cumulative opioid use.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.1,2,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain reduced in newborns undergoing minimal access major surgery? Minimal access surgery to fix esophageal atresia or congenital diaphragmatic hernia does not lead to decreased total opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.1,3,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns lead to less pain? Repairing esophageal atresia or congenital diaphragmatic hernia via minimal access surgery is not linked to reduced cumulative opioid consumption.,9.47438909427412e-08,0.18923071963380345,0.039788435369961024,0.007253705859127518,0.18949457407785042,0.03698224852071005,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.1,4,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is there less pain with minimal access major surgery in newborns? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia does not correspond with lower overall opioid doses.,9.47438909427412e-08,0.13972020673666385,0.004447813134751871,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,0.1,5,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery cause less pain in newborns? The use of minimal access techniques for esophageal atresia or congenital diaphragmatic hernia repair is not associated with decreased total opioid requirements.,4.73719454713706e-08,0.06742663438990348,0.0020762161887946107,0.003626852929563759,0.06669137449867346,0.0,0.003621603081905747,0.06899287148695077,0.0,4.737194547137081e-08,0.07145896398214369,0.0
21,0.1,6,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is minimal access major surgery less painful for newborns? Minimal access procedures for esophageal atresia or congenital diaphragmatic hernia do not reduce the cumulative opioid dose needed.,1.421158364141118e-07,0.21763667988247315,0.007182518210197705,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,0.1,7,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Do newborns experience less pain with minimal access major surgery? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia does not reduce the total opioid dose administered.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.1,8,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minimal access surgery in newborns result in less pain? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia is not linked to lower cumulative opioid doses.,1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,0.1,9,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain lessened by minimal access major surgery in newborns? Minimal access surgery for esophageal atresia or congenital diaphragmatic hernia repair does not decrease overall opioid use.,1.421158364141118e-07,0.21763667988247315,0.007182518210197705,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,0.1,10,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Are newborns less hurt by minimal access major surgery? Minimal access repair of esophageal atresia or congenital diaphragmatic hernia is not associated with reduced cumulative opioid doses.,1.421158364141118e-07,0.21763667988247315,0.007182518210197705,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
22,0.1,1,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Does family practice at residency teaching sites mirror community practice? The residency training sites of the Northeastern Ohio Universities College of Medicine offer patient care across diverse settings such as community health centers, rural hospitals, and private practices. This variety ensures residents experience multiple clinical environments, equipping them for various practice settings.",3.079176455639103e-07,0.1837357518503513,0.03121748178980229,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
22,0.1,2,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Is family practice at residency teaching sites representative of community practice? At the Northeastern Ohio Universities College of Medicine, residency training occurs in multiple settings including community health centers, rural hospitals, and private practices. This range of environments provides residents with broad clinical experience, preparing them for diverse practice scenarios.",3.552895910352811e-07,0.22374108646404967,0.03121748178980229,0.02720139697172809,0.2719337154836441,0.0,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
22,0.1,3,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Do residency teaching sites for family practice reflect the nature of community practice? The Northeastern Ohio Universities College of Medicines residency sites deliver patient care in settings like community health centers, rural hospitals, and private practices. This diversity allows residents to gain experience in different clinical contexts, readying them for a wide array of practice environments.",2.1317375462116866e-07,0.1082281993422054,0.03121748178980229,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
22,0.1,4,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Does family practice training at residency sites correspond to community practice? The residency programs at Northeastern Ohio Universities College of Medicine involve patient care in various locations such as community health centers, rural hospitals, and private practices. This ensures residents obtain experience in multiple clinical settings, preparing them for diverse practice types.",3.079176455639103e-07,0.1837357518503513,0.03121748178980229,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
22,0.1,5,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Is the family practice at residency teaching sites aligned with community practice? Residency training at Northeastern Ohio Universities College of Medicine takes place in diverse settings including community health centers, rural hospitals, and private practices. This variety helps residents gain experience across different clinical environments, equipping them for a broad range of practice settings.",2.6054570009253947e-07,0.1452694710225555,0.03121748178980229,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
22,0.1,6,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Are family practice residency teaching sites reflective of community practice? The Northeastern Ohio Universities College of Medicines residency sites provide patient care in a variety of settings like community health centers, rural hospitals, and private practices. This diversity ensures residents experience a wide range of clinical environments, preparing them for multiple practice settings.",2.8423167282822487e-07,0.1643176659932486,0.03121748178980229,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
22,0.1,7,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Does family practice at residency teaching sites represent community practice? Residency training at Northeastern Ohio Universities College of Medicine occurs in diverse settings such as community health centers, rural hospitals, and private practices. This variety ensures residents gain experience in various clinical environments, preparing them for different practice settings.",3.789755637709665e-07,0.24436037366678542,0.03121748178980229,0.029014823436509962,0.29298712468147725,0.0,0.028972824655245866,0.29849298855599704,0.0,3.789755637709665e-07,0.30421137440299084,0.0
22,0.1,8,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Is family practice at residency teaching sites similar to community practice? The residency training sites of Northeastern Ohio Universities College of Medicine offer patient care in multiple settings including community health centers, rural hospitals, and private practices. This diversity provides residents with experience in a broad range of clinical environments, preparing them for various practice settings.",2.1317375462116866e-07,0.1082281993422054,0.03121748178980229,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
22,0.1,9,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Does family practice at residency teaching sites reflect the community practice environment? The residency training sites at Northeastern Ohio Universities College of Medicine provide patient care across diverse settings like community health centers, rural hospitals, and private practices. This range ensures residents gain experience in multiple clinical contexts, preparing them for a variety of practice settings.",2.1317375462116866e-07,0.1082281993422054,0.03121748178980229,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
22,0.1,10,ai,"Question: Does family practice at residency teaching sites reflect community practice? 
Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care in a variety of settings, including community health centers, rural hospitals, and private practices. This diversity of settings ensures that residents gain experience in a range of clinical environments, preparing them for a wide variety of practice settings. 
","Is family practice at residency teaching sites indicative of community practice? The residency training sites of Northeastern Ohio Universities College of Medicine deliver patient care in various settings including community health centers, rural hospitals, and private practices. This diversity allows residents to gain experience in different clinical environments, preparing them for a wide range of practice settings.",1.8948778188548325e-07,0.09020969383952693,0.03121748178980229,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
23,0.1,1,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
",Is the length of psychological treatment for depression associated with the likelihood of returning to treatment? The findings indicate that extended treatment duration might help prevent patients from needing to return. This underscores the importance of adequate treatment time to ensure lasting recovery and lower relapse risk for those with depression.,2.3685972735685406e-08,0.034561857453619726,0.039150354019158694,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
23,0.1,2,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
","Does the duration of psychological therapy for depression influence the chances of returning to treatment? Results suggest that longer treatment periods may reduce the need for subsequent treatment, emphasizing the value of sufficient therapy duration for sustained recovery and relapse prevention.",2.6054570009253947e-07,0.18858169386058954,0.039150354019158694,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
23,0.1,3,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
","Is there a connection between how long psychological treatment for depression lasts and the probability of returning for further treatment? The data imply that longer treatment can help avoid return visits, highlighting the necessity of ample treatment time to promote enduring recovery and minimize relapse.",1.6580180914979784e-07,0.09327151405626388,0.039150354019158694,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
23,0.1,4,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
","Does the length of psychological treatment for depression affect the likelihood of patients returning to treatment? Findings suggest that prolonged treatment may prevent relapse, stressing the importance of providing enough treatment time to achieve lasting recovery.",3.7897556377096597e-07,0.3221130864851123,0.039150354019158694,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
23,0.1,5,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
","Is the duration of depression treatment linked to the chance of returning to therapy? The results indicate that longer treatment durations may reduce the likelihood of returning, emphasizing the need for sufficient treatment time to ensure sustained recovery and lower relapse rates.",2.3685972735685406e-07,0.16388908127021784,0.039150354019158694,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
23,0.1,6,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
","Is there an association between the length of psychological treatment for depression and the risk of returning to treatment? The findings suggest that extended treatment duration can help prevent relapse, highlighting the importance of adequate therapy time for lasting recovery.",2.8423167282822477e-07,0.21389950184488127,0.039150354019158694,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
23,0.1,7,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
","Does the time spent in psychological treatment for depression relate to the probability of returning to treatment? Results show that longer treatment may help prevent return visits, underscoring the importance of sufficient treatment duration for enduring recovery and relapse reduction.",2.8423167282822477e-07,0.21389950184488127,0.039150354019158694,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
23,0.1,8,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
","Is the duration of psychological treatment for depression connected to the likelihood of returning for further treatment? The findings suggest that longer treatment periods may reduce relapse risk, emphasizing the importance of adequate treatment time for lasting recovery.",3.3160361829959537e-07,0.2665432353303001,0.039150354019158694,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
23,0.1,9,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
","Is the length of psychological therapy for depression related to the chance of returning to treatment? The results indicate that extended treatment duration might prevent relapse, highlighting the need for sufficient therapy time to achieve sustained recovery.",3.5528959103528067e-07,0.29394220951841543,0.039150354019158694,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
23,0.1,10,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? 

Answer: The results suggest that a longer duration of treatment may prevent return into treatment. This finding highlights the importance of providing sufficient treatment time for individuals with depression to achieve lasting recovery and reduce the likelihood of relapse. 
","Is the duration of treatment for depression associated with the likelihood of returning to treatment? Findings suggest that longer treatment may help prevent relapse, underscoring the importance of providing enough treatment time for lasting recovery.",4.0266153650665127e-07,0.3511006233583638,0.039150354019158694,0.03082824990129185,0.4155154439616653,0.0,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
24,0.1,1,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can a new surgical technique for the temporomandibular joint enhance access and minimize complications? The VMPA offers direct access and excellent visibility to the TMJ area, resulting in favorable aesthetic and functional outcomes. It is regarded as the preferred method for typical TMJ surgeries.",1.1842986367842703e-07,0.026715768867978884,0.05940199771368603,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
24,0.1,2,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Is it possible that a novel surgical method for the temporomandibular joint improves accessibility and lowers complication rates? The VMPA provides straightforward access and clear visibility to the TMJ region, delivering good cosmetic and functional results. This approach is often chosen for standard TMJ procedures.",9.474389094274162e-08,0.028513153103694844,0.08264462809917356,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.1,3,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Could an innovative surgical approach to the temporomandibular joint improve access and reduce the risk of complications? The VMPA allows direct access and optimal visibility of the TMJ area, achieving positive aesthetic and functional outcomes. It is considered the preferred technique for common TMJ operations.",9.474389094274162e-08,0.0029935369217577446,0.05992964702832444,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,0.1,4,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Does a new surgical approach to the temporomandibular joint enhance access and decrease complications? The VMPA grants direct access and favorable visibility to the TMJ region, producing excellent esthetic and functional results. It is often the approach of choice for routine TMJ surgeries.",1.4211583641411244e-07,0.08402087972738315,0.03514462809917354,0.010880558788691236,0.10707991030107156,0.021266540642722105,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
24,0.1,5,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Might a novel surgical technique for the temporomandibular joint improve access and lessen complications? The VMPA provides direct access and good visibility to the TMJ area, yielding satisfactory aesthetic and functional outcomes. It is regarded as the preferred approach for typical TMJ surgeries.",1.4211583641411244e-07,0.05101387112929068,0.058849268194355,0.010880558788691236,0.10707991030107156,0.021266540642722105,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
24,0.1,6,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can a fresh surgical approach to the temporomandibular joint improve access and reduce complications? The VMPA offers direct access and clear visibility to the TMJ region, resulting in favorable esthetic and functional results. It is considered the method of choice for common TMJ surgeries.",1.1842986367842703e-07,0.05895517261495309,0.03624367628477735,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
24,0.1,7,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Is a novel surgical approach to the temporomandibular joint capable of improving access and minimizing complications? The VMPA provides direct access and excellent visibility to the TMJ area, leading to good aesthetic and functional outcomes. It is often selected as the preferred approach for standard TMJ surgeries.",4.737194547137081e-08,0.012691247799749839,0.03925619834710743,0.0036268529295637453,0.013989487235059883,0.021266540642722105,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
24,0.1,8,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Could a new surgical technique for the temporomandibular joint enhance access and reduce complications? The VMPA allows direct access and favorable visibility to the TMJ region, producing positive esthetic and functional results. It is considered the approach of choice for common TMJ procedures.",1.4211583641411244e-07,0.05101387112929068,0.058849268194355,0.010880558788691236,0.10707991030107156,0.021266540642722105,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
24,0.1,9,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Does an innovative surgical approach to the temporomandibular joint improve access and lower complication risks? The VMPA grants direct access and good visibility to the TMJ area, yielding excellent aesthetic and functional outcomes. It is regarded as the preferred method for routine TMJ surgeries.",1.1842986367842703e-07,0.05895517261495309,0.03624367628477735,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
24,0.1,10,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Might a fresh surgical approach to the temporomandibular joint enhance access and decrease complications? The VMPA offers direct access and optimal visibility to the TMJ region, resulting in favorable esthetic and functional results. It is often the chosen approach for common TMJ surgeries.",1.4211583641411244e-07,0.08402087972738315,0.03514462809917354,0.010880558788691236,0.10707991030107156,0.021266540642722105,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
25,0.1,1,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypersons and healthcare professionals consider it acceptable to violate confidentiality to safeguard a patient's wife from a sexually transmitted infection? Most individuals in France base their judgment on situational factors when determining if a doctor should breach confidentiality to protect the spouse of a patient with an STD.,4.737194547137081e-08,0.013249670855493001,0.03819444444444445,0.0036268529295637453,0.014629779924541175,0.039930555555555566,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,0.1,2,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Are French non-experts and medical professionals agreeable to breaking confidentiality to protect a patient's wife from a sexually transmitted disease? In France, most people are influenced by the context when deciding whether a physician should disclose confidential information to protect the patient's spouse from an STD.",1.4211583641411244e-07,0.0744229571875259,0.03638300619834711,0.010880558788691236,0.07238159706508807,0.039930555555555566,0.0108648092457172,0.10232846076155644,0.020399305555555556,1.4211583641411244e-07,0.13353139262452318,0.0
25,0.1,3,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French health workers and laypeople find it acceptable to breach confidentiality to protect a patient's wife from an STD? The majority of people in France consider situational factors when deciding if a doctor should break confidentiality to protect the spouse of a patient infected with a sexually transmitted disease.,4.737194547137081e-08,0.015042050800014639,0.017851332616568565,0.0036268529295637453,0.014251352598789513,0.019106653337357282,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,0.1,4,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is it acceptable for French laypeople and healthcare providers to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Most French individuals are influenced by the circumstances when deciding if a physician should disclose confidential information to protect the patient's spouse from an STD.,1.1842986367842703e-07,0.051774343047919835,0.0368653549382716,0.009067132323909363,0.04990874121303035,0.039930555555555566,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
25,0.1,5,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Do French medical professionals and laypersons accept breaching confidentiality to protect a patient's wife from a sexually transmitted infection? In France, most people take situational factors into account when deciding if a doctor should breach confidentiality to safeguard the spouse of a patient with an STD.",1.4211583641411244e-07,0.0744229571875259,0.03638300619834711,0.010880558788691236,0.07238159706508807,0.039930555555555566,0.0108648092457172,0.10232846076155644,0.020399305555555556,1.4211583641411244e-07,0.13353139262452318,0.0
25,0.1,6,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and health professionals approve of breaching confidentiality to protect a patient's wife from an STD? Most people in France rely on situational factors when deciding whether a physician should break confidentiality to protect the spouse of a patient infected with a sexually transmitted disease.,1.1842986367842703e-07,0.08191117698530892,0.015205320247933876,0.009067132323909363,0.08071528257125005,0.017719811753902675,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
25,0.1,7,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Are French health professionals and laypersons comfortable with breaching confidentiality to protect a patient's wife from a sexually transmitted disease? Most individuals in France consider the situation when deciding if a doctor should breach confidentiality to protect the spouse of a patient with an STD.,1.6580180914979784e-07,0.12910265173226865,0.013242276077097506,0.012693985253473108,0.1276105190367618,0.016687925170068042,0.012675610786670066,0.12585895817175086,0.020399305555555556,1.6580180914979784e-07,0.1576289442035832,0.0
25,0.1,8,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypeople and healthcare professionals find it acceptable to violate confidentiality to protect a patient's wife from an STD? Most people in France are influenced by the context when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with a sexually transmitted disease.,4.737194547137081e-08,0.015042050800014639,0.017851332616568565,0.0036268529295637453,0.014251352598789513,0.019106653337357282,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,0.1,9,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Is breaching confidentiality to protect a patient's wife from a sexually transmitted disease acceptable to French laypeople and health professionals? Most French people are influenced by situational factors when deciding if a doctor should disclose confidential information to protect the spouse of a patient with an STD.,1.1842986367842703e-07,0.051774343047919835,0.0368653549382716,0.009067132323909363,0.04990874121303035,0.039930555555555566,0.009054007704764333,0.07933894253685692,0.020399305555555556,1.1842986367842703e-07,0.11000089521432876,0.0
25,0.1,10,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Do French laypersons and health professionals consider it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with an STD.,4.737194547137081e-08,0.04333377245552272,0.002370333175803374,0.0036268529295637453,0.043132485122120645,0.0016573461457676936,0.003621603081905733,0.04287659944973932,0.0008672350871665457,4.737194547137081e-08,0.04255961441879652,0.0
26,0.1,1,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
",Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: Our conclusion is that the higher cardiovascular risk seen in individuals with the D allele of the ACE gene I/D polymorphism cannot be attributed to variations in insulin sensitivity. This implies that the ACE gene I/D polymorphism is unlikely to be a primary candidate gene for insulin resistance.,9.474389094274162e-08,0.031174202250110028,0.048644988207367734,0.0072537058591274906,0.048788529433761774,0.03824265121202208,0.007243206163811466,0.04480122368940487,0.04267612393836143,9.474389094274162e-08,0.04051842317779908,0.047121785359813685
26,0.1,2,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? Answer: We find that the increased cardiovascular risk associated with the D allele of the ACE gene I/D polymorphism is not due to differences in insulin sensitivity, indicating that this polymorphism may not be a key gene for insulin resistance.",1.4211583641411244e-07,0.04367436901456845,0.1999167013744274,0.010880558788691236,0.008335345690273943,0.132131604142257,0.0108648092457172,0.062023819694388305,0.06315868447479975,1.4211583641411244e-07,0.1174729320512502,0.005905803711263556
26,0.1,3,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: Our results show that the elevated cardiovascular risk in carriers of the D allele of the ACE gene I/D polymorphism is not explained by insulin sensitivity differences, suggesting the polymorphism is not a primary candidate gene for insulin resistance.",7.105791820705622e-08,0.04782473625971484,0.07107703233293633,0.005440279394345618,0.020475165058277067,0.08715034633301086,0.0054324046228586,0.026114335235725594,0.04969991961631534,7.105791820705622e-08,0.05702100062745208,0.002793657391559491
26,0.1,4,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Is the ACE gene I/D polymorphism insertion allele a candidate gene for insulin resistance? Answer: We conclude that the increased cardiovascular risk in individuals with the D allele of the ACE gene I/D polymorphism is not due to insulin sensitivity variations, implying it may not be a main candidate gene for insulin resistance.",1.8948778188548325e-07,0.02523027220095564,0.17835491513066792,0.014507411718254981,0.051012619403603576,0.12869445171086286,0.014486412327622933,0.07741083812840133,0.07953369749021,1.8948778188548325e-07,0.1044410115930905,0.031578577796441576
26,0.1,5,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: The insertion allele of the ACE gene I/D polymorphism: a candidate gene for insulin resistance? Answer: Our findings indicate that the higher cardiovascular risk in those with the D allele of the ACE gene I/D polymorphism is not explained by insulin sensitivity differences, suggesting it is unlikely to be a primary candidate gene for insulin resistance.",1.1842986367842703e-07,0.014882935050861246,0.16848303947429313,0.009067132323909363,0.012857730151664803,0.1163048652834482,0.009054007704764333,0.041394168357818284,0.06452744749021,1.1842986367842703e-07,0.07075921100595828,0.013892431709355293
26,0.1,6,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Is the insertion allele of the ACE gene I/D polymorphism associated with insulin resistance? Answer: We conclude that the increased cardiovascular risk linked to the D allele of the ACE gene I/D polymorphism is not caused by differences in insulin sensitivity, indicating the polymorphism may not be a primary candidate gene for insulin resistance.",1.6580180914979784e-07,0.02252463567744245,0.19799692836318206,0.012693985253473108,0.02944937660794711,0.13044412004998068,0.012675610786670066,0.08308405292505272,0.06173855860132112,1.6580180914979784e-07,0.1384592241992122,0.00702350206611569
26,0.1,7,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Could the ACE gene I/D polymorphism insertion allele be a candidate gene for insulin resistance? Answer: Our study shows that the elevated cardiovascular risk in individuals with the D allele of the ACE gene I/D polymorphism is not explained by insulin sensitivity, suggesting it is not a primary candidate gene for insulin resistance.",1.8948778188548325e-07,0.051386769580576086,0.1611990888570092,0.014507411718254981,0.051012619403603576,0.12869445171086286,0.014486412327622933,0.07741083812840133,0.07953369749021,1.8948778188548325e-07,0.1044410115930905,0.031578577796441576
26,0.1,8,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Is the insertion allele of the ACE gene I/D polymorphism a primary candidate gene for insulin resistance? Answer: We find that the increased cardiovascular risk in carriers of the D allele of the ACE gene I/D polymorphism is not due to insulin sensitivity differences, implying it may not be a key gene for insulin resistance.",1.4211583641411244e-07,0.04145528966041656,0.10652126673747317,0.010880558788691236,0.0340074634887908,0.11438509227220289,0.0108648092457172,0.062023819694388305,0.06315868447479975,1.4211583641411244e-07,0.1174729320512502,0.005905803711263556
26,0.1,9,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: The ACE gene I/D polymorphism insertion allele as a candidate gene for insulin resistance? Answer: Our conclusion is that the higher cardiovascular risk associated with the D allele of the ACE gene I/D polymorphism is not explained by insulin sensitivity variations, suggesting it is unlikely to be a primary candidate gene for insulin resistance.",1.6580180914979784e-07,0.003147482121070855,0.18061774094806216,0.012693985253473108,0.02944937660794711,0.13044412004998068,0.012675610786670066,0.05642454598043933,0.08065139584506215,1.6580180914979784e-07,0.08409473944941226,0.03197024793388432
26,0.1,10,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of individuals with the D allele of the ACE gene I/D polymorphism is not explained by differences in insulin sensitivity. This finding suggests that the ACE gene I/D polymorphism may not be a primary candidate gene for insulin resistance. 
","Question: Is the insertion allele of the ACE gene I/D polymorphism involved in insulin resistance? Answer: We conclude that the increased cardiovascular risk in individuals with the D allele of the ACE gene I/D polymorphism is not attributable to differences in insulin sensitivity, indicating the polymorphism may not be a primary candidate gene for insulin resistance.",1.4211583641411244e-07,0.018469016994206555,0.18280595614095985,0.010880558788691236,0.008335345690273943,0.132131604142257,0.0108648092457172,0.062023819694388305,0.06315868447479975,1.4211583641411244e-07,0.1174729320512502,0.005905803711263556
27,0.1,1,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Is there a relationship between androgens and sexual desire in women? The current study found that FT and androstenedione were statistically linked to sexual desire, indicating a possible connection between these androgens and female libido.",2.36859727356853e-08,0.030152490117890007,0.0008380438547157774,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
27,0.1,2,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Does a correlation exist between androgens and sexual desire in women? This study showed that FT and androstenedione had a significant association with sexual desire, implying a potential link to female libido.",9.47438909427412e-08,0.08175244668655557,0.02854671280276816,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
27,0.1,3,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Are androgens related to sexual desire in women? Findings from this study reveal that FT and androstenedione are statistically connected to sexual desire, suggesting these androgens may influence female libido.",1.421158364141118e-07,0.19624707501694916,0.005892062707435933,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
27,0.1,4,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Is sexual desire in women correlated with androgens? The present research demonstrated a statistical association between FT, androstenedione, and sexual desire, pointing to a possible link with female libido.",1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
27,0.1,5,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Does sexual desire in women correlate with androgen levels? The study indicates that FT and androstenedione are significantly associated with sexual desire, hinting at a connection to female libido.",1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
27,0.1,6,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Is there an association between androgens and female sexual desire? According to this study, FT and androstenedione showed a statistical relationship with sexual desire, suggesting a link to female libido.",1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
27,0.1,7,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Are female sexual desire and androgens connected? The research found that FT and androstenedione were statistically related to sexual desire, indicating a potential association with female libido.",2.131737546211677e-07,0.2576431131502197,0.02854671280276816,0.016320838183036916,0.3074846997479619,0.0,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
27,0.1,8,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Is there a statistical link between androgens and sexual desire in women? The study identified FT and androstenedione as significantly associated with sexual desire, implying a connection to female libido.",1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
27,0.1,9,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Do androgens influence sexual desire in women? This study found a statistical association between FT, androstenedione, and sexual desire, suggesting these androgens may affect female libido.",2.36859727356853e-07,0.29686382630350217,0.02854671280276816,0.018134264647818796,0.3483066942682167,0.0,0.018108015409528735,0.36101334553733055,0.0,2.3685972735685406e-07,0.3746934494414109,0.0
27,0.1,10,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically associated with sexual desire, suggesting a potential link between these androgens and female libido.","Is female sexual desire associated with androgen levels? The present study revealed that FT and androstenedione were statistically linked to sexual desire, indicating a possible connection to female libido.",1.658018091497971e-07,0.18353514099649804,0.02854671280276816,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
28,0.1,1,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals useful and pertinent to both practitioners and athletes? There is a lack of research focusing on diagnostic and treatment methods in sports, leading to a gap in evidence-based practice. Sports medicine journals are essential as they offer practitioners up-to-date research, clinical guidelines, and case studies to enhance athlete care and performance.",9.474389094274162e-08,0.07499994574745728,0.0025434730105059616,0.0072537058591274906,0.07459489795819252,0.0013226814394396783,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
28,0.1,2,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Do sports medicine journals hold relevance and practical value for practitioners and athletes? Few studies address diagnostic and treatment interventions in sports, resulting in a deficiency in evidence-based practice. These journals are vital by supplying practitioners with current research, clinical protocols, and case reports to improve athlete care and performance.",2.1317375462116866e-07,0.12081945860407206,0.03443877551020409,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
28,0.1,3,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals applicable and important to practitioners and athletes? There is a shortage of studies on diagnostic and treatment approaches in sports, causing a gap in evidence-based practice. Sports medicine journals are key resources that provide practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance.",1.1842986367842703e-07,0.09466083792181923,0.003239040714324924,0.009067132323909363,0.09414610249387811,0.0016851103186372555,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
28,0.1,4,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Is the content of sports medicine journals relevant and useful for practitioners and athletes? The scarcity of studies on diagnostic and treatment interventions in sports creates a gap in evidence-based practice. Sports medicine journals play a significant role by delivering the latest research, clinical guidelines, and case studies to practitioners to enhance athlete care and performance.",7.105791820705622e-08,0.05571727552295114,0.001873079242376896,0.005440279394345618,0.05541838536493415,0.0009736606461737268,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
28,0.1,5,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Do sports medicine journals serve as relevant and applicable resources for practitioners and athletes? A lack of studies on diagnostic and treatment interventions in sports leads to a gap in evidence-based practice. These journals are crucial in providing practitioners with updated research, clinical guidelines, and case studies to optimize athlete care and performance.",1.4211583641411244e-07,0.06139603813327099,0.03443877551020409,0.010880558788691236,0.08690468140636742,0.017538265306122455,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
28,0.1,6,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals pertinent and beneficial to practitioners and athletes? There is a deficiency of research on diagnostic and treatment interventions in sports, which creates a gap in evidence-based practice. Sports medicine journals are important as they offer practitioners the latest research, clinical guidelines, and case studies to improve athlete care and performance.",1.1842986367842703e-07,0.09466083792181923,0.003239040714324924,0.009067132323909363,0.09414610249387811,0.0016851103186372555,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
28,0.1,7,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals significant and applicable to practitioners and athletes? The limited number of studies on diagnostic and treatment interventions in sports results in a gap in evidence-based practice. These journals play a vital role by providing practitioners with current research, clinical guidelines, and case studies to enhance athlete care and performance.",1.4211583641411244e-07,0.06139603813327099,0.03443877551020409,0.010880558788691236,0.08690468140636742,0.017538265306122455,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
28,0.1,8,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals relevant and practical for practitioners and athletes? The shortage of studies addressing diagnostic and treatment interventions in sports causes a gap in evidence-based practice. Sports medicine journals are essential as they provide practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance.",1.6580180914979784e-07,0.13517860874017318,0.004711578508954602,0.012693985253473108,0.13443319592494518,0.0024534048313202793,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
28,0.1,9,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals valuable and applicable to practitioners and athletes? There is a lack of studies focusing on diagnostic and treatment interventions in sports, which creates a gap in evidence-based practice. These journals are crucial by offering practitioners up-to-date research, clinical guidelines, and case studies to improve athlete care and performance.",1.6580180914979784e-07,0.08081412399037369,0.03443877551020409,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
28,0.1,10,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? 
Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports. This creates a gap in evidence-based practice. Sports medicine journals play a crucial role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance. 
","Are sports medicine journals important and relevant to practitioners and athletes? The scarcity of studies on diagnostic and treatment interventions in sports leads to a gap in evidence-based practice. Sports medicine journals play a key role by providing practitioners with the latest research, clinical guidelines, and case studies to optimize athlete care and performance.",1.1842986367842703e-07,0.09466083792181923,0.003239040714324924,0.009067132323909363,0.09414610249387811,0.0016851103186372555,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
29,0.1,1,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Does the quantity of needles influence acupuncture treatment for neck pain? The effectiveness is not mainly determined by using 5 or 10 needles. Instead, acupuncture points are selected according to the patient's unique pain pattern and root cause. The practitioner's expertise is key to achieving the best outcomes.",1.6580180914979784e-07,0.0874922092571837,0.036982248520710054,0.012693985253473108,0.11549401968340556,0.018860946745562133,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
29,0.1,2,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","In acupuncture for neck pain, does the number of needles used matter? Whether 5 or 10 needles are applied, this is not the main factor affecting treatment success. Points are chosen based on the individual's specific pain and cause, with the practitioner's skill playing a vital role.",1.8948778188548325e-07,0.10899841447814707,0.036982248520710054,0.014507411718254981,0.13747292640218056,0.018860946745562133,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
29,0.1,3,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","When treating neck pain with acupuncture, is the needle count important? The difference between using 5 or 10 needles does not primarily affect effectiveness. The selection of acupuncture points depends on the patient's pain pattern and underlying cause, and the practitioner's proficiency is essential.",2.6054570009253947e-07,0.1764396952736793,0.036982248520710054,0.0199476911126006,0.20646579788913222,0.018860946745562133,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
29,0.1,4,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Is the number of needles significant in acupuncture treatment for neck pain? Using 5 or 10 needles does not chiefly determine the treatment's success. Acupuncture points are carefully selected based on the patient's specific pain and cause, with the practitioner's experience being crucial.",2.8423167282822487e-07,0.19997019268387373,0.036982248520710054,0.02176111757738247,0.23056334946819224,0.018860946745562133,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
29,0.1,5,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Does the number of needles impact acupuncture therapy for neck pain? The choice between 5 or 10 needles is not the main factor for effectiveness. Points are strategically chosen according to the individual's pain pattern and cause, and the practitioner's skill is critical.",2.8423167282822487e-07,0.19997019268387373,0.036982248520710054,0.02176111757738247,0.23056334946819224,0.018860946745562133,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
29,0.1,6,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","In acupuncture for neck pain, does needle quantity affect results? The use of 5 versus 10 needles is not the primary determinant of success. Instead, points are selected based on the patient's unique pain and cause, with the practitioner's expertise being vital.",3.079176455639103e-07,0.22406774426293374,0.036982248520710054,0.023574544042164344,0.25525596205856393,0.018860946745562133,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
29,0.1,7,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Is needle count a key factor in acupuncture treatment for neck pain? Whether 5 or 10 needles are used does not mainly influence effectiveness. The acupuncture points are chosen according to the individual's pain pattern and underlying cause, and the practitioner's skill is essential.",2.6054570009253947e-07,0.1764396952736793,0.036982248520710054,0.0199476911126006,0.20646579788913222,0.018860946745562133,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
29,0.1,8,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Does the number of needles used in acupuncture affect neck pain treatment? The difference between 5 and 10 needles is not the main factor for effectiveness. Points are selected based on the patient's specific pain and cause, with the practitioner's experience playing a crucial role.",2.3685972735685406e-07,0.15345017704897979,0.036982248520710054,0.018134264647818726,0.1829353004789378,0.018860946745562133,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
29,0.1,9,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","In treating neck pain with acupuncture, is the number of needles important? The effectiveness is not primarily determined by using 5 or 10 needles. Acupuncture points are chosen based on the individual's pain pattern and cause, and the practitioner's skill is key.",3.079176455639103e-07,0.22406774426293374,0.036982248520710054,0.023574544042164344,0.25525596205856393,0.018860946745562133,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
29,0.1,10,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? 
Answer: For this pathology, the number of needles, 5 or 10, is not the primary factor determining effectiveness.  Acupuncture points are strategically chosen based on the individual's specific pain pattern and underlying cause. The practitioner's skill and experience are crucial for optimal results. 
","Is the quantity of needles used in acupuncture relevant for neck pain treatment? The choice between 5 or 10 needles does not chiefly affect effectiveness. Points are selected according to the patient's specific pain and underlying cause, with the practitioner's expertise being critical.",2.8423167282822487e-07,0.19997019268387373,0.036982248520710054,0.02176111757738247,0.23056334946819224,0.018860946745562133,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
30,0.1,1,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are we adhering to guidelines when preparing high fall-risk patients for discharge after rehabilitation? Answer: Evidence shows minimal systematic falls risk assessments for high-risk individuals during rehab. When risks were found, strategies were usually applied. However, failure to",2.6054570009253926e-07,0.14106725176220847,0.08098765432098766,0.0199476911126006,0.17363970069367252,0.06222222222222222,0.019918816950481533,0.20763741384459067,0.04246913580246913,2.6054570009253947e-07,0.24315650106229247,0.021728395061728398
30,0.1,2,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we follow guidelines in preparing patients at high fall risk for discharge post-rehabilitation? Answer: There is scant evidence that systematic falls risk assessments occur for high-risk patients during rehab. When risks are detected, strategies tend to be implemented. However, failure to",1.6580180914979784e-07,0.04098379320522705,0.08098765432098766,0.012693985253473108,0.07098554663359025,0.06222222222222222,0.012675610786670066,0.10227689818676478,0.04246913580246913,1.6580180914979784e-07,0.13494291642206147,0.021728395061728398
30,0.1,3,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are guidelines met in preparing high fall-risk patients for discharge after rehabilitation? Answer: Little evidence exists that systematic falls risk assessments are conducted during rehab for those at high risk. When risks are identified, strategies are generally put in place. However, failure to",1.4211583641411244e-07,0.01745329579503263,0.08098765432098766,0.010880558788691236,0.04688799505453023,0.06222222222222222,0.0108648092457172,0.07758428559639308,0.04246913580246913,1.4211583641411244e-07,0.10962510843776974,0.021728395061728398
30,0.1,4,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Is the preparation of high fall-risk patients for discharge after rehabilitation guideline-compliant? Answer: There is limited evidence that systematic falls risk assessments are performed during rehabilitation for high-risk patients. When risks are recognized, strategies are typically implemented. However, failure to",2.1317375462116866e-07,0.08977395737465876,0.08098765432098766,0.016320838183036854,0.12099596720825367,0.06222222222222222,0.0162972138685758,0.15357019257431448,0.04246913580246913,2.1317375462116866e-07,0.1875866499074803,0.021728395061728398
30,0.1,5,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we comply with guidelines when preparing patients at high risk of falls for discharge after rehabilitation? Answer: Evidence suggests that systematic falls risk assessments are rarely done during rehab for high-risk individuals. When a risk is identified, a strategy is usually enacted. However, failure to",7.105791820705622e-08,0.04998798500049961,0.08098765432098766,0.005440279394345618,0.022104876432421428,0.06222222222222222,0.0054324046228586,0.006966718382439119,0.04246913580246913,7.105791820705622e-08,0.0373044468581436,0.021728395061728398
30,0.1,6,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are patients at high risk of falls adequately assessed and prepared for discharge after rehabilitation according to guidelines? Answer: There is little proof that systematic falls risk assessments are conducted during rehab for high-risk patients. When risks are found, strategies are generally applied. However, failure to",7.105791820705622e-08,0.04998798500049961,0.08098765432098766,0.005440279394345618,0.022104876432421428,0.06222222222222222,0.0054324046228586,0.006966718382439119,0.04246913580246913,7.105791820705622e-08,0.0373044468581436,0.021728395061728398
30,0.1,7,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: How well do we meet guidelines in preparing high fall-risk patients for discharge post-rehabilitation? Answer: Minimal evidence supports systematic falls risk assessments during rehab for those at high risk. When risks are identified, strategies are commonly implemented. However, failure to",2.1317375462116866e-07,0.08977395737465876,0.08098765432098766,0.016320838183036854,0.12099596720825367,0.06222222222222222,0.0162972138685758,0.15357019257431448,0.04246913580246913,2.1317375462116866e-07,0.1875866499074803,0.021728395061728398
30,0.1,8,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are guidelines followed in preparing patients at high risk of falls for discharge after rehabilitation? Answer: There is scarce evidence that systematic falls risk assessments take place during rehab for high-risk patients. When risks are detected, strategies are usually put into action. However, failure to",9.474389094274162e-08,0.02800907828172461,0.08098765432098766,0.0072537058591274906,0.00036797941963628844,0.06222222222222222,0.007243206163811466,0.029956236607138642,0.04246913580246913,9.474389094274162e-08,0.06083494426833802,0.021728395061728398
30,0.1,9,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Is the discharge preparation of patients at high risk of falls after rehabilitation consistent with guidelines? Answer: Little evidence indicates that systematic falls risk assessments occur during rehab for high-risk individuals. When risks are identified, strategies tend to be implemented. However, failure to",1.4211583641411244e-07,0.01745329579503263,0.08098765432098766,0.010880558788691236,0.04688799505453023,0.06222222222222222,0.0108648092457172,0.07758428559639308,0.04246913580246913,1.4211583641411244e-07,0.10962510843776974,0.021728395061728398
30,0.1,10,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we meet the recommended guidelines when preparing high fall-risk patients for discharge after rehabilitation? Answer: Evidence is limited that systematic falls risk assessments are performed during rehabilitation for high-risk patients. When a risk is found, a strategy is generally applied. However, failure to",1.1842986367842703e-07,0.005536222429666893,0.08098765432098766,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
31,0.1,1,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Do symptoms play a role in selecting patients for phase I clinical trials? Older adults with more symptoms participating in PICT might trade off Quality of Life (QOL) to gain access to experimental treatments, which raises ethical issues about exploiting vulnerable groups and underscores the importance of strong informed consent and patient-focused trial designs.",2.3685972735685406e-08,0.0190481949706931,0.0,0.0018134264647818726,0.019418085857102696,0.0,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
31,0.1,2,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Are symptoms important when choosing patients for phase I clinical trials? Older adults enrolled in PICT who have more symptoms may compromise their Quality of Life (QOL) to receive experimental treatments, posing ethical concerns about the exploitation of vulnerable populations and emphasizing the need for thorough informed consent and patient-centered trial frameworks.",2.3685972735685406e-08,0.019418085857102696,0.0,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
31,0.1,3,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","When considering patients for phase I clinical trials, do symptoms matter? Older adults with more symptoms in PICT might sacrifice their Quality of Life (QOL) to access experimental therapies, raising ethical questions about potential exploitation of vulnerable groups and highlighting the necessity for comprehensive informed consent and patient-focused trial designs.",7.105791820705622e-08,0.05942342047080107,0.0,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
31,0.1,4,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Is symptom presence significant in selecting patients for phase I clinical trials? Older adults with greater symptom burden in PICT may give up Quality of Life (QOL) to obtain experimental treatment, which brings up ethical concerns regarding the exploitation of vulnerable populations and stresses the importance of robust informed consent and patient-centered trial design.",2.3685972735685406e-08,0.0190481949706931,0.0,0.0018134264647818726,0.019418085857102696,0.0,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
31,0.1,5,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Do symptoms influence patient selection for phase I clinical trials? Older adults enrolled in PICT who experience more symptoms might sacrifice their Quality of Life (QOL) to access experimental treatments, raising ethical issues about exploiting vulnerable populations and the need for strong informed consent and patient-focused trial design.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
31,0.1,6,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Are symptoms a factor when considering patients for phase I clinical trials? Older adults with more symptoms in PICT may trade off Quality of Life (QOL) for access to experimental treatments, which raises ethical concerns about potential exploitation of vulnerable groups and highlights the importance of thorough informed consent and patient-centered trial design.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
31,0.1,7,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Does symptom severity matter in choosing patients for phase I clinical trials? Older adults enrolled in PICT with more symptoms might sacrifice their Quality of Life (QOL) to gain access to experimental treatments, raising ethical concerns about exploiting vulnerable populations and emphasizing the need for robust informed consent and patient-focused trial design.",2.3685972735685406e-08,0.019418085857102696,0.0,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
31,0.1,8,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","When selecting patients for phase I clinical trials, do symptoms matter? Older adults with more symptoms in PICT may compromise their Quality of Life (QOL) to receive experimental treatments, which raises ethical issues about the exploitation of vulnerable populations and underscores the importance of comprehensive informed consent and patient-centered trial design.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
31,0.1,9,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Is symptom burden relevant when considering patients for phase I clinical trials? Older adults enrolled in PICT who have more symptoms might sacrifice Quality of Life (QOL) to access experimental treatments, raising ethical concerns about potential exploitation of vulnerable populations and highlighting the need for strong informed consent and patient-focused trial design.",2.3685972735685406e-08,0.019418085857102696,0.0,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
31,0.1,10,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? 

Answer: Older adults enrolled in PICT with more symptoms may sacrifice Quality of Life (QOL) for experimental treatment access. This raises ethical concerns about potential exploitation of vulnerable populations, highlighting the need for robust informed consent procedures and patient-centered trial design. 
","Do symptoms impact the consideration of patients for phase I clinical trials? Older adults with more symptoms in PICT may trade off Quality of Life (QOL) to obtain experimental treatments, raising ethical concerns about exploiting vulnerable populations and emphasizing the importance of robust informed consent and patient-centered trial design.",9.474389094274162e-08,0.08004270767353683,0.0,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
32,0.1,1,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgery might enhance blood lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, possibly offering significant metabolic and cardiovascular advantages. Further prospective research is needed to confirm this.",7.105791820705622e-08,0.05540919288785506,0.09,0.005440279394345618,0.007841854085677724,0.046400951814396206,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
32,0.1,2,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can airway surgery decrease serum lipid concentrations in obstructive sleep apnea sufferers? Surgical intervention may improve lipid levels in OSA patients, especially those with dyslipidemia before surgery, potentially providing important metabolic and cardiovascular benefits. Prospective studies should investigate this further.",1.1842986367842692e-07,0.005398772313191635,0.09,0.009067132323909363,0.05913514847322743,0.046400951814396206,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
32,0.1,3,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is there a reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients? Surgery could lead to better blood lipid levels in OSA patients, notably in those with preoperative dyslipidemia, which might result in substantial metabolic and cardiovascular improvements. This warrants prospective study.",2.3685972735685406e-08,0.11769307459564704,0.06778925619834711,0.0018134264647818726,0.08746832571864793,0.046400951814396206,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
32,0.1,4,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does performing airway surgery lower serum lipid levels in individuals with obstructive sleep apnea? The procedure may positively affect blood lipid levels in OSA patients, particularly those with dyslipidemia prior to surgery, potentially offering major metabolic and cardiovascular benefits. Prospective studies are recommended.",4.737194547137081e-08,0.01349272727073103,0.04249999999999998,0.0036268529295637453,0.016961299083595893,0.022025951814396205,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
32,0.1,5,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can surgery on the airway reduce serum lipid levels in patients suffering from obstructive sleep apnea? Airway surgery may improve lipid profiles in OSA patients, especially those with preoperative dyslipidemia, potentially leading to significant metabolic and cardiovascular benefits. This should be explored in prospective studies.",0.0,0.12602676010180902,0.09,0.0,0.06447880749394841,0.046400951814396206,0.0,0.0,0.0,0.0,0.0,0.0
32,0.1,6,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is airway surgery effective in lowering serum lipid levels among obstructive sleep apnea patients? Surgical treatment might improve blood lipid levels in OSA patients, particularly those with dyslipidemia before surgery, potentially providing important metabolic and cardiovascular advantages. Prospective studies need to evaluate this.",4.737194547137081e-08,0.0464997358688235,0.06620464009518144,0.0036268529295637453,0.016850758504693975,0.046400951814396206,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
32,0.1,7,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery have an impact on serum lipid levels in obstructive sleep apnea patients? Surgery may enhance lipid levels in patients with OSA, especially those with preoperative dyslipidemia, potentially resulting in major metabolic and cardiovascular benefits. Further prospective research is necessary.",7.105791820705622e-08,0.012214922288724672,0.041347797501643656,0.005440279394345618,0.042499213113674106,0.021417388369294285,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
32,0.1,8,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can obstructive sleep apnea patients experience lowered serum lipid levels after airway surgery? Surgery might improve blood lipid profiles in OSA patients, particularly those with dyslipidemia prior to surgery, potentially yielding significant metabolic and cardiovascular benefits. Prospective studies should be conducted.",9.474389094274162e-08,0.030716580297483365,0.09,0.0072537058591274906,0.03315966206996945,0.046400951814396206,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
32,0.1,9,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is there evidence that airway surgery lowers serum lipid levels in obstructive sleep apnea patients? Surgical intervention may improve lipid levels in OSA patients, especially those with preoperative dyslipidemia, potentially offering major benefits in metabolism and cardiovascular outcomes. This should be examined in prospective studies.",0.0,0.06301338005090429,0.0446485260770975,0.0,0.032239403746974205,0.023158321428908682,0.0,0.0,0.0,0.0,0.0,0.0
32,0.1,10,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery contribute to lowering serum lipid levels in patients with obstructive sleep apnea? Surgery may improve blood lipid levels in OSA patients, particularly those with preoperative dyslipidemia, potentially providing significant metabolic and cardiovascular benefits. Prospective studies are warranted.",1.1842986367842692e-07,0.06569324620577666,0.038867786705624546,0.009067132323909363,0.09561657902901377,0.020104384977288833,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
33,0.1,1,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography a suitable alternative to bone scintigraphy for detecting bone metastases in breast cancer? Answer: Our results indicate that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are conducted.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.1,2,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans replace bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our study suggests that routine bone scintigraphy is not needed for patients with metastatic breast cancer when CT imaging of the thorax, abdomen, and pelvis is performed.",1.421158364141119e-07,0.12441194762660457,0.024375,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,0.1,3,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it possible to substitute bone scintigraphy with computerized tomography for detecting bone metastases in breast cancer patients? Answer: Findings show that routine bone scintigraphy is not required if CT scans of the thorax, abdomen, and pelvis are done in patients with metastatic breast cancer.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.1,4,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can computerized tomography serve as a replacement for bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our data suggest that routine bone scintigraphy is unnecessary for metastatic breast cancer patients if CT imaging of the thorax, abdomen, and pelvis is carried out.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,0.1,5,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Does computerized tomography have the potential to replace bone scintigraphy in the detection of bone metastases in breast cancer? Answer: According to our findings, routine bone scintigraphy is not required for patients with metastatic breast cancer when CT scans of the thorax, abdomen, and pelvis are performed.",2.8423167282822434e-07,0.265303915515966,0.0212665406427221,0.02176111757738248,0.3022808718729326,0.0,0.021729618491434413,0.3101549283038394,0.0,2.8423167282822487e-07,0.31845373111853537,0.0
33,0.1,6,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT imaging replace bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: Our evidence suggests that routine bone scintigraphy is not needed if CT scans of the thorax, abdomen, and pelvis are conducted in patients presenting with metastatic breast cancer.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
33,0.1,7,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is computerized tomography an effective alternative to bone scintigraphy in identifying bone metastases from breast cancer? Answer: Our findings indicate that routine bone scintigraphy is unnecessary for metastatic breast cancer patients if CT of the thorax, abdomen, and pelvis is performed.",1.421158364141119e-07,0.12441194762660457,0.024375,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,0.1,8,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can bone scintigraphy be replaced by computerized tomography in the detection of bone metastases in breast cancer? Answer: Our results imply that routine bone scintigraphy is not required for patients with metastatic breast cancer when CT imaging of the thorax, abdomen, and pelvis is done.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.1,9,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Is it feasible to use computerized tomography instead of bone scintigraphy to detect bone metastases in breast cancer? Answer: Our study suggests that routine bone scintigraphy is unnecessary if CT scans of the thorax, abdomen, and pelvis are performed in patients with metastatic breast cancer.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,0.1,10,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Question: Can CT scans substitute bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: Our findings suggest that routine bone scintigraphy is not needed for patients presenting with metastatic breast cancer if CT imaging of the thorax, abdomen, and pelvis is carried out.",2.1317375462116813e-07,0.16582819237794366,0.045351473922902494,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
34,0.1,1,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a clinically significant issue in general adult psychiatry? We discovered that pain can be a major clinical concern for psychiatric patients who have a higher likelihood of chronic pain conditions, probably because of the greater occurrence of depression, anxiety, and substance abuse among them.",1.8948778188548325e-07,0.13747292640218056,0.018860946745562133,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
34,0.1,2,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Does pain represent a clinically relevant problem in adult psychiatry? Evidence shows that pain is a notable clinical issue in psychiatric patients prone to chronic pain, likely due to the higher rates of depression, anxiety, and substance abuse in this group.",3.079176455639103e-07,0.25525596205856393,0.018860946745562133,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
34,0.1,3,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain an important clinical problem in general adult psychiatry? Our findings indicate that pain can be a significant concern in psychiatric patients at increased risk for chronic pain, likely linked to the higher prevalence of depression, anxiety, and substance abuse.",3.079176455639103e-07,0.25525596205856393,0.018860946745562133,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
34,0.1,4,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a clinically meaningful problem in adult psychiatry? We found that pain is a considerable clinical issue among psychiatric patients who are more susceptible to chronic pain conditions, probably because of the elevated rates of depression, anxiety, and substance abuse.",3.079176455639103e-07,0.25525596205856393,0.018860946745562133,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
34,0.1,5,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a relevant clinical problem in general adult psychiatry? Evidence suggests that pain can be a significant clinical challenge in psychiatric patients with a higher risk of chronic pain, likely due to the increased presence of depression, anxiety, and substance abuse.",2.8423167282822487e-07,0.23056334946819224,0.018860946745562133,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
34,0.1,6,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a clinically pertinent issue in adult psychiatry? Our research shows that pain may be a major clinical problem for psychiatric patients who have a greater risk of chronic pain conditions, likely because of the higher incidence of depression, anxiety, and substance abuse.",2.3685972735685406e-07,0.1829353004789378,0.018860946745562133,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
34,0.1,7,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a clinically important problem in general adult psychiatry? We found evidence that pain can be a significant clinical issue in psychiatric patients at higher risk for chronic pain, probably due to the increased prevalence of depression, anxiety, and substance abuse.",2.8423167282822487e-07,0.23056334946819224,0.018860946745562133,0.02176111757738247,0.2623642644674917,0.0,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
34,0.1,8,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a clinically relevant concern in adult psychiatry? Findings indicate that pain is a significant clinical problem among psychiatric patients more prone to chronic pain, likely because of the higher rates of depression, anxiety, and substance abuse.",3.789755637709662e-07,0.3332175035282745,0.018860946745562133,0.029014823436509962,0.3677247801253176,0.0,0.028972824655245866,0.37647757123491177,0.0,3.789755637709665e-07,0.3856624808119835,0.0
34,0.1,9,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a clinically significant concern in general adult psychiatry? We observed that pain can be a major clinical problem in psychiatric patients who are at increased risk for chronic pain, likely due to the higher occurrence of depression, anxiety, and substance abuse.",2.6054570009253947e-07,0.20646579788913222,0.018860946745562133,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
34,0.1,10,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? 
Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients who are at higher risk for chronic pain conditions. This is likely due to the increased prevalence of conditions like depression, anxiety, and substance abuse in these patients. 
","Is pain a clinically relevant issue in adult psychiatry? Evidence reveals that pain can be a significant clinical problem in psychiatric patients with elevated risk for chronic pain conditions, probably because of the greater prevalence of depression, anxiety, and substance abuse.",3.079176455639103e-07,0.25525596205856393,0.018860946745562133,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
35,0.1,1,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.1,2,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can preoperative statins lower the incidence of atrial fibrillation following coronary artery bypass grafting? Answer: Our research suggests that administering statins before surgery may decrease the occurrence of AF after CABG.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
35,0.1,3,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Are preoperative statins effective in preventing atrial fibrillation post-coronary artery bypass grafting? Answer: Findings from our study show that preoperative statin use appears to reduce AF after CABG.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
35,0.1,4,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does the use of statins before coronary artery bypass grafting reduce atrial fibrillation? Answer: Our study demonstrated that preoperative statin therapy likely diminishes the risk of AF development following CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,0.1,5,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,"Question: Is atrial fibrillation less common after CABG when patients receive statins preoperatively? Answer: According to our study, preoperative statin treatment seems to lower AF incidence after CABG.",2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,0.1,6,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do statins given before coronary artery bypass grafting help in reducing atrial fibrillation? Answer: Our findings indicate that preoperative statin therapy may reduce the chance of AF after CABG.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
35,0.1,7,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can pre-surgery statin therapy decrease atrial fibrillation rates after coronary artery bypass grafting? Answer: Our study suggests that statins administered preoperatively reduce AF development post-CABG.,2.36859727356853e-08,0.03922071315328246,0.0,0.0018134264647818796,0.04082199452025481,0.0,0.0018108015409528735,0.04255961441879563,0.0,2.3685972735685406e-08,0.04445176257083405,0.0
35,0.1,8,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does preoperative statin administration impact atrial fibrillation occurrence after CABG? Answer: The study results imply that preoperative statin use reduces AF following coronary artery bypass grafting.,0.0,0.053319013889226774,0.03840000000000001,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,0.1,9,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Are patients less likely to develop atrial fibrillation after CABG if given statins beforehand? Answer: Our research indicates that preoperative statin therapy appears to lower AF risk after CABG.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
35,0.1,10,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does taking statins before coronary artery bypass grafting reduce the likelihood of atrial fibrillation? Answer: Our study found that preoperative statin treatment seems to decrease AF development after CABG.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
36,0.1,1,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals pertinent and useful for practitioners and athletes? There is a lack of research focusing on diagnostic and treatment methods in sports medicine literature. The evidence supporting sports medicine needs to grow both in quantity and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.1,2,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals hold relevance and applicability for practitioners and athletes? Studies on diagnostic and treatment interventions in sports medicine are scarce. The body of evidence in sports medicine should expand in volume and improve in quality.,1.6580180914979753e-07,0.22491042517533,0.04630283485943398,0.012693985253473108,0.21618935393522687,0.02775510204081633,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
36,0.1,3,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and relevant to practitioners and athletes? The sports medicine literature shows a shortage of studies on diagnostic and treatment interventions. The evidence base in sports medicine requires further growth in both amount and quality.,1.4211583641411222e-07,0.15843063997897167,0.015054169816074561,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.1,4,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Is the content of sports medicine journals relevant and useful to practitioners and athletes? There is a notable deficiency of research on diagnostic and treatment interventions within sports medicine literature. The evidence supporting sports medicine must increase in both volume and quality.,7.105791820705622e-08,0.0760984489201686,0.006963732238457573,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
36,0.1,5,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals meaningful and applicable to practitioners and athletes? Few studies address diagnostic and treatment interventions in the sports medicine field. The evidence base for sports medicine needs to be expanded in terms of both quantity and quality.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,0.1,6,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals provide relevant and applicable information for practitioners and athletes? There is a scarcity of studies on diagnostic and treatment interventions in sports medicine literature. The evidence base must continue to grow in volume and quality.,1.4211583641411222e-07,0.10817952142938081,0.06667395470484272,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,0.1,7,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and practical for practitioners and athletes? The literature in sports medicine lacks sufficient studies on diagnostic and treatment interventions. The evidence supporting sports medicine should increase in both quantity and quality.,2.1317375462116813e-07,0.2481029567106905,0.02456850508798565,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
36,0.1,8,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals useful and relevant to practitioners and athletes? There is a shortage of research on diagnostic and treatment interventions in sports medicine literature. The evidence base for sports medicine must be enhanced in terms of volume and quality.,9.474389094274162e-08,0.10280071813615255,0.00952255325029372,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
36,0.1,9,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and significant for practitioners and athletes? The sports medicine literature has limited studies on diagnostic and treatment interventions. The evidence base needs to grow in both volume and quality.,2.605457000925387e-07,0.25478560916743653,0.0626970840419501,0.01994769111260062,0.29546421289383584,0.0,0.01991881695048156,0.30368241379822125,0.0,2.6054570009253947e-07,0.31237468504215293,0.0
36,0.1,10,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals relevant and beneficial to practitioners and athletes? There is a deficiency of studies addressing diagnostic and treatment interventions in sports medicine literature. The evidence base must continue to expand in both quantity and quality.,1.6580180914979753e-07,0.13583375312115775,0.06596434870244393,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
37,0.1,1,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? This research demonstrated for the first time that RALP causes less tissue damage than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.1,2,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy result in less invasiveness than retropubic radical prostatectomy? The study revealed that RALP leads to reduced tissue trauma compared to RRP for the first time.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,0.1,3,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP less invasive than RRP? This investigation showed initially that robotically assisted laparoscopic radical prostatectomy produces lower tissue injury than retropubic radical prostatectomy.,1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
37,0.1,4,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy associated with less invasiveness than retropubic radical prostatectomy? The findings indicated for the first time that RALP causes less tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,0.1,5,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the invasiveness of robotically assisted laparoscopic radical prostatectomy less than that of retropubic radical prostatectomy? This study was the first to show that RALP results in decreased tissue trauma compared to RRP.,9.47438909427412e-08,0.1335313926245223,0.0,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
37,0.1,6,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy cause less tissue trauma than retropubic radical prostatectomy? This research demonstrated for the first time that RALP is less invasive than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.1,7,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? The study showed for the first time that RALP induces less tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,0.1,8,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP less invasive than retropubic radical prostatectomy? This study revealed for the first time that robotically assisted laparoscopic radical prostatectomy results in lower tissue trauma than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,0.1,9,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? This study was the first to demonstrate that RALP causes less tissue trauma than RRP.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
37,0.1,10,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy associated with reduced invasiveness compared to retropubic radical prostatectomy? The study showed for the first time that RALP induces lower tissue trauma than RRP.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
38,0.1,1,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there an ideal duration of acid suppression for optimal healing in Los Angeles grades C and D reflux oesophagitis? Answer: After 4 weeks of acid-suppressive treatment for LA grade C or D oesophagitis, healing seems to plateau, with further improvements unlikely even if the duration of intragastric pH>4 is increased.",2.6054570009253947e-07,0.2224909946956659,0.019599999999999992,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
38,0.1,2,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the best length of acid suppression therapy for maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: Healing of LA grade C or D oesophagitis after 4 weeks of acid suppression reaches a limit, beyond which additional hours with intragastric pH>4 do not significantly enhance recovery.",2.6054570009253947e-07,0.24967323707056588,0.039150354019158694,0.0199476911126006,0.22657674596756294,0.019991670137442734,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
38,0.1,3,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: For Los Angeles grades C and D reflux oesophagitis, is there an optimal acid suppression time to maximize healing? Answer: After 4 weeks of acid-suppressive therapy, healing in LA grade C or D oesophagitis attains a threshold, and further increases in intragastric pH>4 duration do not yield notable improvements.",3.079176455639103e-07,0.23531408693446476,0.0,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,0.1,4,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Does an optimal acid suppression duration exist for maximal healing in LA grade C and D reflux oesophagitis? Answer: Successful healing after 4 weeks of acid suppression in LA grade C or D oesophagitis reaches a plateau, with little benefit from extending the time with intragastric pH>4.",3.552895910352811e-07,0.3949692821537476,0.08436992969172526,0.02720139697172809,0.34250613555899356,0.043388429752066124,0.027162023114293,0.3184886138099996,0.02221074380165289,3.552895910352811e-07,0.2933478099874569,0.0
38,0.1,5,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the optimal acid suppression period for healing Los Angeles grades C and D reflux oesophagitis? Answer: After 4 weeks of acid-suppressive therapy, healing in LA grade C or D oesophagitis appears to reach a maximum, beyond which increasing intragastric pH>4 hours does not improve outcomes.",3.552895910352811e-07,0.2769867833350337,0.0,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,0.1,6,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there a best duration for acid suppression to achieve maximal healing in LA grade C and D reflux oesophagitis? Answer: Healing after 4 weeks of acid suppression in LA grade C or D oesophagitis seems to hit a ceiling, with no further gains despite longer periods of intragastric pH>4.",2.8423167282822487e-07,0.32601492850653724,0.07939508506616258,0.02176111757738247,0.2756370093736993,0.040742417383431435,0.0217296184914344,0.25202468383753907,0.020823902218198284,2.8423167282822487e-07,0.22738984219566083,0.0
38,0.1,7,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: How long should acid suppression be applied for optimal healing in Los Angeles grades C and D reflux oesophagitis? Answer: Four weeks of acid-suppressive therapy leads to a healing threshold in LA grade C or D oesophagitis, beyond which additional intragastric pH>4 time does not enhance healing.",3.552895910352811e-07,0.2769867833350337,0.0,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,0.1,8,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there an optimal acid suppression timeframe for maximal healing in LA grade C and D reflux oesophagitis? Answer: After 4 weeks of acid suppression, healing in LA grade C or D oesophagitis reaches a plateau, and increasing intragastric pH>4 duration does not further improve healing.",3.789755637709665e-07,0.4190403243055525,0.08616780045351476,0.029014823436509962,0.39663099847764993,0.06632653061224489,0.028972824655245866,0.37316830835474235,0.045351473922902494,3.789755637709665e-07,0.34857673195913064,0.023242630385487524
38,0.1,9,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What duration of acid suppression yields maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: Healing after 4 weeks of acid-suppressive therapy in LA grade C or D oesophagitis appears to reach a limit, with no significant improvement from longer intragastric pH>4 exposure.",3.789755637709665e-07,0.29849298855599704,0.0,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
38,0.1,10,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there an optimal length of acid suppression for maximal healing in LA grade C and D reflux oesophagitis? Answer: After 4 weeks of acid-suppressive treatment, healing in LA grade C or D oesophagitis seems to plateau, with further increases in intragastric pH>4 hours unlikely to enhance recovery.",3.316036182995957e-07,0.3714579042305246,0.08264462809917356,0.025387970506946217,0.3492131365772879,0.06353305785123965,0.025351221573340132,0.3259768336077826,0.043388429752066124,3.316036182995957e-07,0.3016814954936189,0.02221074380165289
39,0.1,1,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Does viral infection contribute to benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, especially in spring and autumn. Viral infections may trigger BPPV episodes by causing vestibulopathy or secondary BPPV through neurolabyrinthitis related to viral infection.",3.0791764556391007e-07,0.29423947299793873,0.0,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.1,2,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a connection between viral infections and benign paroxysmal positional vertigo? BPPV shows association with positive viral serology, particularly in spring and autumn months. Viral infections could lead to BPPV attacks by inducing vestibulopathy or secondary BPPV via viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,0.1,3,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections play a role in benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, mainly during spring and autumn. Viral infections might cause BPPV episodes by developing vestibulopathy or triggering secondary BPPV through viral neurolabyrinthitis.",3.3160361829959537e-07,0.358375135245502,0.027006172839506164,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
39,0.1,4,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections involved in benign paroxysmal positional vertigo? BPPV is connected to positive viral serology, especially in spring and autumn seasons. Viral infections may provoke BPPV attacks by causing vestibulopathy or secondary BPPV via viral neurolabyrinthitis.",3.5528959103528067e-07,0.38681487096598977,0.02775510204081633,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,0.1,5,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Can viral infections influence benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, particularly in spring and autumn. Viral infections might promote BPPV by inducing vestibulopathy or secondary BPPV through viral neurolabyrinthitis.",4.2634750924233657e-07,0.4773269912917808,0.0302734375,0.03264167636607373,0.446287102628419,0.0,0.03259442773715163,0.4578330936254802,0.0,4.263475092423373e-07,0.47000362924573613,0.0
39,0.1,6,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is benign paroxysmal positional vertigo linked to viral infections? BPPV is related to positive viral serology, mainly in spring and autumn. Viral infections could trigger BPPV attacks by causing vestibulopathy or secondary BPPV via viral neurolabyrinthitis.",3.7897556377096597e-07,0.37647757123491177,0.0,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
39,0.1,7,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections have an impact on benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially during spring and autumn. Viral infections may lead to BPPV episodes by developing vestibulopathy or secondary BPPV through viral neurolabyrinthitis.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
39,0.1,8,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Are viral infections a factor in benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, particularly in spring and autumn months. Viral infections might induce BPPV attacks by causing vestibulopathy or secondary BPPV via viral neurolabyrinthitis.",3.5528959103528067e-07,0.38681487096598977,0.02775510204081633,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,0.1,9,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Could viral infections contribute to benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, mainly during spring and autumn. Viral infections may promote BPPV by inducing vestibulopathy or secondary BPPV through viral neurolabyrinthitis.",4.0266153650665127e-07,0.446238471670513,0.029384756657483937,0.03082824990129185,0.4155154439616653,0.0,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
39,0.1,10,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a role for viral infections in benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, especially in spring and autumn. Viral infections might trigger BPPV attacks by causing vestibulopathy or secondary BPPV via viral neurolabyrinthitis.",3.0791764556391007e-07,0.3307209035537251,0.026296566837107373,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
40,0.1,1,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults who are at risk for Type 2 diabetes? In this at-risk population with skin microvascular dysfunction, maximal oxygen uptake was similar to healthy controls. Yet, within the at-risk group, those with greater aerobic fitness showed improved microvascular and endothelial responsiveness.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
40,0.1,2,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there an impact of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes? Among this at-risk group exhibiting skin microvascular dysfunction, maximal oxygen uptake did not differ from healthy controls. However, individuals with higher aerobic fitness in this group demonstrated enhanced microvascular and endothelial function.",1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
40,0.1,3,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness influence microvascular function in healthy adults predisposed to Type 2 diabetes? In this at-risk cohort with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. Still, within the at-risk group, higher aerobic fitness correlated with better microvascular and endothelial responsiveness.",2.1317375462116866e-07,0.18855475257743093,0.007076574999485136,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.1,4,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness relate to microvascular function in healthy adults at risk for Type 2 diabetes? The at-risk group with skin microvascular dysfunction showed no reduction in maximal oxygen uptake compared to healthy controls. Nevertheless, those with higher aerobic fitness in this group had superior microvascular and endothelial responses.",1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
40,0.1,5,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is aerobic fitness associated with microvascular function in healthy adults at risk of developing Type 2 diabetes? In this at-risk group with skin microvascular dysfunction, maximal oxygen uptake was comparable to healthy controls. Yet, among these individuals, higher aerobic fitness was linked to improved microvascular and endothelial responsiveness.",1.8948778188548325e-07,0.13627050418636832,0.015045314109858886,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.1,6,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness impact microvascular function in healthy adults at risk for Type 2 diabetes? Maximal oxygen uptake was not diminished in the at-risk group with skin microvascular dysfunction compared to healthy controls. However, within this group, individuals with greater aerobic fitness exhibited better microvascular and endothelial function.",1.8948778188548325e-07,0.13627050418636832,0.015045314109858886,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.1,7,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","What is the effect of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes? In the at-risk group with skin microvascular dysfunction, maximal oxygen uptake matched that of healthy controls. Still, those with higher aerobic fitness had enhanced microvascular and endothelial responsiveness.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,0.1,8,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Can aerobic fitness influence microvascular function in healthy adults at risk for Type 2 diabetes? Among the at-risk group with skin microvascular dysfunction, maximal oxygen uptake was not reduced relative to healthy controls. However, higher aerobic fitness within this group was associated with improved microvascular and endothelial function.",1.8948778188548325e-07,0.13627050418636832,0.015045314109858886,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.1,9,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults at risk of Type 2 diabetes? In this at-risk population with skin microvascular dysfunction, maximal oxygen uptake was not lower than in healthy controls. Yet, individuals with higher aerobic fitness in this group showed better microvascular and endothelial responsiveness.",1.8948778188548325e-07,0.19526175359572528,0.027221203098658664,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,0.1,10,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there a relationship between aerobic fitness and microvascular function in healthy adults at risk for Type 2 diabetes? The at-risk group with skin microvascular dysfunction did not have reduced maximal oxygen uptake compared to healthy controls. However, those with higher aerobic fitness within this group demonstrated improved microvascular and endothelial function.",9.474389094274162e-08,0.052279090842322073,0.016711854752580996,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
41,0.1,1,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our findings indicate that UHR intake criteria forecast transition within 6 months in the sequence of Trait alone<APS<BLIPS. The observation that BLIPS patients face the greatest short-term transition risk aligns with the ""early"" versus ""late"" prodrome model. It also suggests",1.4211583641411244e-07,0.07677922342075583,0.015621063240110858,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
41,0.1,2,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: According to our data, UHR intake criteria predict a 6-month transition risk in the order Trait alone<APS<BLIPS. The highest short-term transition risk in BLIPS patients supports the ""early"" versus ""late"" prodrome framework. It further implies",2.6054570009253947e-07,0.21924331517429518,0.022056752984418164,0.0199476911126006,0.21855051475472065,0.01922337562475971,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
41,0.1,3,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our research shows that UHR intake criteria estimate transition risk over 6 months as Trait alone<APS<BLIPS. The elevated short-term risk for BLIPS patients is consistent with the ""early"" versus ""late"" prodrome concept. It also indicates",2.6054570009253947e-07,0.19308681779467474,0.0032398835054512753,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
41,0.1,4,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Data from our study suggest that UHR intake criteria rank transition risk within 6 months as Trait alone<APS<BLIPS. The fact that BLIPS patients have the highest short-term transition risk aligns with the ""early"" versus ""late"" prodrome model. It also points to",1.1842986367842703e-07,0.08318130465670848,0.0013230509097107834,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
41,0.1,5,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our evidence suggests UHR intake criteria predict 6-month transition risk in the order Trait alone<APS<BLIPS. The highest risk for BLIPS patients over the short term is consistent with the ""early"" versus ""late"" prodrome theory. It also indicates",2.1317375462116866e-07,0.15509440075506564,0.0025545197502869436,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
41,0.1,6,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: The data imply that UHR intake criteria forecast transition within 6 months as Trait alone<APS<BLIPS. The greatest short-term transition risk in BLIPS patients supports the ""early"" versus ""late"" prodrome model. It also suggests",3.079176455639103e-07,0.20539660124284964,0.015621063240110858,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
41,0.1,7,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our analysis indicates that UHR intake criteria predict transition risk over 6 months in the order Trait alone<APS<BLIPS. The fact that BLIPS patients are at highest short-term risk aligns with the ""early"" versus ""late"" prodrome framework. It also implies",1.6580180914979784e-07,0.09417096613262466,0.015621063240110858,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
41,0.1,8,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Findings from our data suggest UHR intake criteria rank transition risk within 6 months as Trait alone<APS<BLIPS. The highest short-term risk for BLIPS patients is consistent with the ""early"" versus ""late"" prodrome model. It also indicates",2.3685972735685406e-07,0.17391030520141637,0.002890862712185324,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
41,0.1,9,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our study data suggest that UHR intake criteria predict transition over 6 months in the order Trait alone<APS<BLIPS. The fact that BLIPS patients have the highest short-term transition risk aligns with the ""early"" versus ""late"" prodrome model. It also suggests",1.4211583641411244e-07,0.07677922342075583,0.015621063240110858,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
41,0.1,10,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Evidence from our data indicates that UHR intake criteria forecast transition risk within 6 months as Trait alone<APS<BLIPS. The highest short-term risk for BLIPS patients supports the ""early"" versus ""late"" prodrome concept. It also implies",2.6054570009253947e-07,0.19308681779467474,0.0032398835054512753,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
42,0.1,1,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Is preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Preoperative platelet count serves as a predictor for long-term survival and recurrence in ESCC patients. Higher platelet levels correlate with advanced tumor stage, lymph node metastasis, and worse outcomes. Additional studies are required to understand the mechanisms and clinical significance of this link.",2.3685972735685406e-07,0.1345998748224373,0.025239973701512167,0.018134264647818726,0.15498996542157784,0.012850958656211584,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
42,0.1,2,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Does preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? The platelet count before surgery can forecast long-term survival and recurrence in patients with ESCC. Elevated platelet counts are linked to higher tumor stages, lymph node involvement, and poorer prognosis. More research is necessary to clarify the biological and clinical relevance of this relationship.",2.3685972735685406e-07,0.10892775702392044,0.043710296269926036,0.018134264647818726,0.12883346804195694,0.03171190540177372,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
42,0.1,3,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Can preoperative platelet count be used as a prognostic factor in esophageal squamous cell carcinoma? In ESCC patients, preoperative platelet count predicts survival and recurrence risks. Increased platelet counts are associated with advanced tumor progression, lymph node metastasis, and unfavorable prognosis. Further investigation is needed to explore the underlying mechanisms and clinical impact.",2.8423167282822487e-07,0.17431498109747778,0.02382222222222221,0.02176111757738247,0.19448199124465226,0.012111905401773725,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
42,0.1,4,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Is the platelet count before surgery a prognostic marker in esophageal squamous cell carcinoma? Preoperative platelet levels predict long-term survival and recurrence in ESCC cases. Elevated platelet counts correspond with more advanced tumor stages, lymph node metastases, and worse prognosis. Additional research is required to understand the mechanisms and clinical implications.",3.316036182995957e-07,0.16021668036153347,0.06222222222222222,0.025387970506946217,0.2073050834834511,0.03171190540177372,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
42,0.1,5,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Does the preoperative platelet count influence prognosis in esophageal squamous cell carcinoma? Preoperative platelet count is a prognostic factor for survival and recurrence in ESCC patients. Higher platelet counts are linked to increased tumor stage, lymph node metastasis, and poorer outcomes. Further studies are needed to clarify the biological and clinical significance.",3.079176455639103e-07,0.1947785378151532,0.023071868203063527,0.023574544042164344,0.2148282633883305,0.011720235264330983,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
42,0.1,6,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Is preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? The platelet count before surgery predicts long-term survival and recurrence in patients with ESCC. Elevated platelet counts are associated with advanced tumor stage, lymph node metastasis, and worse prognosis. More research is necessary to elucidate the underlying mechanisms and clinical relevance.",2.6054570009253947e-07,0.1281042696171788,0.04336127547666009,0.0199476911126006,0.14788166301265004,0.03171190540177372,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
42,0.1,7,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Can the preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? In ESCC patients, preoperative platelet count forecasts survival and recurrence. Higher platelet counts correlate with advanced tumor stages, lymph node metastasis, and poorer prognosis. Further investigation is needed to understand the clinical and biological implications.",3.552895910352811e-07,0.2370028309900678,0.021479804838790785,0.02720139697172809,0.25680550320951756,0.010888003183575433,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
42,0.1,8,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Is the preoperative platelet count a useful prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival and recurrence in ESCC patients. Elevated platelet counts are linked to increased tumor stage, lymph node metastasis, and unfavorable prognosis. Additional research is required to clarify the mechanisms and clinical significance.",3.316036182995957e-07,0.215668454806329,0.022291666666666654,0.025387970506946217,0.2355968051389592,0.011312599846218161,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
42,0.1,9,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Does preoperative platelet count have prognostic value in esophageal squamous cell carcinoma? The platelet count before surgery is predictive of survival and recurrence in ESCC. Higher platelet counts are associated with advanced tumor stage, lymph node metastasis, and poorer prognosis. Further studies are needed to explore the underlying mechanisms and clinical implications.",3.079176455639103e-07,0.16759629544025323,0.04262222222222223,0.023574544042164344,0.1871023761659325,0.03171190540177372,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
42,0.1,10,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? 

Answer: Preoperative platelet count is a predictive factor for long-term survival and recurrence in patients with esophageal squamous cell carcinoma (ESCC). Elevated platelet counts are associated with increased tumor stage, lymph node metastasis, and poorer prognosis. Further research is needed to elucidate the underlying mechanisms and clinical implications of this association. 
","Is preoperative platelet count a significant prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival and recurrence in patients with ESCC. Elevated platelet counts correlate with increased tumor stage, lymph node metastasis, and worse prognosis. More research is necessary to understand the biological and clinical relevance.",3.552895910352811e-07,0.2370028309900678,0.021479804838790785,0.02720139697172809,0.25680550320951756,0.010888003183575433,0.027162023114293,0.2769867833350337,0.0,3.552895910352811e-07,0.28223246768421584,0.0
43,0.1,1,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do the leadership abilities of residents correlate with their technical skill ratings? Research on general surgery residents found that intraoperative leadership skills significantly correlated with their perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions might offer an additional personalized intraoperative evaluation metric. Further study is needed.,7.105791820705622e-08,0.0623235119648653,0.0012239022181982917,0.005440279394345618,0.06187540371808753,0.0,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
43,0.1,2,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Is there a relationship between residents' leadership skills and their technical skill ratings? Studies on general surgery research residents revealed that intraoperative leadership skills were significantly linked to their views on skill decay and task difficulty during bowel repair. Evaluating residents' directional commands could provide another individualized intraoperative assessment tool. More research is warranted.,1.1842986367842703e-07,0.10181553778793972,0.0019629554726361513,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
43,0.1,3,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are residents' leadership skills associated with their technical skill ratings? Research involving general surgery residents showed significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Analyzing residents' directional instructions may serve as an additional personalized intraoperative assessment measure. Further investigation is required.,2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
43,0.1,4,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do leadership skills of residents have a connection to their technical skill ratings? General surgery research residents' intraoperative leadership skills demonstrated significant correlations with their perceptions of skill decay and task difficulty during bowel repair. Assessing directional instructions given by residents might offer an extra individualized intraoperative evaluation metric. Additional evaluation is necessary.,9.474389094274162e-08,0.08226433325225413,0.001600526593438574,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
43,0.1,5,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Is there a link between residents' leadership abilities and their technical skill ratings? Research on general surgery residents indicated that intraoperative leadership skills significantly correlated with perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions could provide a supplementary individualized intraoperative assessment metric. Further study is needed.,7.105791820705622e-08,0.08950575433976482,0.020823902218198284,0.005440279394345618,0.06187540371808753,0.0,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
43,0.1,6,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,"Do residents' leadership skills relate to their technical skill ratings? In general surgery research residents, intraoperative leadership skills showed significant correlations with perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions may offer an additional personalized intraoperative evaluation metric. Further evaluation is required.",2.3685972735685406e-08,0.021667901379180954,0.00044263842452381755,0.0018134264647818726,0.02150620522096336,0.0,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
43,0.1,7,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are residents' leadership skills connected to their technical skill ratings? Research on general surgery residents found significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Evaluating directional instructions from residents might provide an extra individualized intraoperative assessment tool. More research is necessary.,2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
43,0.1,8,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Is there an association between residents' leadership skills and their technical skill ratings? Studies with general surgery research residents revealed significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Assessing residents' directional instructions may serve as an additional personalized intraoperative evaluation metric. Further investigation is warranted.,1.1842986367842703e-07,0.07565904040831928,0.016853914006330732,0.009067132323909363,0.0744366099267566,0.01922337562475971,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
43,0.1,9,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do the leadership skills of residents impact their technical skill ratings? Research on general surgery residents demonstrated significant correlations between intraoperative leadership skills and perceptions of skill decay and task difficulty during bowel repair. Evaluating residents' directional instructions could provide an additional individualized intraoperative assessment measure. More study is needed.,2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
43,0.1,10,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are residents' leadership skills linked to their technical skill ratings? General surgery research residents' intraoperative leadership skills showed significant correlations with their perceptions of skill decay and task difficulty during bowel repair. Assessing directional instructions given by residents might offer a supplementary personalized intraoperative evaluation metric. Further evaluation is necessary.,2.3685972735685406e-08,0.021208698070558363,0.0004245966626427282,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
44,0.1,1,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there a link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype is identified as a potential risk factor for causing and progressing chronic kidney failure in hypertensive individuals.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.1,2,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the polymorphism of the angiotensin-converting enzyme-1 (ACE-1) gene contribute to chronic kidney disease in patients with hypertension? Answer: It is concluded that the ACE-DD genotype may increase the risk of developing chronic kidney failure among hypertensive patients.,0.0,0.03648143055578679,0.026172568965361766,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
44,0.1,3,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease in hypertensive patients? Answer: The ACE-DD genotype is considered a risk factor for the onset and progression of chronic kidney failure in those with hypertension.,7.10579182070559e-08,0.04888364744311113,0.02392242299970098,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
44,0.1,4,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is chronic kidney disease among hypertensive patients associated with angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? Answer: Findings suggest that the ACE-DD genotype may be a contributing risk factor for chronic kidney failure in hypertensive patients.,9.47438909427412e-08,0.07903613756100114,0.023084379144985203,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
44,0.1,5,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the ACE-1 gene polymorphism influence the development of chronic kidney disease in hypertensive individuals? Answer: The ACE-DD genotype is concluded to be a risk factor for chronic kidney failure among patients with hypertension.,9.47438909427412e-08,0.07903613756100114,0.023084379144985203,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
44,0.1,6,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there an association between ACE-1 gene polymorphism and chronic kidney disease in hypertensive patients? Answer: It is concluded that the ACE-DD genotype may play a role as a risk factor in the causation and progression of chronic kidney failure in hypertensive patients.,1.1842986367842682e-07,0.13209800958480056,0.006068183988072934,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
44,0.1,7,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the presence of angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease in patients with hypertension? Answer: The ACE-DD genotype may be a risk factor for the development and causation of chronic kidney failure among hypertensive patients.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
44,0.1,8,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the ACE-1 gene polymorphism a factor in chronic kidney disease among hypertensive patients? Answer: The ACE-DD genotype is identified as a possible risk factor for causing and developing chronic kidney failure in hypertensive individuals.,7.10579182070559e-08,0.04888364744311113,0.02392242299970098,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
44,0.1,9,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene result in chronic kidney disease in hypertensive patients? Answer: It is concluded that the ACE-DD genotype may contribute as a risk factor to the causation and progression of chronic kidney failure in hypertensive patients.,9.474389094274141e-08,0.1070323024723705,0.004969135802469125,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
44,0.1,10,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is chronic kidney disease in hypertensive patients linked to angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? Answer: The ACE-DD genotype may be a significant risk factor for the causation and development of chronic kidney failure among hypertensive patients.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
45,0.1,1,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are laboratories accurately reporting serum quantitative hCG results? Many factors lead to errors in hCG result reporting, such as (a) the complexity of the hCG molecule and confusion over the nomenclature of its various forms; (b) lack of awareness among laboratory personnel.",2.3685972735685406e-08,0.008909457019031564,0.023795359904818555,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
45,0.1,2,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Do laboratories report serum quantitative hCG results correctly? Errors in hCG reporting arise from multiple factors, including (a) the complex nature of the hCG molecule and confusion about the different forms of hCG; (b) insufficient awareness by laboratory staff.",9.474389094274141e-08,0.06707644995888984,0.023795359904818555,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
45,0.1,3,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are serum quantitative hCG results being reported correctly by laboratories? Several factors cause incorrect hCG reporting, including (a) the complexity and confusing nomenclature of hCG forms; (b) laboratory personnel not being fully aware.",2.3685972735685321e-07,0.23892670688554984,0.023795359904818555,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
45,0.1,4,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Is the reporting of serum quantitative hCG results by laboratories accurate? Many issues contribute to erroneous hCG reporting, such as (a) the complicated structure and confusing names of hCG variants; (b) lack of knowledge among lab workers.",1.42115836414112e-07,0.12114367122916603,0.023795359904818555,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
45,0.1,5,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Do laboratories provide accurate serum quantitative hCG results? Errors stem from factors like (a) the complexity of the hCG molecule and confusion about its various forms; (b) laboratory staff's lack of awareness.,2.605457000925385e-07,0.27067540520012967,0.023795359904818555,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
45,0.1,6,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are serum quantitative hCG results correctly reported by laboratories? Multiple factors contribute to mistakes, including (a) the complex hCG molecule and confusing nomenclature; (b) laboratory personnel's limited awareness.",3.552895910352797e-07,0.4088257436809468,0.023795359904818555,0.027201396971728152,0.45547552868282537,0.0,0.02716202311429307,0.47000362924573613,0.0,3.552895910352811e-07,0.4855078157816992,0.0
45,0.1,7,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Is the serum quantitative hCG reporting by labs accurate? Errors occur due to (a) the complexity and confusing terminology of hCG forms; (b) lab personnel's lack of understanding.,3.552895910352797e-07,0.4088257436809468,0.023795359904818555,0.027201396971728152,0.45547552868282537,0.0,0.02716202311429307,0.47000362924573613,0.0,3.552895910352811e-07,0.4855078157816992,0.0
45,0.1,8,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are laboratories correctly reporting serum quantitative hCG results? Several factors cause errors, including (a) the complexity of the hCG molecule and confusion over its nomenclature; (b) lack of awareness among laboratory staff.",2.605457000925385e-07,0.27067540520012967,0.023795359904818555,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
45,0.1,9,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Do labs report serum quantitative hCG results accurately? Many factors contribute to errors, such as (a) the complex hCG molecule and confusing names of its forms; (b) laboratory personnel's insufficient awareness.",2.842316728282238e-07,0.30346522802312137,0.023795359904818555,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
45,0.1,10,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Are serum quantitative hCG results being accurately reported by laboratories? Errors arise from (a) the complexity and confusing nomenclature of hCG forms; (b) laboratory staff's lack of awareness.,3.552895910352797e-07,0.4088257436809468,0.023795359904818555,0.027201396971728152,0.45547552868282537,0.0,0.02716202311429307,0.47000362924573613,0.0,3.552895910352811e-07,0.4855078157816992,0.0
46,0.1,1,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Does the fibronectin-aggrecan complex exist in cervical disk disease? Biochemical studies of damaged cervical intervertebral disks showed increased fibronectin and aggrecan levels, indicating the complex's presence in this disease. This insight could aid in understanding the disease's pathogenesis and identifying therapeutic targets.",2.3685972735685406e-07,0.16388908127021784,0.039150354019158694,0.018134264647818726,0.19541766409181127,0.019991670137442734,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
46,0.1,2,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex found in cervical disk disease? Analysis of injured cervical intervertebral disks demonstrated elevated fibronectin and aggrecan, implying the complex is involved in cervical disk disease. This discovery may help clarify the disease mechanism and guide treatment strategies.",2.6054570009253947e-07,0.25789641191658363,0.010711141825716641,0.0199476911126006,0.2562814813355869,0.00563159856061822,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
46,0.1,3,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex associated with cervical disk disease? Biochemical examination of affected cervical disks revealed higher concentrations of fibronectin and aggrecan, suggesting the complex is present in this condition. This may enhance understanding of disease development and potential therapies.",2.8423167282822477e-07,0.21389950184488127,0.039150354019158694,0.02176111757738247,0.24671095847936098,0.019991670137442734,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
46,0.1,4,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Can the fibronectin-aggrecan complex be detected in cervical disk disease? Injured cervical intervertebral disks showed increased fibronectin and aggrecan levels through biochemical analysis, indicating the complex's presence. This finding could inform the pathogenesis and treatment approaches for the disease.",3.0791764556391007e-07,0.23987498824813924,0.039150354019158694,0.023574544042164344,0.27337920556152184,0.019991670137442734,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
46,0.1,5,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Elevated fibronectin and aggrecan levels were found in injured cervical disks via biochemical analysis, suggesting the complex's involvement. This may contribute to understanding the disease's pathophysiology and therapeutic options.",2.8423167282822477e-07,0.21389950184488127,0.039150354019158694,0.02176111757738247,0.24671095847936098,0.019991670137442734,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
46,0.1,6,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Does cervical disk disease involve the fibronectin-aggrecan complex? Biochemical analysis of damaged cervical intervertebral disks revealed raised fibronectin and aggrecan levels, indicating the complex's presence. This finding might aid in comprehending the disease mechanism and potential treatments.",3.5528959103528067e-07,0.29394220951841543,0.039150354019158694,0.02720139697172809,0.328949056716334,0.019991670137442734,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
46,0.1,7,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex detectable in cervical disk disease? Injured cervical disks showed elevated fibronectin and aggrecan in biochemical tests, suggesting the complex exists in this condition. This could help in understanding disease progression and therapeutic targets.",3.5528959103528067e-07,0.29394220951841543,0.039150354019158694,0.02720139697172809,0.328949056716334,0.019991670137442734,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
46,0.1,8,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex implicated in cervical disk disease? Biochemical studies of injured cervical intervertebral disks found increased fibronectin and aggrecan, indicating the complex's presence. This may provide insights into the disease's pathogenesis and treatment possibilities.",3.7897556377096597e-07,0.3221130864851123,0.039150354019158694,0.02901482343650997,0.3579365935895855,0.019991670137442734,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
46,0.1,9,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex present within cervical disk disease? Analysis of injured cervical disks revealed elevated fibronectin and aggrecan levels, suggesting the complex's involvement. This finding could enhance understanding of the disease and inform therapeutic development.",3.7897556377096597e-07,0.3221130864851123,0.039150354019158694,0.02901482343650997,0.3579365935895855,0.019991670137442734,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
46,0.1,10,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? 
Answer: Biochemical analysis of injured cervical intervertebral disks revealed elevated levels of fibronectin and aggrecan, suggesting the presence of this complex in cervical disk disease. This finding may contribute to the understanding of the pathogenesis and potential therapeutic targets for this condition. 
","Is the fibronectin-aggrecan complex involved in cervical disk disease? Biochemical analysis of damaged cervical intervertebral disks showed increased fibronectin and aggrecan, implying the complex is present. This may contribute to understanding the disease's pathogenesis and potential treatments.",3.5528959103528067e-07,0.29394220951841543,0.039150354019158694,0.02720139697172809,0.328949056716334,0.019991670137442734,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
47,0.1,1,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Does the criteria for selecting residents predict their performance in orthopaedic surgery residency? We discovered that USMLE Step 2 scores, the count of honors received in medical school, and research output were significantly linked to performance in orthopaedic surgery residency. However, these factors accounted for only a small fraction of the variation in resident performance, indicating that other elements like personality traits and non-academic experiences might also influence outcomes.",7.105791820705622e-08,0.04794320660401752,0.00202211700090512,0.005440279394345618,0.04774931358882917,0.0013949965827017088,0.0054324046228586,0.04752022801664957,0.0007209575823999993,7.105791820705622e-08,0.04725288485054513,0.0
47,0.1,2,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Can residency selection criteria forecast performance in orthopaedic surgery residency? Our findings show that USMLE Step 2 results, the number of medical school honors, and research productivity were significantly correlated with orthopaedic surgery residency performance. Nonetheless, these variables explained only a minor part of the differences in resident performance, implying that other factors such as personality and extracurricular experiences could also be important.",7.105791820705622e-08,0.00562965465315024,0.029921087978039537,0.005440279394345618,0.004687520401366108,0.031217481789802295,0.0054324046228586,0.026785491770707992,0.01586888657648284,7.105791820705622e-08,0.04959694113937285,0.0
47,0.1,3,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Is performance in orthopaedic surgery residency predicted by residency selection criteria? We found significant associations between USMLE Step 2 scores, medical school honors count, and research productivity with residency performance in orthopaedics. Yet, these factors explained only a small portion of the variability, suggesting that additional factors like personality traits and non-academic experiences may contribute.",2.6054570009253947e-07,0.14709252446280718,0.027533859687662202,0.0199476911126006,0.1452694710225555,0.031217481789802295,0.019918816950481533,0.16988633541137954,0.01586888657648284,2.6054570009253947e-07,0.1953087523207664,0.0
47,0.1,4,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Do residency selection criteria predict how well residents perform in orthopaedic surgery? Our study found that USMLE Step 2 scores, the number of honors earned during medical school, and research productivity were significantly linked to performance in orthopaedic surgery residency. However, these factors only accounted for a small amount of the variation in performance, indicating that other influences such as personality and non-academic experiences might also be relevant.",4.737194547137081e-08,0.07359720554867,0.03112383889982983,0.0036268529295637453,0.07409335745174772,0.031217481789802295,0.003621603081905733,0.05325721590282928,0.01586888657648284,4.737194547137081e-08,0.031748698314579826,0.0
47,0.1,5,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Are the criteria used to select residents predictive of their performance in orthopaedic surgery residency? We observed that USMLE Step 2 scores, the quantity of honors in medical school, and research productivity had significant associations with orthopaedic surgery residency performance. Still, these factors explained only a small part of the performance variability, suggesting other factors like personality traits and non-academic experiences may also play a role.",0.0,0.04265521111137982,0.030664926264958384,0.0,0.04332169878499492,0.031217481789802295,0.0,0.02200467239872772,0.01586888657648284,0.0,0.0,0.0
47,0.1,6,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Does the selection criteria for residency predict performance outcomes in orthopaedic surgery residency? Our results indicated that USMLE Step 2 scores, number of medical school honors, and research productivity were significantly associated with residency performance in orthopaedics. However, these factors explained only a small portion of the variability, implying that other factors such as personality and non-academic experiences might also influence performance.",9.474389094274162e-08,0.00046941094474473033,0.046045785639958384,0.0072537058591274906,0.021216822352577047,0.031217481789802295,0.007243206163811466,0.0435926100870887,0.01586888657648284,9.474389094274162e-08,0.06669137449867257,0.0
47,0.1,7,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Can the criteria for selecting orthopaedic surgery residents predict their performance? We found that USMLE Step 2 scores, honors achieved in medical school, and research productivity were significantly linked to performance during orthopaedic surgery residency. Nonetheless, these factors accounted for only a small fraction of the variability in performance, suggesting that other factors like personality traits and non-academic experiences may also be important.",7.105791820705622e-08,0.00562965465315024,0.029921087978039537,0.005440279394345618,0.004687520401366108,0.031217481789802295,0.0054324046228586,0.026785491770707992,0.01586888657648284,7.105791820705622e-08,0.04959694113937285,0.0
47,0.1,8,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Is there a predictive relationship between residency selection criteria and performance in orthopaedic surgery residency? Our findings showed that USMLE Step 2 scores, the number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors explained only a small part of the variability, indicating that other factors such as personality and non-academic experiences might also contribute.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
47,0.1,9,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Do the criteria used for residency selection predict performance in orthopaedic surgery residency? We found significant associations between USMLE Step 2 scores, medical school honors, and research productivity with orthopaedic surgery residency performance. Yet, these factors accounted for only a small portion of the variability, suggesting that other influences like personality traits and non-academic experiences may also be involved.",1.6580180914979784e-07,0.0738630695980067,0.028809713002223698,0.012693985253473108,0.0725101167401263,0.031217481789802295,0.012675610786670066,0.09577836325765787,0.01586888657648284,1.6580180914979784e-07,0.1198011998126205,0.0
47,0.1,10,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? 

Answer: We found that USMLE Step 2, number of honors in medical school, and research productivity were significantly associated with performance in orthopaedic surgery residency. However, these factors only explained a small portion of the variability in resident performance, suggesting that other factors, such as personality traits and non-academic experiences, may also play a role. 
","Are residency selection criteria effective predictors of performance in orthopaedic surgery residency? Our study revealed that USMLE Step 2 scores, the number of honors earned in medical school, and research productivity were significantly linked to performance in orthopaedic surgery residency. However, these factors explained only a small amount of the variation in performance, implying that other factors such as personality and non-academic experiences might also play a role.",4.737194547137081e-08,0.0322152843212109,0.0013680512649583837,0.0036268529295637453,0.03208443741781242,0.0009440442898022948,0.003621603081905733,0.03192961034713804,0.00048802720148283935,4.737194547137081e-08,0.031748698314579826,0.0
48,0.1,1,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Is visual loss due to amblyopia permanent? Answer: In older individuals with a history of amblyopia, if visual loss occurs in the previously unaffected eye, the amblyopic eye may regain visual function gradually over time.",1.8948778188548272e-07,0.14874225328093704,0.04082828719723183,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
48,0.1,2,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Does amblyopia cause permanent visual loss? Answer: Older adults who have amblyopia and then lose vision in their previously normal eye can sometimes recover vision in the amblyopic eye over a period of time.,2.1317375462116802e-07,0.17889474339882705,0.03999024334251606,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
48,0.1,3,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Is the visual loss from amblyopia irreversible? Answer: In elderly patients with amblyopia, visual function in the amblyopic eye can improve over time if the previously normal eye develops visual loss.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
48,0.1,4,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Can visual loss from amblyopia be reversed? Answer: Older people with amblyopia history who experience vision loss in their previously normal eye may see recovery of vision in the amblyopic eye over time.,2.3685972735685332e-07,0.1679743429861591,0.06937499999999999,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
48,0.1,5,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Does amblyopia lead to permanent vision loss? Answer: Visual function in the amblyopic eye can recover over time in older individuals if the previously normal eye suffers visual loss.,3.316036182995945e-07,0.2971860744661661,0.06937499999999999,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
48,0.1,6,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Is vision loss caused by amblyopia permanent? Answer: In older adults with amblyopia, if the normal eye loses vision, the amblyopic eye may regain visual function gradually.",3.789755637709651e-07,0.36864503844830976,0.06937499999999999,0.029014823436510025,0.4795730802618854,0.0,0.028972824655245935,0.49469624183610783,0.0,3.789755637709665e-07,0.5108256237659909,0.0
48,0.1,7,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Can vision lost from amblyopia be restored? Answer: Older patients with amblyopia who develop vision loss in their previously normal eye can experience gradual recovery of vision in the amblyopic eye.,2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
48,0.1,8,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Is the vision loss in amblyopia permanent? Answer: Visual function in the amblyopic eye may improve over time in older people if the previously normal eye becomes impaired.,3.552895910352798e-07,0.3322773942774351,0.06937499999999999,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
48,0.1,9,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Question: Does amblyopia cause irreversible vision loss? Answer: In older individuals with amblyopia, loss of vision in the previously normal eye can lead to recovery of vision in the amblyopic eye over time.",2.605457000925386e-07,0.32871109800790377,0.023371730083234232,0.019947691112600627,0.3931207596769237,0.06420927467300831,0.019918816950481567,0.3585844970794825,0.033293697978596916,2.6054570009253947e-07,0.321583624127463,0.0
48,0.1,10,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Question: Is visual impairment from amblyopia permanent? Answer: Older people with a history of amblyopia who lose vision in their previously normal eye can experience a gradual return of visual function in the amblyopic eye.,2.1317375462116802e-07,0.13812137983647732,0.06937499999999999,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
49,0.1,1,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Are high flow nasal cannulae louder than bubble CPAP for preterm infants? At the gas flows examined, HFNC are not. A recent study measured noise levels of HFNC and bubble CPAP near the infant's ear and found no significant difference.",4.026615365066518e-07,0.34782554096784946,0.010042026226493216,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
49,0.1,2,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? According to the gas flows studied, HFNC do not. A recent study using a sound level meter near the infant's ear showed no notable noise difference between HFNC and bubble CPAP.",2.8423167282822487e-07,0.19165154391974815,0.03566529492455417,0.02176111757738247,0.2461330695389088,0.0,0.0217296184914344,0.25131442828090744,0.0,2.8423167282822487e-07,0.2567198468478131,0.0
49,0.1,3,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Is the noise level of high flow nasal cannulae higher than bubble CPAP for preterm infants? At the studied gas flows, HFNC are not noisier. A recent study compared noise near the infant's ear and found no significant difference between HFNC and bubble CPAP.",3.079176455639103e-07,0.21464106214444767,0.03566529492455417,0.023574544042164344,0.2696635669491032,0.0,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
49,0.1,4,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
",Are high flow nasal cannulae noisier compared to bubble CPAP in preterm infants? The gas flows studied indicate HFNC are not. A recent study measured sound levels near the infant's ear and found no significant noise difference between the two.,4.026615365066518e-07,0.31227953170836553,0.03566529492455417,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
49,0.1,5,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Do high flow nasal cannulae generate more noise than bubble CPAP for preterm infants? At the gas flows tested, HFNC are not noisier. A recent study using a sound meter near the infant's ear showed no significant difference in noise levels.",3.789755637709665e-07,0.2869617237240738,0.03566529492455417,0.029014823436509962,0.34377153910282665,0.0,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
49,0.1,6,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Is there more noise from high flow nasal cannulae than bubble CPAP in preterm infants? At the gas flows studied, HFNC are not louder. A recent study measured noise near the infant's ear and found no significant difference between HFNC and bubble CPAP.",3.316036182995957e-07,0.2381715595546421,0.03566529492455417,0.025387970506946217,0.2937611185281632,0.0,0.025351221573340132,0.30010459245033916,0.0,3.316036182995957e-07,0.30673026742247655,0.0
49,0.1,7,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
",Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? The gas flows studied show HFNC are not. A recent study using a sound level meter near the infant's ear found no significant noise difference between the two.,4.026615365066518e-07,0.31227953170836553,0.03566529492455417,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
49,0.1,8,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Do high flow nasal cannulae produce louder sounds than bubble CPAP in preterm infants? At the gas flows studied, HFNC are not louder. A recent study measured noise near the infant's ear and found no significant difference.",4.737194547137077e-07,0.3923222393818997,0.03566529492455417,0.03626852929563745,0.45198512374305766,0.0,0.03621603081905734,0.4626235219481134,0.0,4.737194547137081e-07,0.47378435208564085,0.0
49,0.1,9,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Is the noise from high flow nasal cannulae greater than bubble CPAP for preterm infants? At the gas flows studied, HFNC are not. A recent study compared noise levels near the infant's ear and found no significant difference.",4.500334819780224e-07,0.3649232651937844,0.03566529492455417,0.03445510283085558,0.4238142467763608,0.0,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
49,0.1,10,ai,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not.  A recent study compared the noise levels of HFNC and bubble CPAP using a sound level meter placed near the infant's ear. The results showed no significant difference in noise levels between the two modalities. 
","Are high flow nasal cannulae louder than bubble CPAP for preterm infants? At the gas flows studied, HFNC are not. A recent study measured sound levels near the infant's ear and found no significant difference between the two.",4.500334819780224e-07,0.3649232651937844,0.03566529492455417,0.03445510283085558,0.4238142467763608,0.0,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
50,0.1,1,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","This case report describes a novel method for handling acute overt-obscure gastrointestinal bleeding by integrating emergency double-balloon enteroscopy with real-time capsule endoscopy viewing, enabling effective diagnosis and treatment and demonstrating the advantages of this combined technique in difficult scenarios.",4.974054274493933e-07,0.27547568201256567,0.11649408284023668,0.038081955760419325,0.3539185902387523,0.06858710562414265,0.0380268323600102,0.43521137567458235,0.017538265306122455,4.974054274493935e-07,0.47000362924573613,0.0
50,0.1,2,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","In this case report, a distinctive approach to acute overt-obscure gastrointestinal bleeding is detailed, where emergency double-balloon enteroscopy is combined with real-time capsule endoscopy visualization, facilitating successful diagnosis and therapy and underscoring the value of this combined method in complex cases.",4.500334819780227e-07,0.22418238762501597,0.11649408284023668,0.03445510283085558,0.30127485675333343,0.06858710562414265,0.034405229278104466,0.38114415440430616,0.017538265306122455,4.500334819780227e-07,0.41443377809092397,0.0
50,0.1,3,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","The report highlights a unique strategy for managing acute overt-obscure gastrointestinal bleeding by merging emergency double-balloon enteroscopy with live capsule endoscopy viewing, which led to accurate diagnosis and treatment, emphasizing the potential of this combined approach in challenging clinical situations.",4.73719454713708e-07,0.2495001956093077,0.11649408284023668,0.03626852929563745,0.3272503431565914,0.06858710562414265,0.03621603081905733,0.407812401486467,0.017538265306122455,4.737194547137081e-07,0.4418327522790393,0.0
50,0.1,4,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","This case study presents an innovative approach to acute overt-obscure gastrointestinal bleeding, utilizing emergency double-balloon enteroscopy alongside real-time capsule endoscopy observation, resulting in successful diagnosis and intervention and showcasing the benefits of this combined technique in difficult cases.",5.210914001850786e-07,0.30214392909472654,0.11649408284023668,0.0398953822252012,0.3813175644268676,0.06858710562414265,0.039837633900963065,0.4633822526412792,0.017538265306122455,5.210914001850789e-07,0.49899116611898764,0.0
50,0.1,5,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","A novel combined approach involving emergency double-balloon enteroscopy and real-time capsule endoscopy viewing is presented in this case report for acute overt-obscure gastrointestinal bleeding, enabling effective diagnosis and treatment and highlighting its potential in complex clinical scenarios.",5.447773729207639e-07,0.32954290328284186,0.11649408284023668,0.04170880868998307,0.40948844139356444,0.06858710562414265,0.04164843544191594,0.4923697895145307,0.017538265306122455,5.447773729207643e-07,0.5288441292686694,0.0
50,0.1,6,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","This report illustrates a unique combined method for acute overt-obscure gastrointestinal bleeding management, integrating emergency double-balloon enteroscopy with real-time capsule endoscopy, which facilitated successful diagnosis and treatment and demonstrated the advantages of this approach in challenging cases.",5.447773729207639e-07,0.32954290328284186,0.11649408284023668,0.04170880868998307,0.40948844139356444,0.06858710562414265,0.04164843544191594,0.4923697895145307,0.017538265306122455,5.447773729207643e-07,0.5288441292686694,0.0
50,0.1,7,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","The case report introduces a combined strategy of emergency double-balloon enteroscopy and real-time capsule endoscopy viewing for acute overt-obscure gastrointestinal bleeding, allowing for accurate diagnosis and effective treatment, and highlighting the promise of this method in difficult cases.",5.210914001850786e-07,0.30214392909472654,0.11649408284023668,0.0398953822252012,0.3813175644268676,0.06858710562414265,0.039837633900963065,0.4633822526412792,0.017538265306122455,5.210914001850789e-07,0.49899116611898764,0.0
50,0.1,8,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","In this case report, an innovative combined approach using emergency double-balloon enteroscopy and real-time capsule endoscopy viewing is described for acute overt-obscure gastrointestinal bleeding, leading to successful diagnosis and management and emphasizing the benefits of this technique in complex situations.",4.73719454713708e-07,0.2495001956093077,0.11649408284023668,0.03626852929563745,0.3272503431565914,0.06858710562414265,0.03621603081905733,0.407812401486467,0.017538265306122455,4.737194547137081e-07,0.4418327522790393,0.0
50,0.1,9,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","This case report showcases a combined approach of emergency double-balloon enteroscopy with real-time capsule endoscopy viewing for acute overt-obscure gastrointestinal bleeding, which enabled successful diagnosis and treatment and underscored the potential advantages of this method in challenging cases.",5.210914001850786e-07,0.30214392909472654,0.11649408284023668,0.0398953822252012,0.3813175644268676,0.06858710562414265,0.039837633900963065,0.4633822526412792,0.017538265306122455,5.210914001850789e-07,0.49899116611898764,0.0
50,0.1,10,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding?

Answer:This case report presents a unique approach to managing acute overt-obscure gastrointestinal bleeding. Combining emergency double-balloon enteroscopy and real-time viewing of capsule endoscopy allowed for successful diagnosis and treatment, highlighting the potential benefits of this combined strategy in challenging cases. 
","The report details a unique combined approach for acute overt-obscure gastrointestinal bleeding involving emergency double-balloon enteroscopy and real-time capsule endoscopy viewing, resulting in effective diagnosis and treatment and highlighting the value of this strategy in difficult clinical scenarios.",5.210914001850786e-07,0.30214392909472654,0.11649408284023668,0.0398953822252012,0.3813175644268676,0.06858710562414265,0.039837633900963065,0.4633822526412792,0.017538265306122455,5.210914001850789e-07,0.49899116611898764,0.0
51,0.1,1,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification responsible for the birthweight differences between Australian Aborigines and whites? Answer: It is improbable that gestational age misclassification accounts for the observed differences in average birthweights between Aborigines and whites. These findings may assist in understanding other comparisons across populations.,0.0,0.031506690025452144,0.022183224271267066,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
51,0.1,2,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could gestational age misclassification explain the birthweight disparity between Australian Aborigines and whites? Answer: Gestational age misclassification is unlikely to explain the reported differences in average birthweights between Aborigines and whites. The results may aid in interpreting other population comparisons.,9.474389094274162e-08,0.13941954583995742,0.030948656370032523,0.0072537058591274906,0.10094507507642758,0.00238063831257343,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,0.1,3,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does misclassification of gestational age account for birthweight differences in Australian Aborigines versus whites? Answer: Misclassification of gestational age is an unlikely cause for the observed birthweight differences between Aborigines and whites. These findings might help interpret other between-population analyses.,9.474389094274162e-08,0.13941954583995697,0.030948656370032537,0.0072537058591274906,0.13649108433591195,0.027889582908887926,0.007243206163811466,0.13656488911276776,0.026296566837107373,9.474389094274162e-08,0.10265415406008227,0.0
51,0.1,4,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? Answer: Gestational age misclassification probably does not explain the reported birthweight differences between Aborigines and whites. The results could assist in understanding other population comparisons.,9.474389094274162e-08,0.07010482778396288,0.017955279883857596,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,0.1,5,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Can gestational age misclassification explain the birthweight gap between Australian Aborigines and whites? Answer: It is unlikely that gestational age misclassification explains the observed divergence in average birthweights between Aborigines and whites. These results may help interpret other inter-population comparisons.,9.474389094274162e-08,0.1047621868119597,0.0066901636430713035,0.0072537058591274906,0.10094507507642758,0.00238063831257343,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,0.1,6,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does the misclassification of gestational age explain birthweight differences between Australian Aborigines and whites? Answer: The misclassification of gestational age is an improbable explanation for the reported differences in average birthweights between Aborigines and whites. The findings might aid in interpreting other population comparisons.,0.0,0.06301338005090251,0.04395179757830192,0.0,0.06447880749394885,0.04613236961451247,0.0,0.06601401719618405,0.047500000000000014,0.0,0.03381205758828987,0.024375
51,0.1,7,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is gestational age misclassification the reason for birthweight differences between Australian Aborigines and whites? Answer: Gestational age misclassification is unlikely to be the cause of the reported birthweight differences between Aborigines and whites. These results may help with the interpretation of other comparisons between populations.,2.3685972735685406e-08,0.03703978086268389,0.04155822427126707,0.0018134264647818726,0.007784458079231005,0.02210884353741497,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
51,0.1,8,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Could the difference in birthweights between Australian Aborigines and whites be due to gestational age misclassification? Answer: Gestational age misclassification is an unlikely explanation for the observed divergence in average birthweights between Aborigines and whites. The findings might assist in interpreting other between-population comparisons.,0.0,0.0,0.0,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0
51,0.1,9,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Does gestational age misclassification account for the birthweight differences seen in Australian Aborigines and whites? Answer: It is improbable that gestational age misclassification explains the reported differences in average birthweights between Aborigines and whites. These results may help interpret other population comparisons.,4.737194547137081e-08,0.0510209713528158,0.0031891414310303706,0.0036268529295637453,0.0492007028305701,0.0011323696145124768,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
51,0.1,10,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Question: Is the variation in birthweights between Australian Aborigines and whites explained by gestational age misclassification? Answer: Gestational age misclassification is unlikely to explain the observed differences in average birthweights between Aborigines and whites. The findings might help with interpreting other comparisons across populations.,2.3685972735685406e-08,0.025187659389265704,0.0015582242712670613,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
52,0.1,1,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Is it possible to maintain a zero rate of central line-associated bloodstream infections? Achieving this requires excellent training, adherence to evidence-based protocols, and meticulous environmental cleanliness. Ongoing surveillance, data evaluation, and proactive measures are vital for long-term success.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
52,0.1,2,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Can a zero central line-associated bloodstream infection rate be maintained? This depends on high-quality training, strict adherence to evidence-based guidelines, and comprehensive environmental hygiene. Continuous monitoring, data analysis, and proactive interventions are key to sustaining this outcome.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
52,0.1,3,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Is sustaining a zero central line-associated bloodstream infection rate feasible? It demands rigorous training, strict compliance with evidence-based practices, and thorough environmental sanitation. Persistent monitoring, data review, and proactive actions are necessary for ongoing success.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
52,0.1,4,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Is a zero rate of central line-associated bloodstream infections sustainable? Maintaining this requires superior training, strict observance of evidence-based guidelines, and diligent environmental hygiene. Continuous oversight, data analysis, and proactive steps are essential for lasting success.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
52,0.1,5,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Can zero central line-associated bloodstream infection rates be sustained? This is achievable through high-quality training, strict adherence to evidence-based protocols, and thorough environmental hygiene. Ongoing monitoring, data analysis, and proactive interventions are crucial for sustained success.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
52,0.1,6,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Is it sustainable to have zero central line-associated bloodstream infections? Achieving this involves excellent training, strict compliance with evidence-based guidelines, and comprehensive environmental hygiene. Continuous monitoring, data analysis, and proactive measures are essential for maintaining success.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
52,0.1,7,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Is maintaining a zero central line-associated bloodstream infection rate possible? It requires top-notch training, strict adherence to evidence-based guidelines, and thorough environmental cleanliness. Continuous monitoring, data analysis, and proactive interventions are critical for sustained success.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
52,0.1,8,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Is zero central line-associated bloodstream infection rate achievable and sustainable? This depends on high-quality training, strict compliance with evidence-based protocols, and meticulous environmental hygiene. Ongoing monitoring, data analysis, and proactive measures are vital for long-term success.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
52,0.1,9,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Is it feasible to sustain a zero rate of central line-associated bloodstream infections? This necessitates excellent training, strict adherence to evidence-based guidelines, and thorough environmental hygiene. Continuous monitoring, data evaluation, and proactive interventions are essential for sustained success.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
52,0.1,10,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough environmental hygiene are crucial. Continuous monitoring, data analysis, and proactive interventions are essential for sustained success. 
","Can zero central line-associated bloodstream infection rates be maintained over time? Achieving this requires high-quality training, strict compliance with evidence-based guidelines, and comprehensive environmental hygiene. Continuous monitoring, data analysis, and proactive interventions are key to ongoing success.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
53,0.1,1,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism characterized following injury and hemorrhagic shock, and do hormonal differences play a role? Answer: The protective effect of being female against multiple organ failure and hospital-acquired infections is significant in both premenopausal and postmenopausal women compared to men of the same age, which contrasts with earlier experimental findings.",4.737194547137081e-08,0.03774032798284743,0.0,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
53,0.1,2,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What defines gender differences after injury and hemorrhagic shock, and are hormones the cause? Answer: Female gender independently offers protection against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women relative to age-matched men, opposing previous experimental data.",3.079176455639103e-07,0.27541197985996746,0.0,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
53,0.1,3,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How does gender dimorphism manifest after injury and hemorrhagic shock, and is it due to hormonal variations? Answer: The female gender shows a significant protective effect against multiple organ failure and hospital infections in both premenopausal and postmenopausal women compared to men of similar age, which contradicts earlier studies.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
53,0.1,4,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What characterizes gender dimorphism post-injury and hemorrhagic shock, and are hormonal differences responsible? Answer: Female gender independently reduces the risk of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women versus similarly aged men, differing from prior experimental research.",2.8423167282822487e-07,0.25131442828090744,0.0,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
53,0.1,5,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism after injury and hemorrhagic shock characterized, and do hormones explain it? Answer: The protective influence of female gender on multiple organ failure and hospital-acquired infections remains significant in both premenopausal and postmenopausal women compared to men of the same age, contrary to previous studies.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
53,0.1,6,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What is the nature of gender dimorphism following injury and hemorrhagic shock, and are hormonal differences the cause? Answer: Female gender independently confers protection against multiple organ failure and nosocomial infection rates in both premenopausal and postmenopausal women when compared with age-matched men, opposing earlier experimental findings.",1.6580180914979784e-07,0.13883644485421742,0.0,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
53,0.1,7,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How does gender dimorphism present after injury and hemorrhagic shock, and are hormones responsible? Answer: The female gender's protective effect on multiple organ failure and hospital infection rates is significant in both premenopausal and postmenopausal women compared to similarly aged men, which is contrary to previous experimental studies.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
53,0.1,8,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What defines the gender dimorphism after injury and hemorrhagic shock, and is it due to hormonal differences? Answer: Female gender independently protects against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women relative to men of similar age, differing from prior experimental data.",1.8948778188548325e-07,0.16034265007518078,0.0,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
53,0.1,9,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: How is gender dimorphism characterized after injury and hemorrhagic shock, and do hormones play a role? Answer: The protective effect of female gender on multiple organ failure and hospital-acquired infection rates remains significant in both premenopausal and postmenopausal women compared to age-matched men, contrary to earlier experimental studies.",1.4211583641411244e-07,0.11778303565638426,0.0,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
53,0.1,10,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Question: What characterizes gender dimorphism following injury and hemorrhagic shock, and are hormonal differences responsible? Answer: Female gender independently reduces the incidence of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women when compared with similarly aged men, which contrasts with previous experimental findings.",1.8948778188548325e-07,0.16034265007518078,0.0,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
54,0.1,1,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Do African American women need fewer calories to keep their weight? The findings do not back the idea that African American women have a higher obesity risk because they require fewer calories. The research showed that, on average, African American women need the same calorie intake to maintain weight as women from other racial groups. Still, individual factors such as activity level and genetics should be considered when assessing calorie needs.",0.0,0.05455835728241443,0.0897731601640301,0.0,0.04776575168121866,0.05920184067793379,0.0,0.020386681781174865,0.014702606371129419,0.0,0.0,0.0
54,0.1,2,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Is it true that African American women require fewer calories to maintain their weight? The study's results do not support the notion that African American women are more prone to obesity due to lower calorie needs. On average, African American women need similar calorie amounts to maintain weight compared to other racial groups. However, personal factors like physical activity and genetics are important when determining calorie requirements.",9.474389094274162e-08,0.1413106490046765,0.113895448132472,0.007253705859127504,0.11166080018629732,0.06381423077892477,0.007243206163811466,0.08228547120893381,0.015621063240110858,9.474389094274162e-08,0.0615578929994296,0.0
54,0.1,3,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Do African American women have lower calorie needs to sustain their weight? The evidence does not support the claim that African American women face a higher obesity risk because they need fewer calories. The study found that African American women generally require the same calories to maintain weight as other racial groups. Nonetheless, individual differences such as activity levels and genetics must be taken into account when calculating calorie needs.",2.3685972735685406e-08,0.07059884796290206,0.0917502658408053,0.0018134264647818865,0.06336244778334432,0.06030328003112138,0.0018108015409528666,0.035506046398873004,0.014921946740128554,2.3685972735685406e-08,0.015037877364540542,0.0
54,0.1,4,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Are fewer calories required by African American women to maintain their weight? The results do not confirm that African American women are at increased obesity risk due to lower calorie requirements. On average, African American women need the same calorie intake as other racial groups to maintain weight. Still, factors like genetics and activity levels should be considered individually when determining calorie needs.",1.8948778188548325e-07,0.19062514625558036,0.10742884302320764,0.014507411718254995,0.1571715303564698,0.05215789570471039,0.014486412327622933,0.1251631429540092,0.0,1.8948778188548325e-07,0.12715517548524602,0.0
54,0.1,5,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Do African American women need fewer calories to keep their weight stable? The study does not support the idea that African American women have a greater obesity risk because of lower calorie needs. It found that, on average, African American women require the same calories as other racial groups to maintain weight. However, individual factors such as genetics and activity levels are important in assessing calorie requirements.",9.474389094274162e-08,0.09930172897074119,0.08209870862501448,0.007253705859127504,0.09033319463060696,0.04799463358328079,0.007243206163811466,0.06062462181643724,0.0,9.474389094274162e-08,0.0615578929994296,0.0
54,0.1,6,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
",Is the calorie requirement lower for African American women to maintain weight? The findings do not support the belief that African American women are more susceptible to obesity due to needing fewer calories. The study showed that African American women generally need the same amount of calories as other racial groups to maintain weight. Individual factors like genetics and activity levels should still be considered when determining calorie needs.,4.737194547137081e-08,0.10728466337092613,0.10915385950950977,0.003626852929563759,0.07920521821008553,0.06143811499783736,0.003621603081905733,0.05085742316665165,0.01514792899408284,4.737194547137081e-08,0.030305349495328038,0.0
54,0.1,7,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Do African American women require fewer calories to maintain their weight? The study results do not support the view that African American women have a higher risk of obesity because of lower calorie requirements. On average, African American women need the same calories as other racial groups to maintain weight. However, individual differences such as activity levels and genetics are important to consider when calculating calorie needs.",9.474389094274162e-08,0.12030618898770928,0.09805114104656316,0.007253705859127504,0.09033319463060696,0.04799463358328079,0.007243206163811466,0.06062462181643724,0.0,9.474389094274162e-08,0.0615578929994296,0.0
54,0.1,8,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Are African American women at risk of obesity due to lower calorie needs to maintain weight? The results do not support this idea. The study found that African American women require, on average, the same calorie intake as other racial groups to maintain weight. Still, individual factors like genetics and activity levels must be taken into account when determining calorie needs.",2.3685972735685406e-07,0.16405278240668597,0.007090277310680633,0.01813426464781874,0.1599743526618651,0.0024544947726590025,0.018108015409528666,0.15906469462968964,0.0,2.3685972735685406e-07,0.16164135155641457,0.0
54,0.1,9,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Do African American women need fewer calories to maintain their weight compared to other groups? The study does not support the notion that African American women are at greater obesity risk due to lower calorie requirements. On average, they require the same calories as other racial groups to maintain weight. However, individual factors such as genetics and activity levels should be considered when assessing calorie needs.",1.1842986367842703e-07,0.07867817334422611,0.0032745671057636816,0.009067132323909377,0.07679304800515663,0.0011314438629482192,0.009054007704764333,0.0763729787845735,0.0,1.1842986367842703e-07,0.07755823434587317,0.0
54,0.1,10,ai,"Question: Do African American women require fewer calories to maintain weight? 
Answer: These results do not support the view that AA women are at greater risk for obesity due to a lower calorie requirement. The study found that, on average, AA women need the same amount of calories to maintain weight as other racial groups. However, it's important to consider individual factors like activity levels and genetics when determining calorie needs. 
","Is a lower calorie intake necessary for African American women to maintain weight? The findings do not support the idea that African American women are at increased risk of obesity because of lower calorie needs. The study found that, on average, African American women need the same calories as other racial groups to maintain weight. Nonetheless, individual factors like genetics and activity levels are important when determining calorie requirements.",4.737194547137081e-08,0.10728466337092613,0.1091538595095098,0.003626852929563759,0.05851425759635642,0.046102096599168724,0.003621603081905733,0.02985296314968444,0.0,4.737194547137081e-08,0.030305349495328038,0.0
55,0.1,1,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Does increased neutrophil migration after major trauma play a role in causing acute respiratory distress syndrome? These findings show that major blunt trauma triggers a strong neutrophil migratory response, which may contribute to ARDS development. Although more research is required, our results imply that inhibiting neutrophil activation and migration could be a potential treatment approach for trauma-induced ARDS.",2.1317375462116866e-07,0.06258563412400253,0.060353798126951096,0.016320838183036854,0.10638036804910644,0.030738221214411676,0.0162972138685758,0.12988904873470375,0.015621063240110858,2.1317375462116866e-07,0.15415067982725983,0.0
55,0.1,2,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Is heightened neutrophil migratory activity following major trauma a factor in the onset of acute respiratory distress syndrome? The data demonstrate that significant blunt trauma provokes a pronounced neutrophil migration, possibly leading to ARDS. Further studies are necessary, but our observations indicate that targeting neutrophil movement and activation might offer therapeutic benefits for ARDS after trauma.",2.6054570009253947e-07,0.09830371672608162,0.060353798126951096,0.0199476911126006,0.14274801221998068,0.030738221214411676,0.019918816950481533,0.16693032041505385,0.015621063240110858,2.6054570009253947e-07,0.19189100781010726,0.0
55,0.1,3,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Could increased neutrophil migration after severe trauma be involved in the etiology of acute respiratory distress syndrome? Our data reveal that major blunt trauma causes a strong neutrophil migratory response, which may play a role in ARDS development. While additional research is needed, these findings suggest that therapies aimed at neutrophil activation and migration could be effective for ARDS post-trauma.",1.6580180914979784e-07,0.02809945805283398,0.060353798126951096,0.012693985253473108,0.071289048237837,0.030738221214411676,0.012675610786670066,0.09417096613262466,0.015621063240110858,1.6580180914979784e-07,0.11778303565638559,0.0
55,0.1,4,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Is the enhanced neutrophil migratory response following major trauma a contributing factor to acute respiratory distress syndrome? The evidence indicates that blunt trauma induces a significant neutrophil migration that may contribute to ARDS. Although further investigation is warranted, our findings propose that modulating neutrophil activation and migration could be a promising treatment for trauma-related ARDS.",2.8423167282822487e-07,0.11665285539427739,0.060353798126951096,0.02176111757738247,0.161440145232135,0.030738221214411676,0.0217296184914344,0.18597851538574695,0.015621063240110858,2.8423167282822487e-07,0.21130909366720996,0.0
55,0.1,5,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Does major trauma-induced neutrophil migration contribute to the pathogenesis of acute respiratory distress syndrome? The results show that blunt trauma elicits a robust neutrophil migratory response potentially involved in ARDS development. More research is needed, but targeting neutrophil activation and migration may represent a viable therapeutic strategy for ARDS after trauma.",3.789755637709665e-07,0.19361389653040728,0.060353798126951096,0.029014823436509962,0.23991176067362918,0.030738221214411676,0.028972824655245866,0.2660212230592838,0.015621063240110858,3.789755637709665e-07,0.29298712468147725,0.0
55,0.1,6,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Is increased neutrophil migratory activity after major trauma implicated in the development of acute respiratory distress syndrome? Data suggest that major blunt trauma triggers a strong neutrophil migration, which might contribute to ARDS. Further studies are necessary, yet our findings indicate that inhibiting neutrophil activation and migration could be beneficial in treating trauma-induced ARDS.",3.079176455639103e-07,0.13534498840643172,0.060353798126951096,0.023574544042164344,0.1804883402028281,0.030738221214411676,0.023540420032387266,0.20539660124284964,0.015621063240110858,3.079176455639103e-07,0.23111172096338972,0.0
55,0.1,7,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Could the rise in neutrophil migration following major trauma be a factor in acute respiratory distress syndrome etiology? Findings demonstrate that blunt trauma causes a marked neutrophil migratory response, potentially leading to ARDS. While more research is required, these results suggest that targeting neutrophil activation and migration may offer therapeutic potential for ARDS post-trauma.",3.079176455639103e-07,0.13534498840643172,0.060353798126951096,0.023574544042164344,0.1804883402028281,0.030738221214411676,0.023540420032387266,0.20539660124284964,0.015621063240110858,3.079176455639103e-07,0.23111172096338972,0.0
55,0.1,8,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Is the increased neutrophil migratory response after major trauma a key factor in acute respiratory distress syndrome development? The data indicate that major blunt trauma induces a strong neutrophil migration that may contribute to ARDS. Further investigation is needed, but our findings support the idea that modulating neutrophil activation and migration could be a promising ARDS treatment after trauma.",1.8948778188548325e-07,0.0451938914121337,0.060353798126951096,0.014507411718254981,0.08868079094970582,0.030738221214411676,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
55,0.1,9,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Does the enhanced neutrophil migration following major trauma play a role in the etiology of acute respiratory distress syndrome? Evidence shows that blunt trauma provokes a robust neutrophil migratory response, possibly contributing to ARDS. Additional research is necessary, yet these findings suggest that targeting neutrophil activation and migration might be an effective therapeutic approach for trauma-related ARDS.",2.3685972735685406e-07,0.08028521122340315,0.060353798126951096,0.018134264647818726,0.12439887355178492,0.030738221214411676,0.018108015409528666,0.1482381874028995,0.015621063240110858,2.3685972735685406e-07,0.17284281283941416,0.0
55,0.1,10,ai,"Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? 

**Answer:** These data indicate that major blunt trauma induces a robust neutrophil migratory response, potentially contributing to the development of acute respiratory distress syndrome (ARDS). While further investigation is needed, our findings suggest that targeting neutrophil activation and migration may be a promising therapeutic strategy for ARDS following trauma. 
","Is the neutrophil migratory activity increase after major trauma a contributing factor to acute respiratory distress syndrome? The data reveal that major blunt trauma induces a significant neutrophil migration, which may be involved in ARDS development. While further studies are needed, our results imply that therapies aimed at neutrophil activation and migration could be beneficial for ARDS following trauma.",1.8948778188548325e-07,0.0451938914121337,0.060353798126951096,0.014507411718254981,0.08868079094970582,0.030738221214411676,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
56,0.1,1,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in such cases was unclear. Early diagnosis of sarcoidosis in other organs and steroid treatment are necessary.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.1,2,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery work for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The impact of decompression was not apparent. Early detection of sarcoidosis in other organs and steroid therapy is required.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.1,3,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective in treating spinal cord sarcoidosis with compressive cervical myelopathy? The benefits of decompression were not evident. Early diagnosis of sarcoidosis from other organs and steroid treatment should be implemented.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
56,0.1,4,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery help spinal cord sarcoidosis patients with compressive cervical myelopathy? The effect of decompression was not clear. Early identification of sarcoidosis in other organs and steroid therapy is necessary.,2.605457000925384e-07,0.17712645468899346,0.09642074506939374,0.01994769111260064,0.2522689060714689,0.049861495844875335,0.01991881695048158,0.29581112669495635,0.025623268698060954,2.6054570009253947e-07,0.341749293722057,0.0
56,0.1,5,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a successful treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The results of decompression were inconclusive. Early diagnosis of sarcoidosis in other organs and steroid therapy are important.,2.368597273568531e-07,0.14433663186600176,0.09642074506939374,0.01813426464781876,0.21836735439578714,0.049861495844875335,0.018108015409528708,0.26071980688368734,0.025623268698060954,2.3685972735685406e-07,0.3053816495511823,0.0
56,0.1,6,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery show effectiveness for spinal cord sarcoidosis with compressive cervical myelopathy? The effect was not evident. Early diagnosis of sarcoidosis in other organs and steroid treatment is needed.,2.842316728282237e-07,0.21102800636467522,0.09642074506939374,0.02176111757738252,0.2873602258827379,0.049861495844875335,0.021729618491434455,0.33217877086583103,0.025623268698060954,2.8423167282822487e-07,0.37948962170490397,0.0
56,0.1,7,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery a viable option for spinal cord sarcoidosis with compressive cervical myelopathy? The benefit of decompression was not demonstrated. Early diagnosis of sarcoidosis from other organs and steroid therapy should be pursued.,1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
56,0.1,8,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? The effect of decompression was unclear. Early diagnosis of sarcoidosis in other organs and steroid therapy is essential.,2.842316728282237e-07,0.21102800636467522,0.09642074506939374,0.02176111757738252,0.2873602258827379,0.049861495844875335,0.021729618491434455,0.33217877086583103,0.025623268698060954,2.8423167282822487e-07,0.37948962170490397,0.0
56,0.1,9,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery provide benefit in spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness was not evident. Early diagnosis of sarcoidosis from other organs and steroid treatment is necessary.,2.842316728282237e-07,0.21102800636467522,0.09642074506939374,0.02176111757738252,0.2873602258827379,0.049861495844875335,0.021729618491434455,0.33217877086583103,0.025623268698060954,2.8423167282822487e-07,0.37948962170490397,0.0
56,0.1,10,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery useful for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The effect of decompression was not obvious. Early diagnosis of sarcoidosis in other organs and steroid therapy should be considered.,2.131737546211678e-07,0.11258793355142194,0.09642074506939374,0.01632083818303688,0.18557753157279544,0.049861495844875335,0.016297213868575834,0.22681825520800558,0.025623268698060954,2.1317375462116866e-07,0.2702903297399133,0.0
57,0.1,1,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a contraindication for laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective option for treating GERD in elderly patients, showing low morbidity and mortality and symptom improvement similar to younger individuals.",9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
57,0.1,2,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age contraindicate GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery remains a safe and effective treatment for GERD in elderly patients, with low rates of morbidity and mortality and symptom relief comparable to that in younger patients.",9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
57,0.1,3,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is elderly age a contraindication for GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is both safe and effective for GERD treatment in elderly patients, demonstrating low morbidity and mortality and symptom improvement on par with younger patients.",1.1842986367842671e-07,0.1642191208045447,0.027006172839506164,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.1,4,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age prevent laparoscopic surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality and symptom improvement comparable to younger patients.",1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.1,5,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is laparoscopic surgery for GERD contraindicated in older adults? Answer: Laparoscopic antireflux surgery is safe and effective for elderly GERD patients, showing low morbidity and mortality rates and symptom improvement similar to younger patients.",1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
57,0.1,6,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is advanced age a limiting factor for GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality and symptom relief comparable to younger patients.",1.1842986367842671e-07,0.1642191208045447,0.027006172839506164,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
57,0.1,7,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Can elderly patients safely undergo laparoscopic surgery for GERD? Answer: Yes, laparoscopic antireflux surgery is safe and effective in elderly patients, with low morbidity and mortality and symptom improvement similar to younger patients.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
57,0.1,8,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is age a contraindication for laparoscopic antireflux surgery in GERD? Answer: Laparoscopic antireflux surgery is safe and effective for elderly patients with GERD, showing low morbidity and mortality and symptom improvement comparable to younger patients.",1.6580180914979731e-07,0.26153837742937647,0.056932966023875105,0.012693985253473115,0.22798490565049567,0.029384756657483937,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
57,0.1,9,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Does advanced age contraindicate laparoscopic antireflux surgery for GERD? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality and symptom relief similar to younger patients.",1.42115836414112e-07,0.2311670332228073,0.055363321799307974,0.010880558788691236,0.19783241553260567,0.02854671280276816,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
57,0.1,10,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Question: Is laparoscopic surgery for GERD safe in elderly patients? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients, with low morbidity and mortality rates and symptom improvement comparable to younger patients.",1.1842986367842671e-07,0.201686535969948,0.05387755102040818,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
58,0.1,1,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Is it acceptable for French laypeople and healthcare professionals to break confidentiality to protect a patient's wife from a sexually transmitted infection? Answer: This ethical issue is complex and lacks a straightforward solution. French law emphasizes patient confidentiality while also acknowledging the importance of safeguarding public health. The choice to reveal sensitive information should be evaluated individually, taking all relevant factors into account.",7.105791820705622e-08,0.025515555617921848,0.01514792899408284,0.005440279394345618,0.04725288485054513,0.0,0.0054324046228586,0.04800921918636103,0.0,7.105791820705622e-08,0.04879016416943571,0.0
58,0.1,2,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Do French non-experts and medical professionals consider it acceptable to violate confidentiality to shield a patient's wife from a sexually transmitted disease? Answer: This presents a challenging ethical dilemma without a simple resolution. French legislation prioritizes patient privacy but also supports protecting public health. Decisions about disclosing sensitive information must be made on a case-by-case basis, weighing all circumstances.",1.6580180914979784e-07,0.09111283810373827,0.01514792899408284,0.012693985253473108,0.1139442593492177,0.0,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
58,0.1,3,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Are French laypersons and health workers comfortable breaching confidentiality to protect a patient's spouse from an STD? Answer: This is a nuanced ethical issue with no clear-cut answer. French law upholds patient confidentiality but also acknowledges the necessity of protecting public health. Ultimately, disclosure decisions should be made individually, considering all relevant factors.",3.079176455639103e-07,0.198358368457336,0.01514792899408284,0.023574544042164344,0.22314355131420882,0.0,0.023540420032387266,0.22705745063534621,0.0,3.079176455639103e-07,0.23111172096338972,0.0
58,0.1,4,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Do French health professionals and the general public find it acceptable to break confidentiality to protect a patient's wife from a sexually transmitted infection? Answer: This ethical dilemma is complex and does not have an easy answer. French law prioritizes confidentiality but also recognizes the importance of public health protection. The decision to disclose sensitive information must be made on a case-by-case basis, taking all factors into consideration.",4.737194547137081e-08,0.05085742316665165,0.01514792899408284,0.0036268529295637453,0.030305349495328038,0.0,0.003621603081905733,0.0307716586667528,0.0,4.737194547137081e-08,0.03125254350410156,0.0
58,0.1,5,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Is it acceptable in France for laypeople and healthcare providers to breach confidentiality to protect a patient's wife from an STD? Answer: This is a complicated ethical issue with no simple solution. French law values patient confidentiality but also acknowledges the need to protect public health. The decision to reveal sensitive information should be made individually, considering all relevant factors.",1.4211583641411244e-07,0.09741062580602211,0.0015139497763854166,0.010880558788691236,0.09684982598991798,0.0,0.0108648092457172,0.0984400728132524,0.0,1.4211583641411244e-07,0.10008345855698497,0.0
58,0.1,6,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Do French laypeople and medical professionals accept breaching confidentiality to protect a patient's wife from sexually transmitted diseases? Answer: This is a difficult ethical dilemma without an easy answer. French law prioritizes patient confidentiality but also recognizes the necessity of protecting public health. Disclosure decisions must be made on a case-by-case basis, evaluating all involved factors.",2.3685972735685406e-07,0.14329859127430744,0.01514792899408284,0.018134264647818726,0.16705408466316563,0.0,0.018108015409528666,0.16989903679539609,0.0,2.3685972735685406e-07,0.17284281283941416,0.0
58,0.1,7,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Are breaches of confidentiality to protect a patient's wife from an STD acceptable to French laypeople and health professionals? Answer: This ethical question is complex and lacks a straightforward answer. French law emphasizes patient confidentiality but also supports public health protection. Decisions about disclosing sensitive information should be made individually, considering all circumstances.",3.079176455639103e-07,0.198358368457336,0.01514792899408284,0.023574544042164344,0.22314355131420882,0.0,0.023540420032387266,0.22705745063534621,0.0,3.079176455639103e-07,0.23111172096338972,0.0
58,0.1,8,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Do French health professionals and laypersons find it acceptable to violate confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: This is a complex ethical issue with no easy solution. French law prioritizes patient confidentiality while also recognizing the importance of public health. The choice to disclose sensitive information must be made on a case-by-case basis, taking all factors into account.",4.737194547137081e-08,0.009767198649785591,0.01514792899408284,0.0036268529295637453,0.03125254350410156,0.0,0.003621603081905733,0.031748698314579826,0.0,4.737194547137081e-08,0.03226086221822477,0.0
58,0.1,9,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Is it acceptable among French laypeople and healthcare professionals to breach confidentiality to protect a patient's wife from an STD? Answer: This ethical dilemma is complicated and has no simple answer. French law upholds patient confidentiality but also acknowledges the need to protect public health. Ultimately, decisions to disclose sensitive information should be made individually, considering all relevant factors.",1.6580180914979784e-07,0.11460935269899064,0.0017961851557388008,0.012693985253473108,0.1139442593492177,0.0,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
58,0.1,10,ai,"Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? 

Answer: This is a complex ethical dilemma with no easy answer. French law prioritizes patient confidentiality, but also recognizes the need to protect public health. Ultimately, the decision to disclose sensitive information must be made on a case-by-case basis, considering all factors involved. 
","Question: Do French laypeople and health professionals consider it acceptable to break confidentiality to protect a patient's wife from a sexually transmitted infection? Answer: This is a challenging ethical dilemma with no straightforward answer. French law prioritizes patient confidentiality but also recognizes the importance of protecting public health. The decision to disclose sensitive information must be made on a case-by-case basis, weighing all factors involved.",4.737194547137081e-08,0.009767198649785591,0.01514792899408284,0.0036268529295637453,0.03125254350410156,0.0,0.003621603081905733,0.031748698314579826,0.0,4.737194547137081e-08,0.03226086221822477,0.0
59,0.1,1,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Can diffusion-weighted echo-planar MR imaging predict different histologic subtypes of primary parotid gland tumors? Answer: epiDWI shows promise in distinguishing pleomorphic adenoma and myoepithelial adenomas from other studied tumor types. However, there is overlap among benign and malignant lesions as well.",1.8948778188548325e-07,0.17824823140631896,0.0,0.014507411718254981,0.1823215567939549,0.0,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
59,0.1,2,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Is it possible to use diffusion-weighted echo-planar MR imaging to predict histologic subtypes of primary parotid gland tumors? Answer: epiDWI may help differentiate pleomorphic adenoma and myoepithelial adenomas from other entities examined, though some overlap exists between benign and malignant lesions.",1.8948778188548325e-07,0.17824823140631896,0.0,0.014507411718254981,0.1823215567939549,0.0,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
59,0.1,3,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Can primary parotid gland tumor histologic subtypes be predicted by diffusion-weighted echo-planar MR imaging? Answer: epiDWI can potentially separate pleomorphic adenoma and myoepithelial adenomas from other tumor types studied, despite overlaps within benign and malignant groups.",3.0791764556390986e-07,0.30830135965451655,0.0,0.023574544042164344,0.31585294941847764,0.0,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
59,0.1,4,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Does diffusion-weighted echo-planar MR imaging allow prediction of different histologic subtypes in primary parotid gland tumors? Answer: epiDWI has the ability to distinguish pleomorphic adenoma and myoepithelial adenomas from other examined lesions, although overlaps occur among benign and malignant tumors.",2.1317375462116866e-07,0.20294084399669066,0.0,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
59,0.1,5,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Is predicting histologic subtypes of primary parotid gland tumors feasible with diffusion-weighted echo-planar MR imaging? Answer: epiDWI can differentiate pleomorphic adenoma and myoepithelial adenomas from other entities studied, but overlaps exist within benign and malignant lesion groups.",2.8423167282822456e-07,0.2809023854664012,0.0,0.02176111757738247,0.2876820724517808,0.0,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
59,0.1,6,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Can diffusion-weighted echo-planar MR imaging differentiate histologic subtypes of primary parotid gland tumors? Answer: epiDWI shows potential in distinguishing pleomorphic adenoma and myoepithelial adenomas from other examined tumors, despite some overlap between benign and malignant lesions.",3.0791764556390986e-07,0.30830135965451655,0.0,0.023574544042164344,0.31585294941847764,0.0,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
59,0.1,7,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Is it possible to predict different histologic subtypes of primary parotid gland tumors using diffusion-weighted echo-planar MR imaging? Answer: epiDWI may differentiate pleomorphic adenoma and myoepithelial adenomas from other entities, although overlaps occur within benign and malignant lesion groups.",2.3685972735685396e-07,0.22825865198098239,0.0,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
59,0.1,8,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Can diffusion-weighted echo-planar MR imaging be used to predict histologic subtypes of primary parotid gland tumors? Answer: epiDWI has potential to separate pleomorphic adenoma and myoepithelial adenomas from other studied lesions, but overlaps exist among benign and malignant tumors.",2.3685972735685396e-07,0.22825865198098239,0.0,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
59,0.1,9,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Does diffusion-weighted echo-planar MR imaging enable prediction of histologic subtypes in primary parotid gland tumors? Answer: epiDWI can distinguish pleomorphic adenoma and myoepithelial adenomas from other examined entities, though there is overlap within benign and malignant lesion groups.",2.6054570009253926e-07,0.25423413838424036,0.0,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
59,0.1,10,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Question: Is diffusion-weighted echo-planar MR imaging effective in predicting different histologic subtypes of primary parotid gland tumors? Answer: epiDWI may help differentiate pleomorphic adenoma and myoepithelial adenomas from other tumor types studied, despite overlaps among benign and malignant lesions.",2.6054570009253926e-07,0.25423413838424036,0.0,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
60,0.1,1,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
","Is it possible to obtain correlated results from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? These findings indicate that in-house developed quantitative real-time PCR assays can be dependable and yield results closely matching those from commercial kits, providing a cost-effective option for clinical BCRABL transcript detection.",4.737194547137081e-08,0.015406597899723096,0.018167643794376173,0.0036268529295637453,0.013380974745060836,0.020399305555555556,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
60,0.1,2,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
","Can homebrew assays produce correlated results for BCRABL transcript detection via quantitative real-time PCR? The data suggest that quantitative real-time PCR assays created internally are reliable and generate results that strongly correlate with commercial kit outcomes, making them a budget-friendly choice for clinical use.",1.6580180914979784e-07,0.09988463181436424,0.03651291511021191,0.012693985253473108,0.12585895817175086,0.020399305555555556,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
60,0.1,3,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
","Are correlated results achievable from homebrew quantitative real-time PCR assays for detecting BCRABL transcripts? The evidence shows that in-house quantitative real-time PCR assays can be trustworthy and deliver results highly consistent with those from commercial kits, offering an economical alternative in clinical diagnostics.",1.8948778188548325e-07,0.1901967512718632,0.011250371664063868,0.014507411718254981,0.2175806249273906,0.028252896942800785,0.014486412327622933,0.21697891582195128,0.02498356344510192,1.8948778188548325e-07,0.18658595558041347,0.0
60,0.1,4,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
","Is it feasible to get correlated results from homebrew assays in quantitative real-time PCR for BCRABL transcript detection? Results imply that internally developed quantitative real-time PCR assays are reliable and produce outcomes closely aligned with commercial kits, serving as a cost-effective clinical tool.",1.8948778188548325e-07,0.1571897426737685,0.012255545495699419,0.014507411718254981,0.18376856733910074,0.003975694444444445,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
60,0.1,5,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
","Can quantitative real-time PCR assays developed in-house yield correlated results for BCRABL transcript detection? Findings suggest these homebrew assays are dependable and provide results that correlate well with commercial kits, presenting a cost-saving option for clinical applications.",3.3160361829959526e-07,0.24532640530484207,0.05975554549569943,0.025387970506946217,0.3081805149657053,0.020399305555555556,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
60,0.1,6,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
","Do homebrew quantitative real-time PCR assays provide correlated results for BCRABL transcript detection? The results indicate that in-house assays can be reliable and produce data highly correlated with commercial kits, offering a more affordable clinical alternative.",3.5528959103528056e-07,0.2734972822715389,0.05975554549569943,0.027201396971728097,0.3371680518389568,0.020399305555555556,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
60,0.1,7,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
","Is correlated detection of BCRABL transcripts possible using homebrew quantitative real-time PCR assays? The study suggests that in-house developed assays are reliable and yield results closely matching commercial kits, making them a cost-effective choice for clinical settings.",3.3160361829959526e-07,0.24532640530484207,0.05975554549569943,0.025387970506946217,0.3081805149657053,0.020399305555555556,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
60,0.1,8,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
","Are homebrew quantitative real-time PCR assays capable of producing correlated results for BCRABL transcript detection? Evidence shows these assays can be trustworthy and generate results that align well with commercial kits, providing a budget-friendly clinical option.",3.5528959103528056e-07,0.2734972822715389,0.05975554549569943,0.027201396971728097,0.3371680518389568,0.020399305555555556,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
60,0.1,9,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
","Can reliable and correlated results for BCRABL transcript detection be obtained from homebrew quantitative real-time PCR assays? The findings indicate that in-house assays are dependable and produce outcomes comparable to commercial kits, offering a cost-effective clinical alternative.",3.3160361829959526e-07,0.24532640530484207,0.05975554549569943,0.025387970506946217,0.3081805149657053,0.020399305555555556,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
60,0.1,10,ai,"Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? 
Answer: These results suggest that quantitative real-time PCR assays developed in-house can be reliable and produce results highly correlated with those from commercially available kits, offering a cost-effective alternative for BCRABL transcript detection in clinical settings. 
","Is it possible for homebrew quantitative real-time PCR assays to produce results correlated with commercial kits for BCRABL transcript detection? The data suggest that these in-house assays are reliable and yield results highly consistent with commercial options, providing an economical clinical solution.",2.1317375462116866e-07,0.14908533464493434,0.03538054549569943,0.016320838183036854,0.17464912234118257,0.020399305555555556,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
61,0.1,1,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Question: Is imaging necessary to diagnose appendicitis in children? Answer: Diagnosis of appendicitis primarily relies on clinical evaluation. However, for girls over 10 years old, selective imaging is recommended to prevent unnecessary surgeries. In uncertain cases, the preferred imaging method should be used.",4.737194547137081e-08,0.01649336441601079,0.045351473922902494,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
61,0.1,2,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Question: Should imaging be used to diagnose appendicitis in children? Answer: Clinical examination remains the cornerstone for diagnosing appendicitis. Yet, in girls older than 10, imaging should be selectively applied to avoid unwarranted appendectomies. The imaging modality of choice should be employed in ambiguous cases.",0.0,0.031506690025452144,0.022636492852053387,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
61,0.1,3,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Question: Do children with suspected appendicitis require imaging for diagnosis? Answer: The diagnosis of appendicitis depends mainly on clinical assessment. Still, in girls above 10 years, selective imaging is advised to reduce unnecessary appendectomies. The recommended imaging technique should be used when the diagnosis is unclear.",2.3685972735685406e-08,0.05467969454474275,0.023140730121249602,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
61,0.1,4,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Question: Is imaging required to diagnose appendicitis in pediatric patients? Answer: Clinical assessment is essential for diagnosing appendicitis. Nonetheless, in girls older than 10 years, selective imaging should be considered to prevent unnecessary appendectomies. The imaging method of choice should be applied in equivocal situations.",0.0,0.031506690025452144,0.022636492852053387,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
61,0.1,5,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Question: For diagnosing appendicitis in children, do we need imaging? Answer: Appendicitis diagnosis is primarily clinical. However, in girls over 10 years old, selective imaging is warranted to avoid unnecessary surgeries. In doubtful cases, the preferred imaging approach should be utilized.",9.474389094274162e-08,0.032296799753420924,0.045351473922902494,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
61,0.1,6,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Question: Does diagnosing appendicitis in children require imaging? Answer: Clinical evaluation is key to diagnosing appendicitis. Yet, in girls older than 10, selective imaging is recommended to prevent unnecessary appendectomies. The imaging of choice should be used in uncertain cases.",1.1842986367842692e-07,0.05761460773771265,0.045351473922902494,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
61,0.1,7,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Question: Is imaging necessary for diagnosing appendicitis in children? Answer: Diagnosis relies mainly on clinical assessment. However, selective imaging should be used in girls older than 10 years to avoid unnecessary appendectomies. The chosen imaging technique should be applied in equivocal cases.",7.105791820705622e-08,0.04141624475133909,0.020976473922902493,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
61,0.1,8,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Question: Should imaging be performed to diagnose appendicitis in children? Answer: Clinical assessment is fundamental for diagnosis. Nevertheless, in girls above 10 years, selective imaging is advised to prevent unnecessary appendectomies. The imaging modality of choice should be used in ambiguous cases.",7.105791820705622e-08,0.007604187163049225,0.045351473922902494,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
61,0.1,9,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Question: Do we require imaging to diagnose appendicitis in children? Answer: The diagnosis is primarily clinical. However, in girls older than 10 years, selective imaging should be implemented to avoid unnecessary appendectomies. The preferred imaging method should be used in uncertain cases.",7.105791820705622e-08,0.04141624475133909,0.020976473922902493,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
61,0.1,10,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Question: Is imaging indicated for diagnosing appendicitis in children? Answer: Clinical assessment is the main diagnostic tool. Still, in girls over 10 years, selective imaging is recommended to prevent unnecessary appendectomies. The imaging technique of choice should be employed in equivocal cases.",7.105791820705622e-08,0.007604187163049225,0.045351473922902494,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
62,0.1,1,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Using MEP and SSEP monitoring, it is safe to sacrifice up to 15 intercostal and lumbar arteries during TAA/A repair without reimplantation, leading to low rates of immediate and delayed paraplegia. This suggests that routine surgical reimplantation of segmental vessels may not be necessary.",4.737194547137081e-08,0.01079664565701588,0.016661878770468257,0.0036268529295637453,0.03448617607116855,0.0,0.003621603081905733,0.03509131981126945,0.0,4.737194547137081e-08,0.03571808260207909,0.0
62,0.1,2,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Monitoring MEP and SSEP allows for the safe sacrifice of as many as 15 intercostal and lumbar arteries during TAA/A repair without reimplantation, resulting in acceptably low rates of paraplegia both immediately and delayed. This experience indicates that routine reimplantation of segmental arteries might be unnecessary.",9.474389094274162e-08,0.0443317880289964,0.016124697661918846,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
62,0.1,3,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries during TAA/A repair without reimplantation is safe and leads to low rates of immediate and delayed paraplegia, suggesting that routine reimplantation of segmental vessels may not be required.",2.3685972735685406e-08,0.04171269641572639,0.017538265306122455,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
62,0.1,4,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The use of MEP and SSEP monitoring shows that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low rates of immediate and delayed paraplegia, implying that routine segmental vessel reimplantation may be unnecessary.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
62,0.1,5,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: By monitoring MEP and SSEP, surgeons can safely sacrifice up to 15 intercostal and lumbar arteries during TAA/A repair without reimplantation, resulting in low rates of immediate and delayed paraplegia, suggesting routine reimplantation of segmental vessels might be redundant.",7.105791820705622e-08,0.07831517733430982,0.0181755829903978,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
62,0.1,6,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The experience with MEP and SSEP monitoring indicates that sacrificing as many as 15 intercostal and lumbar arteries during TAA/A repair without reimplantation is safe and results in low immediate and delayed paraplegia rates, suggesting routine reimplantation may not be necessary.",2.3685972735685406e-08,0.01739174271186883,0.0,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
62,0.1,7,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Monitoring MEP and SSEP demonstrates that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with acceptably low rates of immediate and delayed paraplegia, indicating that routine segmental vessel reimplantation may be unnecessary.",7.105791820705622e-08,0.05310982531394792,0.0,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
62,0.1,8,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With the aid of MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries during TAA/A repair without reimplantation is safe and results in low rates of immediate and delayed paraplegia, suggesting that routine reimplantation of segmental arteries might be unnecessary.",4.737194547137081e-08,0.01079664565701588,0.016661878770468257,0.0036268529295637453,0.03448617607116855,0.0,0.003621603081905733,0.03509131981126945,0.0,4.737194547137081e-08,0.03571808260207909,0.0
62,0.1,9,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The use of MEP and SSEP monitoring supports that sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, with low immediate and delayed paraplegia rates, implying that routine segmental vessel reimplantation may be unnecessary.",4.737194547137081e-08,0.03509131981126945,0.0,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
62,0.1,10,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Experience with MEP and SSEP monitoring shows that sacrificing as many as 15 intercostal and lumbar arteries during TAA/A repair without reimplantation is safe and results in acceptably low rates of immediate and delayed paraplegia, suggesting that routine surgical reimplantation of segmental vessels may not be needed.",1.1842986367842703e-07,0.06068704344638842,0.01586888657648284,0.009067132323909363,0.0840831172105414,0.0,0.009054007704764333,0.08552217343816082,0.0,1.1842986367842703e-07,0.08701137698962835,0.0
63,0.1,1,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study indicates a potential link, especially in those with extensive cervical cord lesions. More research is necessary to understand the relationship and its clinical significance.",4.974054274493934e-07,0.22655906276921556,0.1743767313019391,0.038081955760419325,0.2519791674173133,0.13225682429834681,0.0380268323600102,0.2822137094911721,0.1184159938485198,4.974054274493935e-07,0.31360660715529365,0.10380622837370242
63,0.1,2,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Does a relationship exist between cervical cord plaques and discopathy in patients with multiple sclerosis? Data from the study suggests a possible association, notably in patients with widespread cervical cord lesions. Additional studies are required to define the exact nature and clinical impact.",4.263475092423373e-07,0.21592610715028693,0.12899408284023672,0.03264167636607371,0.20980531802768176,0.1078818242983468,0.0325944277371516,0.2042521680214615,0.1184159938485198,4.263475092423373e-07,0.23356389948175948,0.10380622837370242
63,0.1,3,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Are cervical cord plaques related to discopathy in multiple sclerosis patients? The findings imply a possible correlation, particularly in individuals with more severe cervical cord lesions. Further investigation is needed to clarify this relationship and its clinical relevance.",5.44777372920764e-07,0.2811242021605529,0.17299382716049388,0.04170880868998307,0.3060463886875895,0.13225682429834681,0.04164843544191593,0.33778356064598425,0.1184159938485198,5.447773729207643e-07,0.370765020995242,0.10380622837370242
63,0.1,4,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Is there an association between cervical cord plaques and discopathy among multiple sclerosis patients? Study results point to a potential correlation, especially in those with extensive cervical cord lesions. More research is needed to better understand the clinical implications.",5.210914001850787e-07,0.25346997046877595,0.17370343316289266,0.0398953822252012,0.27864741449947417,0.13225682429834681,0.039837633900963065,0.3096126836792874,0.1184159938485198,5.210914001850789e-07,0.3417774841219905,0.10380622837370242
63,0.1,5,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Can cervical cord plaques be linked to discopathy in patients with multiple sclerosis? The study data suggests a possible connection, particularly in patients with more extensive cervical cord lesions. Further research is necessary to elucidate the relationship and its clinical importance.",4.737194547137081e-07,0.2696673226094308,0.12549306062819582,0.03626852929563745,0.26154969027353925,0.10663355560028587,0.03621603081905733,0.2555454624090112,0.1184159938485198,4.737194547137081e-07,0.2862076329671783,0.10380622837370242
63,0.1,6,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Is there any link between cervical cord plaques and discopathy in multiple sclerosis patients? The study suggests a potential correlation, especially in individuals with widespread cervical cord lesions. Additional research is required to clarify the exact relationship and its clinical consequences.",4.737194547137081e-07,0.2003526045534363,0.17501643655489812,0.03626852929563745,0.22600368101405532,0.13225682429834681,0.03621603081905733,0.2555454624090112,0.1184159938485198,4.737194547137081e-07,0.2862076329671783,0.10380622837370242
63,0.1,7,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Does cervical cord plaque presence correlate with discopathy in multiple sclerosis patients? Study data indicates a possible association, notably in those with extensive cervical cord lesions. Further studies are needed to understand the clinical implications.",6.158352911278199e-07,0.3689875385855639,0.1706152433425161,0.0471490880843287,0.3930577656772196,0.13225682429834681,0.04708084006477455,0.4273957193356712,0.1184159938485198,6.158352911278206e-07,0.4631383411262573,0.10380622837370242
63,0.1,8,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Is there a relationship between cervical cord plaques and discopathy in patients with multiple sclerosis? The data suggests a possible link, particularly in patients with more extensive cervical cord lesions. More research is needed to clarify the clinical significance.",5.210914001850787e-07,0.32643283158034997,0.12163265306122453,0.0398953822252012,0.3161148296648766,0.10525065145884065,0.039837633900963065,0.3096126836792874,0.1184159938485198,5.210914001850789e-07,0.3417774841219905,0.10380622837370242
63,0.1,9,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Are cervical cord plaques connected to discopathy in multiple sclerosis patients? The study findings suggest a potential correlation, especially in individuals with widespread cervical cord lesions. Further research is necessary to define the exact relationship and its clinical impact.",5.210914001850787e-07,0.25346997046877595,0.17370343316289266,0.0398953822252012,0.27864741449947417,0.13225682429834681,0.039837633900963065,0.3096126836792874,0.1184159938485198,5.210914001850789e-07,0.3417774841219905,0.10380622837370242
63,0.1,10,ai,"Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? 

Answer: The study data suggests a possible correlation between cervical cord plaques and discopathy in patients with multiple sclerosis. This correlation is particularly evident in individuals with more extensive cervical cord lesions. Further research is needed to clarify the exact relationship and its clinical implications. 
","Is there any correlation between cervical cord plaques and discopathy in multiple sclerosis patients? The study data points to a possible association, particularly in those with extensive cervical cord lesions. Additional research is needed to clarify the clinical implications.",5.210914001850787e-07,0.25346997046877595,0.17370343316289266,0.0398953822252012,0.27864741449947417,0.13225682429834681,0.039837633900963065,0.3096126836792874,0.1184159938485198,5.210914001850789e-07,0.3417774841219905,0.10380622837370242
64,0.1,1,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","This article examines the concerningly high mortality rates in emergency general surgery laparotomies, emphasizing the critical need for better surgical methods, pre-operative evaluations, and post-operative management to reduce these dangers.",4.974054274493924e-07,0.4615495137744787,0.05975554549569942,0.038081955760419374,0.5313240662799146,0.020399305555555556,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
64,0.1,2,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","The focus of this article is on the significant mortality rates following emergency general surgery laparotomies, underscoring the necessity for advancements in surgical procedures, thorough pre-operative assessments, and enhanced post-operative care to improve outcomes.",4.0266153650665116e-07,0.33233778229447175,0.05975554549569942,0.030828249901291856,0.3977926736553923,0.020399305555555556,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
64,0.1,3,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Highlighting the alarmingly high death rates in emergency general surgery laparotomies, this article stresses the importance of refining surgical techniques, improving pre-operative evaluations, and strengthening post-operative care to lower these risks.",4.7371945471370706e-07,0.42764796209879696,0.05975554549569942,0.036268529295637494,0.49623274646864557,0.020399305555555556,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
64,0.1,4,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","This article addresses the high mortality associated with emergency general surgery laparotomies, pointing out the urgent requirement for improved surgical approaches, comprehensive pre-operative assessments, and better post-operative care to mitigate these risks.",4.5003348197802176e-07,0.39485813927580526,0.05975554549569942,0.034455102830855615,0.4623311947929638,0.020399305555555556,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
64,0.1,5,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Exploring the elevated mortality rates in emergency general surgery laparotomies, this article calls attention to the need for enhanced surgical practices, detailed pre-operative assessments, and improved post-operative care to reduce patient risk.",4.5003348197802176e-07,0.39485813927580526,0.05975554549569942,0.034455102830855615,0.4623311947929638,0.020399305555555556,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
64,0.1,6,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","The article discusses the troublingly high death rates in emergency general surgery laparotomies and highlights the pressing need for advancements in surgical techniques, pre-operative evaluation, and post-operative care to improve survival.",4.7371945471370706e-07,0.42764796209879696,0.05975554549569942,0.036268529295637494,0.49623274646864557,0.020399305555555556,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
64,0.1,7,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Focusing on the high mortality rates in emergency general surgery laparotomies, this article emphasizes the critical need for better surgical methods, thorough pre-operative assessments, and improved post-operative care to decrease these risks.",4.5003348197802176e-07,0.39485813927580526,0.05975554549569942,0.034455102830855615,0.4623311947929638,0.020399305555555556,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
64,0.1,8,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","This article explores the significant mortality rates in emergency general surgery laparotomies, stressing the urgent need for improved surgical techniques, comprehensive pre-operative evaluations, and enhanced post-operative care to mitigate these dangers.",4.7371945471370706e-07,0.42764796209879696,0.05975554549569942,0.036268529295637494,0.49623274646864557,0.020399305555555556,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
64,0.1,9,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","Addressing the high death rates in emergency general surgery laparotomies, this article highlights the necessity for advancements in surgical procedures, detailed pre-operative assessments, and better post-operative care to reduce mortality.",4.974054274493924e-07,0.4615495137744787,0.05975554549569942,0.038081955760419374,0.5313240662799146,0.020399305555555556,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
64,0.1,10,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: This article will explore the alarmingly high mortality rates associated with emergency general surgery laparotomies, highlighting the urgent need for improved surgical techniques, pre-operative assessments, and post-operative care to mitigate these risks. 
","This article investigates the alarmingly high mortality rates in emergency general surgery laparotomies, underscoring the urgent need for improved surgical techniques, thorough pre-operative assessments, and enhanced post-operative care to lower these risks.",4.5003348197802176e-07,0.39485813927580526,0.05975554549569942,0.034455102830855615,0.4623311947929638,0.020399305555555556,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
65,0.1,1,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Emergency double-balloon enteroscopy (DBE) combined with real-time capsule endoscopy viewing is a viable method for acute overt-obscure gastrointestinal bleeding (OGIB).,5.210914001850768e-07,0.7353210299495778,0.024375,0.039895382225201316,0.7985076962177713,0.0,0.03983763390096319,0.8303483020734284,0.0,5.210914001850787e-07,0.8649974374866054,0.0
65,0.1,2,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","In cases of acute OGIB, emergency DBE paired with real-time capsule endoscopy is a feasible and effective approach.",5.684633456564475e-07,0.8465466650598019,0.024375,0.04352223515476507,0.9162907318741551,0.0,0.04345923698286894,0.955511445027434,0.0,5.684633456564493e-07,0.9985288301111281,0.0
65,0.1,3,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",The combination of emergency DBE and real-time capsule endoscopy viewing is safe and practical for managing acute overt-obscure gastrointestinal bleeding.,5.210914001850768e-07,0.7353210299495778,0.024375,0.039895382225201316,0.7985076962177713,0.0,0.03983763390096319,0.8303483020734284,0.0,5.210914001850787e-07,0.8649974374866054,0.0
65,0.1,4,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Emergency DBE, when used alongside real-time capsule endoscopy, proves to be a safe and effective treatment for acute OGIB.",5.447773729207622e-07,0.7893882512198531,0.024375,0.041708808689983196,0.8556661100577201,0.0,0.04164843544191606,0.8909729238898634,0.0,5.44777372920764e-07,0.929535958624176,0.0
65,0.1,5,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Using emergency DBE with real-time capsule endoscopy is a feasible strategy to diagnose and treat acute overt-obscure gastrointestinal bleeding.,5.447773729207622e-07,0.7893882512198531,0.024375,0.041708808689983196,0.8556661100577201,0.0,0.04164843544191606,0.8909729238898634,0.0,5.44777372920764e-07,0.929535958624176,0.0
65,0.1,6,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Acute OGIB can be effectively managed with emergency DBE combined with real-time capsule endoscopy, potentially avoiding major surgery.",5.684633456564475e-07,0.8465466650598019,0.024375,0.04352223515476507,0.9162907318741551,0.0,0.04345923698286894,0.955511445027434,0.0,5.684633456564493e-07,0.9985288301111281,0.0
65,0.1,7,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Emergency double-balloon enteroscopy with real-time capsule endoscopy viewing is a safe and effective approach in acute OGIB cases.,5.684633456564475e-07,0.8465466650598019,0.024375,0.04352223515476507,0.9162907318741551,0.0,0.04345923698286894,0.955511445027434,0.0,5.684633456564493e-07,0.9985288301111281,0.0
65,0.1,8,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",The combined use of emergency DBE and real-time capsule endoscopy is a practical and successful method for acute overt-obscure gastrointestinal bleeding.,4.974054274493914e-07,0.6840277355620277,0.024375,0.038081955760419436,0.744440474947496,0.0,0.03802683236001032,0.7731898882334796,0.0,4.974054274493933e-07,0.8043728156701704,0.0
65,0.1,9,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Emergency DBE is a feasible and safe procedure for acute OGIB when integrated with real-time capsule endoscopy, helping to avoid major surgery.",4.737194547137061e-07,0.6352375713925964,0.024375,0.03626852929563756,0.6931471805599458,0.0,0.03621603081905744,0.7191226669632043,0.0,4.7371945471370796e-07,0.7472144018302216,0.0
65,0.1,10,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","In acute overt-obscure gastrointestinal bleeding, emergency DBE combined with real-time capsule endoscopy is an effective and safe treatment option.",5.447773729207622e-07,0.7893882512198531,0.024375,0.041708808689983196,0.8556661100577201,0.0,0.04164843544191606,0.8909729238898634,0.0,5.44777372920764e-07,0.929535958624176,0.0
66,0.1,1,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex affect the outcome of intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis might alter the typical survival and recovery benefits seen in men during ischemic stroke.,1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
66,0.1,2,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests that intravenous thrombolysis could change the usual survival and recovery advantage observed in men with ischemic stroke.,1.1842986367842703e-07,0.1187445534356879,0.002646604938271603,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
66,0.1,3,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does gender impact the effectiveness of intravenous thrombolysis in ischemic stroke? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register imply that intravenous thrombolysis may modify the expected survival and recovery benefits for men in ischemic stroke.,1.6580180914979774e-07,0.20603493494102976,0.029403818232647053,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
66,0.1,4,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is there a sex-based difference in response to intravenous thrombolysis for ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis might influence the survival and recovery advantage typically seen in men.,1.6580180914979774e-07,0.1704889256815454,0.003894873636332556,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
66,0.1,5,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,","Does intravenous thrombolysis response in ischemic stroke vary by sex? According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis may alter the survival and recovery benefits usually expected for men.",2.8423167282822424e-07,0.3129174014978937,0.007656361595755539,0.021761117577382486,0.3101549283038394,0.0,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
66,0.1,6,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex influence outcomes after intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis could modify the survival and recovery advantage normally observed in men.,2.3685972735685364e-07,0.25349380079337047,0.006026706979087932,0.018134264647818726,0.2513144282809061,0.0,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
66,0.1,7,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the effect of intravenous thrombolysis on ischemic stroke outcomes affected by sex? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data suggest that intravenous thrombolysis may change the survival and recovery benefits typically seen in men.,1.8948778188548304e-07,0.19739983338110578,0.004568171775378976,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
66,0.1,8,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does the sex of a patient affect the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis might alter the expected survival and recovery advantage for men.,1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
66,0.1,9,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is there a difference in intravenous thrombolysis response in ischemic stroke based on sex? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis may modify the survival and recovery benefits usually observed in men.,1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
66,0.1,10,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,","Does sex play a role in the response to intravenous thrombolysis in ischemic stroke? According to data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis might change the survival and recovery advantage typically expected in men.",1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
67,0.1,1,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Is GABA released by mossy fibers? We have presented strong evidence indicating the presence of a GABAergic signal from mossy fibers. The exact physiological function of this signal is still unknown. Nonetheless, our results imply that GABA release from mossy fibers might play a role in modulating neuronal activity within the hippocampus.",2.3685972735685406e-08,0.020346272143678235,0.00039167013744273796,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
67,0.1,2,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Do mossy fibers secrete GABA? Our research provides convincing proof of a GABAergic signal originating from mossy fibers. The physiological purpose of this signal has yet to be clarified. However, the data suggest that GABA release by mossy fibers could influence the regulation of neuronal activity in the hippocampus.",4.737194547137081e-08,0.04197723982118706,0.0008322320807555503,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
67,0.1,3,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Are mossy fibers responsible for releasing GABA? We have demonstrated compelling evidence supporting the existence of a GABAergic signal from mossy fibers. The physiological role of this signal remains unclear. Still, our findings indicate that GABA release from mossy fibers may help regulate neuronal activity in the hippocampus.",7.105791820705622e-08,0.0931407659050465,0.022477465665026397,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
67,0.1,4,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Do mossy fibers emit GABA? We have supplied strong evidence that mossy fibers produce a GABAergic signal. The physiological significance of this signal is yet to be determined. However, our observations suggest that GABA release by mossy fibers might contribute to controlling neuronal activity in the hippocampus.",9.474389094274162e-08,0.12730434923848621,0.06885130506916884,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
67,0.1,5,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Is there GABA release from mossy fibers? We have provided convincing evidence for a GABAergic signal from mossy fibers. The physiological role of this signal is not yet known. Nevertheless, our findings propose that mossy fiber GABA release could play a part in regulating hippocampal neuronal activity.",9.474389094274162e-08,0.11592938959143062,0.02339675961462339,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
67,0.1,6,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Do mossy fibers discharge GABA? We have presented compelling evidence indicating a GABAergic signal from mossy fibers. The physiological function of this signal remains to be established. However, our results suggest that GABA release by mossy fibers may be involved in modulating neuronal activity in the hippocampus.",9.474389094274162e-08,0.08579255565404154,0.0017367249242856639,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
67,0.1,7,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Are mossy fibers a source of GABA release? We have shown strong evidence supporting a GABAergic signal from mossy fibers. The physiological role of this signal is still unknown. Yet, our findings imply that GABA release from mossy fibers might contribute to the regulation of neuronal activity in the hippocampus.",2.3685972735685406e-08,0.04906026340613634,0.020750747245988695,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
67,0.1,8,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Do mossy fibers liberate GABA? We have provided substantial evidence for a GABAergic signal from mossy fibers. The physiological role of this signal remains to be identified. However, our data suggest that GABA release by mossy fibers may influence neuronal activity regulation in the hippocampus.",1.4211583641411244e-07,0.1316141743129382,0.002723310933406376,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
67,0.1,9,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Is GABA released by mossy fibers? We have demonstrated strong evidence of a GABAergic signal from mossy fibers. The physiological role of this signal is yet to be defined. Nonetheless, our findings indicate that mossy fiber GABA release might contribute to the control of neuronal activity in the hippocampus.",4.737194547137081e-08,0.013096107297856374,0.019991670137442734,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
67,0.1,10,ai,"Question: Do mossy fibers release GABA? 

Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this signal remains to be determined. However, our findings suggest that mossy fiber GABA release may contribute to the regulation of neuronal activity in the hippocampus. 
","Do mossy fibers produce GABA? We have provided compelling evidence that mossy fibers generate a GABAergic signal. The physiological role of this signal remains undetermined. However, our findings suggest that GABA release from mossy fibers could play a role in regulating neuronal activity in the hippocampus.",1.1842986367842703e-07,0.1508754476799683,0.07086825414595371,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
68,0.1,1,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Assessing living arrangements is essential to understand and clarify gender disparities in mortality risks related to marital status. The effects of living alone versus living with a partner appear to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.1,2,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Analyzing living arrangements is key to identifying and explaining gender differences in mortality risk associated with marital status. The influence of living alone compared to living with a partner seems to",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
68,0.1,3,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Understanding living arrangements is vital for recognizing and explaining gender-based differences in mortality risks linked to marital status. The role of living alone and living with a partner appears to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.1,4,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluating living arrangements plays a critical role in uncovering and explaining gender disparities in mortality risks by marital status. The impact of living alone versus cohabiting with a partner seems to",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
68,0.1,5,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The assessment of living arrangements is important for identifying and explaining gender differences in mortality risk related to marital status. The effect of living alone and living with a partner appears to",4.737194547137081e-08,0.04689523646551175,0.0010318865838346326,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
68,0.1,6,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Investigating living arrangements is crucial for understanding and explaining gender differences in mortality risks associated with marital status. The influence of living alone compared to living with a partner seems to",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
68,0.1,7,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Examining living arrangements is essential to identify and explain gender disparities in mortality risk by marital status. The impact of living alone and living with a partner appears to",2.3685972735685406e-08,0.008708906336779787,0.023242630385487524,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
68,0.1,8,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Considering living arrangements is key to recognizing and explaining gender differences in mortality risks linked to marital status. The role of living alone versus living with a partner seems to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.1,9,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Reviewing living arrangements is vital for identifying and explaining gender-based differences in mortality risks related to marital status. The effect of living alone and living with a partner appears to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,0.1,10,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Studying living arrangements is important for understanding and explaining gender disparities in mortality risks associated with marital status. The influence of living alone compared to living with a partner seems to",2.3685972735685406e-08,0.05522892197167373,0.023242630385487524,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
69,0.1,1,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Patients taking aromatase inhibitors (AIs) who develop osteoporosis tend to have a higher chance of musculoskeletal symptoms. Preventing osteoporosis is important, but addressing these symptoms also involves exercise, calcium and vitamin D supplements, and pain relief strategies.",3.0791764556390986e-07,0.28000963799900846,0.020399305555555556,0.023574544042164344,0.31585294941847764,0.0,0.023540420032387273,0.323787077093896,0.0,3.079176455639103e-07,0.3321338350226144,0.0
69,0.1,2,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Musculoskeletal symptoms are more common in patients on aromatase inhibitors who develop osteoporosis. Although osteoporosis prevention is vital, effective symptom management includes exercise, supplementation with calcium and vitamin D, and pain control.",4.2634750924233636e-07,0.4295413719699721,0.020399305555555556,0.03264167636607374,0.47000362924573613,0.0,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
69,0.1,3,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Individuals on AIs who develop osteoporosis are at increased risk for musculoskeletal symptoms. Preventing osteoporosis is key, but symptom management also requires a combination of exercise, calcium and vitamin D intake, and pain management.",3.7897556377096576e-07,0.3670210149886386,0.020399305555555556,0.029014823436509983,0.4054651081081646,0.0,0.028972824655245893,0.41616039722491127,0.0,3.789755637709665e-07,0.4274440148269396,0.0
69,0.1,4,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Osteoporosis development in patients using aromatase inhibitors is linked to a higher likelihood of musculoskeletal symptoms. Preventing osteoporosis is essential, yet managing these symptoms demands a comprehensive approach including exercise, calcium and vitamin D supplementation, and pain relief.",2.8423167282822456e-07,0.25261066381089314,0.020399305555555556,0.02176111757738247,0.2876820724517808,0.0,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
69,0.1,5,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Patients receiving aromatase inhibitors who develop osteoporosis are more prone to musculoskeletal symptoms. While osteoporosis prevention is critical, managing these symptoms involves exercise, calcium and vitamin D supplements, and pain management.",4.5003348197802166e-07,0.4623311947929638,0.020399305555555556,0.03445510283085562,0.5039051809214179,0.0,0.034405229278104514,0.5179430915348537,0.0,4.500334819780227e-07,0.5328045304847651,0.0
69,0.1,6,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Musculoskeletal symptoms frequently occur in patients on AIs who develop osteoporosis. Preventing osteoporosis is important, but symptom control also requires exercise, calcium and vitamin D supplementation, and pain management.",4.974054274493923e-07,0.5313240662799146,0.020399305555555556,0.03808195576041938,0.5753641449035616,0.0,0.03802683236001026,0.5920510636885754,0.0,4.974054274493935e-07,0.6097655716208945,0.0
69,0.1,7,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Those on aromatase inhibitors who develop osteoporosis have a greater risk of musculoskeletal symptoms. Preventing osteoporosis is necessary, but managing symptoms also calls for exercise, calcium and vitamin D supplementation, and pain relief.",4.0266153650665106e-07,0.3977926736553923,0.020399305555555556,0.030828249901291863,0.43721380642274443,0.0,0.030783626196198767,0.44895022004790297,0.0,4.026615365066519e-07,0.4613455665026214,0.0
69,0.1,8,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Patients treated with aromatase inhibitors who develop osteoporosis are more likely to experience musculoskeletal symptoms. Preventing osteoporosis is crucial, but symptom management includes exercise, calcium and vitamin D supplements, and pain control.",4.2634750924233636e-07,0.4295413719699721,0.020399305555555556,0.03264167636607374,0.47000362924573613,0.0,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
69,0.1,9,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","The occurrence of musculoskeletal symptoms is higher in patients on AIs who develop osteoporosis. While preventing osteoporosis is vital, managing these symptoms requires a multifaceted strategy including exercise, calcium and vitamin D supplementation, and pain management.",3.3160361829959516e-07,0.3081805149657053,0.020399305555555556,0.025387970506946224,0.34484048629172914,0.0,0.025351221573340146,0.35364004024357776,0.0,3.316036182995957e-07,0.3629054936893681,0.0
69,0.1,10,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are more likely to experience musculoskeletal symptoms. While preventing osteoporosis is crucial, managing these symptoms requires a multifaceted approach, including exercise, calcium and vitamin D supplementation, and pain management. 
","Musculoskeletal symptoms are more prevalent among patients on aromatase inhibitors who develop osteoporosis. Preventing osteoporosis is important, but effective symptom management also involves exercise, calcium and vitamin D supplementation, and pain relief.",4.2634750924233636e-07,0.4295413719699721,0.020399305555555556,0.03264167636607374,0.47000362924573613,0.0,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
70,0.1,1,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Colorectal cancer in young individuals might represent a distinct clinical entity. Additional studies are required to confirm our results and determine the best management strategy for this group.,0.0,4.440892098500626e-16,0.0,0.0,0.03648143055578679,0.026172568965361766,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
70,0.1,2,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients represent a separate clinical entity? Answer: Colorectal cancer in younger patients could be considered a distinct clinical entity. More research is necessary to validate these findings and establish the optimal treatment approach for this population.,4.7371945471370706e-08,0.08902433317653635,0.027736686390532554,0.0036268529295637453,0.053117365915339665,0.0013130033920054525,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
70,0.1,3,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a different clinical entity? Answer: Colorectal cancer among young patients may be a unique clinical entity. Further investigation is needed to confirm our observations and define the best approach for this demographic.,2.36859727356853e-08,0.0076996802636215556,0.023919753086419755,0.0018134264647818726,0.009813183473625475,0.026296566837107373,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
70,0.1,4,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients be a distinct clinical entity? Answer: Colorectal cancer in young individuals may constitute a separate clinical entity. Additional research is essential to validate our findings and identify the optimal management for this group.,0.0,4.440892098500626e-16,0.0,0.0,0.03648143055578679,0.026172568965361766,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
70,0.1,5,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a separate clinical entity? Answer: Colorectal cancer in young patients might represent a distinct clinical entity. Further studies are needed to confirm our findings and determine the best approach for this population.,2.36859727356853e-08,0.06526318084795246,0.027417339484813535,0.0018134264647818726,0.10258906202258311,0.05415326015251197,0.0018108015409528666,0.10441532758366501,0.055363321799307974,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
70,0.1,6,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients form a distinct clinical entity? Answer: Colorectal cancer among young patients could be a unique clinical entity. More research is required to validate these findings and define the optimal treatment strategy.,4.73719454713706e-08,0.020940536037771906,0.022511337868480717,0.0036268529295637453,0.017585790714489846,0.026296566837107373,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
70,0.1,7,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients considered a distinct clinical entity? Answer: Colorectal cancer in young individuals may be a distinct clinical entity. Further research is necessary to confirm our results and establish the best approach for this population.,0.0,0.07109201851896785,0.04904363706266818,0.0,0.07296286111157402,0.05207078010166813,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
70,0.1,8,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a clinically distinct entity? Answer: Colorectal cancer in young patients might be a separate clinical entity. Additional studies are needed to validate our findings and determine the optimal management approach.,7.10579182070559e-08,0.12743738668618088,0.032986111111111105,0.005440279394345618,0.16458189863431993,0.05866437066289262,0.005432404622858607,0.16610411515276358,0.05859375,7.105791820705622e-08,0.12902029702356588,0.0302734375
70,0.1,9,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in young patients represent a unique clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further investigation is required to confirm our findings and define the best treatment approach.,4.73719454713706e-08,0.020940536037771906,0.022511337868480717,0.0036268529295637453,0.017585790714489846,0.026296566837107373,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
70,0.1,10,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: Colorectal cancer in young patients could be considered a distinct clinical entity. More research is needed to validate our observations and establish the optimal approach for this group.,0.0,0.03554600925948348,0.024835600907029506,0.0,0.07296286111157402,0.05207078010166813,0.0,0.07493483033080572,0.05387755102040818,0.0,0.03850817669777484,0.02775510204081633
71,0.1,1,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Answer: Findings from this study indicate that septoplasty does not impact compensatory hypertrophy of the middle turbinate, even after a year.",2.36859727356853e-08,0.04922265103184431,0.05520175742860451,0.0018134264647818796,0.09525510143505445,0.09000000000000004,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
71,0.1,2,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is the compensatory hypertrophy of the middle turbinate changed by septoplasty? Answer: The current study's results suggest that septoplasty does not affect the compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.07680410906996382,0.031128117913832118,0.0018134264647818796,0.07803169370493279,0.032448979591836694,0.0018108015409528735,0.07926281956263947,0.033441043083900245,2.3685972735685406e-08,0.08049027395829977,0.034104308390022674
71,0.1,3,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty influence the dimensions of compensatory hypertrophy in the middle turbinate? Answer: According to the present study, compensatory hypertrophy of the middle turbinate remains unchanged following septoplasty, even after one year.",4.73719454713706e-08,0.015825434862968724,0.053333333333333365,0.003626852929563759,0.06350640312047462,0.09000000000000004,0.003621603081905747,0.02210487643242276,0.06222222222222223,4.737194547137081e-08,0.021972201559322446,0.0322222222222222
71,0.1,4,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Can septoplasty modify the compensatory hypertrophy size of the middle turbinate? Answer: The study findings show that septoplasty does not alter compensatory hypertrophy of the middle turbinate, even after a year.",7.10579182070559e-08,0.06343738469967075,0.01989229024943312,0.005440279394345639,0.015493231739846625,0.05670630202140312,0.005432404622858621,0.011796675243259003,0.06222222222222223,7.105791820705622e-08,0.05706352137059145,0.0322222222222222
71,0.1,5,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty impact the compensatory hypertrophy of the middle turbinate? Answer: The results of this study suggest that compensatory hypertrophy of the middle turbinate is unaffected by septoplasty, even after one year.",4.73719454713706e-08,0.07081796270702423,0.00689342403628114,0.003626852929563759,0.07065111569757931,0.005663265306122434,0.003621603081905747,0.07031474764223633,0.004104308390022647,4.737194547137081e-08,0.06977545539104257,0.0022165532879818914
71,0.1,6,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is there a change in compensatory hypertrophy of the middle turbinate after septoplasty? Answer: The present study indicates no change in compensatory hypertrophy of the middle turbinate following septoplasty, even after one year.",2.36859727356853e-08,0.1608219491378362,0.0811900065746219,0.0018134264647818796,0.1646750912749253,0.08751479289940824,0.0018108015409528735,0.16870116544134195,0.09310322156476,2.3685972735685406e-08,0.1729098980329593,0.09795529257067723
71,0.1,7,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty affect the size of compensatory hypertrophy in the middle turbinate? Answer: Findings from this study suggest that septoplasty does not influence compensatory hypertrophy of the middle turbinate, even after one year.",2.36859727356853e-08,0.04922265103184431,0.05520175742860451,0.0018134264647818796,0.09525510143505445,0.09000000000000004,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
71,0.1,8,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty cause changes in compensatory hypertrophy of the middle turbinate? Answer: The study's findings indicate that compensatory hypertrophy of the middle turbinate is not altered by septoplasty, even after one year.",4.73719454713706e-08,0.07081796270702423,0.00689342403628114,0.003626852929563759,0.07065111569757931,0.005663265306122434,0.003621603081905747,0.07031474764223633,0.004104308390022647,4.737194547137081e-08,0.06977545539104257,0.0022165532879818914
71,0.1,9,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Is compensatory hypertrophy of the middle turbinate altered by septoplasty? Answer: According to the study, septoplasty does not affect compensatory hypertrophy of the middle turbinate, even after one year.",1.184298636784265e-07,0.1871842557071708,0.018844444444444372,0.009067132323909398,0.1868078298808853,0.015599999999999989,0.009054007704764368,0.18594411041946923,0.011377777777777758,1.1842986367842703e-07,0.1844905074135399,0.00617777777777781
71,0.1,10,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Question: Does septoplasty lead to changes in the compensatory hypertrophy of the middle turbinate? Answer: The current study suggests that compensatory hypertrophy of the middle turbinate remains unaffected by septoplasty, even after one year.",2.36859727356853e-08,0.03479518903602763,0.0033505086537191087,0.0018134264647818796,0.034709994919936094,0.002746730083234214,0.0018108015409528735,0.034543646623288016,0.001987052450786085,2.3685972735685406e-08,0.03428046192097023,0.0010714757563747151
72,0.1,1,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Do the features of general practices affect the adoption of IT innovations in primary care? The analysis indicates that structural aspects like practice size, location, and staff makeup significantly influence the uptake of new IT tools. Practices with larger patient bases, urban settings, and more nurses and administrative personnel tend to adopt new IT innovations more readily.",2.8423167282822487e-07,0.22327984555692382,0.020962688553424747,0.02176111757738247,0.19735943415849366,0.0,0.0217296184914344,0.20067069546214888,0.0,2.8423167282822487e-07,0.20409535634351572,0.0
72,0.1,2,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Are general practice characteristics linked to the adoption of IT innovations in primary care? Findings reveal that structural factors such as the size, location, and staff composition of a practice play a significant role in adopting new IT technologies. Practices with bigger patient populations, urban locations, and a greater number of nurses and administrative staff are more inclined to implement new IT innovations.",1.4211583641411244e-07,0.09434622481951838,0.0014220912907894206,0.010880558788691236,0.09381875521765437,0.0,0.0108648092457172,0.09531017980432477,0.0,1.4211583641411244e-07,0.09684982598991798,0.0
72,0.1,3,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Does the nature of general practice impact the uptake of IT innovations in primary care? The study shows that structural features like size, location, and staff composition are strongly associated with adopting new IT tools. Larger practices in urban areas with more nurses and administrative staff are more likely to embrace IT innovations.",3.789755637709665e-07,0.2478773048135059,0.014702606371129422,0.029014823436509962,0.27286698666663955,0.0,0.028972824655245866,0.2776317365982788,0.0,3.789755637709665e-07,0.2825669717850099,0.0
72,0.1,4,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Do characteristics of general practices influence the adoption of IT innovations in primary care? Analysis demonstrates that structural elements such as practice size, geographic location, and staff composition significantly affect the adoption of new IT tools. Practices with larger patient groups, urban locations, and higher proportions of nurses and administrative staff tend to adopt IT innovations more frequently.",2.6054570009253947e-07,0.22903261667195718,0.03776652943133969,0.0199476911126006,0.204096185104385,0.017851239669421492,0.019918816950481533,0.18232155679395312,0.0,2.6054570009253947e-07,0.1854032233313614,0.0
72,0.1,5,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Is the uptake of IT innovations in primary care affected by general practice characteristics? The data suggest that structural characteristics including size, location, and staff makeup are significantly linked to the adoption of new IT tools. Practices with larger patient populations, urban settings, and more nurses and administrative staff show higher adoption rates.",3.789755637709665e-07,0.2478773048135059,0.014702606371129422,0.029014823436509962,0.27286698666663955,0.0,0.028972824655245866,0.2776317365982788,0.0,3.789755637709665e-07,0.2825669717850099,0.0
72,0.1,6,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Do general practice features affect the adoption of IT innovations in primary care? The analysis reveals that structural characteristics like size, location, and staff composition are significantly related to the uptake of new IT tools. Practices with larger patient numbers, urban locations, and a higher ratio of nurses and administrative staff are more likely to adopt IT innovations.",2.6054570009253947e-07,0.1560697555603836,0.014702606371129422,0.0199476911126006,0.1793409286558152,0.0,0.019918816950481533,0.18232155679395312,0.0,2.6054570009253947e-07,0.1854032233313614,0.0
72,0.1,7,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Are the structural characteristics of general practices influential in the adoption of IT innovations in primary care? The findings indicate that factors such as practice size, location, and staff composition significantly impact the adoption of new IT tools. Practices with larger patient populations, urban locations, and more nurses and administrative staff tend to adopt IT innovations more readily.",2.6054570009253947e-07,0.22903261667195718,0.03776652943133969,0.0199476911126006,0.204096185104385,0.017851239669421492,0.019918816950481533,0.18232155679395312,0.0,2.6054570009253947e-07,0.1854032233313614,0.0
72,0.1,8,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Does the adoption of IT innovations in primary care depend on general practice characteristics? The analysis shows that structural factors like size, location, and staff composition are significantly associated with the uptake of new IT tools. Practices with larger patient bases, urban settings, and a higher proportion of nurses and administrative staff are more likely to adopt new IT innovations.",2.1317375462116866e-07,0.14508009408446743,0.0022415077786922186,0.016320838183036854,0.14424960884454574,0.0,0.0162972138685758,0.14660347419187403,0.0,2.1317375462116866e-07,0.14903557916048715,0.0
72,0.1,9,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Are general practice structural characteristics linked to the uptake of IT innovations in primary care? The study finds that size, location, and staff composition significantly influence the adoption of new IT tools. Practices with larger patient populations, urban locations, and more nurses and administrative staff are more inclined to adopt IT innovations.",4.026615365066519e-07,0.2672953906706086,0.014702606371129422,0.030828249901291835,0.2926696139628193,0.0,0.030783626196198732,0.2978344439157974,0.0,4.026615365066519e-07,0.30318625898774565,0.0
72,0.1,10,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a general practice, such as size, location, and staff composition, are significantly associated with the adoption of new IT tools. Practices with larger patient populations, urban locations, and a higher proportion of nurses and administrative staff were more likely to adopt the new IT innovation. 
","Do the structural features of general practices affect the adoption of IT innovations in primary care? The analysis demonstrates that characteristics such as size, location, and staff composition are significantly associated with the uptake of new IT tools. Practices with larger patient groups, urban locations, and a higher proportion of nurses and administrative staff tend to adopt new IT innovations.",2.1317375462116866e-07,0.14508009408446743,0.0022415077786922186,0.016320838183036854,0.14424960884454574,0.0,0.0162972138685758,0.14660347419187403,0.0,2.1317375462116866e-07,0.14903557916048715,0.0
73,0.1,1,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) involves eosinophilic inflammation of the esophageal lining. Although mucosal fragility may be seen in EE, it is not a pathognomonic sign. More typical features include linear furrows, white plaques, and rings.",1.1842986367842703e-07,0.08110831069574109,0.01274654079318803,0.009067132323909363,0.10393223463143508,0.0020431650179623916,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
73,0.1,2,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Does esophageal mucosal fragility serve as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is marked by eosinophilic inflammation in the esophageal mucosa. While fragility of the mucosa can occur in EE, it is not a definitive diagnostic sign. Other signs such as linear furrows, white plaques, and rings are more characteristic.",4.737194547137081e-08,0.11646190917846999,0.056793180025012435,0.0036268529295637453,0.06439983492746082,0.01922337562475971,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
73,0.1,3,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is the fragility of the esophageal mucosa a unique endoscopic marker of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is defined by eosinophilic inflammation of the esophageal mucosa. Although mucosal fragility may be present in EE, it is not pathognomonic. More distinctive features include linear furrows, white plaques, and rings.",9.474389094274162e-08,0.05872079088953619,0.014004679839606855,0.0072537058591274906,0.08226433325225413,0.001600526593438574,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
73,0.1,4,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Can esophageal mucosal fragility be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation in the esophageal mucosa. Esophageal mucosal fragility may be observed but is not a pathognomonic sign. More characteristic findings are linear furrows, white plaques, and rings.",1.1842986367842703e-07,0.10998944321907222,0.00767586508376332,0.009067132323909363,0.10393223463143508,0.0020431650179623916,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
73,0.1,5,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is esophageal mucosal fragility a definitive endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) involves eosinophilic inflammation of the esophageal mucosa. Although fragility can be seen, it is not pathognomonic. More typical signs include linear furrows, white plaques, and rings.",2.8423167282822487e-07,0.1859059149176212,0.050593763015410236,0.02176111757738247,0.23570475752287834,0.01922337562475971,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
73,0.1,6,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Does fragility of the esophageal mucosa indicate primary eosinophilic esophagitis as a pathognomonic endoscopic sign? Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While mucosal fragility may be present, it is not a pathognomonic feature. More characteristic signs include linear furrows, white plaques, and rings.",9.474389094274162e-08,0.11530423420055236,0.025754377480457488,0.0072537058591274906,0.11114546577558526,0.02236452607656355,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
73,0.1,7,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is mucosal fragility of the esophagus a pathognomonic endoscopic sign for primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is marked by eosinophilic inflammation of the esophageal mucosa. Although fragility can be observed, it is not pathognomonic. More typical features are linear furrows, white plaques, and rings.",1.8948778188548325e-07,0.12061651697975906,0.030620466638990547,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
73,0.1,8,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Can fragility of the esophageal mucosa be used as a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation in the esophageal mucosa. While mucosal fragility may be noted, it is not a definitive sign. More characteristic findings include linear furrows, white plaques, and rings.",4.737194547137081e-08,0.011795223940886501,0.03581840899625154,0.0036268529295637453,0.012561206208669073,0.01922337562475971,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
73,0.1,9,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Is the fragility of the esophageal mucosa a pathognomonic endoscopic feature of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) involves eosinophilic inflammation of the esophageal mucosa. Although mucosal fragility can be seen, it is not pathognomonic. More typical signs include linear furrows, white plaques, and rings.",1.8948778188548325e-07,0.15142305833797876,0.008642232403165348,0.014507411718254981,0.17190126774400527,0.0034916054460894,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
73,0.1,10,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? 

Answer: Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While esophageal mucosal fragility can be observed in EE, it's not a pathognomonic sign. Other features like linear furrows, white plaques, and rings are more characteristic. 
","Does esophageal mucosal fragility represent a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis (EE) is characterized by eosinophilic inflammation of the esophageal mucosa. While fragility may be observed, it is not a pathognomonic sign. More characteristic features include linear furrows, white plaques, and rings.",1.6580180914979784e-07,0.09729819541932239,0.03158033326334411,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
74,0.1,1,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","The study indicates that spinal cord untethering might not be required for patients with myelomeningocele undergoing scoliosis correction if they show no clinical signs of tethered cord, despite radiographic evidence of tethering.",4.5003348197802176e-07,0.4780358009429988,0.0,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
74,0.1,2,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","According to the study, patients with myelomeningocele who are having scoliosis surgery may not need spinal cord untethering if they lack clinical symptoms of tethered cord, even when imaging shows tethering.",4.7371945471370706e-07,0.5108256237659905,0.0,0.036268529295637494,0.5245244681241537,0.0,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
74,0.1,3,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Results suggest that untethering the spinal cord is potentially unnecessary before scoliosis correction in myelomeningocele patients without clinical tethered cord symptoms, despite radiographic tethering.",6.395212638635042e-07,0.7765287894989958,0.0,0.04896251454911065,0.8007778447523113,0.0,0.048891641605727496,0.8266785731844695,0.0,6.39521263863506e-07,0.8544153281560676,0.0
74,0.1,4,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For patients with myelomeningocele undergoing scoliosis correction, spinal cord untethering may be avoidable if there are no clinical signs of tethered cord, even if imaging reveals tethering, according to the study.",4.7371945471370706e-07,0.5108256237659905,0.0,0.036268529295637494,0.5245244681241537,0.0,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
74,0.1,5,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","The findings imply that spinal cord untethering might not be essential prior to scoliosis surgery in myelomeningocele patients who do not exhibit clinical symptoms of tethered cord, despite radiographic evidence.",4.974054274493924e-07,0.5447271754416723,0.0,0.038081955760419374,0.5596157879354227,0.0,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
74,0.1,6,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In patients with myelomeningocele undergoing scoliosis correction, untethering the spinal cord may not be necessary if clinical symptoms of tethered cord are absent, even when tethering is seen on imaging.",4.974054274493924e-07,0.5447271754416723,0.0,0.038081955760419374,0.5596157879354227,0.0,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
74,0.1,7,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","The study suggests that spinal cord untethering before scoliosis correction is not mandatory for myelomeningocele patients without clinical tethered cord symptoms, despite radiographic tethering.",6.395212638635042e-07,0.7765287894989958,0.0,0.04896251454911065,0.8007778447523113,0.0,0.048891641605727496,0.8266785731844695,0.0,6.39521263863506e-07,0.8544153281560676,0.0
74,0.1,8,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Patients with myelomeningocele who lack clinical signs of tethered cord may not require spinal cord untethering before scoliosis surgery, even if tethering is visible on radiographs, as per the study.",4.974054274493924e-07,0.5447271754416723,0.0,0.038081955760419374,0.5596157879354227,0.0,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
74,0.1,9,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","According to the study, spinal cord untethering may be unnecessary in myelomeningocele patients undergoing scoliosis correction if they do not have clinical symptoms of tethered cord, despite radiographic tethering.",5.210914001850777e-07,0.5798184952529413,0.0,0.039895382225201254,0.5959834321062973,0.0,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
74,0.1,10,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","The research suggests that for myelomeningocele patients without clinical tethered cord symptoms, spinal cord untethering prior to scoliosis correction might not be needed, even if tethering is shown on imaging.",4.974054274493924e-07,0.5447271754416723,0.0,0.038081955760419374,0.5596157879354227,0.0,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
75,0.1,1,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","What is the clinical importance of bile duct sludge compared to bile duct stones? The results suggest that symptomatic bile duct sludge (BDS) has a clinical significance comparable to that of small bile duct stones. BDS can lead to biliary colic, pancreatitis, and cholangitis, though it is less prone to causing obstruction than larger stones. Differentiating between these two conditions is crucial since treatment approaches may differ.",0.0,0.00792800217825107,0.0490925173404821,0.0,0.021327605555689466,0.015357361839411676,0.0,0.021660849392496573,0.015621063240110858,0.0,0.0,0.0
75,0.1,2,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","How does the clinical significance of bile duct sludge differ from that of bile duct stones? The evidence shows that symptomatic BDS shares similar clinical implications with small bile duct stones. While BDS can result in biliary colic, pancreatitis, and cholangitis, it is less likely to cause obstruction compared to larger stones. Distinguishing between these conditions is important because treatment strategies may vary.",9.474389094274162e-08,0.025088300317020362,0.02587517557013344,0.0072537058591274906,0.043584331678484745,0.014349332325522778,0.007243206163811466,0.042877671745075396,0.015621063240110858,9.474389094274162e-08,0.06559728248581642,0.0
75,0.1,3,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","What is the clinical relevance of bile duct sludge versus bile duct stones? Findings reveal that symptomatic bile duct sludge has clinical significance akin to small bile duct stones. BDS may cause biliary colic, pancreatitis, and cholangitis but is less likely to obstruct the bile duct than larger stones. It is essential to differentiate these conditions as their treatments might differ.",1.4211583641411244e-07,0.13958460959607288,0.19279097194613576,0.010880558788691236,0.07769112947378964,0.013794107064590035,0.0108648092457172,0.07677922342075583,0.015621063240110858,1.4211583641411244e-07,0.10008345855698497,0.0
75,0.1,4,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","Is the clinical significance of bile duct sludge different from that of bile duct stones? The data indicate that symptomatic BDS has a clinical impact similar to that of small bile duct stones. BDS can cause biliary colic, pancreatitis, and cholangitis, though it is less likely to cause obstruction than larger stones. Differentiating between the two is important because treatment options may differ.",9.474389094274162e-08,0.04744788678669565,0.00934344104115821,0.0072537058591274906,0.043584331678484745,0.014349332325522778,0.007243206163811466,0.042877671745075396,0.015621063240110858,9.474389094274162e-08,0.06559728248581642,0.0
75,0.1,5,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","What distinguishes the clinical significance of bile duct sludge from bile duct stones? The findings demonstrate that symptomatic bile duct sludge is clinically similar to small bile duct stones. BDS can lead to biliary colic, pancreatitis, and cholangitis but is less likely to cause obstruction than larger stones. It is important to distinguish between these conditions as treatment may vary.",1.6580180914979784e-07,0.11664956883387534,0.06849345128497854,0.012693985253473108,0.09519067515369706,0.01350214857667699,0.012675610786670066,0.09417096613262466,0.015621063240110858,1.6580180914979784e-07,0.11778303565638559,0.0
75,0.1,6,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","How significant is bile duct sludge clinically compared to bile duct stones? The research shows that symptomatic BDS has clinical significance comparable to small bile duct stones. BDS can cause biliary colic, pancreatitis, and cholangitis but is less likely to cause obstruction than larger stones. Differentiating the two conditions is crucial since treatment options may differ.",2.6054570009253947e-07,0.1292955611854869,0.03398777052567148,0.0199476911126006,0.14274801221998068,0.030738221214411676,0.019918816950481533,0.16693032041505385,0.015621063240110858,2.6054570009253947e-07,0.19189100781010726,0.0
75,0.1,7,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","What is the clinical difference between bile duct sludge and bile duct stones? The findings suggest that symptomatic BDS has a clinical significance similar to that of small bile duct stones. BDS can cause biliary colic, pancreatitis, and cholangitis but is less likely to cause obstruction than larger stones. It is important to distinguish between these conditions because treatment may vary.",1.4211583641411244e-07,0.03729049197463841,0.04025901773556964,0.010880558788691236,0.05419461487853727,0.030738221214411676,0.0108648092457172,0.07677922342075583,0.015621063240110858,1.4211583641411244e-07,0.10008345855698497,0.0
75,0.1,8,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","How does bile duct sludge compare clinically to bile duct stones? The evidence indicates that symptomatic BDS has clinical significance akin to small bile duct stones. BDS can cause biliary colic, pancreatitis, and cholangitis but is less likely to cause obstruction than larger stones. Differentiating between the two is important as treatment options may differ.",2.8423167282822487e-07,0.1487544092361759,0.03259168735260767,0.02176111757738247,0.161440145232135,0.030738221214411676,0.0217296184914344,0.18597851538574695,0.015621063240110858,2.8423167282822487e-07,0.21130909366720996,0.0
75,0.1,9,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","What is the clinical impact of bile duct sludge relative to bile duct stones? The findings reveal that symptomatic BDS shares clinical significance with small bile duct stones. BDS can cause biliary colic, pancreatitis, and cholangitis but is less likely to cause obstruction than larger stones. It is important to differentiate these conditions since treatment may vary.",2.3685972735685406e-07,0.11020697877826224,0.035333142373264986,0.018134264647818726,0.12439887355178492,0.030738221214411676,0.018108015409528666,0.1482381874028995,0.015621063240110858,2.3685972735685406e-07,0.17284281283941416,0.0
75,0.1,10,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? 
Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of small bile duct stones.  BDS can cause biliary colic, pancreatitis, and cholangitis, but is less likely to cause obstruction than larger stones.  It is important to differentiate between the two conditions, as treatment options may vary. 
","Is there a difference in clinical significance between bile duct sludge and bile duct stones? The data show that symptomatic BDS has clinical significance similar to small bile duct stones. BDS can cause biliary colic, pancreatitis, and cholangitis but is less likely to cause obstruction than larger stones. Differentiating the two conditions is important because treatment options may differ.",1.8948778188548325e-07,0.09698782968457431,0.020101590037335595,0.014507411718254981,0.08868079094970582,0.030738221214411676,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
76,0.1,1,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Are correlated results achievable from homebrew assays for BCRABL transcript detection by quantitative real-time PCR? The findings indicate that quantitative real-time PCR assays for BCRABL detection can yield comparable results across laboratories despite methodological differences, provided the same positive control cell line and quality control gene are utilized. Standardization of assays between laboratories is essential.",2.3685972735685406e-07,0.2035936914059513,0.024145840009505665,0.018134264647818726,0.17699463782030733,0.0029920601690792935,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
76,0.1,2,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Is it possible to obtain correlated results from homebrew assays in BCRABL transcript detection using quantitative real-time PCR? The data suggest that quantitative real-time PCR assays for BCRABL detection can be consistent between labs even with significant methodological variations if the same positive control cell line and quality control gene are employed. Some degree of assay standardization among laboratories is crucial.,9.474389094274162e-08,0.0443217283712416,0.014555603019334038,0.0072537058591274906,0.0435926100870887,0.01586888657648284,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
76,0.1,3,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can homebrew assays produce correlated results for BCRABL transcript detection by quantitative real-time PCR? Results imply that quantitative real-time PCR assays for BCRABL detection may be comparable across different labs despite methodological differences, as long as the same positive control cell line and quality control gene are used. It is vital to adopt some assay standardization between labs.",1.6580180914979784e-07,0.12115202414784232,0.0038238405242473107,0.012693985253473108,0.09577836325765787,0.01586888657648284,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
76,0.1,4,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Are correlated outcomes feasible from homebrew assays for BCRABL transcript detection via quantitative real-time PCR? The evidence suggests that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite methodological differences if the same positive control cell line and quality control gene are applied. Implementing assay standardization between labs is necessary.,2.6054570009253947e-07,0.22373896316141728,0.02518251821019773,0.0199476911126006,0.19654584235599293,0.0033544890482768708,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
76,0.1,5,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Is it feasible to achieve correlated results from homebrew assays in BCRABL transcript detection by quantitative real-time PCR? Findings indicate that quantitative real-time PCR assays for BCRABL detection can be consistent across laboratories despite significant methodological differences, provided the same positive control cell line and quality control gene are used. Assay standardization among laboratories is imperative.",2.1317375462116866e-07,0.1334335513625673,0.013041898799404494,0.016320838183036854,0.1321460074285321,0.01586888657648284,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
76,0.1,6,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Can quantitative real-time PCR assays for BCRABL detection yield correlated results from homebrew assays? The results suggest that despite methodological differences, assays can be comparable between labs if the same positive control cell line and quality control gene are employed. Some level of assay standardization between laboratories is essential.",3.789755637709665e-07,0.24436037366678542,0.031217481789802295,0.029014823436509962,0.27098245228274953,0.01586888657648284,0.028972824655245866,0.29849298855599704,0.0,3.789755637709665e-07,0.30421137440299084,0.0
76,0.1,7,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Are correlated results possible from homebrew assays for BCRABL transcript detection using quantitative real-time PCR? The data indicate that quantitative real-time PCR assays for BCRABL detection can be comparable between labs despite methodological variations if the same positive control cell line and quality control gene are used. It is critical to adopt assay standardization between laboratories.,2.1317375462116866e-07,0.18384425540329064,0.023146423535641506,0.016320838183036854,0.15781812522704897,0.002643039375813342,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
76,0.1,8,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Is it possible to obtain consistent results from homebrew assays in BCRABL transcript detection by quantitative real-time PCR? The findings suggest that quantitative real-time PCR assays for BCRABL detection can be comparable across laboratories despite methodological differences, provided the same positive control cell line and quality control gene are utilized. Assay standardization between labs is essential.",2.1317375462116866e-07,0.1334335513625673,0.013041898799404494,0.016320838183036854,0.1321460074285321,0.01586888657648284,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
76,0.1,9,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Can homebrew assays provide correlated results for BCRABL transcript detection by quantitative real-time PCR? The evidence shows that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant methodological differences if the same positive control cell line and quality control gene are used. It is imperative to implement assay standardization between labs.,2.1317375462116866e-07,0.15863890338292874,0.005094372962778693,0.016320838183036854,0.1321460074285321,0.01586888657648284,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
76,0.1,10,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Are correlated results achievable from homebrew assays in BCRABL transcript detection using quantitative real-time PCR? The results indicate that quantitative real-time PCR assays for BCRABL detection can be consistent between labs despite methodological differences if the same positive control cell line and quality control gene are employed. Some level of assay standardization between laboratories is necessary.,2.1317375462116866e-07,0.1334335513625673,0.013041898799404494,0.016320838183036854,0.1321460074285321,0.01586888657648284,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
77,0.1,1,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex found in cervical disk disease? Biochemical studies of damaged cervical intervertebral disks show inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and a link to pH. Further analysis of FAC is needed.",1.4211583641411233e-07,0.1122943022824554,0.02221074380165289,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
77,0.1,2,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does cervical disk disease involve the fibronectin-aggrecan complex? Injured cervical intervertebral disks exhibit inflammatory markers including MCP, structural matrix protein fragments like FAC, and a pH correlation. Additional assessment of FAC follows.",3.3160361829959473e-07,0.3418687439269532,0.02221074380165289,0.02538797050694625,0.3829922522561069,0.0,0.025351221573340174,0.39390428570708913,0.0,3.316036182995957e-07,0.4054651081081637,0.0
77,0.1,3,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex detected in cervical disk disease? Biochemical examination of injured cervical intervertebral disks identifies inflammatory markers such as MCP, fragments of matrix proteins like FAC, and a relationship with pH. Further study of FAC is ongoing.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
77,0.1,4,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex present in cases of cervical disk disease? Analysis of injured cervical intervertebral disks reveals inflammatory markers like MCP, fragments of structural matrix proteins such as FAC, and an association with pH. FAC is further evaluated.",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
77,0.1,5,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does the fibronectin-aggrecan complex occur in cervical disk disease? Biochemical analysis of damaged cervical intervertebral disks shows inflammatory markers including MCP, fragments of matrix proteins like FAC, and a correlation with pH. FAC undergoes further evaluation.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
77,0.1,6,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex involved in cervical disk disease? Injured cervical intervertebral disks contain inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and a pH correlation. Further examination of FAC is conducted.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
77,0.1,7,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex present in cervical disk disease? Biochemical studies of injured cervical intervertebral disks reveal inflammatory markers like MCP, fragments of matrix proteins such as FAC, and a link to pH. FAC is further analyzed.",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
77,0.1,8,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex found in cervical disk disease? Analysis of injured cervical intervertebral disks shows inflammatory markers including MCP, fragments of structural matrix proteins like FAC, and a relationship with pH. Further evaluation of FAC is performed.",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
77,0.1,9,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does cervical disk disease feature the fibronectin-aggrecan complex? Biochemical analysis of injured cervical intervertebral disks reveals inflammatory markers such as MCP, fragments of matrix proteins like FAC, and a correlation with pH. FAC is further studied.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
77,0.1,10,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex present in cervical disk disease? Injured cervical intervertebral disks show inflammatory markers including MCP, fragments of structural matrix proteins such as FAC, and a pH association. Further evaluation of FAC is underway.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
78,0.1,1,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Question: Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis be an early indicator of bronchiectasis? Answer: A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi might play a role in neutrophilic inflammation and NTHi colonization seen in both PBB and bronchiectasis. However, it is still unclear if this mechanism drives the progression from PBB to bronchiectasis.",1.1842986367842703e-07,0.0912122689930226,0.0030181567739840723,0.009067132323909363,0.0907290005447079,0.0015678118024745405,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
78,0.1,2,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is the phagocytic dysfunction of alveolar macrophages in children suffering from protracted bacterial bronchitis a precursor to bronchiectasis? Answer: A weakened alveolar macrophage phagocytic activity against apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis alike. The role of this mechanism in the advancement of PBB to bronchiectasis remains uncertain.,4.737194547137081e-08,0.08612878664280244,0.03631185475258099,0.0036268529295637453,0.062039761969391094,0.01851192595229618,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
78,0.1,3,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis precede bronchiectasis? Answer: Reduced phagocytic function of alveolar macrophages towards apoptotic cells or NTHi could contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this dysfunction leads to the progression from PBB to bronchiectasis is still unknown.,7.105791820705622e-08,0.005678762610319854,0.03631185475258099,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,0.1,4,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is impaired alveolar macrophage phagocytosis in children with protracted bacterial bronchitis an early sign of bronchiectasis? Answer: A decreased alveolar macrophage phagocytic response to apoptotic cells or NTHi may be involved in neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. It remains to be determined if this contributes to PBB progressing into bronchiectasis.,2.3685972735685406e-08,0.00638944757401072,0.017799928800284807,0.0018134264647818726,0.006979984786362525,0.01851192595229618,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
78,0.1,5,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could dysfunction in alveolar macrophage phagocytosis in children with protracted bacterial bronchitis signal the onset of bronchiectasis? Answer: A lowered alveolar macrophage phagocytic response to apoptotic cells or NTHi might facilitate neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. The connection between this mechanism and the progression from PBB to bronchiectasis is not yet established.,4.737194547137081e-08,0.06180783293894487,0.018773589446458534,0.0036268529295637453,0.062039761969391094,0.01851192595229618,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
78,0.1,6,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is alveolar macrophage phagocytic impairment in children with protracted bacterial bronchitis a potential precursor to bronchiectasis? Answer: A reduced phagocytic host response by alveolar macrophages to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. Whether this mechanism influences the progression of PBB to bronchiectasis is still unknown.,0.0,0.05041070404072334,0.03631185475258099,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
78,0.1,7,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Does phagocytic dysfunction of alveolar macrophages in children with protracted bacterial bronchitis indicate a risk for bronchiectasis? Answer: A diminished alveolar macrophage phagocytic response to apoptotic cells or NTHi could promote neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. It remains unclear if this mechanism plays a role in PBB progressing to bronchiectasis.,0.0,0.05041070404072334,0.03631185475258099,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
78,0.1,8,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is the reduced phagocytic function of alveolar macrophages in children with protracted bacterial bronchitis a forerunner to bronchiectasis? Answer: A lowered alveolar macrophage phagocytic response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. The involvement of this mechanism in the progression from PBB to bronchiectasis is yet to be determined.,9.474389094274162e-08,0.12061496271397099,0.03631185475258099,0.0072537058591274906,0.09713108178066054,0.01851192595229618,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
78,0.1,9,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis be an early factor leading to bronchiectasis? Answer: A decreased alveolar macrophage phagocytic response to apoptotic cells or NTHi might contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also drives the progression of PBB to bronchiectasis remains unknown.,2.3685972735685406e-08,0.018918696646262223,0.0006465598280268187,0.0018134264647818726,0.01881590444635073,0.0003363429618983803,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
78,0.1,10,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Question: Is impaired alveolar macrophage phagocytosis in children with protracted bacterial bronchitis a potential early marker for bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may be involved in neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. It is still unknown if this mechanism contributes to the progression from PBB to bronchiectasis.,7.105791820705622e-08,0.0796189024388112,0.019075782114846302,0.005440279394345618,0.07973933906879171,0.01851192595229618,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
79,0.1,1,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
",Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women?,1.5632742005552343e-06,1.8167729791211014,0.013640329518707903,0.11968614667560387,1.8718021769015944,0.0,0.11951290170288938,1.9459101490553135,0.0,1.5632742005552362e-06,2.0281482472922847,0.0
79,0.1,2,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
",Do biochemical markers of bone turnover accurately reflect bone histomorphometry in a study of 370 postmenopausal women?,1.4922162823481783e-06,1.5024955865644043,0.09002921840759678,0.11424586728125824,1.6486586255873847,0.0,0.11408049708003075,1.7047480922384257,0.0,1.4922162823481802e-06,1.765783982824793,0.0
79,0.1,3,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","In 370 postmenopausal women, are bone turnover biochemical markers representative of bone histomorphometric measurements?",1.5632742005552343e-06,1.7101349513426483,0.09002921840759678,0.11968614667560387,1.8718021769015944,0.0,0.11951290170288938,1.9459101490553135,0.0,1.5632742005552362e-06,2.0281482472922847,0.0
79,0.1,4,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
",Can biochemical markers of bone turnover serve as reliable indicators of bone histomorphometry in 370 postmenopausal women?,1.4922162823481783e-06,1.5891389841343972,0.027806996185374543,0.11424586728125824,1.6486586255873847,0.0,0.11408049708003075,1.7047480922384257,0.0,1.4922162823481802e-06,1.765783982824793,0.0
79,0.1,5,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
",Is there a correlation between biochemical markers of bone turnover and bone histomorphometry in 370 postmenopausal women?,1.4922162823481783e-06,1.5024955865644043,0.09002921840759678,0.11424586728125824,1.6486586255873847,0.0,0.11408049708003075,1.7047480922384257,0.0,1.4922162823481802e-06,1.765783982824793,0.0
79,0.1,6,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
",Are bone turnover biochemical markers reflective of bone histomorphometric parameters in a cohort of 370 postmenopausal women?,1.4922162823481783e-06,1.5024955865644043,0.09002921840759678,0.11424586728125824,1.6486586255873847,0.0,0.11408049708003075,1.7047480922384257,0.0,1.4922162823481802e-06,1.765783982824793,0.0
79,0.1,7,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
",Do biochemical markers of bone turnover correspond to bone histomorphometry findings in 370 postmenopausal women?,1.539588227819549e-06,1.636026979188927,0.09002921840759678,0.117872720210822,1.791759469228058,0.0,0.1177021001619365,1.8588987720656833,0.0,1.5395882278195508e-06,1.9328380674879595,0.0
79,0.1,8,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
","In a study involving 370 postmenopausal women, are biochemical markers of bone turnover representative of bone histomorphometry?",1.4922162823481783e-06,1.5891389841343972,0.027806996185374556,0.11424586728125824,1.6486586255873847,0.0,0.11408049708003075,1.7047480922384257,0.0,1.4922162823481802e-06,1.765783982824793,0.0
79,0.1,9,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
",Are biochemical markers of bone turnover valid proxies for bone histomorphometry in 370 postmenopausal women?,1.539588227819549e-06,1.636026979188927,0.09002921840759678,0.117872720210822,1.791759469228058,0.0,0.1177021001619365,1.8588987720656833,0.0,1.5395882278195508e-06,1.9328380674879595,0.0
79,0.1,10,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?**

**Answer:** Bone turnover markers (BTMs) are commonly used to assess bone metabolism. However, their correlation with bone histomorphometry, the gold standard for evaluating bone structure, is unclear. A study of 370 postmenopausal women investigated this relationship, finding that certain BTMs, particularly those reflecting bone formation, were significantly correlated with bone histomorphometric parameters. These findings suggest that BTMs can provide valuable insights into bone turnover dynamics. 
",Does bone histomorphometry correlate with biochemical markers of bone turnover in 370 postmenopausal women?,1.5632742005552343e-06,1.7101349513426483,0.09002921840759678,0.11968614667560387,1.8718021769015944,0.0,0.11951290170288938,1.9459101490553135,0.0,1.5632742005552362e-06,2.0281482472922847,0.0
80,0.1,1,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? Documentation of opioid dependence and MMT is essential for patients undergoing MMT and medical care to ensure accurate diagnosis, treatment planning, and monitoring, including dates of diagnosis, treatment start, and progress.",9.474389094274162e-08,0.09717882314338322,0.00584194214876034,0.0072537058591274906,0.0938419528664296,0.0020669648430901577,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
80,0.1,2,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Are opioid dependence and methadone maintenance treatment (MMT) noted in the patient's medical record? For patients receiving MMT and medical care, it is important to document opioid dependence and MMT accurately, including diagnosis date, treatment initiation, and ongoing progress for proper diagnosis and treatment planning.",7.105791820705622e-08,0.04048447372866537,0.01818158392833716,0.005440279394345618,0.06954385060511781,0.0015142353237591263,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
80,0.1,3,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Proper recording of opioid dependence and MMT among patients on MMT and medical care is vital for accurate diagnosis, treatment planning, and monitoring, covering diagnosis date, treatment start, and progress.",7.105791820705622e-08,0.07199116375411752,0.004283717877493279,0.005440279394345618,0.10178325435209201,0.02467255675266781,0.0054324046228586,0.10199988008504324,0.023795359904818555,7.105791820705622e-08,0.07061756721395396,0.0
80,0.1,4,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical records? For patients receiving MMT and medical care, documenting opioid dependence and MMT is critical for accurate diagnosis, treatment planning, and monitoring, including the date of diagnosis, treatment initiation, and ongoing progress.",9.474389094274162e-08,0.09717882314338322,0.00584194214876034,0.0072537058591274906,0.0938419528664296,0.0020669648430901577,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
80,0.1,5,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Documentation of opioid dependence and MMT is important for patients undergoing MMT and medical care to ensure accurate diagnosis, treatment planning, and monitoring, including dates of diagnosis, treatment start, and progress.",9.474389094274162e-08,0.09717882314338322,0.00584194214876034,0.0072537058591274906,0.0938419528664296,0.0020669648430901577,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
80,0.1,6,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? For patients receiving MMT and medical care, it is essential to document opioid dependence and MMT for accurate diagnosis, treatment planning, and monitoring, including the date of diagnosis, treatment initiation, and ongoing progress.",4.737194547137081e-08,0.04741786190036201,0.0027934727610052362,0.0036268529295637453,0.04582161865889667,0.0009865860091207122,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
80,0.1,7,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Is opioid dependence and methadone maintenance treatment (MMT) documented in the patient's medical record? Accurate documentation of opioid dependence and MMT is crucial for patients receiving MMT and medical care to support diagnosis, treatment planning, and monitoring, including diagnosis date, treatment start, and progress.",9.474389094274162e-08,0.06493941939640857,0.017132106036843446,0.0072537058591274906,0.0938419528664296,0.0020669648430901577,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
80,0.1,8,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Proper documentation of opioid dependence and MMT among patients receiving MMT and medical care is necessary for accurate diagnosis, treatment planning, and monitoring, including the date of diagnosis, treatment initiation, and ongoing progress.",4.737194547137081e-08,0.04741786190036201,0.0027934727610052362,0.0036268529295637453,0.04582161865889667,0.0009865860091207122,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
80,0.1,9,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? For patients on MMT and receiving medical care, documenting opioid dependence and MMT is vital for accurate diagnosis, treatment planning, and monitoring, including diagnosis date, treatment initiation, and progress.",1.4211583641411244e-07,0.11571277606829433,0.014880855352883311,0.010880558788691236,0.14428246746576612,0.003255168383373523,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
80,0.1,10,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? 

Answer: Among patients receiving MMT and medical care, documentation of opioid dependence and MMT is crucial for accurate diagnosis, treatment planning, and monitoring. This includes the date of diagnosis, treatment initiation, and ongoing progress. 
","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Documentation of opioid dependence and MMT is essential for patients undergoing MMT and medical care to ensure accurate diagnosis, treatment planning, and monitoring, including the date of diagnosis, treatment initiation, and ongoing progress.",4.737194547137081e-08,0.04741786190036201,0.0027934727610052362,0.0036268529295637453,0.04582161865889667,0.0009865860091207122,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
81,0.1,1,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Is the current prediction equation suitable for estimating basal metabolic rate in Chinese individuals? Answer: Currently, the Singapore equation is the most precise for predicting basal metabolic rate in Chinese adults, surpassing traditional formulas such as Mifflin-St Jeor and Harris-Benedict. Nonetheless, additional studies are required to confirm its relevance across various Chinese subgroups and ages.",7.105791820705622e-08,0.10743170466817542,0.03842975206611567,0.005440279394345618,0.08244166725810897,0.020321999485258355,0.0054324046228586,0.08261751549370011,0.019826576555107524,7.105791820705622e-08,0.08274897359565658,0.01922337562475971
81,0.1,2,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Are existing prediction equations valid for estimating basal metabolic rate in Chinese populations? Answer: The newly formulated Singapore equation currently provides the most accurate basal metabolic rate predictions for Chinese adults, outperforming well-known equations like Mifflin-St Jeor and Harris-Benedict. However, more research is necessary to verify its effectiveness among different Chinese demographics and age ranges.",7.105791820705622e-08,0.031815648607090186,0.015258393181303322,0.005440279394345618,0.031097431661075703,0.016529396361753424,0.0054324046228586,0.030304520734458773,0.017851239669421492,7.105791820705622e-08,0.056089466651043196,0.0
81,0.1,3,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Can current basal metabolic rate prediction equations be applied to Chinese individuals? Answer: The Singapore equation, recently developed, is the most accurate for estimating basal metabolic rate in Chinese adults, exceeding the accuracy of established equations such as Mifflin-St Jeor and Harris-Benedict. Further validation is needed to assess its applicability across diverse Chinese subpopulations and age groups.",2.3685972735685406e-08,0.005671230627996238,0.016528925619834704,0.0018134264647818726,0.006187073859745595,0.017190082644628114,0.0018108015409528666,0.006736750945891323,0.017851239669421492,2.3685972735685406e-08,0.018349138668195764,0.0
81,0.1,4,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: How accurate are current basal metabolic rate prediction equations for Chinese adults? Answer: Among existing formulas, the Singapore equation is the most precise for Chinese adults, outperforming traditional equations like Mifflin-St Jeor and Harris-Benedict. Still, further investigation is required to confirm its use across different Chinese subpopulations and age categories.",1.8948778188548325e-07,0.1044410115930905,0.031578577796441576,0.014507411718254981,0.10258906231620735,0.035041322314049606,0.014486412327622933,0.1293954233786887,0.017851239669421492,1.8948778188548325e-07,0.15718558352241319,0.0
81,0.1,5,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Are the current basal metabolic rate prediction models applicable to Chinese populations? Answer: The Singapore equation is presently the most accurate for predicting basal metabolic rate in Chinese adults, surpassing established models such as Mifflin-St Jeor and Harris-Benedict. However, additional research is needed to validate its applicability across various Chinese subgroups and age brackets.",9.474389094274162e-08,0.05109831883159632,0.014587999413174256,0.0072537058591274906,0.05027394425433407,0.016180375568487473,0.007243206163811466,0.04935271570515187,0.017851239669421492,9.474389094274162e-08,0.07550755250814589,0.0
81,0.1,6,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Is the Singapore equation the best for estimating basal metabolic rate in Chinese adults? Answer: Yes, it currently outperforms traditional equations like Mifflin-St Jeor and Harris-Benedict, but further studies are necessary to confirm its accuracy across different Chinese populations and age groups.",3.789755637709665e-07,0.25106851151547005,0.05157024793388431,0.029014823436509962,0.2808372937225263,0.035041322314049606,0.028972824655245866,0.3117169801726436,0.017851239669421492,3.789755637709665e-07,0.34377153910282665,0.0
81,0.1,7,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Do current prediction equations accurately estimate basal metabolic rate in Chinese adults? Answer: The Singapore equation is the most accurate to date, exceeding the performance of established equations such as Mifflin-St Jeor and Harris-Benedict. Nonetheless, more research is needed to validate its use among diverse Chinese subpopulations and age groups.",1.8948778188548325e-07,0.0767151243706925,0.05157024793388431,0.014507411718254981,0.10258906231620735,0.035041322314049606,0.014486412327622933,0.1293954233786887,0.017851239669421492,1.8948778188548325e-07,0.15718558352241319,0.0
81,0.1,8,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: What is the best equation for predicting basal metabolic rate in Chinese adults? Answer: The newly developed Singapore equation is currently the most accurate, outperforming traditional formulas like Mifflin-St Jeor and Harris-Benedict. Further validation is required to ensure its applicability across different Chinese subpopulations and age ranges.",2.6054570009253947e-07,0.13859052808878003,0.05157024793388431,0.0199476911126006,0.16576796393773963,0.035041322314049606,0.019918816950481533,0.19393394451626023,0.017851239669421492,2.6054570009253947e-07,0.22314355131420927,0.0
81,0.1,9,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: Are traditional basal metabolic rate prediction equations effective for Chinese adults? Answer: The Singapore equation, developed recently, provides the most accurate predictions for Chinese adults, surpassing established equations such as Mifflin-St Jeor and Harris-Benedict. However, further research is necessary to confirm its applicability across various Chinese subpopulations and age groups.",1.8948778188548325e-07,0.1044410115930905,0.031578577796441576,0.014507411718254981,0.10258906231620735,0.035041322314049606,0.014486412327622933,0.1293954233786887,0.017851239669421492,1.8948778188548325e-07,0.15718558352241319,0.0
81,0.1,10,ai,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? 

Answer: To date, the newly developed Singapore equation is the most accurate prediction equation for basal metabolic rate in Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. However, further research is needed to validate its applicability across different Chinese subpopulations and age groups. 
","Question: How well do current basal metabolic rate prediction equations apply to Chinese adults? Answer: The Singapore equation is the most accurate prediction model currently available for Chinese adults, outperforming established equations like Mifflin-St Jeor and Harris-Benedict. Additional studies are needed to validate its use across different Chinese subpopulations and age groups.",1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.08238635499868874,0.035041322314049606,0.012675610786670066,0.10877613617595294,0.017851239669421492,1.6580180914979784e-07,0.13613217432458002,0.0
82,0.1,1,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, prevent colon cancer in coronary artery disease patients? Our findings from coronary artery disease patients support the hypothesis that bezafibrate may have a preventive effect on colon cancer development.",1.1842986367842682e-07,0.13634003639361314,0.008992346938775514,0.009067132323909363,0.09820510360836066,0.02049382716049385,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
82,0.1,2,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a peroxisome proliferator-activated receptor ligand used to lower lipids, effective in preventing colon cancer in patients with coronary artery disease? Data from these patients suggest that bezafibrate could potentially prevent colon cancer.",2.3685972735685332e-07,0.1679743429861591,0.06937499999999999,0.018134264647818747,0.20591969828745738,0.047500000000000014,0.018108015409528694,0.24577280463087137,0.024375,2.3685972735685406e-07,0.28768207245178123,0.0
82,0.1,3,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Can the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate reduce the risk of colon cancer in individuals with coronary artery disease? Our patient data support the idea that bezafibrate might help prevent colon cancer.,2.605457000925386e-07,0.19874600165291278,0.06937499999999999,0.019947691112600627,0.2376683966020372,0.047500000000000014,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
82,0.1,4,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, which targets peroxisome proliferator-activated receptors to lower lipids, prevent colon cancer in coronary artery disease patients? Evidence from these patients backs the hypothesis of bezafibrates preventive role against colon cancer.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,0.1,5,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is there a preventive effect of the lipid-lowering drug bezafibrate, a peroxisome proliferator-activated receptor ligand, on colon cancer in patients with coronary artery disease? Our data from such patients support this possible effect.",2.605457000925386e-07,0.19874600165291278,0.06937499999999999,0.019947691112600627,0.2376683966020372,0.047500000000000014,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
82,0.1,6,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the peroxisome proliferator-activated receptor ligand bezafibrate, known for lowering lipids, prevent colon cancer in patients suffering from coronary artery disease? Our findings support the hypothesis of bezafibrates potential to prevent colon cancer.",2.605457000925386e-07,0.24206770043791037,0.03815751821019769,0.019947691112600627,0.2376683966020372,0.047500000000000014,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
82,0.1,7,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Can bezafibrate, a lipid-lowering ligand of peroxisome proliferator-activated receptors, prevent colon cancer in coronary artery disease patients? Data from these patients support the hypothesis of a preventive effect.",3.789755637709651e-07,0.36864503844830976,0.06937499999999999,0.029014823436510025,0.41355906306570134,0.047500000000000014,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
82,0.1,8,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Is the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate effective in preventing colon cancer among patients with coronary artery disease? Our patient-derived data support this possible preventive effect.,4.026615365066504e-07,0.40638536643115675,0.06937499999999999,0.030828249901291904,0.4527797762189838,0.047500000000000014,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
82,0.1,9,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does treatment with bezafibrate, a peroxisome proliferator-activated receptor ligand that lowers lipids, prevent colon cancer in patients with coronary artery disease? Our data from these patients support the hypothesis of a preventive benefit.",2.605457000925386e-07,0.19874600165291278,0.06937499999999999,0.019947691112600627,0.2376683966020372,0.047500000000000014,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
82,0.1,10,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, have a preventive effect on colon cancer in patients with coronary artery disease? Our data from these patients support this hypothesis.",3.552895910352798e-07,0.3322773942774351,0.06937499999999999,0.027201396971728145,0.37581873508285435,0.047500000000000014,0.02716202311429306,0.4216634710945355,0.024375,3.552895910352811e-07,0.47000362924573613,0.0
83,0.1,1,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists content with the training and support provided for suspected child abuse cases? Answer: The survey reveals considerable dissatisfaction among consultant radiologists regarding the current service, highlights a small number of paediatric radiologists involved in this area, and indicates a possibility to boost the number of radiology child abuse specialists by 27% with enhanced training.",2.3685972735685406e-08,0.006187073859745595,0.017190082644628107,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
83,0.1,2,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do UK radiologists feel adequately trained and supported in cases of suspected child abuse? Answer: The survey indicates notable dissatisfaction among consultant radiologists with the existing service, confirms a limited number of paediatric radiologists handling such cases, and suggests that improved training could increase the number of radiology child abuse experts by 27%.",7.105791820705622e-08,0.056461018114079664,0.001009707076140641,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
83,0.1,3,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are radiologists in the UK satisfied with the training and support they receive for suspected child abuse? Answer: The survey demonstrates significant dissatisfaction among consultant radiologists with the current service, shows a low number of paediatric radiologists working in this field, and proposes that better training could raise the number of radiology child abuse specialists by 27%.",2.3685972735685406e-08,0.006187073859745595,0.017190082644628107,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
83,0.1,4,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: How satisfied are UK radiologists with the training and support for suspected child abuse? Answer: The survey highlights considerable dissatisfaction among consultant radiologists with the present service, confirms few paediatric radiologists are involved, and suggests that enhanced training might increase the number of radiology child abuse experts by 27%.",1.6580180914979784e-07,0.16535957948696867,0.022891177714009944,0.012693985253473108,0.1650133068479107,0.020823902218198284,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
83,0.1,5,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists happy with the training and support they get for suspected child abuse cases? Answer: The survey reveals significant dissatisfaction among consultant radiologists with the current service, notes a low number of paediatric radiologists engaged in this work, and indicates that improved training could boost the number of radiology child abuse specialists by 27%.",0.0,0.04951051289713915,0.035548546731432915,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
83,0.1,6,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do consultant radiologists in the UK feel satisfied with the training and support for suspected child abuse? Answer: The survey shows marked dissatisfaction among consultant radiologists with the existing service, confirms a small number of paediatric radiologists involved, and suggests that better training could increase the number of radiology child abuse experts by 27%.",4.737194547137081e-08,0.08862874111785457,0.037512082129886465,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
83,0.1,7,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists content with the support and training they receive for suspected child abuse? Answer: The survey points to significant dissatisfaction among consultant radiologists with the current service, highlights a limited number of paediatric radiologists working in this area, and suggests that improved training could raise the number of radiology child abuse specialists by 27%.",0.0,0.024755256448570684,0.017814055255132678,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
83,0.1,8,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: How do UK radiologists rate the training and support for suspected child abuse? Answer: The survey reveals considerable dissatisfaction among consultant radiologists with the current service, confirms few paediatric radiologists are involved, and indicates that enhanced training could increase the number of radiology child abuse experts by 27%.",1.8948778188548325e-07,0.1293954233786887,0.017851239669421492,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
83,0.1,9,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Are UK radiologists satisfied with the level of training and support for suspected child abuse? Answer: The survey shows significant dissatisfaction among consultant radiologists with the current service, notes a low number of paediatric radiologists engaged in this work, and suggests that better training could boost the number of radiology child abuse specialists by 27%.",2.3685972735685406e-08,0.04367395309483202,0.018460615083159496,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
83,0.1,10,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Question: Do UK radiologists feel the training and support for suspected child abuse is adequate? Answer: The survey indicates notable dissatisfaction among consultant radiologists with the existing service, confirms a small number of paediatric radiologists involved, and suggests that improved training could increase the number of radiology child abuse experts by 27%.",1.1842986367842703e-07,0.12313528631205406,0.021299114349737202,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
84,0.1,1,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Is Residency Selection Criteria Predictive of Performance in Orthopaedic Surgery Residency? Answer: Our findings indicate that USMLE Step 2 scores, the number of honors received during medical school clerkships, and AOA membership showed the strongest correlations with resident performance. The purpose of analyzing this data was to help residency programs broadly understand which criteria might be considered ""high"".",7.105791820705622e-08,0.05310982531394792,0.0,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
84,0.1,2,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Can Residency Selection Criteria Forecast Performance in Orthopaedic Surgery Residency? Answer: We discovered that USMLE Step 2 results, the count of honors in medical school clerkships, and AOA membership had the most significant correlations with resident performance. Our aim in reviewing these data was to offer residency programs a general idea of which criteria could be deemed ""high"".",7.105791820705622e-08,0.05310982531394792,0.0,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
84,0.1,3,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Does the Residency Selection Criteria Predict Orthopaedic Surgery Residency Performance? Answer: We identified that USMLE Step 2 scores, the number of honors earned in medical school clerkships, and AOA membership were most strongly correlated with resident performance. Our objective in analyzing these data was to provide residency programs with an understanding of which criteria may be considered ""high"".",7.105791820705622e-08,0.05310982531394792,0.0,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
84,0.1,4,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Are Residency Selection Criteria Indicators of Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, the quantity of honors in medical school clerkships, and AOA membership had the strongest links to resident performance. Our goal in examining these data was to give residency programs a sense of which criteria might be ""high"".",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
84,0.1,5,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Do Residency Selection Criteria Predict Success in Orthopaedic Surgery Residency? Answer: Our study showed that USMLE Step 2 scores, number of honors in medical school clerkships, and AOA membership were the best predictors of resident performance. The intent behind analyzing these data was to assist residency programs in identifying which criteria may be ""high"".",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
84,0.1,6,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Is There a Correlation Between Residency Selection Criteria and Performance in Orthopaedic Surgery Residency? Answer: We observed that USMLE Step 2, honors in medical school clerkships, and AOA membership had the strongest correlations with resident performance. Our purpose in analyzing these data was to help residency programs understand which criteria might be considered ""high"".",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
84,0.1,7,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Can Residency Selection Criteria Serve as Predictors of Orthopaedic Surgery Residency Performance? Answer: We found that USMLE Step 2 scores, the number of honors in medical school clerkships, and AOA membership correlated most strongly with resident performance. Our goal in analyzing these data was to provide residency programs with insight into which criteria may be ""high"".",2.3685972735685406e-08,0.018018505502678472,0.0,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
84,0.1,8,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Does the Selection Criteria for Residency Predict Performance in Orthopaedic Surgery Residency? Answer: We discovered that USMLE Step 2, the number of honors in medical school clerkships, and AOA membership showed the strongest correlations with resident performance. Our aim in analyzing these data was to offer residency programs a sense of which criteria might be ""high"".",2.3685972735685406e-08,0.018018505502678472,0.0,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
84,0.1,9,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Are the Criteria Used for Residency Selection Predictive of Orthopaedic Surgery Residency Performance? Answer: We found that USMLE Step 2 scores, honors in medical school clerkships, and AOA membership had the strongest associations with resident performance. Our objective in analyzing these data was to provide residency programs with an understanding of which criteria may be ""high"".",2.3685972735685406e-08,0.018018505502678472,0.0,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
84,0.1,10,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Do Residency Selection Factors Predict Performance in Orthopaedic Surgery Residency? Answer: Our findings revealed that USMLE Step 2, the number of honors in medical school clerkships, and AOA membership were the strongest predictors of resident performance. The goal of analyzing these data was to help residency programs identify which criteria might be considered ""high"".",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
85,0.1,1,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy effective for treating gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma, though additional research is needed to clarify its role in palliative or adjuvant therapy.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.1,2,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external palliative radiotherapy work well for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative approach for gallbladder carcinoma, but more studies are required to define its role in palliative or adjuvant care.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.1,3,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy an effective palliative treatment for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative option for gallbladder carcinoma; however, further research is necessary to establish its role in palliative or adjuvant treatment.",1.8948778188548283e-07,0.25318184550457135,0.03729315417627105,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.1,4,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy appears to be a safe and effective method for palliative management of gallbladder carcinoma, yet more studies are needed to determine its role in palliative or adjuvant therapy.",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.1,5,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a safe and effective palliative treatment for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative treatment for gallbladder carcinoma, but additional research is essential to understand its role in palliative or adjuvant treatment.",1.1842986367842692e-07,0.34198268181358715,0.14611574772121833,0.009067132323909363,0.3102631355549219,0.12910111961451248,0.009054007704764333,0.3140887814661557,0.1318359375,1.1842986367842703e-07,0.28408583503929696,0.109375
85,0.1,6,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How effective is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy is regarded as a safe and effective palliative treatment for gallbladder carcinoma, although further studies are necessary to clarify its role in palliative or adjuvant therapy.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,0.1,7,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy provide effective palliative care for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative treatment for gallbladder carcinoma; however, more research is needed to define its role in palliative or adjuvant treatment.",1.6580180914979753e-07,0.22266058671934008,0.03509835306671685,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.1,8,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy beneficial for gallbladder carcinoma patients? External radiotherapy seems to be a safe and effective palliative management option for gallbladder carcinoma, but further studies are required to determine its role in palliative or adjuvant therapy.",1.6580180914979753e-07,0.1477257563885339,0.01834530108339633,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.1,9,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","What is the effectiveness of external palliative radiotherapy in gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative treatment for gallbladder carcinoma, though additional research is necessary to establish its role in palliative or adjuvant treatment.",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,0.1,10,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a reliable palliative treatment for gallbladder carcinoma? External radiotherapy appears to be a safe and effective method for palliative management of gallbladder carcinoma; however, further studies are needed to clarify its role in palliative or adjuvant therapy.",1.1842986367842692e-07,0.09316061699719658,0.01972820522484154,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
86,0.1,1,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a reliable predictor of fluid responsiveness? Answer: Evidence does not support the common use of central venous pressure for guiding fluid therapy. This method of fluid resuscitation should be discontinued.,2.36859727356853e-08,0.07209080692487779,0.030475982987571308,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.1,2,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure indicate fluid responsiveness? Answer: There is no data backing the routine use of central venous pressure to direct fluid therapy. This practice should be stopped.,1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,0.1,3,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does measuring central venous pressure help predict fluid responsiveness? Answer: Current data do not justify using central venous pressure to guide fluid treatment. This strategy for fluid resuscitation should be abandoned.,9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
86,0.1,4,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure effective in predicting fluid responsiveness? Answer: No evidence supports the widespread use of central venous pressure for fluid therapy guidance. This approach should be discontinued.,1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,0.1,5,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure serve as a predictor for fluid responsiveness? Answer: There is a lack of data supporting the use of central venous pressure to guide fluid therapy. This practice should be abandoned.,2.36859727356853e-08,0.031317443362529396,0.0016607839761248952,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.1,6,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure be used to predict fluid responsiveness? Answer: Data do not support the common practice of using central venous pressure to guide fluid resuscitation. This method should be stopped.,7.10579182070559e-08,0.09703873562425924,0.005289256198347123,0.005440279394345639,0.09631912950801658,0.002837465564738264,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
86,0.1,7,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a valid tool for predicting fluid responsiveness? Answer: There is no evidence to endorse the routine use of central venous pressure in guiding fluid therapy. This approach should be abandoned.,2.36859727356853e-08,0.031317443362529396,0.0016607839761248952,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,0.1,8,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Does central venous pressure reliably predict fluid responsiveness? Answer: The widespread practice of using central venous pressure to guide fluid therapy is not supported by data and should be discontinued.,1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
86,0.1,9,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Can central venous pressure guide fluid responsiveness prediction? Answer: No data support the common use of central venous pressure for fluid therapy guidance, so this practice should be stopped.",1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,0.1,10,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Is the use of central venous pressure justified in predicting fluid responsiveness? Answer: There is no supporting data for using central venous pressure to guide fluid resuscitation, and this practice should be abandoned.",4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
87,0.1,1,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Is (18)F-FDG an effective surrogate tracer for assessing tumor hypoxia? This study demonstrated that FDG does not serve well as a surrogate tracer for tumor hypoxia in either normal or low oxygen conditions, being specific only to certain hypoxia types.",1.421158364141118e-07,0.13797098617813175,0.02085877579437545,0.010880558788691257,0.13536882637087366,0.026296566837107373,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
87,0.1,2,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Can (18)F-FDG be used as a surrogate tracer to evaluate tumor hypoxia? The findings indicate that FDG is not a reliable surrogate tracer for tumor hypoxia under both ambient and hypoxic environments, only targeting specific hypoxia.",4.73719454713706e-08,0.0612410097391578,0.0017267246972318406,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
87,0.1,3,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Does (18)F-FDG function as a surrogate tracer for tumor hypoxia measurement? Research shows FDG is ineffective as a surrogate tracer for tumor hypoxia in ambient or hypoxic states, being limited to particular hypoxia.",2.36859727356853e-08,0.24869293134279769,0.14724135539940827,0.0018134264647818796,0.25534456301133623,0.15532544378698224,0.0018108015409528735,0.21762907097231032,0.13017751479289943,2.3685972735685406e-08,0.17731131317084214,0.10207100591715977
87,0.1,4,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Is (18)F-FDG suitable as a surrogate tracer for tumor hypoxia detection? The study revealed that FDG is not a good surrogate tracer for tumor hypoxia under normal or hypoxic conditions, only applicable to specific hypoxia.",2.36859727356853e-08,0.09123157106578095,0.08528211805555559,0.0018134264647818796,0.09525510143505445,0.09000000000000004,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
87,0.1,5,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Can tumor hypoxia be measured using (18)F-FDG as a surrogate tracer? This study found FDG to be an inadequate surrogate tracer for tumor hypoxia in both ambient and hypoxic conditions, only specific to certain hypoxia.",2.36859727356853e-08,0.031088519621267796,0.0008886808425160632,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
87,0.1,6,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Is (18)F-FDG a valid surrogate tracer for tumor hypoxia? The research concluded that FDG does not effectively serve as a surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions, only for specific hypoxia.",2.36859727356853e-08,0.050458207503430774,0.05713551151144641,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
87,0.1,7,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Does (18)F-FDG act as a surrogate tracer for tumor hypoxia? The study showed FDG is not a suitable surrogate tracer for tumor hypoxia in ambient or hypoxic conditions, only for particular hypoxia.",4.73719454713706e-08,0.1546689557654517,0.06538982780612247,0.003626852929563759,0.15695814521223062,0.06632653061224487,0.003621603081905747,0.11449462833039359,0.03443877551020409,4.737194547137081e-08,0.06899287148695077,0.0
87,0.1,8,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Is (18)F-FDG an appropriate surrogate tracer to measure tumor hypoxia? Findings indicate FDG is not a good surrogate tracer for tumor hypoxia under normal or hypoxic conditions, only specific to certain hypoxia.",4.73719454713706e-08,0.06523060988674878,0.0019487847222222007,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
87,0.1,9,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Can (18)F-FDG be considered a surrogate tracer for tumor hypoxia? The study demonstrated that FDG is not effective as a surrogate tracer for tumor hypoxia in either ambient or hypoxic states, only for specific hypoxia.",2.36859727356853e-08,0.09123157106578095,0.08528211805555559,0.0018134264647818796,0.09525510143505445,0.09000000000000004,0.0018108015409528735,0.05489469925541446,0.06222222222222223,2.3685972735685406e-08,0.011929350116359316,0.0322222222222222
87,0.1,10,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Is (18)F-FDG useful as a surrogate tracer for tumor hypoxia? This study showed FDG is not a reliable surrogate tracer for tumor hypoxia under both ambient and hypoxic conditions, only for specific hypoxia.",2.36859727356853e-08,0.11872783498780848,0.06247329258323425,0.0018134264647818796,0.1211870441932823,0.06420927467300831,0.0018108015409528735,0.07899963486032124,0.033293697978596916,2.3685972735685406e-08,0.03390155167568176,0.0
88,0.1,1,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is specialized breast pathology evaluation essential for managing ductal carcinoma in situ? Expert breast pathology evaluations remain crucial in DCIS management.,2.1317375462116776e-07,0.24966525916159688,0.08453850415512462,0.016320838183036916,0.28874450521448525,0.07100591715976333,0.016297213868575862,0.4054651081081646,0.0,2.1317375462116844e-07,0.4248831939652664,0.0
88,0.1,2,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Does the management of ductal carcinoma in situ require expert breast pathology assessment? Expert assessments in breast pathology are still necessary for DCIS management.,1.421158364141118e-07,0.10086226660522124,0.09101157024793383,0.010880558788691277,0.1421410310226099,0.07100591715976333,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.1,3,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert assessment in breast pathology needed for the treatment of ductal carcinoma in situ? Expert breast pathology evaluations continue to be important in managing DCIS.,9.47438909427412e-08,0.012658764236187725,0.09446944444444441,0.007253705859127518,0.0551296540329802,0.07100591715976333,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
88,0.1,4,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is it necessary to have expert breast pathology evaluation for managing ductal carcinoma in situ? Expert breast pathology assessments remain vital in the management of DCIS.,9.47438909427412e-08,0.0681105386809846,0.05500491493383737,0.007253705859127518,0.11289191907964069,0.02941801545844007,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
88,0.1,5,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology review required for the management of ductal carcinoma in situ? Expert breast pathology assessments are still essential in DCIS management.,1.421158364141118e-07,0.16113593447999897,0.048232199546485235,0.010880558788691277,0.20515441107351418,0.02565444323686082,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.1,6,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology analysis necessary for the management of ductal carcinoma in situ? Expert breast pathology evaluations continue to play a key role in managing DCIS.,7.10579182070559e-08,0.024624304416563714,0.05801111111111108,0.005440279394345639,0.06975943395752049,0.03107536160420777,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
88,0.1,7,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is specialized breast pathology assessment required for managing ductal carcinoma in situ? Expert breast pathology assessments remain indispensable in DCIS management.,2.1317375462116776e-07,0.24966525916159688,0.08453850415512462,0.016320838183036916,0.28874450521448525,0.07100591715976333,0.016297213868575862,0.4054651081081646,0.0,2.1317375462116844e-07,0.4248831939652664,0.0
88,0.1,8,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology examination necessary for the management of ductal carcinoma in situ? Expert breast pathology assessments continue to be critical in managing DCIS.,1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.157962936326554,0.0276174874076972,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
88,0.1,9,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology evaluation essential for the management of ductal carcinoma in situ? Expert breast pathology assessments are still necessary in DCIS management.,1.421158364141118e-07,0.16113593447999897,0.048232199546485235,0.010880558788691277,0.20515441107351418,0.02565444323686082,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,0.1,10,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology assessment important for managing ductal carcinoma in situ? Expert breast pathology evaluations continue to be necessary in the management of DCIS.,1.184298636784265e-07,0.11355351440497019,0.05175537190082642,0.009067132323909398,0.157962936326554,0.0276174874076972,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
89,0.1,1,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple pregnancies? Our research indicates that pregnancy-induced glomerular hyperfiltration does not negatively impact the kidneys in women with higher parity. Pregnancy might offer protective effects for the kidneys against the harmful consequences of glomerular hyperfiltration.,1.4211583641411244e-07,0.09692359066558609,0.021267763897151196,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,0.1,2,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is kidney damage caused by glomerular hyperfiltration in pregnant women who have had several pregnancies? According to our study, glomerular hyperfiltration from pregnancy does not adversely affect the kidneys in women with more parities. Pregnancy may provide protective mechanisms for the kidneys against the detrimental effects of glomerular hyperfiltration.",7.105791820705622e-08,0.04470656738630341,0.07396765385423232,0.005440279394345618,0.021302257949105563,0.05975554549569943,0.0054324046228586,0.006595458310516555,0.040742417383431435,7.105791820705622e-08,0.03565738861424084,0.020823902218198284
89,0.1,3,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnancy lead to kidney damage in women with multiple childbirths? Our findings suggest that glomerular hyperfiltration during pregnancy does not harm the kidneys of women with higher parity. Pregnancy might have protective roles for the kidneys against the negative impacts of glomerular hyperfiltration.,1.1842986367842703e-07,0.030501283797997658,0.050655609638843815,0.009067132323909363,0.0221828539906328,0.05975554549569943,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
89,0.1,4,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Can glomerular hyperfiltration during pregnancy cause kidney damage in women with many pregnancies? Our study proposes that pregnancy-related glomerular hyperfiltration does not cause kidney damage in women with increased parity. Pregnancy may have protective mechanisms that shield the kidneys from the adverse effects of glomerular hyperfiltration.,1.4211583641411244e-07,0.14690893685392536,0.014621959237343898,0.010880558788691236,0.17068246994449954,0.030244454504300564,0.0108648092457172,0.17075495034697186,0.028632582616568557,1.4211583641411244e-07,0.17066427729737654,0.02667609778180173
89,0.1,5,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is there kidney damage from glomerular hyperfiltration in pregnant women with more parities? Our research suggests that glomerular hyperfiltration due to pregnancy does not harm the kidneys in women with multiple pregnancies. Pregnancy might protect the kidneys from the harmful effects of glomerular hyperfiltration.,1.8948778188548325e-07,0.1042502740222866,0.04618055555555557,0.014507411718254981,0.09117572547758446,0.05975554549569943,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.1,6,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does pregnancy-induced glomerular hyperfiltration damage kidneys in women with higher parity? Our study indicates that glomerular hyperfiltration during pregnancy does not adversely affect the kidneys in women with more parities. Pregnancy may have protective effects that guard the kidneys against glomerular hyperfiltration's negative consequences.,1.8948778188548325e-07,0.16872908151623411,0.0012896275777163069,0.014507411718254981,0.1571897426737685,0.012255545495699419,0.014486412327622933,0.1554768456835931,0.016367417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.1,7,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy cause kidney injury in women with several childbirths? Our findings suggest that pregnancy-related glomerular hyperfiltration does not damage the kidneys in women with increased parity. Pregnancy might provide protective mechanisms for the kidneys against the harmful effects of glomerular hyperfiltration.,1.6580180914979784e-07,0.11056930465847348,0.025555555555555567,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.1,8,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is kidney function impaired by glomerular hyperfiltration in pregnant women with multiple parities? Our study suggests that glomerular hyperfiltration from pregnancy does not negatively impact kidney function in women with more parities. Pregnancy may have protective mechanisms that prevent kidney damage from glomerular hyperfiltration.,1.8948778188548325e-07,0.1042502740222866,0.04618055555555557,0.014507411718254981,0.09117572547758446,0.05975554549569943,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,0.1,9,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration in pregnancy adversely affect kidneys in women with many pregnancies? Our research indicates that pregnancy-induced glomerular hyperfiltration does not cause kidney damage in women with higher parity. Pregnancy might offer protective benefits to the kidneys against the adverse effects of glomerular hyperfiltration.,1.6580180914979784e-07,0.07906261463302089,0.04773877982682265,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,0.1,10,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Can glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple parities? Our study suggests that glomerular hyperfiltration caused by pregnancy does not have harmful effects on the kidneys in women with more parities. Pregnancy may have protective mechanisms that defend the kidneys from the negative impacts of glomerular hyperfiltration.,2.3685972735685406e-08,0.02192231518833765,0.0073177903801722455,0.0018134264647818726,0.06297495434967448,0.05975554549569943,0.0018108015409528666,0.035964156108279965,0.040742417383431435,2.3685972735685406e-08,0.007827723325497526,0.020823902218198284
90,0.1,1,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Are the home blood pressure readings reported by stroke patients dependable? This elderly stroke patient group reliably recorded their blood pressures, showing strong agreement with clinic measurements, indicating home BP monitoring is useful for managing hypertension in these patients.",2.1317375462116844e-07,0.21256144198367144,0.0,0.016320838183036854,0.21772348384486895,0.0,0.0162972138685758,0.22314355131420927,0.0,2.1317375462116866e-07,0.2288415724288484,0.0
90,0.1,2,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Can stroke patients be trusted to report their home blood pressure readings accurately? Elderly stroke patients in this study reliably measured their BPs, matching clinic results well, suggesting home monitoring is effective for hypertension management.",3.0791764556390964e-07,0.3645604406562457,0.029384756657483937,0.023574544042164358,0.3321338350226144,0.0,0.023540420032387287,0.3409265869705931,0.0,3.079176455639103e-07,0.3502024294331152,0.0
90,0.1,3,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Do stroke patients provide reliable home blood pressure readings? This group of elderly stroke patients consistently recorded their BPs with good concordance to clinic measurements, implying home BP monitoring is beneficial for hypertension control.",3.3160361829959494e-07,0.3956489602775135,0.0302734375,0.025387970506946238,0.3629054936893681,0.0,0.02535122157334016,0.3726752852851729,0.0,3.316036182995957e-07,0.3829922522561069,0.0
90,0.1,4,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Is the home blood pressure data reported by stroke patients accurate? Elderly stroke patients reliably documented their BPs, aligning closely with clinic measurements, supporting the use of home BP monitoring for hypertension management.",3.5528959103528024e-07,0.42773339769532903,0.031217481789802305,0.027201396971728117,0.3946541920039479,0.0,0.027162023114293034,0.4054651081081646,0.0,3.552895910352811e-07,0.41689380393178865,0.0
90,0.1,5,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Are home blood pressure readings from stroke patients trustworthy? The elderly stroke patients reliably recorded their BPs, showing good agreement with clinical data, indicating home monitoring is a valuable hypertension management tool.",3.7897556377096555e-07,0.4608795701642623,0.0322222222222222,0.029014823436509997,0.4274440148269396,0.0,0.028972824655245907,0.43936665978384637,0.0,3.789755637709665e-07,0.45198512374305766,0.0
90,0.1,6,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Can elderly stroke patients reliably report their home blood pressure readings? This group demonstrated consistent BP recordings that matched clinic measurements well, suggesting home monitoring aids hypertension management.",4.7371945471370675e-07,0.5543107357057284,0.0,0.036268529295637515,0.570544858467612,0.0,0.0362160308190574,0.5877866649021195,0.0,4.737194547137081e-07,0.6061358035703166,0.0
90,0.1,7,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","How reliable are stroke patients' reports of home blood pressure? Elderly stroke patients in this study reliably recorded their BPs, with strong agreement to clinic readings, supporting home BP monitoring for hypertension care.",3.5528959103528024e-07,0.38441169891033145,0.0,0.027201396971728117,0.3946541920039479,0.0,0.027162023114293034,0.4054651081081646,0.0,3.552895910352811e-07,0.41689380393178865,0.0
90,0.1,8,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Do elderly stroke patients provide dependable home blood pressure readings? This group reliably measured their BPs, achieving good concordance with clinic measurements, indicating home monitoring is effective for managing hypertension.",4.2634750924233615e-07,0.48285177172358473,0.0,0.032641676366073756,0.4964368863138904,0.0,0.032594427737151654,0.5108256237659901,0.0,4.263475092423373e-07,0.5260930958967793,0.0
90,0.1,9,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Is home blood pressure monitoring by stroke patients reliable? The elderly stroke patients consistently recorded their BPs in agreement with clinic measurements, suggesting it is a useful tool for hypertension management.",4.0266153650665085e-07,0.4951600320852325,0.033293697978596916,0.030828249901291876,0.4613455665026214,0.0,0.03078362619619878,0.4744579795951154,0.0,4.026615365066519e-07,0.48835276791393234,0.0
90,0.1,10,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable?** 

**Answer:** This group of elderly stroke patients were able to record their BPs reliably, achieving good agreement with clinic measurements. This suggests that home BP monitoring can be a valuable tool for managing hypertension in this population. 
","Are reports of home blood pressure readings from stroke patients accurate? This group of elderly stroke patients reliably recorded their BPs, showing good agreement with clinic measurements, supporting home BP monitoring as valuable for hypertension management.",2.8423167282822434e-07,0.3344079505383557,0.02854671280276816,0.02176111757738248,0.3022808718729326,0.0,0.021729618491434413,0.3101549283038394,0.0,2.8423167282822487e-07,0.31845373111853537,0.0
91,0.1,1,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Our findings indicate that reduced vessel compliance and heightened vascular resistance characterize young, obese, normotensive individuals, independent of cardiovascular risk factors. Alterations in arterial wall properties may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,0.1,2,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do increased carotid artery pulsatility and resistance indexes signal early vascular abnormalities in young obese males? The results show that young, obese, normotensive subjects exhibit decreased vessel compliance and increased vascular resistance, beyond traditional cardiovascular risk factors. Changes in arterial wall properties might...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.1,3,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is an increase in carotid artery pulsatility and resistance indexes an early marker of vascular abnormalities in young obese males? Our study suggests that young, obese, normotensive individuals have impaired vessel compliance and elevated vascular resistance, regardless of cardiovascular risk factors. Modifications in arterial wall properties could...",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
91,0.1,4,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are higher carotid artery pulsatility and resistance indexes early signs of vascular issues in young obese males? Findings reveal that young, obese, normotensive subjects present with reduced vessel compliance and increased vascular resistance, independent of cardiovascular risk factors. Arterial wall property changes may...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.1,5,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Can increased carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? The data suggest that depressed vessel compliance and raised vascular resistance are characteristics of young, obese, normotensive individuals, separate from cardiovascular risk factors. Changes in arterial wall properties may...",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,0.1,6,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do young obese males show early vascular abnormalities through increased carotid artery pulsatility and resistance indexes? Our results imply that young, obese, normotensive subjects have diminished vessel compliance and heightened vascular resistance, independent of cardiovascular risk factors. Alterations in arterial wall properties may...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.1,7,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are early vascular abnormalities in young obese males reflected by increased carotid artery pulsatility and resistance indexes? The study indicates that young, obese, normotensive individuals exhibit decreased vessel compliance and increased vascular resistance, beyond cardiovascular risk factors. Changes in arterial wall properties might...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.1,8,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is increased carotid artery pulsatility and resistance indexes a sign of early vascular abnormalities in young obese males? Results suggest that young, obese, normotensive subjects have impaired vessel compliance and elevated vascular resistance, independent of cardiovascular risk factors. Arterial wall property changes may...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,0.1,9,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Could increased carotid artery pulsatility and resistance indexes be early indicators of vascular abnormalities in young obese males? Findings suggest that depressed vessel compliance and increased vascular resistance are present in young, obese, normotensive individuals, regardless of cardiovascular risk factors. Changes in arterial wall properties may...",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,0.1,10,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are increased carotid artery pulsatility and resistance indexes early markers of vascular abnormalities in young obese males? Our results indicate that young, obese, normotensive subjects show reduced vessel compliance and increased vascular resistance, independent of cardiovascular risk factors. Alterations in arterial wall properties may...",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
92,0.1,1,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does having an optimistic perspective predict improved survival rates in advanced age? Evidence suggests that optimism is a strong predictor of survival in the oldest-old women and potentially for men, though the male sample size is limited.",1.8948778188548283e-07,0.04313724533489216,0.11176857330703485,0.014507411718254981,0.10913384296322581,0.06937499999999999,0.01448641232762294,0.17830208506911438,0.023795359904818555,1.8948778188548325e-07,0.21706450523782772,0.0
92,0.1,2,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is an optimistic attitude linked to better survival outcomes in very old age? Findings indicate that optimism significantly predicts survival among the oldest-old women and possibly men, but the male sample is small.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.1,3,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can optimism forecast greater longevity in advanced years? An optimistic outlook seems to be a key survival predictor for the oldest-old women and may also be important for men, although the male sample size is small.",2.1317375462116813e-07,0.071308122301589,0.11176857330703485,0.01632083818303686,0.13812137983647732,0.06937499999999999,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
92,0.1,4,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does maintaining optimism enhance survival chances in the oldest age groups? Optimism appears to be a significant survival predictor for the oldest-old women and might be for men, but the male sample is limited.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.1,5,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is a positive outlook associated with improved survival at advanced ages? Optimism is a notable predictor of survival among the oldest-old women and potentially men, though the male sample size is small.",3.0791764556390933e-07,0.23738815224520682,0.07954635108481264,0.02357454404216438,0.2632845227904843,0.06937499999999999,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
92,0.1,6,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does an optimistic mindset predict better survival among the very elderly? Optimism seems to be a significant survival factor for the oldest-old women and possibly men, but the male sample size is small.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,0.1,7,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is optimism a predictor of longevity in advanced age? An optimistic outlook is a significant survival predictor for the oldest-old women and may also be for men, but the male sample size is limited.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.1,8,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Does having a hopeful outlook correlate with better survival in advanced age? Optimism appears to significantly predict survival among the oldest-old women and possibly men, though the male sample size is small.",3.0791764556390933e-07,0.1926689793058558,0.11176857330703485,0.02357454404216438,0.2632845227904843,0.06937499999999999,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
92,0.1,9,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Can a positive attitude predict longer survival at advanced ages? Optimism is a significant predictor of survival for the oldest-old women and may also be for men, but the male sample size is small.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,0.1,10,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Is an optimistic perspective linked to increased survival in the oldest-old? Optimism seems to be a key predictor of survival among the oldest-old women and potentially men, but the male sample size is limited.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
93,0.1,1,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Does the radiographic transition zone correspond to the level of aganglionosis in Hirschsprung's disease specimens? Yes, the radiographic transition zone, marked by a sudden change from normal bowel diameter to the narrowed aganglionic segment, typically indicates the aganglionosis level, though some inconsistencies may arise. This relationship is useful for surgical planning and assessing disease extent.",7.105791820705622e-08,0.03379975985039385,0.014412399097808448,0.005440279394345618,0.03170576166550987,0.016804348178992037,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
93,0.1,2,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Is there a correlation between the radiographic transition zone and the aganglionosis level in Hirschsprung's disease? Indeed, the radiographic transition zone, where the bowel caliber shifts abruptly from normal to narrowed aganglionic tissue, usually matches the aganglionosis level, despite occasional mismatches. This helps in preoperative evaluation and determining disease severity.",1.8948778188548325e-07,0.1388223198750156,0.008811637721313034,0.014507411718254981,0.1335212994534496,0.014841392706355885,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
93,0.1,3,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Does the radiographic transition zone align with the aganglionosis level in Hirschsprung's disease specimens? Correct, the transition zone seen radiographically, characterized by an abrupt change from normal bowel size to the narrowed aganglionic segment, generally corresponds to the aganglionosis level, although discrepancies can occur. This correlation assists in surgical planning and understanding disease extent.",9.474389094274162e-08,0.053945031605859395,0.013375720897116382,0.0072537058591274906,0.024597459256582077,0.03566529492455417,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
93,0.1,4,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Is the radiographic transition zone indicative of the aganglionosis level in Hirschsprung's disease? Yes, the radiographic transition zone, where the bowel diameter suddenly narrows from normal to aganglionic, typically reflects the level of aganglionosis, though some variation may exist. This aids in preoperative planning and evaluating the disease's extent.",2.1317375462116866e-07,0.13232870715788936,0.02818781919579315,0.016320838183036854,0.15518920083263055,0.014398754281832068,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
93,0.1,5,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Does the radiographic transition zone reflect the level of aganglionosis in Hirschsprung's disease specimens? Correct, the radiographic transition zone, marked by an abrupt change from normal bowel caliber to the narrowed aganglionic segment, generally corresponds to the aganglionosis level, despite occasional discrepancies. This relationship is valuable for surgical planning and understanding disease extent.",1.1842986367842703e-07,0.07450225527153087,0.012299669251968556,0.009067132323909363,0.0711977874885843,0.016065294924554177,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
93,0.1,6,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Is there a relationship between the radiographic transition zone and the aganglionosis level in Hirschsprung's disease? Yes, the radiographic transition zone, where the bowel caliber abruptly changes from normal to narrowed aganglionic tissue, usually indicates the level of aganglionosis, although some inconsistencies may be present. This helps in preoperative assessment and determining the extent of disease.",4.737194547137081e-08,0.011155028172629144,0.03346386614453542,0.0036268529295637453,0.012529249072251503,0.017153368972257988,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
93,0.1,7,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Does the radiographic transition zone correspond with the aganglionosis level in Hirschsprung's disease? Indeed, the radiographic transition zone, characterized by a sudden shift from normal bowel diameter to the narrowed aganglionic segment, generally reflects the aganglionosis level, though discrepancies can occur. This correlation is useful for surgical planning and understanding the disease extent.",1.1842986367842703e-07,0.07450225527153087,0.012299669251968542,0.009067132323909363,0.0711977874885843,0.016065294924554177,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
93,0.1,8,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Is the radiographic transition zone a reliable indicator of aganglionosis level in Hirschsprung's disease? Yes, the radiographic transition zone, where the bowel caliber abruptly narrows from normal to aganglionic, typically corresponds to the aganglionosis level, despite occasional mismatches. This aids in preoperative planning and evaluating disease severity.",2.6054570009253947e-07,0.17739972440480178,0.026387291145050285,0.0199476911126006,0.19998522942591013,0.013454551122901278,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
93,0.1,9,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Does the radiographic transition zone match the level of aganglionosis in Hirschsprung's disease specimens? Correct, the radiographic transition zone, marked by an abrupt change from normal bowel size to the narrowed aganglionic segment, generally aligns with the aganglionosis level, although some variation may exist. This relationship assists in surgical planning and understanding the extent of disease.",4.737194547137081e-08,0.011155028172629144,0.03346386614453542,0.0036268529295637453,0.012529249072251503,0.017153368972257988,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
93,0.1,10,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correct. The radiographic transition zone, where normal bowel caliber abruptly transitions to the narrowed aganglionic segment, generally reflects the level of aganglionosis, although discrepancies can occur. This correlation aids in pre-operative planning and understanding the extent of the disease. 
","Is the radiographic transition zone indicative of the extent of aganglionosis in Hirschsprung's disease? Yes, the radiographic transition zone, where normal bowel caliber suddenly transitions to the narrowed aganglionic segment, usually reflects the level of aganglionosis, though discrepancies can occur. This correlation aids in preoperative planning and assessing disease extent.",1.8948778188548325e-07,0.1105305982195075,0.029033303513684973,0.014507411718254981,0.1335212994534496,0.014841392706355885,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
94,0.1,1,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer serve as a novel diagnostic marker for acute appendicitis? Answer: Elevated D-dimer levels should not be used as a diagnostic criterion for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.1,2,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic tool for acute appendicitis? Answer: High D-dimer levels are not reliable for diagnosing acute appendicitis.,1.421158364141118e-07,0.19997019268387461,0.03698224852071005,0.010880558788691277,0.26236426446749217,0.0,0.010864809245717241,0.27443684570175986,0.0,1.4211583641411228e-07,0.28768207245178035,0.0
94,0.1,3,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer be introduced as a diagnostic parameter for acute appendicitis? Answer: Increased D-dimer should not be regarded as a diagnostic indicator for acute appendicitis.,4.73719454713706e-08,0.19197212887348414,0.08078634652061223,0.003626852929563759,0.13780497272019776,0.04158790170132326,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.1,4,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be utilized as a new diagnostic parameter in acute appendicitis? Answer: Raised D-dimer levels should not be considered diagnostic for acute appendicitis.,7.10579182070559e-08,0.06643880005935099,0.03698224852071005,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,0.1,5,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is it possible for D-dimer to become a diagnostic marker for acute appendicitis? Answer: Elevated D-dimer values are not suitable as diagnostic parameters for acute appendicitis.,2.36859727356853e-08,0.03971510627504049,0.0014177514792899637,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,0.1,6,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer levels be used as a new diagnostic criterion for acute appendicitis? Answer: Increased D-dimer should not be taken as a diagnostic marker for acute appendicitis.,0.0,0.05134423559703327,0.03661775147928994,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
94,0.1,7,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer act as a novel diagnostic parameter for acute appendicitis? Answer: Higher D-dimer levels should not be used to diagnose acute appendicitis.,9.47438909427412e-08,0.10899841447814662,0.03698224852071005,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,0.1,8,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a viable new diagnostic parameter for acute appendicitis? Answer: Elevated D-dimer levels are not appropriate for diagnosing acute appendicitis.,1.421158364141118e-07,0.19997019268387461,0.03698224852071005,0.010880558788691277,0.26236426446749217,0.0,0.010864809245717241,0.27443684570175986,0.0,1.4211583641411228e-07,0.28768207245178035,0.0
94,0.1,9,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be considered a new diagnostic tool for acute appendicitis? Answer: Increased D-dimer should not be used as a diagnostic parameter in acute appendicitis.,4.73719454713706e-08,0.025616805539096177,0.03698224852071005,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,0.1,10,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Might D-dimer become a diagnostic parameter for acute appendicitis? Answer: Raised D-dimer levels should not be considered diagnostic for acute appendicitis.,1.421158364141118e-07,0.26598420988005955,0.010517751479289968,0.010880558788691277,0.26236426446749217,0.0,0.010864809245717241,0.27443684570175986,0.0,1.4211583641411228e-07,0.28768207245178035,0.0
95,0.1,1,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-1 expression.","Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? The study found higher expression of TGF-1 and VEGF in polyps compared to nearby normal endometrial tissue, indicating these cytokines may contribute to polyp development. Additionally, a significant correlation was observed between steroid receptor expression and the levels of VEGF and TGF-1.",7.105791820705622e-08,0.03812829180554278,0.062113388768176216,0.005440279394345618,0.02723735466969668,0.016124697661918846,0.0054324046228586,0.05043085362689137,0.0,7.105791820705622e-08,0.05129329438754926,0.0
95,0.1,2,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-1 expression.","Does endometrial polyp formation correlate with increased expression of VEGF and TGF-1? Results showed that TGF-1 and VEGF were more highly expressed in polyps than in adjacent normal endometrium, suggesting these cytokines could be involved in polyp formation. Moreover, steroid receptor expression was significantly associated with VEGF and TGF-1 expression.",3.316036182995957e-07,0.16958278794277337,0.05837596198308892,0.025387970506946217,0.23357378766752435,0.016124697661918846,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
95,0.1,3,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-1 expression.","Is there an association between endometrial polyp formation and elevated expression of vascular endothelial growth factor and transforming growth factor-beta1? Findings revealed increased TGF-1 and VEGF expression in polyps relative to normal endometrial tissue nearby, implying these cytokines might influence polyp development. A notable correlation was also found between steroid receptor levels and VEGF and TGF-1 expression.",1.6580180914979784e-07,0.032514930111312346,0.06092402786922298,0.012693985253473108,0.09744161334294432,0.016124697661918846,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
95,0.1,4,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-1 expression.","Are increased levels of VEGF and TGF-1 linked to the formation of endometrial polyps? The data indicated that TGF-1 and VEGF expression was higher in polyps compared to adjacent normal tissue, suggesting a role for these cytokines in polyp formation. There was also a significant relationship between steroid receptor expression and the expression of VEGF and TGF-1.",1.6580180914979784e-07,0.05727018655988214,0.0431099726140903,0.012693985253473108,0.12264696536330622,0.0020508853284789547,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
95,0.1,5,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-1 expression.","Is endometrial polyp formation associated with higher expression of vascular endothelial growth factor and transforming growth factor-beta1? The study demonstrated increased TGF-1 and VEGF in polyps versus normal endometrial tissue, suggesting these cytokines may contribute to polyp development. Additionally, steroid receptor expression correlated significantly with VEGF and TGF-1 levels.",3.552895910352811e-07,0.16191035349000105,0.07877526753864447,0.02720139697172809,0.2546271968653575,0.016124697661918846,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
95,0.1,6,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-1 expression.","Does the formation of endometrial polyps involve increased expression of VEGF and TGF-1? Increased expression of these cytokines was observed in polyps compared to adjacent normal tissue, indicating their potential role in polyp formation. Furthermore, steroid receptor expression showed a significant correlation with VEGF and TGF-1 expression.",4.026615365066519e-07,0.2948804697209644,0.013875321621932724,0.030828249901291835,0.32891885016331557,0.006086046139734045,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
95,0.1,7,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-1 expression.","Is there a link between endometrial polyp formation and elevated VEGF and TGF-1 expression? The findings showed that polyps had higher TGF-1 and VEGF expression than surrounding normal endometrium, suggesting these cytokines might be involved in polyp development. A significant correlation was also found between steroid receptor expression and VEGF and TGF-1 levels.",2.6054570009253947e-07,0.16184616665030438,0.021299215893496606,0.0199476911126006,0.20013140822598974,0.003475302338081146,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
95,0.1,8,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-1 expression.","Are vascular endothelial growth factor and transforming growth factor-beta1 expressions increased in endometrial polyps? The study found elevated TGF-1 and VEGF in polyps compared to adjacent normal tissue, implying these cytokines may play a role in polyp formation. There was also a significant association between steroid receptor expression and VEGF and TGF-1 expression.",2.6054570009253947e-07,0.1085271527610776,0.05955189191388476,0.0199476911126006,0.17294916585109021,0.016124697661918846,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
95,0.1,9,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-1 expression.","Is increased expression of VEGF and TGF-1 associated with the development of endometrial polyps? Results indicated higher levels of these cytokines in polyps than in adjacent normal endometrium, suggesting their involvement in polyp formation. Additionally, steroid receptor expression was significantly correlated with VEGF and TGF-1 expression.",4.263475092423373e-07,0.28806195734401197,0.03442697116222479,0.03264167636607371,0.3520918546826062,0.0065902834089302635,0.0325944277371516,0.3496737484797481,0.0,4.263475092423373e-07,0.35667494393873156,0.0
95,0.1,10,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-1 expression.","Does the expression of vascular endothelial growth factor and transforming growth factor-beta1 increase in endometrial polyps? The study observed increased TGF-1 and VEGF in polyps compared to normal endometrial tissue nearby, suggesting these cytokines might contribute to polyp formation. A significant correlation was also noted between steroid receptor expression and VEGF and TGF-1 levels.",2.3685972735685406e-07,0.08897594822539201,0.05991432079308234,0.018134264647818726,0.15353107999398752,0.016124697661918846,0.018108015409528666,0.17904823144898518,0.0,2.3685972735685406e-07,0.182321556793954,0.0
96,0.1,1,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Isolated sternal fractures in children usually result from common age-related injuries like falls or sports accidents. Although uncommon, these fractures are frequently overlooked because of their location and the child's nonspecific symptoms.",4.0266153650665095e-07,0.40833267389941375,0.020823902218198284,0.03082824990129187,0.44895022004790297,0.0,0.030783626196198774,0.4613455665026214,0.0,4.026615365066519e-07,0.4744579795951154,0.0
96,0.1,2,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","In growing children, isolated sternal fractures typically arise from usual childhood traumas such as falls or sports injuries. These fractures are rare and can be easily missed due to their position and the often unclear symptoms presented by the child.",2.1317375462116855e-07,0.17875823225491594,0.020823902218198284,0.016320838183036854,0.21256144198367144,0.0,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
96,0.1,3,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
",Sternal fractures in children are uncommon and often caused by typical childhood trauma like falls or sports injuries. They are frequently overlooked because of their location and the vague symptoms children exhibit.,4.0266153650665095e-07,0.40833267389941375,0.020823902218198284,0.03082824990129187,0.44895022004790297,0.0,0.030783626196198774,0.4613455665026214,0.0,4.026615365066519e-07,0.4744579795951154,0.0
96,0.1,4,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","In children, isolated sternal fractures are rare and generally caused by common injuries related to age, including falls and sports. These fractures can be easily missed due to their anatomical location and the child's often subtle symptoms.",2.8423167282822445e-07,0.2588009399284501,0.020823902218198284,0.02176111757738247,0.2947995402206445,0.0,0.021729618491434406,0.3022808718729326,0.0,2.8423167282822487e-07,0.3101549283038394,0.0
96,0.1,5,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
",Isolated fractures of the sternum in growing children are rare and usually result from typical childhood trauma such as falls or sports injuries. These fractures are often overlooked because of their location and the child's vague symptoms.,2.8423167282822445e-07,0.2588009399284501,0.020823902218198284,0.02176111757738247,0.2947995402206445,0.0,0.021729618491434406,0.3022808718729326,0.0,2.8423167282822487e-07,0.3101549283038394,0.0
96,0.1,6,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Sternal fractures in childhood are uncommon and typically caused by age-related trauma like falls or sports injuries. Due to their location and the child's often unclear symptoms, these fractures can be easily missed.",3.7897556377096565e-07,0.3765839755848339,0.020823902218198284,0.02901482343650999,0.41616039722491127,0.0,0.0289728246552459,0.4274440148269396,0.0,3.789755637709665e-07,0.43936665978384637,0.0
96,0.1,7,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","In growing children, isolated sternal fractures are rare and usually stem from common injuries such as falls or sports accidents. These fractures are often overlooked because of their position and the child's vague symptoms.",3.5528959103528035e-07,0.387821236952016,0.009449535281801716,0.02720139697172811,0.38441169891033145,0.0,0.027162023114293027,0.3946541920039479,0.0,3.552895910352811e-07,0.4054651081081646,0.0
96,0.1,8,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Isolated sternal fractures in children are infrequent and generally caused by typical childhood trauma, including falls and sports injuries. These fractures can be easily missed due to their location and the child's nonspecific symptoms.",3.5528959103528035e-07,0.34581231691808023,0.020823902218198284,0.02720139697172811,0.38441169891033145,0.0,0.027162023114293027,0.3946541920039479,0.0,3.552895910352811e-07,0.4054651081081646,0.0
96,0.1,9,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","Sternal fractures in children, though rare, often result from typical age-related trauma like falls or sports injuries. They can be easily overlooked because of their location and the child's often vague symptoms.",4.0266153650665095e-07,0.40833267389941375,0.020823902218198284,0.03082824990129187,0.44895022004790297,0.0,0.030783626196198774,0.4613455665026214,0.0,4.026615365066519e-07,0.4744579795951154,0.0
96,0.1,10,ai,"Question: Sternal fracture in growing children: A rare and often overlooked fracture? 
Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma, such as falls or sports injuries. While rare, these fractures can be easily missed due to the location and the child's often vague symptoms. 
","In childhood, isolated sternal fractures are rare and usually caused by common injuries such as falls or sports accidents. These fractures are often missed due to their location and the child's vague symptoms.",3.7897556377096565e-07,0.4199056743698315,0.010393579571604021,0.02901482343650999,0.41616039722491127,0.0,0.0289728246552459,0.4274440148269396,0.0,3.789755637709665e-07,0.43936665978384637,0.0
97,0.1,1,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight stable? Answer: The findings do not back the idea that African American women have a higher obesity risk due to needing fewer calories for weight maintenance.,4.73719454713706e-08,0.10160124692944805,0.03193310745366887,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.1,2,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it true that African American women require fewer calories to maintain their weight? Answer: The results do not support the notion that African American women are more prone to obesity because they need fewer calories to maintain weight.,9.47438909427412e-08,0.05337117035417105,0.03637739613522416,0.0072537058591274975,0.0876200035741257,0.016397279362256018,0.00724320616381148,0.12349336091481211,0.006476247106542904,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,0.1,3,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have lower calorie needs to maintain their weight? Answer: These findings do not confirm that African American women are at increased obesity risk due to lower calorie requirements for weight maintenance.,0.0,0.03960841031771123,0.027421996943288215,0.0,0.08154672712469857,0.05802419235396247,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305
97,0.1,4,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are fewer calories needed by African American women to sustain their weight? Answer: The evidence does not support the claim that African American women face greater obesity risk because they require fewer calories to maintain weight.,2.36859727356853e-08,0.07107998814421679,0.029738306344114673,0.0018134264647818796,0.11169921724258858,0.058862236208678254,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.1,5,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require less caloric intake to maintain their weight? Answer: The results do not uphold the view that African American women are more susceptible to obesity because they need fewer calories to maintain weight.,4.73719454713706e-08,0.10160124692944805,0.03193310745366887,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,0.1,6,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the calorie requirement for weight maintenance lower in African American women? Answer: The data do not support the perspective that African American women have a higher risk of obesity due to lower calorie needs for maintaining weight.,7.10579182070559e-08,0.20419030895203116,0.08608636760618084,0.005440279394345625,0.20687747871511197,0.08740894901144641,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.1,7,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight steady? Answer: These results do not endorse the belief that African American women are at greater risk of obesity because of lower calorie requirements for weight maintenance.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.1,8,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are African American womens calorie needs for weight maintenance lower? Answer: The findings do not back the idea that African American women are more likely to become obese because they require fewer calories to maintain weight.,2.36859727356853e-08,0.14809634153976647,0.08462783240247189,0.0018134264647818796,0.1513076275602998,0.08740894901144641,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
97,0.1,9,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require a reduced calorie intake to maintain weight? Answer: The evidence does not support the notion that African American women have an increased risk of obesity due to needing fewer calories to maintain weight.,7.10579182070559e-08,0.13122744784045715,0.034015587504512695,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,0.1,10,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it the case that African American women need fewer calories to maintain their weight? Answer: The results do not support the hypothesis that African American women are at higher risk for obesity because they require fewer calories to maintain weight.,1.421158364141119e-07,0.11378530095599926,0.029657881883242435,0.010880558788691243,0.14620958407283435,0.011356483087319041,0.010864809245717214,0.17997990621206839,0.009221584832575631,1.4211583641411244e-07,0.2151719557116576,0.031217481789802305
98,0.1,1,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Are UK radiologists content with the training and support provided for suspected child abuse cases? The survey reveals considerable dissatisfaction among consultant radiologists regarding the training and support available for suspected child abuse cases. Issues raised include the absence of standardized training, limited resources, and a lack of clear ethical guidance. This underscores the necessity for enhanced training and support frameworks to deliver optimal care for children.",7.105791820705622e-08,0.0725382758258597,0.023199365009447,0.005440279394345618,0.07056688173315884,0.019878472222222263,0.0054324046228586,0.04774931358882917,0.0013949965827017088,7.105791820705622e-08,0.025515555617921848,0.01514792899408284
98,0.1,2,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Do UK radiologists feel adequately trained and supported in cases of suspected child abuse? Findings indicate that many consultant radiologists are unhappy with the current training and support related to suspected child abuse. Key concerns involve inconsistent training standards, insufficient resources, and inadequate ethical guidance. This points to a pressing need for better training and support mechanisms to improve child care outcomes.",1.8948778188548325e-07,0.035605880389345756,0.11562346495488124,0.014507411718254981,0.0590264962043765,0.07318187122953174,0.014486412327622933,0.08577325425778692,0.029822485207100586,1.8948778188548325e-07,0.10820727146303799,0.01514792899408284
98,0.1,3,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Is the training and support for suspected child abuse satisfactory to UK radiologists? The survey highlights notable dissatisfaction among consultant radiologists about the training and support they receive in suspected child abuse scenarios. Problems include a lack of uniform training, scarce resources, and insufficient ethical direction. This emphasizes the importance of upgrading training and support systems to ensure high-quality care for children.",1.8948778188548325e-07,0.1436661055042423,0.022227646384581634,0.014507411718254981,0.13706201665644446,0.012197066326530628,0.014486412327622933,0.1092697688530393,0.012878371057278945,1.8948778188548325e-07,0.10820727146303799,0.01514792899408284
98,0.1,4,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Are consultant radiologists in the UK satisfied with the support and training for suspected child abuse? Survey results show significant discontent among consultant radiologists concerning the training and support for suspected child abuse cases. Concerns focus on the absence of standardized training, inadequate resources, and limited ethical guidance. This signals a need for improved training and support to provide the best care for children.",1.4211583641411244e-07,0.045189968962146665,0.08589694890256255,0.010880558788691236,0.047850940302071265,0.0576215277777778,0.0108648092457172,0.052436833990195275,0.029822485207100586,1.4211583641411244e-07,0.07430571978735756,0.01514792899408284
98,0.1,5,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","How do UK radiologists view the training and support they get for suspected child abuse? The survey indicates considerable dissatisfaction among consultant radiologists with the current training and support in suspected child abuse cases. Issues include non-standardized training, lack of resources, and insufficient ethical guidance. This highlights the necessity for enhanced training and support systems to ensure optimal child care.",2.3685972735685406e-07,0.1359836876429381,0.0065789379775581525,0.018134264647818726,0.12664791541319076,0.01969068877551018,0.018108015409528666,0.12025943032895547,0.029822485207100586,2.3685972735685406e-07,0.14329859127430744,0.01514792899408284
98,0.1,6,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Are UK radiologists happy with the training and support provided for suspected child abuse? The survey reveals that many consultant radiologists are dissatisfied with the training and support they receive when handling suspected child abuse. Key issues include the lack of standardized training, inadequate resources, and insufficient ethical guidance. This points to the need for better training and support frameworks to improve care for children.",1.1842986367842703e-07,0.08739570024049703,0.01322867614112605,0.009067132323909363,0.08345564170269171,0.007254784903763314,0.009054007704764333,0.08089548605776553,0.0023997370151216148,1.1842986367842703e-07,0.08050255490368574,0.0012409598948060572
98,0.1,7,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Do consultant radiologists in the UK feel supported and well-trained for suspected child abuse cases? Survey findings show significant dissatisfaction among consultant radiologists regarding their training and support in suspected child abuse. Concerns include the absence of standardized training, limited resources, and inadequate ethical guidance. This underscores the need for enhanced training and support systems to ensure the best care for children.",1.8948778188548325e-07,0.05833201745688488,0.09942137002692572,0.014507411718254981,0.0590264962043765,0.07318187122953174,0.014486412327622933,0.08577325425778692,0.029822485207100586,1.8948778188548325e-07,0.10820727146303799,0.01514792899408284
98,0.1,8,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Is the current training and support for suspected child abuse adequate for UK radiologists? The survey demonstrates notable dissatisfaction among consultant radiologists with the training and support they receive in suspected child abuse cases. Issues raised include lack of standardized training, insufficient resources, and inadequate ethical guidance. This highlights the urgent need for improved training and support to provide optimal care for children.",1.6580180914979784e-07,0.1022034395125031,0.002419620293486857,0.012693985253473108,0.09614853785948796,0.006312239892984545,0.012675610786670066,0.06896613594140621,0.029822485207100586,1.6580180914979784e-07,0.09111283810373827,0.01514792899408284
98,0.1,9,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","Are UK consultant radiologists satisfied with the training and support related to suspected child abuse? Survey results indicate significant dissatisfaction among consultant radiologists concerning the training and support for suspected child abuse. Problems include non-standardized training, inadequate resources, and insufficient ethical guidance. This emphasizes the importance of enhancing training and support systems to ensure the best care for children.",2.6054570009253947e-07,0.20321275066479805,0.032175149956332444,0.0199476911126006,0.16935753768070416,0.0003375771604938599,0.019918816950481533,0.1627142638769259,0.011971245537679094,2.6054570009253947e-07,0.1613170967769859,0.01514792899408284
98,0.1,10,ai,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? 

Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the training and support they receive when dealing with suspected child abuse cases.  Concerns include lack of standardized training, inadequate resources, and insufficient guidance on ethical considerations.  This highlights the need for improved training and support systems to ensure the best possible care for children. 
","How satisfied are UK radiologists with the training and support for suspected child abuse? The survey shows considerable dissatisfaction among consultant radiologists about the training and support they receive in suspected child abuse cases. Key concerns include the lack of standardized training, limited resources, and insufficient ethical guidance. This highlights the need for improved training and support to ensure optimal care for children.",1.6580180914979784e-07,0.1022034395125031,0.002419620293486857,0.012693985253473108,0.09614853785948796,0.006312239892984545,0.012675610786670066,0.09207104196007077,0.01316060643663233,1.6580180914979784e-07,0.09111283810373827,0.01514792899408284
99,0.1,1,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: Enhancing hospital efficiency by reducing the length of stay does not seem to lead to higher readmission rates or more physician visits within 30 days post-discharge. Further research is necessary to determine the ideal length of stay and anticipated readmission rates.,4.737194547137081e-08,0.06180783293894487,0.018773589446458537,0.0036268529295637453,0.062039761969391094,0.018511925952296185,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
99,0.1,2,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is early discharge from Winnipeg hospitals detrimental to care quality? Answer: Shortening hospital stays to improve efficiency does not appear to increase readmission rates or physician visits within 30 days after discharge. Additional studies are required to establish optimal stay durations and expected readmission figures.,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
99,0.1,3,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier discharge from Winnipeg hospitals compromise care quality? Answer: Reducing length of hospital stay to boost efficiency does not seem to cause more readmissions or physician visits within 30 days post-discharge. Research is needed to find the best length of stay and typical readmission rates.,2.6054570009253947e-07,0.22022575157898672,0.004190129755605947,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.1,4,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients sooner from Winnipeg hospitals affect care quality negatively? Answer: Improving hospital efficiency by shortening stays does not appear to raise readmission rates or physician visits within 30 days after discharge. Further investigation is needed to identify optimal stay lengths and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.1,5,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier patient discharge from Winnipeg hospitals harm quality of care? Answer: Making hospital stays shorter to improve efficiency does not seem to increase readmission or physician visit rates within 30 days post-discharge. Research is required to determine ideal lengths of stay and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.1,6,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is the quality of care affected by earlier discharge from Winnipeg hospitals? Answer: Enhancing hospital efficiency by reducing length of stay does not appear to increase readmission or physician visit rates within 30 days after discharge. More research is needed to identify optimal stay durations and expected readmission rates.,1.8948778188548325e-07,0.1269100160200658,0.01753826530612245,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.1,7,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier in Winnipeg hospitals lead to poorer care quality? Answer: Shortening hospital stays to improve efficiency does not seem to result in higher readmission or physician visit rates within 30 days post-discharge. Further research is necessary to determine optimal lengths of stay and expected readmission rates.,1.8948778188548325e-07,0.1269100160200658,0.01753826530612245,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,0.1,8,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does early discharge from Winnipeg hospitals adversely impact care quality? Answer: Reducing length of stay to enhance hospital efficiency does not appear to increase readmission or physician visits within 30 days after discharge. Additional research is needed to find optimal stay lengths and expected readmission rates.,2.6054570009253947e-07,0.19008891764159808,0.01753826530612245,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
99,0.1,9,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does releasing patients earlier from Winnipeg hospitals negatively affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not seem to cause increased readmission rates or physician visits within 30 days post-discharge. Research is needed to establish optimal stay durations and expected readmission rates.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,0.1,10,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does earlier discharge from Winnipeg hospitals have a negative effect on care quality? Answer: Enhancing hospital efficiency by reducing length of stay does not appear to lead to higher readmission or physician visit rates within 30 days after discharge. Further studies are required to identify optimal lengths of stay and expected readmission rates.,9.474389094274162e-08,0.07459489795819252,0.0013226814394396817,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
100,0.1,1,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Is there an initial night effect on sleep bruxism? The findings indicated no general first night effect on the severity of RMMA frequency. However, masseter EMG activity significantly increased on the first night, implying participants might have been more conscious of their sleep surroundings. Additional studies are required to explore the first night effect's influence on sleep bruxism.",1.8948778188548325e-07,0.08249096551111501,0.12210943798517719,0.014507411718254981,0.03363089761795912,0.12750928891431879,0.014486412327622933,0.0614819978713772,0.08083333333333335,1.8948778188548325e-07,0.11579075201114009,0.016124697661918846
100,0.1,2,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Does sleep bruxism exhibit a first night effect? Results revealed no overall first night impact on RMMA frequency severity. Yet, there was a notable rise in masseter EMG activity during the first night, suggesting heightened participant awareness of their sleep environment. More research is necessary to clarify the first night effect's role in sleep bruxism.",2.6054570009253947e-07,0.0773385983938768,0.13133665828506186,0.0199476911126006,0.0639354183524179,0.14536052858374027,0.019918816950481533,0.1175714645224204,0.08083333333333335,2.6054570009253947e-07,0.17294916585109021,0.016124697661918846
100,0.1,3,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Is there a first night effect in sleep bruxism? The study showed no overall first night effect on RMMA frequency severity. Nonetheless, masseter EMG activity increased significantly on the first night, indicating participants may have been more aware of their sleeping environment. Further investigation is needed to understand how the first night effect influences sleep bruxism.",2.3685972735685406e-07,0.11733729121965686,0.05591566635887957,0.018134264647818726,0.10627730137738123,0.06991674160149174,0.018108015409528666,0.0985232695517273,0.08083333333333335,2.3685972735685406e-07,0.15353107999398752,0.016124697661918846
100,0.1,4,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Does the first night effect influence sleep bruxism? Findings demonstrated no general first night effect on the severity of RMMA frequency. However, a significant increase in masseter EMG activity was observed on the first night, suggesting participants were more aware of their sleep setting. Further research is essential to comprehend the first night effect's impact on sleep bruxism.",1.8948778188548325e-07,0.10085054950285333,0.04367806543615757,0.014507411718254981,0.05838615406652892,0.1096952336591861,0.014486412327622933,0.0614819978713772,0.08083333333333335,1.8948778188548325e-07,0.11579075201114009,0.016124697661918846
100,0.1,5,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Is there a first night effect on sleep bruxism severity? The results showed no overall first night effect on RMMA frequency severity. However, masseter EMG activity significantly rose during the first night, implying participants might have been more conscious of their sleep environment. Additional research is needed to understand the first night effect's influence on sleep bruxism.",2.1317375462116866e-07,0.1121400759317237,0.08031566635887954,0.016320838183036854,0.07730485071279114,0.10904867383115928,0.0162972138685758,0.10550325433808982,0.06232140738103717,2.1317375462116866e-07,0.13448288502329442,0.016124697661918846
100,0.1,6,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Does sleep bruxism show a first night effect? The data indicated no overall first night effect on RMMA frequency severity. Yet, there was a significant increase in masseter EMG activity on the first night, suggesting participants were more aware of their sleep surroundings. Further studies are required to explore the first night effect's impact on sleep bruxism.",2.1317375462116866e-07,0.03787430658601565,0.13478003090142143,0.016320838183036854,0.026894146672067798,0.14536052858374027,0.0162972138685758,0.07983113653957297,0.08083333333333335,2.1317375462116866e-07,0.13448288502329442,0.016124697661918846
100,0.1,7,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Is there an effect of the first night on sleep bruxism? Results showed no overall first night effect on the severity of RMMA frequency. However, masseter EMG activity significantly increased during the first night, indicating participants may have been more aware of their sleep environment. More research is needed to understand the first night effect's role in sleep bruxism.",1.6580180914979784e-07,0.032823047679697126,0.08325448666066293,0.012693985253473108,0.015497017773846267,0.1278222632776178,0.012675610786670066,0.04346349236869873,0.08083333333333335,1.6580180914979784e-07,0.09744161334294432,0.016124697661918846
100,0.1,8,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Does the first night affect sleep bruxism? The findings revealed no overall first night effect on RMMA frequency severity. However, there was a significant rise in masseter EMG activity on the first night, suggesting participants might have been more conscious of their sleep environment. Further investigation is necessary to understand the first night effect on sleep bruxism.",2.1317375462116866e-07,0.12148379278466237,0.04031566635887954,0.016320838183036854,0.10251020273315303,0.09099662325829647,0.0162972138685758,0.10550325433808982,0.06232140738103717,2.1317375462116866e-07,0.13448288502329442,0.016124697661918846
100,0.1,9,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Is there a first night impact on sleep bruxism? The study found no overall first night effect on the severity of RMMA frequency. Nonetheless, masseter EMG activity increased significantly during the first night, implying participants were more aware of their sleep surroundings. Additional research is needed to clarify the first night effect's influence on sleep bruxism.",2.3685972735685406e-07,0.0826183365853943,0.11442008773527332,0.018134264647818726,0.04524328534026356,0.14536052858374027,0.018108015409528666,0.0985232695517273,0.08083333333333335,2.3685972735685406e-07,0.15353107999398752,0.016124697661918846
100,0.1,10,ai,"Question: Is there a first night effect on sleep bruxism? 
Answer: The results showed no overall first night effect on severity of RMMA frequ. However, there was a significant increase in masseter EMG activity during the first night, suggesting that participants may have been more aware of their sleep environment. Further research is needed to understand the impact of the first night effect on sleep bruxism. 
","Does the first night phenomenon affect sleep bruxism? Results indicated no overall first night effect on RMMA frequency severity. However, a significant increase in masseter EMG activity was observed on the first night, suggesting participants may have been more conscious of their sleep environment. Further studies are required to understand the first night effect's impact on sleep bruxism.",1.8948778188548325e-07,0.052208642095137314,0.08066824734855566,0.014507411718254981,0.03363089761795912,0.12750928891431879,0.014486412327622933,0.0614819978713772,0.08083333333333335,1.8948778188548325e-07,0.11579075201114009,0.016124697661918846
101,0.1,1,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Grandmultiparous women exhibited higher maternal and neonatal morbidity and neonatal mortality rates even after adjusting for confounding factors, indicating the necessity for more vigilant monitoring compared to regular multiparous patients during labor and delivery.",4.737194547137081e-08,0.0492007028305701,0.0011323696145124768,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
101,0.1,2,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Women with grandmultiparity showed elevated maternal and neonatal complications and neonatal death rates despite controlling for confounders, implying they require closer observation than typical multiparous women during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.1,3,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a standalone risk factor for poor perinatal outcomes? Grandmultiparous women experienced greater maternal and neonatal morbidity and neonatal mortality after accounting for confounders, suggesting the need for enhanced monitoring compared to standard multiparous patients during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.1,4,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Can grandmultiparity independently contribute to adverse perinatal outcomes? Even after adjusting for confounding variables, grandmultiparous women had increased maternal and neonatal morbidity and neonatal mortality, highlighting the importance of closer surveillance than that given to regular multiparous women during labor and delivery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.1,5,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent predictor of adverse perinatal outcomes? Grandmultiparous women showed increased rates of maternal and neonatal morbidity and neonatal mortality after controlling for confounders, indicating a requirement for more attentive observation than usual multiparous patients during labor and delivery.",2.3685972735685406e-08,0.025537914030078213,0.0006085634451019166,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,0.1,6,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently raise the risk of negative perinatal outcomes? After controlling for confounders, grandmultiparous women had higher maternal and neonatal morbidity and neonatal mortality, suggesting they need closer monitoring than regular multiparous women during labor and delivery.",9.474389094274131e-08,0.10630951163719482,0.002631172839506167,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
101,0.1,7,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for unfavorable perinatal outcomes? Grandmultiparous women demonstrated increased maternal and neonatal morbidity and neonatal mortality even after adjusting for confounders, pointing to the need for more careful observation than typical multiparous patients during labor and delivery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101,0.1,8,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently associated with adverse perinatal outcomes? Women with grandmultiparity had elevated maternal and neonatal morbidity and neonatal mortality rates despite controlling for confounders, indicating a need for closer monitoring than regular multiparous women during labor and delivery.",7.1057918207056e-08,0.07865527994541788,0.0019215668371073726,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
101,0.1,9,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a distinct risk factor for adverse perinatal outcomes? Grandmultiparous women experienced increased maternal and neonatal morbidity and neonatal mortality after accounting for confounders, suggesting the necessity for more vigilant observation than standard multiparous patients during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.001248268698060953,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,0.1,10,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently linked to adverse perinatal outcomes? Even after controlling for confounding factors, grandmultiparous women had higher maternal and neonatal morbidity and neonatal mortality, emphasizing the need for closer observation compared to regular multiparous women during labor and delivery.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
102,0.1,1,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are doctors adequately addressing the needs of family caregivers for the frail elderly? Several hypotheses explain this dissatisfaction. Physicians might lack interest in assisting caregivers; even if willing to counsel them, they may receive insufficient compensation for the typical counseling sessions caregivers require; and they might be acting as professional caregivers to family caregivers.",1.1842986367842703e-07,0.09240596745805885,0.0016248741078274467,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
102,0.1,2,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Do physicians fulfill the needs of family caregivers of frail elderly patients? Proposed reasons for this dissatisfaction include physicians possibly being uninterested in supporting caregivers; even if open to counseling, they might be poorly paid for the usual types of counseling sessions caregivers need; and they may serve as professional caregivers to family caregivers.",1.1842986367842703e-07,0.06624947007843796,0.017236072637734686,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
102,0.1,3,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are the needs of family caregivers of frail elderly individuals being met by physicians? Hypotheses for this dissatisfaction suggest that doctors may be uninterested in aiding caregivers; even if they are willing to counsel caregivers, they might be inadequately compensated for the typical counseling sessions; and they might function as professional caregivers to family caregivers.",9.474389094274162e-08,0.07322945486480048,0.0012758533145614988,0.0072537058591274906,0.07275935428242919,0.0,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
102,0.1,4,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Is the medical community meeting the needs of family caregivers for the frail elderly? The dissatisfaction may stem from physicians' lack of interest in helping caregivers; even if they are receptive to counseling, they could be poorly remunerated for the usual counseling sessions; and they might act as professional caregivers to family caregivers.",1.4211583641411244e-07,0.11195717199374444,0.001987302987025024,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
102,0.1,5,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians addressing the needs of family caregivers of frail elderly patients? The dissatisfaction could be due to physicians being uninterested in assisting caregivers; even if they are open to counseling, they may be underpaid for the typical counseling sessions caregivers require; and they might be professional caregivers to family caregivers.",1.8948778188548325e-07,0.12451837820241352,0.017236072637734686,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
102,0.1,6,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Do physicians meet the needs of family caregivers caring for the frail elderly? Hypotheses for this dissatisfaction include physicians possibly being uninterested in helping caregivers; even if they are willing to counsel, they might be poorly compensated for the usual counseling sessions; and they might serve as professional caregivers to family caregivers.",1.6580180914979784e-07,0.15908023565603324,0.021914281381424008,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
102,0.1,7,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are family caregivers of frail elderly individuals receiving adequate support from physicians? The dissatisfaction may be explained by physicians' lack of interest in helping caregivers; even if they are receptive to counseling, they might be poorly paid for the typical counseling sessions; and they might act as professional caregivers to family caregivers.",1.6580180914979784e-07,0.13189799328113327,0.00236392736226531,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
102,0.1,8,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are physicians fulfilling the needs of family caregivers of the frail elderly? Hypotheses for this discontent include physicians possibly being uninterested in assisting caregivers; even if they are open to counseling, they may be inadequately remunerated for the usual counseling sessions; and they might function as professional caregivers to family caregivers.",1.8948778188548325e-07,0.12451837820241352,0.017236072637734686,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
102,0.1,9,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Are the needs of family caregivers for frail elderly patients being met by physicians? The dissatisfaction might be due to physicians' lack of interest in helping caregivers; even if they are willing to counsel caregivers, they could be poorly compensated for the typical counseling sessions; and they might be professional caregivers to family caregivers.",1.1842986367842703e-07,0.09240596745805885,0.0016248741078274467,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
102,0.1,10,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Do physicians adequately support family caregivers of the frail elderly? Hypotheses for this dissatisfaction suggest physicians may be uninterested in assisting caregivers; even if they are receptive to counseling, they might be underpaid for the usual counseling sessions; and they might serve as professional caregivers to family caregivers.",2.6054570009253947e-07,0.21588940662517953,0.004030468004987419,0.0199476911126006,0.21440987134545564,0.0,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
103,0.1,1,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgery might enhance blood lipid profiles in OSA patients, particularly those who are obese or have metabolic syndrome. Nonetheless, additional studies are required to verify this link and understand the underlying mechanisms.",4.737194547137081e-08,0.015821905303945005,0.043388429752066124,0.0036268529295637453,0.014655832718537543,0.02221074380165289,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
103,0.1,2,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Can airway surgery decrease serum lipid levels in obstructive sleep apnea sufferers? Surgical intervention may improve lipid levels in the blood of OSA patients, especially among individuals with obesity or metabolic syndrome. However, more research is necessary to confirm this relationship and clarify the mechanisms involved.",2.3685972735685406e-08,0.023318321560436672,0.0009598666243535586,0.0018134264647818726,0.023173004519290608,0.0005042372691962185,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
103,0.1,3,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Is there a reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients? Airway surgery could potentially improve blood lipid levels in patients with OSA, notably those with obesity or metabolic syndrome. Further investigation is needed to substantiate this connection and elucidate the exact processes.",2.3685972735685406e-08,0.022788623686384124,0.0009192939495969929,0.0018134264647818726,0.0527854480769947,0.02221074380165289,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
103,0.1,4,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Does performing airway surgery lower serum lipid concentrations in patients with obstructive sleep apnea? Surgery may lead to better blood lipid levels in OSA patients, particularly those who are obese or have metabolic syndrome. Still, more research is essential to confirm this association and identify the mechanisms at play.",4.737194547137081e-08,0.10283328229357425,0.043388429752066124,0.0036268529295637453,0.07429165329795806,0.02221074380165289,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
103,0.1,5,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Can airway surgery help reduce serum lipid levels in obstructive sleep apnea patients? It is possible that surgery improves lipid profiles in OSA patients, especially those with obesity or metabolic syndrome. However, further studies are required to confirm this and understand the mechanisms involved.",7.105791820705622e-08,0.007167612920754518,0.043388429752066124,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
103,0.1,6,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Is airway surgery effective in lowering serum lipid levels in patients with obstructive sleep apnea? Surgery might improve blood lipid levels in OSA patients, particularly in those with obesity or metabolic syndrome. Yet, additional research is needed to confirm this effect and determine the underlying mechanisms.",2.3685972735685406e-08,0.023318321560436672,0.0009598666243535586,0.0018134264647818726,0.023173004519290608,0.0005042372691962185,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
103,0.1,7,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Does airway surgery have an impact on serum lipid levels in obstructive sleep apnea patients? Surgical treatment may enhance blood lipid levels in patients with OSA, especially those suffering from obesity or metabolic syndrome. More research is necessary to confirm this and explore the mechanisms involved.",2.3685972735685406e-08,0.023318321560436672,0.0009598666243535586,0.0018134264647818726,0.023173004519290608,0.0005042372691962185,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
103,0.1,8,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Can serum lipid levels be reduced by airway surgery in obstructive sleep apnea patients? Surgery may improve lipid levels in the blood of OSA patients, particularly those with obesity or metabolic syndrome. However, further research is needed to verify this association and understand the mechanisms.",4.737194547137081e-08,0.015684784721507583,0.020673448681217014,0.0036268529295637453,0.014655832718537543,0.02221074380165289,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
103,0.1,9,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Is there evidence that airway surgery lowers serum lipid levels in obstructive sleep apnea patients? Surgery could improve blood lipid profiles in OSA patients, especially those with obesity or metabolic syndrome. Nonetheless, more studies are required to confirm this link and clarify the mechanisms.",7.105791820705622e-08,0.007167612920754518,0.043388429752066124,0.005440279394345618,0.03818633012873196,0.02221074380165289,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
103,0.1,10,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in those with  obesity or metabolic syndrome.  However, further research is needed to confirm this association and determine the exact mechanisms involved. 
","Does airway surgery contribute to lowering serum lipid levels in patients with obstructive sleep apnea? Surgical intervention may improve lipid levels in OSA patients, particularly those with obesity or metabolic syndrome. Further research is needed to confirm this relationship and determine the exact mechanisms involved.",4.737194547137081e-08,0.04719147474695973,0.00196304417083637,0.0036268529295637453,0.04689523646551175,0.0010318865838346326,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
104,0.1,1,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Does the use of audits to identify maternal mortality vary only between wealthy and poor settings? Answer: The effectiveness of audits in identifying maternal mortality is greatly affected by differences in healthcare infrastructure, resource availability, and cultural factors. Wealthier areas tend to have strong data collection systems, whereas poorer regions often face challenges with data accuracy and access, limiting audit effectiveness.",7.105791820705622e-08,0.0718006439289427,0.01712814675701641,0.005440279394345618,0.04879016416943571,0.0,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
104,0.1,2,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the difference in using audits to detect maternal mortality solely a matter of wealth disparity? Answer: Variations in healthcare infrastructure, resource availability, and cultural influences play a crucial role in how well audits identify maternal mortality. Richer settings usually have reliable data systems, while poorer ones often encounter difficulties with data accuracy and accessibility, which hampers audit success.",1.1842986367842703e-07,0.059684790061456106,0.015621063240110858,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
104,0.1,3,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: When using audits to identify maternal mortality, is the main difference between rich and poor settings? Answer: The success of audits in detecting maternal mortality depends heavily on healthcare infrastructure, resource availability, and cultural factors. Wealthier environments often possess comprehensive data collection, whereas poorer settings struggle with data quality and access, affecting audit outcomes.",2.3685972735685406e-07,0.1482381874028995,0.015621063240110858,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
104,0.1,4,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Does the use of audits for maternal mortality identification differ only between affluent and impoverished areas? Answer: The impact of audits on identifying maternal mortality is influenced by disparities in healthcare infrastructure, resource availability, and cultural contexts. Wealthier regions typically have robust data systems, while poorer areas face challenges in data accuracy and accessibility, limiting audit effectiveness.",1.6580180914979784e-07,0.14281287354034067,0.019420259073938746,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
104,0.1,5,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the disparity in maternal mortality audits simply a reflection of economic differences? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly affect the ability of audits to identify maternal mortality. Wealthier settings often maintain strong data collection mechanisms, whereas poorer settings struggle with data accuracy and access, hindering audit implementation.",2.6054570009253947e-07,0.16693032041505385,0.015621063240110858,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
104,0.1,6,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Are audits for identifying maternal mortality only different between rich and poor settings? Answer: The effectiveness of maternal mortality audits is shaped by variations in healthcare infrastructure, resource availability, and cultural influences. Wealthier settings generally have reliable data systems, while poorer ones face challenges with data accuracy and accessibility, reducing audit effectiveness.",2.8423167282822487e-07,0.21263802233036033,0.0036023123846488526,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
104,0.1,7,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the use of audits to detect maternal mortality just a matter of economic status? Answer: The ability of audits to identify maternal mortality is greatly influenced by differences in healthcare infrastructure, resource availability, and cultural factors. Wealthier areas tend to have strong data collection systems, whereas poorer areas often struggle with data quality and access, limiting audit success.",1.1842986367842703e-07,0.13017433384721322,0.03508046737213404,0.009067132323909363,0.1065933427609762,0.017236072637734686,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
104,0.1,8,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Does the identification of maternal mortality through audits differ only due to wealth disparities? Answer: The effectiveness of audits in identifying maternal mortality is affected by healthcare infrastructure, resource availability, and cultural factors. Wealthier settings usually have robust data systems, while poorer settings often face challenges with data accuracy and accessibility, hindering audit implementation.",2.3685972735685406e-07,0.17391030520141637,0.002890862712185324,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
104,0.1,9,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the difference in maternal mortality audit outcomes solely between rich and poor regions? Answer: Variations in healthcare infrastructure, resource availability, and cultural factors significantly influence audit effectiveness. Wealthier regions typically have comprehensive data collection, whereas poorer regions struggle with data accuracy and access, limiting audit success.",4.026615365066519e-07,0.28707463225711694,0.015621063240110858,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
104,0.1,10,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in healthcare infrastructure, resource availability, and cultural factors significantly influence the effectiveness of audit in identifying maternal mortality. While wealthier settings may have robust data collection systems, poorer settings often struggle with data accuracy and accessibility, hindering effective audit implementation. 
","Question: Is the use of audit to identify maternal mortality merely a contrast between wealthy and poor settings? Answer: The success of audits in identifying maternal mortality depends on healthcare infrastructure, resource availability, and cultural factors. Wealthier settings often have strong data collection systems, while poorer settings face challenges with data accuracy and accessibility, affecting audit implementation.",1.8948778188548325e-07,0.13662579968059507,0.0022301764293106343,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
105,0.1,1,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","What causes gender differences after injury and hemorrhagic shock: are hormones the key factor? The protective advantage of females has been repeatedly seen in both lab and clinical research. Although hormones might influence this, newer studies indicate that immune system responses and tissue healing processes are also crucial in this gender-based resilience.",1.4211583641411244e-07,0.08690468140636742,0.017538265306122455,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
105,0.1,2,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Are hormonal variations responsible for gender dimorphism following injury and hemorrhagic shock? Female gender's protective effect has been consistently documented in experimental and clinical settings. Besides hormones, recent findings highlight the importance of immune responses and tissue repair in this gender-specific protection.",3.789755637709665e-07,0.30515824742638475,0.017538265306122455,0.029014823436509962,0.3364722366212134,0.0,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
105,0.1,3,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Is the gender dimorphism observed after injury and hemorrhagic shock due to hormonal differences? The female gender's independent protective effect is well-established in preclinical and clinical studies. However, recent research points to immune function and tissue regeneration as significant contributors to this gender-related resilience.",3.316036182995957e-07,0.2575301984371303,0.017538265306122455,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
105,0.1,4,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Does hormonal disparity explain the gender dimorphism seen after injury and hemorrhagic shock? Female gender consistently shows protective effects in both preclinical and clinical studies. While hormones may play a role, recent evidence suggests immune responses and tissue repair mechanisms are also key factors.",3.316036182995957e-07,0.2575301984371303,0.017538265306122455,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
105,0.1,5,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
",Are hormonal differences the cause of gender dimorphism following injury and hemorrhagic shock? The protective effect of being female has been reliably observed in research. Recent studies propose that immune system activity and tissue repair also significantly contribute to this gender-specific protection.,3.789755637709665e-07,0.30515824742638475,0.017538265306122455,0.029014823436509962,0.3364722366212134,0.0,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
105,0.1,6,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Is the gender dimorphism after injury and hemorrhagic shock attributable to hormonal differences? Female gender's protective effect has been consistently noted in clinical and preclinical research. Beyond hormones, immune response and tissue repair mechanisms are important in this gender-specific resilience.",4.263475092423372e-07,0.3551686680010482,0.017538265306122455,0.03264167636607371,0.3877655310087631,0.0,0.0325944277371516,0.3964152725882455,0.0,4.263475092423373e-07,0.40546510810816505,0.0
105,0.1,7,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
",Are hormonal factors responsible for the gender dimorphism seen after injury and hemorrhagic shock? The female gender's protective effect is well-documented in both clinical and preclinical studies. Recent research suggests that immune responses and tissue repair also play vital roles.,4.263475092423372e-07,0.3551686680010482,0.017538265306122455,0.03264167636607371,0.3877655310087631,0.0,0.0325944277371516,0.3964152725882455,0.0,4.263475092423373e-07,0.40546510810816505,0.0
105,0.1,8,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Do hormonal differences explain the gender dimorphism observed after injury and hemorrhagic shock? Female gender consistently exhibits protective effects in studies. However, recent findings indicate that immune response and tissue repair mechanisms significantly contribute to this resilience.",4.974054274493931e-07,0.43521137567458235,0.017538265306122455,0.038081955760419325,0.47000362924573613,0.0,0.038026832360010206,0.48097266061630917,0.0,4.974054274493935e-07,0.4924764850977952,0.0
105,0.1,9,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
",Is hormonal variation the reason for gender dimorphism following injury and hemorrhagic shock? The protective effect of female gender has been repeatedly observed in clinical and preclinical studies. Recent research highlights the role of immune response and tissue repair in this gender-specific advantage.,3.552895910352811e-07,0.28106069584732474,0.017538265306122455,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
105,0.1,10,ai,"Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? 
Answer: The independent protective effect of female gender has been consistently observed in preclinical and clinical studies. While hormonal differences may contribute, recent research suggests that other factors, including immune response and tissue repair mechanisms, play a significant role in this gender-specific resilience. 
","Are hormonal differences responsible for the gender dimorphism after injury and hemorrhagic shock? Female gender's protective effect is consistently seen in preclinical and clinical studies. Nonetheless, recent research points to immune response and tissue repair as important factors in this gender-specific resilience.",3.789755637709665e-07,0.30515824742638475,0.017538265306122455,0.029014823436509962,0.3364722366212134,0.0,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
106,0.1,1,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the impact of MPH programs on strengthening health systems in low- and middle-income countries? The programs had a significant effect at multiple levels; graduates were seen as valuable contributors to their workplaces and frequently held influence nationally. The impact largely aligned with the goals of public health education. The qualitative study provided deeper insights into the graduates' influence.,1.8948778188548325e-07,0.1506516900804984,0.01694411414982164,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.1,2,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs contribute to health system strengthening in low- and middle-income countries? There was notable impact across various levels; graduates were recognized for their substantial contributions at work and often influenced national policies. Much of the observed impact matched the objectives of public health education. The qualitative research offered a more detailed understanding of graduates' effects.,2.3685972735685406e-07,0.16164135155641457,0.0,0.018134264647818726,0.16430305129127465,0.0,0.018108015409528666,0.16705408466316563,0.0,2.3685972735685406e-07,0.16989903679539609,0.0
106,0.1,3,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the role of MPH programs in enhancing health systems in low- and middle-income countries? The impact was significant on many fronts; graduates were perceived as key contributors to their workplaces and frequently had national-level influence. The described impact corresponded closely with public health education goals. The qualitative study revealed deeper insights into the graduates' impact.,2.6054570009253947e-07,0.1793409286558152,0.0,0.0199476911126006,0.18232155679395312,0.0,0.019918816950481533,0.1854032233313614,0.0,2.6054570009253947e-07,0.18859116980755042,0.0
106,0.1,4,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs affect health system strengthening in low- and middle-income countries? There was considerable influence at multiple levels; graduates were viewed as important contributors to their workplaces and often had national influence. Much of the impact aligned with public health educational aims. The qualitative method study provided a more in-depth understanding of graduates' impact.,2.8423167282822487e-07,0.19735943415849366,0.0,0.02176111757738247,0.20067069546214888,0.0,0.0217296184914344,0.20409535634351572,0.0,2.8423167282822487e-07,0.20763936477824352,0.0
106,0.1,5,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What impact do MPH programs have on health system strengthening in low- and middle-income countries? The programs showed significant effects at various levels; graduates were seen as able to contribute meaningfully to their workplaces and often influenced national health policies. The impact described was consistent with public health education goals. The qualitative study offered deeper insights into the graduates' contributions.,1.8948778188548325e-07,0.12715517548524602,0.0,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
106,0.1,6,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How significant is the impact of MPH programs on health system strengthening in low- and middle-income countries? There was a notable impact at many levels; graduates were perceived as significant contributors to their workplaces and often had influence at the national level. Much of the impact aligned with the aims of public health education. The qualitative study revealed a deeper understanding of graduates' impact.,9.474389094274162e-08,0.08356256539815732,0.01586888657648284,0.0072537058591274906,0.06252035698133263,0.0,0.007243206163811466,0.06351340572232633,0.0,9.474389094274162e-08,0.06453852113757197,0.0
106,0.1,7,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What contributions do MPH programs make to health system strengthening in low- and middle-income countries? The impact was considerable across multiple levels; graduates were recognized for their ability to contribute significantly to their workplaces and often had national influence. The impact described matched public health educational objectives. The qualitative method study provided deeper insights into graduates' impact.,2.6054570009253947e-07,0.204096185104385,0.017851239669421492,0.0199476911126006,0.18232155679395312,0.0,0.019918816950481533,0.1854032233313614,0.0,2.6054570009253947e-07,0.18859116980755042,0.0
106,0.1,8,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs influence health system strengthening in low- and middle-income countries? There was substantial impact at various levels; graduates were seen as valuable contributors to their workplaces and often held influence nationally. Much of the impact was consistent with public health education goals. The qualitative study revealed more detailed understanding of graduates' impact.,3.079176455639103e-07,0.21570857282668943,0.0,0.023574544042164344,0.21936282847430322,0.0,0.023540420032387266,0.22314355131420882,0.0,3.079176455639103e-07,0.22705745063534621,0.0
106,0.1,9,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the effect of MPH programs on health system strengthening in low- and middle-income countries? The programs had a considerable impact at many levels; graduates were perceived as able to contribute significantly to their workplaces and often influenced national health systems. The impact described aligned with public health educational aims. The qualitative method study provided deeper insights into graduates' impact.,1.6580180914979784e-07,0.11034805716886531,0.0,0.012693985253473108,0.11211729812070548,0.0,0.012675610786670066,0.1139442593492177,0.0,1.6580180914979784e-07,0.11583181552512123,0.0
106,0.1,10,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs contribute to strengthening health systems in low- and middle-income countries? There was significant impact at multiple levels; graduates were recognized for their substantial contributions to their workplaces and often had influence at the national level. Much of the impact corresponded with public health education goals. The qualitative study revealed a more in-depth understanding of graduates' impact.,1.8948778188548325e-07,0.12715517548524602,0.0,0.014507411718254981,0.1292117314800052,0.0,0.014486412327622933,0.13133600206108653,0.0,1.8948778188548325e-07,0.13353139262452185,0.0
107,0.1,1,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can neoadjuvant chemotherapy alter the scope of lymphadenectomy in cervical cancer? The occurrence and location of lymph node metastases remain unchanged by NACT, with clinical non-responders exhibiting more affected lymph nodes. Therefore, a thorough and systemic lymphadenectomy is recommended for patients undergoing NACT followed by surgery.",9.474389094274162e-08,0.0568660866847992,0.020399305555555556,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
107,0.1,2,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is it possible to adjust the extent of lymphadenectomy based on neoadjuvant chemotherapy in cervical cancer? Neoadjuvant chemotherapy does not change the frequency or distribution of lymph node metastases, and patients who do not respond clinically have more involved lymph nodes. Hence, an extensive systemic lymphadenectomy should be carried out in patients treated with NACT plus surgery.",1.6580180914979784e-07,0.13706785783146103,0.002548065886134064,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
107,0.1,3,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Does neoadjuvant chemotherapy influence the extent of lymphadenectomy in cervical cancer cases? The rate and anatomical spread of lymph node metastases are not altered by NACT, and clinical non-responders tend to have more lymph nodes involved. Consequently, patients receiving NACT and surgery should undergo a comprehensive systemic lymphadenectomy.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
107,0.1,4,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can the range of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? The frequency and distribution of lymph node metastases are unaffected by NACT, with clinical non-responders showing a higher number of involved lymph nodes. Thus, a systemic and extensive lymphadenectomy is advised for patients treated with NACT plus surgery.",2.3685972735685406e-08,0.04849442897302669,0.020399305555555556,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
107,0.1,5,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is the extent of lymphadenectomy in cervical cancer modifiable by neoadjuvant chemotherapy? NACT does not impact the frequency or topographic distribution of lymph node metastases, and clinical non-responders have more involved lymph nodes. Therefore, a systemic and thorough lymphadenectomy should be performed in patients undergoing NACT followed by surgery.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
107,0.1,6,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Could neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer? The occurrence and anatomical distribution of lymph node metastases remain the same after NACT, with clinical non-responders having more involved lymph nodes. Hence, a systemic and extensive lymphadenectomy is necessary for patients treated with NACT plus surgery.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
107,0.1,7,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is it feasible to modify the extent of lymphadenectomy through neoadjuvant chemotherapy in cervical cancer? The frequency and location of lymph node metastases are not altered by NACT, and clinical non-responders present with more involved lymph nodes. Therefore, a comprehensive systemic lymphadenectomy should be conducted in patients receiving NACT and surgery.",2.3685972735685406e-08,0.04849442897302669,0.020399305555555556,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
107,0.1,8,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can neoadjuvant chemotherapy affect the extent of lymphadenectomy in cervical cancer? The frequency and topographic distribution of lymph node metastases do not change with NACT, and clinical non-responders have a higher number of involved lymph nodes. Thus, patients treated with NACT plus surgery require a systemic and extensive lymphadenectomy.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
107,0.1,9,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is it possible for neoadjuvant chemotherapy to modify lymphadenectomy extent in cervical cancer? NACT does not modify the frequency or distribution of lymph node metastases, and clinical non-responders show more involved lymph nodes. Consequently, a systemic and thorough lymphadenectomy should be performed in patients treated with NACT and surgery.",2.3685972735685406e-08,0.007672434452772325,0.020399305555555556,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
107,0.1,10,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Could the scope of lymphadenectomy be altered by neoadjuvant chemotherapy in cervical cancer? The frequency and anatomical distribution of lymph node metastases remain unchanged by NACT, with clinical non-responders exhibiting more involved lymph nodes. Therefore, a systemic and extensive lymphadenectomy is recommended for patients undergoing NACT plus surgery.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
108,0.1,1,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
","Are doctors adequately addressing the needs of family caregivers for the frail elderly? Possible reasons for dissatisfaction are discussed. Physicians might be indifferent or too busy to handle the complex demands of caregivers. Additionally, insufficient training in geriatrics or caregiving support could be factors.",4.737194547137081e-08,0.014655832718537543,0.02221074380165289,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
108,0.1,2,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Do physicians fulfill the requirements of family caregivers of frail elderly patients? Theories explaining this dissatisfaction are offered. Doctors may show disinterest or have limited time for the intricate needs of caregivers. A lack of education in geriatrics or caregiving assistance might also play a role.,0.0,0.030806541358219697,0.02221074380165289,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
108,0.1,3,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are medical professionals meeting the expectations of family caregivers for the frail elderly? Hypotheses for this dissatisfaction are explored. Physicians may be uninterested or lack sufficient time to address caregivers' complex needs. Inadequate training in geriatrics or caregiving support may also be contributing factors.,4.737194547137081e-08,0.014655832718537543,0.02221074380165289,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
108,0.1,4,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are physicians adequately supporting family caregivers of frail elderly individuals? Possible explanations for this dissatisfaction are presented. Doctors may be uninterested or too pressed for time to meet caregivers' complex needs. A deficiency in geriatrics or caregiving training might also be involved.,9.474389094274162e-08,0.06228388170779198,0.02221074380165289,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
108,0.1,5,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Do physicians meet the needs of family caregivers caring for frail elderly patients? Hypotheses for this dissatisfaction are provided. Physicians may lack interest or time to address the complex needs of caregivers. Insufficient training in geriatrics or caregiving support may also contribute.,9.474389094274162e-08,0.09609593929608184,0.0021642561983471094,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
108,0.1,6,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are doctors addressing the needs of family caregivers of frail elderly patients? Theories for this dissatisfaction are outlined. Physicians might be uninterested or too busy to manage the complex needs of caregivers. Lack of training in geriatrics or caregiving support could also be a factor.,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
108,0.1,7,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are physicians fulfilling the needs of family caregivers for the frail elderly? Hypotheses explaining this dissatisfaction are given. Doctors may be uninterested or lack time to handle caregivers' complex needs. A lack of geriatrics or caregiving training may also contribute.,1.4211583641411233e-07,0.1122943022824554,0.02221074380165289,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
108,0.1,8,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are medical practitioners meeting the needs of family caregivers of frail elderly individuals? Possible reasons for this dissatisfaction are discussed. Physicians may be uninterested or too busy to address the complex needs of caregivers. Lack of training in geriatrics or caregiving support might also be a factor.,2.3685972735685406e-08,0.02264861413960606,0.0004823487399244937,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
108,0.1,9,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are physicians adequately responding to the needs of family caregivers of the frail elderly? Hypotheses for this dissatisfaction are presented. Doctors may be uninterested or lack the time to meet caregivers' complex needs. Insufficient training in geriatrics or caregiving support may also play a role.,2.3685972735685406e-08,0.00833368550616198,0.02221074380165289,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
108,0.1,10,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in, or lack the time for, the complex needs of caregivers. Lack of training in geriatrics or caregiving support may also contribute. 
",Are doctors meeting the needs of family caregivers for frail elderly patients? Possible explanations for this dissatisfaction are offered. Physicians may be uninterested or lack time to address the complex needs of caregivers. A lack of training in geriatrics or caregiving support may also contribute.,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
109,0.1,1,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Is neck pain linked to poorer health-related quality of life six months later? Our findings indicate that neck pain negatively impacts physical health-related quality of life but does not affect mental health-related quality of life. This suggests that neck pain could be a factor in future declines in physical HRQoL within the population.,1.1842986367842703e-07,0.01325189354728229,0.1542424093434468,0.009067132323909363,0.014332333148224574,0.09868808298263564,0.009054007704764333,0.0776346284354279,0.019991670137442734,1.1842986367842703e-07,0.107630664192365,0.0
109,0.1,2,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Does neck pain correlate with a decline in health-related quality of life after six months? We observed that neck pain was associated with worse physical HRQoL but had no significant effect on mental HRQoL. This implies that neck pain might contribute to poorer physical health outcomes over time.,0.0,0.02949562470467848,0.021893954292916906,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
109,0.1,3,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is there an association between neck pain and reduced health-related quality of life six months afterward? Our study found that neck pain adversely affects physical HRQoL but not mental HRQoL, indicating that neck pain may lead to future physical health quality declines in the population.",7.105791820705622e-08,0.04325460308778206,0.014284294065091074,0.005440279394345618,0.06954385060511781,0.0015142353237591263,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
109,0.1,4,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does experiencing neck pain predict worse health-related quality of life six months later? The results show a negative relationship between neck pain and physical HRQoL, while mental HRQoL remains unaffected, suggesting neck pain as a potential cause of future physical health deterioration.",1.4211583641411244e-07,0.08784636198249851,0.030947303818294344,0.010880558788691236,0.10962510843776974,0.021728395061728398,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
109,0.1,5,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain connected to diminished health-related quality of life half a year later? We discovered that neck pain is linked to poorer physical HRQoL but does not influence mental HRQoL, pointing to neck pain as a possible contributor to future physical health challenges.",9.474389094274162e-08,0.036479416945593535,0.03570011797942779,0.0072537058591274906,0.06083494426833802,0.021728395061728398,0.007243206163811466,0.09309042306601167,0.0,9.474389094274162e-08,0.09531017980432566,0.0
109,0.1,6,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Can neck pain be associated with lower health-related quality of life six months down the line? Our analysis reveals that neck pain negatively impacts physical HRQoL but not mental HRQoL, suggesting it may contribute to future physical health quality issues.",1.8948778188548314e-07,0.09301652679215033,0.10525828890064107,0.014507411718254981,0.16091840282531944,0.021728395061728398,0.014486412327622933,0.19574457712609394,0.0,1.8948778188548325e-07,0.20067069546215155,0.0
109,0.1,7,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain related to worse health-related quality of life after six months? Findings indicate neck pain is negatively associated with physical HRQoL but shows no effect on mental HRQoL, implying neck pain could be a factor in future physical health decline.",1.4211583641411244e-07,0.08784636198249851,0.030947303818294344,0.010880558788691236,0.10962510843776974,0.021728395061728398,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
109,0.1,8,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does neck pain affect health-related quality of life six months later? We found a negative association between neck pain and physical HRQoL, with no impact on mental HRQoL, suggesting neck pain may contribute to future physical health problems.",2.3685972735685374e-07,0.1991909230722575,0.019861149435436695,0.018134264647818726,0.21498562409559563,0.021728395061728398,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
109,0.1,9,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is there a link between neck pain and poorer health-related quality of life six months later? Our data show neck pain adversely affects physical HRQoL but not mental HRQoL, indicating it may be a factor in future physical health deterioration.",1.8948778188548314e-07,0.09301652679215033,0.10525828890064107,0.014507411718254981,0.16091840282531944,0.021728395061728398,0.014486412327622933,0.19574457712609394,0.0,1.8948778188548325e-07,0.20067069546215155,0.0
109,0.1,10,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain associated with a decline in health-related quality of life six months later? The study found neck pain negatively influences physical HRQoL but not mental HRQoL, suggesting it could contribute to future physical health quality issues.",2.3685972735685374e-07,0.14758166618348767,0.10387538475919585,0.018134264647818726,0.21498562409559563,0.021728395061728398,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
110,0.1,1,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,What is the clinical importance of bile duct sludge compared to bile duct stones? The results suggest that symptomatic bile duct sludge (BDS) has clinical significance comparable to common bile duct (CBD) stones. Bile duct sludge appears to represent an initial phase of choledocholithiasis.,0.0,0.09042573206536808,0.34734646677822545,0.0,0.01245828913725111,0.04999999999999999,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,0.1,2,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,How does the clinical relevance of bile duct sludge differ from bile duct stones? Findings show that symptomatic BDS shares similar clinical significance with CBD stones. Bile duct sludge likely constitutes an early stage in the development of choledocholithiasis.,1.1842986367842682e-07,0.07346235541057267,0.03138730284357505,0.009067132323909363,0.09820510360836066,0.02049382716049385,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
110,0.1,3,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Is the clinical significance of bile duct sludge distinct from that of bile duct stones? Evidence indicates that symptomatic BDS has clinical implications akin to those of CBD stones. Bile duct sludge may be an early form of choledocholithiasis.,1.1842986367842682e-07,0.10994378596635945,0.00426774913974054,0.009067132323909363,0.13567251877376396,0.006377551020408163,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
110,0.1,4,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,What is the difference in clinical significance between bile duct sludge and bile duct stones? The data reveal that symptomatic BDS is clinically similar to CBD stones. Bile duct sludge seems to be an initial stage of choledocholithiasis.,1.4211583641411212e-07,0.10346071005114421,0.02762415052382361,0.010880558788691236,0.1266448393288484,0.019744897959183685,0.0108648092457172,0.12441194762660457,0.024375,1.4211583641411244e-07,0.16251892949777424,0.0
110,0.1,5,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Does bile duct sludge have a different clinical significance than bile duct stones? The findings demonstrate that symptomatic BDS is clinically comparable to CBD stones. Bile duct sludge appears to represent an early phase of choledocholithiasis.,1.8948778188548272e-07,0.16626165190421638,0.01943656942520769,0.014507411718254988,0.18606844003337164,0.018115243342516078,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
110,0.1,6,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,How significant is bile duct sludge clinically compared to bile duct stones? The study indicates that symptomatic BDS has a clinical significance similar to that of CBD stones. Bile duct sludge seems to be an early stage in choledocholithiasis development.,9.474389094274152e-08,0.044327536195488904,0.034953062480763186,0.0072537058591274906,0.07055087191658371,0.02120343316289264,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
110,0.1,7,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,What clinical importance does bile duct sludge hold relative to bile duct stones? Results suggest symptomatic BDS shares clinical significance with CBD stones. Bile duct sludge may be an early stage of choledocholithiasis.,2.605457000925386e-07,0.26841523352370134,0.005185259600594155,0.019947691112600627,0.2823875695413882,0.015277777777777814,0.019918816950481567,0.27856262745386307,0.024375,2.6054570009253947e-07,0.321583624127463,0.0
110,0.1,8,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Is there a clinical difference between bile duct sludge and bile duct stones? Findings indicate symptomatic BDS has clinical significance comparable to CBD stones. Bile duct sludge appears to be an early stage of choledocholithiasis.,2.1317375462116802e-07,0.19918375283387446,0.014972428881503186,0.016320838183036868,0.21715695965463944,0.017226562500000014,0.01629721386857582,0.21402410631629154,0.024375,2.1317375462116866e-07,0.25489224962878954,0.0
110,0.1,9,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,How does the clinical impact of bile duct sludge compare to bile duct stones? The evidence shows symptomatic BDS is clinically similar to CBD stones. Bile duct sludge seems to be an initial phase of choledocholithiasis.,1.8948778188548272e-07,0.16626165190421638,0.01943656942520769,0.014507411718254988,0.18606844003337164,0.018115243342516078,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
110,0.1,10,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,What is the clinical relevance of bile duct sludge versus bile duct stones? The findings reveal that symptomatic BDS has clinical significance akin to CBD stones. Bile duct sludge likely represents an early stage of choledocholithiasis.,1.8948778188548272e-07,0.16626165190421638,0.01943656942520769,0.014507411718254988,0.18606844003337164,0.018115243342516078,0.014486412327622947,0.18325244764953785,0.024375,1.8948778188548325e-07,0.2231435513142097,0.0
111,0.1,1,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Does a previous benign prostate biopsy influence the outcomes for patients receiving radical perineal prostatectomy?,1.0421828003701555e-06,1.3257791732677195,0.06858710562414265,0.07979076445040253,1.429460002965297,0.035041322314049606,0.07967526780192628,1.515689784498579,0.017851239669421492,1.0421828003701574e-06,1.6094379124341005,0.0
111,0.1,2,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Can a history of benign prostate biopsy predict the results of radical perineal prostatectomy in patients?,1.0184968276344701e-06,1.2567863017807674,0.06858710562414265,0.07797733798562065,1.3553520308115758,0.035041322314049606,0.07786446626097342,1.4356470768250427,0.017851239669421492,1.018496827634472e-06,1.5224265354444704,0.0
111,0.1,3,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Is there a predictive relationship between prior benign prostate biopsy and outcomes after radical perineal prostatectomy?,1.0184968276344701e-06,1.2567863017807674,0.06858710562414265,0.07797733798562065,1.3553520308115758,0.035041322314049606,0.07786446626097342,1.4356470768250427,0.017851239669421492,1.018496827634472e-06,1.5224265354444704,0.0
111,0.1,4,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Does having a prior benign prostate biopsy affect the prognosis for patients treated with radical perineal prostatectomy?,9.948108548987847e-07,1.1922477806431968,0.06858710562414265,0.07616391152083878,1.2863591593246237,0.035041322314049606,0.07605366472002054,1.3615391046713214,0.017851239669421492,9.948108548987866e-07,1.442383827770934,0.0
111,0.1,5,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Can prior benign prostate biopsy serve as a predictor for surgical outcomes in radical perineal prostatectomy patients?,9.948108548987847e-07,1.1922477806431968,0.06858710562414265,0.07616391152083878,1.2863591593246237,0.035041322314049606,0.07605366472002054,1.3615391046713214,0.017851239669421492,9.948108548987866e-07,1.442383827770934,0.0
111,0.1,6,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Is the outcome of radical perineal prostatectomy influenced by a previous benign prostate biopsy?,1.065868773105841e-06,1.3998871454214408,0.06858710562414265,0.08160419091518441,1.5095027106388335,0.035041322314049606,0.08148606934287916,1.6027011614882092,0.017851239669421492,1.0658687731058426e-06,1.7047480922384257,0.0
111,0.1,7,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Does a history of benign prostate biopsy correlate with the results of radical perineal prostatectomy?,1.0421828003701555e-06,1.3257791732677195,0.06858710562414265,0.07979076445040253,1.429460002965297,0.035041322314049606,0.07967526780192628,1.515689784498579,0.017851239669421492,1.0421828003701574e-06,1.6094379124341005,0.0
111,0.1,8,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Can prior benign prostate biopsy independently predict the risk of positive surgical margins in radical perineal prostatectomy?,9.948108548987847e-07,1.1922477806431968,0.06858710562414265,0.07616391152083878,1.2863591593246237,0.035041322314049606,0.07605366472002054,1.3615391046713214,0.017851239669421492,9.948108548987866e-07,1.442383827770934,0.0
111,0.1,9,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Is there an association between prior benign prostate biopsy and surgical margin status in patients undergoing radical perineal prostatectomy?,9.474389094274141e-07,1.074464744986813,0.06858710562414265,0.07253705859127503,1.161196016370618,0.035041322314049606,0.07243206163811479,1.2280077120467987,0.017851239669421492,9.474389094274159e-07,1.2992829841302607,0.0
111,0.1,10,ai,"Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? 
Answer: A prior benign prostate biopsy may be independently associated with a higher risk of positive surgical margins in patients undergoing radical perineal prostatectomy. This finding highlights the importance of considering the potential impact of prior biopsies when planning surgical management for prostate cancer. 
",Does a previous benign prostate biopsy impact the surgical outcomes for patients undergoing radical perineal prostatectomy?,1.0184968276344701e-06,1.2567863017807674,0.06858710562414265,0.07797733798562065,1.3553520308115758,0.035041322314049606,0.07786446626097342,1.4356470768250427,0.017851239669421492,1.018496827634472e-06,1.5224265354444704,0.0
113,0.1,1,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Can bedside evaluation reliably rule out aspiration after an acute stroke?,8.290090457489866e-07,1.3808512313433954,0.08804283164782867,0.0634699262673657,1.5554583665565898,0.02271498107084911,0.06337805393335051,1.6817585740137266,0.0,8.290090457489885e-07,1.791759469228054,0.0
113,0.1,2,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Is bedside swallowing assessment sufficient to exclude aspiration following an acute stroke?,8.053230730133013e-07,1.2855410515390702,0.08804283164782867,0.061656499802583815,1.4500978508987639,0.02271498107084911,0.061567252392397645,1.5639755383573428,0.0,8.053230730133032e-07,1.6582280766035322,0.0
113,0.1,3,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Does bedside assessment effectively exclude aspiration risk post-acute stroke?,8.763809912203573e-07,1.603994782657605,0.08804283164782867,0.06709677919692944,1.8067727948374954,0.02271498107084911,0.06699965701525626,1.9694406464655074,0.0,8.763809912203592e-07,2.1282317058492675,0.0
113,0.1,4,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Can aspiration be reliably excluded after acute stroke using bedside assessment?,8.290090457489866e-07,1.3808512313433954,0.08804283164782867,0.0634699262673657,1.5554583665565898,0.02271498107084911,0.06337805393335051,1.6817585740137266,0.0,8.290090457489885e-07,1.791759469228054,0.0
113,0.1,5,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Is bedside swallowing evaluation dependable for ruling out aspiration after an acute stroke?,7.816371002776159e-07,1.19852967454944,0.08804283164782867,0.059843073337801936,1.3547876710944387,0.02271498107084911,0.059756450851444765,1.458615022699517,0.0,7.816371002776178e-07,1.5404450409471484,0.0
113,0.1,6,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Does bedside assessment have enough sensitivity to exclude aspiration following an acute stroke?,7.816371002776159e-07,1.19852967454944,0.08804283164782867,0.059843073337801936,1.3547876710944387,0.02271498107084911,0.059756450851444765,1.458615022699517,0.0,7.816371002776178e-07,1.5404450409471484,0.0
113,0.1,7,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Can bedside swallowing tests reliably identify absence of aspiration after acute stroke?,8.053230730133013e-07,1.2855410515390702,0.08804283164782867,0.061656499802583815,1.4500978508987639,0.02271498107084911,0.061567252392397645,1.5639755383573428,0.0,8.053230730133032e-07,1.6582280766035322,0.0
113,0.1,8,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Is bedside assessment a reliable method to exclude aspiration risk post-acute stroke?,8.053230730133013e-07,1.2855410515390702,0.08804283164782867,0.061656499802583815,1.4500978508987639,0.02271498107084911,0.061567252392397645,1.5639755383573428,0.0,8.053230730133032e-07,1.6582280766035322,0.0
113,0.1,9,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Can aspiration risk be confidently ruled out by bedside assessment after an acute stroke?,7.579511275419306e-07,1.1184869668759037,0.08804283164782867,0.05802964687302006,1.2677762941048085,0.02271498107084911,0.0579456493104919,1.3633048428951917,0.0,7.579511275419324e-07,1.4350845252893225,0.0
113,0.1,10,ai,"Question: Can bedside assessment reliably exclude aspiration following acute stroke?**

**Answer:** Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument for aspiration.  A more comprehensive assessment, such as a modified barium swallow study, is required to reliably exclude aspiration risk. 
",Is bedside swallowing assessment adequate to exclude aspiration following an acute stroke?,8.053230730133013e-07,1.2855410515390702,0.08804283164782867,0.061656499802583815,1.4500978508987639,0.02271498107084911,0.061567252392397645,1.5639755383573428,0.0,8.053230730133032e-07,1.6582280766035322,0.0
114,0.1,1,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","Did the Catholic bishops' boycott call in Kenya in 2015 influence polio vaccination rates? The boycott, motivated by vaccine safety worries, caused a drop in vaccination coverage, raising public health concerns due to the risk of polio outbreaks.",9.711248821631014e-07,0.5680608677479464,0.12543252595155713,0.0743504850560569,0.6882711919108266,0.05179208106586603,0.07424286317906754,0.7571445635190241,0.013155555555555561,9.711248821631017e-07,0.7911275889201472,0.0
114,0.1,2,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","In 2015, did the Catholic bishops' boycott affect polio vaccine coverage in Kenya? Yes, their safety concerns led to reduced vaccination rates, increasing the risk of polio outbreaks and public health issues.",1.113240718577213e-06,0.7449915759070254,0.12543252595155713,0.08523104384474817,0.870592748704782,0.05179208106586603,0.08510767242478479,0.9451967950219644,0.013155555555555561,1.113240718577214e-06,0.985283603361105,0.0
114,0.1,3,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","Was polio vaccination coverage in Kenya in 2015 impacted by the Catholic bishops' boycott? The boycott, based on vaccine safety fears, significantly lowered vaccination rates, heightening the risk of polio spread.",1.1369266913128984e-06,0.7777813987300171,0.12543252595155713,0.08704447030953005,0.9044943003804637,0.05179208106586603,0.08691847396573765,0.9802881148332334,0.013155555555555561,1.1369266913128995e-06,1.0216512475319797,0.0
114,0.1,4,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","Did the 2015 boycott call by Catholic bishops in Kenya reduce polio vaccination coverage? The safety concerns they raised caused a decline in vaccinations, posing a public health threat from polio.",1.1369266913128984e-06,0.7777813987300171,0.12543252595155713,0.08704447030953005,0.9044943003804637,0.05179208106586603,0.08691847396573765,0.9802881148332334,0.013155555555555561,1.1369266913128995e-06,1.0216512475319797,0.0
114,0.1,5,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","How did the Catholic bishops' 2015 boycott in Kenya affect polio vaccination? Their concerns about vaccine safety led to decreased coverage, increasing the potential for polio outbreaks.",1.2316705822556396e-06,0.9208822423706895,0.12543252595155713,0.09429817616865757,1.0529143054987369,0.05179208106586603,0.09416168012954915,1.1344387946604924,0.013155555555555561,1.2316705822556411e-06,1.1819938976071596,0.0
114,0.1,6,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","In Kenya, did the 2015 boycott urged by Catholic bishops impact polio vaccine uptake? Yes, safety worries led to a drop in vaccination rates, raising public health alarms.",1.2079846095199542e-06,0.8831419143878425,0.12543252595155713,0.09248474970387568,1.0136935923454544,0.05179208106586603,0.09235087858859628,1.0936168001402375,0.013155555555555561,1.2079846095199557e-06,1.139434283188364,0.0
114,0.1,7,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","Did the Catholic bishops' boycott in Kenya during 2015 influence polio vaccination coverage? The boycott, driven by safety concerns, caused a significant decline in vaccination, risking polio outbreaks.",1.2079846095199542e-06,0.8831419143878425,0.12543252595155713,0.09248474970387568,1.0136935923454544,0.05179208106586603,0.09235087858859628,1.0936168001402375,0.013155555555555561,1.2079846095199557e-06,1.139434283188364,0.0
114,0.1,8,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","Was the polio vaccination coverage in Kenya in 2015 affected by the Catholic bishops' boycott? Their call, based on vaccine safety issues, led to reduced vaccination rates and increased outbreak risk.",1.1369266913128984e-06,0.7777813987300171,0.12543252595155713,0.08704447030953005,0.9044943003804637,0.05179208106586603,0.08691847396573765,0.9802881148332334,0.013155555555555561,1.1369266913128995e-06,1.0216512475319797,0.0
114,0.1,9,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
",Did the 2015 boycott by Catholic bishops in Kenya have an effect on polio vaccination rates? The safety concerns they expressed resulted in lower vaccination coverage and heightened public health risks.,1.1369266913128984e-06,0.7777813987300171,0.12543252595155713,0.08704447030953005,0.9044943003804637,0.05179208106586603,0.08691847396573765,0.9802881148332334,0.013155555555555561,1.1369266913128995e-06,1.0216512475319797,0.0
114,0.1,10,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? 
Answer: The call for a boycott by Catholic bishops in Kenya in 2015 significantly impacted polio vaccination coverage.  The boycott was driven by concerns about the safety of the vaccine, leading to a decline in vaccination rates. This raised public health concerns as polio is a potentially debilitating disease, and a decline in vaccination can increase the risk of outbreaks. 
","How did the 2015 boycott call from Catholic bishops in Kenya impact polio vaccination? The boycott, due to vaccine safety fears, caused a notable decrease in vaccination coverage, raising concerns about polio outbreaks.",1.0895547458415278e-06,0.7132428775924455,0.12543252595155713,0.0834176173799663,0.8378029258817903,0.05179208106586603,0.08329687088383192,0.9112952433462826,0.013155555555555561,1.0895547458415287e-06,0.950192283549836,0.0
115,0.1,1,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy feasible? Answer: Performing transgastric endoscopic splenectomy in a pig model seems technically possible. Further long-term survival studies are scheduled.,0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
115,0.1,2,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be done? Answer: Transgastric endoscopic splenectomy in a porcine model is technically achievable. Additional experiments focusing on long-term survival are planned.,4.73719454713706e-08,0.03275172792423664,0.03600665531409646,0.003626852929563759,0.029249111942969197,0.04158790170132326,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.1,3,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is it possible to perform transgastric endoscopic splenectomy? Answer: In a pig model, transgastric endoscopic splenectomy appears to be technically feasible. More long-term survival trials are intended.",9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
115,0.1,4,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Transgastric endoscopic splenectomy: is it achievable? Answer: The procedure seems technically feasible in a porcine model. Further long-term survival experiments will be conducted.,0.0,0.06027366787477817,0.04338842975206613,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
115,0.1,5,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be performed? Answer: It appears technically feasible in a porcine model. Additional long-term survival studies are planned.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.1,6,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy technically possible? Answer: In a pig model, this approach seems feasible. Further long-term survival experiments are planned.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,0.1,7,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy doable? Answer: The technique appears feasible in a porcine model. Additional long-term survival experiments are planned.,7.105791820705595e-08,0.0794882745003811,0.04338842975206613,0.005440279394345639,0.14660347419187536,0.0,0.005432404622858621,0.15415067982725672,0.0,7.105791820705606e-08,0.16251892949777424,0.0
115,0.1,8,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is it feasible to do transgastric endoscopic splenectomy? Answer: Transgastric endoscopic splenectomy in a pig model appears technically possible. Further long-term survival studies are planned.,4.73719454713706e-08,0.08820350236903352,0.0034578741965105714,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
115,0.1,9,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Transgastric endoscopic splenectomy: can it be done? Answer: It seems technically feasible in a porcine model. Additional long-term survival experiments are planned.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,0.1,10,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy possible? Answer: The procedure appears technically feasible in a porcine model. Further long-term survival experiments are planned.,4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
116,0.1,1,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux used for perioperative bridging? Answer: The use of fondaparinux in perioperative bridging has not been clearly defined, and it has significant limitations that prevent it from being a standard bridging option.",7.10579182070559e-08,0.009995023594080443,0.055363321799307974,0.005440279394345639,0.05000374837197574,0.02854671280276816,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
116,0.1,2,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux have a role in perioperative bridging? Answer: Fondaparinux's role in perioperative bridging therapy remains unproven, with notable restrictions limiting its routine application.",2.842316728282236e-07,0.4439732848059381,0.027281306299865568,0.021761117577382555,0.4405191031173308,0.014841716949297971,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
116,0.1,3,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Can fondaparinux be used for perioperative bridging? Answer: The application of fondaparinux in perioperative bridging is not well established, and there are key limitations to its regular use as a bridging agent.",9.47438909427412e-08,0.04076668226083413,0.055363321799307974,0.007253705859127518,0.08175244668655557,0.02854671280276816,0.007243206163811494,0.125163142954007,0.0,9.474389094274162e-08,0.12921173148000697,0.0
116,0.1,4,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux recommended for perioperative bridging? Answer: Fondaparinux is not currently established as a perioperative bridging therapy, and its use is limited by important constraints.",2.605457000925383e-07,0.28762676019236055,0.055363321799307974,0.019947691112600675,0.337685820823757,0.02854671280276816,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
116,0.1,5,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: What is the role of fondaparinux in perioperative bridging? Answer: Fondaparinux has not been established as a standard agent for perioperative bridging, with several important limitations affecting its routine use.",1.421158364141118e-07,0.10530520339840566,0.055363321799307974,0.010880558788691277,0.14844382118522903,0.02854671280276816,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
116,0.1,6,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux play a part in perioperative bridging? Answer: The role of fondaparinux in perioperative bridging therapy has yet to be established, and there are significant limitations to its routine use.",1.184298636784265e-07,0.11723455351476497,0.023141099577085773,0.009067132323909398,0.11454226950954727,0.02854671280276816,0.009054007704764368,0.15906469462968875,0.0,1.1842986367842703e-07,0.16430305129127598,0.0
116,0.1,7,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux effective for perioperative bridging? Answer: The effectiveness of fondaparinux in perioperative bridging has not been confirmed, and its use is restricted by important limitations.",2.36859727356853e-07,0.2484060470390781,0.055363321799307974,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.1,8,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Should fondaparinux be used in perioperative bridging? Answer: Fondaparinux is not established for use in perioperative bridging and has notable limitations that hinder its routine application.,2.36859727356853e-07,0.30172506092830487,0.016963321799307964,0.018134264647818796,0.29686382630350217,0.02854671280276816,0.018108015409528735,0.3483066942682167,0.0,2.3685972735685406e-07,0.36101334553733055,0.0
116,0.1,9,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is there an established role for fondaparinux in perioperative bridging? Answer: There is no established role for fondaparinux in perioperative bridging, and its use is limited by important factors.",1.658018091497971e-07,0.3782230242326885,0.1095672337562476,0.012693985253473157,0.3815771925850546,0.11034217608612071,0.012675610786670115,0.38455636540293225,0.109375,1.6580180914979784e-07,0.3450490512234512,0.07638888888888888
116,0.1,10,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Can fondaparinux serve as a perioperative bridging agent? Answer: Fondaparinux has not been established as a perioperative bridging agent, and there are significant limitations to its routine use.",1.894877818854824e-07,0.322829613576773,0.05023667820069207,0.014507411718255037,0.32259125636143926,0.045053287197231826,0.014486412327622988,0.3215830004839062,0.03840000000000001,1.8948778188548325e-07,0.2776317365982801,0.0
117,0.1,1,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Does selective attention to headache-related visual stimuli occur in episodic migraineurs? This study, supported by a large sample size and prior pilot testing of stimuli, offers strong evidence that episodic migraineurs show increased attentional bias toward headache-related visual cues, indicating that selective attention mechanisms may play a role in migraine development.",1.6580180914979784e-07,0.13783812944348428,0.004889233241505961,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
117,0.1,2,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Are episodic migraine sufferers more likely to focus on headache-related visual stimuli? Based on a large sample and previous pilot tests, the study strongly suggests that episodic migraineurs have a heightened attentional bias to headache-related visuals, implying selective attention could be involved in migraine pathogenesis.",3.079176455639103e-07,0.21021972650857235,0.035041322314049606,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
117,0.1,3,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Do individuals with episodic migraines selectively attend to headache-related visual stimuli? The study, backed by extensive sampling and pilot testing, provides strong evidence that episodic migraineurs demonstrate increased attention to headache-related visual stimuli, suggesting selective attention mechanisms may contribute to migraine pathogenesis.",3.789755637709665e-07,0.34846140889910604,0.013610880184306735,0.029014823436509962,0.3711295956492098,0.02498356344510192,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
117,0.1,4,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Is there selective attention to headache-related visual stimuli among episodic migraineurs? With a large sample and prior pilot testing, this research presents compelling evidence that episodic migraineurs exhibit a heightened attentional bias toward headache-related visuals, indicating selective attention may be involved in migraine development.",3.316036182995957e-07,0.2654486484802461,0.011798691928562081,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
117,0.1,5,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Do episodic migraine patients show selective attention to headache-related visual stimuli? This study, supported by a large sample size and earlier pilot testing, provides strong evidence that episodic migraineurs have an increased attentional bias toward headache-related visual stimuli, suggesting selective attention mechanisms might play a role in migraine pathogenesis.",2.1317375462116866e-07,0.18097061456560493,0.006546579387273654,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
117,0.1,6,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Are headache-related visual stimuli selectively attended to by episodic migraineurs? Given the large sample and prior pilot testing, the study offers compelling evidence that episodic migraineurs display a heightened attentional bias to such stimuli, implying selective attention may be a factor in migraine pathogenesis.",3.316036182995957e-07,0.23320924473327187,0.035041322314049606,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
117,0.1,7,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Do episodic migraine sufferers selectively focus on headache-related visual stimuli? The study, with a large sample and previous pilot testing, provides strong evidence that episodic migraineurs have an increased attentional bias toward headache-related visuals, suggesting selective attention mechanisms could be involved in migraine development.",3.316036182995957e-07,0.23320924473327187,0.035041322314049606,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
117,0.1,8,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Is selective attention to headache-related visual stimuli present in episodic migraineurs? Supported by a large sample size and prior pilot testing, this study provides compelling evidence that episodic migraineurs exhibit heightened attentional bias toward headache-related stimuli, indicating selective attention may contribute to migraine pathogenesis.",3.316036182995957e-07,0.2654486484802461,0.011798691928562081,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
117,0.1,9,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Do episodic migraineurs demonstrate selective attention to headache-related visual stimuli? This research, based on a large sample and earlier pilot testing, strongly suggests that episodic migraineurs show increased attentional bias toward headache-related visuals, implying selective attention mechanisms may be involved in migraine development.",3.552895910352811e-07,0.32275375933965034,0.012458677685950409,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
117,0.1,10,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? 
Answer: In light of the large sample size and prior pilot testing of presented stimuli, this study provides compelling evidence that episodic migraineurs do exhibit a heightened attentional bias toward headache-related visual stimuli. This finding suggests that a mechanism of selective attention may be involved in migraine pathogenesis. 
","Are episodic migraine patients more attentive to headache-related visual stimuli? With a large sample size and prior pilot testing, the study provides compelling evidence that episodic migraineurs have a heightened attentional bias toward headache-related visual stimuli, suggesting selective attention may play a role in migraine pathogenesis.",2.8423167282822487e-07,0.21855341201473433,0.012830578512396714,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
118,0.1,1,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the surgeon's prior experience a factor in their ability to perform transurethral resection of the prostate? The senior urologist tends to have completed more procedures, gaining more experience and possibly achieving better results. Nevertheless, personal skill and training are also crucial.",1.8948778188548325e-07,0.17824823140631896,0.0,0.014507411718254981,0.1823215567939549,0.0,0.014486412327622933,0.18658595558041347,0.0,1.8948778188548325e-07,0.19105523676270808,0.0
118,0.1,2,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Does a surgeon's previous experience affect their capability to carry out transurethral resection of the prostate? Senior urologists usually have done more surgeries, which contributes to greater expertise and potentially improved outcomes. However, individual proficiency and education remain important.",2.6054570009253926e-07,0.25423413838424036,0.0,0.0199476911126006,0.26028309826366547,0.0,0.019918816950481533,0.26662866325394763,0.0,2.6054570009253947e-07,0.2732933349996811,0.0
118,0.1,3,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the proficiency in performing transurethral resection of the prostate dependent on the surgeon's past experience? Senior urologists are more likely to have conducted a larger number of these operations, resulting in enhanced experience and possibly superior results. Still, personal skill and training are significant factors.",9.474389094274162e-08,0.08515780834030728,0.0,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
118,0.1,4,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Does the surgeon's experience influence their ability to perform transurethral resection of the prostate? Senior urologists often have more procedural experience, which may lead to better outcomes. Yet, individual skill and training also matter greatly.",3.5528959103528046e-07,0.3654597734944649,0.0,0.027201396971728103,0.3746934494414109,0.0,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
118,0.1,5,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the capability to perform transurethral resection of the prostate affected by the surgeon's previous experience? Senior urologists generally have performed more procedures, gaining more experience and potentially better results. However, individual skill and training are also key.",2.8423167282822456e-07,0.2809023854664012,0.0,0.02176111757738247,0.2876820724517808,0.0,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
118,0.1,6,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the ability to conduct transurethral resection of the prostate linked to the surgeon's prior experience? Senior urologists tend to have completed more surgeries, leading to greater expertise and possibly improved outcomes. Nonetheless, individual skill and training play an important role.",2.1317375462116866e-07,0.20294084399669066,0.0,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
118,0.1,7,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Does prior experience impact a surgeon's ability to perform transurethral resection of the prostate? Senior urologists are more likely to have done a higher number of procedures, resulting in more experience and potentially better results. However, individual skill and training are also essential.",1.6580180914979784e-07,0.15415067982725894,0.0,0.012693985253473108,0.1576289442035832,0.0,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
118,0.1,8,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the surgeon's previous experience a determinant in performing transurethral resection of the prostate? Senior urologists usually have more procedural experience, which can lead to better outcomes. Still, individual skill and training are significant.",3.7897556377096576e-07,0.3953127366441467,0.0,0.029014823436509983,0.4054651081081646,0.0,0.028972824655245893,0.41616039722491127,0.0,3.789755637709665e-07,0.4274440148269396,0.0
118,0.1,9,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Is the skill to perform transurethral resection of the prostate influenced by the surgeon's earlier experience? Senior urologists often have conducted more procedures, gaining more experience and possibly achieving better outcomes. Yet, individual skill and training remain important.",2.8423167282822456e-07,0.2809023854664012,0.0,0.02176111757738247,0.2876820724517808,0.0,0.0217296184914344,0.2947995402206445,0.0,2.8423167282822487e-07,0.3022808718729326,0.0
118,0.1,10,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? 
Answer: The senior urologist was more likely to have performed a higher number of procedures, leading to greater experience and potentially better outcomes.  However, individual skill and training also play a significant role. 
","Does the surgeon's experience level affect their ability to perform transurethral resection of the prostate? Senior urologists typically have performed more surgeries, leading to greater experience and potentially improved results. However, individual skill and training also play a vital role.",2.3685972735685396e-07,0.22825865198098239,0.0,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
119,0.1,1,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","How do marital status and living arrangements influence mortality, and does this relationship differ by gender?",1.0421828003701555e-06,1.3694872428035083,0.0,0.07979076445040253,1.4213856809311607,0.0,0.07967526780192628,1.478101910373013,0.0,1.0421828003701574e-06,1.5404450409471488,0.0
119,0.1,2,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Does the link between marital status, living arrangements, and mortality change depending on gender?",1.0895547458415261e-06,1.5125880864441816,0.0,0.08341761737996628,1.5755363607584183,0.0,0.08329687088383203,1.6451559950361796,0.0,1.089554745841528e-06,1.7227665977411042,0.0
119,0.1,3,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Is the association between marital status, living arrangements, and mortality affected by gender?",1.1132407185772115e-06,1.592630794117718,0.0,0.08523104384474815,1.6625477377480484,0.0,0.0851076724247849,1.7404661748405048,0.0,1.1132407185772135e-06,1.82812711339893,0.0
119,0.1,4,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
",Do marital status and living arrangements impact mortality differently for men and women?,1.1132407185772115e-06,1.592630794117718,0.0,0.08523104384474815,1.6625477377480484,0.0,0.0851076724247849,1.7404661748405048,0.0,1.1132407185772135e-06,1.82812711339893,0.0
119,0.1,5,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Does gender modify the relationship between marital status, living arrangements, and mortality?",1.136926691312897e-06,1.6796421711073481,0.0,0.08704447030953003,1.7578579175523736,0.0,0.08691847396573778,1.8458266904983307,0.0,1.1369266913128989e-06,1.945910149055314,0.0
119,0.1,6,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
",Are the effects of marital status and living arrangements on mortality distinct across genders?,1.0895547458415261e-06,1.5125880864441816,0.0,0.08341761737996628,1.5755363607584183,0.0,0.08329687088383203,1.6451559950361796,0.0,1.089554745841528e-06,1.7227665977411042,0.0
119,0.1,7,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","How does gender influence the connection between marital status, living arrangements, and mortality?",1.1132407185772115e-06,1.592630794117718,0.0,0.08523104384474815,1.6625477377480484,0.0,0.0851076724247849,1.7404661748405048,0.0,1.1132407185772135e-06,1.82812711339893,0.0
119,0.1,8,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
",Is there a gender-based variation in how marital status and living arrangements relate to mortality?,1.065868773105841e-06,1.4384801142904604,0.0,0.08160419091518441,1.495493653084882,0.0,0.08148606934287915,1.5581446180465495,0.0,1.0658687731058426e-06,1.627456417936779,0.0
119,0.1,9,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Do the associations between marital status, living arrangements, and mortality vary according to gender?",1.0895547458415261e-06,1.5125880864441816,0.0,0.08341761737996628,1.5755363607584183,0.0,0.08329687088383203,1.6451559950361796,0.0,1.089554745841528e-06,1.7227665977411042,0.0
119,0.1,10,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? 
Answer: Evaluation of living arrangements is crucial for identifying and explaining gender disparities in mortality. Studies indicate that marital status and living arrangements, particularly for women, have a significant impact on health outcomes. Understanding these associations allows for targeted interventions and policies to promote well-being across genders. 
","Does the relationship between living arrangements, marital status, and mortality differ by gender?",1.1132407185772115e-06,1.592630794117718,0.0,0.08523104384474815,1.6625477377480484,0.0,0.0851076724247849,1.7404661748405048,0.0,1.1132407185772135e-06,1.82812711339893,0.0
120,0.1,1,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Does the timing of living in an urban environment affect non-communicable disease risk in Thailand? Urban living was linked to higher behavioral and physiological risk factors, but these did not necessarily lead to increased biological risk factors. The biological risks likely stem from a complex interplay of long-term exposure and early life influences.",2.6054570009253947e-07,0.12587699061392144,0.0475,0.0199476911126006,0.1953087523207664,0.0,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
120,0.1,2,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","In Thailand, does the timing of urban residence impact the risk of non-communicable diseases? Urbanicity correlated with elevated behavioral and physiological risks, yet these did not directly cause higher biological risk factors. The biological risks probably arise from a complex interaction of prolonged exposure and early life conditions.",3.789755637709665e-07,0.22697310748529143,0.0475,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
120,0.1,3,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","How does living in an urban area influence non-communicable disease risk in Thailand over time? Urban living was associated with increased behavioral and physiological risk factors, though this did not straightforwardly increase biological risk factors. These biological risks likely result from a complex mix of long-term exposure and early life experiences.",3.079176455639103e-07,0.1650977037672039,0.0475,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
120,0.1,4,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Is the timing of urban living important for non-communicable disease risk in Thailand? Urbanicity was linked to rises in behavioral and physiological risk factors, but these associations may not directly increase biological risk factors. The biological risks are probably due to a complex interaction between long-term exposure and early life factors.",3.079176455639103e-07,0.1650977037672039,0.0475,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
120,0.1,5,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Does the timing of urban exposure affect non-communicable disease risk in Thailand? Urban living was connected to higher behavioral and physiological risks, but these did not necessarily translate into greater biological risk factors. The biological risks likely come from a complex interplay of accumulated exposure and early life influences.",3.552895910352811e-07,0.20591969828745826,0.0475,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
120,0.1,6,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","In Thailand, does when one lives in an urban environment matter for non-communicable disease risk? Urbanicity was associated with increased behavioral and physiological risk factors, though these may not directly cause higher biological risk factors. The biological risks probably result from a complex interaction of long-term exposure and early life conditions.",3.079176455639103e-07,0.1650977037672039,0.0475,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
120,0.1,7,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Does timing of urban residence influence non-communicable disease risk in Thailand? Urban living correlated with elevated behavioral and physiological risk factors, but these links may not directly lead to increased biological risk factors. The biological risks likely stem from a complex combination of long-term exposure and early life factors.",3.552895910352811e-07,0.20591969828745826,0.0475,0.02720139697172809,0.2769867833350337,0.0,0.027162023114293,0.28223246768421584,0.0,3.552895910352811e-07,0.2876820724517799,0.0
120,0.1,8,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","How does the timing of living in urban areas affect non-communicable disease risk in Thailand? Urbanicity was associated with rises in behavioral and physiological risk factors, yet these may not directly increase biological risk factors. The biological risks are likely due to a complex interaction between long-term exposure and early life influences.",2.8423167282822487e-07,0.14529507647102413,0.0475,0.02176111757738247,0.21511137961694615,0.0,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
120,0.1,9,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Is the timing of urban living significant for non-communicable disease risk in Thailand? Urban living was linked to increased behavioral and physiological risk factors, but these associations might not directly raise biological risk factors. The biological risks probably arise from a complex interplay of prolonged exposure and early life experiences.",3.316036182995957e-07,0.2135921327402306,0.027100694444444445,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
120,0.1,10,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Does living in an urban environment at different times affect non-communicable disease risk in Thailand? Urbanicity was connected to higher behavioral and physiological risk factors, though these may not directly translate into increased biological risk factors. The biological risks likely result from a complex interaction of long-term exposure and early life factors.",2.8423167282822487e-07,0.14529507647102413,0.0475,0.02176111757738247,0.21511137961694615,0.0,0.0217296184914344,0.21905356606268356,0.0,2.8423167282822487e-07,0.22314355131420838,0.0
121,0.1,1,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
",Does sex affect the effectiveness of intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) indicates that women might have a reduced chance of favorable outcomes compared to men following intravenous thrombolysis for ischemic stroke. This underscores the necessity for additional studies to explore possible sex-related differences in treatment response.,1.4211583641411244e-07,0.07902000094411754,0.013981409152067609,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
121,0.1,2,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
",Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may be less likely than men to achieve positive outcomes after intravenous thrombolysis for ischemic stroke. This points to the importance of further research into sex-specific treatment responses.,2.1317375462116866e-07,0.1334335513625673,0.013041898799404494,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
121,0.1,3,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Does gender impact the response to intravenous thrombolysis in ischemic stroke patients? According to data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR), women appear to have a lower probability of favorable outcomes compared to men after receiving intravenous thrombolysis for ischemic stroke. This finding calls for more research to clarify sex-based differences in treatment efficacy.",1.1842986367842703e-07,0.06152045526421013,0.014273367639980654,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
121,0.1,4,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
",Is there a sex difference in the response to intravenous thrombolysis for ischemic stroke? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) show that women may have a decreased likelihood of achieving good outcomes relative to men after intravenous thrombolysis. This highlights the need for further investigation into sex-specific responses to this therapy.,1.6580180914979784e-07,0.0725101167401263,0.031217481789802295,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
121,0.1,5,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
",Does biological sex influence outcomes after intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests women might have a lower chance of favorable results compared to men following intravenous thrombolysis. This emphasizes the importance of additional research on sex-related differences in treatment response.,2.8423167282822487e-07,0.1643176659932486,0.031217481789802295,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
121,0.1,6,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
",How does sex affect the response to intravenous thrombolysis in ischemic stroke? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) data indicates that women may be less likely than men to experience favorable outcomes after intravenous thrombolysis for ischemic stroke. This finding stresses the need for further studies on sex-specific treatment effects.,2.3685972735685406e-07,0.15224945580891802,0.012705555837506113,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
121,0.1,7,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
","Is the effectiveness of intravenous thrombolysis in ischemic stroke influenced by patient sex? According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR), women may have a lower probability of favorable outcomes than men after intravenous thrombolysis. This suggests a need for more research into sex-specific differences in treatment response.",2.8423167282822487e-07,0.1643176659932486,0.031217481789802295,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
121,0.1,8,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
",Does sex play a role in the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) indicates that women might have a reduced likelihood of achieving positive outcomes compared to men after intravenous thrombolysis. This finding calls for further research to understand sex-specific treatment responses.,2.1317375462116866e-07,0.1082281993422054,0.031217481789802295,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
121,0.1,9,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
",Are there sex-based differences in response to intravenous thrombolysis for ischemic stroke? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) data suggests that women may have a lower chance of favorable outcomes than men following intravenous thrombolysis. This highlights the need for additional studies on sex-specific treatment effects.,3.316036182995957e-07,0.20353837914653106,0.031217481789802295,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
121,0.1,10,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? 

**Answer:** Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests that women may have a lower likelihood of achieving favorable outcomes compared to men after intravenous thrombolysis for ischemic stroke. This finding highlights the need for further research to understand the potential sex-specific differences in response to this treatment. 
",Does patient sex influence the outcome of intravenous thrombolysis in ischemic stroke? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Registry (SITS-ISTR) suggests women may be less likely than men to achieve favorable outcomes after intravenous thrombolysis. This underscores the importance of further research into sex-specific differences in treatment response.,2.8423167282822487e-07,0.1643176659932486,0.031217481789802295,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
122,0.1,1,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is withdrawal-induced anxiety in alcoholism linked to a deficiency in beta-endorphin? Our findings provide initial evidence that reduced beta-endorphin levels during alcohol withdrawal are associated with heightened anxiety symptoms, indicating a possible role of beta-endorphin deficiency in withdrawal-related anxiety.",7.1057918207056e-08,0.11246733753370775,0.026296566837107373,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
122,0.1,2,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? The results show for the first time that decreased beta-endorphin during alcohol withdrawal correlates with increased anxiety, suggesting beta-endorphin deficiency may contribute to withdrawal anxiety.",2.131737546211678e-07,0.291157862689579,0.031217481789802305,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
122,0.1,3,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is anxiety caused by alcohol withdrawal related to a lack of beta-endorphin? Our study presents the first evidence that lower beta-endorphin levels during withdrawal coincide with greater anxiety symptoms, implying beta-endorphin deficiency plays a role in withdrawal anxiety.",9.474389094274131e-08,0.10265415406008227,0.0,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
122,0.1,4,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is withdrawal anxiety in alcoholism due to beta-endorphin deficiency? The data reveal that reduced beta-endorphin during alcohol withdrawal is linked to elevated anxiety symptoms, supporting a potential involvement of beta-endorphin deficiency in withdrawal-induced anxiety.",1.894877818854825e-07,0.21706450523782772,0.0,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
122,0.1,5,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Does a deficiency in beta-endorphin cause anxiety during alcohol withdrawal? Our findings provide initial proof that decreased beta-endorphin levels during withdrawal are associated with increased anxiety, suggesting beta-endorphin deficiency may be a factor in withdrawal anxiety.",1.421158364141119e-07,0.15822400521489444,0.0,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
122,0.1,6,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is the anxiety experienced during alcohol withdrawal caused by low beta-endorphin levels? Our results offer the first evidence that lowered beta-endorphin during withdrawal correlates with heightened anxiety symptoms, indicating a possible role for beta-endorphin deficiency.",1.658018091497972e-07,0.18721154208814594,0.0,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
122,0.1,7,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is withdrawal-induced anxiety in alcoholism a result of beta-endorphin deficiency? The findings show that reduced beta-endorphin levels during alcohol withdrawal are linked to increased anxiety symptoms, suggesting beta-endorphin deficiency may contribute to withdrawal anxiety.",1.894877818854825e-07,0.21706450523782772,0.0,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
122,0.1,8,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is beta-endorphin deficiency responsible for anxiety during alcohol withdrawal? Our study provides initial evidence that lower beta-endorphin levels during withdrawal correlate with increased anxiety symptoms, implying a role for beta-endorphin deficiency in withdrawal-induced anxiety.",1.894877818854825e-07,0.25907342527176347,0.0302734375,0.014507411718255002,0.2231435513142097,0.0,0.01448641232762296,0.2295744416444978,0.0,1.8948778188548325e-07,0.23638877806423153,0.0
122,0.1,9,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Could beta-endorphin deficiency be the cause of anxiety during alcohol withdrawal? The results indicate that decreased beta-endorphin during withdrawal is associated with increased anxiety symptoms, suggesting a potential role for beta-endorphin deficiency.",2.368597273568531e-07,0.27958486221916123,0.0,0.01813426464781876,0.28768207245178123,0.0,0.018108015409528708,0.29626581614317127,0.0,2.3685972735685406e-07,0.3053816495511823,0.0
122,0.1,10,ai,"Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta-endorphin levels during alcohol withdrawal correlate with increased anxiety symptoms. This suggests a potential role for beta-endorphin deficiency in the development of withdrawal-induced anxiety. 
","Is the anxiety seen in alcohol withdrawal connected to a deficiency in beta-endorphin? Our findings give first evidence that lowered beta-endorphin levels during withdrawal correlate with increased anxiety symptoms, pointing to a possible role of beta-endorphin deficiency in withdrawal anxiety.",4.7371945471370706e-08,0.12110243909363172,0.05113221329437545,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
123,0.1,1,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Are we adhering to guidelines when preparing high fall-risk patients for discharge after rehabilitation? Evidence shows insufficient fall risk assessments, interventions, and education for these patients, indicating a need to improve fall prevention practices.",5.447773729207636e-07,0.4298231034743911,0.07100591715976332,0.04170880868998309,0.4659812263716594,0.05436390532544381,0.04164843544191596,0.503652606482095,0.036982248520710054,5.447773729207643e-07,0.5429380345103452,0.018860946745562133
123,0.1,2,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Do we comply with guidelines in preparing patients at high risk of falls for discharge post-rehabilitation? Findings reveal a lack of adequate fall risk assessments, interventions, and education, highlighting a gap in current care.",5.447773729207636e-07,0.4298231034743911,0.07100591715976332,0.04170880868998309,0.4659812263716594,0.05436390532544381,0.04164843544191596,0.503652606482095,0.036982248520710054,5.447773729207643e-07,0.5429380345103452,0.018860946745562133
123,0.1,3,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Is the preparation of high fall-risk patients for discharge after rehabilitation aligned with guidelines? There is minimal evidence that these patients receive proper fall risk assessments, interventions, or education, suggesting room for improvement.",5.684633456564489e-07,0.4605947621411448,0.07100591715976332,0.04352223515476497,0.4977299246862392,0.05436390532544381,0.04345923698286883,0.5364424293050867,0.036982248520710054,5.684633456564497e-07,0.5768395861860269,0.018860946745562133
123,0.1,4,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","When discharging patients at high risk of falls after rehabilitation, do we meet established guidelines? The evidence points to inadequate fall risk assessments, interventions, and education, indicating a shortfall in practice.",6.158352911278195e-07,0.5251332832787163,0.07100591715976332,0.04714908808432873,0.5644212991849127,0.05436390532544381,0.04708084006477458,0.6054353007920374,0.036982248520710054,6.158352911278206e-07,0.6482985501681706,0.018860946745562133
123,0.1,5,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Are guidelines followed in preparing patients at high risk of falls for home discharge after rehabilitation? Data shows insufficient fall risk assessments and education, revealing a need to enhance fall prevention efforts.",5.921493183921342e-07,0.49234346045572464,0.07100591715976332,0.04533566161954685,0.5305197475092309,0.05436390532544381,0.04527003852382171,0.5703439809807684,0.036982248520710054,5.921493183921352e-07,0.6119309059972959,0.018860946745562133
123,0.1,6,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Do current practices meet guidelines for preparing high fall-risk patients for discharge after rehabilitation? There is little proof that adequate fall risk assessments and interventions are provided, suggesting a practice gap.",6.158352911278195e-07,0.5251332832787163,0.07100591715976332,0.04714908808432873,0.5644212991849127,0.05436390532544381,0.04708084006477458,0.6054353007920374,0.036982248520710054,6.158352911278206e-07,0.6482985501681706,0.018860946745562133
123,0.1,7,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Is there compliance with fall prevention guidelines when discharging patients at high risk of falls post-rehabilitation? Evidence suggests these patients often lack proper assessments and education, indicating a need for improvement.",6.158352911278195e-07,0.5251332832787163,0.07100591715976332,0.04714908808432873,0.5644212991849127,0.05436390532544381,0.04708084006477458,0.6054353007920374,0.036982248520710054,6.158352911278206e-07,0.6482985501681706,0.018860946745562133
123,0.1,8,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Are patients at high risk of falls adequately prepared for discharge home after rehabilitation according to guidelines? Findings indicate a deficiency in fall risk assessments, interventions, and education during rehabilitation.",6.395212638635048e-07,0.5590348349543981,0.07100591715976332,0.04896251454911061,0.5995126189961817,0.05436390532544381,0.048891641605727454,0.6418029449629121,0.036982248520710054,6.39521263863506e-07,0.6860388781510176,0.018860946745562133
123,0.1,9,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Do we fulfill the guidelines for preparing high fall-risk patients for discharge after rehabilitation? The evidence reveals a lack of sufficient fall risk assessments and preventive education, highlighting a gap in care.",5.921493183921342e-07,0.49234346045572464,0.07100591715976332,0.04533566161954685,0.5305197475092309,0.05436390532544381,0.04527003852382171,0.5703439809807684,0.036982248520710054,5.921493183921352e-07,0.6119309059972959,0.018860946745562133
123,0.1,10,ai,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received adequate fall risk assessments, interventions, or education during rehabilitation. This suggests a gap in current practice and the need for improvement in meeting fall prevention guidelines. 
","Is the discharge preparation for patients at high risk of falls after rehabilitation consistent with guidelines? There is little evidence that these patients receive adequate fall risk assessments and interventions, pointing to a need for better adherence.",4.737194547137077e-07,0.342811726484761,0.07100591715976332,0.03626852929563745,0.3763690676819724,0.05436390532544381,0.03621603081905734,0.4112792863510797,0.036982248520710054,4.737194547137081e-07,0.44762785470601996,0.018860946745562133
124,0.1,1,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective method for managing postoperative cerebrospinal fluid fistulas following spine surgery? Lumbar drainage appears to be both effective and safe for preventing CSF fistulas in patients with large dural tears or those who are debilitated or irradiated, as well as for treating existing CSF leaks.",1.8948778188548325e-07,0.1880977832986206,0.004159661226903637,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
124,0.1,2,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage effectively treat postoperative cerebrospinal fluid fistulas after spine surgery? Evidence suggests lumbar drainage is a safe and effective approach to prevent CSF fistulas in cases involving large dural tears and compromised patients, and it also helps in treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,0.1,3,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is lumbar drainage a reliable treatment for cerebrospinal fluid fistulas after spine surgery? Lumbar drainage seems to be a safe and effective method for both preventing CSF fistulas in patients with significant dural tears or weakened conditions and for managing CSF leaks.,2.3685972735685406e-08,0.025537914030078213,0.0006085634451019201,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
124,0.1,4,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage effectively prevent and treat postoperative cerebrospinal fluid fistulas following spine surgery? It appears that lumbar drainage is both safe and effective in preventing CSF fistulas in patients with large dural tears or those who are debilitated or irradiated, as well as in treating CSF leaks.",1.6580180914979784e-07,0.16642988191943964,0.0037170228023798192,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
124,0.1,5,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage effective and safe for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage seems to work well in preventing CSF fistulas in cases of large dural tears and in patients who are debilitated or irradiated, and it is also effective in treating CSF leaks.",1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
124,0.1,6,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,How effective is lumbar drainage for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage is considered both safe and effective for preventing CSF fistulas in patients with large dural tears or compromised health and for treating CSF leaks.,4.73719454713706e-08,0.053117365915339665,0.0013130033920054525,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
124,0.1,7,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage provide effective treatment for cerebrospinal fluid fistulas after spine surgery? It appears to be a safe and effective option for preventing CSF fistulas in cases of large dural tears and in debilitated or irradiated patients, as well as for treating CSF leaks.",9.474389094274162e-08,0.12996753883232204,0.02498356344510192,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
124,0.1,8,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is lumbar drainage a safe and effective approach for postoperative cerebrospinal fluid fistulas after spine surgery? Lumbar drainage seems to prevent CSF fistulas in patients with large dural tears or weakened conditions and also effectively treats CSF leaks.,7.10579182070559e-08,0.08077159760711661,0.0020226093944042435,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
124,0.1,9,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage safely and effectively manage postoperative cerebrospinal fluid fistulas after spine surgery? It appears to be effective in preventing CSF fistulas in cases of large dural tears and in debilitated or irradiated patients, and it also treats CSF leaks successfully.",2.3685972735685406e-08,0.05934997161836808,0.02498356344510192,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
124,0.1,10,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,Is lumbar drainage a beneficial treatment for postoperative cerebrospinal fluid fistulas following spine surgery? Lumbar drainage seems to be both safe and effective in preventing CSF fistulas in patients with large dural tears or compromised health and in treating CSF leaks.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
125,0.1,1,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? In this study, we reviewed patient records for those receiving ventriculoperitoneal shunts, comparing cases with concurrent endoscopic third ventriculostomy (ETV) to those without. Our results show that employing a neuroendoscope during shunt insertion does not significantly raise infection risk.",3.316036182995957e-07,0.16628171819143311,0.057572248276806064,0.025387970506946217,0.2073050834834511,0.03171190540177372,0.025351221573340132,0.23357378766752435,0.016124697661918846,3.316036182995957e-07,0.2607262624632525,0.0
125,0.1,2,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Is the incidence of ventriculoperitoneal shunt infection influenced by the simultaneous use of a neuroendoscope? We analyzed patient data from ventriculoperitoneal shunt procedures, contrasting those with simultaneous endoscopic third ventriculostomy (ETV) against those without. The study found no significant increase in shunt infection risk when a neuroendoscope was used.",3.789755637709665e-07,0.2371400905359513,0.03597601671292554,0.029014823436509962,0.24897777988402003,0.03171190540177372,0.028972824655245866,0.27613340208632087,0.016124697661918846,3.789755637709665e-07,0.30421137440299084,0.0
125,0.1,3,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Does simultaneous neuroendoscope use impact ventriculoperitoneal shunt infection rates? Our study examined records of patients undergoing ventriculoperitoneal shunt placement, comparing those who had concurrent endoscopic third ventriculostomy (ETV) to those who did not. Findings suggest that neuroendoscope use during shunt placement does not significantly elevate infection risk.",4.263475092423373e-07,0.3123479417202528,0.012663972497537049,0.03264167636607371,0.2924628918237584,0.03171190540177372,0.0325944277371516,0.3205851646571536,0.016124697661918846,4.263475092423373e-07,0.3496737484797481,0.0
125,0.1,4,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Does the concurrent use of a neuroendoscope affect the frequency of ventriculoperitoneal shunt infections? We reviewed patient records for ventriculoperitoneal shunt placements, comparing those with simultaneous endoscopic third ventriculostomy (ETV) to those without. The data indicates no significant increase in infection risk with neuroendoscope use.",4.737194547137081e-07,0.2978958925043713,0.054848937343399684,0.03626852929563745,0.33792526590051564,0.03171190540177372,0.03621603081905733,0.36710518029204753,0.016124697661918846,4.737194547137081e-07,0.3973017974690025,0.0
125,0.1,5,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
","Is there an effect on ventriculoperitoneal shunt infection rates when a neuroendoscope is used simultaneously? This study analyzed patient records of ventriculoperitoneal shunt placements, comparing cases with and without simultaneous endoscopic third ventriculostomy (ETV). Results show no significant rise in infection risk due to neuroendoscope use.",4.500334819780227e-07,0.2747228879850807,0.05535317461259591,0.03445510283085558,0.3149357476758161,0.03171190540177372,0.034405229278104466,0.3435746828818531,0.016124697661918846,4.500334819780227e-07,0.3732042458899425,0.0
125,0.1,6,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
",Does the use of a neuroendoscope at the same time as ventriculoperitoneal shunt placement influence infection incidence? We studied patient records comparing those who had simultaneous endoscopic third ventriculostomy (ETV) with those who did not. Our findings reveal no significant increase in shunt infection risk with neuroendoscope use.,4.026615365066519e-07,0.22992685939180113,0.05629737777152669,0.030828249901291835,0.2704839851049834,0.03171190540177372,0.030783626196198732,0.29811230880509587,0.016124697661918846,4.026615365066519e-07,0.32668423025504856,0.0
125,0.1,7,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
",Does simultaneous neuroendoscope application during ventriculoperitoneal shunt surgery affect infection rates? We analyzed patient data comparing ventriculoperitoneal shunt placements with and without concurrent endoscopic third ventriculostomy (ETV). The study found no significant difference in infection risk associated with neuroendoscope use.,5.92149318392135e-07,0.42256319952702004,0.051940649716187844,0.045335661619546816,0.4615392218676915,0.03171190540177372,0.045270038523821665,0.4938568859311898,0.016124697661918846,5.921493183921352e-07,0.5273549257172001,0.0
125,0.1,8,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
",Is the incidence of infection in ventriculoperitoneal shunts affected by the simultaneous use of a neuroendoscope? Patient records were reviewed comparing those undergoing shunt placement with and without simultaneous endoscopic third ventriculostomy (ETV). Findings indicate no significant increase in infection risk from neuroendoscope use.,4.974054274493935e-07,0.28937872070361825,0.0775639184142488,0.038081955760419325,0.36145576331071005,0.03171190540177372,0.0380268323600102,0.39120273187110755,0.016124697661918846,4.974054274493935e-07,0.4219944100593742,0.0
125,0.1,9,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
",Does the simultaneous employment of a neuroendoscope during ventriculoperitoneal shunt placement alter the infection risk? We examined patient records comparing those with concurrent endoscopic third ventriculostomy (ETV) to those without. The results show no significant increase in shunt infection risk due to neuroendoscope use.,4.974054274493935e-07,0.28937872070361825,0.0775639184142488,0.038081955760419325,0.36145576331071005,0.03171190540177372,0.0380268323600102,0.39120273187110755,0.016124697661918846,4.974054274493935e-07,0.4219944100593742,0.0
125,0.1,10,ai,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? 

Answer: In the present study, we analyzed the records of patients undergoing ventriculoperitoneal shunt placement, comparing those who underwent simultaneous endoscopic third ventriculostomy (ETV) to those who did not. Our findings indicate that the use of a neuroendoscope during shunt placement does not significantly increase the risk of shunt infection. 
",Does using a neuroendoscope concurrently with ventriculoperitoneal shunt placement impact the rate of shunt infections? Our study reviewed patient data comparing those who had simultaneous endoscopic third ventriculostomy (ETV) to those who did not. The findings demonstrate no significant increase in infection risk associated with neuroendoscope use.,4.263475092423373e-07,0.25207427384547465,0.0558355233525204,0.03264167636607371,0.2924628918237584,0.03171190540177372,0.0325944277371516,0.3205851646571536,0.016124697661918846,4.263475092423373e-07,0.3496737484797481,0.0
126,0.1,1,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
126,0.1,2,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can automatic transmission enhance driving habits in elderly drivers? Answer: It is advisable for older drivers to switch to automatic transmission to help preserve safe driving and improve their transportation quality.,9.47438909427412e-08,0.12647161962590658,0.0036755094194540414,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
126,0.1,3,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Is driving behavior better in older drivers with automatic transmission? Answer: Older drivers might benefit from using automatic transmission to sustain safe driving and ensure better transport mobility.,1.658018091497971e-07,0.23304565389363718,0.007118582121786017,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.1,4,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does using automatic transmission aid older drivers in driving safely? Answer: Recommending automatic transmission for older drivers can help maintain their safe driving and overall transport quality.,1.894877818854824e-07,0.32259125636143926,0.045053287197231826,0.014507411718255037,0.2682639865946794,0.0,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
126,0.1,5,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can automatic transmission support safer driving in elderly drivers? Answer: Older drivers are often advised to switch to automatic transmission to uphold safe driving and enhance their mobility.,1.658018091497971e-07,0.23304565389363718,0.007118582121786017,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.1,6,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,"Question: Does automatic transmission contribute to improved driving in senior drivers? Answer: For older drivers, adopting automatic transmission may help maintain safe driving and the quality of their transportation.",1.658018091497971e-07,0.23304565389363718,0.007118582121786017,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.1,7,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Is automatic transmission beneficial for driving behavior in older adults? Answer: Switching to automatic transmission is suggested for older adults to keep their driving safe and maintain transport mobility.,1.421158364141118e-07,0.19624707501694916,0.005892062707435933,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.1,8,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does automatic transmission help older drivers drive more safely? Answer: It is recommended that older drivers use automatic transmission to sustain safe driving and improve their transport experience.,1.658018091497971e-07,0.2825561667907768,0.04245920435699517,0.012693985253473157,0.23052365861183244,0.0,0.012675610786670115,0.23841102344499765,0.0,1.6580180914979784e-07,0.24686007793152642,0.0
126,0.1,9,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can older drivers improve their driving by using automatic transmission? Answer: Older drivers may be encouraged to switch to automatic transmission to preserve safe driving and enhance their mobility.,1.421158364141118e-07,0.19624707501694916,0.005892062707435933,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,0.1,10,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does automatic transmission improve the driving safety of elderly drivers? Answer: Using automatic transmission is often recommended for older drivers to maintain safe driving and the quality of their transport mobility.,9.47438909427412e-08,0.12647161962590658,0.0036755094194540414,0.007253705859127518,0.125163142954007,0.0,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
127,0.1,1,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia negatively impact the results of colon and rectal surgeries? Answer: Analysis of this extensive multicenter database indicates that severe, moderate, and even mild preoperative anemia independently increases the risk of complications and prolongs hospital stays following colon surgery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.1,2,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is there an adverse effect of preoperative anemia on colon and rectal surgery outcomes? Answer: Findings from a large multicenter database study reveal that severe, moderate, and mild preoperative anemia serve as independent risk factors for postoperative complications and extended hospitalization after colon surgery.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
127,0.1,3,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does having anemia before surgery worsen outcomes in colon and rectal procedures? Answer: This comprehensive multicenter database analysis shows that severe, moderate, and mild preoperative anemia independently contribute to higher complication rates and longer hospital stays post-colon surgery.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,0.1,4,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: How does preoperative anemia influence the outcomes of colon and rectal surgeries? Answer: Data from a large multicenter database suggest that severe, moderate, and mild anemia before surgery independently increase the likelihood of complications and lengthen hospital stays after colon surgery.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
127,0.1,5,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Is preoperative anemia linked to poorer outcomes in colon and rectal surgery? Answer: According to this large multicenter database analysis, severe, moderate, and mild preoperative anemia are independent risk factors for complications and prolonged hospitalization following colon surgery.",1.4211583641411222e-07,0.15157821472220911,0.0035815857662582634,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,0.1,6,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does preoperative anemia affect the success of colon and rectal surgeries? Answer: This analysis of a large multicenter database indicates that severe, moderate, and mild anemia prior to surgery independently raise the risk of complications and extend hospital stays after colon surgery.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
127,0.1,7,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: What impact does preoperative anemia have on colon and rectal surgery outcomes? Answer: The results from a large multicenter database analysis suggest that severe, moderate, and mild preoperative anemia independently increase complication risks and hospital stay duration after colon surgery.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,0.1,8,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Are colon and rectal surgery outcomes adversely affected by preoperative anemia? Answer: Evidence from a large multicenter database analysis shows that severe, moderate, and mild preoperative anemia independently heighten the risk of complications and lengthen hospital stays post-colon surgery.",1.1842986367842692e-07,0.0891212977631648,0.02271498107084911,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,0.1,9,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Does anemia before surgery worsen outcomes in colon and rectal operations? Answer: This large multicenter database study suggests that severe, moderate, and mild preoperative anemia independently pose a risk for complications and longer hospitalization after colon surgery.",1.6580180914979753e-07,0.14176503124858364,0.02271498107084911,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
127,0.1,10,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Question: Can preoperative anemia lead to worse outcomes in colon and rectal surgery? Answer: Analysis from a large multicenter database indicates that severe, moderate, and mild anemia before surgery independently increase the chances of complications and extended hospital stays following colon surgery.",7.105791820705622e-08,0.03911087718850137,0.02271498107084911,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
128,0.1,1,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of negative maternal and neonatal outcomes? Early identification of preeclampsia is vital for better maternal and neonatal health. Although ACR serves as an important marker, studies indicate its early prognostic utility might be limited. More research is needed to clarify its predictive role for adverse outcomes.",1.6580180914979784e-07,0.11959346185555919,0.005350056689342415,0.012693985253473108,0.11651828070938652,0.001855213262734686,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
128,0.1,2,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Does the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia predict maternal and neonatal complications? Detecting preeclampsia early is essential to enhance outcomes for both mother and baby. While ACR is a useful indicator, evidence suggests its prognostic value at the onset of preeclampsia may be restricted. Additional studies are necessary to assess its predictive accuracy for adverse events.",1.1842986367842703e-07,0.01576749780221043,0.04535147392290249,0.009067132323909363,0.05871510211784603,0.015380859375,0.009054007704764333,0.08134563945395268,0.0,1.1842986367842703e-07,0.08269171584511614,0.0
128,0.1,3,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic factor for maternal and neonatal adverse outcomes? Early diagnosis of preeclampsia is key to improving outcomes for mothers and newborns. Although ACR is a significant marker, research shows its early prognostic significance might be limited. Further investigation is required to establish its predictive potential for negative outcomes.",9.474389094274162e-08,0.0218665634001054,0.02922677626098364,0.0072537058591274906,0.04218580016663509,0.015380859375,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
128,0.1,4,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia an effective prognostic indicator for adverse maternal and neonatal outcomes? Early detection of preeclampsia plays a critical role in enhancing maternal and neonatal health. Despite ACR being a valuable marker, studies suggest its early prognostic value may be limited. More research is needed to determine its predictive capabilities for adverse outcomes.",9.474389094274162e-08,0.06658573633945686,0.0029105197570745284,0.0072537058591274906,0.06491193723417421,0.0010080295138888938,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
128,0.1,5,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict poor maternal and neonatal outcomes? Early recognition of preeclampsia is crucial for better health outcomes in mothers and babies. While ACR is an important marker, current research indicates its prognostic value in early preeclampsia might be limited. Further studies are necessary to evaluate its predictive role for adverse outcomes.",1.1842986367842703e-07,0.03849363486974955,0.02896258503401359,0.009067132323909363,0.05871510211784603,0.015380859375,0.009054007704764333,0.08134563945395268,0.0,1.1842986367842703e-07,0.08269171584511614,0.0
128,0.1,6,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Is the first urinary albumin/creatinine ratio (ACR) measurement in women with suspected preeclampsia a reliable prognostic factor for maternal and neonatal adverse outcomes? Early identification of preeclampsia is essential to improve outcomes for both mother and child. Although ACR is a useful marker, evidence points to limited prognostic value in the early stages of preeclampsia. Additional research is needed to confirm its predictive effectiveness for adverse outcomes.",0.0,0.0630133800509034,0.04535147392290249,0.0,0.021327605555691243,0.015380859375,0.0,0.0,0.0,0.0,0.0,0.0
128,0.1,7,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Can the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict adverse maternal and neonatal outcomes? Early detection of preeclampsia is vital for improving health outcomes for mothers and newborns. While ACR is a valuable biomarker, studies suggest its prognostic value at the onset of preeclampsia may be limited. Further investigation is required to determine its predictive accuracy for adverse events.",9.474389094274162e-08,0.05266563605953145,0.02020408163265309,0.0072537058591274906,0.04218580016663509,0.015380859375,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
128,0.1,8,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic marker for maternal and neonatal adverse outcomes? Early diagnosis of preeclampsia is critical for better maternal and neonatal outcomes. Although ACR is an important marker, research indicates its early prognostic value might be limited. More studies are needed to assess its predictive role for adverse outcomes.",1.6580180914979784e-07,0.09609694726030682,0.011494902670209362,0.012693985253473108,0.11651828070938652,0.001855213262734686,0.012675610786670066,0.11583181552512123,0.0,1.6580180914979784e-07,0.11778303565638559,0.0
128,0.1,9,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia serve as a prognostic factor for adverse maternal and neonatal outcomes? Early detection of preeclampsia is crucial to improve outcomes for both mother and baby. While ACR is a useful marker, evidence suggests its prognostic value in early preeclampsia may be limited. Further research is necessary to evaluate its predictive capabilities for adverse outcomes.",2.3685972735685406e-08,0.005090696808735196,0.014613252708490811,0.0018134264647818726,0.0058234190197259394,0.015380859375,0.0018108015409528666,0.015748356968136257,0.0,2.3685972735685406e-08,0.01600034134644357,0.0
128,0.1,10,ai,"Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes?

**Answer:**  Early detection of preeclampsia is crucial for improving maternal and neonatal outcomes. While ACR is a valuable marker, research suggests its prognostic value in the initial stages of preeclampsia may be limited. Further investigation is required to determine its predictive capabilities for adverse outcomes. 
","Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a useful prognostic factor for maternal and neonatal adverse outcomes? Early identification of preeclampsia is essential for enhancing maternal and neonatal health. Although ACR is a valuable marker, studies indicate its prognostic value in the initial stages of preeclampsia may be limited. Additional investigation is required to determine its predictive potential for adverse outcomes.",2.3685972735685406e-08,0.01623690874695516,0.0006943117170558968,0.0018134264647818726,0.015837430372770633,0.00024020386511085755,0.0018108015409528666,0.015748356968136257,0.0,2.3685972735685406e-08,0.01600034134644357,0.0
129,0.1,1,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Does PET/CT provide additional benefits compared to multidetector CT in the preoperative staging of colorectal liver metastases? PET/CT has advantages over MDCT, especially in identifying small lesions, extrahepatic disease, and evaluating response to neoadjuvant therapy, though its role is still debated and requires more research.",2.3685972735685406e-07,0.12777805925046337,0.05536332179930796,0.018134264647818726,0.1829353004789378,0.018860946745562133,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
129,0.1,2,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","In preoperative staging of liver metastases from colorectal cancer, does PET/CT add value beyond multidetector CT? PET/CT can better detect small lesions, extrahepatic spread, and monitor neoadjuvant therapy response, but its utility remains controversial and further studies are necessary.",3.789755637709663e-07,0.27438153344233873,0.05536332179930796,0.029014823436509962,0.3332175035282745,0.018860946745562133,0.028972824655245866,0.3677247801253176,0.0,3.789755637709665e-07,0.37647757123491177,0.0
129,0.1,3,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Is PET/CT truly beneficial over multidetector CT for preoperative staging in colorectal liver metastases? PET/CT offers improved detection of small lesions, extrahepatic disease, and therapy response assessment, yet its role is debated and needs additional research.",4.500334819780222e-07,0.35661963167931177,0.05536332179930796,0.03445510283085559,0.4177748915563382,0.018860946745562133,0.03440522927810448,0.45473615711494775,0.0,4.500334819780227e-07,0.46608972992459874,0.0
129,0.1,4,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","When staging colorectal liver metastases preoperatively, does PET/CT contribute more than multidetector CT? PET/CT shows advantages in spotting small lesions, extrahepatic involvement, and evaluating neoadjuvant therapy response, but its role is still controversial and warrants further investigation.",4.263475092423369e-07,0.3284487547126149,0.05536332179930796,0.03264167636607371,0.38878735468308667,0.018860946745562133,0.032594427737151606,0.42488319396526597,0.0,4.263475092423373e-07,0.43531807125784505,0.0
129,0.1,5,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Does PET/CT enhance preoperative staging of colorectal liver metastases compared to multidetector CT? PET/CT is superior in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant treatment, although its role remains debated and more research is needed.",4.026615365066516e-07,0.3010497805244996,0.05536332179930796,0.030828249901291835,0.3606164777163898,0.018860946745562133,0.030783626196198732,0.39589565709201446,0.0,4.026615365066519e-07,0.4054651081081633,0.0
129,0.1,6,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","In the context of preoperative staging for colorectal liver metastases, does PET/CT add value over multidetector CT? PET/CT excels in identifying small lesions, extrahepatic disease, and therapy response, but its role is controversial and requires further study.",4.263475092423369e-07,0.3284487547126149,0.05536332179930796,0.03264167636607371,0.38878735468308667,0.018860946745562133,0.032594427737151606,0.42488319396526597,0.0,4.263475092423373e-07,0.43531807125784505,0.0
129,0.1,7,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","For preoperative staging of colorectal liver metastases, does PET/CT offer benefits beyond multidetector CT? PET/CT is advantageous in detecting small lesions, extrahepatic disease, and assessing neoadjuvant therapy response, yet its role is still debated and needs more research.",4.026615365066516e-07,0.3010497805244996,0.05536332179930796,0.030828249901291835,0.3606164777163898,0.018860946745562133,0.030783626196198732,0.39589565709201446,0.0,4.026615365066519e-07,0.4054651081081633,0.0
129,0.1,8,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Is PET/CT truly advantageous compared to multidetector CT in preoperative staging of colorectal liver metastases? PET/CT improves detection of small lesions, extrahepatic disease, and therapy response evaluation, but its role remains controversial and further research is necessary.",4.263475092423369e-07,0.3284487547126149,0.05536332179930796,0.03264167636607371,0.38878735468308667,0.018860946745562133,0.032594427737151606,0.42488319396526597,0.0,4.263475092423373e-07,0.43531807125784505,0.0
129,0.1,9,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","Does PET/CT provide additional insights over multidetector CT in preoperative staging of colorectal liver metastases? PET/CT offers benefits in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy, though its role is still debated and requires more investigation.",3.55289591035281e-07,0.24840604703908076,0.05536332179930796,0.02720139697172809,0.30654925644611364,0.018860946745562133,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
129,0.1,10,ai,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? 

Answer: PET/CT offers advantages over MDCT in preoperative staging of colorectal liver metastases, particularly in detecting small lesions, extrahepatic disease, and assessing response to neoadjuvant therapy. However, its role remains controversial and further research is needed. 
","In preoperative staging of colorectal liver metastases, does PET/CT add significant value compared to multidetector CT? PET/CT has advantages in identifying small lesions, extrahepatic disease, and evaluating neoadjuvant therapy response, but its role remains controversial and further research is needed.",3.55289591035281e-07,0.24840604703908076,0.05536332179930796,0.02720139697172809,0.30654925644611364,0.018860946745562133,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
130,0.1,1,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? A history of PIPE might increase the risk of IPE, but multivariate analysis shows it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.1,2,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How significant are postictal psychotic episodes II in the long term? Are they indicative of interictal psychotic episodes? While PIPE history may pose a risk for IPE, multivariate analysis suggests it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.1,3,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the lasting impact of postictal psychotic episodes II? Can they forecast interictal psychotic episodes? A history of PIPE could be a risk factor for IPE, but multivariate analysis reveals it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.1,4,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term relevance of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? Although PIPE history may increase IPE risk, multivariate analysis shows it is not an independent predictor.",3.0791764556390943e-07,0.3409265869705931,0.0,0.023574544042164372,0.3502024294331152,0.0,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
130,0.1,5,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How important are postictal psychotic episodes II over time? Do they predict interictal psychotic episodes? A history of PIPE might be linked to IPE risk, but multivariate analysis indicates it is not an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
130,0.1,6,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the enduring significance of postictal psychotic episodes II? Are they a predictor of interictal psychotic episodes? PIPE history may be a risk factor for IPE, yet multivariate analysis shows it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.1,7,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term impact of postictal psychotic episodes II? Can they predict interictal psychotic episodes? A history of PIPE may increase the risk of IPE, but multivariate analysis suggests it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.1,8,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the lasting significance of postictal psychotic episodes II? Are they indicative of interictal psychotic episodes? While PIPE history might be a risk factor for IPE, multivariate analysis indicates it is not an independent predictor.",2.3685972735685353e-07,0.2513144282809061,0.0,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
130,0.1,9,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How significant are postictal psychotic episodes II in the long run? Do they predict interictal psychotic episodes? A history of PIPE may raise the risk of IPE, but multivariate analysis shows it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,0.1,10,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term importance of postictal psychotic episodes II? Are they predictive of interictal psychotic episodes? Although a history of PIPE may be a risk factor for IPE, multivariate analysis reveals it is not an independent predictor.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
131,0.1,1,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a previous benign prostate biopsy influence the results for patients undergoing radical perineal prostatectomy? Answer: Having a prior benign prostate biopsy might be independently linked to better surgical and biochemical outcomes following prostatectomy. Further research is required to validate these results.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.1,2,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can a history of benign prostate biopsy predict outcomes in patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy could be independently associated with improved surgical and biochemical outcomes after prostatectomy. More studies are necessary to confirm these observations.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.1,3,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is prior benign prostate biopsy a predictor of outcomes for patients receiving radical perineal prostatectomy? Answer: A previous benign prostate biopsy may independently correlate with more favorable surgical and biochemical results post-prostatectomy. Additional investigations are needed to verify these findings.,2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
131,0.1,4,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does having a benign prostate biopsy before surgery predict the outcome for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy might be independently linked to better surgical and biochemical outcomes after prostatectomy. Further studies are needed to confirm this.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,0.1,5,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can prior benign prostate biopsy forecast outcomes in patients undergoing radical perineal prostatectomy? Answer: A history of benign prostate biopsy may be independently associated with improved surgical and biochemical outcomes following prostatectomy. Additional research is required to confirm these findings.,2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
131,0.1,6,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a previous benign prostate biopsy serve as a predictor for outcomes in radical perineal prostatectomy patients? Answer: Prior benign prostate biopsy could independently predict more favorable surgical and biochemical outcomes after prostatectomy. More studies are needed to validate these results.,0.0,0.03381205758829031,0.024062478942086886,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
131,0.1,7,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is a prior benign prostate biopsy indicative of outcomes for patients treated with radical perineal prostatectomy? Answer: Having a prior benign prostate biopsy may be independently linked to better surgical and biochemical outcomes post-prostatectomy. Further research is necessary to confirm these findings.,2.3685972735685406e-08,0.006494310048441143,0.02146814404432129,0.0018134264647818726,0.007428842118504253,0.02285318559556789,0.0018108015409528666,0.008450900812218443,0.02423822714681438,2.3685972735685406e-08,0.00957052285622595,0.025623268698060954
131,0.1,8,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a history of benign prostate biopsy predict surgical and biochemical outcomes in radical perineal prostatectomy? Answer: A prior benign prostate biopsy might be independently associated with more favorable outcomes after prostatectomy. Additional studies are needed to confirm this.,4.7371945471370706e-08,0.019666266328761672,0.021582468146067776,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,0.1,9,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can a prior benign prostate biopsy independently predict outcomes for patients undergoing radical perineal prostatectomy? Answer: A previous benign prostate biopsy may be linked to improved surgical and biochemical outcomes following prostatectomy. Further research is required to verify these findings.,2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
131,0.1,10,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is prior benign prostate biopsy a factor in predicting outcomes for patients treated with radical perineal prostatectomy? Answer: Prior benign prostate biopsy might be independently associated with better surgical and biochemical outcomes after prostatectomy. Additional studies are necessary to confirm these results.,2.3685972735685406e-08,0.026512698549651326,0.0017087642806799253,0.0018134264647818726,0.02638321546978606,0.0012092933465189942,0.0018108015409528666,0.02620645821577927,0.000639705252959033,2.3685972735685406e-08,0.025975486403257975,0.0
132,0.1,1,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Could neoadjuvant chemotherapy alter the scope of lymphadenectomy in cervical cancer? The occurrence and location of lymph node metastases (LNM), along with treatment response, are crucial considerations. Neoadjuvant chemotherapy may downstage the disease, potentially lessening the extent of lymphadenectomy required in certain cases.",1.6580180914979784e-07,0.1918729753679349,0.02710069444444446,0.012693985253473108,0.1576289442035832,0.0,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
132,0.1,2,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Is it possible to adjust the extent of lymphadenectomy in cervical cancer through neoadjuvant chemotherapy? Key factors include the frequency and anatomical distribution of lymph node metastases and how the disease responds to treatment. Neoadjuvant chemotherapy might reduce disease stage, thereby decreasing the need for extensive lymphadenectomy in some patients.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132,0.1,3,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Can neoadjuvant chemotherapy influence the degree of lymphadenectomy performed in cervical cancer? Important aspects to evaluate are the prevalence and location of lymph node metastases and the treatment response. This chemotherapy can downstage the cancer, which may reduce the necessity for extensive lymphadenectomy in select cases.",9.474389094274162e-08,0.0568660866847992,0.020399305555555556,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
132,0.1,4,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Does neoadjuvant chemotherapy have the potential to modify lymphadenectomy extent in cervical cancer? The frequency and topographic distribution of lymph node metastases, along with treatment response, are essential factors. Neoadjuvant chemotherapy can downstage the disease, possibly minimizing the need for extensive lymphadenectomy in some instances.",1.1842986367842703e-07,0.1108456325623095,0.002315675515293554,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
132,0.1,5,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Might the extent of lymphadenectomy be changed by neoadjuvant chemotherapy in cervical cancer? Considerations include the frequency and distribution of lymph node metastases and the response to treatment. Neoadjuvant chemotherapy can downstage the disease, potentially reducing the requirement for extensive lymphadenectomy in certain cases.",1.4211583641411244e-07,0.13456786450853064,0.002843324829931968,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
132,0.1,6,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Is the extent of lymphadenectomy in cervical cancer modifiable by neoadjuvant chemotherapy? The key factors are the frequency and location of lymph node metastases and the treatment response. Neoadjuvant chemotherapy may downstage the disease, thereby lessening the need for extensive lymphadenectomy in some situations.",1.4211583641411244e-07,0.13456786450853064,0.002843324829931968,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
132,0.1,7,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Could neoadjuvant chemotherapy impact the extent of lymphadenectomy in cervical cancer? The frequency and topographic distribution of lymph node metastases and treatment response are critical factors. Neoadjuvant chemotherapy can downstage the disease, which might reduce the necessity for extensive lymphadenectomy in some cases.",1.6580180914979784e-07,0.1918729753679349,0.02710069444444446,0.012693985253473108,0.1576289442035832,0.0,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
132,0.1,8,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Can the scope of lymphadenectomy be altered by neoadjuvant chemotherapy in cervical cancer? Important factors include the frequency and distribution of lymph node metastases and the response to treatment. Neoadjuvant chemotherapy may downstage the disease, potentially decreasing the need for extensive lymphadenectomy in certain patients.",1.1842986367842703e-07,0.1108456325623095,0.002315675515293554,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
132,0.1,9,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Is it feasible to modify the extent of lymphadenectomy with neoadjuvant chemotherapy in cervical cancer? The frequency and topographic distribution of lymph node metastases and treatment response are key considerations. Neoadjuvant chemotherapy can downstage the disease, possibly reducing the extent of lymphadenectomy required in some cases.",9.474389094274162e-08,0.180092252117678,0.0676435260922731,0.0072537058591274906,0.15002475704053397,0.045351473922902494,0.007243206163811466,0.12118688976346981,0.023242630385487524,9.474389094274162e-08,0.09097177820572666,0.0
132,0.1,10,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? 
Answer: The frequency and topographic distribution of LNM,  as well as the response to treatment, are key factors to consider.  Neoadjuvant chemotherapy can potentially downstage the disease, reducing the need for extensive lymphadenectomy in some cases. 
","Could the application of neoadjuvant chemotherapy change the extent of lymphadenectomy in cervical cancer? The frequency and anatomical distribution of lymph node metastases, along with treatment response, are important factors. Neoadjuvant chemotherapy may downstage the disease, thereby reducing the need for extensive lymphadenectomy in some patients.",9.474389094274162e-08,0.1184791694012386,0.023948990820864127,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
133,0.1,1,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental factors significant in primary systemic vasculitis? A notable link between farming and PSV has been discovered for the first time. The findings also confirm earlier reported connections with silica, solvents, and allergies.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
133,0.1,2,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Do environmental factors play a role in primary systemic vasculitis? For the first time, a strong association between farming and PSV has been found. The results also back previously noted links with silica, solvents, and allergic reactions.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.1,3,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is there an importance of environmental factors in primary systemic vasculitis? A significant correlation between farming and PSV has been identified for the first time. The data also support earlier reported associations with silica, solvents, and allergies.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.1,4,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental influences relevant in primary systemic vasculitis? A first-time significant association between farming and PSV has been established. The findings also reinforce previously reported links with silica, solvents, and allergy.",9.47438909427412e-08,0.125163142954007,0.0,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
133,0.1,5,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Do environmental factors matter in primary systemic vasculitis? A significant connection between farming and PSV has been identified for the first time. The results also uphold earlier reported associations with silica, solvents, and allergies.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
133,0.1,6,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is there a significant role of environmental factors in primary systemic vasculitis? For the first time, a strong association between farming and PSV has been found. The findings also support previously reported links with silica, solvents, and allergy.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
133,0.1,7,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental factors crucial in primary systemic vasculitis? A significant association between farming and PSV has been discovered for the first time. The results also confirm earlier reported connections with silica, solvents, and allergies.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
133,0.1,8,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Do environmental factors influence primary systemic vasculitis? A significant link between farming and PSV has been identified for the first time. The findings also back previously reported associations with silica, solvents, and allergy.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
133,0.1,9,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is the role of environmental factors important in primary systemic vasculitis? For the first time, a significant association between farming and PSV has been found. The results also support earlier reported links with silica, solvents, and allergies.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
133,0.1,10,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental factors key in primary systemic vasculitis? A significant association between farming and PSV has been identified for the first time. The findings also confirm previously reported connections with silica, solvents, and allergy.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
134,0.1,1,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
134,0.1,2,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies providing income support could be an important tool for enhancing the health and quality of life of elderly individuals. Although the SSI program mainly offers financial aid, its effects on health measures such as disability deserve more investigation.",7.105791820705622e-08,0.05826890812397556,0.0,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
134,0.1,3,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support initiatives might serve as a crucial mechanism to boost the health and welfare of senior citizens. Even though SSI focuses on monetary help, its influence on health outcomes like disability warrants additional study.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
134,0.1,4,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Financial assistance policies may represent a valuable approach to improving older adults' health and well-being. The SSI program, while centered on income support, could have significant effects on health indicators including disability that need further research.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
134,0.1,5,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support programs might be a key strategy for enhancing the health and overall well-being of the elderly. Although SSI primarily delivers financial aid, its potential impact on disability and other health outcomes calls for more detailed examination.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
134,0.1,6,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Providing income support could be an effective way to improve health and quality of life among older adults. The SSI program mainly offers financial assistance, but its role in influencing health outcomes such as disability requires further study.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
134,0.1,7,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies may offer a promising avenue for advancing the health and well-being of seniors. While the SSI program is chiefly financial in nature, its effects on disability and health outcomes should be explored more thoroughly.",2.3685972735685406e-08,0.019802627296179764,0.0,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
134,0.1,8,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Financial support policies could be an important factor in promoting better health and well-being among older populations. Although SSI primarily provides monetary aid, its impact on disability and related health outcomes merits further investigation.",4.737194547137081e-08,0.04082199452025437,0.0,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
134,0.1,9,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support may be a vital tool for enhancing the health and welfare of elderly individuals. The SSI program mainly offers financial assistance, but its influence on health outcomes, including disability, needs more research.",4.737194547137081e-08,0.04082199452025437,0.0,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
134,0.1,10,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? 

Answer: Income support policy may be a significant new lever for improving the health and well-being of older adults. While the SSI program primarily provides financial assistance, its impact on health outcomes, including disability, merits further exploration. 
","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies that provide income support might play a significant role in improving the health and well-being of older adults. While SSI focuses on financial aid, its effects on disability and other health outcomes require further exploration.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
135,0.1,1,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is primary angioplasty a viable alternative to thrombolysis? Reorganizing care to provide primary angioplasty services significantly reduced mortality, especially in patients with ST-segment elevation myocardial infarction (STEMI).",3.079176455639089e-07,0.4232381127379048,0.012776731301939057,0.023574544042164414,0.41871033485818643,0.0,0.023540420032387342,0.4328640822962804,0.0,3.079176455639103e-07,0.4480247225269607,0.0
135,0.1,2,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Can primary angioplasty be considered an acceptable substitute for thrombolysis? Implementing primary angioplasty services led to a notable decrease in mortality, particularly among patients with ST-segment elevation myocardial infarction (STEMI).",2.36859727356853e-07,0.30852306071540747,0.008815506812143138,0.018134264647818775,0.3053816495511823,0.0,0.01810801540952872,0.3150810466398961,0.0,2.3685972735685406e-07,0.3254224004346278,0.0
135,0.1,3,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is it acceptable to use primary angioplasty instead of thrombolysis? The reorganization of care to include primary angioplasty was linked to a significant drop in mortality, most notably in patients with ST-segment elevation myocardial infarction (STEMI).",9.47438909427412e-08,0.11227598569845831,0.0029234441047072054,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
135,0.1,4,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Does primary angioplasty serve as an acceptable alternative to thrombolysis? Offering primary angioplasty through care reorganization resulted in a marked reduction in mortality, especially for patients with ST-segment elevation myocardial infarction (STEMI).",1.894877818854824e-07,0.2387476053243649,0.006598953524161247,0.014507411718255016,0.23638877806423153,0.0,0.014486412327622974,0.24362208265775243,0.0,1.8948778188548325e-07,0.2513144282809061,0.0
135,0.1,5,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is primary angioplasty an effective alternative to thrombolysis? Care restructuring to provide primary angioplasty services was associated with a significant mortality reduction, particularly in patients with ST-segment elevation myocardial infarction (STEMI).",2.131737546211677e-07,0.2730280672453351,0.007670429280535962,0.016320838183036895,0.2702903297399133,0.0,0.016297213868575848,0.27871340246902143,0.0,2.1317375462116866e-07,0.2876820724517808,0.0
135,0.1,6,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Could primary angioplasty replace thrombolysis as an acceptable treatment? The introduction of primary angioplasty services through care reorganization significantly lowered mortality rates, especially in patients with ST-segment elevation myocardial infarction (STEMI).",2.131737546211677e-07,0.2730280672453351,0.007670429280535962,0.016320838183036895,0.2702903297399133,0.0,0.016297213868575848,0.27871340246902143,0.0,2.1317375462116866e-07,0.2876820724517808,0.0
135,0.1,7,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is primary angioplasty a suitable alternative to thrombolysis? Reorganizing healthcare to offer primary angioplasty led to a significant decrease in mortality, most evident in patients with ST-segment elevation myocardial infarction (STEMI).",2.131737546211677e-07,0.2730280672453351,0.007670429280535962,0.016320838183036895,0.2702903297399133,0.0,0.016297213868575848,0.27871340246902143,0.0,2.1317375462116866e-07,0.2876820724517808,0.0
135,0.1,8,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is primary angioplasty considered an acceptable alternative to thrombolysis? The establishment of primary angioplasty services was linked to a significant mortality reduction, particularly in patients with ST-segment elevation myocardial infarction (STEMI).",2.131737546211677e-07,0.2730280672453351,0.007670429280535962,0.016320838183036895,0.2702903297399133,0.0,0.016297213868575848,0.27871340246902143,0.0,2.1317375462116866e-07,0.2876820724517808,0.0
135,0.1,9,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Can primary angioplasty be used as an alternative to thrombolysis? Care reorganization to provide primary angioplasty was associated with a significant decline in mortality, especially in patients with ST-segment elevation myocardial infarction (STEMI).",1.658018091497971e-07,0.20560143285543164,0.005594213091741351,0.012693985253473136,0.20359895524123983,0.0,0.012675610786670101,0.20972053098207066,0.0,1.6580180914979784e-07,0.2162231084696371,0.0
135,0.1,10,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was associated with a significant reduction in mortality. This benefit was most pronounced in patients with ST-segment elevation myocardial infarction (STEMI).  
","Is primary angioplasty an acceptable treatment alternative to thrombolysis? The reorganization of care to offer primary angioplasty services resulted in a significant reduction in mortality, most notably in patients with ST-segment elevation myocardial infarction (STEMI).",1.184298636784265e-07,0.14242847581634832,0.003761487959422983,0.009067132323909377,0.14107859825990632,0.0,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
136,0.1,1,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","This article examines whether culture, attitudes, and faith have a role in recovery outcome measures, focusing on the cultural relevance of the RAQ and how cultural, personal, and religious factors affect self-reported recovery.",5.210914001850781e-07,0.47190390816751515,0.036982248520710054,0.039895382225201226,0.5363047090669744,0.0,0.0398376339009631,0.550046336919273,0.0,5.210914001850789e-07,0.564529802737852,0.0
136,0.1,2,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","The paper explores the cultural suitability of the RAQ recovery outcome measure, considering how cultural background, individual attitudes, and religious beliefs impact reported recovery progress.",7.105791820705605e-07,0.7595859806192964,0.036982248520710054,0.05440279394345626,0.8347976976229714,0.0,0.05432404622858609,0.8602012652231124,0.0,7.105791820705622e-07,0.8873031950009036,0.0
136,0.1,3,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","This study addresses the importance of culture, attitudes, and faith in recovery outcome assessments, analyzing the RAQ's cultural appropriateness and the influence of these factors on self-reported recovery.",6.395212638635046e-07,0.6418029449629121,0.036982248520710054,0.048962514549110624,0.7121953755306385,0.0,0.04889164160572747,0.7323678937132279,0.0,6.39521263863506e-07,0.75377180237638,0.0
136,0.1,4,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","The discussion centers on the RAQ as a recovery outcome tool, evaluating the role of cultural factors, personal attitudes, and faith in shaping recovery reports and the need for culturally sensitive measures.",5.447773729207634e-07,0.503652606482095,0.036982248520710054,0.041708808689983105,0.5690945318899661,0.0,0.041648435441915974,0.5839478885949547,0.0,5.447773729207643e-07,0.599621122549121,0.0
136,0.1,5,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","This paper investigates the place of culture, attitudes, and religious faith in recovery outcome measures, highlighting the RAQ's cultural relevance and the impact of these elements on recovery self-assessments.",6.158352911278193e-07,0.6054353007920374,0.036982248520710054,0.047149088084328744,0.6744550475477915,0.0,0.047080840064774594,0.6931471805599454,0.0,6.158352911278206e-07,0.7129498078561252,0.0
136,0.1,6,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","Focusing on the RAQ, this article considers how culture, individual attitudes, and faith contribute to recovery outcome measures and emphasizes the necessity for culturally tailored assessments.",6.868932093348752e-07,0.7187639860990416,0.036982248520710054,0.05258936747867438,0.7922380832041758,0.0,0.052513244687633215,0.8157495026522783,0.0,6.868932093348768e-07,0.8407831793660097,0.0
136,0.1,7,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","The research explores the integration of cultural, attitudinal, and faith-based factors in recovery outcome measures, particularly the RAQ, and their effect on self-reported recovery progress.",7.105791820705605e-07,0.7595859806192964,0.036982248520710054,0.05440279394345626,0.8347976976229714,0.0,0.05432404622858609,0.8602012652231124,0.0,7.105791820705622e-07,0.8873031950009036,0.0
136,0.1,8,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","This paper discusses the significance of cultural appropriateness in the RAQ recovery measure, examining how culture, attitudes, and religious beliefs influence recovery outcomes.",7.579511275419311e-07,0.8465973576089261,0.036982248520710054,0.05802964687302002,0.9257694758286994,0.0,0.057945649310491835,0.9555114450274376,0.0,7.579511275419329e-07,0.987386653557885,0.0
136,0.1,9,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","The study highlights the role of culture, attitudes, and faith in recovery outcome measures, analyzing the RAQ's effectiveness across diverse cultural contexts and the need for sensitive interventions.",6.395212638635046e-07,0.6418029449629121,0.036982248520710054,0.048962514549110624,0.7121953755306385,0.0,0.04889164160572747,0.7323678937132279,0.0,6.39521263863506e-07,0.75377180237638,0.0
136,0.1,10,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ, a widely used recovery outcome measure, exploring the influence of cultural factors, individual attitudes, and religious beliefs on self-reported recovery progress. It highlights the need for culturally sensitive assessments and tailored interventions. 
","This article evaluates the impact of cultural, attitudinal, and faith-related factors on recovery outcome measures, focusing on the RAQ and advocating for culturally informed assessment practices.",6.868932093348752e-07,0.7187639860990416,0.036982248520710054,0.05258936747867438,0.7922380832041758,0.0,0.052513244687633215,0.8157495026522783,0.0,6.868932093348768e-07,0.8407831793660097,0.0
137,0.1,1,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Is cholecystectomy truly an indication for simultaneous splenectomy in cases of mild hereditary spherocytosis? The recommendation to carry out a splenectomy alongside cholecystectomy in mild hereditary spherocytosis is still debated. Although splenectomy may reduce anemia, the potential benefits need to be balanced against the heightened risk of complications and the lifelong vulnerability to infections in patients with a mild disease form.",2.3685972735685406e-08,0.06419175608347327,0.034039651841776646,0.0018134264647818726,0.040996060275159785,0.017236072637734686,0.0018108015409528666,0.01739174271186883,0.0,2.3685972735685406e-08,0.01769957709940062,0.0
137,0.1,2,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Does cholecystectomy warrant a concurrent splenectomy in mild hereditary spherocytosis? The suggestion to perform splenectomy during cholecystectomy in mild hereditary spherocytosis is controversial. While splenectomy can improve anemia, its advantages must be considered alongside the increased risk of complications and lifelong infection susceptibility in mild cases.",3.316036182995957e-07,0.3044327709524022,0.06324404761904762,0.025387970506946217,0.2838584397377497,0.005478908433114424,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
137,0.1,3,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Is performing a splenectomy alongside cholecystectomy justified in mild hereditary spherocytosis? The indication for concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains a matter of debate. Splenectomy may relieve anemia, but the benefits must be weighed against the risks of complications and lifelong infection susceptibility in mild disease.",2.6054570009253947e-07,0.2333912897771584,0.055965136054421716,0.0199476911126006,0.21588940662517953,0.004030468004987416,0.019918816950481533,0.21440987134545564,0.0,2.6054570009253947e-07,0.21868920096483002,0.0
137,0.1,4,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Should splenectomy be done at the same time as cholecystectomy in mild hereditary spherocytosis? The recommendation for concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis is controversial. Although splenectomy can reduce anemia, the risks of complications and lifelong infection vulnerability must be carefully considered in mild cases.",3.079176455639103e-07,0.3103287990274781,0.08308531746031746,0.023574544042164344,0.2914919765766788,0.027112223738684996,0.023540420032387266,0.29036832394174095,0.02271498107084911,3.079176455639103e-07,0.26415157504158726,0.0
137,0.1,5,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Is concomitant splenectomy indicated during cholecystectomy for mild hereditary spherocytosis? The advice to perform splenectomy alongside cholecystectomy in mild hereditary spherocytosis is debated. While splenectomy can alleviate anemia, its benefits must be balanced against the increased risk of complications and lifelong susceptibility to infections in mild disease.",3.079176455639103e-07,0.2386801715056448,0.007313100860178785,0.023574544042164344,0.2298788938602394,0.017236072637734686,0.023540420032387266,0.25886163391628836,0.0,3.079176455639103e-07,0.26415157504158726,0.0
137,0.1,6,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
",Does mild hereditary spherocytosis require splenectomy when undergoing cholecystectomy? The recommendation for simultaneous splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial. Splenectomy may help anemia but must be weighed against the risks of complications and lifelong infection susceptibility.,4.974054274493933e-07,0.4424246015051483,0.0017676051902242376,0.038081955760419325,0.46309088615173577,0.009770100201771478,0.0380268323600102,0.4595323293784399,0.0,4.974054274493935e-07,0.47000362924573613,0.0
137,0.1,7,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Is it necessary to perform splenectomy with cholecystectomy in mild hereditary spherocytosis? The indication for concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis is still controversial. While splenectomy can improve anemia, the increased risk of complications and lifelong infection susceptibility must be considered.",4.026615365066519e-07,0.3683993076308725,0.0203043865475184,0.030828249901291835,0.3905934321028308,0.03141612986062166,0.030783626196198732,0.3888291727486104,0.02498356344510192,4.026615365066519e-07,0.3617900446055051,0.0
137,0.1,8,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Should a splenectomy be performed concurrently with cholecystectomy in mild hereditary spherocytosis? The advice to do a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis is debated. Although splenectomy can relieve anemia, the risks of complications and lifelong infection vulnerability must be weighed.",4.026615365066519e-07,0.3683993076308725,0.0203043865475184,0.030828249901291835,0.3905934321028308,0.03141612986062166,0.030783626196198732,0.3888291727486104,0.02498356344510192,4.026615365066519e-07,0.3617900446055051,0.0
137,0.1,9,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
","Is concomitant splenectomy justified during cholecystectomy in mild hereditary spherocytosis? The recommendation to perform splenectomy alongside cholecystectomy in mild hereditary spherocytosis remains controversial. While splenectomy can alleviate anemia, its benefits must be balanced against the increased risk of complications and lifelong susceptibility to infections.",3.789755637709665e-07,0.3425659956673224,0.01867346938775509,0.029014823436509962,0.3648857825433751,0.03026392736226533,0.028972824655245866,0.3632912587185322,0.024375,3.789755637709665e-07,0.3364722366212134,0.0
137,0.1,10,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? 

Answer: The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis remains controversial.  While splenectomy can alleviate anemia, its benefits must be weighed against the increased risk of complications and lifelong susceptibility to infections in a patient with a mild form of the disease. 
",Does mild hereditary spherocytosis justify splenectomy at the time of cholecystectomy? The advice to perform a concomitant splenectomy during cholecystectomy in mild hereditary spherocytosis is controversial. Splenectomy can reduce anemia but must be weighed against the risks of complications and lifelong infection susceptibility.,4.026615365066519e-07,0.3353922990327778,0.0032015306122448878,0.030828249901291835,0.35678137451454095,0.007138927362265315,0.030783626196198732,0.354171813720614,0.0,4.026615365066519e-07,0.3617900446055051,0.0
138,0.1,1,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is aneurysm repair warranted for patients aged 80 or above following aneurysmal subarachnoid hemorrhage? Surgical intervention tends to yield better outcomes in patients under 80, but the decision must weigh risks and benefits individually, factoring in health status, life expectancy, and patient wishes.",3.079176455639103e-07,0.2696635669491032,0.0,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
138,0.1,2,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Should aneurysm repair be performed on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Surgery shows improved prognosis in those younger than 80, yet each case requires careful assessment of risks versus benefits, considering overall health, expected lifespan, and patient preferences.",3.316036182995957e-07,0.2937611185281632,0.0,0.025387970506946217,0.30010459245033916,0.0,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
138,0.1,3,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is it appropriate to conduct aneurysm repair in patients aged 80 and above after aneurysmal subarachnoid hemorrhage? Patients under 80 generally have better surgical outcomes, but the risk-benefit balance should be evaluated on a case-by-case basis, taking into account health, life expectancy, and patient choices.",2.6054570009253947e-07,0.22314355131420927,0.0,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
138,0.1,4,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Does aneurysm repair justify treatment in patients aged 80 or older following aneurysmal subarachnoid hemorrhage? Surgery offers better prognosis for those under 80, but individual evaluation of risks and benefits is essential, including health condition, life expectancy, and patient preferences.",3.789755637709664e-07,0.34377153910282665,0.0,0.029014823436509962,0.35139788683788886,0.0,0.028972824655245866,0.3593740009078954,0.0,3.789755637709665e-07,0.3677247801253176,0.0
138,0.1,5,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is aneurysm repair advisable for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? While patients younger than 80 tend to have better surgical outcomes, the decision should be personalized by assessing risks, benefits, overall health, life expectancy, and patient desires.",3.552895910352811e-07,0.3184537311185349,0.0,0.02720139697172809,0.3254224004346309,0.0,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
138,0.1,6,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is aneurysm repair justified in patients aged 80 or above after aneurysmal subarachnoid hemorrhage? Surgery results are more favorable in patients under 80, but each case requires a thorough risk-benefit analysis considering health status, longevity, and patient preferences.",4.26347509242337e-07,0.4338826877536479,0.027006172839506164,0.03264167636607371,0.40546510810816505,0.0,0.0325944277371516,0.41494385206270756,0.0,4.263475092423373e-07,0.42488319396526597,0.0
138,0.1,7,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Should aneurysm repair be considered for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Better outcomes are seen in those younger than 80, but the risk-benefit ratio must be carefully weighed individually, factoring in overall health, life expectancy, and patient preferences.",3.316036182995957e-07,0.2937611185281632,0.0,0.025387970506946217,0.30010459245033916,0.0,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
138,0.1,8,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is aneurysm repair appropriate for patients aged 80 or older following aneurysmal subarachnoid hemorrhage? Patients under 80 generally have better prognoses post-surgery, but the decision should be individualized by evaluating risks, benefits, health, life expectancy, and patient preferences.",4.26347509242337e-07,0.3964152725882455,0.0,0.03264167636607371,0.40546510810816505,0.0,0.0325944277371516,0.41494385206270756,0.0,4.263475092423373e-07,0.42488319396526597,0.0
138,0.1,9,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is aneurysm repair warranted for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Surgery tends to yield better results in those younger than 80, but the risk-benefit ratio should be assessed carefully for each patient, considering health, life expectancy, and patient preferences.",3.079176455639103e-07,0.2696635669491032,0.0,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
138,0.1,10,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when surgery was performed in patients younger than 80 years of age. However, the risk-benefit ratio should be carefully evaluated in each individual case, considering factors such as overall health, life expectancy, and patient preferences. 
","Is aneurysm repair indicated for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? While surgery shows better prognosis in patients under 80, the risk-benefit balance must be evaluated individually, taking into account overall health, life expectancy, and patient preferences.",3.789755637709664e-07,0.34377153910282665,0.0,0.029014823436509962,0.35139788683788886,0.0,0.028972824655245866,0.3593740009078954,0.0,3.789755637709665e-07,0.3677247801253176,0.0
139,0.1,1,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during",Does blood pressure vary in treated hypertensive patients based on whether a physician or a nurse takes the measurement? Systolic BP readings taken by nurses are significantly lower than those taken by physicians and closely match ambulatory BP monitoring. Nurse-measured blood pressure is preferred for diagnosis and assessing blood pressure control.,5.447773729207643e-07,0.28683049125439997,0.08104087238993885,0.041708808689983126,0.32708355585876614,0.041587901701323246,0.041648435441915946,0.3719535934415963,0.014081632653061225,5.447773729207643e-07,0.3983476403393005,0.0
139,0.1,2,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In treated hypertensive patients, does blood pressure differ when measured by a physician versus a nurse? Systolic blood pressure recorded by nurses is notably lower than that recorded by physicians and aligns closely with ambulatory blood pressure monitoring. Measuring blood pressure by nurses is beneficial for diagnosis and monitoring control levels.",5.447773729207643e-07,0.3872690772687002,0.07078262202995861,0.041708808689983126,0.3553752775142742,0.02118859614576769,0.041648435441915946,0.3719535934415963,0.014081632653061225,5.447773729207643e-07,0.3983476403393005,0.0
139,0.1,3,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Is there a difference in blood pressure readings in treated hypertensive patients depending on whether a nurse or physician measures it? Nurses record significantly lower systolic BP than physicians, with values nearly identical to ambulatory monitoring. Nurse measurements are recommended for diagnosis and evaluating blood pressure control.",6.39521263863506e-07,0.3067063095883551,0.1616212143132716,0.04896251454911062,0.4122413641990734,0.041587901701323246,0.04889164160572741,0.4589649704312255,0.014081632653061225,6.39521263863506e-07,0.4872951263557961,0.0
139,0.1,4,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","For treated hypertensive patients, does blood pressure change depending on if a nurse or physician measures it? Systolic BP measured by nurses is significantly lower than physician measurements and closely matches ambulatory BP monitoring. Nurse measurements are useful for diagnosis and assessing blood pressure control.",6.868932093348768e-07,0.35252792824725177,0.1606346283041509,0.05258936747867436,0.45770373827583066,0.041587901701323246,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
139,0.1,5,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does the blood pressure of treated hypertensive patients differ when measured by a nurse compared to a physician? Nurses obtain significantly lower systolic BP readings than physicians, which are almost the same as ambulatory BP monitoring. Blood pressure measurement by nurses is preferred for diagnosis and control evaluation.",6.158352911278206e-07,0.2845588951346816,0.1620830687322779,0.047149088084328744,0.3902624574802984,0.041587901701323246,0.047080840064774546,0.4364921145791678,0.014081632653061225,6.158352911278206e-07,0.46430560813109656,0.0
139,0.1,6,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In patients treated for hypertension, does blood pressure vary based on whether a nurse or physician measures it? Systolic BP taken by nurses is significantly lower than that by physicians and nearly identical to ambulatory BP monitoring. Nurse measurements are desirable for diagnosis and control assessment.",6.632072365991914e-07,0.29854838236974146,0.183349609375,0.05077594101389249,0.43471422005113114,0.041587901701323246,0.05070244314668028,0.48195448865592505,0.014081632653061225,6.632072365991914e-07,0.5108256237659905,0.0
139,0.1,7,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does blood pressure in treated hypertensive patients differ when measured by a physician versus a nurse? Nurses record systolic BP significantly lower than physicians, closely matching ambulatory BP monitoring. Nurse-measured blood pressure is recommended for diagnosis and control evaluation.",8.29009045748989e-07,0.5041061429694609,0.15705304253789262,0.0634699262673656,0.6079859413251674,0.041587901701323246,0.06337805393335035,0.6596356658933771,0.014081632653061225,8.290090457489892e-07,0.693147180559945,0.0
139,0.1,8,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during",Is there a difference in blood pressure readings in treated hypertensive patients when measured by a nurse compared to a physician? Systolic BP measured by nurses is significantly lower than by physicians and nearly identical to ambulatory BP monitoring. Nurse measurements are preferred for diagnosis and control assessment.,6.158352911278206e-07,0.2845588951346816,0.1620830687322779,0.047149088084328744,0.3902624574802984,0.041587901701323246,0.047080840064774546,0.4364921145791678,0.014081632653061225,6.158352911278206e-07,0.46430560813109656,0.0
139,0.1,9,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In treated hypertensive patients, does blood pressure change depending on whether a nurse or physician measures it? Nurses measure systolic BP significantly lower than physicians, with readings almost identical to ambulatory BP monitoring. Blood pressure measurement by nurses is desirable for diagnosis and control evaluation.",6.868932093348768e-07,0.35252792824725177,0.1606346283041509,0.05258936747867436,0.45770373827583066,0.041587901701323246,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
139,0.1,10,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during",Does blood pressure in treated hypertensive patients vary depending on whether it is measured by a nurse or a physician? Systolic BP measured by nurses is significantly lower than that measured by physicians and closely matches ambulatory BP monitoring. Nurse measurement is recommended for diagnosis and evaluating blood pressure control.,5.684633456564497e-07,0.30894427254217316,0.07890726532963141,0.043522235154765,0.3477028430615019,0.041587901701323246,0.04345923698286881,0.39300700263942945,0.014081632653061225,5.684633456564497e-07,0.41985384556026384,0.0
140,0.1,1,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the use of audits to identify maternal mortality merely a reflection of disparities between wealthy and impoverished settings? Answer: Variations in maternal mortality extend beyond simple economic divides. Recognizing the scale of maternal deaths and mobilizing robust political commitment are crucial. Nonetheless, no universal remedy exists to lower maternal mortality, and problem identification must be tailored.",3.789755637709665e-07,0.16960967565654617,0.07999633677000212,0.029014823436510018,0.2128062515831317,0.027755102040816333,0.02897282465524588,0.23582141911701626,0.014081632653061225,3.789755637709665e-07,0.25951119548508306,0.0
140,0.1,2,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality only highlight the gap between rich and poor areas? Answer: Maternal mortality differences are more complex than just economic status. It is vital to understand the extent of the issue and to engage strong political will to address it. However, there is no one-size-fits-all solution, and identifying the underlying problems is essential.",4.026615365066519e-07,0.18774355550065902,0.07968336240670308,0.03082824990129189,0.23082475708581018,0.027755102040816333,0.030783626196198746,0.254170557785212,0.014081632653061225,4.026615365066519e-07,0.2782033284972374,0.0
140,0.1,3,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the disparity in maternal mortality identified through audits solely a matter of wealth differences? Answer: The gap in maternal mortality involves more than just wealth disparities. Recognizing the severity of maternal deaths and fostering political determination are key. Still, reducing maternal mortality requires more than a single solution, and problem identification is necessary.",4.500334819780227e-07,0.31173419485711484,0.01606539792387543,0.034455102830855636,0.29402252614578117,0.0088941552952542,0.03440522927810448,0.29191088576805946,0.014081632653061225,4.500334819780227e-07,0.3166696093250332,0.0
140,0.1,4,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality simply reveal differences between rich and poor populations? Answer: Differences in maternal mortality go beyond economic status. Acknowledging the problem's scale and securing political will are important. Yet, no single approach can reduce maternal mortality, and identifying specific issues is needed.",6.632072365991914e-07,0.41248404137513894,0.07532385827447169,0.05077594101389249,0.45396830840001945,0.027755102040816333,0.05070244314668028,0.48195448865592505,0.014081632653061225,6.632072365991914e-07,0.5108256237659905,0.0
140,0.1,5,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the use of audits to detect maternal mortality just about the divide between affluent and poor communities? Answer: Maternal mortality differences surpass the rich-poor divide. Understanding the magnitude and applying strong political resolve are critical. However, there is no universal fix, and problem identification must be conducted carefully.",5.684633456564497e-07,0.32481141333212005,0.07713529652056902,0.043522235154765,0.3669569314103902,0.027755102040816333,0.04345923698286881,0.39300700263942945,0.014081632653061225,5.684633456564497e-07,0.41985384556026384,0.0
140,0.1,6,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing maternal mortality only reflect economic disparities? Answer: Maternal mortality variations are more complex than economic differences alone. Recognizing the extent and harnessing political will are vital. Nonetheless, no single solution exists, and identifying the problems is essential.",8.053230730133037e-07,0.5603243529170783,0.07191133337806363,0.061656499802583725,0.6005717825918948,0.027755102040816333,0.06156725239239748,0.6322366917052618,0.014081632653061225,8.053230730133038e-07,0.6649763035932481,0.0
140,0.1,7,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the identification of maternal mortality through audits merely a contrast between wealthy and poor settings? Answer: The differences in maternal mortality are more than economic contrasts. Acknowledging the scale and political commitment are important. However, no general solution exists, and problem identification is necessary.",6.632072365991914e-07,0.41248404137513894,0.07532385827447169,0.05077594101389249,0.45396830840001945,0.027755102040816333,0.05070244314668028,0.48195448865592505,0.014081632653061225,6.632072365991914e-07,0.5108256237659905,0.0
140,0.1,8,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does the use of audits to identify maternal mortality simply highlight the rich-poor gap? Answer: Maternal mortality differences involve more than economic status. Recognizing the magnitude and political will are crucial. Still, no single solution can reduce maternal mortality, and problem identification is required.",6.868932093348768e-07,0.43565704589442955,0.07481962100527546,0.05258936747867436,0.476957826624719,0.027755102040816333,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
140,0.1,9,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is auditing maternal mortality just about distinguishing between rich and poor areas? Answer: Differences in maternal mortality exceed economic divides. Understanding the scale and political determination are key. However, no universal solution exists, and identifying problems is essential.",8.29009045748989e-07,0.5872352606166387,0.0712380352390172,0.0634699262673656,0.6272400296740557,0.027755102040816333,0.06337805393335035,0.6596356658933771,0.014081632653061225,8.290090457489892e-07,0.693147180559945,0.0
140,0.1,10,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does the use of audits to detect maternal mortality only show disparities between rich and poor? Answer: Maternal mortality differences are more complex than just economic status. Recognizing the problem's magnitude and political will are important. Yet, no single solution exists, and problem identification is necessary.",6.39521263863506e-07,0.3898354272355329,0.07580620701439618,0.04896251454911062,0.43149545254796173,0.027755102040816333,0.04889164160572741,0.4589649704312255,0.014081632653061225,6.39521263863506e-07,0.4872951263557961,0.0
141,0.1,1,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is it possible for visceral adipose tissue area measurement at a single level to represent visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is practical and can indicate changes in VAT volume and body weight. New insights: VAT area at a CT slice 3 cm above...,9.474389094274162e-08,0.00041498207223256145,0.0827715118700541,0.0072537058591274906,0.001632036846618501,0.05091477415155428,0.007243206163811466,0.024597459256582077,0.03566529492455417,9.474389094274162e-08,0.050302200487784,0.0181755829903978
141,0.1,2,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can visceral adipose tissue area measured at one level accurately reflect visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower edge of the L3 vertebra is feasible and can mirror changes in VAT volume and body weight. Knowledge update: VAT area at a CT slice 3 cm above...,9.474389094274162e-08,0.00041498207223256145,0.08277151187005406,0.0072537058591274906,0.001632036846618501,0.05091477415155428,0.007243206163811466,0.024597459256582077,0.03566529492455417,9.474389094274162e-08,0.050302200487784,0.0181755829903978
141,0.1,3,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Does measuring visceral adipose tissue area at a single level represent the volume of visceral adipose tissue? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is achievable and reflects changes in VAT volume and body weight. Advances: VAT area at a CT slice 3 cm above...,9.474389094274162e-08,0.08629115176340019,0.01274555765595467,0.0072537058591274906,0.053945031605859395,0.013375720897116382,0.007243206163811466,0.051256966201195464,0.01644191929979446,9.474389094274162e-08,0.050302200487784,0.0181755829903978
141,0.1,4,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can a single-level measurement of visceral adipose tissue area represent the total visceral adipose tissue volume? Measuring VAT area 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. New knowledge: VAT area at a CT slice 3 cm above...,1.6580180914979784e-07,0.037111812274734035,0.09653671344499769,0.012693985253473108,0.061470334813371164,0.049784050759673674,0.012675610786670066,0.08402087972738315,0.03566529492455417,1.6580180914979784e-07,0.11092682230421813,0.0181755829903978
141,0.1,5,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is a single-level visceral adipose tissue area measurement indicative of visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is practical and can reflect changes in VAT volume and body weight. Advances in understanding: VAT area at a CT slice 3 cm above...,9.474389094274162e-08,0.02525713572628474,0.06502499999999997,0.0072537058591274906,0.001632036846618501,0.05091477415155428,0.007243206163811466,0.024597459256582077,0.03566529492455417,9.474389094274162e-08,0.050302200487784,0.0181755829903978
141,0.1,6,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can visceral adipose tissue volume be represented by measuring VAT area at a single level? VAT area measurement 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Knowledge advancement: VAT area at a CT slice 3 cm above...,1.8948778188548325e-07,0.09727986905859387,0.031190123456790064,0.014507411718254981,0.1105305982195075,0.029033303513684973,0.014486412327622933,0.1335212994534496,0.014841392706355885,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
141,0.1,7,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Does a single-level measurement of visceral adipose tissue area correspond to visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. New findings: VAT area at a CT slice 3 cm above...,9.474389094274162e-08,0.00041498207223256145,0.0827715118700541,0.0072537058591274906,0.001632036846618501,0.05091477415155428,0.007243206163811466,0.024597459256582077,0.03566529492455417,9.474389094274162e-08,0.050302200487784,0.0181755829903978
141,0.1,8,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is measuring visceral adipose tissue area at one level sufficient to represent visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances: VAT area at a CT slice 3 cm above...,9.474389094274162e-08,0.02525713572628474,0.06502499999999997,0.0072537058591274906,0.001632036846618501,0.05091477415155428,0.007243206163811466,0.024597459256582077,0.03566529492455417,9.474389094274162e-08,0.050302200487784,0.0181755829903978
141,0.1,9,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can the visceral adipose tissue area at a single level serve as a proxy for visceral adipose tissue volume? VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Knowledge update: VAT area at a CT slice 3 cm above...,0.0,0.023901626915860064,0.016353852561432763,0.0,0.0,0.0,0.0,0.024755256448569796,0.017814055255132678,0.0,0.025205352020361893,0.0181755829903978
141,0.1,10,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is it feasible to use visceral adipose tissue area measurement at a single level to represent visceral adipose tissue volume? VAT area measurement 3 cm above the lower margin of the L3 vertebra is practical and can reflect changes in VAT volume and body weight. Advances in knowledge: VAT area at a CT slice 3 cm above...,4.737194547137081e-08,0.0166116765442732,0.06879999999999994,0.0036268529295637453,0.03636038019299059,0.05160013790671861,0.003621603081905733,0.013142868726265355,0.03566529492455417,4.737194547137081e-08,0.011835919659988203,0.0181755829903978
142,0.1,1,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does the menopausal transition influence quality of life? This longitudinal research involving 1,000 women over five years found no significant impact of menopausal transition on the quality of life in postmenopausal women, assessing physical, mental, and social well-being, indicating no negative effect overall.",3.789755637709665e-07,0.3080610089915754,0.040433884297520595,0.029014823436509962,0.3294792011302423,0.0,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
142,0.1,2,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Is quality of life affected by the menopausal transition? A five-year longitudinal study of 1,000 postmenopausal women showed no significant changes in quality of life during menopause, with assessments of physical, mental, and social health revealing no adverse effects.",4.737194547137079e-07,0.4150933114639459,0.03546474849505147,0.03626852929563745,0.469600770355727,0.027006172839506164,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
142,0.1,3,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does going through menopause affect quality of life? According to a longitudinal study tracking 1,000 women for five years, menopausal transition did not significantly alter quality of life in postmenopausal women, with no negative impact on physical, mental, or social well-being.",4.263475092423373e-07,0.32549451499281945,0.0629503208524187,0.03264167636607371,0.37948962170490574,0.0,0.0325944277371516,0.3877655310087631,0.0,4.263475092423373e-07,0.3964152725882455,0.0
142,0.1,4,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Is there an effect of menopausal transition on quality of life? This study followed 1,000 women over five years and found no significant influence of menopause on quality of life, indicating that physical, mental, and social well-being remain stable.",4.737194547137079e-07,0.4150933114639459,0.03546474849505147,0.03626852929563745,0.469600770355727,0.027006172839506164,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
142,0.1,5,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does menopause transition impact quality of life? A longitudinal study of 1,000 women over five years found no significant effect of menopausal transition on the quality of life of postmenopausal women, with no decline in physical, mental, or social health.",4.500334819780226e-07,0.3517009732085987,0.062310615599459655,0.03445510283085558,0.4054651081081637,0.0,0.034405229278104466,0.41443377809092397,0.0,4.500334819780227e-07,0.4238142467763608,0.0
142,0.1,6,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does the transition through menopause affect quality of life? A five-year longitudinal study with 1,000 women found no significant impact on quality of life during menopausal transition, showing stable physical, mental, and social well-being.",5.921493183921344e-07,0.5252179686462148,0.05766044679752061,0.04533566161954684,0.5773153650348237,0.0,0.04527003852382169,0.5913644862500029,0.0,5.921493183921352e-07,0.6061358035703162,0.0
142,0.1,7,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Is quality of life influenced by menopausal transition? This longitudinal study of 1,000 postmenopausal women over five years found no significant effect on quality of life, with assessments showing no negative impact on physical, mental, or social aspects.",4.974054274493932e-07,0.40626611259993606,0.06092771145801444,0.038081955760419325,0.4595323293784399,0.0,0.0380268323600102,0.47000362924573613,0.0,4.974054274493935e-07,0.48097266061630917,0.0
142,0.1,8,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does menopausal transition alter quality of life? A longitudinal study tracking 1,000 women for five years found no significant changes in quality of life during menopause, indicating no detrimental effects on physical, mental, or social well-being.",5.447773729207638e-07,0.46397695890705704,0.05938717149475245,0.04170880868998308,0.5166907432183883,0.0,0.041648435441915946,0.5288441292686694,0.0,5.447773729207643e-07,0.5415972824327446,0.0
142,0.1,9,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Is there a significant effect of menopausal transition on quality of life? This study followed 1,000 women over five years and found no negative impact of menopause on quality of life, with physical, mental, and social health remaining unaffected.",4.737194547137079e-07,0.4150933114639459,0.03546474849505147,0.03626852929563745,0.469600770355727,0.027006172839506164,0.03621603081905733,0.4418327522790393,0.0,4.737194547137081e-07,0.45198512374305766,0.0
142,0.1,10,ai,"Question: Does menopausal transition affect the quality of life? 
Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among postmenopausal women. The study followed 1,000 women over a five-year period, assessing their physical, mental, and social well-being. The results suggest that the transition into menopause does not negatively impact overall quality of life. 
","Does the menopausal transition have an impact on quality of life? A longitudinal study of 1,000 women over five years found no significant effect on quality of life among postmenopausal women, with no decline in physical, mental, or social well-being.",4.500334819780226e-07,0.3872469824680831,0.03680167100314516,0.03445510283085558,0.44194653866395006,0.026296566837107373,0.034405229278104466,0.41443377809092397,0.0,4.500334819780227e-07,0.4238142467763608,0.0
143,0.1,1,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis for low-tone sudden deafnessdoes it always lead to Meniere's disease? Our findings indicate that not every patient with low-tone sudden deafness (SD) experiences endolymphatic hydrops, even if vertigo occurs at onset, and that electrocochleography (ECochG) serves as a valuable prognostic indicator.",4.737194547137081e-08,0.015684784721507583,0.020673448681217014,0.0036268529295637453,0.014655832718537543,0.02221074380165289,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
143,0.1,2,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably progress to Meniere's disease? We conclude that patients with low-tone sudden deafness (SD) do not all develop endolymphatic hydrops, even when vertigo is present initially, and that electrocochleography (ECochG) is a useful tool for prognosis.",1.6580180914979774e-07,0.17589810100364067,0.0077437835423093265,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
143,0.1,3,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is the prognosis of low-tone sudden deafness always progression to Meniere's disease? Our study shows that not all low-tone sudden deafness (SD) patients have endolymphatic hydrops despite vertigo attacks at onset, and electrocochleography (ECochG) is an effective prognostic method.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.1,4,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably lead to Meniere's disease? We found that not all patients with low-tone sudden deafness (SD) suffer from endolymphatic hydrops even if vertigo occurs initially, and that electrocochleography (ECochG) is a useful prognostic tool.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,0.1,5,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression to Meniere's disease unavoidable in low-tone sudden deafness? Our conclusion is that not all low-tone sudden deafness (SD) patients have endolymphatic hydrops despite vertigo at onset, and electrocochleography (ECochG) provides valuable prognostic information.",2.8423167282822424e-07,0.2827805675605046,0.014003673094582187,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
143,0.1,6,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the likelihood that low-tone sudden deafness progresses to Meniere's disease? We conclude that endolymphatic hydrops is not present in all low-tone sudden deafness (SD) patients even with initial vertigo, and electrocochleography (ECochG) is a helpful prognostic tool.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.1,7,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always develop into Meniere's disease? Our findings suggest that not all patients with low-tone sudden deafness (SD) experience endolymphatic hydrops, even if vertigo is present at onset, and that electrocochleography (ECochG) is useful for prognosis.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.1,8,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is Meniere's disease an inevitable outcome of low-tone sudden deafness? We conclude that endolymphatic hydrops does not affect all low-tone sudden deafness (SD) patients, even those with vertigo attacks initially, and that electrocochleography (ECochG) is a valuable prognostic tool.",1.8948778188548304e-07,0.1672629994437167,0.01709186291495875,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,0.1,9,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness necessarily progress to Meniere's disease? Our study indicates that not all patients with low-tone sudden deafness (SD) have endolymphatic hydrops despite vertigo at onset, and that electrocochleography (ECochG) is an effective prognostic tool.",2.3685972735685364e-07,0.26186514355375623,0.01197489204724185,0.018134264647818726,0.26011629724039764,0.006335969001115268,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
143,0.1,10,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is the prognosis of low-tone sudden deafness inevitably linked to Meniere's disease? We conclude that not all low-tone sudden deafness (SD) patients suffer from endolymphatic hydrops even if vertigo occurs at onset, and that electrocochleography (ECochG) is a useful prognostic method.",1.4211583641411244e-07,0.14880299255637475,0.006473066092809211,0.010880558788691236,0.14784031154193933,0.0034125248964080625,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
144,0.1,1,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Do the leadership skills of residents correlate with their technical skill ratings? General surgery research residents' leadership during surgery significantly correlates with attending surgeons' assessments of their technical abilities, indicating a strong link between leadership and perceived surgical skill. More studies are required to identify which leadership traits influence this connection.",1.6580180914979784e-07,0.11011224222108673,0.015049652176606872,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
144,0.1,2,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Is there a relationship between residents' leadership abilities and their technical skill ratings? In general surgery research, residents' intraoperative leadership skills significantly correlate with attending surgeons' evaluations of their technical proficiency, suggesting a close association between leadership and surgical competence. Further investigation is necessary to pinpoint the leadership factors involved.",1.8948778188548325e-07,0.13088078397171543,0.01464201675849405,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
144,0.1,3,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Are residents' leadership skills associated with their technical skill ratings? Research in general surgery shows that residents' leadership during operations significantly correlates with attending surgeons' ratings of their technical skills, implying a strong connection between leadership and perceived surgical expertise. Additional research is needed to clarify which leadership elements contribute.",1.8948778188548325e-07,0.15917250562722307,0.00570109506938183,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
144,0.1,4,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Do leadership skills of surgical residents relate to their technical skill ratings? Studies indicate that general surgery research residents' intraoperative leadership abilities significantly correlate with attending surgeons' technical skill ratings, highlighting a strong link between leadership and surgical competence. More research is required to explore the specific leadership aspects involved.",1.8948778188548325e-07,0.13088078397171543,0.01464201675849405,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
144,0.1,5,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Is there a link between residents' leadership skills and technical skill ratings? General surgery research residents' leadership during surgery has a significant correlation with attending surgeons' assessments of their technical skills, suggesting a strong relationship between leadership and perceived surgical ability. Further studies are needed to understand the leadership components that matter.",1.4211583641411244e-07,0.0897659700774085,0.015441322314049613,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
144,0.1,6,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","How do residents' leadership skills relate to their technical skill ratings? In general surgery research, residents' intraoperative leadership skills show a significant correlation with attending surgeons' ratings of their technical competence, indicating a strong connection between leadership and surgical skill perception. Additional research is necessary to identify key leadership factors.",1.8948778188548325e-07,0.15917250562722307,0.00570109506938183,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
144,0.1,7,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Do residents' leadership abilities impact their technical skill ratings? Evidence from general surgery research reveals a significant correlation between residents' intraoperative leadership skills and attending surgeons' evaluations of technical skill, suggesting a strong association between leadership and surgical proficiency. Further research is needed to determine specific leadership contributions.",2.3685972735685406e-07,0.14426175871677627,0.035041322314049606,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
144,0.1,8,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Is there a correlation between surgical residents' leadership skills and their technical skill ratings? General surgery research finds that residents' leadership during operations significantly correlates with attending surgeons' technical skill ratings, indicating a strong link between leadership and perceived surgical competence. More research is required to explore this relationship.",2.1317375462116866e-07,0.18097061456560493,0.006546579387273654,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
144,0.1,9,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Are leadership skills of residents connected to their technical skill ratings? Studies in general surgery research show a significant correlation between residents' intraoperative leadership abilities and attending surgeons' assessments of technical skill, suggesting a strong relationship between leadership and surgical expertise. Further investigation is needed to understand the leadership factors involved.",1.6580180914979784e-07,0.08238635499868874,0.035041322314049606,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
144,0.1,10,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? 

**Answer:** General surgery research residents' intraoperative leadership skills showed significant correlation with attending surgeons' ratings of their technical skill. This suggests a strong connection between leadership abilities and perceived surgical competence. Further research is needed to understand the specific aspects of leadership that contribute to this relationship. 
","Do residents' leadership skills influence their technical skill ratings? Research in general surgery indicates a significant correlation between residents' intraoperative leadership skills and attending surgeons' ratings of technical competence, highlighting a strong connection between leadership and perceived surgical skill. Additional studies are necessary to clarify this association.",2.6054570009253947e-07,0.19590479787512827,0.013312927252321208,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
145,0.1,1,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
","Is it acceptable for student examiners to act as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears quite reasonable and justified to promote the use of student examiners in such settings. They offer fresh insights and valuable feedback, while their participation boosts their learning and engagement.",9.474389094274162e-08,0.049345778432572374,0.08938332986255726,0.0072537058591274906,0.026154374076988063,0.07496876301541025,0.007243206163811466,6.418683969666716e-05,0.057476051645147866,9.474389094274162e-08,0.027313546264467803,0.039150354019158694
145,0.1,2,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
","Can student examiners serve as suitable substitute examiners for faculty during an undergraduate OSCE focused on medical emergencies? Encouraging student examiners in this context seems both permissible and justified. They bring new perspectives and useful feedback, and their involvement enhances their educational experience and engagement.",2.3685972735685406e-07,0.08226839588036583,0.08666001892915089,0.018134264647818726,0.10446580834007646,0.07496876301541025,0.018108015409528666,0.13359557946421985,0.057476051645147866,2.3685972735685406e-07,0.16388908127021784,0.039150354019158694
145,0.1,3,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
","Are student examiners appropriate substitutes for faculty examiners in an undergraduate OSCE on medical emergencies? It seems quite valid and justified to support the use of student examiners in these exams. They provide fresh viewpoints and constructive feedback, and their participation improves their learning and involvement.",2.1317375462116866e-07,0.08990193271929492,0.06502670362358032,0.016320838183036854,0.08147629011537694,0.07496876301541025,0.0162972138685758,0.11006508205402543,0.057476051645147866,2.1317375462116866e-07,0.13979152969115782,0.039150354019158694
145,0.1,4,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
","May student examiners reasonably replace faculty examiners in an undergraduate OSCE on medical emergencies? It appears acceptable and justified to encourage student examiners in this role. They contribute fresh perspectives and valuable feedback, while also enhancing their own learning and engagement.",3.316036182995957e-07,0.215386603715233,0.059513504155124665,0.025387970506946217,0.20210427790399432,0.07496876301541025,0.025351221573340132,0.23367903802120127,0.057476051645147866,3.316036182995957e-07,0.2665432353303001,0.039150354019158694
145,0.1,5,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
","Is it reasonable to have student examiners substitute for faculty in an undergraduate OSCE on medical emergencies? The use of student examiners seems justified and admissible, as they offer new insights and helpful feedback, and their involvement promotes their learning and engagement.",3.079176455639103e-07,0.15519133065715707,0.08499999999999999,0.023574544042164344,0.1767864699197026,0.07496876301541025,0.023540420032387266,0.2077035516179433,0.057476051645147866,3.079176455639103e-07,0.23987498824813924,0.039150354019158694
145,0.1,6,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
","Can student examiners be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems justified and appropriate to encourage their use. They provide fresh perspectives and valuable feedback, and their participation enhances their learning and engagement.",3.55289591035281e-07,0.17138969364353063,0.109375,0.02720139697172809,0.2280797643072523,0.07496876301541025,0.027162023114293,0.26034728510336214,0.057476051645147866,3.552895910352811e-07,0.29394220951841543,0.039150354019158694
145,0.1,7,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
","Are student examiners justified as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Encouraging student examiners appears both admissible and beneficial, as they bring fresh viewpoints and useful feedback, while also improving their own learning and engagement.",3.55289591035281e-07,0.20693570290301455,0.08375173130193905,0.02720139697172809,0.2280797643072523,0.07496876301541025,0.027162023114293,0.26034728510336214,0.057476051645147866,3.552895910352811e-07,0.29394220951841543,0.039150354019158694
145,0.1,8,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
","Is it acceptable to use student examiners as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems quite justified to promote student examiners, who offer fresh perspectives and valuable feedback, and whose involvement enhances their learning and engagement.",3.079176455639103e-07,0.1213792730688672,0.109375,0.023574544042164344,0.1767864699197026,0.07496876301541025,0.023540420032387266,0.2077035516179433,0.057476051645147866,3.079176455639103e-07,0.23987498824813924,0.039150354019158694
145,0.1,9,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
","May student examiners be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears justified and appropriate to encourage their participation, as they provide fresh insights and valuable feedback, enhancing their learning and engagement.",4.026615365066516e-07,0.22403342712894947,0.109375,0.030828249901291835,0.2821469855775285,0.07496876301541025,0.030783626196198732,0.3159171362581743,0.057476051645147866,4.026615365066519e-07,0.3511006233583638,0.039150354019158694
145,0.1,10,ai,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? 
Answer: It seems quite admissible and justified to encourage the use of student examiners in an undergraduate OSCE on medical emergencies. They can provide a fresh perspective and valuable feedback,  and their involvement enhances their learning and engagement.  
","Can student examiners reasonably substitute for faculty examiners in an undergraduate OSCE on medical emergencies? Encouraging their use seems justified and beneficial, as they bring fresh perspectives and valuable feedback, while also enhancing their own learning and engagement.",4.026615365066516e-07,0.22403342712894947,0.109375,0.030828249901291835,0.2821469855775285,0.07496876301541025,0.030783626196198732,0.3159171362581743,0.057476051645147866,4.026615365066519e-07,0.3511006233583638,0.039150354019158694
146,0.1,1,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy could be a crucial new tool for enhancing population health, particularly for lower-income individuals. Although the results are strong, additional studies are necessary to verify their accuracy. Future research should explore various income support policies and consider a wider scope.",1.6580180914979784e-07,0.11849191983648222,0.001917202066011597,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
146,0.1,2,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies providing income support may serve as an important mechanism to improve health outcomes, especially among low-income groups. Despite robust findings, more analysis is required to confirm these results. Further studies should investigate different income support programs and a broader range of factors.",1.6580180914979784e-07,0.11849191983648222,0.0019172020660115936,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
146,0.1,3,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies might represent a significant approach to enhancing public health, particularly for those with lower incomes. While the findings are solid, further research is needed to ensure their validity. Future investigations should assess multiple income support policies and a wider array of related issues.",9.474389094274162e-08,0.0890874837824045,0.017672634738486057,0.0072537058591274906,0.08909379708106879,0.01694411414982164,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
146,0.1,4,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support initiatives may be a key strategy for improving health among populations, especially low-income individuals. Although the evidence is strong, additional research is necessary to confirm these findings. Future work should examine various income support policies and a broader spectrum of related factors.",1.4211583641411244e-07,0.10068085033661589,0.0016150093976238285,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
146,0.1,5,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy has the potential to be an important lever for enhancing population health, particularly for lower-income people. Despite robust findings, further analysis is needed to validate the results. Future studies should explore a range of income support policies and consider a wider scope.",1.1842986367842703e-07,0.08318130465670848,0.0013230509097107834,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
146,0.1,6,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support programs may offer a significant opportunity to improve health outcomes, especially among lower-income populations. Even though the findings are strong, more research is required to confirm their reliability. Future research should investigate various income support policies and a broader range of factors.",1.4211583641411244e-07,0.10068085033661589,0.0016150093976238285,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
146,0.1,7,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies could be a vital tool for enhancing the health of populations, particularly those with lower incomes. While the findings are robust, further studies are necessary to verify their accuracy. Future research should examine different income support policies and a wider variety of related issues.",7.105791820705622e-08,0.0718006439289427,0.01712814675701641,0.005440279394345618,0.07189507018810026,0.016661878770468257,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
146,0.1,8,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may serve as an important mechanism for improving population health, especially for low-income individuals. Although the findings are strong, additional analysis is needed to confirm their validity. Future research should explore a variety of income support policies and a broader range of factors.",9.474389094274162e-08,0.06598257776373995,0.0010408155303573991,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
146,0.1,9,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support initiatives might be a key factor in enhancing health outcomes, particularly for lower-income groups. Despite robust findings, further research is necessary to validate these results. Future studies should assess multiple income support policies and a wider scope of related issues.",1.8948778188548325e-07,0.13662579968059507,0.0022301764293106343,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
146,0.1,10,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may represent a significant new approach to improving population health, especially among lower-income individuals. While the findings are solid, more research is needed to confirm their reliability. Future investigations should examine various income support policies and a broader range of factors.",1.4211583641411244e-07,0.10068085033661589,0.0016150093976238285,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
147,0.1,1,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone correspond to the extent of aganglionosis in Hirschsprung's disease specimens? The correlation between the transition zone seen on contrast enema and the length of aganglionosis is minimal. Preoperative biopsy is systematic.,4.73719454713706e-08,0.015082988871376823,0.04958677685950413,0.003626852929563752,0.01865023714217351,0.02775510204081633,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
147,0.1,2,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is there a correlation between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease? The link between the transition zone on contrast enema and aganglionosis length is weak. Preoperative biopsy is routinely performed.,4.73719454713706e-08,0.015082988871376823,0.04958677685950413,0.003626852929563752,0.01865023714217351,0.02775510204081633,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
147,0.1,3,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone align with the aganglionosis level in Hirschsprung's disease specimens? The association between the transition zone on contrast enema and aganglionosis length is low. Systematic preoperative biopsy is done.,1.184298636784265e-07,0.03863404796788572,0.07530226109357693,0.009067132323909391,0.1110235572731888,0.02775510204081633,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
147,0.1,4,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is the radiographic transition zone indicative of the aganglionosis extent in Hirschsprung's disease? The correlation between the transition zone on contrast enema and aganglionosis length remains limited. Preoperative biopsy is standard practice.,1.421158364141118e-07,0.07178022043681898,0.07429752066115702,0.01088055878869127,0.1438133800961805,0.02775510204081633,0.010864809245717241,0.18805223150294026,0.0,1.4211583641411244e-07,0.19415601444095776,0.0
147,0.1,5,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone match the level of aganglionosis in Hirschsprung's disease specimens? The correlation between the transition zone on contrast enema and aganglionosis length is weak. Preoperative biopsy is systematically performed.,1.184298636784265e-07,0.03863404796788572,0.07530226109357693,0.009067132323909391,0.1110235572731888,0.02775510204081633,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
147,0.1,6,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is there a relationship between the radiographic transition zone and aganglionosis length in Hirschsprung's disease? The correlation between the transition zone on contrast enema and aganglionosis extent is low. Systematic preoperative biopsy is conducted.,9.47438909427412e-08,0.09056745061794258,0.016519742883379193,0.007253705859127511,0.07927485895860897,0.02775510204081633,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
147,0.1,7,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone correspond with the aganglionosis level in Hirschsprung's disease? The correlation between the transition zone on contrast enema and aganglionosis length remains low. Preoperative biopsy is routinely done.,1.421158364141118e-07,0.07178022043681898,0.07429752066115702,0.01088055878869127,0.1438133800961805,0.02775510204081633,0.010864809245717241,0.18805223150294026,0.0,1.4211583641411244e-07,0.19415601444095776,0.0
147,0.1,8,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is the radiographic transition zone correlated with the level of aganglionosis in Hirschsprung's disease specimens? The association between the transition zone on contrast enema and aganglionosis length is minimal. Systematic preoperative biopsy is performed.,9.47438909427412e-08,0.006549610550070195,0.07624630538337923,0.007253705859127511,0.07927485895860897,0.02775510204081633,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
147,0.1,9,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone reflect the extent of aganglionosis in Hirschsprung's disease? The correlation between the transition zone on contrast enema and aganglionosis length is limited. Preoperative biopsy is systematically carried out.,1.184298636784265e-07,0.03863404796788572,0.07530226109357693,0.009067132323909391,0.1110235572731888,0.02775510204081633,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
147,0.1,10,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is there a correlation between the radiographic transition zone and the length of aganglionosis in Hirschsprung's disease? The link between the transition zone on contrast enema and aganglionosis length remains low. Preoperative biopsy is standard.,7.10579182070559e-08,0.016234454491152572,0.04792599288337923,0.005440279394345632,0.048503200291855286,0.02775510204081633,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
148,0.1,1,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in children usually result from common age-specific traumatic events. Ultrasonography serves as an effective diagnostic method for identifying fractures, while radiography is preferred to assess the degree of dislocation.",4.5003348197802176e-07,0.4503099137206008,0.01999167013744273,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
148,0.1,2,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In growing children, isolated sternal fractures typically arise from usual trauma related to their age. Ultrasound is a valuable tool for detecting these fractures, and X-rays are the preferred technique to visualize the extent of displacement.",3.5528959103528056e-07,0.328949056716334,0.01999167013744273,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
148,0.1,3,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in children are rare and often missed, commonly caused by typical trauma for their age group. Ultrasound helps in diagnosing the fracture, whereas radiography is the best way to evaluate how much the bone has shifted.",3.0791764556390996e-07,0.27337920556152184,0.01999167013744273,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
148,0.1,4,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Among children, isolated sternal fractures often occur due to common traumatic incidents associated with their age. Ultrasonography is useful for detecting fractures, and radiography is the preferred method to determine the extent of dislocation.",4.0266153650665116e-07,0.3877895567392673,0.01999167013744273,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
148,0.1,5,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In pediatric patients, isolated sternal fractures generally stem from typical age-related injuries. Ultrasonography is an effective diagnostic approach for fracture detection, while radiography is the standard for assessing dislocation severity.",4.974054274493924e-07,0.5170012882192743,0.01999167013744273,0.038081955760419374,0.5596157879354227,0.0,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
148,0.1,6,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in growing children are uncommon and frequently overlooked, usually caused by typical trauma for their age. Ultrasound is a helpful diagnostic tool, and radiography is the method of choice to visualize dislocation extent.",3.7897556377096586e-07,0.3579365935895855,0.01999167013744273,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
148,0.1,7,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in childhood often result from typical trauma related to the child's age. Ultrasonography is useful for detecting fractures, and radiography is preferred to visualize the degree of dislocation.",4.7371945471370706e-07,0.4830997365435925,0.01999167013744273,0.036268529295637494,0.5245244681241537,0.0,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
148,0.1,8,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In children, isolated sternal fractures are rare and often missed, typically caused by age-specific traumatic events. Ultrasonography aids in fracture detection, and radiography is the preferred imaging technique to assess dislocation.",4.7371945471370706e-07,0.4830997365435925,0.01999167013744273,0.036268529295637494,0.5245244681241537,0.0,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
148,0.1,9,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in growing children are uncommon and frequently overlooked, usually due to typical age-related trauma. Ultrasonography is a valuable diagnostic tool, and radiography is the preferred method to evaluate the extent of dislocation.",4.0266153650665116e-07,0.3877895567392673,0.01999167013744273,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
148,0.1,10,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in children commonly arise from typical traumatic incidents related to their age. Ultrasonography is useful for diagnosis, and radiography is the method of choice for visualizing the extent of bone displacement.",4.0266153650665116e-07,0.3877895567392673,0.01999167013744273,0.030828249901291856,0.42608439531090037,0.0,0.03078362619619876,0.43721380642274443,0.0,4.026615365066519e-07,0.44895022004790297,0.0
149,0.1,1,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be a novel risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The dopamine partial agonist action of aripiprazole might account for the development of pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.1,2,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole a new risk factor for pathological gambling? Answer: Adverse drug reactions were evaluated alongside other published case reports. The dopamine partial agonist mechanism of aripiprazole may explain the emergence of pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.1,3,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole: does it represent a new risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed in relation to other published case reports. The dopamine partial agonist effect of aripiprazole could clarify the occurrence of pathological gambling.,1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
149,0.1,4,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be linked to pathological gambling as a new risk factor? Answer: Adverse drug reactions were reviewed with reference to existing case reports. The dopamine partial agonist property of aripiprazole might explain pathological gambling cases.,7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,0.1,5,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is pathological gambling a new risk associated with aripiprazole? Answer: Adverse drug reactions were compared with other documented case reports. The dopamine partial agonist mechanism of aripiprazole could be responsible for pathological gambling.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
149,0.1,6,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Question: Might aripiprazole be a novel risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with previously published case reports. The dopamine partial agonist action of aripiprazole may explain pathological gambling occurrence.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.1,7,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole's dopamine partial agonist mechanism cause pathological gambling? Answer: Adverse drug reactions were examined alongside other case reports. This mechanism might explain the development of pathological gambling.,1.184298636784265e-07,0.16430305129127598,0.0,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
149,0.1,8,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole a potential new risk factor for pathological gambling? Answer: Adverse drug reactions were assessed in comparison with other published case reports. The dopamine partial agonist effect of aripiprazole could explain pathological gambling.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
149,0.1,9,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Aripiprazole as a new risk factor for pathological gambling? Answer: Adverse drug reactions were analyzed with other published case reports. The dopamine partial agonist mechanism of aripiprazole might account for pathological gambling.,2.36859727356853e-08,0.07409335745175127,0.031217481789802305,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
149,0.1,10,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could the dopamine partial agonist activity of aripiprazole explain pathological gambling as a new risk factor? Answer: Adverse drug reactions were reviewed alongside other case reports. This mechanism may underlie pathological gambling.,2.36859727356853e-08,0.030771658666753687,0.0,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
150,0.1,1,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Does preoperative statin use lower the incidence of atrial fibrillation following coronary artery bypass graft surgery? Our research suggests that taking statins before surgery may decrease the risk of developing AF. Nevertheless, more studies are needed to understand the precise mechanisms and the best length of statin treatment. This result highlights the need for additional research to verify the protective role of statins in preventing AF after CABG.",3.552895910352811e-07,0.28010840775415025,0.01922337562475971,0.02720139697172809,0.257829109302099,0.0,0.027162023114293,0.2623642644674913,0.0,3.552895910352811e-07,0.2670627852490446,0.0
150,0.1,2,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Can preoperative statins prevent atrial fibrillation after coronary artery bypass grafting? Our findings indicate that statin therapy before surgery appears to reduce the occurrence of AF. However, the underlying mechanisms and the ideal duration of statin use remain unclear and require further study. This observation calls for more research to confirm statins' protective effect against post-CABG atrial fibrillation.",1.1842986367842703e-07,0.11846705619773568,0.01922337562475971,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
150,0.1,3,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Do statins administered before coronary artery bypass grafting decrease the risk of atrial fibrillation? The study showed that preoperative statin treatment seems to lower AF development. Still, the exact biological pathways and optimal treatment duration need more investigation. These findings suggest further research is necessary to establish the protective benefits of statins for AF after CABG.",7.105791820705622e-08,0.08274897359565658,0.01922337562475971,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
150,0.1,4,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Is there a reduction in atrial fibrillation after coronary artery bypass grafting with preoperative statin therapy? Our study demonstrated that statins given before surgery may reduce AF incidence. However, the detailed mechanisms and the best duration for statin therapy require additional research. This finding supports the need for further studies to confirm the protective effect of statins on post-CABG AF.",1.6580180914979784e-07,0.15295323226890423,0.01922337562475971,0.012693985253473108,0.12861737782209381,0.0,0.012675610786670066,0.13102826240640475,0.0,1.6580180914979784e-07,0.13353139262452274,0.0
150,0.1,5,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Do preoperative statins help in reducing atrial fibrillation following coronary artery bypass graft surgery? According to our research, statin therapy prior to surgery appears to decrease the likelihood of AF. Nonetheless, the precise mechanisms and optimal timing of statin use need further exploration. This result encourages more research to validate the protective role of statins against AF after CABG.",1.4211583641411244e-07,0.1358587989096045,0.01922337562475971,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
150,0.1,6,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Can the use of statins before coronary artery bypass grafting reduce the incidence of atrial fibrillation? Our study suggests that preoperative statin therapy may lower the risk of AF. Yet, the exact mechanisms and the ideal duration of treatment require further investigation. This finding calls for additional research to confirm the protective effects of statins on post-CABG atrial fibrillation.",1.4211583641411244e-07,0.11195717199374444,0.001987302987025024,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
150,0.1,7,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Does administering statins before coronary artery bypass grafting reduce atrial fibrillation occurrence? Our findings indicate that preoperative statin use seems to diminish AF development. However, the specific mechanisms and optimal treatment length need more study. This observation warrants further research to verify the protective impact of statins against AF after CABG.",4.737194547137081e-08,0.012561206208669073,0.01922337562475971,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
150,0.1,8,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Is preoperative statin therapy effective in reducing atrial fibrillation after coronary artery bypass grafting? Our study found that statins given before surgery appear to reduce AF incidence. Nonetheless, the exact biological mechanisms and best duration of therapy require further investigation. This finding highlights the need for more research to confirm statins' protective effect on post-CABG AF.",7.105791820705622e-08,0.08274897359565658,0.01922337562475971,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
150,0.1,9,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Do statins taken before coronary artery bypass grafting decrease the risk of atrial fibrillation? Our research indicates that preoperative statin therapy may reduce AF development. However, the underlying mechanisms and optimal duration of statin use remain to be clarified through further studies. This result suggests the necessity of additional research to confirm the protective benefits of statins against AF after CABG.",1.8948778188548325e-07,0.16976035058528494,0.01922337562475971,0.014507411718254981,0.14571181118139354,0.0,0.014486412327622933,0.14842000511827358,0.0,1.8948778188548325e-07,0.15123096972392336,0.0
150,0.1,10,ai,"Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? 

Answer: Our study indicated that preoperative statin therapy seems to reduce AF development.  However, the exact mechanisms and optimal duration of statin therapy require further investigation. This finding warrants further research to confirm the protective effect of statins against post-CABG AF. 
","Can preoperative statin treatment reduce the occurrence of atrial fibrillation following coronary artery bypass grafting? Our study suggests that statin therapy before surgery seems to lower the risk of AF. Yet, the precise mechanisms and ideal treatment duration require further investigation. This finding supports the need for more research to validate the protective effect of statins on post-CABG atrial fibrillation.",1.6580180914979784e-07,0.15295323226890423,0.01922337562475971,0.012693985253473108,0.12861737782209381,0.0,0.012675610786670066,0.13102826240640475,0.0,1.6580180914979784e-07,0.13353139262452274,0.0
151,0.1,1,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are there discrepancies between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences exist between clinicians and clinical pathologists regarding the clinical importance of certain RBC morphology terms. Adding interpretive comments to CBC reports is the best method to guarantee that RBC morphology changes are understood as intended by the clinical pathologist. Reporting methods should be carefully reviewed for improvement.,4.737194547137081e-08,0.033233849862913445,0.04676162321956463,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
151,0.1,2,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a mismatch between clinical pathologists and clinicians in how red blood cell morphology is reported and interpreted? Clinicians and clinical pathologists differ notably in their views on the clinical significance of specific RBC morphology terminology. Including explanatory notes on CBC reports is the most effective way to ensure RBC morphology changes are interpreted correctly by clinicians. Reporting procedures need critical evaluation for enhancement.,4.737194547137081e-08,0.011573000470415096,0.03121748178980229,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
151,0.1,3,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Do clinical pathologists and clinicians disagree in reporting and interpreting red blood cell morphology? There are important differences between clinicians and clinical pathologists regarding the clinical relevance of certain RBC morphology terms. The clearest way to ensure RBC morphology changes are interpreted as intended by clinical pathologists is to include interpretive comments on CBC reports. Reporting practices should be critically assessed to improve.,0.0,0.0755182455987784,0.08216029876472278,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.1,4,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there discordance between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Key differences exist between clinicians and clinical pathologists about the clinical relevance of some RBC morphology terms. The inclusion of interpretive comments on CBC reports is the most straightforward way to ensure RBC morphology changes are understood as clinical pathologists intend. Reporting practices should be critically reviewed for improvement.,9.474389094274162e-08,0.008421025247821845,0.07709750566893427,0.0072537058591274906,0.06351340572232633,0.0,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
151,0.1,5,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? Important discrepancies exist between clinicians and clinical pathologists concerning the clinical significance of certain RBC morphology terms. Adding interpretive comments to CBC reports is the clearest method to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be critically examined to enhance quality.,0.0,0.0755182455987784,0.08216029876472278,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.1,6,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a difference between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences about the clinical relevance of specific RBC morphology terms exist between clinicians and clinical pathologists. The best way to ensure RBC morphology changes are interpreted as intended by clinical pathologists is to include interpretive comments on CBC reports. Reporting practices should be critically evaluated for improvement.,4.737194547137081e-08,0.011573000470415096,0.03121748178980229,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
151,0.1,7,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Do clinical pathologists and clinicians have differing views on reporting and interpreting red blood cell morphology? There are notable differences between clinicians and clinical pathologists regarding the clinical importance of certain RBC morphology terms. Including interpretive comments on CBC reports is the clearest approach to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be critically reviewed to improve.,0.0,0.0755182455987784,0.08216029876472278,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,0.1,8,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a gap between clinical pathologists and clinicians in the interpretation and reporting of red blood cell morphology? Important differences exist between clinicians and clinical pathologists about the clinical relevance of some RBC morphology terms. The inclusion of interpretive comments on CBC reports is the clearest way to ensure RBC morphology changes are understood as intended by clinical pathologists. Reporting practices should be critically assessed for enhancement.,1.1842986367842703e-07,0.03617631311841407,0.02982248520710059,0.009067132323909363,0.07878087785311383,0.0,0.009054007704764333,0.08004270767353727,0.0,1.1842986367842703e-07,0.08134563945395268,0.0
151,0.1,9,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are there inconsistencies between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences exist between clinicians and clinical pathologists regarding the clinical significance of certain RBC morphology terms. Adding interpretive comments to CBC reports is the clearest method to ensure RBC morphology changes are interpreted as clinical pathologists intend. Reporting practices should be critically examined for improvement.,2.3685972735685406e-08,0.09301677049676815,0.08353151010701546,0.0018134264647818726,0.01652930195121094,0.0,0.0018108015409528666,0.01680711831638071,0.0,2.3685972735685406e-08,0.01709443335929972,0.0
151,0.1,10,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a divergence between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Key differences about the clinical relevance of specific RBC morphology terms exist between clinicians and clinical pathologists. Including interpretive comments on CBC reports is the clearest way to ensure RBC morphology changes are interpreted as intended by clinical pathologists. Reporting practices should be critically reviewed to enhance quality.,9.474389094274162e-08,0.02051143694739732,0.0302734375,0.0072537058591274906,0.06351340572232633,0.0,0.007243206163811466,0.06453852113757197,0.0,9.474389094274162e-08,0.06559728248581642,0.0
152,0.1,1,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Does viral infection contribute to benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, especially for vestibular neuritis, indicating a potential connection between viral infections and BPPV development. However, the precise mechanisms are not well understood and more research is necessary.",9.474389094274162e-08,0.06083494426833802,0.021728395061728398,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
152,0.1,2,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Is there a role for viral infections in benign paroxysmal positional vertigo? BPPV shows association with positive viral serology, notably for vestibular neuritis, implying a possible relationship between viral infections and BPPV onset. The exact processes remain unclear, requiring further investigation.",1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
152,0.1,3,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Can viral infections influence benign paroxysmal positional vertigo? Positive viral serology, particularly for vestibular neuritis, is associated with BPPV, suggesting a potential link between viral infections and BPPV. Nonetheless, the mechanisms are not fully understood and additional research is needed.",1.6580180914979774e-07,0.1704889256815454,0.003894873636332556,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
152,0.1,4,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Are viral infections involved in benign paroxysmal positional vertigo? BPPV correlates with positive viral serology, especially related to vestibular neuritis, indicating a possible connection between viral infections and BPPV development. The exact mechanisms remain uncertain and further studies are required.",1.6580180914979774e-07,0.1704889256815454,0.003894873636332556,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
152,0.1,5,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Do viral infections play a part in benign paroxysmal positional vertigo? There is an association between BPPV and positive viral serology, particularly for vestibular neuritis, suggesting a potential role of viral infections in BPPV. However, the underlying mechanisms are unclear and more research is warranted.",4.737194547137081e-08,0.04582161865889667,0.0009865860091207122,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
152,0.1,6,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Is benign paroxysmal positional vertigo linked to viral infections? BPPV is associated with positive viral serology, mainly for vestibular neuritis, which suggests a possible involvement of viral infections in its development. The exact mechanisms are still unknown and further research is needed.",1.1842986367842703e-07,0.08493249584739804,0.021728395061728398,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
152,0.1,7,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Could viral infections be related to benign paroxysmal positional vertigo? BPPV has been connected to positive viral serology, especially for vestibular neuritis, indicating a potential link between viral infections and BPPV. The precise mechanisms remain unclear and additional research is necessary.",1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
152,0.1,8,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Does benign paroxysmal positional vertigo have an association with viral infections? Positive viral serology, particularly for vestibular neuritis, is linked to BPPV, suggesting a possible role of viral infections in its development. However, the exact mechanisms are not fully understood and further investigation is needed.",4.737194547137081e-08,0.01431492863344408,0.021728395061728398,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
152,0.1,9,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Are viral infections a factor in benign paroxysmal positional vertigo? BPPV is related to positive viral serology, especially for vestibular neuritis, implying a potential connection between viral infections and BPPV. The mechanisms remain unclear and more research is required.",1.8948778188548304e-07,0.19739983338110578,0.004568171775378976,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
152,0.1,10,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? 
Answer: BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link between viral infections and the development of BPPV. However, the exact mechanisms remain unclear and further research is needed. 
","Is there a connection between viral infections and benign paroxysmal positional vertigo? BPPV is associated with positive viral serology, particularly for vestibular neuritis, suggesting a possible link. However, the exact mechanisms are not well defined and further studies are necessary.",1.6580180914979774e-07,0.13494291642206147,0.021728395061728398,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
153,0.1,1,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Transient tachypnea of the newborn (TTN) may be influenced by polymorphisms in the beta-adrenergic receptor (ADRB) genes, which affect lung function and response to adrenergic signals, according to some studies.",9.000669639560443e-07,0.8373967894044916,0.0,0.06891020566171122,0.85745023185122,0.0,0.06881045855620899,0.8785504038913072,0.0,9.000669639560454e-07,0.9007865453381889,0.0
153,0.1,2,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Research indicates that genetic variations in ADRB genes, which regulate lung activity and adrenergic responsiveness, could play a role in the development of transient tachypnea of the newborn (TTN).",9.237529366917296e-07,0.8724881092157606,0.0,0.07072363212649309,0.8938178760220947,0.0,0.07062126009716185,0.9162907318741542,0.0,9.237529366917308e-07,0.9400072584914714,0.0
153,0.1,3,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","The role of beta-adrenergic receptor gene polymorphisms in transient tachypnea of the newborn (TTN) is being investigated, as these genetic differences may impact lung function and adrenergic response.",9.474389094274149e-07,0.9088557533866353,0.0,0.07253705859127496,0.9315582040049417,0.0,0.07243206163811473,0.9555114450274367,0.0,9.474389094274162e-07,0.9808292530117262,0.0
153,0.1,4,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Some studies suggest that polymorphisms in the ADRB genes, which encode beta-adrenergic receptors, might contribute to transient tachypnea of the newborn (TTN) by affecting lung responsiveness.",9.948108548987854e-07,0.9858167945227647,0.0,0.07616391152083873,1.011600911678479,0.0,0.07605366472002048,1.0388930539664871,0.0,9.94810854898787e-07,1.0678406300013559,0.0
153,0.1,5,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Transient tachypnea of the newborn (TTN) has been linked to genetic variations in the beta-adrenergic receptor genes, which influence how the lungs respond to adrenergic stimulation.",9.948108548987854e-07,0.9858167945227647,0.0,0.07616391152083873,1.011600911678479,0.0,0.07605366472002048,1.0388930539664871,0.0,9.94810854898787e-07,1.0678406300013559,0.0
153,0.1,6,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Ongoing research is examining how polymorphisms in ADRB genes, which affect lung function and adrenergic receptor activity, may be associated with transient tachypnea of the newborn (TTN).",9.711248821631002e-07,0.9465960813694823,0.0,0.07435048505605685,0.9707789171582242,0.0,0.07424286317906761,0.9963334395476915,0.0,9.711248821631017e-07,1.0233888674305218,0.0
153,0.1,7,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Genetic polymorphisms in the beta-adrenergic receptor encoding genes (ADRB) are being studied for their potential role in transient tachypnea of the newborn (TTN), given their impact on lung function.",9.237529366917296e-07,0.8724881092157606,0.0,0.07072363212649309,0.8938178760220947,0.0,0.07062126009716185,0.9162907318741542,0.0,9.237529366917308e-07,0.9400072584914714,0.0
153,0.1,8,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
",The multifactorial causes of transient tachypnea of the newborn (TTN) may include genetic variations in ADRB genes that regulate lung responsiveness to adrenergic stimuli.,1.0421828003701562e-06,1.0691984034618152,0.0,0.07979076445040248,1.0986122886681087,0.0,0.07967526780192623,1.1298648321722151,0.0,1.0421828003701579e-06,1.163150809805681,0.0
153,0.1,9,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
","Studies are exploring the connection between specific ADRB gene polymorphisms and susceptibility to transient tachypnea of the newborn (TTN), focusing on their influence on lung function.",9.948108548987854e-07,0.9858167945227647,0.0,0.07616391152083873,1.011600911678479,0.0,0.07605366472002048,1.0388930539664871,0.0,9.94810854898787e-07,1.0678406300013559,0.0
153,0.1,10,ai,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes.

**Answer:** While the exact causes of TTN are multifaceted, some research suggests potential involvement of genetic variations in ADRB genes, which influence lung function and responsiveness to adrenergic stimulation. Studies exploring the correlation between specific ADRB polymorphisms and TTN susceptibility are ongoing, aiming to shed light on this complex interplay. 
",Evidence suggests that polymorphisms in beta-adrenergic receptor genes (ADRB) could be involved in transient tachypnea of the newborn (TTN) by modulating lung function and adrenergic response.,9.948108548987854e-07,0.9858167945227647,0.0,0.07616391152083873,1.011600911678479,0.0,0.07605366472002048,1.0388930539664871,0.0,9.94810854898787e-07,1.0678406300013559,0.0
154,0.1,1,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Do parents, their children, and the children's doctors have different views on body image? Many children tend to underestimate their overweight or obesity status, whereas parents often overestimate it. Physicians usually align with the children's own perceptions, indicating a gap between children's self-view and the perceptions of parents and doctors.",1.8948778188548325e-07,0.18349345933108152,0.02320415207730898,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
154,0.1,2,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Is there a difference in body image perception among parents, their children, and the children's physicians? Children frequently underestimate their level of overweight or obesity, while parents are more prone to overestimating it. Physicians typically concur with the children's self-assessments, highlighting a disconnect between children's self-perception and that of parents and doctors.",1.4211583641411244e-07,0.11408692378126695,0.002061734693877538,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
154,0.1,3,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","How do parents, children, and children's physicians differ in perceiving body image? Many children underestimate their overweight or obesity, but parents tend to overestimate it. Physicians generally agree with the children's self-perceptions, suggesting a disparity between children's views of themselves and those of their parents and doctors.",2.6054570009253947e-07,0.19008891764159808,0.017538265306122455,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
154,0.1,4,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Do parents, children, and their children's doctors perceive body image differently? Children often underestimate their overweight or obesity, while parents are more likely to overestimate it. Physicians usually agree with the children's self-perceptions, indicating a disconnect between children's self-view and the perceptions of parents and physicians.",2.8423167282822487e-07,0.21206782436037308,0.017538265306122455,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
154,0.1,5,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Are there differences in body image perception among parents, their children, and the children's physicians? Many children underestimate their overweight or obesity, whereas parents tend to overestimate it. Physicians generally align with the children's self-perceptions, suggesting a disconnect between children's self-view and that of parents and doctors.",2.6054570009253947e-07,0.22022575157898672,0.004190129755605943,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
154,0.1,6,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Do parents, children, and children's physicians have differing perceptions of body image? Children frequently underestimate their overweight or obesity, while parents often overestimate it. Physicians typically agree with the children's self-assessments, indicating a gap between children's self-perception and that of parents and physicians.",3.552895910352811e-07,0.28106069584732474,0.017538265306122455,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
154,0.1,7,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Is body image perceived differently by parents, their children, and the children's doctors? Many children underestimate their overweight or obesity, but parents are more likely to overestimate it. Physicians generally concur with the children's self-perceptions, highlighting a disconnect between children's self-view and the perceptions of parents and doctors.",2.3685972735685406e-07,0.22757396182999168,0.024930870496346676,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
154,0.1,8,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","How do parents, children, and children's physicians perceive body image differently? Children often underestimate their overweight or obesity, while parents tend to overestimate it. Physicians usually agree with the children's self-assessments, suggesting a gap between children's self-perception and that of parents and doctors.",3.552895910352811e-07,0.28106069584732474,0.017538265306122455,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
154,0.1,9,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Do parents, their children, and the children's physicians view body image differently? Many children underestimate their overweight or obesity, whereas parents are more prone to overestimating it. Physicians generally align with the children's self-perceptions, indicating a disconnect between children's self-view and the perceptions of parents and physicians.",2.6054570009253947e-07,0.2503625855163758,0.02585016444594367,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
154,0.1,10,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? 
Answer: Many children underestimated their degree of overweight or obesity, while their parents were more likely to overestimate it.  Physicians generally agreed with the children's self-perceptions. This suggests a disconnect between how children view themselves and how parents and physicians perceive their weight. 
","Are perceptions of body image different among parents, children, and children's physicians? Children frequently underestimate their overweight or obesity, while parents often overestimate it. Physicians typically agree with the children's self-assessments, highlighting a gap between children's self-perception and that of parents and doctors.",3.552895910352811e-07,0.28106069584732474,0.017538265306122455,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
155,0.1,1,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Is neck pain linked to a decline in health-related quality of life after six months? Our study showed that neck pain at baseline was correlated with poorer health-related quality of life six months later. Participants with neck pain had notably lower SF-36 scores, reflecting worse physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",4.737194547137081e-08,0.01578003769181624,0.01288933023029376,0.0036268529295637453,0.03748687923508642,0.0012705324385313826,0.003621603081905733,0.0372845055208213,0.0006606862828746896,4.737194547137081e-08,0.037041271680350096,0.0
155,0.1,2,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Does neck pain predict worse health-related quality of life six months later? We observed that individuals with neck pain initially experienced a significant reduction in health-related quality of life half a year later. Their SF-36 questionnaire results indicated diminished physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",1.8948778188548325e-07,0.10689227279262514,0.061137459312535655,0.014507411718254981,0.15917250562722307,0.00570109506938183,0.014486412327622933,0.1582765559020194,0.0029726625487767923,1.8948778188548325e-07,0.15718558352241319,0.0
155,0.1,3,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Is there an association between neck pain and reduced health-related quality of life six months afterward? Our findings revealed that neck pain was linked to poorer health-related quality of life at six months. Those reporting neck pain at baseline scored significantly lower on the SF-36, showing declines in physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",2.3685972735685406e-08,0.04317452899209995,0.019476302952086466,0.0018134264647818726,0.018230396287864714,0.0006025468038455134,0.0018108015409528666,0.018133879844112855,0.00031297436329903727,2.3685972735685406e-08,0.018018505502678472,0.0
155,0.1,4,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Does experiencing neck pain affect health-related quality of life six months later? We found a negative association between baseline neck pain and health-related quality of life after six months. Individuals with neck pain had significantly lower SF-36 scores, indicating worse physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",1.6580180914979784e-07,0.12235707600614898,0.0001733761367322395,0.012693985253473108,0.13783812944348428,0.004889233241505961,0.012675610786670066,0.13706785783146103,0.002548065886134064,1.6580180914979784e-07,0.13613217432458002,0.0
155,0.1,5,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Is neck pain associated with a decline in health-related quality of life six months later? Our research indicated that neck pain at the start was negatively correlated with health-related quality of life after six months. Participants with neck pain reported significantly lower SF-36 scores, reflecting poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",2.3685972735685406e-08,0.004254977988211728,0.015162721893491049,0.0018134264647818726,0.0185681825888242,0.000623972610504564,0.0018108015409528666,0.01846860107447057,0.0003243433209763093,2.3685972735685406e-08,0.018349138668195764,0.0
155,0.1,6,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Does neck pain at baseline relate to worse health-related quality of life six months later? We discovered that neck pain was negatively linked to health-related quality of life half a year later. Those with neck pain had notably lower SF-36 scores, showing reduced physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",9.474389094274162e-08,0.05707805219957196,0.008087729718140063,0.0072537058591274906,0.07643044163395452,0.002636493910479411,0.007243206163811466,0.07601222264976526,0.0013721359553382183,9.474389094274162e-08,0.07550755250814589,0.0
155,0.1,7,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Is there a connection between neck pain and poorer health-related quality of life six months later? Our study found that neck pain was associated with a decline in health-related quality of life six months afterward. Individuals experiencing neck pain initially had significantly lower SF-36 scores, indicating worse physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",0.0,0.023901626915860508,0.01709913574433139,0.0,0.04864190740771557,0.0347343985830668,0.0,0.04951051289713915,0.035548546731432915,0.0,0.05041070404072334,0.03631185475258099
155,0.1,8,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Does baseline neck pain predict worse health-related quality of life six months later? We found that neck pain was negatively associated with health-related quality of life at six months. Participants with neck pain scored significantly lower on the SF-36 questionnaire, reflecting poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",1.1842986367842703e-07,0.07837490916328438,0.005549905489809298,0.009067132323909363,0.09648465573463305,0.003358677685950405,0.009054007704764333,0.09595304393715409,0.0017487603305785006,1.1842986367842703e-07,0.09531017980432566,0.0
155,0.1,9,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Is neck pain linked to poorer health-related quality of life six months later? Our findings showed that neck pain at baseline was negatively associated with health-related quality of life six months later. Those with neck pain reported significantly lower SF-36 scores, indicating declines in physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",7.105791820705622e-08,0.08662961085514143,0.02570009451019062,0.005440279394345618,0.10811378505662583,0.03855867768595038,0.0054324046228586,0.10877401287332056,0.03854876033057854,7.105791820705622e-08,0.10940848054026997,0.03840000000000001
155,0.1,10,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with health-related quality of life six months later. Individuals experiencing neck pain at baseline reported significantly lower scores on the SF-36 questionnaire, indicating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.  
","Does neck pain influence health-related quality of life six months later? We observed that neck pain was negatively correlated with health-related quality of life six months after baseline. Individuals with neck pain had significantly lower SF-36 scores, demonstrating poorer physical functioning, role limitations, bodily pain, general health, vitality, and mental health.",1.8948778188548325e-07,0.20053489733510954,0.0422689699533732,0.014507411718254981,0.21575594893823924,0.045946332006938054,0.014486412327622933,0.21603882094868165,0.044370982552800725,1.8948778188548325e-07,0.21617683293177015,0.04246913580246913
156,0.1,1,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Is (18)F-FDG an effective surrogate tracer for assessing tumor hypoxia? This research indicates that FDG is not a dependable surrogate marker for tumor hypoxia. FDG uptake represents glucose metabolism, which may be affected by factors beyond hypoxia, including tumor cell proliferation and inflammation.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
156,0.1,2,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Can (18)F-FDG serve as a surrogate tracer to evaluate tumor hypoxia? The study found that FDG is not a reliable surrogate indicator of tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by other factors such as tumor cell growth and inflammation.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
156,0.1,3,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Does (18)F-FDG act as a surrogate tracer for measuring tumor hypoxia? Findings from this study demonstrate that FDG is not a trustworthy surrogate marker for tumor hypoxia. FDG uptake corresponds to glucose metabolism, which is affected by variables other than hypoxia, like tumor proliferation and inflammation.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
156,0.1,4,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Is (18)F-FDG a valid surrogate tracer for tumor hypoxia measurement? The study revealed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake indicates glucose metabolism, which can be altered by factors besides hypoxia, including tumor cell proliferation and inflammation.",7.105791820705622e-08,0.10199988008504324,0.023795359904818555,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
156,0.1,5,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Can (18)F-FDG be used as a surrogate tracer to measure tumor hypoxia? This study showed that FDG is not a dependable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, influenced by factors other than hypoxia such as tumor proliferation and inflammation.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
156,0.1,6,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Is (18)F-FDG a suitable surrogate tracer for detecting tumor hypoxia? The research demonstrated that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake mirrors glucose metabolism, which can be affected by factors beyond hypoxia, including tumor cell proliferation and inflammation.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
156,0.1,7,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Does (18)F-FDG reliably serve as a surrogate tracer for tumor hypoxia? This study concluded that FDG is not a dependable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which may be influenced by factors other than hypoxia, such as tumor proliferation and inflammation.",2.3685972735685406e-08,0.053979545877510304,0.02271498107084911,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
156,0.1,8,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Is (18)F-FDG an accurate surrogate tracer for tumor hypoxia? The study indicated that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake corresponds to glucose metabolism, which can be affected by factors besides hypoxia, including tumor cell proliferation and inflammation.",7.105791820705622e-08,0.10199988008504324,0.023795359904818555,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
156,0.1,9,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Can (18)F-FDG reliably measure tumor hypoxia as a surrogate tracer? This study found that FDG is not a dependable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which is influenced by factors other than hypoxia, such as tumor proliferation and inflammation.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
156,0.1,10,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? 
Answer: This study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake reflects glucose metabolism, which can be influenced by factors other than hypoxia, such as tumor cell proliferation and inflammation. 
","Is (18)F-FDG effective as a surrogate tracer for tumor hypoxia? The study showed that FDG is not a reliable surrogate marker for tumor hypoxia. FDG uptake indicates glucose metabolism, which can be affected by factors beyond hypoxia, including tumor cell proliferation and inflammation.",7.105791820705622e-08,0.10199988008504324,0.023795359904818555,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
157,0.1,1,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain considered a clinically significant issue in general adult psychiatry? Our findings indicate that pain is indeed a notable clinical concern among psychiatric patients, often underestimated within psychiatry. Patients in general adult psychiatry exhibit unique risk factors distinct from those seen in other clinical subpopulations.",1.6580180914979784e-07,0.12621579069370759,0.013127755268728183,0.012693985253473108,0.15196044645661644,0.0031149810708491175,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
157,0.1,2,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Does pain represent a clinically relevant problem in general adult psychiatry? Evidence suggests that pain is a considerable clinical issue in psychiatric patients, frequently underrecognized in psychiatric practice. The patients studied in general adult psychiatry possess specific risk factors that differ from those in other medical specialties.",1.4211583641411244e-07,0.13303430307066,0.007423894271563883,0.010880558788691236,0.12878744193732583,0.002610743801652899,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
157,0.1,3,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a clinically important problem in the field of general adult psychiatry? Research shows that pain can be a major clinical challenge for psychiatric patients and is often undervalued in psychiatry. The patients examined in general adult psychiatry have particular risk factors that set them apart from clinical groups in other disciplines.,0.0,0.053319013889226774,0.038252676020388156,0.0,0.027182242374899523,0.019599999999999992,0.0,0.0,0.0,0.0,0.0,0.0
157,0.1,4,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a significant clinical problem in general adult psychiatry? Our research found that pain is a clinically relevant issue for psychiatric patients, which appears to be underestimated in psychiatric care. The patients in general adult psychiatry have distinct risk factors compared to clinical subpopulations in other fields.",1.1842986367842703e-07,0.08010884544688679,0.015006915842678735,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
157,0.1,5,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a clinically relevant concern in general adult psychiatry? We discovered that pain can be a substantial clinical problem among psychiatric patients and is often underestimated in psychiatry. The patients studied in general adult psychiatry show specific risk factors different from those in other clinical specialties.,1.4211583641411244e-07,0.10289746913327091,0.014087621893081742,0.010880558788691236,0.12878744193732583,0.002610743801652899,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
157,0.1,6,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically pertinent problem in general adult psychiatry? Evidence reveals that pain is a significant clinical issue in psychiatric patients, frequently overlooked in psychiatry. The patients investigated in general adult psychiatry are characterized by unique risk factors unlike those in other clinical subpopulations.",1.8948778188548325e-07,0.15008894388023064,0.012124577722245372,0.014507411718254981,0.17568267840283758,0.0036426303854875317,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
157,0.1,7,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically meaningful problem in general adult psychiatry? Findings indicate that pain can be a major clinical concern in psychiatric patients, often underestimated in psychiatric settings. The patients in general adult psychiatry have particular risk factors distinct from other clinical subpopulations.",2.3685972735685406e-07,0.2326166052584986,0.013529865514615422,0.018134264647818726,0.22488338123340768,0.004775000000000008,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
157,0.1,8,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a clinically relevant issue in general adult psychiatry? Our study found that pain is a significant clinical problem among psychiatric patients and tends to be underestimated in psychiatry. The patients examined in general adult psychiatry possess specific risk factors that differ from those in other disciplines.,1.1842986367842703e-07,0.08010884544688679,0.015006915842678735,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
157,0.1,9,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically significant problem in general adult psychiatry? We found evidence that pain is a notable clinical issue in psychiatric patients, which seems to be underappreciated in psychiatry. The patients in general adult psychiatry have distinct risk factors compared to clinical subpopulations in other fields.",1.4211583641411244e-07,0.10289746913327091,0.014087621893081742,0.010880558788691236,0.12878744193732583,0.002610743801652899,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
157,0.1,10,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a clinically important issue in general adult psychiatry? Research indicates that pain can be a significant clinical problem in psychiatric patients and is often underestimated in psychiatry. The patients studied in general adult psychiatry are characterized by specific risk factors different from those in other clinical disciplines.,9.474389094274162e-08,0.05782645188635849,0.015888149943824606,0.0072537058591274906,0.08399141334404625,0.0016665406427221093,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
158,0.1,1,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Question: Are clinical predictors sufficient to identify cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for detecting these fractures because they often present subtly and symptoms may be delayed. Hence, maintaining a high level of suspicion and using appropriate imaging are essential for prompt diagnosis and treatment.",4.737194547137081e-08,0.0372845055208213,0.0006606862828746896,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
158,0.1,2,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Question: Can clinical predictors reliably detect cervical spine fractures in geriatric patients with low-energy blunt trauma? Answer: Clinical predictors are generally inadequate due to the subtle nature of these fractures and the possibility of delayed symptom onset. Therefore, a high suspicion index and proper imaging techniques are vital for timely diagnosis and management.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
158,0.1,3,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Question: Are clinical predictors effective in identifying cervical spine fractures in elderly patients after low-energy blunt trauma? Answer: Clinical predictors appear to be inadequate because these fractures often present with subtle signs and symptoms may be delayed. Consequently, a high degree of suspicion and appropriate imaging are necessary for early diagnosis and treatment.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
158,0.1,4,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Question: Do clinical predictors adequately identify cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors are insufficient due to the often subtle presentation and delayed symptoms. Thus, maintaining a high suspicion and employing suitable imaging are critical for timely diagnosis and management.",2.3685972735685406e-07,0.20209187173487386,0.003877155392306906,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
158,0.1,5,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Question: Is the use of clinical predictors adequate for detecting cervical spine fractures in elderly patients with low-energy blunt trauma? Answer: Clinical predictors are inadequate because these fractures frequently present subtly and symptoms can be delayed. Therefore, a high index of suspicion along with appropriate imaging is essential for prompt diagnosis and care.",9.474389094274162e-08,0.07601222264976526,0.0013721359553382183,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
158,0.1,6,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Question: Are clinical predictors reliable for diagnosing cervical spine fractures in geriatric patients following low-energy blunt trauma? Answer: Clinical predictors are often inadequate due to subtle presentations and delayed symptom onset. Hence, a high suspicion index and proper imaging are crucial for timely diagnosis and management.",2.6054570009253947e-07,0.22474048587447992,0.0043595041322314,0.0199476911126006,0.22314355131420927,0.0,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
158,0.1,7,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Question: Can clinical predictors alone identify cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors alone are inadequate because these fractures often have subtle presentations and symptoms may be delayed. Therefore, a high index of suspicion and appropriate imaging are necessary for early diagnosis and treatment.",1.4211583641411244e-07,0.14402520330322988,0.022079315886134075,0.010880558788691236,0.14380460877735235,0.020399305555555556,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
158,0.1,8,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Question: Are clinical predictors sufficient to detect cervical spine fractures in geriatric patients after low-energy blunt trauma? Answer: Clinical predictors appear insufficient due to the subtle nature of these fractures and potential delayed symptoms. Thus, a high suspicion level and suitable imaging are vital for timely diagnosis and management.",1.8948778188548325e-07,0.1582765559020194,0.0029726625487767923,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
158,0.1,9,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Question: Do clinical predictors adequately detect cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors are inadequate because these fractures often present subtly and symptoms may be delayed. Therefore, maintaining a high index of suspicion and using appropriate imaging are essential for prompt diagnosis and treatment.",1.4211583641411244e-07,0.11629931608083233,0.002140430468021242,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
158,0.1,10,ai,"Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the identification of these fractures. This is due to the frequently subtle presentation and the potential for delayed symptoms. Therefore,  a high index of suspicion and appropriate imaging are crucial for timely diagnosis and management. 
","Question: Is reliance on clinical predictors enough to identify cervical spine fractures in geriatric patients with low-energy blunt trauma? Answer: Clinical predictors are inadequate due to the frequently subtle presentation and delayed symptoms. Hence, a high suspicion index and proper imaging are critical for timely diagnosis and management.",2.1317375462116866e-07,0.17994445728120034,0.00341530097330061,0.016320838183036854,0.17869178874337655,0.0,0.0162972138685758,0.18232155679395579,0.0,2.1317375462116866e-07,0.18610227963385917,0.0
159,0.1,1,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Is there a difference in target motion between the superior and inferior parts of the clinical target volume? Answer: No statistically significant motion differences exist between the SUP-CTV and INF-CTV. The current uniform planning target volume (PTV) margins sufficiently cover both CTV regions.,0.0,0.02432095370385845,0.017503057007927147,0.0,0.024755256448569796,0.017851239669421492,0.0,0.0,0.0,0.0,0.0,0.0
159,0.1,2,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, does interfractional motion of the prostate bed target vary between the superior and inferior sections of the clinical target volume? Answer: There are no statistically significant differences in motion between the superior (SUP-CTV) and inferior (INF-CTV) portions. The uniform planning target volume (PTV) margins currently used adequately encompass both areas.",4.737194547137081e-08,0.01085797490212359,0.03239669421487603,0.0036268529295637453,0.03594494934397918,0.0006151670316868058,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
159,0.1,3,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: When assessing prostate bed target interfractional motion with RTOG consensus definitions and daily CT on rails, does target motion differ between the superior and inferior clinical target volume regions? Answer: No statistically significant differences in motion were found between SUP-CTV and INF-CTV. Existing uniform planning target volume (PTV) margins are sufficient to cover both parts of the CTV.",2.3685972735685406e-08,0.04213202320372478,0.017805249676314912,0.0018134264647818726,0.042454833547970416,0.017851239669421492,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
159,0.1,4,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Does interfractional motion of the prostate bed target, defined by RTOG consensus and monitored via daily CT on rails, differ between the superior and inferior portions of the clinical target volume? Answer: There is no statistically significant difference in motion between the superior and inferior CTV regions. The current uniform planning target volume (PTV) margins adequately cover both.",2.3685972735685406e-08,0.05347448445971681,0.05039833592731744,0.0018134264647818726,0.030508027563603157,0.034617896133047624,0.0018108015409528666,0.03149200739446112,0.035665294924554176,2.3685972735685406e-08,0.0068562133521661295,0.0181755829903978
159,0.1,5,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior parts of the prostate bed clinical target volume? Answer: No statistically significant motion differences were observed between SUP-CTV and INF-CTV. The uniform planning target volume (PTV) margins currently in use are sufficient for both regions.",2.3685972735685406e-08,0.03094233030831539,0.0350413223140496,0.0018134264647818726,0.006736750945891323,0.017851239669421492,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
159,0.1,6,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the interfractional motion of the prostate bed target differ between the superior and inferior clinical target volume areas when assessed with RTOG consensus definitions and daily CT on rails? Answer: No statistically significant differences in motion were detected between the superior and inferior CTV portions. The current uniform planning target volume (PTV) margins adequately cover both.,0.0,0.07296286111157357,0.051866961709619096,0.0,0.04951051289713915,0.035548546731432915,0.0,0.05041070404072334,0.03631185475258099,0.0,0.025672117798516858,0.01851192595229618
159,0.1,7,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: When evaluating prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails, is there a difference between the superior and inferior clinical target volume segments? Answer: There are no statistically significant motion differences between SUP-CTV and INF-CTV. The uniform planning target volume (PTV) margins currently applied sufficiently cover both segments.",7.105791820705622e-08,0.031097431661075703,0.016529396361753414,0.005440279394345618,0.030304520734458773,0.017851239669421492,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
159,0.1,8,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Is there a difference in interfractional motion between the superior and inferior parts of the prostate bed clinical target volume using RTOG consensus definitions and daily CT on rails? Answer: No statistically significant differences in motion exist between the superior and inferior CTV. The current uniform planning target volume (PTV) margins are adequate to cover both areas.,0.0,0.07296286111157357,0.051866961709619096,0.0,0.04951051289713915,0.035548546731432915,0.0,0.05041070404072334,0.03631185475258099,0.0,0.025672117798516858,0.01851192595229618
159,0.1,9,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using RTOG consensus definitions and daily CT on rails, does the interfractional motion of the prostate bed target vary between the superior and inferior clinical target volume regions? Answer: There are no statistically significant motion differences between SUP-CTV and INF-CTV. The uniform planning target volume (PTV) margins currently used are sufficient to cover both regions.",4.737194547137081e-08,0.012281527214724974,0.016865739323651797,0.0036268529295637453,0.01161238772230444,0.017851239669421492,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
159,0.1,10,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does interfractional motion differ between the superior and inferior portions of the prostate bed clinical target volume when assessed with RTOG consensus definitions and daily CT on rails? Answer: No statistically significant differences in motion were found between the superior and inferior CTV portions. The current uniform planning target volume (PTV) margins adequately cover both.,4.737194547137081e-08,0.11310293529617166,0.054958677685950384,0.0036268529295637453,0.08862874111785457,0.037512082129886465,0.003621603081905733,0.08935426643959143,0.037677816224529016,4.737194547137081e-08,0.06439983492746082,0.01922337562475971
160,0.1,1,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Are laboratories accurately reporting serum quantitative hCG results? Numerous factors lead to incorrect hCG result reporting, such as (a) differences in assay methods, (b) improper handling of samples, (c) mistakes by operators, and (d) insufficient quality control procedures.",2.36859727356853e-08,0.026668247082160867,0.0,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
160,0.1,2,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Do laboratories report serum quantitative hCG results correctly? Errors in hCG reporting often arise from (a) assay methodology variations, (b) poor sample handling, (c) operator mistakes, and (d) lack of adequate quality control.",1.421158364141118e-07,0.17185025692666,0.0,0.010880558788691264,0.17693070815907896,0.0,0.010864809245717234,0.18232155679395534,0.0,1.4211583641411244e-07,0.18805223150294026,0.0
160,0.1,3,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Is the reporting of serum quantitative hCG results by laboratories accurate? Several factors cause erroneous hCG reporting, including (a) assay method differences, (b) mishandling of samples, (c) operator errors, and (d) inadequate quality control.",1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
160,0.1,4,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Are serum quantitative hCG results being reported correctly by laboratories? Incorrect reporting can result from (a) variations in assay techniques, (b) improper sample management, (c) errors by operators, and (d) insufficient quality control.",1.421158364141118e-07,0.17185025692666,0.0,0.010880558788691264,0.17693070815907896,0.0,0.010864809245717234,0.18232155679395534,0.0,1.4211583641411244e-07,0.18805223150294026,0.0
160,0.1,5,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Do laboratories provide accurate serum quantitative hCG results? Many causes of erroneous hCG reporting include (a) assay methodology differences, (b) sample mishandling, (c) operator error, and (d) poor quality control.",2.131737546211677e-07,0.2702903297399133,0.0,0.016320838183036902,0.27871340246902143,0.0,0.016297213868575855,0.2876820724517808,0.0,2.1317375462116866e-07,0.29725152346793093,0.0
160,0.1,6,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Are serum quantitative hCG results reported accurately by labs? Factors contributing to errors include (a) assay method variability, (b) improper sample handling, (c) operator mistakes, and (d) inadequate quality control measures.",1.894877818854824e-07,0.23638877806423153,0.0,0.014507411718255023,0.24362208265775243,0.0,0.014486412327622981,0.2513144282809061,0.0,1.8948778188548325e-07,0.25951119548508395,0.0
160,0.1,7,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Is the serum quantitative hCG reporting by laboratories correct? Errors often stem from (a) assay method variations, (b) sample handling issues, (c) operator errors, and (d) insufficient quality control.",2.36859727356853e-07,0.3053816495511823,0.0,0.018134264647818782,0.3150810466398961,0.0,0.01810801540952873,0.3254224004346278,0.0,2.3685972735685406e-07,0.3364722366212134,0.0
160,0.1,8,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Are laboratories correctly reporting serum quantitative hCG results? Erroneous results can be due to (a) differences in assay methodologies, (b) improper handling of samples, (c) operator errors, and (d) lack of adequate quality control.",1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
160,0.1,9,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Do labs report serum quantitative hCG results correctly? Many factors cause errors, including (a) assay method differences, (b) improper sample handling, (c) operator mistakes, and (d) inadequate quality control.",2.36859727356853e-07,0.3053816495511823,0.0,0.018134264647818782,0.3150810466398961,0.0,0.01810801540952873,0.3254224004346278,0.0,2.3685972735685406e-07,0.3364722366212134,0.0
160,0.1,10,ai,"Question: Are laboratories reporting serum quantitative hCG results correctly? 
Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) variations in assay methodologies, (b) improper sample handling, (c) operator error, and (d) inadequate quality control measures. 
","Are serum quantitative hCG results from laboratories reported accurately? Errors arise from (a) assay methodology variations, (b) poor sample handling, (c) operator error, and (d) insufficient quality control.",2.605457000925383e-07,0.341749293722057,0.0,0.01994769111260066,0.3528213746227431,0.0,0.019918816950481602,0.36464311358791024,0.0,2.6054570009253947e-07,0.3772942311414682,0.0
161,0.1,1,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","We present for the first time that ESLD etiology serves as a prognostic factor for HRS, based on a large retrospective study, indicating its potential use in risk stratification for HRS patients. Further studies are required to confirm this and assess clinical impacts.",4.263475092423373e-07,0.333570037920067,0.016661878770468257,0.03264167636607371,0.36396537720141087,0.0,0.0325944277371516,0.37156355643248284,0.0,4.263475092423373e-07,0.37948962170490574,0.0
161,0.1,2,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","This study is the first to identify ESLD etiology as a prognostic indicator for HRS, derived from extensive retrospective data, suggesting it could aid in risk assessment of HRS patients. Additional research is necessary to validate and understand its clinical relevance.",4.737194547137081e-07,0.3823602020894987,0.016661878770468257,0.03626852929563745,0.4139757977760743,0.0,0.03621603081905733,0.42285685082003255,0.0,4.737194547137081e-07,0.4321333551903246,0.0
161,0.1,3,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","For the first time, we highlight ESLD etiology as a prognostic factor in HRS, supported by a large retrospective analysis, implying it may help stratify risk in HRS cases. Further investigation is needed to confirm and explore clinical applications.",5.210914001850787e-07,0.43365349647704843,0.016661878770468257,0.0398953822252012,0.46661953126149314,0.0,0.039837633900963065,0.47692407209030874,0.0,5.210914001850789e-07,0.48770320634513675,0.0
161,0.1,4,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","Our findings reveal ESLD etiology as a novel prognostic factor for HRS, based on a comprehensive retrospective study, proposing its utility in risk stratification among HRS patients. More research is essential to validate and clarify its clinical significance.",5.44777372920764e-07,0.4603217435592093,0.016661878770468257,0.04170880868998307,0.49401850544960846,0.0,0.04164843544191593,0.5050949490570056,0.0,5.447773729207643e-07,0.5166907432183883,0.0
161,0.1,5,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","We report ESLD etiology as a prognostic factor for HRS for the first time, grounded in a large retrospective study, suggesting it could be a valuable tool for risk stratification in HRS. Further validation and clinical exploration are warranted.",5.210914001850787e-07,0.43365349647704843,0.016661878770468257,0.0398953822252012,0.46661953126149314,0.0,0.039837633900963065,0.47692407209030874,0.0,5.210914001850789e-07,0.48770320634513675,0.0
161,0.1,6,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","This is the first report identifying ESLD etiology as a prognostic factor in HRS, based on extensive retrospective data, indicating its potential role in risk stratification. Additional studies are needed to confirm and explore clinical implications.",5.921493183921346e-07,0.5158915947140215,0.016661878770468257,0.04533566161954682,0.5511769192895568,0.0,0.04527003852382168,0.5639354490799389,0.0,5.921493183921352e-07,0.5773153650348237,0.0
161,0.1,7,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","Our retrospective study is the first to show ESLD etiology as a prognostic factor for HRS, suggesting it may be useful for risk stratification. Further research is required to validate this finding and its clinical impact.",5.921493183921346e-07,0.5158915947140215,0.016661878770468257,0.04533566161954682,0.5511769192895568,0.0,0.04527003852382168,0.5639354490799389,0.0,5.921493183921352e-07,0.5773153650348237,0.0
161,0.1,8,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","We identify ESLD etiology as a prognostic factor for HRS for the first time, supported by a large retrospective study, which suggests its usefulness in risk stratification. Further studies should validate and investigate its clinical relevance.",5.921493183921346e-07,0.5158915947140215,0.016661878770468257,0.04533566161954682,0.5511769192895568,0.0,0.04527003852382168,0.5639354490799389,0.0,5.921493183921352e-07,0.5773153650348237,0.0
161,0.1,9,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","This large retrospective study is the first to report ESLD etiology as a prognostic factor for HRS, implying it could serve as a risk stratification tool. Further research is necessary to confirm and explore clinical implications.",5.921493183921346e-07,0.5555000050317327,0.011884834032299903,0.04533566161954682,0.5511769192895568,0.0,0.04527003852382168,0.5639354490799389,0.0,5.921493183921352e-07,0.5773153650348237,0.0
161,0.1,10,ai,"Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for HRS.  This finding, based on a large retrospective study, suggests that ESLD etiology may be a useful tool for risk stratification in patients with HRS. Further research is needed to validate this finding and explore its clinical implications. 
","For the first time, ESLD etiology is reported as a prognostic factor for HRS in a large retrospective study, indicating its potential utility in risk stratification. Further validation and clinical research are needed.",6.632072365991905e-07,0.6055037534037084,0.016661878770468257,0.05077594101389246,0.6435502394205721,0.0,0.0507024431466803,0.6592456288842641,0.0,6.632072365991914e-07,0.675755437848077,0.0
162,0.1,1,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does cup-cage reconstruction using oversized cups ensure initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Most acetabular components in this group remained stable despite limited contact between the component and pelvic bone, although 3 out of 10 showed migration beyond thresholds indicating potential loosening.",1.1842986367842703e-07,0.10318423623523065,0.0,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
162,0.1,2,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In THA for osteoporotic acetabular fractures, does using oversized cups in cup-cage reconstruction provide initial stability? The majority of acetabular components were stable despite minimal contact with pelvic bone, but 3 of 10 migrated beyond limits that suggest future loosening.",2.8423167282822477e-07,0.26826398659468076,0.0,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
162,0.1,3,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Is initial stability achieved in THA for osteoporotic acetabular fractures with cup-cage reconstruction using oversized cups? Most components remained stable despite small contact surfaces, though 3 out of 10 migrated past the limits predicting loosening.",4.0266153650665127e-07,0.4054651081081633,0.0,0.03082824990129185,0.4155154439616653,0.0,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
162,0.1,4,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does the use of oversized cups in cup-cage reconstruction offer initial stability in THA for osteoporotic acetabular fractures? Although the contact area between component and pelvic bone was small, most acetabular components were stable; however, 3 of 10 migrated beyond loosening thresholds.",2.3685972735685406e-07,0.21825356602001733,0.0,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
162,0.1,5,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Can cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Despite limited contact between component and pelvic bone, most acetabular components were stable, but 3 out of 10 migrated beyond limits indicating loosening.",3.3160361829959537e-07,0.3209077200800996,0.0,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
162,0.1,6,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In the context of THA for osteoporotic acetabular fractures, does cup-cage reconstruction with oversized cups ensure initial stability? The majority of components were stable despite small contact surfaces, though 3 of 10 migrated beyond the limits that predict loosening.",3.0791764556391007e-07,0.29423947299793873,0.0,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
162,0.1,7,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does cup-cage reconstruction using oversized cups achieve initial stability in THA for osteoporotic acetabular fractures? Most acetabular components remained stable despite minimal contact with pelvic bone, but 3 out of 10 migrated beyond thresholds for loosening.",3.7897556377096597e-07,0.37647757123491177,0.0,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
162,0.1,8,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Is initial stability provided by cup-cage reconstruction with oversized cups in THA for osteoporotic acetabular fractures? Despite a small contact surface, most components were stable, although 3 of 10 migrated beyond limits that forecast loosening.",4.0266153650665127e-07,0.4054651081081633,0.0,0.03082824990129185,0.4155154439616653,0.0,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
162,0.1,9,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does the application of oversized cups in cup-cage reconstruction yield initial stability in THA for osteoporotic acetabular fractures? Most acetabular components were stable despite limited contact with pelvic bone, but 3 out of 10 migrated beyond loosening prediction limits.",3.0791764556391007e-07,0.29423947299793873,0.0,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
162,0.1,10,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In THA for osteoporotic acetabular fractures, does cup-cage reconstruction with oversized cups provide initial stability? The majority of components were stable despite small contact areas, though 3 of 10 migrated beyond thresholds indicating potential loosening.",4.0266153650665127e-07,0.4054651081081633,0.0,0.03082824990129185,0.4155154439616653,0.0,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
163,0.1,1,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study data indicates a potential link between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,2,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Does a relationship exist between cervical cord plaques and discopathy in patients with multiple sclerosis? Study findings suggest a possible association between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,3,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques related to discopathy in multiple sclerosis patients? The research data points to a possible correlation between cervical discopathy and cervical MS plaques.,1.184298636784265e-07,0.13611174475662535,0.033293697978596916,0.009067132323909398,0.18924199963852795,0.0,0.009054007704764368,0.19671029424605457,0.0,1.1842986367842703e-07,0.20479441264601395,0.0
163,0.1,4,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any association between cervical cord plaques and discopathy in multiple sclerosis cases? The study data implies a potential connection between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,5,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Can cervical cord plaques be linked to discopathy in patients with multiple sclerosis? Study results suggest a possible relationship between cervical discopathy and cervical MS plaques.,1.184298636784265e-07,0.13611174475662535,0.033293697978596916,0.009067132323909398,0.18924199963852795,0.0,0.009054007704764368,0.19671029424605457,0.0,1.1842986367842703e-07,0.20479441264601395,0.0
163,0.1,6,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a correlation between cervical cord plaques and discopathy in multiple sclerosis patients? The study data suggests a potential link between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,7,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Do cervical cord plaques have any relation to discopathy in multiple sclerosis patients? The research indicates a possible association between cervical discopathy and cervical MS plaques.,1.184298636784265e-07,0.13611174475662535,0.033293697978596916,0.009067132323909398,0.18924199963852795,0.0,0.009054007704764368,0.19671029424605457,0.0,1.1842986367842703e-07,0.20479441264601395,0.0
163,0.1,8,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any connection between cervical cord plaques and discopathy in patients with multiple sclerosis? Study data suggests a possible correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
163,0.1,9,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques associated with discopathy in multiple sclerosis patients? The study findings suggest a potential link between cervical discopathy and cervical MS plaques.,1.421158364141118e-07,0.17693373927688016,0.033293697978596916,0.010880558788691277,0.23180161405732358,0.0,0.010864809245717241,0.24116205681688863,0.0,1.4211583641411244e-07,0.2513144282809079,0.0
163,0.1,10,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a possible relationship between cervical cord plaques and discopathy in multiple sclerosis patients? The study data suggests a correlation between cervical discopathy and cervical MS plaques.,7.10579182070559e-08,0.11049493921752918,0.003688550542113131,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
164,0.1,1,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair warranted for patients aged 80 or above following aneurysmal subarachnoid hemorrhage? The study shows improved outcomes when ruptured aneurysms are surgically repaired in elderly patients compared to conservative treatment. Therefore, definitive surgery should be confidently offered to elderly patients with aSAH.",2.3685972735685406e-07,0.18901820684629156,0.0144351858390415,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.1,2,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should aneurysm repair be performed on patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The findings indicate that elderly patients have a better prognosis with surgical repair of ruptured aneurysms than with conservative management. Hence, definitive surgery is recommended for elderly aSAH patients.",2.3685972735685406e-07,0.15677880309931735,0.03767781622452902,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.1,3,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to perform aneurysm repair in patients aged 80+ after aneurysmal subarachnoid hemorrhage? This study demonstrates that elderly patients achieve better outcomes when ruptured aneurysms are repaired surgically rather than treated conservatively. Thus, definitive surgery should be considered for elderly aSAH cases.",2.3685972735685406e-07,0.15677880309931735,0.03767781622452902,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.1,4,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Does aneurysm repair benefit patients aged 80 or older following aneurysmal subarachnoid hemorrhage? Results reveal that elderly patients have improved prognosis with surgical repair of ruptured aneurysms compared to conservative treatment. Consequently, definitive surgery should be offered without hesitation to elderly aSAH patients.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
164,0.1,5,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair justified in patients aged 80 and above after aneurysmal subarachnoid hemorrhage? The study results show superior prognosis in elderly patients undergoing surgical repair of ruptured aneurysms versus conservative care. Therefore, definitive surgery should be confidently provided to elderly individuals with aSAH.",2.3685972735685406e-07,0.15677880309931735,0.03767781622452902,0.018134264647818726,0.21357410029806,0.0,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
164,0.1,6,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should patients aged 80 or older receive aneurysm repair after aneurysmal subarachnoid hemorrhage? Evidence from this study suggests better outcomes with surgical repair of ruptured aneurysms in the elderly compared to conservative treatment. Hence, definitive surgery should be offered to elderly aSAH patients.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
164,0.1,7,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is surgical repair of aneurysms justified for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The study indicates that elderly patients have a better prognosis when ruptured aneurysms are repaired surgically rather than managed conservatively. Thus, definitive surgery should be pursued for elderly aSAH patients.",1.8948778188548325e-07,0.11131642902256011,0.03767781622452902,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
164,0.1,8,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it advisable to perform aneurysm repair on patients aged 80 or above following aneurysmal subarachnoid hemorrhage? Findings show that elderly patients benefit from surgical repair of ruptured aneurysms with better prognosis than conservative treatment. Therefore, definitive surgery should be offered to elderly patients with aSAH.",1.8948778188548325e-07,0.1421229703807798,0.015467072422876132,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
164,0.1,9,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair appropriate for patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The study demonstrates improved prognosis in elderly patients who undergo surgical repair of ruptured aneurysms compared to conservative management. Consequently, definitive surgery should be recommended for elderly aSAH patients.",2.6054570009253947e-07,0.18030930050951177,0.03767781622452902,0.0199476911126006,0.23767165187712003,0.0,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
164,0.1,10,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair warranted for elderly patients aged 80 or above after aneurysmal subarachnoid hemorrhage? Results indicate better outcomes with surgical repair of ruptured aneurysms than with conservative treatment in this age group. Thus, definitive surgery should be confidently offered to elderly patients with aSAH.",2.1317375462116866e-07,0.16529597490007042,0.014962835153679913,0.016320838183036854,0.1900436028878656,0.0,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
165,0.1,1,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do individuals with episodic migraines specifically focus on headache-related visual cues? Answer: Considering the substantial sample size and previous pilot testing of the images shown, findings indicate that episodic migraine sufferers do not show selective attention to headache-related facial stimuli. While there is limited evidence of attentional biases in chronic headache groups, these",1.1842986367842703e-07,0.18573430021422288,0.06222222222222222,0.009067132323909363,0.13059174157604847,0.0212665406427221,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
165,0.1,2,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are episodic migraine patients more likely to attend to headache-related visual stimuli? Answer: Based on the large sample and earlier pilot tests of the images, the results imply that episodic migraineurs do not preferentially attend to headache-related facial images. There is some modest evidence of attentional biases in chronic headache populations, but these",1.1842986367842703e-07,0.13342130545498154,0.024544405997693204,0.009067132323909363,0.10393223463143508,0.0020431650179623916,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
165,0.1,3,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do people with episodic migraines selectively focus on headache-related visual stimuli? Answer: Given the large sample size and prior pilot testing of the images used, the data suggest that episodic migraineurs do not exhibit differential attention to headache-related facial stimuli. Some modest evidence exists for attentional biases in chronic headache sufferers, however, these",1.1842986367842703e-07,0.18573430021422288,0.06222222222222222,0.009067132323909363,0.13059174157604847,0.0212665406427221,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
165,0.1,4,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Is there selective attention to headache-related visual stimuli among episodic migraineurs? Answer: Taking into account the large sample and previous pilot testing of the images, the findings suggest that episodic migraineurs do not selectively attend to headache-related facial stimuli. There is limited but modest evidence of attentional biases in chronic headache samples, though these",1.4211583641411244e-07,0.17875431542786036,0.043710296269926036,0.010880558788691236,0.14963993654674157,0.0212665406427221,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
165,0.1,5,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do episodic migraine sufferers show selective attention to headache-related visual cues? Answer: With a large sample size and prior pilot testing of the images, results indicate that episodic migraineurs do not differentially focus on headache-related facial stimuli. Modest evidence of attentional biases has been found in chronic headache groups, but these",7.105791820705622e-08,0.14726801938642708,0.06222222222222222,0.005440279394345618,0.09137102842276601,0.0212665406427221,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
165,0.1,6,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are headache-related visual stimuli selectively attended to by episodic migraineurs? Answer: Considering the extensive sample size and earlier pilot testing of the images, results suggest that episodic migraineurs do not show selective attention to headache-related facial stimuli. There is some modest evidence for attentional biases in chronic headache populations, however, these",7.105791820705622e-08,0.14726801938642708,0.06222222222222222,0.005440279394345618,0.09137102842276601,0.0212665406427221,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
165,0.1,7,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do individuals with episodic migraines pay more attention to headache-related visual stimuli? Answer: Based on the large sample and prior pilot testing of the images, findings suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Modest evidence exists for attentional biases among chronic headache sufferers, but these",4.737194547137081e-08,0.09973950486784933,0.04223055208477949,0.0036268529295637453,0.0711683211052474,0.0212665406427221,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
165,0.1,8,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Is selective attention to headache-related visual stimuli present in episodic migraineurs? Answer: Given the large sample size and previous pilot testing of the images, results indicate that episodic migraineurs do not selectively attend to headache-related facial stimuli. There is some modest evidence of attentional biases in chronic headache groups, though these",7.105791820705622e-08,0.12008577701152756,0.04262222222222223,0.005440279394345618,0.09137102842276601,0.0212665406427221,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
165,0.1,9,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do episodic migraine patients exhibit selective attention to headache-related visual stimuli? Answer: Taking into account the large sample and prior pilot testing of the images, the results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Modest evidence of attentional biases has been observed in chronic headache samples, but these",1.1842986367842703e-07,0.159577802834602,0.04336127547666009,0.009067132323909363,0.13059174157604847,0.0212665406427221,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
165,0.1,10,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are headache-related facial stimuli selectively attended to by episodic migraineurs? Answer: Considering the large sample size and earlier pilot testing of the images, findings suggest that episodic migraineurs do not show selective attention to headache-related facial stimuli. There is limited but modest evidence of attentional biases in chronic headache populations, however, these",9.474389094274162e-08,0.1400265982989164,0.04299884659746251,0.0072537058591274906,0.11117365571894577,0.0212665406427221,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
166,0.1,1,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does Kenya's health care benefits distribution align with universal coverage principles? Universal coverage means everyone should access quality health care regardless of payment ability. Kenya has progressed but disparities remain, especially in rural and marginalized areas. Access and financial protection are still major issues.",4.500334819780227e-07,0.36333431743645006,0.0018610418655808092,0.03445510283085558,0.32775197175486426,0.03274920999712727,0.034405229278104466,0.357667589499127,0.016661878770468257,4.500334819780227e-07,0.38865798979178257,0.0
166,0.1,2,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Universal coverage ensures all individuals receive quality health care irrespective of their financial capacity. Kenya has advanced towards this goal, yet inequalities persist, mainly in rural and marginalized communities. Access to essential services and financial safeguards are ongoing challenges.",2.3685972735685406e-07,0.16213092094386283,0.009861993679977005,0.018134264647818726,0.13359595731390694,0.03274920999712727,0.018108015409528666,0.15921665077528946,0.016661878770468257,2.3685972735685406e-07,0.1857171457950919,0.0
166,0.1,3,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does Kenya's health care benefits distribution fulfill the universal coverage principles? Universal coverage demands that all people benefit from quality health care regardless of their ability to pay. Kenya has made progress, but disparities continue, especially in rural and marginalized regions. Access to key services and financial protection remain significant hurdles.",2.8423167282822487e-07,0.20348439465271406,0.008331438124421449,0.02176111757738247,0.17360129192760532,0.03274920999712727,0.0217296184914344,0.20003864529554383,0.016661878770468257,2.8423167282822487e-07,0.22738984219566083,0.0
166,0.1,4,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does the way health care benefits are distributed in Kenya meet the standards of universal coverage? Universal coverage requires everyone to have access to quality health care without financial barriers. Kenya has taken steps forward, but inequalities persist, particularly in rural and marginalized communities. Access and financial protection are still problematic.",2.8423167282822487e-07,0.1757585074303165,0.02827032354253428,0.02176111757738247,0.17360129192760532,0.03274920999712727,0.0217296184914344,0.20003864529554383,0.016661878770468257,2.8423167282822487e-07,0.22738984219566083,0.0
166,0.1,5,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Is the distribution of health care benefits in Kenya aligned with the principles of universal coverage? Universal coverage means all individuals should receive quality health care regardless of payment ability. Kenya has made progress, but disparities remain, especially in rural and marginalized areas. Access to essential services and financial protection continue to be challenges.",2.1317375462116866e-07,0.11592020946356385,0.029401046934414882,0.016320838183036854,0.11417787145680425,0.03274920999712727,0.0162972138685758,0.1394140234791097,0.016661878770468257,2.1317375462116866e-07,0.1655144384775733,0.0
166,0.1,6,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does Kenya's distribution of health care benefits comply with universal coverage principles? Universal coverage ensures everyone benefits from quality health care regardless of their ability to pay. Kenya has advanced towards universal coverage, but disparities persist, particularly in rural and marginalized communities. Access and financial protection remain significant challenges.",3.316036182995957e-07,0.2466168797748347,0.006674091978653755,0.025387970506946217,0.21527398832817424,0.03274920999712727,0.025351221573340132,0.24259825971434035,0.016661878770468257,3.316036182995957e-07,0.2708749541353992,0.0
166,0.1,7,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Is the distribution of health care benefits in Kenya in accordance with universal coverage principles? Universal coverage requires that all people have access to quality health care regardless of their financial means. Kenya has made strides, but inequalities persist, especially in rural and marginalized areas. Access to essential services and financial protection are ongoing issues.",1.8948778188548325e-07,0.1480879324673383,0.007101328119330945,0.014507411718254981,0.09512967648611115,0.03274920999712727,0.014486412327622933,0.119995937622007,0.016661878770468257,1.8948778188548325e-07,0.14571181118139354,0.0
166,0.1,8,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does the distribution of health care benefits in Kenya satisfy the principles of universal coverage? Universal coverage means everyone should benefit from quality health care regardless of their ability to pay. Kenya has progressed towards this goal, but disparities remain, particularly in rural and marginalized communities. Access and financial protection are still major challenges.",2.1317375462116866e-07,0.11592020946356385,0.029401046934414882,0.016320838183036854,0.11417787145680425,0.03274920999712727,0.0162972138685758,0.1394140234791097,0.016661878770468257,2.1317375462116866e-07,0.1655144384775733,0.0
166,0.1,9,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Is Kenya's distribution of health care benefits consistent with universal coverage principles? Universal coverage demands that all individuals receive quality health care regardless of their financial capacity. Kenya has made progress, but inequalities persist, especially in rural and marginalized regions. Access to essential services and financial protection remain significant challenges.",3.079176455639103e-07,0.22481877083645285,0.00751957629654558,0.023574544042164344,0.19422057913034108,0.03274920999712727,0.023540420032387266,0.221092054493377,0.016661878770468257,3.079176455639103e-07,0.2488960474166242,0.0
166,0.1,10,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from quality health care, regardless of their ability to pay. While Kenya has made strides towards universal coverage, disparities persist, particularly in rural and marginalized communities. Access to essential services and financial protection remain significant challenges. 
","Does the distribution of health care benefits in Kenya adhere to the principles of universal coverage? Universal coverage requires that everyone benefits from quality health care regardless of their ability to pay. Kenya has made strides towards universal coverage, but disparities continue, particularly in rural and marginalized communities. Access and financial protection remain key challenges.",1.8948778188548325e-07,0.09674369687030548,0.029750067727680834,0.014507411718254981,0.09512967648611115,0.03274920999712727,0.014486412327622933,0.119995937622007,0.016661878770468257,1.8948778188548325e-07,0.14571181118139354,0.0
167,0.1,1,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Can a new surgical method for the temporomandibular joint enhance access and lower complication rates? The VMPA allows direct access and clear visualization of the joint, reducing harm to nearby tissues. This approach may lead to better surgical results and fewer postoperative issues.",4.737194547137081e-08,0.04802033420753293,0.0010803788339694455,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
167,0.1,2,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Is it possible that a novel surgical technique for the temporomandibular joint improves accessibility and decreases complications? The VMPA provides straightforward access and visualization of the joint, minimizing damage to adjacent structures. This method holds promise for enhanced surgical outcomes and fewer postoperative complications.",2.3685972735685406e-08,0.008517171800753065,0.02271498107084911,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
167,0.1,3,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Could an innovative surgical approach to the temporomandibular joint improve joint access and reduce the risk of complications? The VMPA offers direct access and clear visualization, limiting injury to surrounding areas. This technique has potential to improve surgical success and reduce postoperative problems.",4.737194547137081e-08,0.0810273428056254,0.024785018929150904,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
167,0.1,4,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Does a new surgical approach to the temporomandibular joint enhance access and reduce complications? The VMPA technique enables direct visualization and access to the joint, minimizing collateral damage to nearby tissues. This method may improve surgical outcomes and lower postoperative complication rates.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
167,0.1,5,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Might a novel surgical technique for the temporomandibular joint improve access and decrease complications? The VMPA provides direct joint access and visualization, reducing harm to surrounding structures. This approach could lead to better surgical results and fewer postoperative complications.",1.4211583641411222e-07,0.15157821472220911,0.0035815857662582634,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
167,0.1,6,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Can a novel surgical approach to the temporomandibular joint improve access and minimize complications? The VMPA facilitates direct visualization and access to the joint, limiting damage to adjacent tissues. This technique offers potential for enhanced surgical outcomes and reduced postoperative complications.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
167,0.1,7,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Is a new surgical method for the temporomandibular joint capable of improving access and reducing complications? The VMPA allows direct access and visualization of the joint, minimizing injury to surrounding structures. This approach may result in improved surgical outcomes and fewer postoperative complications.",4.737194547137081e-08,0.04802033420753293,0.0010803788339694455,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
167,0.1,8,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Could a novel surgical technique for the temporomandibular joint enhance access and lower complication risks? The VMPA provides direct joint access and visualization, minimizing collateral damage. This method offers potential for better surgical outcomes and reduced postoperative complications.",1.6580180914979753e-07,0.17923244641398606,0.004291191768657054,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
167,0.1,9,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Does a new surgical approach to the temporomandibular joint improve access and reduce the likelihood of complications? The VMPA enables direct visualization and access to the joint, limiting damage to surrounding tissues. This technique may improve surgical success and decrease postoperative complications.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
167,0.1,10,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visualization of the joint, minimizing collateral damage to surrounding structures. This technique offers potential for improved surgical outcomes and reduced postoperative complications. 
","Might an innovative surgical approach to the temporomandibular joint improve access and reduce complications? The VMPA offers direct access and visualization of the joint, minimizing harm to adjacent structures. This method holds promise for enhanced surgical outcomes and fewer postoperative complications.",9.474389094274162e-08,0.09846084880686945,0.002268582374252811,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
168,0.1,1,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Does the position of the head affect anterior chamber depth in pseudoexfoliation syndrome? In patients with clinically evident unilateral pseudoexfoliation, the anterior chamber depth was notably shallower in the affected eye than in the unaffected eye, independent of head position. This indicates that pseudoexfoliation itself, not head positioning, causes differences in anterior chamber depth.",0.0,0.009872606486123203,0.04081632653061226,0.0,0.03672197124777776,0.05917662437524026,0.0,0.0,0.0,0.0,0.0,0.0
168,0.1,2,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Is anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? Among patients with unilateral pseudoexfoliation, the anterior chamber depth was significantly reduced in the affected eye compared to the unaffected eye, regardless of how the head was positioned. This implies that the condition of pseudoexfoliation, rather than head position, affects anterior chamber depth.",0.0,0.036029103865744094,0.06020141607663479,0.0,0.03672197124777776,0.05917662437524026,0.0,0.0,0.0,0.0,0.0,0.0
168,0.1,3,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Does head posture impact anterior chamber depth in cases of pseudoexfoliation syndrome? In individuals with clinically obvious unilateral pseudoexfoliation, the anterior chamber depth was consistently shallower in the affected eye versus the unaffected eye, no matter the head position. This suggests that the pseudoexfoliation condition itself leads to anterior chamber depth differences, not the head position.",4.737194547137081e-08,0.00884684317889306,0.032486463973344426,0.0036268529295637453,0.014415672339604058,0.016179008073817766,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
168,0.1,4,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Is there an effect of head positioning on anterior chamber depth in pseudoexfoliation syndrome? Patients with unilateral pseudoexfoliation showed a significantly shallower anterior chamber depth in the affected eye compared to the unaffected eye, regardless of head orientation. This finding suggests that pseudoexfoliation, rather than head position, is responsible for anterior chamber depth variations.",0.0,0.05231299475924178,0.03986757441680125,0.0,0.026659506944613387,0.019892378175760145,0.0,0.027182242374899523,0.019599999999999992,0.0,0.0,0.0
168,0.1,5,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Does the orientation of the head influence anterior chamber depth in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, the anterior chamber depth was markedly shallower in the affected eye than the unaffected eye, independent of head orientation. This indicates that pseudoexfoliation itself, not head positioning, accounts for anterior chamber depth differences.",7.105791820705622e-08,0.06573118027341929,0.009750190728658265,0.005440279394345618,0.06330391913564082,0.004895608872793153,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
168,0.1,6,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Can head positioning alter anterior chamber depth in pseudoexfoliation syndrome? In clinically apparent unilateral pseudoexfoliation cases, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that the depth discrepancy is due to pseudoexfoliation itself, not head positioning.",9.474389094274162e-08,0.01068385626178081,0.11585899869320335,0.0072537058591274906,0.04554236200447637,0.057576097781801686,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
168,0.1,7,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Does changing head position affect anterior chamber depth in pseudoexfoliation syndrome? Among patients with unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye than in the unaffected eye, irrespective of head position. This implies that pseudoexfoliation itself causes the anterior chamber depth difference, not the head position.",7.105791820705622e-08,0.14890884194061282,0.07271172616241339,0.005440279394345618,0.0915956407911489,0.02604234404536862,0.0054324046228586,0.08950575433976482,0.020823902218198284,7.105791820705622e-08,0.06187540371808753,0.0
168,0.1,8,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Is anterior chamber depth in pseudoexfoliation syndrome affected by head position? In patients with clinically evident unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, influences anterior chamber depth.",7.105791820705622e-08,0.027540330175730876,0.05429267909157365,0.005440279394345618,0.024333663933918004,0.05800069444444442,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
168,0.1,9,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Does head positioning have an impact on anterior chamber depth in pseudoexfoliation syndrome? In unilateral pseudoexfoliation patients, the anterior chamber depth was significantly shallower in the affected eye than the unaffected eye, independent of head position. This indicates that pseudoexfoliation itself, not head positioning, contributes to anterior chamber depth differences.",9.474389094274162e-08,0.08862436666522733,0.013275127133241749,0.0072537058591274906,0.08532449752290239,0.006666162570888451,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
168,0.1,10,ai,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? 
Answer: In patients with clinically apparent unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that pseudoexfoliation itself, rather than head positioning, contributes to anterior chamber depth discrepancies. 
","Is anterior chamber depth influenced by the position of the head in pseudoexfoliation syndrome? In patients with unilateral pseudoexfoliation, the anterior chamber depth was significantly shallower in the affected eye compared to the unaffected eye, regardless of head position. This suggests that the anterior chamber depth discrepancy is due to pseudoexfoliation itself, not head positioning.",2.3685972735685406e-08,0.004676814369868776,0.01665972511453559,0.0018134264647818726,0.005912425461900739,0.018000000000000016,0.0018108015409528666,0.007241421087510691,0.01922337562475971,2.3685972735685406e-08,0.019802627296179764,0.0
169,0.1,1,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there a link between the CYP2D6*4 allele and breast cancer risk? It is suggested that CYP2D6*4 poor metabolizers may have reduced activation of procarcinogens, potentially offering protection against carcinogens.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
169,0.1,2,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Does the CYP2D6*4 allele influence breast cancer risk? Poor metabolizers with CYP2D6*4 might transform procarcinogens less efficiently, which could provide a protective effect against carcinogens.",1.184298636784265e-07,0.18924199963852795,0.0,0.009067132323909398,0.19671029424605457,0.0,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
169,0.1,3,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is breast cancer risk associated with the CYP2D6*4 allele? The decreased conversion of procarcinogens by CYP2D6*4 poor metabolizers may lead to a protective effect against carcinogens.,9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.1,4,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"What is the relationship between the CYP2D6*4 allele and breast cancer risk? CYP2D6*4 poor metabolizers might have a reduced ability to activate procarcinogens, possibly resulting in protection from carcinogens.",2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
169,0.1,5,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Does carrying the CYP2D6*4 allele affect breast cancer risk? A potential reduction in procarcinogen transformation by CYP2D6*4 poor metabolizers could confer protection against carcinogens.,1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.1,6,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there an association between the CYP2D6*4 allele and breast cancer risk? CYP2D6*4 poor metabolizers may have decreased procarcinogen activation, which might protect against carcinogens.",1.184298636784265e-07,0.18924199963852795,0.0,0.009067132323909398,0.19671029424605457,0.0,0.009054007704764368,0.20479441264601395,0.0,1.1842986367842703e-07,0.2135741002980609,0.0
169,0.1,7,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Could the CYP2D6*4 allele be linked to breast cancer risk? The poor metabolizer status of CYP2D6*4 may reduce procarcinogen transformation, potentially offering a protective effect against carcinogens.",7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
169,0.1,8,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Does the CYP2D6*4 allele correlate with breast cancer risk? Reduced procarcinogen metabolism in CYP2D6*4 poor metabolizers could result in a protective effect against carcinogens.,1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,0.1,9,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there any connection between the CYP2D6*4 allele and breast cancer risk? CYP2D6*4 poor metabolizers might have diminished procarcinogen transformation, possibly leading to protection against carcinogens.",9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,0.1,10,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,What association exists between the CYP2D6*4 allele and breast cancer risk? The decreased activation of procarcinogens by CYP2D6*4 poor metabolizers could provide a protective effect against carcinogens.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
170,0.1,1,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call impact Kenya's polio vaccination coverage in 2015? The boycott did not significantly affect the campaign, but a future repeat could.",3.789755637709649e-07,0.2197253891743305,0.33996539792387537,0.02901482343651004,0.3460337804657754,0.20987654320987656,0.02897282465524595,0.443558792610641,0.1051862673484295,3.789755637709665e-07,0.5465437063680709,0.0
170,0.1,2,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","In 2015, did the Catholic bishops' boycott call influence polio vaccination rates in Kenya? The campaign was not significantly impacted, though a future boycott might have effects.",3.552895910352796e-07,0.18050467602104803,0.33996539792387537,0.02720139697172816,0.30521178594552056,0.20987654320987656,0.027162023114293075,0.4009991781918454,0.1051862673484295,3.552895910352811e-07,0.5020919437972369,0.0
170,0.1,3,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was the 2015 polio vaccination coverage in Kenya affected by the Catholic bishops' boycott call? The campaign remained largely unaffected, but a repeated boycott could pose risks.",3.552895910352796e-07,0.18050467602104803,0.33996539792387537,0.02720139697172816,0.30521178594552056,0.20987654320987656,0.027162023114293075,0.4009991781918454,0.1051862673484295,3.552895910352811e-07,0.5020919437972369,0.0
170,0.1,4,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the boycott urged by Catholic bishops alter Kenya's 2015 polio vaccination coverage? The campaign was not notably affected, but future calls might change that.",4.026615365066502e-07,0.2605473836945853,0.33996539792387537,0.030828249901291918,0.388593394884571,0.20987654320987656,0.030783626196198823,0.48801055518147507,0.1051862673484295,4.026615365066519e-07,0.5930637220029649,0.0
170,0.1,5,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","In 2015, did the Catholic bishops' boycott call affect polio vaccination coverage in Kenya? The campaign was not significantly impacted, yet future repetitions could.",4.263475092423355e-07,0.30310699811338093,0.33996539792387537,0.0326416763660738,0.43304515745540506,0.20987654320987656,0.032594427737151696,0.534530570816369,0.1051862673484295,4.2634750924233726e-07,0.6418538861723961,0.0
170,0.1,6,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call in 2015 influence Kenya's polio vaccination campaign? The impact was minimal, but future calls could have consequences.",4.500334819780208e-07,0.347558760684215,0.33996539792387537,0.03445510283085568,0.479565173090299,0.20987654320987656,0.03440522927810457,0.5833207349858003,0.1051862673484295,4.500334819780226e-07,0.6931471805599463,0.0
170,0.1,7,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was Kenya's 2015 polio vaccination coverage influenced by the Catholic bishops' boycott call? The campaign was not significantly affected, though future calls might.",4.500334819780208e-07,0.347558760684215,0.33996539792387537,0.03445510283085568,0.479565173090299,0.20987654320987656,0.03440522927810457,0.5833207349858003,0.1051862673484295,4.500334819780226e-07,0.6931471805599463,0.0
170,0.1,8,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the call for boycott by Catholic bishops affect Kenya's 2015 polio vaccination coverage? The campaign was largely unaffected, but repeated calls could have an impact.",3.789755637709649e-07,0.2197253891743305,0.33996539792387537,0.02901482343651004,0.3460337804657754,0.20987654320987656,0.02897282465524595,0.443558792610641,0.1051862673484295,3.789755637709665e-07,0.5465437063680709,0.0
170,0.1,9,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","In 2015, did the Catholic bishops' boycott call impact polio vaccination coverage in Kenya? The campaign was not significantly influenced, but future repetitions might.",4.263475092423355e-07,0.30310699811338093,0.33996539792387537,0.0326416763660738,0.43304515745540506,0.20987654320987656,0.032594427737151696,0.534530570816369,0.1051862673484295,4.2634750924233726e-07,0.6418538861723961,0.0
170,0.1,10,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call affect Kenya's polio vaccination coverage in 2015? The campaign was not significantly impacted, but future calls could potentially affect it.",3.789755637709649e-07,0.2197253891743305,0.33996539792387537,0.02901482343651004,0.3460337804657754,0.20987654320987656,0.02897282465524595,0.443558792610641,0.1051862673484295,3.789755637709665e-07,0.5465437063680709,0.0
171,0.1,1,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","Research indicates that mutations in KCNQ1 could increase susceptibility to atrial fibrillation, though the onset of the disease probably results from an interplay between genetic predispositions and environmental influences. Factors like hypertension and aging may act as triggers in those carrying these mutations.",4.500334819780227e-07,0.32775197175486426,0.03274920999712727,0.03445510283085558,0.357667589499127,0.016661878770468257,0.034405229278104466,0.38865798979178257,0.0,4.500334819780227e-07,0.3968813644167746,0.0
171,0.1,2,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","The findings imply that KCNQ1 mutations may make individuals more prone to atrial fibrillation, but the manifestation of the condition is likely due to a mix of genetic and environmental contributors. Environmental elements such as high blood pressure and aging might initiate the disease in mutation carriers.",3.552895910352811e-07,0.2367801935491376,0.03274920999712727,0.02720139697172809,0.26457716643311535,0.016661878770468257,0.027162023114293,0.2933478099874569,0.0,3.552895910352811e-07,0.2992428948528567,0.0
171,0.1,3,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","Data suggest that while KCNQ1 mutations can predispose people to atrial fibrillation, the actual occurrence of the disease likely depends on both genetic and environmental factors. Conditions like hypertension and aging could provoke the disease in those with these mutations.",5.210914001850788e-07,0.4374059531680716,0.0071259412990663205,0.0398953822252012,0.43365349647704843,0.016661878770468257,0.039837633900963065,0.46661953126149314,0.0,5.210914001850789e-07,0.47692407209030874,0.0
171,0.1,4,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","These results indicate that KCNQ1 mutations may increase the risk of atrial fibrillation, but the disease's development probably involves a combination of inherited genetic factors and environmental triggers such as hypertension and aging.",6.868932093348759e-07,0.5996856872385057,0.03274920999712727,0.052589367478674334,0.6372524517182883,0.016661878770468257,0.052513244687633166,0.6763400622435638,0.0,6.868932093348768e-07,0.6931471805599458,0.0
171,0.1,5,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","Evidence points to KCNQ1 mutations as a genetic risk factor for atrial fibrillation, yet the disease likely emerges from a combination of genetic susceptibility and environmental influences like hypertension and aging.",7.342651548062465e-07,0.6642242083760772,0.03274920999712727,0.05621622040823809,0.7039438262169617,0.016661878770468257,0.05613484776953891,0.7453329337305146,0.0,7.342651548062476e-07,0.7646061445420895,0.0
171,0.1,6,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","KCNQ1 mutations appear to predispose individuals to atrial fibrillation; however, the condition's development is probably influenced by both genetic and environmental factors, including hypertension and aging.",8.52695018484673e-07,0.8465457651700321,0.03274920999712727,0.0652833527321475,0.8931858258554897,0.016661878770468257,0.06518885547430328,0.9420432279765691,0.0,8.526950184846746e-07,0.9694005571881035,0.0
171,0.1,7,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","The data suggest that mutations in KCNQ1 might contribute to atrial fibrillation risk, but the disease likely arises from an interaction between genetic predisposition and environmental factors such as hypertension and aging.",7.105791820705612e-07,0.6314343855530855,0.03274920999712727,0.054402793943456214,0.67004227454128,0.016661878770468257,0.05432404622858604,0.7102416139192456,0.0,7.105791820705622e-07,0.7282385003712148,0.0
171,0.1,8,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","KCNQ1 mutations may increase vulnerability to atrial fibrillation, but the actual disease development likely requires both genetic and environmental factors, with hypertension and aging serving as potential triggers.",8.053230730133024e-07,0.7695847240339027,0.03274920999712727,0.06165649980258373,0.8131431181819524,0.016661878770468257,0.061567252392397534,0.8586616190375187,0.0,8.053230730133038e-07,0.8823891801984738,0.0
171,0.1,9,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","Findings suggest that while KCNQ1 mutations can predispose individuals to atrial fibrillation, the disease's onset probably depends on a combination of genetic and environmental factors, including hypertension and aging.",7.816371002776171e-07,0.733217079863028,0.03274920999712727,0.05984307333780185,0.7754027901991054,0.016661878770468257,0.05975645085144466,0.8194409058842362,0.0,7.816371002776184e-07,0.841567185678219,0.0
171,0.1,10,ai,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? 
Answer: These data suggest that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the actual development of the condition likely involves a combination of genetic and environmental factors. Environmental factors, such as hypertension and aging, may trigger the disease in individuals with these mutations. 
","Research shows that KCNQ1 mutations might predispose individuals to atrial fibrillation, but the condition's development likely involves both genetic and environmental factors, with hypertension and aging potentially triggering the disease.",7.579511275419318e-07,0.698125760051759,0.03274920999712727,0.05802964687301997,0.7390351460282307,0.016661878770468257,0.05794564931049179,0.7817005779013892,0.0,7.57951127541933e-07,0.8023464725249365,0.0
172,0.1,1,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Is decompressive surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression in this condition remains uncertain. Although surgery can alleviate compression, the inflammatory characteristics of sarcoidosis might reduce long-term success. More studies are required to determine the best treatment approach.",1.8948778188548325e-07,0.03375654994010002,0.09506564056134,0.014507411718254981,0.08907878990606388,0.05859375,0.014486412327622933,0.14662749992237956,0.019991670137442734,1.8948778188548325e-07,0.17824823140631896,0.0
172,0.1,2,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Does decompressive surgery work for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The impact of decompression in such cases is not well defined. Surgery may relieve pressure, but the inflammatory nature of sarcoidosis could limit lasting improvement. Additional research is necessary to find optimal therapies.",1.6580180914979784e-07,0.011283694088042306,0.09506564056134,0.012693985253473108,0.06608927168136436,0.05859375,0.012675610786670066,0.12309700251218514,0.019991670137442734,1.6580180914979784e-07,0.15415067982725894,0.0
172,0.1,3,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Can decompressive surgery effectively treat spinal cord sarcoidosis with compressive cervical myelopathy? The benefits of decompression are unclear. While surgery can reduce compression, the ongoing inflammation from sarcoidosis may hinder long-term outcomes. Further investigation is needed to identify the best treatment methods.",2.6054570009253947e-07,0.10437411715405398,0.09506564056134,0.0199476911126006,0.16139945148569002,0.05859375,0.019918816950481533,0.220735472076103,0.019991670137442734,2.6054570009253947e-07,0.25423413838424036,0.0
172,0.1,4,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Is decompressive surgery an effective option for spinal cord sarcoidosis with compressive cervical myelopathy? The role of decompression remains ambiguous. Surgery can ease compression, but the inflammatory process of sarcoidosis might restrict sustained benefits. More research is essential to establish ideal treatment protocols.",2.3685972735685406e-07,0.08027656557499396,0.09506564056134,0.018134264647818726,0.13670683889531832,0.05859375,0.018108015409528666,0.19541766409181127,0.019991670137442734,2.3685972735685406e-07,0.22825865198098239,0.0
172,0.1,5,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","How effective is decompressive surgery for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness is uncertain. Surgery can relieve compression, yet the inflammatory nature of sarcoidosis may limit long-term results. Further studies are required to define optimal treatment strategies.",3.079176455639102e-07,0.1543845377287174,0.09506564056134,0.023574544042164344,0.21269274587323972,0.05859375,0.023540420032387266,0.27337920556152184,0.019991670137442734,3.079176455639103e-07,0.30830135965451655,0.0
172,0.1,6,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Is decompression surgery beneficial for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The effect of decompression is unclear. Although surgery can alleviate compression, the inflammatory characteristics of sarcoidosis might reduce long-term benefits. Additional research is needed to determine the best treatment options.",2.3685972735685406e-07,0.08027656557499396,0.09506564056134,0.018134264647818726,0.13670683889531832,0.05859375,0.018108015409528666,0.19541766409181127,0.019991670137442734,2.3685972735685406e-07,0.22825865198098239,0.0
172,0.1,7,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Does decompressive surgery provide effective relief for spinal cord sarcoidosis with compressive cervical myelopathy? The impact of decompression remains uncertain. Surgery may relieve compression, but the inflammatory nature of sarcoidosis could limit lasting improvement. Further research is necessary to establish optimal treatment approaches.",2.3685972735685406e-07,0.08027656557499396,0.09506564056134,0.018134264647818726,0.13670683889531832,0.05859375,0.018108015409528666,0.19541766409181127,0.019991670137442734,2.3685972735685406e-07,0.22825865198098239,0.0
172,0.1,8,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Can decompressive surgery effectively address spinal cord sarcoidosis with compressive cervical myelopathy? The benefits of decompression are not well established. While surgery can reduce compression, the inflammatory process of sarcoidosis may hinder long-term outcomes. More studies are needed to identify the best treatment strategies.",2.1317375462116866e-07,0.056746068164799546,0.09506564056134,0.016320838183036854,0.1126092873162583,0.05859375,0.0162972138685758,0.17072505150143957,0.019991670137442734,2.1317375462116866e-07,0.20294084399669066,0.0
172,0.1,9,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","Is decompressive surgery a viable treatment for spinal cord sarcoidosis with compressive cervical myelopathy? The effectiveness of decompression is unclear. Surgery can relieve compression, but the inflammatory nature of sarcoidosis might limit sustained benefits. Further research is essential to determine optimal treatment methods.",2.3685972735685406e-07,0.08027656557499396,0.09506564056134,0.018134264647818726,0.13670683889531832,0.05859375,0.018108015409528666,0.19541766409181127,0.019991670137442734,2.3685972735685406e-07,0.22825865198098239,0.0
172,0.1,10,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? 

Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is unclear. While surgery can relieve compression, the underlying inflammatory nature of sarcoidosis may limit long-term benefits. Further research is needed to establish optimal treatment strategies. 
","How effective is decompressive surgery in managing spinal cord sarcoidosis with compressive cervical myelopathy? The role of decompression remains ambiguous. Surgery can ease compression, yet the inflammatory process of sarcoidosis may restrict long-term success. Additional studies are required to establish the best treatment protocols.",2.1317375462116866e-07,0.056746068164799546,0.09506564056134,0.016320838183036854,0.1126092873162583,0.05859375,0.0162972138685758,0.17072505150143957,0.019991670137442734,2.1317375462116866e-07,0.20294084399669066,0.0
173,0.1,1,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,"Question: Do Indigenous Australians experience premature aging? Answer: This study, which examines a range of specific conditions, does not strongly support the notion that Indigenous people age prematurely. The existing emphasis and nature of services offered by the aged care sector might not be",2.3685972735685406e-08,0.023530497410194418,0.0,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
173,0.1,2,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Question: Is premature aging common among Indigenous Australians? Answer: The concept that Indigenous Australians age prematurely is not strongly backed by this study of various distinct conditions. The current focus and types of services in the aged care sector may not be,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
173,0.1,3,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,"Question: Are Indigenous Australians prone to premature aging? Answer: According to this study analyzing several discrete conditions, there is little evidence to support the idea that Indigenous people age prematurely. The aged care sector's current focus and service types may not be",2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
173,0.1,4,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Question: Do Indigenous Australians show signs of premature aging? Answer: This study of multiple specific conditions does not provide strong support for the belief that Indigenous Australians age prematurely. The aged care sector's current focus and service offerings may not be,4.737194547137081e-08,0.0834475231974281,0.02498356344510192,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
173,0.1,5,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Question: Is there premature aging among Indigenous Australians? Answer: The study of a series of discrete conditions does not strongly support the idea that Indigenous people age prematurely. The current focus and types of services provided by the aged care sector might not be,2.3685972735685406e-08,0.023530497410194418,0.0,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
173,0.1,6,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Question: Do Indigenous Australians age faster than others? Answer: The notion that Indigenous people age prematurely is not well supported by this study examining various distinct conditions. The aged care sector's current focus and service types may not be,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
173,0.1,7,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Question: Are Indigenous Australians affected by premature aging? Answer: This study of several discrete conditions does not strongly back the idea that Indigenous Australians age prematurely. The current focus and nature of services in the aged care sector may not be,4.737194547137081e-08,0.0834475231974281,0.02498356344510192,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
173,0.1,8,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Question: Is premature aging a characteristic of Indigenous Australians? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of specific conditions. The aged care sector's current focus and types of services may not be,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
173,0.1,9,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Question: Do Indigenous Australians experience early aging? Answer: The study of various discrete conditions does not strongly support the belief that Indigenous people age prematurely. The current focus and service types in the aged care sector may not be,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
173,0.1,10,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Question: Are Indigenous Australians subject to premature aging? Answer: This study examining a series of distinct conditions does not provide strong evidence that Indigenous people age prematurely. The aged care sector's current focus and services may not be,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
174,0.1,1,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero central line-associated bloodstream infection rate achievable over time? Consistent high-quality training, adherence to evidence-based protocols, and meticulous documentation contribute to major decreases in CLABSIs. Thoughtful organization can enhance comprehension of a unit's capacity to manage peak workloads and maintain exceptional performance long-term.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.1,2,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be sustained? Significant reductions in CLABSIs are linked to rigorous training, strict adherence to evidence-based guidelines, and detailed documentation. Careful structuring may improve understanding of how a unit manages peak demands and sustains outstanding long-term performance.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.1,3,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to sustain a zero central line-associated bloodstream infection rate? Effective training, strict compliance with evidence-based practices, and comprehensive documentation are associated with notable CLABSI reductions. Mindful organization helps clarify what enables a unit to handle peak pressures and maintain exceptional performance over time.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.1,4,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero central line-associated bloodstream infection rates be maintained consistently? High-quality training, strict guideline adherence, and thorough documentation correlate with significant CLABSI decreases. Thoughtful management may foster better insight into a unit's ability to meet peak demands and sustain superior long-term outcomes.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
174,0.1,5,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining a zero central line-associated bloodstream infection rate feasible? Significant CLABSI reductions are linked to excellent training, strict compliance with evidence-based protocols, and detailed documentation. Mindful organization can lead to improved understanding of how a unit manages peak workloads and maintains exceptional performance over the long haul.",1.1842986367842703e-07,0.10109611687136999,0.0,0.009067132323909363,0.10318423623523065,0.0,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
174,0.1,6,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is a zero central line-associated bloodstream infection rate sustainable? Rigorous training, adherence to evidence-based guidelines, and meticulous documentation are associated with major CLABSI reductions. Careful organization may enhance understanding of a unit's capacity to handle peak demands and sustain extraordinary long-term performance.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
174,0.1,7,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be maintained sustainably? High-quality training, strict compliance with evidence-based standards, and thorough documentation contribute to significant CLABSI decreases. Mindful structuring may improve insight into a unit's ability to manage peak demands and maintain exceptional performance over time.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,0.1,8,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it sustainable to have zero central line-associated bloodstream infections? Consistent high-quality training, strict adherence to evidence-based guidelines, and comprehensive documentation are linked to significant reductions in CLABSIs. Thoughtful organization may help better understand how a unit handles peak demands and sustains outstanding long-term performance.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.1,9,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining zero central line-associated bloodstream infection rates achievable long-term? Effective training, strict compliance with evidence-based protocols, and detailed documentation are associated with significant CLABSI reductions. Mindful organization can improve understanding of a unit's capacity to manage peak workloads and sustain exceptional performance over time.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,0.1,10,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to sustain zero central line-associated bloodstream infection rates? High-quality training, strict adherence to evidence-based guidelines, and thorough documentation correlate with major decreases in CLABSIs. Thoughtful organization may lead to better insight into a unit's ability to handle peak demands and maintain extraordinary long-term performance.",1.4211583641411244e-07,0.12260232209233335,0.0,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
175,0.1,1,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Does pretreatment with estradiol and antagonists before microdose leuprolide enhance IVF success in women with PCOS?,8.290090457489869e-07,0.9821657065467528,0.15419501133786845,0.06346992626736567,1.1113043602178285,0.10072314049586774,0.06337805393335048,1.219608255876361,0.06222222222222221,8.290090457489888e-07,1.3357453272173787,0.021266540642722105
175,0.1,2,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Can estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF results in women suffering from PCOS?,8.053230730133015e-07,0.9176271854091822,0.15419501133786845,0.061656499802583795,1.0423114887308764,0.10072314049586774,0.0615672523923976,1.1455002837226398,0.06222222222222221,8.053230730133034e-07,1.2557026195438423,0.021266540642722105
175,0.1,3,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Exploring whether estradiol and antagonist pretreatment before microdose leuprolide boosts IVF outcomes in PCOS patients.,8.526950184846723e-07,1.051158578033705,0.15419501133786845,0.06528335273214755,1.1854123323715497,0.10072314049586774,0.06518885547430335,1.2996509635498974,0.06222222222222221,8.526950184846741e-07,1.4227567042070088,0.021266540642722105
175,0.1,4,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Does administering estradiol and antagonist pretreatment before microdose leuprolide lead to better IVF outcomes in women with PCOS?,7.816371002776162e-07,0.8570025635927472,0.15419501133786845,0.05984307333780192,0.9777729675933058,0.10072314049586774,0.05975645085144474,1.0765074122356877,0.06222222222222221,7.81637100277618e-07,1.181594647390121,0.021266540642722105
175,0.1,5,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Investigating the impact of estradiol and antagonist pretreatment combined with microdose leuprolide on IVF success in PCOS women.,7.816371002776162e-07,0.8570025635927472,0.15419501133786845,0.05984307333780192,0.9777729675933058,0.10072314049586774,0.05975645085144474,1.0765074122356877,0.06222222222222221,7.81637100277618e-07,1.181594647390121,0.021266540642722105
175,0.1,6,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Is there an improvement in IVF outcomes for PCOS women when estradiol and antagonist pretreatment precedes microdose leuprolide?,7.816371002776162e-07,0.8570025635927472,0.15419501133786845,0.05984307333780192,0.9777729675933058,0.10072314049586774,0.05975645085144474,1.0765074122356877,0.06222222222222221,7.81637100277618e-07,1.181594647390121,0.021266540642722105
175,0.1,7,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Assessing if estradiol and antagonist pretreatment before microdose leuprolide enhances IVF results in women diagnosed with PCOS.,8.053230730133015e-07,0.9176271854091822,0.15419501133786845,0.061656499802583795,1.0423114887308764,0.10072314049586774,0.0615672523923976,1.1455002837226398,0.06222222222222221,8.053230730133034e-07,1.2557026195438423,0.021266540642722105
175,0.1,8,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Can the use of estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF outcomes in women with polycystic ovarian syndrome?,7.105791820705601e-07,0.6944836340949729,0.15419501133786845,0.05440279394345629,0.8059227106666467,0.10072314049586774,0.054324046228586116,0.8941858554417332,0.06222222222222221,7.10579182070562e-07,0.9874386329491633,0.021266540642722105
175,0.1,9,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Does pretreatment with estradiol and antagonists before microdose leuprolide administration improve IVF success rates in PCOS patients?,8.053230730133015e-07,0.9176271854091822,0.15419501133786845,0.061656499802583795,1.0423114887308764,0.10072314049586774,0.0615672523923976,1.1455002837226398,0.06222222222222221,8.053230730133034e-07,1.2557026195438423,0.021266540642722105
175,0.1,10,ai,"Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Women with Polycystic Ovarian Syndrome (PCOS)? 

Answer: This article will explore the potential benefits of estradiol and antagonist pretreatment in combination with microdose leuprolide for improving IVF outcomes in women with PCOS. 
",Evaluating whether estradiol and antagonist pretreatment before microdose leuprolide improves IVF outcomes in women affected by PCOS.,8.053230730133015e-07,0.9176271854091822,0.15419501133786845,0.061656499802583795,1.0423114887308764,0.10072314049586774,0.0615672523923976,1.1455002837226398,0.06222222222222221,8.053230730133034e-07,1.2557026195438423,0.021266540642722105
176,0.1,1,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Preoperative platelet count serves as a predictor for long-term survival in ESCC, particularly among patients with positive lymph nodes. We suggest that a platelet count of 205 (10(9)/L) is the optimal cutoff for forecasting survival in ESCC cases.",2.3685972735685406e-08,0.0050462715015138215,0.01777777777777778,0.0018134264647818726,0.007083023584949277,0.01991851516523315,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
176,0.1,2,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? It is a significant prognostic factor for long-term survival in ESCC, especially in those with nodal involvement. The ideal platelet count threshold for survival prediction appears to be 205 (10(9)/L).",2.3685972735685406e-07,0.10870651135492615,0.118226313098108,0.018134264647818726,0.17167520866996666,0.040742417383431435,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
176,0.1,3,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count be used as a prognostic factor in esophageal squamous cell carcinoma? Yes, it predicts long-term survival in ESCC patients, notably in those with positive lymph nodes. A cutoff value of 205 (10(9)/L) is proposed for survival prediction.",2.3685972735685406e-07,0.07404915232692977,0.1432098765432099,0.018134264647818726,0.17167520866996666,0.040742417383431435,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
176,0.1,4,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the preoperative platelet count a useful prognostic marker in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival in ESCC, particularly in nodal-positive patients. The optimal cutoff for platelet count in survival prediction is 205 (10(9)/L).",3.0791764556390996e-07,0.278554781016215,0.003936520141825828,0.023574544042164344,0.29022609304127567,0.012987315342615106,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
176,0.1,5,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the platelet count before surgery have prognostic value in esophageal squamous cell carcinoma? Preoperative platelet count is a prognostic factor for long-term survival in ESCC, especially in patients with lymph node positivity. A cutoff of 205 (10(9)/L) is recommended for survival prediction.",1.8948778188548325e-07,0.05826599675558963,0.11941451663839135,0.014507411718254981,0.12166478809530323,0.040742417383431435,0.014486412327622933,0.1823215567939549,0.0,1.8948778188548325e-07,0.18658595558041347,0.0
176,0.1,6,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count associated with prognosis in esophageal squamous cell carcinoma? It is a predictive factor for long-term survival in ESCC, mainly in nodal-positive cases. The suggested cutoff point for platelet count is 205 (10(9)/L) for survival prediction.",2.8423167282822466e-07,0.16182387727026581,0.11691330970610253,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
176,0.1,7,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count predict survival in esophageal squamous cell carcinoma? Yes, it is a prognostic factor for long-term survival in ESCC, particularly in patients with positive lymph nodes. The optimal cutoff platelet count is 205 (10(9)/L).",3.3160361829959526e-07,0.25642602138030535,0.08784655474390193,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
176,0.1,8,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is there prognostic significance of preoperative platelet count in esophageal squamous cell carcinoma? Preoperative platelet count predicts long-term survival in ESCC, especially in nodal-positive patients. The cutoff point of 205 (10(9)/L) is considered optimal for survival prediction.",3.3160361829959526e-07,0.25642602138030535,0.08784655474390193,0.025387970506946217,0.3194972036279089,0.012195704580663276,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
176,0.1,9,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? It is a predictive marker for long-term survival in ESCC, particularly in patients with nodal involvement. The optimal cutoff for platelet count is 205 (10(9)/L).",2.8423167282822466e-07,0.16182387727026581,0.11691330970610253,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
176,0.1,10,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a reliable prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet count is predictive of long-term survival in ESCC, especially in nodal-positive patients. The recommended cutoff value is 205 (10(9)/L) for survival prediction.",3.3160361829959526e-07,0.25642602138030535,0.08784655474390193,0.025387970506946217,0.3194972036279089,0.012195704580663276,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
177,0.1,1,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is cholecystectomy truly a reason to perform a simultaneous splenectomy in cases of mild hereditary spherocytosis? The recommendation to carry out a splenectomy alongside cholecystectomy in children with mild HS who have symptomatic gallstones requires reevaluation. With the advent of minimally invasive surgery, the decision to remove the spleen in these children should be considered independently.",4.737194547137081e-08,0.12538337030533508,0.09639999999999999,0.0036268529295637453,0.06439983492746082,0.01922337562475971,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
177,0.1,2,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy warrant a concurrent splenectomy in mild hereditary spherocytosis? The suggestion to do a splenectomy at the same time as cholecystectomy in children with mild HS and symptomatic gallstones should be reconsidered. Given the advances in minimal access surgery, the necessity of splenectomy should be assessed on its own.",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.05338320072892344,0.01922337562475971,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
177,0.1,3,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is performing a splenectomy alongside cholecystectomy justified in mild hereditary spherocytosis? The current advice to conduct a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs to be reviewed. In the context of minimally invasive surgery, the indication for splenectomy should be evaluated independently.",1.4211583641411244e-07,0.0318022132170781,0.09639999999999999,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
177,0.1,4,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should cholecystectomy be an indication for simultaneous splenectomy in mild hereditary spherocytosis? The recommendation to perform splenectomy together with cholecystectomy in children with mild HS and symptomatic gallstones warrants reconsideration. With minimal access surgical techniques, the decision for splenectomy should be made on its own basis.",1.8948778188548325e-07,0.07528732515681646,0.09639999999999999,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
177,0.1,5,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is concomitant splenectomy necessary during cholecystectomy in mild hereditary spherocytosis? The advice to perform splenectomy alongside cholecystectomy in children with mild HS who have symptomatic gallstones should be revisited. In the era of minimally invasive surgery, the need for splenectomy should be judged independently.",2.3685972735685406e-07,0.1852285067275221,0.04999904818560378,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
177,0.1,6,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does mild hereditary spherocytosis require splenectomy when cholecystectomy is performed? The guidance to do a simultaneous splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs reexamination. With modern minimal access surgery, the indication for splenectomy should be considered separately.",2.8423167282822487e-07,0.16837774822282814,0.09639999999999999,0.02176111757738247,0.23570475752287834,0.01922337562475971,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
177,0.1,7,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is it necessary to do a splenectomy along with cholecystectomy in mild hereditary spherocytosis? The advice to perform concomitant splenectomy in children with mild HS having cholecystectomy for symptomatic gallstones should be reviewed. Given the advances in minimal access surgery, splenectomy should be judged on its own merits.",1.4211583641411244e-07,0.06129783792175658,0.07513345935727789,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
177,0.1,8,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should splenectomy be routinely done with cholecystectomy in mild hereditary spherocytosis? The recommendation for concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs to be reconsidered. In the era of minimal access surgery, the need for splenectomy should be evaluated independently.",2.1317375462116866e-07,0.09776018100887418,0.09639999999999999,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
177,0.1,9,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is splenectomy indicated alongside cholecystectomy in mild hereditary spherocytosis? The advice to perform a concomitant splenectomy in children with mild HS who are undergoing cholecystectomy for symptomatic gallstones requires reassessment. With minimal access surgical methods, the necessity of splenectomy should be judged on its own.",2.1317375462116866e-07,0.09776018100887418,0.09639999999999999,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
177,0.1,10,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy in mild hereditary spherocytosis justify a concurrent splenectomy? The recommendation to carry out splenectomy simultaneously in children with mild HS undergoing cholecystectomy for symptomatic gallstones should be revisited. In the context of minimal access surgery, the decision for splenectomy should be made independently.",2.1317375462116866e-07,0.12926687103432677,0.07368501892915089,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
178,0.1,1,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
",Is measuring visceral adipose tissue area at one level an accurate representation of its total volume?,1.1132407185772118e-06,1.2541275924653994,0.14743801652892552,0.08523104384474814,1.3809119862878956,0.06525084641428129,0.08510767242478488,1.4831853927232332,0.033293697978596916,1.1132407185772137e-06,1.5691342795224656,0.01694411414982164
178,0.1,2,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
",Can a single-level measurement of visceral adipose tissue area reliably indicate the overall volume of visceral fat?,1.0895547458415264e-06,1.2762324688978217,0.08521579430670329,0.08341761737996627,1.3119191148009435,0.06525084641428129,0.083296870883832,1.409077420569512,0.033293697978596916,1.0895547458415283e-06,1.4890915718489293,0.01694411414982164
178,0.1,3,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
",Does assessing visceral adipose tissue area at a single point effectively represent the entire visceral fat volume?,1.0895547458415264e-06,1.1895890713278288,0.14743801652892552,0.08341761737996627,1.3119191148009435,0.06525084641428129,0.083296870883832,1.409077420569512,0.033293697978596916,1.0895547458415283e-06,1.4890915718489293,0.01694411414982164
178,0.1,4,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
",Is a single-level visceral adipose tissue area measurement sufficient to estimate total visceral fat volume?,1.1369266913128972e-06,1.3231204639523515,0.14743801652892552,0.08704447030953003,1.4550199584416168,0.06525084641428129,0.08691847396573775,1.5632281003967696,0.033293697978596916,1.136926691312899e-06,1.6561456565120958,0.01694411414982164
178,0.1,5,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
",Can the area of visceral adipose tissue measured at one level serve as a true indicator of its total volume?,1.0184968276344703e-06,1.0177388144011696,0.14743801652892552,0.07797733798562065,1.129597558006989,0.06525084641428129,0.07786446626097339,1.2149214061285543,0.033293697978596916,1.0184968276344723e-06,1.2814522070706853,0.01694411414982164
178,0.1,6,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
",Does measuring visceral adipose tissue area at one abdominal level accurately reflect the total visceral fat volume?,1.0895547458415264e-06,1.1895890713278288,0.14743801652892552,0.08341761737996627,1.3119191148009435,0.06525084641428129,0.083296870883832,1.409077420569512,0.033293697978596916,1.0895547458415283e-06,1.4890915718489293,0.01694411414982164
178,0.1,7,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
",Is it valid to use a single-level VAT area measurement as a proxy for the entire visceral adipose tissue volume?,1.0184968276344703e-06,1.0177388144011696,0.14743801652892552,0.07797733798562065,1.129597558006989,0.06525084641428129,0.07786446626097339,1.2149214061285543,0.033293697978596916,1.0184968276344723e-06,1.2814522070706853,0.01694411414982164
178,0.1,8,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
",Can a single cross-sectional measurement of visceral adipose tissue area represent the full volume of visceral fat?,1.0895547458415264e-06,1.2762324688978217,0.08521579430670329,0.08341761737996627,1.3119191148009435,0.06525084641428129,0.083296870883832,1.409077420569512,0.033293697978596916,1.0895547458415283e-06,1.4890915718489293,0.01694411414982164
178,0.1,9,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
",Is the visceral adipose tissue area at one level a precise measure of the total VAT volume?,1.0895547458415264e-06,1.1895890713278288,0.14743801652892552,0.08341761737996627,1.3119191148009435,0.06525084641428129,0.083296870883832,1.409077420569512,0.033293697978596916,1.0895547458415283e-06,1.4890915718489293,0.01694411414982164
178,0.1,10,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? 

Answer: VAT area measurement at a single level, while convenient, is an imprecise proxy for VAT volume.  The volume of VAT can vary significantly across different levels of the abdomen. Therefore, using a single level measurement may not accurately reflect the total amount of visceral fat. 
",Does a single-level measurement of visceral adipose tissue area provide an accurate estimate of total visceral fat volume?,1.065868773105841e-06,1.1289644495113937,0.14743801652892552,0.0816041909151844,1.2473805936633728,0.06525084641428129,0.08148606934287914,1.34008454908256,0.033293697978596916,1.0658687731058429e-06,1.414983599695208,0.01694411414982164
179,0.1,1,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can locoregional opening of the rodent blood-brain barrier for paclitaxel be achieved using Nd:YAG laser-induced thermo therapy as a novel adjuvant glioma treatment? Answer: LITT facilitates localized entry of chemotherapy drugs into brain tissue, which may benefit brain tumor therapy.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.1,2,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is Nd:YAG laser-induced thermo therapy effective for locoregional opening of the rodent blood-brain barrier to deliver paclitaxel as a new adjuvant glioma treatment? Answer: LITT promotes targeted passage of chemotherapeutic agents into brain tissue, offering potential for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.1,3,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does Nd:YAG laser-induced thermo therapy enable locoregional opening of the rodent blood-brain barrier for paclitaxel in adjuvant glioma therapy? Answer: LITT allows localized delivery of chemotherapy drugs into brain tissue, which could be valuable for treating brain tumors.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
179,0.1,4,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can the rodent blood-brain barrier be locally opened for paclitaxel delivery using Nd:YAG laser-induced thermo therapy as a novel glioma adjuvant therapy? Answer: LITT induces a localized passage of chemotherapeutic agents into brain tissue, potentially useful for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,0.1,5,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is locoregional opening of the rodent blood-brain barrier for paclitaxel possible with Nd:YAG laser-induced thermo therapy as a new concept in glioma adjuvant therapy? Answer: LITT enables targeted entry of chemotherapy drugs into brain tissue, which may aid brain tumor treatment.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.1,6,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does Nd:YAG laser-induced thermo therapy provide locoregional opening of the rodent blood-brain barrier for paclitaxel in glioma adjuvant therapy? Answer: LITT facilitates localized passage of chemotherapeutic agents into brain tissue, offering promise for brain tumor treatment.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
179,0.1,7,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy be used to open the rodent blood-brain barrier locally for paclitaxel delivery as a novel glioma adjuvant therapy? Answer: LITT induces localized chemotherapeutic agent passage into brain tissue, which is potentially beneficial for brain tumor treatment.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,0.1,8,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is the locoregional opening of the rodent blood-brain barrier for paclitaxel achievable via Nd:YAG laser-induced thermo therapy as a new adjuvant glioma treatment? Answer: LITT promotes localized delivery of chemotherapy drugs into brain tissue, which may be advantageous for brain tumor therapy.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
179,0.1,9,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy induce locoregional opening of the rodent blood-brain barrier for paclitaxel in glioma adjuvant therapy? Answer: LITT allows targeted passage of chemotherapeutic agents into brain tissue, potentially useful for brain tumor treatment.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
179,0.1,10,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is it possible to open the rodent blood-brain barrier locoregionally for paclitaxel using Nd:YAG laser-induced thermo therapy as a novel adjuvant glioma therapy? Answer: LITT facilitates localized entry of chemotherapy drugs into brain tissue, which could be beneficial for brain tumor treatment.",7.105791820705622e-08,0.06899287148695166,0.0,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
180,0.1,1,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Does a geriatric oncology consultation alter the cancer treatment strategy for elderly patients? The consultation resulted in changes to the treatment plan in 32% of cases, including adjustments to dosage, timing, or therapy type, highlighting the need for personalized care in older adults.",1.4211583641411244e-07,0.04688799505453023,0.06222222222222222,0.010880558788691236,0.10707991030107156,0.0212665406427221,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
180,0.1,2,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Can a geriatric oncology consultation change the cancer treatment plan for older patients? In 32% of cases, the consultation led to modifications such as dose, schedule, or therapy type changes, demonstrating the customized approach necessary for elderly patients.",2.6054570009253915e-07,0.17363970069367252,0.06222222222222222,0.0199476911126006,0.23713303854926915,0.0212665406427221,0.019918816950481533,0.2732933349996811,0.0,2.6054570009253947e-07,0.2803019651541576,0.0
180,0.1,3,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Is the cancer treatment plan for elderly patients modified after a geriatric oncology consultation? Treatment plans were altered in 32% of cases following the consultation, with adjustments to dose, schedule, or therapy type to suit the needs of older adults.",2.1317375462116855e-07,0.12099596720825367,0.06222222222222222,0.016320838183036854,0.18306581727899296,0.0212665406427221,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
180,0.1,4,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Does consulting a geriatric oncologist impact the cancer treatment plan for elderly patients? The consultation prompted changes in 32% of treatment plans, including dose, schedule, or therapy type modifications, reflecting tailored care for seniors.",3.5528959103528035e-07,0.28805005187141797,0.06222222222222222,0.02720139697172811,0.35491607420565296,0.0212665406427221,0.027162023114293027,0.3946541920039479,0.0,3.552895910352811e-07,0.4054651081081646,0.0
180,0.1,5,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","How does a geriatric oncology consultation affect cancer treatment plans for elderly patients? In 32% of cases, the consultation led to treatment plan changes involving dose, schedule, or therapy type, emphasizing individualized treatment for older adults.",3.0791764556390975e-07,0.22920955184848468,0.06222222222222222,0.02357454404216435,0.2942914523892175,0.0212665406427221,0.02354042003238728,0.3321338350226144,0.0,3.079176455639103e-07,0.3409265869705931,0.0
180,0.1,6,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Does a geriatric oncology consultation influence the cancer treatment approach for elderly patients? The consultation resulted in treatment plan modifications in 32% of cases, such as changes in dose, schedule, or therapy type, underscoring the need for personalized care.",2.3685972735685385e-07,0.14697145361151165,0.06222222222222222,0.018134264647818726,0.20973406436115383,0.0212665406427221,0.018108015409528666,0.24512245803298427,0.0,2.3685972735685406e-07,0.2513144282809061,0.0
180,0.1,7,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Can a geriatric oncology consultation modify cancer treatment plans for elderly patients? Treatment plans were adjusted in 32% of cases after consultation, including changes to dose, schedule, or therapy type, reflecting the tailored approach for older adults.",2.8423167282822445e-07,0.23954685157956268,0.034467120181405894,0.02176111757738247,0.265303915515966,0.0212665406427221,0.021729618491434406,0.3022808718729326,0.0,2.8423167282822487e-07,0.3101549283038394,0.0
180,0.1,8,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Is the cancer treatment plan for elderly patients changed by a geriatric oncology consultation? The consultation led to modifications in 32% of cases, involving dose, schedule, or therapy type adjustments to meet the specific needs of older adults.",2.6054570009253915e-07,0.17363970069367252,0.06222222222222222,0.0199476911126006,0.23713303854926915,0.0212665406427221,0.019918816950481533,0.2732933349996811,0.0,2.6054570009253947e-07,0.2803019651541576,0.0
180,0.1,9,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","Does a geriatric oncology consultation result in changes to cancer treatment plans for elderly patients? In 32% of cases, the consultation caused alterations in dose, schedule, or therapy type, highlighting the importance of individualized treatment for seniors.",2.8423167282822445e-07,0.20103867488178784,0.06222222222222222,0.02176111757738247,0.265303915515966,0.0212665406427221,0.021729618491434406,0.3022808718729326,0.0,2.8423167282822487e-07,0.3101549283038394,0.0
180,0.1,10,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? 
Answer: The geriatric oncology consultation led to a modification of the treatment plan in 32% of cases. This included changes to dose, schedule, or type of therapy, reflecting the tailored approach required for older adults. 
","How often does a geriatric oncology consultation change the cancer treatment plan for elderly patients? The consultation modified treatment plans in 32% of cases, including dose, schedule, or therapy type changes, demonstrating the necessity of tailored treatment for older adults.",2.1317375462116855e-07,0.12099596720825367,0.06222222222222222,0.016320838183036854,0.18306581727899296,0.0212665406427221,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
181,0.1,1,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be implemented in community palliative care? Answer: Implementing an advance care planning model is feasible within community palliative care services. Quality audit procedures are a crucial part of the model, with documentation of advance care planning discussions recognized as a key outcome metric.",4.737194547137081e-08,0.051008829110396725,0.010248015873015964,0.0036268529295637453,0.04805637672698815,0.005687674518843333,0.003621603081905733,0.046106945246820796,0.0018791605739505515,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
181,0.1,2,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it possible to apply an advance care planning model in community palliative care? Answer: Yes, an advance care planning model can be effectively applied in community palliative care services. The model relies heavily on quality audit processes, with the recording of advance care planning discussions serving as an important outcome measure.",1.1842986367842703e-07,0.09643038409894933,0.004705578512396724,0.009067132323909363,0.08893555223254657,0.006572320169403623,0.009054007704764333,0.11152182392946974,0.004417740820864116,1.1842986367842703e-07,0.1108456325623095,0.002315675515293554
181,0.1,3,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Does an advance care planning model work in community palliative care? Answer: An advance care planning model is practical and feasible for use in community palliative care services. Integral to the model are quality audit processes, and documenting advance care planning discussions is considered a vital outcome indicator.",2.3685972735685406e-08,0.0030624055881909307,0.015625,0.0018134264647818726,0.005182562134851576,0.0187074829931973,0.0018108015409528666,0.023318321560436672,0.0009598666243535586,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185
181,0.1,4,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the use of an advance care planning model viable in community palliative care? Answer: The use of an advance care planning model is viable for community palliative care services. Quality audits form an essential part of the model, with the documentation of advance care planning discussions established as a significant outcome measure.",1.4211583641411244e-07,0.06756937646442474,0.02712310708491067,0.010880558788691236,0.05784560457348675,0.04201562106324008,0.0108648092457172,0.05086501379594566,0.05253261099598108,1.4211583641411244e-07,0.04843651264574511,0.05668010399531345
181,0.1,5,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can community palliative care adopt an advance care planning model? Answer: Community palliative care services can adopt an advance care planning model feasibly. Quality audit processes are fundamental to the model, and documenting advance care planning discussions is an important outcome metric.",1.1842986367842703e-07,0.17271537909511947,0.05320285467128033,0.009067132323909363,0.1649694721775412,0.04136747291509199,0.009054007704764333,0.12548467099593807,0.005513199468455653,1.1842986367842703e-07,0.12466730702264872,0.002908287627211844
181,0.1,6,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is an advance care planning model applicable in community palliative care? Answer: An advance care planning model is applicable and feasible in community palliative care services. The model includes quality audit processes as a key component, with documentation of advance care planning discussions recognized as an important outcome measure.",4.737194547137081e-08,0.02271710745488864,0.010235350981558533,0.0036268529295637453,0.019175244203657016,0.015483027535874605,0.003621603081905733,0.046106945246820796,0.0018791605739505515,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
181,0.1,7,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it feasible to implement an advance care planning model in community palliative care? Answer: Implementing an advance care planning model in community palliative care services is feasible. Quality audit processes are essential to the model, with the documentation of advance care planning discussions serving as a critical outcome measure.",7.105791820705622e-08,0.02014774435673994,0.024512566924449697,0.005440279394345618,0.01361938811662844,0.052721088435374125,0.0054324046228586,0.0182540587626443,0.05840995132504054,7.105791820705622e-08,0.020517841001465253,0.06165494862087614
181,0.1,8,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be effectively used in community palliative care? Answer: Yes, an advance care planning model can be effectively used in community palliative care services. Quality audit processes are a vital part of the model, and documenting advance care planning discussions is an important outcome measure.",7.105791820705622e-08,0.035304030088055605,0.0606874589086126,0.005440279394345618,0.04191110977213608,0.07204301510411815,0.0054324046228586,0.0182540587626443,0.05840995132504054,7.105791820705622e-08,0.008977783703213227,0.04081807678039054
181,0.1,9,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the advance care planning model suitable for community palliative care? Answer: The advance care planning model is suitable and feasible for community palliative care services. Quality audit processes are integral to the model, with documentation of advance care planning discussions established as a key outcome measure.",0.0,0.029495624704679813,0.021239727153188726,0.0,0.030136833937389973,0.022072759303999184,0.0,0.0,0.0,0.0,0.0,0.0
181,0.1,10,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is an advance care planning model practical in community palliative care? Answer: An advance care planning model is practical and feasible for community palliative care services. Quality audit processes are a necessary component of the model, with documentation of advance care planning discussions recognized as an important outcome measure.",4.737194547137081e-08,0.051008829110396725,0.010248015873015964,0.0036268529295637453,0.04805637672698815,0.005687674518843333,0.003621603081905733,0.046106945246820796,0.0018791605739505515,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
182,0.1,1,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
","Does central venous pressure indicate fluid responsiveness? There is no evidence supporting the common use of central venous pressure to direct fluid therapy. Although CVP helps evaluate volume status, it does not reliably predict fluid responsiveness. More accurate assessments come from dynamic indices.",3.789755637709665e-07,0.34098415562751505,0.013061224489795922,0.029014823436509962,0.3389703050146746,0.006836734693877546,0.028972824655245866,0.3364722366212134,0.0,3.789755637709665e-07,0.34377153910282665,0.0
182,0.1,2,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
","Can central venous pressure predict fluid responsiveness? Current data do not support using central venous pressure as a guide for fluid administration. While CVP can assess volume status, it is not a dependable predictor of fluid responsiveness. Dynamic indices offer better insights into fluid needs.",3.316036182995957e-07,0.2914635028473418,0.010912698412698402,0.025387970506946217,0.2897696021841045,0.0057043650793650695,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
182,0.1,3,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
",Is central venous pressure a predictor of fluid responsiveness? There is no data backing the routine use of central venous pressure to guide fluid management. CVP can assess volume status but is unreliable for predicting fluid responsiveness. Dynamic indices provide more precise information on fluid requirements.,3.079176455639103e-07,0.26759034966081874,0.00990952086621559,0.023574544042164344,0.2660473702378834,0.005176715764726655,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
182,0.1,4,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
","Does measuring central venous pressure help predict fluid responsiveness? Evidence does not support the widespread practice of using CVP to guide fluid administration. Although CVP assesses volume status, it is not a reliable predictor of fluid responsiveness. Dynamic indices are more accurate for determining fluid needs.",3.079176455639103e-07,0.20597726694437934,0.03443877551020409,0.023574544042164344,0.2345406802124308,0.017538265306122455,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
182,0.1,5,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
",Can fluid responsiveness be predicted by central venous pressure? No data support the common practice of using CVP to guide fluid therapy. CVP can indicate volume status but is not a reliable predictor of fluid responsiveness. Other measures like dynamic indices give more accurate fluid requirement information.,2.8423167282822487e-07,0.18399836022560434,0.03443877551020409,0.02176111757738247,0.21206782436037308,0.017538265306122455,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
182,0.1,6,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
","Is central venous pressure useful for predicting fluid responsiveness? There is no evidence to justify the routine use of CVP for guiding fluid administration. While CVP assesses volume status, it does not reliably predict fluid responsiveness. Dynamic indices provide more accurate fluid requirement data.",3.552895910352811e-07,0.2514396410211366,0.03443877551020409,0.02720139697172809,0.28106069584732474,0.017538265306122455,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
182,0.1,7,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
",Does central venous pressure serve as a predictor for fluid responsiveness? Data do not support the widespread use of CVP to guide fluid management. CVP can assess volume status but is not a reliable predictor of fluid responsiveness. Dynamic indices offer better accuracy in assessing fluid needs.,2.8423167282822487e-07,0.18399836022560434,0.03443877551020409,0.02176111757738247,0.21206782436037308,0.017538265306122455,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
182,0.1,8,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
",Can central venous pressure be used to predict fluid responsiveness? There is no supporting data for the common practice of using CVP to guide fluid administration. CVP helps assess volume status but is not a reliable predictor of fluid responsiveness. More accurate information comes from dynamic indices.,2.8423167282822487e-07,0.18399836022560434,0.03443877551020409,0.02176111757738247,0.21206782436037308,0.017538265306122455,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
182,0.1,9,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
","Is central venous pressure a reliable predictor of fluid responsiveness? No data support the routine use of CVP to guide fluid therapy. Although CVP can assess volume status, it is not dependable for predicting fluid responsiveness. Dynamic indices provide more precise fluid requirement information.",3.552895910352811e-07,0.2514396410211366,0.03443877551020409,0.02720139697172809,0.28106069584732474,0.017538265306122455,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
182,0.1,10,ai,"Question: Does the central venous pressure predict fluid responsiveness? 
Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid administration.  While CVP can be used to assess volume status, it is not a reliable predictor of fluid responsiveness.  Other factors, such as dynamic indices, provide more accurate information regarding fluid requirements. 
","Does central venous pressure predict fluid responsiveness? There is no evidence supporting the widespread use of CVP to guide fluid administration. While CVP assesses volume status, it is not a reliable predictor of fluid responsiveness. Dynamic indices give more accurate insights into fluid needs.",3.552895910352811e-07,0.2514396410211366,0.03443877551020409,0.02720139697172809,0.28106069584732474,0.017538265306122455,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
183,0.1,1,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is it essential to routinely place a nasobiliary drainage tube after endoscopic removal of common bile duct stones in patients with choledocholithiasis? Although nasobiliary drainage tubes are a safe and effective method for managing complications after ERCP, their routine use in all choledocholithiasis patients is debated. Research indicates that selective insertion based on patient-specific risk factors might be adequate.",4.737194547137081e-08,0.011593366554211393,0.01605762534086223,0.0036268529295637453,0.03448617607116855,0.0,0.003621603081905733,0.03509131981126945,0.0,4.737194547137081e-08,0.03571808260207909,0.0
183,0.1,2,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in choledocholithiasis patients? Nasobiliary drainage tubes provide a safe and effective approach to handle post-ERCP complications, but routine placement in every patient with choledocholithiasis is controversial. Evidence suggests selective use tailored to individual risk factors may suffice.",1.8948778188548325e-07,0.12355053854795583,0.014070322353837206,0.014507411718254981,0.14571181118139354,0.0,0.014486412327622933,0.14842000511827358,0.0,1.8948778188548325e-07,0.15123096972392336,0.0
183,0.1,3,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is routine nasobiliary drainage tube insertion necessary after endoscopic clearance of the common bile duct in choledocholithiasis cases? While nasobiliary drainage tubes are effective and safe for managing post-ERCP complications, their routine use in all patients with choledocholithiasis is debated. Studies recommend selective application based on patient risk profiles.",2.8423167282822487e-07,0.20581487180020996,0.012469795760398632,0.02176111757738247,0.22738984219566083,0.0,0.0217296184914344,0.23180161405732447,0.0,2.8423167282822487e-07,0.23638877806423064,0.0
183,0.1,4,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Do all patients with choledocholithiasis require routine nasobiliary drainage tube placement after endoscopic common bile duct clearance? Nasobiliary drainage tubes are a safe and effective option for managing complications post-ERCP, but routine insertion in every patient remains controversial. Research supports selective use depending on individual risk factors.",3.316036182995957e-07,0.24963018763306444,0.011565302916868518,0.025387970506946217,0.2708749541353992,0.0,0.025351221573340132,0.2762533766281572,0.0,3.316036182995957e-07,0.2818511521409879,0.0
183,0.1,5,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is it mandatory to insert a nasobiliary drainage tube routinely after endoscopic removal of common bile duct stones in choledocholithiasis patients? Although nasobiliary drainage tubes effectively manage post-ERCP complications, routine use in all patients is debated. Studies advocate for selective insertion based on patient-specific risks.",3.789755637709665e-07,0.2954518062919611,0.010578716907747806,0.029014823436509962,0.31633732821215643,0.0,0.028972824655245866,0.32277339226305113,0.0,3.789755637709665e-07,0.3294792011302423,0.0
183,0.1,6,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Should nasobiliary drainage tubes be routinely placed after endoscopic clearance of the common bile duct in patients with choledocholithiasis? These tubes are a safe and effective way to manage post-ERCP complications, but routine insertion in all patients is controversial. Evidence suggests selective use according to individual risk factors is sufficient.",2.6054570009253947e-07,0.15631445207414352,0.033293697978596916,0.0199476911126006,0.20633643299782767,0.0,0.019918816950481533,0.2102954088363611,0.0,2.6054570009253947e-07,0.21440987134545564,0.0
183,0.1,7,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is routine placement of a nasobiliary drainage tube necessary following endoscopic clearance of the common bile duct in choledocholithiasis patients? Nasobiliary drainage tubes offer a safe and effective means to manage post-ERCP complications, yet routine insertion in all patients remains controversial. Studies indicate selective use based on patient risk factors may be adequate.",1.8948778188548325e-07,0.12355053854795583,0.014070322353837206,0.014507411718254981,0.14571181118139354,0.0,0.014486412327622933,0.14842000511827358,0.0,1.8948778188548325e-07,0.15123096972392336,0.0
183,0.1,8,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is it required to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis? While nasobiliary drainage tubes are safe and effective for managing post-ERCP complications, routine use in all patients is debated. Research suggests selective application based on individual risk factors.",2.6054570009253947e-07,0.1846061737296516,0.01289439242304136,0.0199476911126006,0.20633643299782767,0.0,0.019918816950481533,0.2102954088363611,0.0,2.6054570009253947e-07,0.21440987134545564,0.0
183,0.1,9,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is routine nasobiliary drainage tube insertion necessary after endoscopic clearance of the common bile duct in choledocholithiasis patients? Nasobiliary drainage tubes provide a safe and effective method to manage post-ERCP complications, but routine placement in all patients is controversial. Studies recommend selective use tailored to patient-specific risk factors.",3.079176455639103e-07,0.22748277317939092,0.012027157335874814,0.023574544042164344,0.2488960474166242,0.0,0.023540420032387266,0.25378052077609947,0.0,3.079176455639103e-07,0.25886163391628836,0.0
183,0.1,10,ai,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis?

Answer: While nasobiliary drainage tubes offer a safe and effective way to manage post-ERCP complications, routine insertion in all patients with choledocholithiasis remains controversial. Studies suggest that selective use, based on individual patient risk factors, may be sufficient. 
","Is it advisable to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis? Although nasobiliary drainage tubes are a safe and effective way to manage post-ERCP complications, their routine use in all patients remains controversial. Evidence supports selective use based on individual patient risk factors.",1.6580180914979784e-07,0.10399933401227024,0.014432751233034783,0.012693985253473108,0.12629372532429084,0.0,0.012675610786670066,0.12861737782209381,0.0,1.6580180914979784e-07,0.13102826240640475,0.0
184,0.1,1,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the length of psychological treatment for depression influence the likelihood of returning to treatment? Answer: Findings indicate that extended treatment duration might reduce the chance of returning to mental health services for certain groups. However, due to the study's design, no causal conclusions can be made. Additional research, ideally through a randomized controlled trial, is necessary to explore if lower intensity treatments are linked to this trend.",7.105791820705622e-08,0.06832988838519238,0.01666102898247444,0.005440279394345618,0.025118575417564237,0.014921946740128552,0.0054324046228586,0.046520015634889056,0.0,7.105791820705622e-08,0.04725288485054513,0.0
184,0.1,2,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is there a connection between the duration of psychological treatment for depression and the probability of returning to treatment? Answer: The results imply that longer treatment periods could help prevent some groups from re-entering mental health care. Nonetheless, the study's design does not allow for causal inferences. Further investigation, preferably via a randomized controlled trial, is required to assess whether lower intensity treatments are related.",0.0,0.06398281666707106,0.046045785639958384,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
184,0.1,3,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of psychological treatment for depression affect the likelihood of patients returning to treatment? Answer: The study suggests that longer treatment durations may reduce the risk of returning to mental health care in certain populations. However, no causal relationship can be established due to the study design. More research, ideally randomized controlled trials, is needed to determine if lower intensity treatments are associated with this pattern.",7.105791820705622e-08,0.06832988838519238,0.01666102898247444,0.005440279394345618,0.04580953603129334,0.0,0.0054324046228586,0.046520015634889056,0.0,7.105791820705622e-08,0.04725288485054513,0.0
184,0.1,4,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the length of psychological treatment for depression associated with the chance of returning to treatment? Answer: Results indicate that longer treatment might prevent some groups from returning to mental health services. However, the study design prevents drawing causal conclusions. Further research, preferably randomized controlled trials, is necessary to clarify if lower intensity treatments contribute to this trend.",1.6580180914979784e-07,0.0738630695980067,0.028809713002223698,0.012693985253473108,0.11583181552512123,0.0,0.012675610786670066,0.11778303565638559,0.0,1.6580180914979784e-07,0.1198011998126205,0.0
184,0.1,5,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the duration of depression treatment influence the likelihood of patients returning to psychological care? Answer: Findings suggest that extended treatment duration may reduce the likelihood of return to mental health care in some groups. Yet, due to the study's design, causal inferences cannot be made. Additional studies, ideally randomized controlled trials, are needed to explore the association with lower intensity treatments.",7.105791820705622e-08,0.027989241122825526,0.013823563417736183,0.005440279394345618,0.07073535625390015,0.016388888888888897,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
184,0.1,6,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is there a relationship between how long psychological treatment for depression lasts and the chance of returning to treatment? Answer: The results suggest that longer treatment durations might prevent some groups from needing further mental health care. However, the study design limits causal conclusions. Further research, preferably randomized controlled trials, is required to investigate the link with lower intensity treatments.",1.1842986367842703e-07,0.01605989100646621,0.046045785639958384,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
184,0.1,7,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the length of psychological treatment for depression relate to the likelihood of returning to treatment? Answer: The findings indicate that longer treatment may help prevent return to mental health care in certain groups. However, no causal inference can be drawn due to the study design. More research, ideally randomized controlled trials, is needed to determine if lower intensity treatments are involved.",7.105791820705622e-08,0.00562965465315024,0.029921087978039537,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
184,0.1,8,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the duration of psychological treatment for depression connected to the probability of returning to treatment? Answer: Results suggest that longer treatment durations could reduce the chance of returning to mental health care for some groups. However, the study design does not allow for causal conclusions. Further research, preferably randomized controlled trials, is necessary to assess the role of lower intensity treatments.",7.105791820705622e-08,0.027989241122825526,0.013823563417736183,0.005440279394345618,0.07073535625390015,0.016388888888888897,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
184,0.1,9,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Does the length of psychological treatment for depression impact the likelihood of patients returning to treatment? Answer: The study indicates that longer treatment may prevent some groups from returning to mental health care. However, causal inferences cannot be made due to the study design. Additional research, ideally randomized controlled trials, is needed to explore the association with lower intensity treatments.",1.1842986367842703e-07,0.06226970304379531,0.012752087661361468,0.009067132323909363,0.08134563945395268,0.0,0.009054007704764333,0.08269171584511614,0.0,1.1842986367842703e-07,0.0840831172105414,0.0
184,0.1,10,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Question: Is the duration of psychological treatment for depression linked to the chance of returning to treatment? Answer: Findings suggest that longer treatment durations might help prevent return to mental health care in certain groups. However, no causal inference can be drawn because of the study design. Further research, preferably randomized controlled trials, is needed to determine if lower intensity treatments are related.",7.105791820705622e-08,0.016729931816525934,0.046045785639958384,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
185,0.1,1,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Is it possible to predict discordance between TEOAE and AABR results in newborns? Given current screening methods, predicting discordant outcomes between TEOAE and AABR in newborns is unreliable. Although some research indicates possible links, no definitive pattern exists to forecast discordance. More studies are necessary to better understand these intricate relationships.",4.737194547137081e-08,0.04428773042305423,0.0024666767265227874,0.0036268529295637453,0.04408050249891016,0.0017267184190376955,0.003621603081905733,0.04381531583285447,0.0009044928435301136,4.737194547137081e-08,0.04348511193973836,0.0
185,0.1,2,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Can discordance in TEOAE and AABR results be anticipated in newborns? With the screening technologies available today, discordant TEOAE and AABR outcomes cannot be reliably predicted. While certain studies hint at correlations, no consistent pattern has been established to foresee discordance. Additional research is required to elucidate these complex interactions.",2.3685972735685406e-08,0.05067924146171299,0.021479804838790785,0.0018134264647818726,0.051163526083859434,0.021645233584270847,0.0018108015409528666,0.051643039158352,0.021728395061728398,2.3685972735685406e-08,0.021978906718775004,0.0
185,0.1,3,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Is it feasible to foresee discordant TEOAE and AABR outcomes in newborns? Current screening tools do not allow for reliable prediction of discordance between TEOAE and AABR results. Some studies suggest possible associations, but no clear pattern exists to predict such discordance. Further investigation is needed to clarify these complicated relationships.",4.737194547137081e-08,0.07201361764545178,0.022291666666666654,0.0036268529295637453,0.0723722241544178,0.022069830246913575,0.003621603081905733,0.07269644835618516,0.021728395061728398,4.737194547137081e-08,0.04348511193973836,0.0
185,0.1,4,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Are discordant results between TEOAE and AABR in newborns predictable? Based on existing screening technologies, predicting discordance in TEOAE and AABR outcomes is not dependable. Although some research points to potential correlations, no established pattern can anticipate discordance. More research is necessary to better understand these complex dynamics.",2.3685972735685406e-08,0.00659873896280283,0.01975308641975309,0.0018134264647818726,0.007348210251004961,0.020740740740740733,0.0018108015409528666,0.008157927218613636,0.021728395061728398,2.3685972735685406e-08,0.022472855852057716,0.0
185,0.1,5,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Can we predict when TEOAE and AABR results will be discordant in newborns? With the current screening methods, discordant outcomes between TEOAE and AABR are not reliably foreseeable. Some studies indicate possible links, but no definitive pattern has been identified to predict discordance. Further studies are needed to clarify these complex relationships.",7.105791820705622e-08,0.0929035346366276,0.023071868203063527,0.005440279394345618,0.0931407659050465,0.022477465665026397,0.0054324046228586,0.09331573555892092,0.021728395061728398,7.105791820705622e-08,0.06453852113757153,0.0
185,0.1,6,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Is it possible to anticipate discordance in TEOAE and AABR outcomes among newborns? Given the screening technologies currently available, such discordance cannot be reliably predicted. While some research suggests potential correlations, no established pattern exists to foresee discordance. Additional research is required to better understand these complex relationships.",2.3685972735685406e-08,0.06558998837215979,0.06222222222222222,0.0018134264647818726,0.0374850441883936,0.04246913580246913,0.0018108015409528666,0.008157927218613636,0.021728395061728398,2.3685972735685406e-08,0.022472855852057716,0.0
185,0.1,7,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Can discordance between TEOAE and AABR results in newborns be predicted? With the screening technologies at hand, predicting discordant outcomes between TEOAE and AABR is unreliable. Although some studies suggest possible correlations, no clear pattern has been established to anticipate discordance. Further research is needed to clarify these complex relationships.",2.3685972735685406e-08,0.022387519806204903,0.0012581390464188463,0.0018134264647818726,0.022282393560528302,0.000881234101145871,0.0018108015409528666,0.02214741445367352,0.00046185441900629606,2.3685972735685406e-08,0.021978906718775004,0.0
185,0.1,8,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Is predicting discordance in TEOAE and AABR outcomes in newborns possible? Current screening technologies do not reliably predict discordant TEOAE and AABR results. Some studies hint at potential correlations, but no definitive pattern exists to anticipate discordance. More research is necessary to understand these complex relationships.",7.105791820705622e-08,0.039508206284017966,0.017873925845802538,0.005440279394345618,0.03847340840789171,0.01975415473162002,0.0054324046228586,0.0373044468581436,0.021728395061728398,7.105791820705622e-08,0.06899287148695166,0.0
185,0.1,9,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Are discordant TEOAE and AABR outcomes in newborns predictable? Given the available screening technologies, such discordance is not reliably predictable. While some studies suggest potential correlations, no established pattern exists to anticipate discordance. Further research is needed to clarify these complex relationships.",1.6580180914979784e-07,0.07098554663359025,0.06222222222222222,0.012693985253473108,0.10227689818676478,0.04246913580246913,0.012675610786670066,0.13494291642206147,0.021728395061728398,1.6580180914979784e-07,0.16907633004393308,0.0
185,0.1,10,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? 

Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes are not reliably predictable.  While some studies suggest potential correlations, there is no established pattern to anticipate discordance. Further research is needed to clarify these complex relationships. 
","Can we reliably predict discordance in TEOAE and AABR outcomes in newborns? With current screening technologies, discordant results between TEOAE and AABR cannot be reliably predicted. Although some studies indicate possible correlations, no definitive pattern has been established to foresee discordance. Additional research is necessary to better understand these complex relationships.",4.737194547137081e-08,0.07201361764545178,0.022291666666666654,0.0036268529295637453,0.0723722241544178,0.022069830246913575,0.003621603081905733,0.07269644835618516,0.021728395061728398,4.737194547137081e-08,0.04348511193973836,0.0
186,0.1,1,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic surgery was found to cause noticeable damage to Kupffer cells, indicating a possible effect on liver function. Additional studies are required to determine the long-term consequences of this observation.",2.36859727356853e-08,0.028170876966696845,0.0,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
186,0.1,2,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? The laparoscopic approach resulted in observable injury to Kupffer cells, implying a potential impact on hepatic function. More research is necessary to explore the lasting effects of this damage.",2.36859727356853e-08,0.028170876966696845,0.0,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
186,0.1,3,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Does undergoing laparoscopic cholecystectomy alter the activity of peri-sinusoidal cells? Evidence shows that laparoscopic procedures induce damage to Kupffer cells, which may affect liver function. Further investigation is needed to assess the long-term outcomes.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
186,0.1,4,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Can laparoscopic cholecystectomy modify peri-sinusoidal cell activity? The procedure caused detectable harm to Kupffer cells, suggesting it might influence liver function. Continued research is essential to understand the prolonged effects.",1.421158364141118e-07,0.18805223150294026,0.0,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
186,0.1,5,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Is there an effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Damage to Kupffer cells was observed following laparoscopic surgery, indicating a possible impact on liver function. Further studies are required to clarify the long-term implications.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
186,0.1,6,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Does laparoscopic cholecystectomy impact the activity of peri-sinusoidal cells? The laparoscopic method led to identifiable damage to Kupffer cells, hinting at a potential effect on liver function. More research is needed to evaluate the long-term significance.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
186,0.1,7,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","How does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic surgery caused measurable damage to Kupffer cells, which may influence liver function. Additional research is necessary to understand the long-term effects.",1.421158364141118e-07,0.18805223150294026,0.0,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
186,0.1,8,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? The procedure resulted in detectable injury to Kupffer cells, suggesting a possible impact on liver function. Further investigation is needed to determine the long-term consequences.",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
186,0.1,9,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cell activity? Damage to Kupffer cells was noted after laparoscopic surgery, implying a potential influence on liver function. More studies are required to explore the long-term outcomes.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
186,0.1,10,ai,"Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? 

Answer: Laparoscopic procedures caused detectable damage to Kupffer cells, suggesting a potential impact on liver function. Further research is needed to understand the long-term implications of this finding. 
","Can peri-sinusoidal cell activity be influenced by laparoscopic cholecystectomy? The laparoscopic procedure caused observable damage to Kupffer cells, indicating a possible effect on liver function. Further research is essential to assess the long-term implications.",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
187,0.1,1,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? This research shows that hospital management can promote process-oriented care by adopting case-mix based reimbursement, which drives hospitals to enhance efficiency and effectiveness, resulting in standardized procedures and better patient outcomes.",1.8948778188548325e-07,0.07612201664985063,0.07141269744756035,0.014507411718254981,0.06679702670063081,0.08264462809917356,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
187,0.1,2,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Can case-mix based reimbursement foster the growth of process-oriented care delivery? The study indicates that hospital management can boost process-oriented care development through case-mix based reimbursement, motivating hospitals to prioritize efficiency and effectiveness, thereby standardizing processes and improving patient results.",2.3685972735685396e-07,0.12960034056690262,0.06893268665154124,0.018134264647818726,0.11809032108818052,0.08264462809917356,0.018108015409528666,0.15074281495179687,0.06353305785123965,2.3685972735685406e-07,0.18484879015820654,0.043388429752066124
187,0.1,3,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Is the development of process-oriented care delivery stimulated by case-mix based reimbursement? Findings reveal that hospital management can encourage this development by implementing case-mix based reimbursement, which pushes hospitals to focus on efficiency and effectiveness, leading to standardized care processes and enhanced patient outcomes.",1.4211583641411244e-07,0.006890743769009333,0.09682226956042916,0.010880558788691236,0.018006862531199097,0.08264462809917356,0.0108648092457172,0.048088660891714596,0.06353305785123965,1.4211583641411244e-07,0.07948827450038065,0.043388429752066124
187,0.1,4,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Does implementing case-mix based reimbursement promote process-oriented care delivery? The study demonstrates that hospital management can drive the evolution of process-oriented care by using case-mix based reimbursement, encouraging hospitals to improve efficiency and effectiveness, standardize procedures, and achieve better patient outcomes.",2.1317375462116866e-07,0.10250523211963669,0.07020340410104137,0.016320838183036854,0.09211483468492254,0.08264462809917356,0.0162972138685758,0.124074567869636,0.06353305785123965,2.1317375462116866e-07,0.15744981597009122,0.043388429752066124
187,0.1,5,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Can the use of case-mix based reimbursement stimulate process-oriented care delivery? Research shows that hospital management can foster the development of process-oriented care by applying case-mix based reimbursement, which incentivizes hospitals to enhance efficiency and effectiveness, standardize processes, and improve patient outcomes.",1.8948778188548325e-07,0.07612201664985063,0.07141269744756035,0.014507411718254981,0.06679702670063081,0.08264462809917356,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
187,0.1,6,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Does case-mix based reimbursement lead to the advancement of process-oriented care delivery? This study proves that hospital management can stimulate process-oriented care by adopting case-mix based reimbursement, encouraging hospitals to focus on efficiency and effectiveness, resulting in standardized processes and improved patient outcomes.",1.6580180914979784e-07,0.05041436709039493,0.0725648999459167,0.012693985253473108,0.042104414110259114,0.08264462809917356,0.012675610786670066,0.0727812734820863,0.06353305785123965,1.6580180914979784e-07,0.10480608248467238,0.043388429752066124
187,0.1,7,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Is process-oriented care delivery development encouraged by case-mix based reimbursement? The research demonstrates that hospital management can promote this by implementing case-mix based reimbursement, which motivates hospitals to enhance efficiency and effectiveness, standardize care processes, and improve patient outcomes.",2.6054570009253926e-07,0.12096523900697864,0.09376833310880932,0.0199476911126006,0.14475856817034138,0.08264462809917356,0.019918816950481533,0.1781417891399122,0.06353305785123965,2.6054570009253947e-07,0.2130196671249034,0.043388429752066124
187,0.1,8,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Does the introduction of case-mix based reimbursement encourage process-oriented care delivery? The study indicates that hospital management can stimulate process-oriented care development through case-mix based reimbursement, leading hospitals to prioritize efficiency and effectiveness, standardize procedures, and achieve better patient outcomes.",2.3685972735685396e-07,0.12960034056690262,0.06893268665154124,0.018134264647818726,0.11809032108818052,0.08264462809917356,0.018108015409528666,0.15074281495179687,0.06353305785123965,2.3685972735685406e-07,0.18484879015820654,0.043388429752066124
187,0.1,9,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Can case-mix based reimbursement drive the development of process-oriented care delivery? Findings show that hospital management can encourage this by implementing case-mix based reimbursement, which pushes hospitals to focus on efficiency and effectiveness, standardize processes, and improve patient outcomes.",2.6054570009253926e-07,0.12096523900697864,0.09376833310880932,0.0199476911126006,0.14475856817034138,0.08264462809917356,0.019918816950481533,0.1781417891399122,0.06353305785123965,2.6054570009253947e-07,0.2130196671249034,0.043388429752066124
187,0.1,10,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? 

Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery by implementing case-mix based reimbursement.  This system encourages hospitals to focus on efficiency and effectiveness, leading to standardized processes and improved patient outcomes. 
","Does case-mix based reimbursement promote the growth of process-oriented care delivery? This research reveals that hospital management can stimulate process-oriented care by adopting case-mix based reimbursement, motivating hospitals to enhance efficiency and effectiveness, standardize procedures, and improve patient outcomes.",2.6054570009253926e-07,0.15744666956276543,0.06759576414344756,0.0199476911126006,0.14475856817034138,0.08264462809917356,0.019918816950481533,0.1781417891399122,0.06353305785123965,2.6054570009253947e-07,0.2130196671249034,0.043388429752066124
188,0.1,1,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside assessment a reliable method to rule out aspiration after an acute stroke? Answer: Bedside swallowing assessments do not have sufficient sensitivity to serve as a screening tool in acute stroke cases, and there are also concerns regarding the use of videofluoroscopy as the gold standard.",1.6580180914979784e-07,0.23058286565211583,0.049861495844875335,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
188,0.1,2,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can aspiration be reliably excluded after acute stroke using bedside assessment? Answer: Bedside swallowing assessments lack the sensitivity required to be effective screening tools in acute stroke, and the use of videofluoroscopy as the gold standard is also questioned.",2.36859727356853e-08,0.043996910071702366,0.049861495844875335,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
188,0.1,3,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Does bedside assessment effectively exclude aspiration following an acute stroke? Answer: Bedside swallowing assessments are not sensitive enough to be used as screening tools in acute stroke, and there are issues with considering videofluoroscopy as the definitive standard.",4.73719454713706e-08,0.018021423668444392,0.049861495844875335,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
188,0.1,4,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside swallowing assessment reliable for excluding aspiration after acute stroke? Answer: The sensitivity of bedside swallowing assessments is insufficient for screening in acute stroke, and concerns exist about relying on videofluoroscopy as the gold standard.",9.47438909427412e-08,0.07455397429960664,0.022106393804059005,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
188,0.1,5,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can aspiration be ruled out reliably by bedside assessment after an acute stroke? Answer: Bedside swallowing assessments do not possess the necessary sensitivity for screening acute stroke patients, and the use of videofluoroscopy as the gold standard is problematic.",2.36859727356853e-08,0.043996910071702366,0.049861495844875335,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
188,0.1,6,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside assessment a dependable method to exclude aspiration post-acute stroke? Answer: Bedside swallowing assessments lack adequate sensitivity for screening in acute stroke, and there are reservations about using videofluoroscopy as the gold standard.",1.421158364141118e-07,0.09320421144178015,0.049861495844875335,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
188,0.1,7,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can bedside swallowing assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessments lack the sensitivity needed for screening in acute stroke, and videofluoroscopy as a gold standard is also under scrutiny.",1.894877818854824e-07,0.1538288332582156,0.049861495844875335,0.014507411718255009,0.2295744416444978,0.0,0.014486412327622968,0.23638877806423153,0.0,1.8948778188548325e-07,0.24362208265775243,0.0
188,0.1,8,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Does bedside assessment have the sensitivity to exclude aspiration after acute stroke? Answer: Bedside swallowing assessments are not sensitive enough to be used as screening tools in acute stroke, and videofluoroscopy as the gold standard raises concerns.",7.10579182070559e-08,0.008646823413716476,0.049861495844875335,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
188,0.1,9,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Is bedside assessment sufficient to rule out aspiration in acute stroke patients? Answer: Bedside swallowing assessments do not have the required sensitivity for screening in acute stroke, and the use of videofluoroscopy as the gold standard is questioned.",4.73719454713706e-08,0.01846000688734195,0.02356492900776796,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
188,0.1,10,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Question: Can aspiration be excluded reliably by bedside assessment in acute stroke? Answer: Bedside swallowing assessments lack the necessary sensitivity for screening acute stroke patients, and there are concerns about using videofluoroscopy as the definitive standard.",1.184298636784265e-07,0.06421667456852864,0.049861495844875335,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
189,0.1,1,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Are aromatase inhibitor-related musculoskeletal symptoms primarily prevented by addressing osteoporosis? Patients undergoing AI therapy who develop osteoporosis face a higher risk of musculoskeletal symptoms and fractures. Using calcium or bisphosphonates alongside reduces these risks. Prior tamoxifen treatment also lowers the chance of AI-related musculoskeletal issues. Our recommendation is...,2.3685972735685406e-07,0.1980783371253132,0.0037282753365996506,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
189,0.1,2,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Is preventing osteoporosis the crucial factor in eliminating musculoskeletal symptoms caused by aromatase inhibitors? Patients on AIs with osteoporosis have an increased risk of bone fractures and musculoskeletal symptoms. Co-treatment with calcium or bisphosphonates decreases this risk. Those previously treated with tamoxifen are less prone to AI-related musculoskeletal symptoms. We suggest...,1.6580180914979784e-07,0.13443319592494518,0.0024534048313202828,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
189,0.1,3,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Does preventing osteoporosis hold the key to stopping musculoskeletal symptoms linked to aromatase inhibitors? Patients receiving AIs who develop osteoporosis are more susceptible to musculoskeletal symptoms and fractures. Supplementing with calcium or bisphosphonates lowers these risks. Patients who had tamoxifen before AIs show fewer musculoskeletal symptoms. Our advice is...,2.1317375462116866e-07,0.17641043574613224,0.003285636912075833,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
189,0.1,4,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Is the prevention of osteoporosis essential to eliminating musculoskeletal symptoms related to aromatase inhibitors? Patients on AI therapy who develop osteoporosis have a higher chance of musculoskeletal symptoms and fractures. Co-medication with calcium or bisphosphonates reduces this likelihood. Prior tamoxifen use also decreases the risk of AI-related musculoskeletal symptoms. We recommend...,1.6580180914979784e-07,0.13443319592494518,0.0024534048313202828,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
189,0.1,5,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Could preventing osteoporosis be the key to resolving aromatase inhibitor-associated musculoskeletal symptoms? Patients treated with AIs who develop osteoporosis face increased risks of musculoskeletal symptoms and fractures. Using calcium or bisphosphonates alongside reduces these risks. Those who received tamoxifen before AIs are less likely to experience these symptoms. Our recommendation is...,1.6580180914979784e-07,0.10670730870254719,0.01753826530612245,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
189,0.1,6,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Is the prevention of osteoporosis the main strategy to eliminate musculoskeletal symptoms caused by aromatase inhibitors? Patients on AIs who develop osteoporosis are at greater risk for musculoskeletal symptoms and fractures. Co-treatment with calcium or bisphosphonates reduces this risk. Patients previously treated with tamoxifen are less likely to develop AI-related musculoskeletal symptoms. We recommend...,9.474389094274162e-08,0.07459489795819252,0.0013226814394396817,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
189,0.1,7,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Does addressing osteoporosis prevent musculoskeletal symptoms related to aromatase inhibitors? Patients on AIs who develop osteoporosis have an increased risk of musculoskeletal symptoms and fractures. Co-medication with calcium or bisphosphonates lowers this risk. Patients who received tamoxifen before AIs are less prone to these symptoms. Our recommendation is...,2.3685972735685406e-07,0.1980783371253132,0.0037282753365996506,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
189,0.1,8,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Is preventing osteoporosis the key to stopping musculoskeletal symptoms associated with aromatase inhibitors? Patients undergoing AI therapy who develop osteoporosis are more likely to experience musculoskeletal symptoms and fractures. Supplementing with calcium or bisphosphonates reduces these risks. Prior tamoxifen treatment also lowers the likelihood of AI-related musculoskeletal symptoms. We suggest...,1.8948778188548325e-07,0.15520173767557388,0.002861040249433105,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
189,0.1,9,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Could the prevention of osteoporosis be crucial in eliminating musculoskeletal symptoms caused by aromatase inhibitors? Patients on AIs who develop osteoporosis face higher risks of musculoskeletal symptoms and fractures. Co-treatment with calcium or bisphosphonates reduces these risks. Patients who had tamoxifen before AIs are less likely to develop these symptoms. Our recommendation is...,1.1842986367842703e-07,0.09414610249387811,0.001685110318637259,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
189,0.1,10,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Is osteoporosis prevention the key to eliminating musculoskeletal symptoms related to aromatase inhibitors? Patients treated with AIs who develop osteoporosis have an increased risk of musculoskeletal symptoms and fractures. Using calcium or bisphosphonates alongside reduces this risk. Those who received tamoxifen before AIs are less likely to experience AI-related musculoskeletal symptoms. We recommend...,1.1842986367842703e-07,0.09414610249387811,0.001685110318637259,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
190,0.1,1,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Are increased depression rates in women explained by differences in symptom reporting? Men and women in this community sample showed similar depressive symptom patterns, with no gender differences in symptom presentation found.",2.131737546211677e-07,0.30967323647949563,0.0392257112279064,0.01632083818303689,0.30857407650481905,0.033293697978596916,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.1,2,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Do higher depression rates in women result from varied symptom reporting? In this community sample, men and women reported depressive symptoms similarly, with no evidence of gender-based differences in symptom presentation.",2.36859727356853e-07,0.25302471342378485,0.024983563445101917,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
190,0.1,3,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Is the higher prevalence of depression in women due to differential symptom reporting? Men and women in this community sample exhibited comparable depressive symptom patterns, showing no gender differences in symptom presentation.",2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.1,4,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Are elevated depression rates among women explained by differences in how symptoms are reported? This community sample revealed men and women had similar depressive symptom patterns, with no gender-based differences detected.",2.36859727356853e-07,0.25302471342378485,0.024983563445101917,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
190,0.1,5,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Could the greater depression rates in women be due to different symptom reporting? Men and women in this community sample reported depressive symptoms similarly, with no gender differences in symptom presentation observed.",2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.1,6,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Is the increased depression rate in women accounted for by differences in symptom reporting? Men and women in this community sample showed similar patterns of depressive symptoms, with no evidence of gender differences in symptom presentation.",1.184298636784265e-07,0.17809085423194837,0.031949402578773184,0.00906713232390937,0.17797448507583224,0.029384756657483937,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,0.1,7,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Do women report depressive symptoms differently, explaining higher depression rates? In this community sample, men and women had similar depressive symptom patterns, with no gender differences found.",3.316036182995942e-07,0.3961255570644573,0.024983563445101917,0.025387970506946286,0.4446858212614444,0.0,0.02535122157334021,0.45953232937844124,0.0,3.316036182995957e-07,0.475423696715076,0.0
190,0.1,8,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Are higher depression rates in women due to differential symptom reporting? Men and women in this community sample reported depressive symptoms in similar ways, with no gender differences in symptom presentation.",2.36859727356853e-07,0.25302471342378485,0.024983563445101917,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
190,0.1,9,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Is the higher incidence of depression in women explained by differences in symptom reporting? Men and women in this community sample showed comparable depressive symptom patterns, with no evidence of gender differences.",2.131737546211677e-07,0.22023489060079315,0.024983563445101917,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
190,0.1,10,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Are increased depression rates in women a result of different symptom reporting? Men and women in this community sample reported depressive symptoms similarly, with no gender differences in symptom presentation.",2.605457000925383e-07,0.2869262650994666,0.024983563445101917,0.019947691112600648,0.3313571359544403,0.0,0.019918816950481588,0.341749293722057,0.0,2.6054570009253947e-07,0.3528213746227431,0.0
191,0.1,1,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is it possible to implement an advance care planning model in community palliative care? An advance care planning model is indeed feasible for community palliative care services. Research indicates that advance care planning enhances communication, alleviates distress, and ensures care aligns with patient values, resulting in more effective and compassionate end-of-life care.",0.0,0.0,0.0,0.0,4.440892098500626e-16,0.0,0.0,0.0,0.0,0.0,0.0,0.0
191,0.1,2,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Can an advance care planning model be applied in community palliative care? Yes, an advance care planning model is practical for community palliative care. Qualitative research demonstrates that it improves communication, reduces patient distress, and aligns care with patient preferences, promoting more compassionate and effective end-of-life care.",1.1842986367842703e-07,0.04307317424828572,0.11761096307294466,0.009067132323909363,0.07641162796760259,0.05654681532348291,0.009054007704764333,0.11406060093225401,0.004609056539471058,1.1842986367842703e-07,0.11335916643797228,0.00241872816728924
191,0.1,3,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is the use of an advance care planning model viable in community palliative care? The advance care planning model is feasible within community palliative care services. Studies show it facilitates better communication, lowers distress, and matches care to patient values, enhancing the quality of end-of-life care.",1.4211583641411244e-07,0.03759407671299542,0.13664725099679953,0.010880558788691236,0.06947823979590595,0.0775218720128253,0.0108648092457172,0.106276142853023,0.01749978699794391,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
191,0.1,4,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is implementing an advance care planning model achievable in community palliative care? An advance care planning model can be successfully implemented in community palliative care. Qualitative evidence suggests it improves communication, decreases distress, and aligns care with patient wishes, leading to more compassionate and effective end-of-life care.",1.1842986367842703e-07,0.0732100081856748,0.0971900826446282,0.009067132323909363,0.10721816932582229,0.03483051428789914,0.009054007704764333,0.11406060093225401,0.004609056539471058,1.1842986367842703e-07,0.11335916643797228,0.00241872816728924
191,0.1,5,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Can community palliative care adopt an advance care planning model? Yes, community palliative care services can feasibly adopt an advance care planning model. Research highlights that it improves communication, reduces distress, and ensures care is consistent with patient values, resulting in better end-of-life care.",1.8948778188548325e-07,0.1532667078387191,0.0888244873195734,0.014507411718254981,0.18501290977226637,0.02869052045096329,0.014486412327622933,0.18928890327188297,0.007909785114924905,1.8948778188548325e-07,0.1880977832986206,0.004159661226903637
191,0.1,6,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is an advance care planning model workable in community palliative care settings? The model is feasible for community palliative care. Qualitative studies reveal that it enhances communication, minimizes distress, and aligns care with patient values, fostering more effective and compassionate end-of-life care.",2.3685972735685406e-07,0.04127039193441817,0.2003150826446282,0.018134264647818726,0.10177503954932687,0.1228733459357278,0.018108015409528666,0.17167520866996666,0.040742417383431435,2.3685972735685406e-07,0.2047337186581739,0.020823902218198284
191,0.1,7,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is it feasible to use an advance care planning model in community palliative care? The advance care planning model is practical for community palliative care services. Evidence shows it improves communication, reduces distress, and aligns care with patient preferences, leading to improved end-of-life care.",1.8948778188548325e-07,0.08878790034477024,0.13264537521530537,0.014507411718254981,0.11899889257607921,0.07537334593572778,0.014486412327622933,0.1554768456835931,0.016367417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
191,0.1,8,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Can an advance care planning model be effectively used in community palliative care? Yes, it is feasible. Qualitative research indicates that advance care planning enhances communication, lowers distress, and aligns care with patient values, resulting in more compassionate and effective end-of-life care.",2.3685972735685406e-07,0.07508244952270804,0.17603788014627186,0.018134264647818726,0.13643239857732326,0.09788978249062588,0.018108015409528666,0.17167520866996666,0.040742417383431435,2.3685972735685406e-07,0.2047337186581739,0.020823902218198284
191,0.1,9,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is the implementation of an advance care planning model feasible in community palliative care? Implementing an advance care planning model is feasible in community palliative care. Studies demonstrate it improves communication, reduces distress, and aligns care with patient values, promoting better end-of-life care.",2.1317375462116866e-07,0.2144098429537169,0.06469008264462817,0.016320838183036854,0.2461427149004045,0.003274580503628985,0.0162972138685758,0.25032947776966585,0.0337645219883728,2.1317375462116866e-07,0.21430424151439986,0.00479936647986267
191,0.1,10,ai,"Question: Is an advance care planning model feasible in community palliative care? 
Answer: An advance care planning model is feasible for community palliative care services. Qualitative studies have shown that advance care planning can improve communication, reduce distress, and align care with patient values, leading to more effective and compassionate end-of-life care. 
","Is an advance care planning model suitable for community palliative care? It is feasible to use an advance care planning model in community palliative care services. Qualitative studies confirm that it improves communication, decreases distress, and aligns care with patient values, leading to more effective and compassionate end-of-life care.",7.105791820705622e-08,0.005764947240799678,0.12193183494316798,0.005440279394345618,0.02899376606724058,0.059340288084488144,0.0054324046228586,0.06686912618529428,0.0026460123686346884,7.105791820705622e-08,0.06646392997246053,0.0013868415834546073
192,0.1,1,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Should second-look laparotomy still be offered for advanced epithelial ovarian carcinoma in Thai women? The procedure does not significantly improve survival or quality of life and carries considerable morbidity, suggesting it may be time to discontinue its use.",4.500334819780224e-07,0.31541275229664567,0.07100591715976332,0.03445510283085558,0.3481981907152756,0.0543639053254438,0.034405229278104466,0.3822917494778282,0.036982248520710054,4.500334819780227e-07,0.4177748915563382,0.018860946745562133
192,0.1,2,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","In Thai women with advanced epithelial ovarian carcinoma, second-look laparotomy provides no meaningful survival or quality of life benefits and is linked to high morbidity, indicating it might be best to stop offering this procedure.",5.210914001850783e-07,0.39997014032470934,0.07100591715976332,0.03989538222520121,0.4352095677049057,0.0543639053254438,0.039837633900963086,0.47190390816751515,0.036982248520710054,5.210914001850789e-07,0.5101482116873535,0.018860946745562133
192,0.1,3,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","For advanced epithelial ovarian carcinoma among Thai women, second-look laparotomy fails to enhance survival or quality of life and involves substantial morbidity, thus it may be advisable to abandon this practice.",6.158352911278195e-07,0.5251332832787163,0.07100591715976332,0.04714908808432873,0.5644212991849127,0.0543639053254438,0.04708084006477458,0.6054353007920374,0.036982248520710054,6.158352911278206e-07,0.6482985501681706,0.018860946745562133
192,0.1,4,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Second-look laparotomy in Thai patients with advanced epithelial ovarian carcinoma does not significantly improve survival or quality of life and is associated with notable morbidity, suggesting discontinuation of this approach.",6.395212638635048e-07,0.5590348349543981,0.07100591715976332,0.04896251454911061,0.5995126189961817,0.0543639053254438,0.048891641605727454,0.6418029449629121,0.036982248520710054,6.39521263863506e-07,0.6860388781510176,0.018860946745562133
192,0.1,5,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","The use of second-look laparotomy in advanced epithelial ovarian carcinoma in Thai women does not yield significant survival or quality of life benefits and is linked to considerable morbidity, implying it should be reconsidered or stopped.",4.97405427449393e-07,0.37098260345145784,0.07100591715976332,0.03808195576041933,0.40535660455522393,0.0543639053254438,0.03802683236001021,0.44113224950076146,0.036982248520710054,4.974054274493935e-07,0.47839951337277364,0.018860946745562133
192,0.1,6,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","In cases of advanced epithelial ovarian carcinoma in Thai women, second-look laparotomy offers no significant advantage in survival or quality of life and carries significant morbidity, indicating it may be a practice to discontinue.",5.447773729207636e-07,0.4298231034743911,0.07100591715976332,0.04170880868998309,0.4659812263716594,0.0543639053254438,0.04164843544191596,0.503652606482095,0.036982248520710054,5.447773729207643e-07,0.5429380345103452,0.018860946745562133
192,0.1,7,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women does not provide meaningful survival or quality of life improvements and is associated with high morbidity, suggesting it should be abandoned.",6.158352911278195e-07,0.5251332832787163,0.07100591715976332,0.04714908808432873,0.5644212991849127,0.0543639053254438,0.04708084006477458,0.6054353007920374,0.036982248520710054,6.158352911278206e-07,0.6482985501681706,0.018860946745562133
192,0.1,8,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","Offering second-look laparotomy to Thai women with advanced epithelial ovarian carcinoma does not significantly benefit survival or quality of life and is accompanied by considerable morbidity, thus it may be prudent to cease this practice.",5.210914001850783e-07,0.39997014032470934,0.07100591715976332,0.03989538222520121,0.4352095677049057,0.0543639053254438,0.039837633900963086,0.47190390816751515,0.036982248520710054,5.210914001850789e-07,0.5101482116873535,0.018860946745562133
192,0.1,9,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","The second-look laparotomy procedure in advanced epithelial ovarian carcinoma among Thai women does not significantly enhance survival or quality of life and involves significant morbidity, indicating it may be time to stop using it.",5.447773729207636e-07,0.4298231034743911,0.07100591715976332,0.04170880868998309,0.4659812263716594,0.0543639053254438,0.04164843544191596,0.503652606482095,0.036982248520710054,5.447773729207643e-07,0.5429380345103452,0.018860946745562133
192,0.1,10,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy does not offer significant benefit in terms of survival or quality of life for patients with advanced epithelial ovarian carcinoma in Thailand.  It is associated with significant morbidity and may be considered a practice that should be abandoned. 
","For Thai women with advanced epithelial ovarian carcinoma, second-look laparotomy does not offer substantial survival or quality of life benefits and is linked to significant morbidity, suggesting it should no longer be offered.",5.684633456564489e-07,0.4605947621411448,0.07100591715976332,0.04352223515476497,0.4977299246862392,0.0543639053254438,0.04345923698286883,0.5364424293050867,0.036982248520710054,5.684633456564497e-07,0.5768395861860269,0.018860946745562133
193,0.1,1,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Does obstructive sleep apnea impact aerobic fitness? In a US Air Force group, OSA does not lead to reduced aerobic fitness, though a slight, clinically negligible drop in VO2 max may occur. Further studies are required to assess OSA's effect on aerobic fitness in other groups.",2.6054570009253947e-07,0.19393394451626023,0.017851239669421492,0.0199476911126006,0.22314355131420927,0.0,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
193,0.1,2,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Is aerobic fitness affected by obstructive sleep apnea? Among US Air Force members, OSA does not predict lower aerobic fitness, but there might be a minor, clinically insignificant reduction in VO2 max. Additional research is necessary to explore OSA's influence on aerobic fitness in different populations.",2.6054570009253947e-07,0.22474048587447992,0.0043595041322314,0.0199476911126006,0.22314355131420927,0.0,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
193,0.1,3,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Does obstructive sleep apnea influence aerobic fitness? In a US Air Force cohort, OSA does not cause a decline in aerobic fitness, although a small, clinically irrelevant decrease in VO2 max could be present. More investigation is needed to understand OSA's impact on aerobic fitness elsewhere.",2.6054570009253947e-07,0.19393394451626023,0.017851239669421492,0.0199476911126006,0.22314355131420927,0.0,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
193,0.1,4,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Can obstructive sleep apnea affect aerobic fitness? For US Air Force personnel, OSA does not indicate decreased aerobic fitness, but there may be a slight, clinically insignificant drop in VO2 max. Further research is needed to evaluate OSA's effects on aerobic fitness in other populations.",2.8423167282822487e-07,0.21640680036831794,0.017851239669421492,0.02176111757738247,0.2461330695389088,0.0,0.0217296184914344,0.25131442828090744,0.0,2.8423167282822487e-07,0.2567198468478131,0.0
193,0.1,5,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Is there an effect of obstructive sleep apnea on aerobic fitness? In the US Air Force population, OSA does not predict reduced aerobic fitness, though a minor, clinically insignificant decrease in VO2 max might exist. More studies are required to determine OSA's impact on aerobic fitness in other groups.",1.8948778188548325e-07,0.1582765559020194,0.0029726625487767923,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
193,0.1,6,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Does obstructive sleep apnea reduce aerobic fitness? Among US Air Force individuals, OSA does not predict a decline in aerobic fitness, but a small, clinically insignificant decrease in VO2 max may occur. Additional research is needed to assess OSA's effect on aerobic fitness in other populations.",2.6054570009253947e-07,0.19393394451626023,0.017851239669421492,0.0199476911126006,0.22314355131420927,0.0,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
193,0.1,7,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","How does obstructive sleep apnea affect aerobic fitness? In a US Air Force population, OSA does not predict lower aerobic fitness, though there may be a slight, clinically insignificant reduction in VO2 max. More research is necessary to understand OSA's impact on aerobic fitness in other groups.",2.3685972735685406e-07,0.17195503779748522,0.017851239669421492,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
193,0.1,8,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Does obstructive sleep apnea have an impact on aerobic fitness? In US Air Force members, OSA does not lead to decreased aerobic fitness, but a small, clinically insignificant drop in VO2 max might be present. Further studies are needed to explore OSA's effect on aerobic fitness in other populations.",1.8948778188548325e-07,0.1582765559020194,0.0029726625487767923,0.014507411718254981,0.15718558352241319,0.0,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
193,0.1,9,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Is aerobic fitness compromised by obstructive sleep apnea? In a US Air Force cohort, OSA does not predict reduced aerobic fitness, although there may be a minor, clinically insignificant decrease in VO2 max. More research is required to determine OSA's impact on aerobic fitness in other populations.",2.3685972735685406e-07,0.20209187173487386,0.003877155392306906,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
193,0.1,10,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? 

Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness. However, there may be a small, clinically insignificant decrease in VO2 max for individuals with OSA. More research is needed to determine the impact of OSA on aerobic fitness in other populations. 
","Does obstructive sleep apnea influence aerobic fitness levels? Among US Air Force personnel, OSA does not cause a decrease in aerobic fitness, but a slight, clinically insignificant reduction in VO2 max may occur. Additional research is needed to evaluate OSA's effects on aerobic fitness in other groups.",2.3685972735685406e-07,0.20209187173487386,0.003877155392306906,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
194,0.1,1,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is advanced age a contraindication for laparoscopic surgery for GERD? Laparoscopic antireflux surgery remains a safe and effective treatment for GERD in elderly patients. Although older age may raise the risk of complications, thorough patient evaluation and careful selection help reduce these risks.",1.1842986367842703e-07,0.11247798342669002,0.0,0.009067132323909363,0.11506932978478668,0.0,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
194,0.1,2,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Does advanced age contraindicate laparoscopic surgery for GERD? Laparoscopic antireflux surgery is a safe and effective option for treating GERD, even in older adults. While age can increase complication risks, careful patient assessment and selection minimize these dangers.",2.3685972735685374e-07,0.2392296890658323,0.0,0.018134264647818726,0.24512245803298427,0.0,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
194,0.1,3,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is elderly age a contraindication for GERD laparoscopic surgery? Laparoscopic antireflux surgery is considered safe and effective for GERD treatment in older patients. Although age may elevate complication risks, thorough evaluation and patient selection can mitigate these risks.",2.3685972735685374e-07,0.2766971042312347,0.027006172839506164,0.018134264647818726,0.24512245803298427,0.0,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
194,0.1,4,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is advanced age a reason to avoid laparoscopic surgery for GERD? Laparoscopic antireflux surgery is a safe and effective treatment for GERD, including in elderly patients. While older age can increase complication risks, careful evaluation and patient selection reduce these risks.",1.6580180914979784e-07,0.16126814759612174,0.0,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
194,0.1,5,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Does being elderly contraindicate laparoscopic surgery for GERD? Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in older patients. Although age may increase the risk of complications, thorough evaluation and careful patient selection help minimize these risks.",1.6580180914979784e-07,0.16126814759612174,0.0,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
194,0.1,6,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is advanced age a contraindication to laparoscopic surgery for GERD? Laparoscopic antireflux surgery is safe and effective for treating GERD in older patients. While age can raise complication risks, careful evaluation and patient selection can lower these risks.",2.3685972735685374e-07,0.2392296890658323,0.0,0.018134264647818726,0.24512245803298427,0.0,0.018108015409528666,0.2513144282809061,0.0,2.3685972735685406e-07,0.2578291093020999,0.0
194,0.1,7,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is old age a contraindication for GERD laparoscopic surgery? Laparoscopic antireflux surgery is a safe and effective treatment for GERD in elderly patients. Although age may increase complication risks, thorough evaluation and careful patient selection can reduce these risks.",2.1317375462116844e-07,0.24904287253945778,0.026296566837107373,0.016320838183036854,0.21772348384486895,0.0,0.0162972138685758,0.22314355131420927,0.0,2.1317375462116866e-07,0.2288415724288484,0.0
194,0.1,8,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is advanced age a barrier to laparoscopic surgery for GERD? Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older adults. While age can increase the risk of complications, careful evaluation and patient selection minimize these risks.",1.4211583641411244e-07,0.13657553500575004,0.0,0.010880558788691236,0.13976194237515838,0.0,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
194,0.1,9,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is elderly age a contraindication for laparoscopic surgery in GERD patients? Laparoscopic antireflux surgery is a safe and effective treatment for GERD in older patients. Although age may increase complication risks, thorough evaluation and careful patient selection can mitigate these risks.",1.6580180914979784e-07,0.16126814759612174,0.0,0.012693985253473108,0.1650797503594501,0.0,0.012675610786670066,0.16907633004393308,0.0,1.6580180914979784e-07,0.17327172127403623,0.0
194,0.1,10,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? 
Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD, even in older patients. While age can increase the risk of complications, a thorough evaluation and careful selection of patients can minimize these risks. 
","Is advanced age a contraindication for laparoscopic antireflux surgery in GERD? Laparoscopic surgery is a safe and effective treatment for GERD even in elderly patients. While age can increase complication risks, careful evaluation and patient selection help minimize these risks.",1.8948778188548314e-07,0.18658595558041347,0.0,0.014507411718254981,0.19105523676270808,0.0,0.014486412327622933,0.19574457712609394,0.0,1.8948778188548325e-07,0.20067069546215155,0.0
195,0.1,1,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean individuals? Both hsCRP levels and carotid IMT showed a strong correlation with conventional factors.,7.10579182070559e-08,0.06643880005935099,0.03698224852071005,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
195,0.1,2,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"Does high-sensitivity C-reactive protein relate to carotid atherosclerosis in healthy Koreans? The study found a strong correlation between hsCRP levels, carotid IMT, and conventional markers.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
195,0.1,3,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Are high-sensitivity C-reactive protein levels associated with carotid atherosclerosis among healthy Koreans? Both hsCRP and carotid IMT were strongly linked to traditional risk factors.,2.36859727356853e-08,0.04255961441879563,0.0,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
195,0.1,4,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"Is high-sensitivity C-reactive protein connected to carotid atherosclerosis in healthy Korean subjects? There was a strong correlation between hsCRP, carotid IMT, and conventional indicators.",2.36859727356853e-08,0.04255961441879563,0.0,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
195,0.1,5,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Does high-sensitivity C-reactive protein have an association with carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT correlated strongly with conventional parameters.,2.36859727356853e-08,0.04255961441879563,0.0,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
195,0.1,6,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean people? hsCRP and carotid IMT were both strongly correlated with conventional factors.,2.36859727356853e-08,0.014629779924540287,0.03993055555555556,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
195,0.1,7,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Are hsCRP levels associated with carotid atherosclerosis in healthy Koreans? Both hsCRP and carotid IMT demonstrated a strong correlation with conventional risk factors.,4.73719454713706e-08,0.08701137698962969,0.0,0.003626852929563759,0.090971778205728,0.0,0.003621603081905747,0.09531017980432521,0.0,4.7371945471370706e-08,0.10008345855698142,0.0
195,0.1,8,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Korean individuals? The levels of hsCRP and carotid IMT were strongly correlated with conventional measures.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
195,0.1,9,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Does high-sensitivity C-reactive protein correlate with carotid atherosclerosis in healthy Koreans? Both hsCRP and carotid IMT showed strong associations with conventional factors.,7.10579182070559e-08,0.13353139262452363,0.0,0.005440279394345639,0.13976194237515926,0.0,0.005432404622858621,0.14660347419187536,0.0,7.105791820705606e-08,0.15415067982725672,0.0
195,0.1,10,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there a relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Both hsCRP levels and carotid IMT were strongly correlated with conventional markers.,2.36859727356853e-08,0.014629779924540287,0.03993055555555556,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
196,0.1,1,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Is fondaparinux used in perioperative bridging? The use of fondaparinux in perioperative bridging is developing. Although it has been mainly used for prophylaxis, its effectiveness and safety for bridging patients at risk of venous thromboembolism (VTE) are gaining recognition. Nonetheless, it is important to carefully evaluate individual patient factors and possible drug interactions.",2.3685972735685406e-08,0.006605292843934851,0.018454440599769306,0.0018134264647818726,0.007241421087510691,0.01922337562475971,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
196,0.1,2,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Does fondaparinux have a role in perioperative bridging? Fondaparinux's role in perioperative bridging therapy is evolving. Traditionally employed for prophylaxis, its safety and efficacy in bridging patients with venous thromboembolism risk are increasingly acknowledged. However, individual patient considerations and potential drug interactions must be carefully assessed.",1.8948778188548325e-07,0.1729295117389995,0.006670480151890666,0.014507411718254981,0.17190126774400527,0.0034916054460894,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
196,0.1,3,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","What is the role of fondaparinux in perioperative bridging? Fondaparinux is increasingly recognized for its role in perioperative bridging therapy. While it has been primarily used for prophylaxis, its effectiveness and safety in patients at risk of venous thromboembolism are becoming more evident. Careful attention to patient-specific factors and drug interactions remains essential.",2.3685972735685406e-08,0.006605292843934851,0.018454440599769306,0.0018134264647818726,0.007241421087510691,0.01922337562475971,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
196,0.1,4,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Can fondaparinux be used for perioperative bridging? The application of fondaparinux in perioperative bridging is evolving. Traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism risk are now more widely accepted. However, individual patient factors and potential drug interactions require careful consideration.",1.6580180914979784e-07,0.11947435624117375,0.01594942116280062,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
196,0.1,5,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Is fondaparinux appropriate for perioperative bridging? Fondaparinux's role in perioperative bridging therapy is progressing. Although it has been mainly used for prophylaxis, its safety and efficacy in bridging patients at risk of venous thromboembolism are increasingly recognized. Careful evaluation of patient-specific factors and drug interactions is necessary.",1.6580180914979784e-07,0.08933752230378511,0.037677816224529016,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
196,0.1,6,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","What role does fondaparinux play in perioperative bridging? The role of fondaparinux in perioperative bridging therapy is evolving. Traditionally used for prophylaxis, its effectiveness and safety in bridging patients with venous thromboembolism risk are gaining recognition. However, careful consideration of individual patient factors and potential drug interactions is important.",1.1842986367842703e-07,0.07565904040831928,0.016853914006330732,0.009067132323909363,0.0744366099267566,0.01922337562475971,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
196,0.1,7,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Is there a place for fondaparinux in perioperative bridging? Fondaparinux's role in perioperative bridging is developing. While it has been primarily used for prophylaxis, its efficacy and safety in bridging patients at risk of venous thromboembolism are increasingly acknowledged. Careful assessment of patient-specific factors and drug interactions is crucial.",1.1842986367842703e-07,0.07565904040831928,0.016853914006330732,0.009067132323909363,0.0744366099267566,0.01922337562475971,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
196,0.1,8,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","How is fondaparinux used in perioperative bridging? The use of fondaparinux in perioperative bridging therapy is evolving. Although traditionally used for prophylaxis, its safety and efficacy in bridging patients with venous thromboembolism risk are becoming more recognized. Individual patient factors and potential drug interactions must be carefully considered.",1.4211583641411244e-07,0.09732694178750023,0.016411275581806915,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
196,0.1,9,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Does fondaparinux have a function in perioperative bridging? Fondaparinux's role in perioperative bridging therapy is progressing. While it has been mainly used for prophylaxis, its effectiveness and safety in bridging patients at risk of venous thromboembolism are increasingly recognized. Careful evaluation of patient-specific factors and drug interactions is essential.",1.1842986367842703e-07,0.07565904040831928,0.016853914006330732,0.009067132323909363,0.0744366099267566,0.01922337562475971,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
196,0.1,10,ai,"Question: Is there a role for fondaparinux in perioperative bridging? 
Answer: The role of fondaparinux in perioperative bridge therapy is evolving. While traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism (VTE) risk is increasingly recognized. However, careful consideration of individual patient factors and potential drug interactions is crucial. 
","Is fondaparinux relevant for perioperative bridging? The role of fondaparinux in perioperative bridging therapy is evolving. Traditionally used for prophylaxis, its efficacy and safety in bridging patients with venous thromboembolism risk are gaining recognition. However, careful consideration of individual patient factors and potential drug interactions is necessary.",1.6580180914979784e-07,0.08933752230378511,0.037677816224529016,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
197,0.1,1,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Is there an importance of environmental factors in primary systemic vasculitis? A notable link between farming and PSV has been discovered for the first time, indicating that environmental exposures like those in farming might contribute to the onset of this autoimmune disease. Additional studies are required to pinpoint the exact environmental elements and their mechanisms.",1.8948778188548325e-07,0.11579075201114009,0.016124697661918846,0.014507411718254981,0.1405819506211894,0.0,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
197,0.1,2,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Do environmental factors play a role in primary systemic vasculitis? For the first time, a significant connection between farming and PSV has been found, implying that environmental exposures related to farming could influence the development of this autoimmune condition. More research is necessary to clarify the specific factors and how they act.",2.6054570009253947e-07,0.17294916585109021,0.016124697661918846,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
197,0.1,3,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
",Are environmental influences significant in primary systemic vasculitis? A newly identified strong association between farming and PSV suggests that environmental exposures encountered in farming may be involved in the disease's development. Further investigation is needed to determine the precise environmental contributors and their mechanisms.,4.500334819780227e-07,0.3435746828818531,0.016124697661918846,0.03445510283085558,0.3732042458899425,0.0,0.034405229278104466,0.3807724955177916,0.0,4.500334819780227e-07,0.38865798979178257,0.0
197,0.1,4,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
",Is primary systemic vasculitis affected by environmental factors? The first-time discovery of a significant link between farming and PSV indicates that environmental exposures from farming might play a role in this autoimmune disease's emergence. Additional research is essential to understand the specific factors and their actions.,4.026615365066519e-07,0.29811230880509587,0.016124697661918846,0.030828249901291835,0.32668423025504856,0.0,0.030783626196198732,0.33314444652853714,0.0,4.026615365066519e-07,0.33986782562235085,0.0
197,0.1,5,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Do environmental factors matter in primary systemic vasculitis? A significant association between farming and PSV has been identified for the first time, suggesting that environmental exposures such as those in farming may contribute to the disease's development. Further studies are needed to explore the exact environmental factors and their mechanisms.",3.079176455639103e-07,0.24124622212029667,0.0042746078936367095,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
197,0.1,6,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Are environmental factors relevant in primary systemic vasculitis? For the first time, a strong connection between farming and PSV has been found, indicating that environmental exposures encountered in farming could influence the development of this autoimmune disease. More research is required to identify the specific factors and their mechanisms.",3.316036182995957e-07,0.23357378766752435,0.016124697661918846,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
197,0.1,7,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Is there a role for environmental factors in primary systemic vasculitis? A significant association between farming and PSV has been discovered for the first time, suggesting that environmental exposures related to farming may be involved in the disease's development. Further research is necessary to understand the specific environmental factors and their mechanisms.",2.6054570009253947e-07,0.20013140822598974,0.003475302338081146,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
197,0.1,8,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
",Do environmental exposures impact primary systemic vasculitis? A newly found significant link between farming and PSV implies that environmental factors encountered in farming might contribute to the development of this autoimmune disease. Additional studies are needed to clarify the exact factors and their mechanisms.,4.500334819780227e-07,0.3435746828818531,0.016124697661918846,0.03445510283085558,0.3732042458899425,0.0,0.034405229278104466,0.3807724955177916,0.0,4.500334819780227e-07,0.38865798979178257,0.0
197,0.1,9,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Are environmental factors important contributors to primary systemic vasculitis? For the first time, a significant association between farming and PSV has been identified, suggesting that environmental exposures such as those in farming may play a role in the disease's onset. Further research is required to explore the specific environmental factors and their mechanisms.",2.3685972735685406e-07,0.1801905869386009,0.0030986779628408637,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
197,0.1,10,ai,"Question: Are environmental factors important in primary systemic vasculitis? 
Answer: A significant association between farming and PSV has been identified for the first time. This finding suggests that environmental exposures, such as those encountered in farming, may play a role in the development of this autoimmune disease. Further research is needed to understand the specific environmental factors involved and their mechanisms of action. 
","Is there evidence that environmental factors influence primary systemic vasculitis? A significant connection between farming and PSV has been found for the first time, indicating that environmental exposures encountered in farming might be involved in the development of this autoimmune disease. More research is needed to understand the specific factors and their mechanisms.",2.3685972735685406e-07,0.1801905869386009,0.0030986779628408637,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
199,0.1,1,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity an independent risk factor for negative perinatal outcomes? Grandmultiparous women experience higher rates of maternal and neonatal complications such as preterm birth, low birth weight, and postpartum hemorrhage, indicating that grandmultiparity itself contributes to adverse perinatal results. More studies are necessary to explore the causes and create effective treatments.",9.474389094274162e-08,0.07707166565497081,0.109375,0.0072537058591274906,0.05231087145660851,0.0933159722222222,0.007243206163811466,0.02659532010491672,0.07638888888888888,9.474389094274162e-08,0.00013130388956827943,0.05859375
199,0.1,2,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Does grandmultiparity independently increase the risk of adverse perinatal outcomes? Women with grandmultiparity show elevated maternal and neonatal morbidity, including preterm delivery, low birth weight infants, and postpartum bleeding, suggesting grandmultiparity is a standalone risk factor. Additional research is required to clarify the mechanisms and improve interventions.",1.8948778188548325e-07,0.006309943284080077,0.109375,0.014507411718254981,0.032846936883698774,0.0933159722222222,0.014486412327622933,0.06041605688471252,0.07638888888888888,1.8948778188548325e-07,0.08907878990606388,0.05859375
199,0.1,3,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity a standalone risk factor for poor perinatal outcomes? Evidence shows that grandmultiparous women have higher maternal and neonatal morbidity rates, such as preterm birth, low birth weight, and postpartum hemorrhage, supporting the idea that grandmultiparity independently raises risk. Further investigation is needed to understand the causes and develop effective strategies.",7.105791820705622e-08,0.09687429295115058,0.109375,0.005440279394345618,0.07251357877412712,0.0933159722222222,0.0054324046228586,0.04721460730765248,0.07638888888888888,7.105791820705622e-08,0.020922105308264882,0.05859375
199,0.1,4,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Can grandmultiparity be considered an independent risk factor for adverse perinatal outcomes? Increased maternal and neonatal complications, including preterm birth, low birth weight, and postpartum hemorrhage, are observed in grandmultiparous women, implying grandmultiparity itself is a risk factor. More research is essential to uncover the underlying mechanisms and design interventions.",1.1842986367842703e-07,0.0568689583374522,0.109375,0.009067132323909363,0.03169158425387275,0.0933159722222222,0.009054007704764333,0.005541910907083558,0.07638888888888888,1.1842986367842703e-07,0.02163750911053164,0.05859375
199,0.1,5,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity independently associated with increased risk of adverse perinatal outcomes? Grandmultiparous women show greater maternal and neonatal morbidity, such as preterm birth, low birth weight, and postpartum hemorrhage, indicating grandmultiparity is an independent risk factor. Further studies are needed to understand the mechanisms and develop effective interventions.",1.6580180914979784e-07,0.015196261936883282,0.109375,0.012693985253473108,0.01086803016492377,0.0933159722222222,0.012675610786670066,0.037943201032654805,0.07638888888888888,1.6580180914979784e-07,0.06608927168136436,0.05859375
199,0.1,6,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Does grandmultiparity independently contribute to adverse perinatal outcomes? The increased maternal and neonatal morbidity seen in grandmultiparous women, including preterm birth, low birth weight, and postpartum hemorrhage, suggests that grandmultiparity is an independent risk factor. Additional research is necessary to explore the underlying causes and improve interventions.",1.8948778188548325e-07,0.006309943284080077,0.109375,0.014507411718254981,0.032846936883698774,0.0933159722222222,0.014486412327622933,0.06041605688471252,0.07638888888888888,1.8948778188548325e-07,0.08907878990606388,0.05859375
199,0.1,7,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity an independent predictor of adverse perinatal outcomes? Grandmultiparous women experience higher rates of maternal and neonatal complications like preterm birth, low birth weight, and postpartum hemorrhage, indicating that grandmultiparity independently increases risk. Further research is needed to understand the mechanisms and develop effective treatments.",2.1317375462116866e-07,0.02828885000285508,0.109375,0.016320838183036854,0.05531979273575649,0.0933159722222222,0.0162972138685758,0.08340557510941204,0.07638888888888888,2.1317375462116866e-07,0.1126092873162583,0.05859375
199,0.1,8,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity a risk factor on its own for adverse perinatal outcomes? Women with grandmultiparity have increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage, suggesting grandmultiparity independently raises the risk. More research is required to identify the underlying mechanisms and create effective interventions.",1.4211583641411244e-07,0.036249671134716444,0.109375,0.010880558788691236,0.01063817505603959,0.0933159722222222,0.0108648092457172,0.0159642943138798,0.07638888888888888,1.4211583641411244e-07,0.04361641582930664,0.05859375
199,0.1,9,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity independently linked to adverse perinatal outcomes? The elevated maternal and neonatal morbidity among grandmultiparous women, such as preterm birth, low birth weight, and postpartum hemorrhage, supports the notion that grandmultiparity is an independent risk factor. Further studies are needed to understand the causes and develop interventions.",1.6580180914979784e-07,0.015196261936883282,0.109375,0.012693985253473108,0.01086803016492377,0.0933159722222222,0.012675610786670066,0.037943201032654805,0.07638888888888888,1.6580180914979784e-07,0.06608927168136436,0.05859375
199,0.1,10,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? 

Answer: Grandmultiparous women had increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage. This suggests that grandmultiparity is an independent risk factor for adverse perinatal outcomes. Further research is needed to understand the underlying mechanisms and develop effective interventions. 
","Is grandmultiparity an independent factor increasing the risk of adverse perinatal outcomes? Grandmultiparous women show increased maternal and neonatal morbidity, including preterm birth, low birth weight, and postpartum hemorrhage, indicating grandmultiparity itself is a risk factor. Additional research is necessary to explore the mechanisms and improve interventions.",1.8948778188548325e-07,0.006309943284080077,0.109375,0.014507411718254981,0.032846936883698774,0.0933159722222222,0.014486412327622933,0.06041605688471252,0.07638888888888888,1.8948778188548325e-07,0.08907878990606388,0.05859375
200,0.1,1,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Is the estimation of basal metabolic rate in Chinese populations accurate using current prediction equations? Answer: So far, the newly developed Singapore equation stands as the most precise BMR prediction formula for Chinese individuals and is suitable for use.",1.184298636784265e-07,0.13720112151348252,0.0,0.009067132323909377,0.14107859825990632,0.0,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
200,0.1,2,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Can current prediction equations accurately estimate basal metabolic rate in Chinese people? Answer: Up to now, the Singapore equation, recently developed, is the most accurate BMR prediction method for Chinese and is applicable.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
200,0.1,3,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Are existing prediction equations valid for estimating basal metabolic rate in Chinese populations? Answer: Currently, the newly formulated Singapore equation is the most reliable BMR prediction equation for Chinese and can be applied effectively.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
200,0.1,4,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: How accurate are current basal metabolic rate prediction equations for Chinese individuals? Answer: To date, the Singapore equation, newly created, provides the most accurate BMR estimates for Chinese and is applicable.",7.10579182070559e-08,0.1370924930703663,0.0322222222222222,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
200,0.1,5,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for",Question: Is the basal metabolic rate estimation in Chinese populations reliable with current equations? Answer: The newly developed Singapore equation is presently the most accurate BMR prediction equation for Chinese and is suitable for application.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
200,0.1,6,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Do current prediction equations apply well to basal metabolic rate estimation in Chinese? Answer: So far, the Singapore equation is the most precise BMR prediction formula developed for Chinese and is applicable.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
200,0.1,7,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Are the current basal metabolic rate prediction equations suitable for Chinese populations? Answer: Up to now, the newly developed Singapore equation is the most accurate for predicting BMR in Chinese and is applicable.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
200,0.1,8,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Can the existing equations accurately predict basal metabolic rate in Chinese individuals? Answer: Currently, the Singapore equation is the most accurate BMR prediction equation developed for Chinese and is applicable.",9.47438909427412e-08,0.125163142954007,0.0,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
200,0.1,9,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Is the estimation of basal metabolic rate in Chinese accurate using current prediction formulas? Answer: To date, the newly developed Singapore equation is the most precise BMR prediction equation for Chinese and is applicable.",0.0,0.04077336356234973,0.029384756657483937,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
200,0.1,10,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Are the current BMR prediction equations effective for Chinese populations? Answer: So far, the Singapore equation, newly developed, is the most accurate for predicting basal metabolic rate in Chinese and is applicable.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
201,0.1,1,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it essential to routinely place a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? A routinely placed ENBD tube did not enhance the clinical outcome, even though patients experienced longer procedure times and more discomfort, making the insertion unnecessary.",7.105791820705622e-08,0.05942342047080107,0.0,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
201,0.1,2,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted following endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine insertion of an ENBD tube did not improve clinical progression and caused increased procedure duration and patient discomfort, thus it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.1,3,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine insertion of a nasobiliary drainage tube required after endoscopic removal of stones from the common bile duct in patients with cholangitis due to choledocholithiasis? The routine use of an ENBD tube did not benefit the clinical course and led to longer procedures and more discomfort, so it is not needed.",2.3685972735685406e-08,0.019418085857102696,0.0,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
201,0.1,4,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it necessary to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients suffering from choledocholithiasis-related cholangitis? Routine ENBD tube placement did not improve clinical outcomes and resulted in longer procedure times and increased patient discomfort, making it unnecessary.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
201,0.1,5,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Does routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct improve outcomes in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube insertion did not enhance the clinical course and caused longer procedures and more discomfort, so it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.1,6,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is the routine placement of a nasobiliary drainage tube after endoscopic clearance of the common bile duct necessary in patients with cholangitis caused by choledocholithiasis? Routine ENBD tube insertion did not improve clinical outcomes and increased procedure time and discomfort, thus it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.1,7,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it required to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube placement did not improve the clinical course and caused longer procedures and more discomfort, so it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.1,8,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely placed after endoscopic clearance of the common bile duct in patients with choledocholithiasis-related cholangitis? Routine insertion of an ENBD tube did not improve clinical outcomes and led to increased procedure time and discomfort, making it unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,0.1,9,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion necessary after endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis? Routine ENBD tube placement did not improve the clinical course and resulted in longer procedures and more discomfort, so it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,0.1,10,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it advisable to routinely insert a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Routine ENBD tube insertion did not improve clinical outcomes and caused increased procedure time and patient discomfort, thus it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
202,0.1,1,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are Pap smears with glandular cell abnormalities identified through rapid prescreening? Yes, rapid prescreening (RPS) frequently flags Pap smears with glandular cell abnormalities as abnormal, achieving a sensitivity of 36.4% at the AGC threshold. Notably, RPS detects some cases of AGC on Pap smears.",1.8948778188548325e-07,0.1856515563663388,0.026093240264126724,0.014507411718254981,0.22320375986995566,0.03442727998906507,0.014486412327622933,0.22310096086017284,0.03197226405701179,1.8948778188548325e-07,0.2227551423266183,0.02903759362667705
202,0.1,2,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Pap smears showing glandular cell abnormalities are often marked abnormal by RPS, with a sensitivity of 36.4% at the AGC threshold. Importantly, RPS identifies certain AGC cases on Pap smears.",2.6054570009253947e-07,0.16608991726708844,0.09049767239709064,0.0199476911126006,0.20082970689079183,0.03413227679763848,0.019918816950481533,0.19765069507322464,0.040742417383431435,2.6054570009253947e-07,0.23140196574033478,0.020823902218198284
202,0.1,3,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Is rapid prescreening effective in detecting glandular cell abnormalities in Pap smears? Pap smears with glandular cell abnormalities are commonly flagged as abnormal by RPS, resulting in a sensitivity rate of 36.4% at the AGC threshold. Crucially, some AGC cases are detected by RPS on Pap smears.",1.1842986367842703e-07,0.01728692471071369,0.09697073848989986,0.009067132323909363,0.0529893953488525,0.037544801694046545,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
202,0.1,4,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Can rapid prescreening detect glandular cell abnormalities in Pap smears? Yes, Pap smears with glandular cell abnormalities are often detected as abnormal by RPS, showing a sensitivity of 36.4% at the AGC threshold. Significantly, RPS identifies some AGC cases on Pap smears.",2.3685972735685406e-07,0.13970670179730238,0.09170696574360965,0.018134264647818726,0.17462324867501255,0.03477198205059751,0.018108015409528666,0.17167520866996666,0.040742417383431435,2.3685972735685406e-07,0.2047337186581739,0.020823902218198284
202,0.1,5,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Pap smears with these abnormalities are frequently flagged as abnormal by RPS, with a sensitivity of 36.4% at the AGC threshold. Importantly, RPS detects some AGC cases on Pap smears.",2.6054570009253947e-07,0.13143255823909072,0.11537560479686407,0.0199476911126006,0.1652836976313079,0.05975554549569943,0.019918816950481533,0.19765069507322464,0.040742417383431435,2.6054570009253947e-07,0.23140196574033478,0.020823902218198284
202,0.1,6,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Does rapid prescreening identify glandular cell abnormalities in Pap smears? Pap smears exhibiting glandular cell abnormalities are often marked abnormal by RPS, achieving a sensitivity of 36.4% at the AGC threshold. Notably, some AGC cases are detected by RPS on Pap smears.",2.3685972735685406e-07,0.13970670179730238,0.09170696574360965,0.018134264647818726,0.17462324867501255,0.03477198205059751,0.018108015409528666,0.17167520866996666,0.040742417383431435,2.3685972735685406e-07,0.2047337186581739,0.020823902218198284
202,0.1,7,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Is the detection of glandular cell abnormalities in Pap smears possible through rapid prescreening? Yes, RPS often flags Pap smears with glandular cell abnormalities as abnormal, with a sensitivity of 36.4% at the AGC threshold. Crucially, some AGC cases are detected on Pap smears by RPS.",1.4211583641411244e-07,0.11384606551569076,0.0035358487892592494,0.010880558788691236,0.0761623998681431,0.03704056442485032,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
202,0.1,8,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Are Pap smears with glandular cell abnormalities detected by rapid prescreening? These smears are often identified as abnormal by RPS, resulting in a sensitivity of 36.4% at the AGC threshold. Importantly, RPS detects some cases of AGC on Pap smears.",2.8423167282822477e-07,0.12209300719538607,0.14035916824196598,0.02176111757738247,0.19125918403456588,0.05975554549569943,0.0217296184914344,0.2243189421553855,0.040742417383431435,2.8423167282822487e-07,0.2588009399284501,0.020823902218198284
202,0.1,9,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Can Pap smears with glandular cell abnormalities be detected by rapid prescreening? Yes, RPS frequently flags these smears as abnormal, with a sensitivity of 36.4% at the AGC threshold. Significantly, some AGC cases are detected on Pap smears by RPS.",2.8423167282822477e-07,0.15763901645487,0.11473589954390503,0.02176111757738247,0.19125918403456588,0.05975554549569943,0.0217296184914344,0.2243189421553855,0.040742417383431435,2.8423167282822487e-07,0.2588009399284501,0.020823902218198284
202,0.1,10,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Do Pap smears with glandular cell abnormalities get detected by rapid prescreening? They are often flagged as abnormal by RPS, achieving a sensitivity of 36.4% at the AGC threshold. Most importantly, some AGC cases are detected on Pap smears by RPS.",2.6054570009253947e-07,0.13143255823909072,0.11537560479686407,0.0199476911126006,0.1652836976313079,0.05975554549569943,0.019918816950481533,0.19765069507322464,0.040742417383431435,2.6054570009253947e-07,0.23140196574033478,0.020823902218198284
203,0.1,1,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Does initiating migraine treatment early decrease the time to headache peak and lessen its intensity? Early intervention with triptans can shorten the time to headache peak and reduce severity. Triptans are migraine-specific medications, and early use can enhance results. Consult your healthcare provider for tailored advice and treatment plans.",2.3685972735685406e-07,0.1902379007600219,0.0006872417843004769,0.018134264647818726,0.18928139642391661,0.0025383543319434376,0.018108015409528666,0.18809977026394353,0.006105971243051567,2.3685972735685406e-07,0.1866677221175057,0.010015608949024125
203,0.1,2,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Can early migraine treatment reduce the duration until headache peak and diminish its severity? Starting treatment early, especially with triptans, may lead to a quicker headache peak and milder symptoms. Triptans target migraines specifically, and early administration improves outcomes. Seek medical advice for personalized treatment.",3.316036182995957e-07,0.19585699518390065,0.05671953199425725,0.025387970506946217,0.1924857873686725,0.06366565363818116,0.025351221573340132,0.18866104665750338,0.07100591715976332,3.316036182995957e-07,0.218145062467078,0.05436390532544381
203,0.1,3,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Is early treatment of migraines effective in shortening the time to headache peak and lowering its severity? Using triptans early can decrease the time to peak headache and reduce its intensity. Triptans are designed for migraines, and early use can improve results. Consult your doctor for individualized guidance.",2.6054570009253947e-07,0.1258768967505568,0.05960187011469061,0.0199476911126006,0.1229419367635547,0.0651798889619403,0.019918816950481533,0.11966817517055173,0.07100591715976332,2.6054570009253947e-07,0.14752749525312403,0.05436390532544381
203,0.1,4,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Does treating migraines early help shorten the time to headache peak and reduce severity? Early use of triptans may lead to a faster headache peak and less severe pain. Triptans are migraine-specific drugs, and early treatment can improve outcomes. Talk to your physician for personalized recommendations.",3.079176455639103e-07,0.1719838419973776,0.05772270954074006,0.023574544042164344,0.16876355542245136,0.06419330295281958,0.023540420032387266,0.16513054924730897,0.07100591715976332,3.079176455639103e-07,0.19404751088801797,0.05436390532544381
203,0.1,5,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Will early migraine treatment shorten the time to headache peak and lessen its severity? Early administration of triptans can reduce the time to headache peak and its severity. Triptans are medications made for migraines, and starting them early can enhance effectiveness. Consult your healthcare provider for personalized advice.",2.6054570009253947e-07,0.21436377086459224,0.002804277529552285,0.0199476911126006,0.2133524385757215,0.0007404835701539381,0.019918816950481533,0.21208779924521082,0.004679386547518427,2.6054570009253947e-07,0.21054087530402876,0.009012431402541314
203,0.1,6,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Does early intervention in migraine treatment reduce the time to headache peak and its severity? Early use of triptans may shorten the time to headache peak and decrease severity. Triptans are specifically for migraines, and early treatment can improve results. Seek your doctor's advice for tailored treatment.",2.8423167282822487e-07,0.2390760222491073,0.005008113654523791,0.02176111757738247,0.23801017497781984,0.0011345476241599595,0.0217296184914344,0.23666110109896632,0.0031891414310303845,2.8423167282822487e-07,0.23499582097177196,0.007962953511047602
203,0.1,7,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Can early migraine treatment shorten the time until headache peak and reduce its severity? Early use of triptans might lead to a quicker headache peak and less severe symptoms. Triptans are migraine-specific medications, and early initiation can improve outcomes. Consult your doctor for personalized treatment options.",3.079176455639103e-07,0.1719838419973776,0.05772270954074006,0.023574544042164344,0.16876355542245136,0.06419330295281958,0.023540420032387266,0.16513054924730897,0.07100591715976332,3.079176455639103e-07,0.19404751088801797,0.05436390532544381
203,0.1,8,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Is early treatment of migraines beneficial in reducing the time to headache peak and its severity? Starting triptans early can shorten the time to headache peak and lessen severity. Triptans are designed for migraines, and early use improves results. Talk to your healthcare provider for individualized advice.",2.8423167282822487e-07,0.2390760222491073,0.005008113654523791,0.02176111757738247,0.23801017497781984,0.0011345476241599733,0.0217296184914344,0.23666110109896632,0.0031891414310303845,2.8423167282822487e-07,0.23499582097177196,0.007962953511047602
203,0.1,9,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Does early use of migraine medication shorten the time to headache peak and reduce severity? Early treatment with triptans may lead to a faster headache peak and milder symptoms. Triptans are migraine-specific drugs, and early administration can improve outcomes. Consult your doctor for personalized guidance.",3.316036182995957e-07,0.19585699518390065,0.05671953199425725,0.025387970506946217,0.1924857873686725,0.06366565363818116,0.025351221573340132,0.18866104665750338,0.07100591715976332,3.316036182995957e-07,0.218145062467078,0.05436390532544381
203,0.1,10,ai,"Question: Does early migraine treatment shorten time to headache peak and reduce its severity? 
Answer: Early treatment and use of triptans may lead to shorter time to headache peak and reduce its severity. Triptans are a class of medication specifically designed for migraines, and starting them early can improve outcomes. Consult your doctor for personalized advice and treatment options. 
","Will early migraine treatment with triptans reduce the time to headache peak and its severity? Early use of triptans can shorten the time to headache peak and decrease severity. Triptans are designed specifically for migraines, and early treatment improves results. Seek medical advice for personalized options.",3.079176455639103e-07,0.2644034660720367,0.007303994082840257,0.023574544042164344,0.2632836254988078,0.0030917159763313024,0.023540420032387266,0.261848760488232,0.0016309171597633232,3.079176455639103e-07,0.260061528084202,0.0068639053254437934
204,0.1,1,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Does cup-cage reconstruction using oversized cups offer initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Most research indicates that it does, as the larger cup size increases the surface area for bone-implant contact, resulting in more secure fixation.",4.974054274493935e-07,0.19473303938398212,0.15763168012302964,0.038081955760419325,0.24594366794313682,0.13017751479289943,0.0380268323600102,0.29897219660781804,0.10039159843360625,4.974054274493935e-07,0.3539185902387523,0.06858710562414265
204,0.1,2,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction with oversized cups? The majority of studies confirm this, attributing it to the enhanced bone-implant interface provided by the oversized cups.",6.632072365991906e-07,0.38710493203143814,0.15763168012302964,0.050775941013892455,0.4437694112730548,0.13017751479289943,0.05070244314668029,0.5025711518490579,0.10039159843360625,6.632072365991914e-07,0.5636391212208229,0.06858710562414265
204,0.1,3,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Can cup-cage reconstruction with oversized cups ensure initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Evidence from most studies suggests yes, due to the increased contact area between bone and implant.",6.868932093348759e-07,0.41787659069819183,0.15763168012302964,0.052589367478674334,0.47551810958763463,0.13017751479289943,0.052513244687633166,0.5353609746720496,0.10039159843360625,6.868932093348768e-07,0.5975406728965047,0.06858710562414265
204,0.1,4,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Does using oversized cups in cup-cage reconstruction provide initial stability during THA for osteoporotic acetabular fractures? Most studies support this, highlighting the larger surface area that improves fixation strength.",7.816371002776171e-07,0.5514079833227141,0.15763168012302964,0.05984307333780185,0.6136684480684518,0.13017751479289943,0.05975645085144466,0.678461818312722,0.10039159843360625,7.816371002776184e-07,0.7459606780147778,0.06858710562414265
204,0.1,5,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Is initial stability in THA for osteoporotic acetabular fractures achieved by cup-cage reconstruction with oversized cups? Research largely agrees, noting that the oversized cups increase bone-implant contact and secure fixation.",7.579511275419318e-07,0.5163166635114451,0.15763168012302964,0.05802964687301997,0.5773008038975771,0.13017751479289943,0.05794564931049179,0.640721490329875,0.10039159843360625,7.57951127541933e-07,0.7067399648614954,0.06858710562414265
204,0.1,6,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Does cup-cage reconstruction with oversized cups contribute to initial stability in total hip arthroplasty for osteoporotic acetabular fractures? The consensus in studies is affirmative, as the increased surface area enhances bone-implant integration.",7.105791820705612e-07,0.44962528901277166,0.15763168012302964,0.054402793943456214,0.5083079324106263,0.13017751479289943,0.05432404622858604,0.5692625263477313,0.10039159843360625,7.105791820705622e-07,0.6326319927077737,0.06858710562414265
204,0.1,7,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Can initial stability be provided by cup-cage reconstruction using oversized cups in THA for osteoporotic acetabular fractures? Most studies affirm this, citing the greater bone-implant contact area as the reason.",7.579511275419318e-07,0.5163166635114451,0.15763168012302964,0.05802964687301997,0.5773008038975771,0.13017751479289943,0.05794564931049179,0.640721490329875,0.10039159843360625,7.57951127541933e-07,0.7067399648614954,0.06858710562414265
204,0.1,8,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Is initial stability in THA for osteoporotic acetabular fractures facilitated by cup-cage reconstruction with oversized cups? The majority of research supports this, due to the improved fixation from the larger cup surface area.",6.868932093348759e-07,0.41787659069819183,0.15763168012302964,0.052589367478674334,0.47551810958763463,0.13017751479289943,0.052513244687633166,0.5353609746720496,0.10039159843360625,6.868932093348768e-07,0.5975406728965047,0.06858710562414265
204,0.1,9,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Does the use of oversized cups in cup-cage reconstruction ensure initial stability in total hip arthroplasty for osteoporotic acetabular fractures? Studies generally agree, attributing this to the increased bone-implant contact surface.",7.342651548062465e-07,0.48241511183576335,0.15763168012302964,0.05621622040823809,0.5422094840863081,0.13017751479289943,0.05613484776953891,0.6043538461590003,0.10039159843360625,7.342651548062476e-07,0.6689996368786484,0.06858710562414265
204,0.1,10,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? 
Answer: The majority of studies have shown that cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic acetabular fractures. This is likely due to the increased surface area of the oversized cup, which allows for greater bone-implant contact and a more secure fixation. 
","Is initial stability in THA for osteoporotic acetabular fractures achieved through cup-cage reconstruction with oversized cups? Most studies indicate yes, as the oversized cups provide a larger surface area for secure fixation.",7.105791820705612e-07,0.44962528901277166,0.15763168012302964,0.054402793943456214,0.5083079324106263,0.13017751479289943,0.05432404622858604,0.5692625263477313,0.10039159843360625,7.105791820705622e-07,0.6326319927077737,0.06858710562414265
205,0.1,1,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is imaging necessary to diagnose appendicitis in children? Clinical evaluation remains the primary method for diagnosis. However, ultrasound can be useful in girls over 10 and boys over 12 to exclude other causes of abdominal pain.",9.47438909427412e-08,0.03712156612126272,0.05113221329437545,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
205,0.1,2,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Do we require imaging to identify appendicitis in pediatric patients? The diagnosis mainly relies on clinical assessment, but ultrasound may assist in ruling out other abdominal pain causes in girls older than 10 and boys older than 12.",4.73719454713706e-08,0.019019130131852968,0.024126040454869283,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
205,0.1,3,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is imaging essential for diagnosing appendicitis in children? Diagnosis is primarily clinical, yet ultrasound can aid in excluding other abdominal pain sources in girls above 10 and boys above 12.",2.36859727356853e-07,0.22517379762420298,0.05113221329437545,0.018134264647818775,0.3053816495511823,0.0,0.01810801540952872,0.3150810466398961,0.0,2.3685972735685406e-07,0.3254224004346278,0.0
205,0.1,4,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Should imaging be used to diagnose appendicitis in children? Clinical examination is crucial for diagnosis, but ultrasound can help rule out alternative causes of abdominal pain in girls older than 10 and boys older than 12.",9.47438909427412e-08,0.07672997643897395,0.022585500491607288,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
205,0.1,5,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is it necessary to use imaging to diagnose appendicitis in children? Clinical assessment is fundamental, although ultrasound can be beneficial in girls over 10 and boys over 12 to exclude other causes of abdominal pain.",1.184298636784265e-07,0.06610910299451422,0.05113221329437545,0.009067132323909377,0.14107859825990632,0.0,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
205,0.1,6,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Do children with suspected appendicitis need imaging for diagnosis? Diagnosis depends mainly on clinical evaluation, but ultrasound can help exclude other abdominal pain causes in girls older than 10 and boys older than 12.",1.421158364141118e-07,0.13797098617813175,0.02085877579437545,0.010880558788691257,0.17185025692666,0.0,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
205,0.1,7,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is imaging required to diagnose appendicitis in children? The key to diagnosis is clinical assessment, but ultrasound may assist in ruling out other causes of abdominal pain in girls above 10 and boys above 12.",1.184298636784265e-07,0.06610910299451422,0.05113221329437545,0.009067132323909377,0.14107859825990632,0.0,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
205,0.1,8,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is imaging needed to diagnose appendicitis in pediatric patients? Clinical assessment is the cornerstone of diagnosis, though ultrasound can help exclude other causes of abdominal pain in girls older than 10 and boys older than 12.",9.47438909427412e-08,0.07672997643897395,0.022585500491607288,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
205,0.1,9,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Do we have to use imaging to diagnose appendicitis in children? Diagnosis relies on clinical assessment, but ultrasound can be useful in girls over 10 and boys over 12 to rule out other abdominal pain causes.",9.47438909427412e-08,0.03712156612126272,0.05113221329437545,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
205,0.1,10,ai,"Question: Do we need imaging to diagnose appendicitis in children? 
Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 and boys older than 12,  ultrasound can help  rule out other causes of abdominal pain. 
","Is imaging necessary for diagnosing appendicitis in children? Clinical evaluation is key, but ultrasound can aid in excluding other causes of abdominal pain in girls older than 10 and boys older than 12.",1.658018091497971e-07,0.17005542359594727,0.019914731504573152,0.012693985253473136,0.20359895524123983,0.0,0.012675610786670101,0.20972053098207066,0.0,1.6580180914979784e-07,0.2162231084696371,0.0
206,0.1,1,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Does cognitive ability forecast how well listeners with normal hearing and cognition recognize frequency compressed speech?,9.474389094274139e-07,1.0976401679673673,0.14124038026256222,0.07253705859127504,1.1958940101579167,0.109375,0.07243206163811482,1.3007165665721017,0.07496876301541024,9.474389094274158e-07,1.386358547959587,0.057476051645147866
206,0.1,2,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Is there a predictive relationship between cognitive function and recognition of frequency compressed speech in individuals with normal hearing and cognition?,8.290090457489871e-07,0.8099580955155874,0.14124038026256222,0.06346992626736565,0.8905123606067349,0.109375,0.06337805393335044,0.9752941661374739,0.07496876301541024,8.29009045748989e-07,1.0380518536913717,0.057476051645147866
206,0.1,3,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Can cognitive function determine the recognition accuracy of frequency compressed speech in listeners who have normal hearing and cognition?,8.763809912203579e-07,0.9153186111734128,0.14124038026256222,0.06709677919692941,1.001737995716959,0.109375,0.06699965701525619,1.0930772017938577,0.07496876301541024,8.763809912203597e-07,1.1632149966453773,0.057476051645147866
206,0.1,4,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Does cognitive performance influence the recognition of frequency compressed speech among those with normal hearing and cognitive abilities?,9.000669639560432e-07,0.9724770250133616,0.14124038026256222,0.06891020566171129,1.062362617533394,0.109375,0.06881045855620907,1.1576157229314283,0.07496876301541024,9.00066963956045e-07,1.2322078681323294,0.057476051645147866
206,0.1,5,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Is the recognition of frequency compressed speech in normal hearing and cognitively normal listeners predicted by their cognitive function?,8.763809912203579e-07,0.9153186111734128,0.14124038026256222,0.06709677919692941,1.001737995716959,0.109375,0.06699965701525619,1.0930772017938577,0.07496876301541024,8.763809912203597e-07,1.1632149966453773,0.057476051645147866
206,0.1,6,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Does cognitive functioning serve as a predictor for frequency compressed speech recognition in listeners with normal hearing and normal cognition?,8.526950184846725e-07,0.8612513899031375,0.14124038026256222,0.06528335273214753,0.9445795818770102,0.109375,0.06518885547430332,1.0324525799774227,0.07496876301541024,8.526950184846744e-07,1.0986764755078067,0.057476051645147866
206,0.1,7,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Is there a correlation between cognitive function and the ability to recognize frequency compressed speech in individuals with normal hearing and cognition?,8.053230730133018e-07,0.7611679313461561,0.14124038026256222,0.061656499802583774,0.8392190662191847,0.109375,0.061567252392397576,0.9212269448671986,0.07496876301541024,8.053230730133036e-07,0.9808934398514229,0.057476051645147866
206,0.1,8,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Can the recognition of frequency compressed speech in listeners with normal hearing and cognition be predicted by their cognitive abilities?,8.526950184846725e-07,0.8612513899031375,0.14124038026256222,0.06528335273214753,0.9445795818770102,0.109375,0.06518885547430332,1.0324525799774227,0.07496876301541024,8.526950184846744e-07,1.0986764755078067,0.057476051645147866
206,0.1,9,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Does cognitive function have an impact on how well listeners with normal hearing and cognition recognize frequency compressed speech?,8.763809912203579e-07,0.9153186111734128,0.14124038026256222,0.06709677919692941,1.001737995716959,0.109375,0.06699965701525619,1.0930772017938577,0.07496876301541024,8.763809912203597e-07,1.1632149966453773,0.057476051645147866
206,0.1,10,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? 

Answer: The relationship between cognitive functioning and recognition of frequency compressed speech in listeners with normal hearing and normal cognition remains unclear. While previous studies have suggested a potential link, more research is needed to establish a definitive connection. 
",Is cognitive function linked to the recognition of frequency compressed speech in listeners who have normal hearing and normal cognition?,8.526950184846725e-07,0.8612513899031375,0.14124038026256222,0.06528335273214753,0.9445795818770102,0.109375,0.06518885547430332,1.0324525799774227,0.07496876301541024,8.526950184846744e-07,1.0986764755078067,0.057476051645147866
207,0.1,1,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Bone turnover markers showed a significant yet modest correlation with bone turnover parameters assessed in iliac cancellous bone. The iliac crest bone might not be representative.,2.36859727356853e-08,0.029134819215083763,0.0035657596371881373,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
207,0.1,2,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do biochemical markers of bone turnover reflect bone histomorphometry in 370 postmenopausal women? There was a significant but modest association between bone turnover markers and bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not fully represent this.,7.1057918207056e-08,0.11881362161458986,0.03557595030122497,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
207,0.1,3,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"In 370 postmenopausal women, are biochemical markers of bone turnover representative of bone histomorphometry? Bone turnover markers were significantly, though modestly, linked to bone turnover parameters in iliac cancellous bone. The iliac crest bone might not be entirely representative.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.1,4,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover reliable indicators of bone histomorphometry in 370 postmenopausal women? Bone turnover markers had a significant but modest relationship with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not be fully representative.,7.1057918207056e-08,0.08500156402629955,0.010163943693821037,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
207,0.1,5,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Can biochemical markers of bone turnover represent bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly yet modestly associated with bone turnover parameters in iliac cancellous bone. The iliac crest bone might not be representative.,4.73719454713706e-08,0.02240426566478826,0.021323352870560003,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
207,0.1,6,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? There was a significant but modest association between bone turnover markers and bone turnover parameters in iliac cancellous bone. The iliac crest bone may not be representative.,4.73719454713706e-08,0.05745399337060908,0.006949210655774363,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
207,0.1,7,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"In 370 postmenopausal women, do biochemical markers of bone turnover correspond to bone histomorphometry? Bone turnover markers showed a significant yet modest association with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone might not be representative.",2.36859727356853e-08,0.06468082847456813,0.030323936733203147,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
207,0.1,8,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover indicative of bone histomorphometry parameters in 370 postmenopausal women? Bone turnover markers were significantly but modestly correlated with bone turnover parameters in iliac cancellous bone. The iliac crest bone may not be representative.,0.0,0.03648143055578679,0.02711955370383451,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,0.1,9,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do biochemical markers of bone turnover correspond to bone histomorphometry in 370 postmenopausal women? Bone turnover markers had a significant but modest association with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone might not be representative.,2.36859727356853e-08,0.06468082847456813,0.030323936733203147,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
207,0.1,10,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are biochemical markers of bone turnover associated with bone histomorphometry in 370 postmenopausal women? Bone turnover markers were significantly yet modestly linked to bone turnover parameters in iliac cancellous bone. The iliac crest bone may not be representative.,2.36859727356853e-08,0.007469060524830873,0.02448979591836732,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
208,0.1,1,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","In patients with coronary disease, profound hypotensive episodes, especially low diastolic pressure, can lead to both symptomatic and silent myocardial ischemic events, indicating a temporal causal relationship.",5.921493183921337e-07,0.554740357678448,0.12041647804436403,0.045335661619546885,0.6376954061151499,0.039930555555555566,0.04527003852382174,0.7137664677626816,0.0,5.921493183921352e-07,0.7357067949787415,0.0
208,0.1,2,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Hypotension in individuals with ischemic heart disease is linked to the occurrence of both symptomatic and silent ischemia, particularly when diastolic blood pressure drops significantly, suggesting susceptibility to ischemic events.",5.210914001850778e-07,0.4455410657134573,0.12041647804436403,0.03989538222520125,0.5243667208081457,0.039930555555555566,0.03983763390096312,0.5959834321062973,0.0,5.210914001850789e-07,0.6131044728864086,0.0
208,0.1,3,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Patients suffering from coronary artery disease may experience myocardial ischemia, both symptomatic and silent, in close temporal association with episodes of hypotension, notably low diastolic pressure.",6.15835291127819e-07,0.5939610708317304,0.12041647804436403,0.047149088084328765,0.6785174006354047,0.039930555555555566,0.047080840064774615,0.7563260821814772,0.0,6.158352911278206e-07,0.7801585575495755,0.0
208,0.1,4,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","There is evidence that profound hypotensive events, especially reductions in diastolic pressure, can trigger myocardial ischemic episodes in patients with ischemic heart disease, indicating a causal temporal link.",5.684633456564484e-07,0.517000029695601,0.12041647804436403,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6729444732424268,0.0,5.684633456564497e-07,0.6931471805599458,0.0
208,0.1,5,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","In coronary disease patients, symptomatic and silent ischemic events have been observed to occur in temporal relation to hypotension, particularly when diastolic pressure is low, implying vulnerability to ischemia.",5.447773729207631e-07,0.4806323855247263,0.12041647804436403,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6337237600891443,0.0,5.447773729207643e-07,0.652325186039691,0.0
208,0.1,6,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Myocardial ischemia, both symptomatic and silent, can be temporally associated with hypotensive episodes in patients with ischemic heart disease, especially when diastolic blood pressure is profoundly reduced.",5.921493183921337e-07,0.554740357678448,0.12041647804436403,0.045335661619546885,0.6376954061151499,0.039930555555555566,0.04527003852382174,0.7137664677626816,0.0,5.921493183921352e-07,0.7357067949787415,0.0
208,0.1,7,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Patients with coronary disease may be prone to ischemic myocardial events triggered by significant hypotension, with a notable temporal connection to low diastolic pressures.",6.632072365991896e-07,0.6773426797707809,0.12041647804436403,0.050775941013892524,0.7655287776250344,0.039930555555555566,0.05070244314668036,0.8472978603872052,0.0,6.632072365991914e-07,0.8754687373539007,0.0
208,0.1,8,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Symptomatic and silent myocardial ischemia in ischemic heart disease patients can occur in close temporal proximity to hypotensive episodes, particularly those involving low diastolic pressure, suggesting a causal relationship.",5.447773729207631e-07,0.4806323855247263,0.12041647804436403,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6337237600891443,0.0,5.447773729207643e-07,0.652325186039691,0.0
208,0.1,9,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Profound hypotension, especially decreased diastolic pressure, can cause myocardial ischemic events in patients with coronary disease, as evidenced by the temporal association of ischemia with hypotensive episodes.",5.921493183921337e-07,0.554740357678448,0.12041647804436403,0.045335661619546885,0.6376954061151499,0.039930555555555566,0.04527003852382174,0.7137664677626816,0.0,5.921493183921352e-07,0.7357067949787415,0.0
208,0.1,10,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","In patients with ischemic heart disease, episodes of significant hypotension, notably low diastolic pressure, are temporally linked to the occurrence of both symptomatic and silent myocardial ischemia, indicating susceptibility to ischemic events.",4.7371945471370717e-07,0.37884969121478385,0.12041647804436403,0.03626852929563749,0.45537384932119496,0.039930555555555566,0.036216030819057374,0.5245244681241537,0.0,4.737194547137081e-07,0.5389965007326869,0.0
209,0.1,1,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive ability forecast the recognition of frequency compressed speech in individuals with normal hearing and cognition? The link between cognitive function and recognizing frequency compressed speech in noisy environments was not statistically significant. Results might have varied with different participants.,4.737194547137081e-08,0.11975523265533106,0.05071157946698568,0.0036268529295637453,0.12110243909363172,0.05113221329437545,0.003621603081905733,0.08777472494333605,0.026296566837107373,4.737194547137081e-08,0.05264373348541884,0.0
209,0.1,2,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is cognitive function a predictor of frequency compressed speech recognition in listeners with normal hearing and cognition? No significant statistical relationship was found between cognitive function and recognition of frequency compressed speech in noise. The outcomes could differ with other participant groups.,2.3685972735685406e-08,0.1263387733341279,0.07262538516457519,0.0018134264647818726,0.0940073306463658,0.049861495844875335,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
209,0.1,3,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Can cognitive function predict how well listeners with normal hearing and cognition recognize frequency compressed speech? The study found no statistically significant association between cognitive function and frequency compressed speech recognition in noise. Different participant samples might yield different results.,7.105791820705611e-08,0.11219298207460016,0.027336853389556895,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
209,0.1,4,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive functioning influence the recognition of frequency compressed speech in noise among normal hearing and cognitively normal listeners? The relationship was not statistically significant. Findings might change if the participant demographics were different.,2.1317375462116791e-07,0.20815504821879616,0.023795359904818555,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
209,0.1,5,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is there a predictive relationship between cognitive function and frequency compressed speech recognition in listeners with normal hearing and cognition? No significant statistical correlation was observed. The results might have been different with other participants.,1.8948778188548261e-07,0.17830208506911438,0.023795359904818555,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
209,0.1,6,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive function serve as a predictor for recognizing frequency compressed speech in noise in individuals with normal hearing and cognition? The study showed no statistically significant link. Different participant characteristics might have altered the findings.,1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
209,0.1,7,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Can cognitive function predict frequency compressed speech recognition in listeners who have normal hearing and cognition? The association was not statistically significant. The findings could differ if the participant group changed.,2.842316728282238e-07,0.30346522802312137,0.023795359904818555,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
209,0.1,8,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is cognitive function linked to frequency compressed speech recognition in noise among listeners with normal hearing and cognition? No statistically significant relationship was found. The results might vary with different participants.,2.842316728282238e-07,0.30346522802312137,0.023795359904818555,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
209,0.1,9,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive function predict the ability to recognize frequency compressed speech in noise for listeners with normal hearing and cognition? The relationship was not statistically significant. Different participant samples might have led to different findings.,1.8948778188548261e-07,0.17830208506911438,0.023795359904818555,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
209,0.1,10,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is there a significant relationship between cognitive function and frequency compressed speech recognition in listeners with normal hearing and cognition? The study found no statistical significance. The findings might differ with other participant groups.,2.1317375462116791e-07,0.20815504821879616,0.023795359904818555,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
210,0.1,1,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does increased neutrophil migratory activity following major trauma contribute to the development of acute respiratory distress syndrome? Answer: The findings suggest that major blunt trauma boosts the migratory ability of circulating neutrophils. This effect is evident within 2 hours of admission and may,2.3685972735685406e-08,0.023530497410194418,0.0,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
210,0.1,2,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Is heightened neutrophil migration after significant trauma a factor in causing acute respiratory distress syndrome? Answer: The data show that major blunt trauma increases the migratory potential of circulating neutrophils. This is observable within 2 hours of hospital admission and may,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
210,0.1,3,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could increased neutrophil migration post-major trauma play a role in the onset of acute respiratory distress syndrome? Answer: These results demonstrate that major blunt trauma enhances the migration capacity of circulating neutrophils. This occurs within 2 hours of admission and may,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
210,0.1,4,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does major trauma-induced neutrophil migratory activity contribute to acute respiratory distress syndrome? Answer: The evidence indicates that major blunt trauma elevates the migratory function of circulating neutrophils. This is apparent within 2 hours of admission and may,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
210,0.1,5,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Is the rise in neutrophil migration after major trauma a contributing factor to acute respiratory distress syndrome? Answer: Data indicate that major blunt trauma augments the migratory ability of circulating neutrophils. This is seen within 2 hours of admission and may,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
210,0.1,6,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could enhanced neutrophil migration following major trauma be involved in the etiology of acute respiratory distress syndrome? Answer: Findings reveal that major blunt trauma increases the migratory capacity of circulating neutrophils. This manifests within 2 hours of admission and may,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
210,0.1,7,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does increased neutrophil migratory activity after severe trauma influence the development of acute respiratory distress syndrome? Answer: The data suggest that major blunt trauma improves the migratory capacity of circulating neutrophils. This is evident within 2 hours of admission and may,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
210,0.1,8,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Is neutrophil migration elevated after major trauma, potentially contributing to acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory ability of circulating neutrophils. This is apparent within 2 hours of admission and may",7.105791820705611e-08,0.07410797215372344,0.0,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
210,0.1,9,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could the increased migratory activity of neutrophils after major trauma be a factor in acute respiratory distress syndrome? Answer: The findings indicate that major blunt trauma boosts the migratory capacity of circulating neutrophils. This is observed within 2 hours of admission and may,2.3685972735685406e-08,0.023530497410194418,0.0,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
210,0.1,10,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does the enhanced migration of neutrophils following major trauma play a role in acute respiratory distress syndrome? Answer: Data show that major blunt trauma increases the migratory function of circulating neutrophils. This is evident within 2 hours of admission and may,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
211,0.1,1,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","What is the impact of MPH programs on strengthening health systems in low- and middle-income countries? MPH programs have had a substantial effect across various levels. Graduates gained essential skills such as epidemiological analysis and program management, enabling them to play a key role in enhancing health systems, shaping policies, and advancing disease prevention in these regions.",7.105791820705622e-08,0.08261751549370011,0.019826576555107524,0.005440279394345618,0.08274897359565658,0.01922337562475971,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
211,0.1,2,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","How do MPH programs contribute to health system strengthening in low- and middle-income countries? The impact is significant at multiple levels. MPH graduates acquire vital skills including epidemiological analysis and program management, which empower them to support health system improvements, policy formulation, and disease prevention initiatives in these countries.",1.1842986367842703e-07,0.07565904040831928,0.016853914006330732,0.009067132323909363,0.0744366099267566,0.01922337562475971,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
211,0.1,3,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","What role do MPH programs play in health system strengthening in low- and middle-income countries? These programs have made a notable impact by equipping graduates with important skills like epidemiological analysis and program management, allowing them to effectively contribute to health system enhancement, policy development, and disease prevention efforts.",1.1842986367842703e-07,0.07565904040831928,0.016853914006330732,0.009067132323909363,0.0744366099267566,0.01922337562475971,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
211,0.1,4,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","In what ways do MPH programs impact health system strengthening in low- and middle-income countries? There is a considerable influence at various levels, as MPH graduates are trained in key skills such as epidemiological analysis and program management, enabling them to significantly aid health system strengthening, policy creation, and disease prevention.",7.105791820705622e-08,0.033681800587132216,0.017686146087086282,0.005440279394345618,0.03276391352618768,0.01922337562475971,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
211,0.1,5,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","How significant is the impact of MPH programs on health systems in low- and middle-income countries? MPH programs have a broad impact by providing graduates with critical skills like epidemiological analysis and program management, which help them contribute meaningfully to strengthening health systems, developing policies, and preventing diseases.",1.4211583641411244e-07,0.09732694178750023,0.016411275581806915,0.010880558788691236,0.09594281514771996,0.01922337562475971,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
211,0.1,6,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","What is the contribution of MPH programs to health system strengthening in low- and middle-income countries? The programs have a strong impact, equipping graduates with essential skills such as epidemiological analysis and program management, which allow them to play a vital role in health system improvement, policy development, and disease prevention.",7.105791820705622e-08,0.033681800587132216,0.017686146087086282,0.005440279394345618,0.03276391352618768,0.01922337562475971,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
211,0.1,7,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","How do MPH programs affect health system strengthening in low- and middle-income countries? They have a considerable impact by training graduates in crucial skills like epidemiological analysis and program management, enabling significant contributions to health system strengthening, policy formulation, and disease prevention.",2.8423167282822487e-07,0.23821890967686166,0.013302816224529015,0.02176111757738247,0.23570475752287834,0.01922337562475971,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
211,0.1,8,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","What impact do MPH programs have on health systems in low- and middle-income countries? MPH programs significantly influence multiple levels by providing graduates with important skills such as epidemiological analysis and program management, which help them contribute to health system strengthening, policy development, and disease prevention.",1.8948778188548325e-07,0.1421229703807798,0.015467072422876125,0.014507411718254981,0.14039457771855268,0.01922337562475971,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
211,0.1,9,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","How do MPH programs contribute to strengthening health systems in low- and middle-income countries? These programs have a meaningful impact by equipping graduates with key skills like epidemiological analysis and program management, allowing them to support health system improvements, policy creation, and disease prevention efforts.",2.1317375462116866e-07,0.13378928487461783,0.037677816224529016,0.016320838183036854,0.1633840959432522,0.01922337562475971,0.0162972138685758,0.19415601444095731,0.0,2.1317375462116866e-07,0.19845093872383757,0.0
211,0.1,10,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. MPH programs equipped graduates with crucial skills, like epidemiological analysis and program management, allowing them to contribute significantly to health system strengthening, policy development, and disease prevention efforts in these settings. 
","What is the effect of MPH programs on health system strengthening in low- and middle-income countries? MPH programs have a notable impact by preparing graduates with essential skills such as epidemiological analysis and program management, enabling them to contribute significantly to health system strengthening, policy development, and disease prevention.",1.1842986367842703e-07,0.10454017293165041,0.003910085476794244,0.009067132323909363,0.0744366099267566,0.01922337562475971,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
212,0.1,1,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a role for polymorphisms in the beta-adrenergic receptor (ADRB) genes in transient tachypnea of the newborn (TTN)? Answer: We conclude that homozygosity for beta1Gly49 and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may increase susceptibility to TTN.",1.1842986367842671e-07,0.0937446970410507,0.023795359904818555,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
212,0.1,2,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes contribute to transient tachypnea of the newborn (TTN)? Answer: Our findings suggest that beta1Gly49 homozygosity and the ADRB2 gene's TACC haplotype, both loss-of-function mutations, might predispose individuals to TTN.",2.36859727356853e-08,0.026668247082160867,0.0,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.1,3,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We conclude that the loss-of-function genetic variations beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene may increase the risk of TTN.,2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.1,4,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): Are polymorphisms in beta-adrenergic receptor (ADRB) genes implicated? Answer: It appears that beta1Gly49 homozygosity and the ADRB2 gene's TACC haplotype, both loss-of-function variants, could predispose to TTN.",9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
212,0.1,5,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there an association between transient tachypnea of the newborn (TTN) and polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We find that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function genetic changes, may contribute to TTN susceptibility.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,0.1,6,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) genes play a role in transient tachypnea of the newborn (TTN)? Answer: Our conclusion is that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, might predispose to TTN.",7.10579182070559e-08,0.04330418244171419,0.02498356344510192,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,0.1,7,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Transient tachypnea of the newborn (TTN): Is there a role for beta-adrenergic receptor (ADRB) gene polymorphisms? Answer: We conclude that loss-of-function variations such as beta1Gly49 homozygosity and the ADRB2 gene's TACC haplotype may increase the risk of TTN.,2.36859727356853e-08,0.026668247082160867,0.0,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.1,8,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Are polymorphisms in beta-adrenergic receptor (ADRB) genes involved in transient tachypnea of the newborn (TTN)? Answer: It is concluded that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function mutations, may predispose to TTN.",0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,0.1,9,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Does transient tachypnea of the newborn (TTN) have a genetic basis involving beta-adrenergic receptor (ADRB) polymorphisms? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, both loss-of-function variants, may increase susceptibility to TTN.",2.36859727356853e-08,0.009813183473625475,0.026296566837107373,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
212,0.1,10,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Transient tachypnea of the newborn (TTN): Are beta-adrenergic receptor (ADRB) gene polymorphisms a factor? Answer: Our conclusion is that beta1Gly49 homozygosity and the ADRB2 gene's TACC haplotype, both loss-of-function genetic variations, may predispose to TTN.",4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
213,0.1,1,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic features of child bipolar I disorder: can the 'Treatment of Early Age Mania (TEAM)' sample be generalized? Answer: The RCT sample's generalizability was supported since only 7.8% of Phenomenology participants did not meet RCT criteria. However, as RCT subjects exhibited more severe illness, it remains uncertain if RCT treatment results apply to children with milder mania.",1.6580180914979784e-07,0.02918841795512961,0.1451222789572694,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
213,0.1,2,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are the diagnostic characteristics of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: Generalization of the RCT sample was confirmed because only 7.8% of Phenomenology subjects failed to meet RCT criteria. Still, since RCT participants were more severely affected, it is unclear whether RCT treatment outcomes are relevant for children with less severe mania.",7.105791820705622e-08,0.03863417838363059,0.1451222789572694,0.005440279394345618,0.04879016416943571,0.0,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
213,0.1,3,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Does the 'Treatment of Early Age Mania (TEAM)' sample generalize regarding diagnostic traits of child bipolar I disorder? Answer: The RCT sample generalizes well, as only 7.8% of Phenomenology subjects did not fit RCT criteria. Nonetheless, due to greater severity in RCT subjects, applicability of RCT treatment findings to children with milder mania is uncertain.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
213,0.1,4,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic markers of child bipolar I disorder: is the 'Treatment of Early Age Mania (TEAM)' sample representative? Answer: The RCT sample was largely generalizable since only 7.8% of Phenomenology subjects were excluded by RCT criteria. However, because RCT subjects had more severe illness, it is unclear if RCT treatment results apply to less severely affected children.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.1,5,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Can the 'Treatment of Early Age Mania (TEAM)' sample be generalized for child bipolar I disorder diagnosis? Answer: Generalization is supported as only 7.8% of Phenomenology subjects did not meet RCT criteria. Yet, since RCT subjects were more severely ill, it is uncertain if RCT treatment findings are applicable to children with less severe mania.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
213,0.1,6,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are diagnostic characteristics of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: The RCT sample generalizes because only 7.8% of Phenomenology subjects failed to meet RCT criteria. However, given the greater severity in RCT subjects, it is unclear if treatment findings apply to children with milder mania.",2.3685972735685406e-07,0.08325563922540447,0.1451222789572694,0.018134264647818726,0.17284281283941416,0.0,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
213,0.1,7,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Does the 'Treatment of Early Age Mania (TEAM)' sample generalize for child bipolar I disorder diagnosis? Answer: Generalization of the RCT sample was supported since only 7.8% of Phenomenology subjects did not fit RCT criteria. Still, because RCT subjects were more severely ill, applicability of RCT treatment findings to children with less severe mania is uncertain.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,0.1,8,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Diagnostic features of child bipolar I disorder: is the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: The RCT sample generalizes well as only 7.8% of Phenomenology subjects did not meet RCT criteria. However, since RCT subjects were more severely ill, it is unclear if RCT treatment results apply to children with milder mania.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
213,0.1,9,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Are the diagnostic traits of child bipolar I disorder from the 'Treatment of Early Age Mania (TEAM)' sample generalizable? Answer: Generalization of the RCT sample was supported because only 7.8% of Phenomenology subjects did not meet RCT criteria. Nevertheless, due to greater severity in RCT subjects, it is uncertain if RCT treatment findings apply to children with less severe mania.",9.474389094274162e-08,0.02210487643241965,0.1451222789572694,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
213,0.1,10,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Question: Does the 'Treatment of Early Age Mania (TEAM)' sample generalize for child bipolar I disorder diagnostic characteristics? Answer: The RCT sample generalizes since only 7.8% of Phenomenology subjects failed to meet RCT criteria. However, because RCT subjects were more severely ill, it remains unclear if RCT treatment findings are applicable to children with less severe mania.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
214,0.1,1,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Is external palliative radiotherapy an effective treatment for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative approach for managing gallbladder carcinoma. It can help reduce pain, enhance quality of life, and control tumor growth, though it is not a cure.",1.1842986367842703e-07,0.11000089521432876,0.0,0.009067132323909363,0.11247798342669002,0.0,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
214,0.1,2,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Does external palliative radiotherapy work well for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative treatment for gallbladder carcinoma, helping to relieve pain, improve quality of life, and manage tumor progression, but it does not cure the disease.",1.8948778188548325e-07,0.21697891582195128,0.02498356344510192,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
214,0.1,3,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Is external radiotherapy effective as palliative care for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative option for gallbladder carcinoma, providing pain relief, better quality of life, and tumor control, though it is not curative.",2.3685972735685385e-07,0.30657771229307773,0.05246913580246914,0.018134264647818726,0.2392296890658323,0.0,0.018108015409528666,0.24512245803298427,0.0,2.3685972735685406e-07,0.2513144282809061,0.0
214,0.1,4,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Can external palliative radiotherapy effectively manage gallbladder carcinoma? External radiotherapy is a safe and effective palliative treatment for gallbladder carcinoma that helps alleviate pain, improve quality of life, and control tumor growth, but it is not a cure.",2.6054570009253915e-07,0.26028309826366547,0.0,0.0199476911126006,0.26662866325394763,0.0,0.019918816950481533,0.2732933349996811,0.0,2.6054570009253947e-07,0.2803019651541576,0.0
214,0.1,5,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Is external radiotherapy a beneficial palliative treatment for gallbladder carcinoma? External radiotherapy appears to be a safe and effective method for palliative care in gallbladder carcinoma, aiding in pain relief, quality of life improvement, and tumor control, without curing the disease.",1.8948778188548325e-07,0.21697891582195128,0.02498356344510192,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
214,0.1,6,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","How effective is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy is a safe and effective palliative treatment for gallbladder carcinoma, which can ease pain, enhance quality of life, and control tumor growth, though it does not cure the cancer.",2.1317375462116855e-07,0.24318537403773055,0.025623268698060954,0.016320838183036854,0.21256144198367144,0.0,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
214,0.1,7,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Does external radiotherapy provide effective palliative care for gallbladder carcinoma? External radiotherapy seems to be a safe and effective palliative approach for gallbladder carcinoma, helping to reduce pain, improve quality of life, and manage tumor growth, but it is not curative.",1.8948778188548325e-07,0.2862936338779458,0.07450693937180423,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
214,0.1,8,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Is external palliative radiotherapy a safe and effective option for gallbladder carcinoma? External radiotherapy is considered a safe and effective palliative treatment for gallbladder carcinoma, offering pain relief, improved quality of life, and tumor control, though it does not cure the disease.",1.6580180914979784e-07,0.29287717455674267,0.09642074506939374,0.012693985253473108,0.23058286565211583,0.049861495844875335,0.012675610786670066,0.20062575961893403,0.025623268698060954,1.6580180914979784e-07,0.16907633004393308,0.0
214,0.1,9,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Can external radiotherapy serve as an effective palliative treatment for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative method for gallbladder carcinoma, helping to alleviate pain, enhance quality of life, and control tumor growth, but it is not curative.",1.4211583641411244e-07,0.23255241841880192,0.07100591715976329,0.010880558788691236,0.13657553500575004,0.0,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
214,0.1,10,ai,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. This treatment can help to alleviate pain, improve quality of life, and control the growth of the tumor, but it is not curative.  
","Is external palliative radiotherapy effective in managing gallbladder carcinoma? External radiotherapy is a safe and effective palliative treatment for gallbladder carcinoma that can relieve pain, improve quality of life, and control tumor progression, although it is not a cure.",2.3685972735685385e-07,0.2336148511815046,0.0,0.018134264647818726,0.2392296890658323,0.0,0.018108015409528666,0.24512245803298427,0.0,2.3685972735685406e-07,0.2513144282809061,0.0
215,0.1,1,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH? IVF success is closely linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Among these, antral follicle assessment predicts IVF outcomes better than age or FSH.",3.316036182995957e-07,0.1950427292784629,0.03513813783174044,0.025387970506946217,0.19931733889777448,0.04398430577155921,0.025351221573340132,0.24259825971434035,0.016661878770468257,3.316036182995957e-07,0.2708749541353992,0.0
215,0.1,2,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Does antral follicle assessment outperform age and FSH in predicting IVF results? The outcome of in vitro fertilization is strongly associated with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment, with antral follicle assessment being the most reliable predictor.",4.026615365066519e-07,0.23720307793037554,0.04929173315416695,0.030828249901291835,0.26728637201034466,0.04253586534343219,0.030783626196198732,0.3100395405098726,0.016661878770468257,4.026615365066519e-07,0.33986782562235085,0.0
215,0.1,3,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Can antral follicle assessment more accurately predict IVF success than age and FSH? IVF outcomes correlate significantly with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with the latter proving to be a better predictor.",5.210914001850789e-07,0.2855961120119952,0.13825374794035755,0.0398953822252012,0.35640766977350946,0.0652508464142813,0.039837633900963065,0.43365349647704843,0.016661878770468257,5.210914001850789e-07,0.46661953126149314,0.0
215,0.1,4,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a better tool than age and FSH for forecasting IVF outcomes? IVF success is strongly linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment, with antral follicle assessment showing superior predictive value.",4.500334819780227e-07,0.2875048641281923,0.04386231138545943,0.03445510283085558,0.3153067062178776,0.04145548650946275,0.034405229278104466,0.357667589499127,0.016661878770468257,4.500334819780227e-07,0.38865798979178257,0.0
215,0.1,5,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Does antral follicle assessment provide a more accurate prediction of IVF outcomes than age and FSH? The success of in vitro fertilization is closely related to maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment being the best predictor.",3.552895910352811e-07,0.18929041873094565,0.05424970807967436,0.02720139697172809,0.221464753351448,0.04352245135255291,0.027162023114293,0.26457716643311535,0.016661878770468257,3.552895910352811e-07,0.2933478099874569,0.0
215,0.1,6,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a more effective predictor of IVF outcomes compared to age and FSH? IVF results are strongly correlated with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment, with antral follicle assessment outperforming the others.",4.500334819780227e-07,0.2875048641281923,0.04386231138545943,0.03445510283085558,0.3153067062178776,0.04145548650946275,0.034405229278104466,0.357667589499127,0.016661878770468257,4.500334819780227e-07,0.38865798979178257,0.0
215,0.1,7,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Can antral follicle assessment better predict IVF outcomes than age and FSH? The outcome of in vitro fertilization is strongly linked to maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment being the superior predictor.",4.500334819780227e-07,0.2875048641281923,0.04386231138545943,0.03445510283085558,0.3153067062178776,0.04145548650946275,0.034405229278104466,0.357667589499127,0.016661878770468257,4.500334819780227e-07,0.38865798979178257,0.0
215,0.1,8,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment a more reliable predictor of IVF success than age and FSH? IVF outcomes correlate strongly with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment, with antral follicle assessment proving to be the best predictor.",4.263475092423373e-07,0.2620406465234062,0.046640047851848526,0.03264167636607371,0.2910086039565658,0.04200821602879378,0.0325944277371516,0.333570037920067,0.016661878770468257,4.263475092423373e-07,0.36396537720141087,0.0
215,0.1,9,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Does antral follicle assessment serve as a better predictor of IVF outcomes than age and FSH? The success of in vitro fertilization is closely associated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle assessment being the most accurate predictor.",3.316036182995957e-07,0.16616159675513176,0.05657064471879285,0.025387970506946217,0.19931733889777448,0.04398430577155921,0.025351221573340132,0.24259825971434035,0.016661878770468257,3.316036182995957e-07,0.2708749541353992,0.0
215,0.1,10,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Is antral follicle assessment superior to age and FSH in predicting IVF outcomes? IVF success is strongly correlated with maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment, with antral follicle assessment providing the best prediction.",4.974054274493935e-07,0.3404444630064125,0.03789105099764786,0.038081955760419325,0.3657472208172141,0.040267282969179384,0.0380268323600102,0.40767801007379045,0.016661878770468257,4.974054274493935e-07,0.43995128417933227,0.0
216,0.1,1,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are home blood pressure readings reported by stroke patients dependable? This elderly stroke patient group reliably recorded their blood pressures at home, with minimal bias unlikely to impact treatment. Given that BP measurements in GP offices often poorly reflect true BP, GPs might consider using hypertensive monitoring.",2.6054570009253947e-07,0.21440987134545564,0.0,0.0199476911126006,0.21868920096483002,0.0,0.019918816950481533,0.22314355131420927,0.0,2.6054570009253947e-07,0.22778393087071303,0.0
216,0.1,2,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Can stroke patients accurately report their home blood pressure readings? Elderly stroke patients in this study reliably measured their blood pressure at home, with only minor bias that probably won't affect clinical decisions. Since BP readings at GP clinics often do not represent true BP, GPs may want to use hypertensive monitoring.",1.4211583641411244e-07,0.16559011986002448,0.039150354019158694,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
216,0.1,3,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Do stroke patients provide reliable home blood pressure readings? This cohort of elderly stroke patients consistently recorded their blood pressures at home with minimal bias, unlikely to influence management. Because BP readings in GP surgeries often poorly indicate actual BP, GPs might consider hypertensive monitoring.",3.079176455639103e-07,0.29036832394174095,0.02271498107084911,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
216,0.1,4,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Is the home blood pressure data reported by stroke patients trustworthy? Elderly stroke patients in this group reliably took their blood pressure at home, with small bias unlikely to affect treatment plans. Since BP readings at GP offices often fail to reflect true BP, GPs might consider hypertensive monitoring.",2.1317375462116866e-07,0.22961252197332094,0.04158790170132326,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
216,0.1,5,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are reports of home blood pressure by stroke patients accurate? This group of elderly stroke patients reliably recorded their blood pressures at home, with negligible bias unlikely to impact management. As BP readings in GP surgeries often poorly represent true BP, GPs might consider hypertensive monitoring.",2.8423167282822487e-07,0.26719531942245034,0.02221074380165289,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
216,0.1,6,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Can elderly stroke patients reliably report their home blood pressure readings? This group was able to record their blood pressures at home accurately, with minimal bias unlikely to affect clinical management. Since BP measurements in GP surgeries often do not reflect true BP, GPs might consider hypertensive monitoring.",2.3685972735685406e-07,0.19290366612449228,0.0,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
216,0.1,7,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","How reliable are home blood pressure readings reported by stroke patients? Elderly stroke patients in this group reliably recorded their blood pressures at home, with only slight bias unlikely to influence treatment. Given that BP readings in GP surgeries often poorly indicate true BP, GPs might consider hypertensive monitoring.",2.1317375462116866e-07,0.17185025692665912,0.0,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
216,0.1,8,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Are home blood pressure readings from stroke patients dependable? This elderly stroke patient group reliably measured their blood pressures at home, with minor bias unlikely to affect management. Since BP readings in GP surgeries often do not accurately reflect true BP, GPs might consider hypertensive monitoring.",2.8423167282822487e-07,0.23638877806423064,0.0,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
216,0.1,9,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Is the blood pressure data reported at home by stroke patients reliable? Elderly stroke patients in this group consistently recorded their blood pressures at home, with small bias unlikely to impact treatment decisions. Because BP readings in GP surgeries often poorly indicate true BP, GPs might consider hypertensive monitoring.",2.1317375462116866e-07,0.2007313894499898,0.020823902218198284,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
216,0.1,10,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Do elderly stroke patients provide trustworthy home blood pressure readings? This group reliably recorded their blood pressures at home, with minimal bias unlikely to affect clinical management. Since BP readings in GP surgeries often do not reflect true BP, GPs might consider hypertensive monitoring.",3.316036182995957e-07,0.2818511521409879,0.0,0.025387970506946217,0.2876820724517817,0.0,0.025351221573340132,0.2937611185281632,0.0,3.316036182995957e-07,0.30010459245033916,0.0
217,0.1,1,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
",Is it necessary to perform spinal cord untethering before scoliosis correction in patients with myelomeningocele? The study indicates that untethering may not be required as it does not significantly enhance neurological outcomes.,2.605457000925385e-07,0.2376683966020372,0.047500000000000014,0.019947691112600634,0.27856262745386307,0.024375,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
217,0.1,2,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","For patients with myelomeningocele, is untethering the spinal cord needed before correcting scoliosis? Research suggests that untethering prior to scoliosis surgery might not be essential since it shows no notable neurological benefit.",2.605457000925385e-07,0.2376683966020372,0.047500000000000014,0.019947691112600634,0.27856262745386307,0.024375,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
217,0.1,3,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
",Should spinal cord untethering be done before scoliosis correction in myelomeningocele patients? The findings imply that untethering before scoliosis correction may not be necessary due to lack of significant neurological improvement.,2.842316728282238e-07,0.362877843499688,0.01882653061224486,0.021761117577382513,0.36026743296126496,0.010063775510204091,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
217,0.1,4,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","In patients with myelomeningocele, is untethering necessary before scoliosis surgery? The study results indicate that untethering the spinal cord prior to scoliosis correction does not significantly improve neurological function and may not be needed.",2.1317375462116791e-07,0.1751480396207037,0.047500000000000014,0.016320838183036875,0.21402410631629154,0.024375,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
217,0.1,5,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","Does spinal cord untethering need to precede scoliosis correction in myelomeningocele cases? According to the study, untethering before scoliosis correction may not be required as it does not lead to meaningful neurological improvement.",2.3685972735685321e-07,0.24924139707245496,0.01628251821019771,0.018134264647818754,0.24577280463087137,0.024375,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
217,0.1,6,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
",Is untethering the spinal cord required before scoliosis correction in patients with myelomeningocele? The research suggests it might not be necessary since it fails to show significant neurological function enhancement.,3.079176455639091e-07,0.30435977110071066,0.047500000000000014,0.023574544042164393,0.34755549894081383,0.024375,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
217,0.1,7,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
","For scoliosis correction in myelomeningocele patients, is prior untethering necessary? Study findings suggest that untethering before scoliosis surgery may not be needed due to lack of significant neurological benefit.",3.316036182995944e-07,0.33945109091197967,0.047500000000000014,0.025387970506946272,0.3839231431116885,0.024375,0.025351221573340195,0.43078291609245367,0.0,3.316036182995957e-07,0.4446858212614444,0.0
217,0.1,8,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
",Is it essential to untether the spinal cord before scoliosis correction in myelomeningocele patients? The study indicates that untethering prior to scoliosis correction does not significantly improve neurological outcomes and may be unnecessary.,2.3685972735685321e-07,0.24924139707245496,0.01628251821019771,0.018134264647818754,0.24577280463087137,0.024375,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
217,0.1,9,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
",Should patients with myelomeningocele undergo spinal cord untethering before scoliosis correction? Research results suggest that untethering before scoliosis surgery may not be necessary as it does not significantly improve neurological function.,2.842316728282238e-07,0.362877843499688,0.01882653061224486,0.021761117577382513,0.36026743296126496,0.010063775510204091,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
217,0.1,10,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering prior to scoliosis correction in patients with myelomeningocele may not be necessary, as it did not demonstrate significant improvement in neurological function. 
",Is spinal cord untethering a prerequisite for scoliosis correction in myelomeningocele patients? The study suggests that untethering prior to scoliosis correction may not be essential since it does not significantly enhance neurological function.,2.3685972735685321e-07,0.24924139707245496,0.01628251821019771,0.018134264647818754,0.24577280463087137,0.024375,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
218,0.1,1,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair unnecessary? With spinal cord function monitoring and prompt action, reimplantation is vital to prevent neurological issues by maintaining sufficient blood flow and protecting neurological health.",4.500334819780222e-07,0.2998321277213041,0.16416162053056518,0.03445510283085559,0.3294327929313532,0.1157850895460225,0.03440522927810448,0.401417143225721,0.03840000000000001,4.500334819780227e-07,0.4389074875496992,0.019599999999999992
218,0.1,2,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","During thoracic and thoracoabdominal aneurysm repair, is reimplantation of spinal cord arteries pointless? Monitoring spinal cord function and timely intervention make reimplantation essential to avoid neurological complications by ensuring adequate spinal cord perfusion.",5.210914001850781e-07,0.4528307781559162,0.06381944444444451,0.039895382225201226,0.4218061130623685,0.1157850895460225,0.0398376339009631,0.4967273230300462,0.03840000000000001,5.210914001850789e-07,0.5373475603629525,0.019599999999999992
218,0.1,3,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","Is it futile to reimplant spinal cord arteries in thoracic and thoracoabdominal aneurysm repair? When spinal cord function is monitored and interventions are timely, reimplantation plays a key role in preventing neurological damage by preserving blood supply.",4.263475092423369e-07,0.27056101713467084,0.16495323129251702,0.03264167636607371,0.3004452560581017,0.1157850895460225,0.032594427737151606,0.3715641800760392,0.03840000000000001,4.263475092423373e-07,0.40813582888294553,0.019599999999999992
218,0.1,4,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","Does reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair serve no purpose? With proper spinal cord monitoring and prompt treatment, reimplantation is critical to reduce ischemia risk and maintain neurological function.",4.974054274493928e-07,0.3610731374604619,0.16243489583333334,0.038081955760419346,0.39005741474778866,0.1157850895460225,0.038026832360010226,0.4639375002070545,0.03840000000000001,4.974054274493935e-07,0.5034460086872707,0.019599999999999992
218,0.1,5,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
",Is reimplantation of spinal cord arteries a waste of effort in thoracic and thoracoabdominal aneurysm repair? Careful monitoring and timely intervention confirm its importance in preventing neurological deficits by ensuring spinal cord blood flow.,4.974054274493928e-07,0.3610731374604619,0.16243489583333334,0.038081955760419346,0.39005741474778866,0.1157850895460225,0.038026832360010226,0.4639375002070545,0.03840000000000001,4.974054274493935e-07,0.5034460086872707,0.019599999999999992
218,0.1,6,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","In thoracic and thoracoabdominal aneurysm repair, is reimplanting spinal cord arteries unnecessary? Monitoring spinal cord function and acting promptly make reimplantation crucial to avoid ischemic injury and preserve neurological integrity.",5.92149318392134e-07,0.49607920273825323,0.15826955782312924,0.045335661619546865,0.523588807372311,0.1157850895460225,0.04527003852382172,0.6020878386878716,0.03840000000000001,5.921493183921352e-07,0.6465468523279432,0.019599999999999992
218,0.1,7,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair ineffective? With spinal cord function surveillance and timely intervention, it is essential to prevent neurological complications by maintaining adequate blood flow.",5.210914001850781e-07,0.3931575748782774,0.16149085154353104,0.039895382225201226,0.4218061130623685,0.1157850895460225,0.0398376339009631,0.4967273230300462,0.03840000000000001,5.210914001850789e-07,0.5373475603629525,0.019599999999999992
218,0.1,8,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
",Is reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair a futile procedure? Continuous monitoring and prompt action highlight its importance in safeguarding neurological function by ensuring sufficient spinal cord perfusion.,5.447773729207634e-07,0.42630374734721066,0.16048611111111113,0.041708808689983105,0.4545959358853602,0.1157850895460225,0.041648435441915974,0.530628874705728,0.03840000000000001,5.447773729207643e-07,0.5724388801742215,0.019599999999999992
218,0.1,9,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
",Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair a pointless measure? Monitoring spinal cord function and timely intervention demonstrate its necessity in preventing ischemia and preserving neurological health.,5.447773729207634e-07,0.42630374734721066,0.16048611111111113,0.041708808689983105,0.4545959358853602,0.1157850895460225,0.041648435441915974,0.530628874705728,0.03840000000000001,5.447773729207643e-07,0.5724388801742215,0.019599999999999992
218,0.1,10,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of spinal cord function and timely intervention, reimplantation of spinal cord arteries is crucial for preventing neurological complications. It ensures adequate blood flow to the spinal cord, reducing the risk of ischemia and preserving neurological integrity. 
","Is reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair a waste of time? With vigilant spinal cord monitoring and prompt intervention, reimplantation is vital to maintain blood flow and prevent neurological complications.",4.737194547137075e-07,0.3299846178391941,0.1633235766758494,0.03626852929563747,0.35928575608103497,0.1157850895460225,0.03621603081905735,0.43218880189247466,0.03840000000000001,4.737194547137081e-07,0.47065618586427904,0.019599999999999992
219,0.1,1,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before surgery enhance outcomes of bariatric surgery? The MSWM does not seem to provide extra advantages over the usual preoperative bariatric surgery protocol regarding weight loss and most behavioral results following LAGB in our patients.,9.474389094274162e-08,0.06528939793786215,0.01997329637641968,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,0.1,2,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is a preoperative medically supervised weight loss program beneficial for improving bariatric surgery results? MSWM appears to offer no additional benefit compared to the standard preoperative bariatric surgery protocol in terms of weight loss and behavioral outcomes after LAGB in our patient group.,7.105791820705622e-08,0.07339380596669631,0.003151703623580332,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
219,0.1,3,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does undergoing a medically supervised weight loss program before surgery improve the results of bariatric surgery? MSWM does not seem to add any benefit beyond the standard preoperative bariatric surgery protocol for weight loss and most behavioral outcomes after LAGB in our patients.,7.105791820705622e-08,0.040386797368603844,0.020552936471601127,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
219,0.1,4,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Can a preoperative medically supervised weight loss program enhance bariatric surgery outcomes? MSWM does not appear to provide extra benefits compared to the standard preoperative bariatric surgery protocol in weight loss and most behavioral outcomes after LAGB in our patient population.,1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
219,0.1,5,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before surgery improve bariatric surgery outcomes? MSWM does not seem to offer additional benefits over the standard preoperative bariatric surgery protocol regarding weight loss and behavioral outcomes after LAGB in our patients.,1.6580180914979763e-07,0.1804261084390668,0.008120839426049457,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
219,0.1,6,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? MSWM does not appear to confer extra benefits compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,2.3685972735685406e-08,0.023318321560436672,0.0009598666243535725,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
219,0.1,7,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically supervised weight loss program lead to better bariatric surgery outcomes? MSWM does not seem to provide added benefits over the standard preoperative bariatric surgery protocol for weight loss and behavioral outcomes after LAGB in our patient group.,1.1842986367842703e-07,0.12548467099593807,0.005513199468455653,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
219,0.1,8,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does participating in a medically supervised weight loss program before surgery improve bariatric surgery results? MSWM does not appear to offer additional advantages compared to the standard preoperative bariatric surgery protocol in weight loss and most behavioral outcomes after LAGB in our patients.,7.105791820705622e-08,0.07339380596669631,0.003151703623580332,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
219,0.1,9,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is a preoperative medically supervised weight loss program effective in improving bariatric surgery outcomes? MSWM does not seem to confer extra benefits relative to the standard preoperative bariatric surgery protocol in terms of weight loss and behavioral outcomes after LAGB in our patient population.,4.737194547137081e-08,0.048328098854266255,0.0020526554379765236,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
219,0.1,10,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program prior to surgery improve outcomes of bariatric surgery? MSWM does not appear to provide additional benefits compared to the standard preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes after LAGB in our patients.,7.105791820705622e-08,0.040386797368603844,0.020552936471601127,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
220,0.1,1,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving birth center care during a woman's initial pregnancy influence her later reproductive outcomes? Answer: In Sweden, the type of care a woman receives, like birth center care, during her first pregnancy does not appear to significantly impact her future reproduction.",9.474389094274162e-08,0.03356828499165143,0.04110458601189319,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
220,0.1,2,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is there an effect of birth center care during a woman's first pregnancy on her subsequent reproductive behavior? Answer: The model of care, including birth center care, during a woman's first pregnancy in Sweden does not seem to be a crucial factor influencing later reproduction.",2.3685972735685406e-08,0.08560111169770668,0.04447505408328825,0.0018134264647818726,0.11699292592841459,0.06781677572873293,0.0018108015409528666,0.08746832571864793,0.046400951814396206,2.3685972735685406e-08,0.056537506008286,0.023795359904818555
220,0.1,3,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does birth center care in a woman's first pregnancy affect her future reproductive patterns? Answer: In Sweden, the care model, such as birth center care, during the first pregnancy does not seem to play a significant role in affecting subsequent reproduction.",1.1842986367842703e-07,0.0922829431491996,0.016247743418355408,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,0.1,4,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Can birth center care during a woman's first pregnancy impact her future reproductive decisions? Answer: A woman's care model, like birth center care, during her initial pregnancy in Sweden does not appear to be an important determinant of later reproduction.",1.4211583641411244e-07,0.11866615861898566,0.015038450071836414,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.1,5,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the type of care, specifically birth center care, during a woman's first pregnancy influence her future reproduction? Answer: In Sweden, birth center care during the first pregnancy does not seem to be a sufficiently significant factor to affect subsequent reproductive outcomes.",9.474389094274162e-08,0.0665752935897439,0.017399945916711734,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
220,0.1,6,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is birth center care during a woman's first pregnancy linked to changes in her future reproduction? Answer: The model of care, such as birth center care, during the first pregnancy in Sweden does not seem to have a meaningful impact on later reproduction.",7.105791820705622e-08,0.04150958647731384,0.018498994102315543,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
220,0.1,7,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving birth center care in the first pregnancy affect a woman's future reproductive behavior? Answer: In Sweden, the care model during the first pregnancy, including birth center care, does not appear to be a key factor influencing subsequent reproduction.",1.4211583641411244e-07,0.11866615861898566,0.015038450071836414,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
220,0.1,8,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does birth center care during a woman's initial pregnancy have any bearing on her future reproduction? Answer: The type of care, like birth center care, during the first pregnancy in Sweden does not seem to be an important factor affecting later reproduction.",9.474389094274162e-08,0.03356828499165143,0.04110458601189319,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
220,0.1,9,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Is there an association between birth center care during a woman's first pregnancy and her future reproductive outcomes? Answer: In Sweden, birth center care during the first pregnancy does not seem to significantly influence subsequent reproduction.",2.3685972735685364e-07,0.30874466301191683,0.04447505408328825,0.018134264647818726,0.3305312489163281,0.056932966023875105,0.018108015409528673,0.29860247286444963,0.029384756657483937,2.3685972735685406e-07,0.26469255422708216,0.0
220,0.1,10,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the model of care, such as birth center care, during a woman's first pregnancy impact her future reproduction? Answer: A woman's first pregnancy care model, including birth center care, in Sweden does not appear to be a sufficiently important factor to affect later reproduction.",2.3685972735685406e-08,0.08560111169770668,0.04447505408328825,0.0018134264647818726,0.11699292592841459,0.06781677572873293,0.0018108015409528666,0.05522892197167373,0.023242630385487524,2.3685972735685406e-08,0.023530497410194418,0.0
221,0.1,1,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Does preoperative anemia negatively impact the outcomes of colon and rectal surgeries? This extensive multicenter database study indicates that both severe and moderate anemia correlate with a higher likelihood of postoperative complications, extended hospital stays, and increased readmission rates following colon and rectal surgery.",4.737194547137081e-08,0.048328098854266255,0.0020526554379765236,0.0036268529295637453,0.04802033420753293,0.0010803788339694455,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
221,0.1,2,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Is there an adverse effect of preoperative anemia on colon and rectal surgery results? Analysis of a large multicenter database reveals that severe and moderate anemia are linked to greater risks of postoperative complications, longer hospitalization, and elevated readmission rates in these surgeries.",7.105791820705622e-08,0.007379788770512263,0.04434829637641968,0.005440279394345618,0.03911087718850137,0.02271498107084911,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
221,0.1,3,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","How does preoperative anemia influence the outcomes of colon and rectal surgery? Findings from a large multicenter database suggest that severe and moderate anemia are associated with increased postoperative complications, prolonged hospital stays, and higher rates of readmission.",1.8948778188548293e-07,0.13413149440965455,0.04434829637641968,0.014507411718254981,0.16916400543669896,0.02271498107084911,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
221,0.1,4,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Does having anemia before surgery worsen the outcomes of colon and rectal procedures? This large-scale multicenter database analysis shows that severe and moderate anemia increase the risk of postoperative complications, lengthen hospital stays, and raise readmission rates.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641968,0.016320838183036854,0.1973348824033958,0.02271498107084911,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
221,0.1,5,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","What is the impact of preoperative anemia on colon and rectal surgery outcomes? According to a large multicenter database analysis, severe and moderate anemia are linked to a higher risk of postoperative complications, longer hospital stays, and more frequent readmissions.",1.4211583641411233e-07,0.11703377018371963,0.01872502767835873,0.010880558788691236,0.11509678416642277,0.02271498107084911,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
221,0.1,6,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Does preoperative anemia affect the results of colon and rectal surgery negatively? The analysis of a large multicenter database suggests that patients with severe and moderate anemia face increased postoperative complications, extended hospitalization, and higher readmission rates.",2.1317375462116823e-07,0.16153046859776987,0.04434829637641968,0.016320838183036854,0.1973348824033958,0.02271498107084911,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
221,0.1,7,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Is preoperative anemia associated with worse outcomes in colon and rectal surgery? This large multicenter database study indicates that severe and moderate anemia correspond with increased postoperative complications, longer hospital stays, and elevated readmission rates.",2.6054570009253883e-07,0.21868888243771822,0.04434829637641968,0.019947691112600613,0.2561753824263291,0.02271498107084911,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
221,0.1,8,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","How does preoperative anemia affect colon and rectal surgery outcomes? A large multicenter database analysis suggests that severe and moderate anemia are linked to greater postoperative complications, prolonged hospital stays, and increased readmission rates.",2.8423167282822413e-07,0.2485418455874,0.04434829637641968,0.021761117577382492,0.2869470410930828,0.02271498107084911,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
221,0.1,9,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","Does the presence of preoperative anemia lead to poorer outcomes in colon and rectal surgery? Analysis from a large multicenter database shows that severe and moderate anemia are associated with higher risks of postoperative complications, longer hospital stays, and increased readmissions.",1.1842986367842703e-07,0.05616995293994398,0.04434829637641968,0.009067132323909363,0.0891212977631648,0.02271498107084911,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
221,0.1,10,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate anemia is associated with increased risk of postoperative complications, prolonged hospital stay, and higher readmission rates in colon and rectal surgery. 
","What effect does preoperative anemia have on colon and rectal surgery outcomes? This analysis of a large multicenter database suggests that severe and moderate anemia increase the likelihood of postoperative complications, extended hospital stays, and higher readmission rates.",1.8948778188548293e-07,0.13413149440965455,0.04434829637641968,0.014507411718254981,0.16916400543669896,0.02271498107084911,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
222,0.1,1,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Precursor to Bronchiectasis? Although no definitive connection has been proven, research indicates a possible link. Dysfunctional macrophages might lead to ongoing inflammation and airway injury, raising the risk of bronchiectasis. More studies are required to confirm this relationship.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
222,0.1,2,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Could Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis Lead to Bronchiectasis? While a clear causal relationship is not yet confirmed, evidence points to a potential association. Impaired macrophage activity may cause chronic airway inflammation and damage, which could increase bronchiectasis risk. Additional research is necessary to better understand this link.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
222,0.1,3,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Is there a connection between Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis and the development of Bronchiectasis? Although a definitive link remains unproven, studies suggest a possible correlation. Macrophage dysfunction may promote persistent inflammation and airway damage, heightening the risk of bronchiectasis. Further investigation is needed to clarify this association.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
222,0.1,4,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Does Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis serve as a precursor to Bronchiectasis? No conclusive evidence exists yet, but research suggests a potential connection. Impaired macrophage function could contribute to chronic inflammation and airway injury, increasing bronchiectasis risk. More research is required to establish this relationship.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
222,0.1,5,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis an early indicator of Bronchiectasis? Definitive proof is lacking, yet studies imply a possible link. Dysfunctional macrophages may lead to sustained inflammation and airway damage, raising the likelihood of bronchiectasis. Further studies are needed to confirm this association.",4.737194547137081e-08,0.04082199452025437,0.0,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
222,0.1,6,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Could dysfunction in alveolar macrophage phagocytosis in children with protracted bacterial bronchitis be a precursor to bronchiectasis? While no definitive link has been established, research suggests a potential correlation. Impaired macrophage function might contribute to chronic inflammation and airway damage, increasing the risk of bronchiectasis. Additional research is necessary to clarify this connection.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
222,0.1,7,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Is alveolar macrophage phagocytic dysfunction in children suffering from protracted bacterial bronchitis a forerunner to bronchiectasis? Although a definitive link has not been confirmed, studies indicate a possible association. Dysfunctional macrophages may cause chronic inflammation and airway damage, which could elevate bronchiectasis risk. Further research is needed to better understand this relationship.",2.3685972735685406e-08,0.019802627296179764,0.0,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
222,0.1,8,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis precede bronchiectasis? No conclusive evidence exists, but studies suggest a potential link. Impaired macrophage function may contribute to ongoing inflammation and airway injury, increasing the risk of bronchiectasis. More research is required to clarify this association.",9.474389094274162e-08,0.08338160893905089,0.0,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
222,0.1,9,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Is there evidence that alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis leads to bronchiectasis? While a definitive connection has not been established, research points to a possible correlation. Dysfunctional macrophages might promote chronic inflammation and airway damage, raising bronchiectasis risk. Further studies are necessary to confirm this link.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
222,0.1,10,ai,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: While a definitive link hasn't been established, studies suggest a potential correlation. Impaired macrophage function may contribute to chronic inflammation and airway damage, increasing bronchiectasis risk. Further research is needed to clarify this association. 
","Could alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis be an early sign of bronchiectasis? Although no definitive link has been proven, studies suggest a potential association. Impaired macrophage function may contribute to chronic inflammation and airway injury, increasing the risk of bronchiectasis. Additional research is needed to better understand this relationship.",7.105791820705622e-08,0.05826890812397556,0.0,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
223,0.1,1,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","Is neck dissection necessary for metastatic carcinoma in cervical nodes when the primary head and neck tumor is unknown? Our experience suggests that neck dissection is usually advised. Even if the primary site is unidentified, metastatic carcinoma in cervical nodes indicates a strong chance of disease advancement. Neck dissection aids in disease control, cancer staging, and may help locate the primary tumor.",2.8423167282822487e-07,0.28359868179027625,0.13550834810501589,0.021761117577382527,0.2323821865010629,0.03597536214124511,0.021729618491434413,0.23213546232610227,0.033856571252693125,2.8423167282822487e-07,0.21195385841879943,0.017236072637734686
223,0.1,2,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","For metastatic carcinoma found in cervical nodes with an unknown primary head and neck tumor, is neck dissection required? Based on our experience, neck dissection is typically recommended. The presence of metastatic carcinoma in cervical nodes implies a significant risk of disease progression despite the unknown primary site. Performing neck dissection assists in managing the disease, staging the cancer, and possibly discovering the primary tumor.",2.1317375462116866e-07,0.17476553782017223,0.05910665133368169,0.01632083818303691,0.13628197667436304,0.001982752872852612,0.016297213868575813,0.13554549199622468,0.0,2.1317375462116866e-07,0.137621377876048,0.0
223,0.1,3,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","When metastatic carcinoma is present in cervical lymph nodes but the primary head and neck tumor is unknown, should neck dissection be performed? Our clinical experience favors neck dissection in such cases. Although the primary tumor site remains unidentified, metastatic involvement of cervical nodes suggests a high probability of disease progression. Neck dissection facilitates disease control, accurate staging, and may uncover the primary tumor.",2.3685972735685406e-07,0.15700278796491407,0.06287400261826685,0.018134264647818782,0.13027764562207889,0.013886133703630227,0.01810801540952868,0.15180601286800588,0.0,2.3685972735685406e-07,0.15415067982725894,0.0
223,0.1,4,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","Is neck dissection indicated for metastatic carcinoma to cervical nodes from an unknown primary head and neck cancer? According to our experience, neck dissection is generally recommended. The detection of metastatic carcinoma in cervical nodes indicates a considerable likelihood of disease progression even if the primary tumor is unknown. Neck dissection helps control the disease, stage the cancer, and potentially identify the primary site.",2.3685972735685406e-07,0.17070193427214253,0.04513518878909194,0.018134264647818782,0.13027764562207889,0.013886133703630227,0.01810801540952868,0.15180601286800588,0.0,2.3685972735685406e-07,0.15415067982725894,0.0
223,0.1,5,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","In cases of metastatic carcinoma to cervical nodes with an unknown primary tumor in the head and neck, is neck dissection necessary? Our experience supports recommending neck dissection. The presence of metastatic carcinoma in cervical nodes points to a high risk of disease progression despite the unknown primary site. Neck dissection aids in disease management, cancer staging, and may help locate the primary tumor.",2.3685972735685406e-07,0.1623964081806415,0.010652430168402241,0.018134264647818782,0.15263723209175506,0.0022385639582886193,0.01810801540952868,0.15180601286800588,0.0,2.3685972735685406e-07,0.15415067982725894,0.0
223,0.1,6,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","Should neck dissection be performed for metastatic carcinoma in cervical nodes when the primary head and neck tumor is unknown? Our experience indicates that neck dissection is generally advised. Metastatic carcinoma in cervical nodes suggests a high chance of disease progression even if the primary tumor site is not identified. Neck dissection assists in controlling the disease, staging the cancer, and potentially finding the primary tumor.",1.8948778188548325e-07,0.2078412900134845,0.12270510969039182,0.014507411718255037,0.16351149548499233,0.03287548951593441,0.014486412327622947,0.16355449544723832,0.03171190540177372,1.8948778188548325e-07,0.14372044347394297,0.016124697661918846
223,0.1,7,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","Is neck dissection warranted for metastatic carcinoma in cervical nodes from an unknown primary site in the head and neck? Based on our experience, neck dissection is usually recommended. The presence of metastatic carcinoma in cervical nodes signifies a strong likelihood of disease progression despite the unknown primary tumor. Neck dissection helps manage the disease, stage the cancer, and may reveal the primary tumor.",2.3685972735685406e-07,0.23671595146832658,0.09253831965455127,0.018134264647818782,0.19735640503110652,0.03437585997634679,0.01810801540952868,0.19725828700308412,0.03274920999712727,2.3685972735685406e-07,0.1772555858459235,0.016661878770468257
223,0.1,8,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","For metastatic carcinoma involving cervical nodes with an unknown primary tumor in the head and neck region, is neck dissection needed? Our clinical experience suggests neck dissection is generally advised. Metastatic carcinoma in cervical nodes indicates a high probability of disease progression even if the primary site is unknown. Neck dissection aids in disease control, cancer staging, and potentially identifying the primary tumor.",2.6054570009253947e-07,0.18861080607157188,0.04698950488891446,0.019947691112600655,0.1465381664938601,0.013886133703630227,0.019918816950481547,0.16833531481921682,0.0,2.6054570009253947e-07,0.17095779814363965,0.0
223,0.1,9,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","When metastatic carcinoma is detected in cervical nodes but the primary head and neck tumor remains unknown, is neck dissection recommended? Our experience shows that neck dissection is typically advised. The presence of metastatic carcinoma in cervical nodes implies a significant risk of disease progression despite the unknown primary site. Neck dissection helps control the disease, stage the cancer, and may help locate the primary tumor.",1.8948778188548325e-07,0.1571361074595714,0.057128527180174346,0.014507411718255037,0.12018979669999563,0.0017349295364806304,0.014486412327622947,0.1195451506497811,0.0,1.8948778188548325e-07,0.1213608570042668,0.0
223,0.1,10,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? 
Answer: In our experience, neck dissection is generally recommended in this scenario. While the primary tumor site may be unknown, the presence of metastatic carcinoma in the cervical nodes signifies a high likelihood of disease progression. Neck dissection helps to control the disease, stage the cancer, and potentially identify the primary tumor. 
","Is neck dissection necessary for metastatic carcinoma to cervical nodes from an unknown primary head and neck tumor? According to our experience, neck dissection is generally recommended. The detection of metastatic carcinoma in cervical nodes indicates a high likelihood of disease progression even if the primary tumor site is unknown. Neck dissection assists in disease management, cancer staging, and potentially identifying the primary tumor.",2.3685972735685406e-07,0.17070193427214253,0.04513518878909194,0.018134264647818782,0.13027764562207889,0.013886133703630227,0.01810801540952868,0.15180601286800588,0.0,2.3685972735685406e-07,0.15415067982725894,0.0
224,0.1,1,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy has a high mortality rate, particularly in patients older than 70, indicating a need for better outcomes.",1.6580180914979753e-07,0.21073913643943865,0.027006172839506164,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
224,0.1,2,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The mortality rate following emergency laparotomy is notably high, especially among those over 70 years old, highlighting the necessity for enhanced care.",9.474389094274162e-08,0.09531017980432566,0.0,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
224,0.1,3,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy is associated with significant mortality, particularly in elderly patients above 70, underscoring the need for improved interventions.",1.6580180914979753e-07,0.21073913643943865,0.027006172839506164,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
224,0.1,4,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: There is a high mortality rate in emergency laparotomy cases, especially for patients over 70, which calls for efforts to improve patient outcomes.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
224,0.1,5,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Mortality following emergency laparotomy remains high, particularly in those aged over 70, necessitating improvements in treatment strategies.",2.1317375462116813e-07,0.2288415724288484,0.0,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
224,0.1,6,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy results in a high death rate, especially among patients older than 70 years, indicating a critical need for better outcome measures.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
224,0.1,7,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The risk of death after emergency laparotomy is elevated, particularly in individuals over 70, emphasizing the importance of improving care.",1.4211583641411222e-07,0.14660347419187536,0.0,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
224,0.1,8,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: High mortality rates in emergency laparotomy, especially in patients above 70, highlight the urgent need for enhanced clinical outcomes.",1.6580180914979753e-07,0.24820655160484195,0.05387755102040818,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
224,0.1,9,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a significant mortality risk, notably in those over 70 years old, pointing to the need for better management.",1.1842986367842692e-07,0.1561739970481013,0.025623268698060954,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
224,0.1,10,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: There is a concerningly high mortality rate in emergency laparotomy patients, particularly those over 70, which demands focused efforts to improve survival rates.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
225,0.1,1,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Is visual loss permanent in amblyopia? Older adults with amblyopia who lose vision in their previously unaffected eye may suffer permanent vision loss, as amblyopia impairs the brain's capacity to interpret signals from the affected eye.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
225,0.1,2,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Does amblyopia cause permanent vision loss? In older individuals with amblyopia, vision loss in the previously normal eye can be permanent due to the brain's reduced ability to process visual input from the amblyopic eye.",2.1317375462116802e-07,0.20260018733042617,0.023242630385487524,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
225,0.1,3,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
",Is the vision loss caused by amblyopia irreversible? Older patients with amblyopia who experience vision loss in their formerly normal eye might have permanent impairment because amblyopia diminishes the brain's processing of visual data from that eye.,1.6580180914979742e-07,0.18394995018825266,0.004512471655328806,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
225,0.1,4,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Can amblyopia lead to lasting visual loss? For older people with amblyopia, losing vision in the previously unaffected eye may result in permanent loss since amblyopia weakens the brain's visual processing from the affected eye.",2.1317375462116802e-07,0.20260018733042617,0.023242630385487524,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
225,0.1,5,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
",Is vision loss permanent in cases of amblyopia? Older adults with a history of amblyopia who develop vision loss in their previously normal eye may face permanent vision loss because amblyopia reduces the brain's ability to process images from the affected eye.,4.737194547137081e-08,0.09577491026677576,0.07669162339492014,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
225,0.1,6,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Does amblyopia cause lasting vision impairment? In older individuals with amblyopia, vision loss in the previously normal eye can be permanent due to the brain's compromised processing of visual information from the affected eye.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
225,0.1,7,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
",Is the visual loss from amblyopia permanent? Older people with amblyopia who lose vision in their previously normal eye may experience permanent loss as amblyopia impairs the brain's ability to handle visual signals from that eye.,1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
225,0.1,8,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
",Can vision loss from amblyopia be permanent? Older adults with amblyopia who develop vision loss in their previously unaffected eye may have permanent vision loss because amblyopia weakens the brain's processing of visual input from the affected eye.,1.4211583641411212e-07,0.20711947135653475,0.08777777777777779,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
225,0.1,9,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
",Is permanent vision loss a risk with amblyopia? Older individuals with amblyopia who experience vision loss in their previously normal eye may suffer permanent loss due to the brain's reduced capacity to process visual information from the affected eye.,1.1842986367842682e-07,0.12785598277598798,0.0030539364516198493,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
225,0.1,10,ai,"Question: Amblyopia: is visual loss permanent? 
Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye may experience permanent vision loss. This is because amblyopia weakens the brain's ability to process visual information from the affected eye. 
","Does amblyopia result in irreversible vision loss? In older people with amblyopia, vision loss in the previously normal eye may be permanent because amblyopia diminishes the brain's ability to process visual data from the affected eye.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
226,0.1,1,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it acceptable for student examiners to serve as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears reasonable and justified to allow medical students to act as examiners in formative OSCE assessments in emergency medicine, though not necessarily in summative evaluations.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
226,0.1,2,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners reasonably replace faculty examiners in an undergraduate OSCE focused on medical emergencies? Encouraging medical students to officiate as examiners in formative emergency medicine OSCEs seems appropriate and justified, but this may not extend to summative assessments.",1.6580180914979763e-07,0.20555776059971942,0.026296566837107373,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.1,3,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners suitable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems both permissible and justified to have medical students serve as examiners during formative OSCE testing in emergency medicine, but not necessarily during summative assessments.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.1,4,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May medical students act as reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? It is apparently acceptable and justified to involve medical students as examiners in formative emergency medicine OSCEs, though this does not necessarily apply to summative evaluations.",7.105791820705622e-08,0.10199988008504324,0.023795359904818555,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
226,0.1,5,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it reasonable to have student examiners replace faculty in an undergraduate OSCE on medical emergencies? Encouraging medical students to officiate in formative OSCE assessments in emergency medicine is justifiable, but this may not be appropriate for summative assessments.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
226,0.1,6,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners be considered reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It seems justified and acceptable to allow medical students to act as examiners in formative OSCE testing for emergency medicine, but not necessarily in summative evaluations.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
226,0.1,7,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners justified as reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears reasonable and justified to permit medical students to serve as examiners in formative emergency medicine OSCEs, though not necessarily in summative assessments.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.1,8,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it permissible for student examiners to substitute for faculty in an undergraduate OSCE on medical emergencies? Encouraging medical students to officiate as examiners in formative OSCEs in emergency medicine seems justified, but this may not apply to summative evaluations.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,0.1,9,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May student examiners reasonably replace faculty examiners in an undergraduate OSCE on medical emergencies? It seems acceptable and justified to involve medical students as examiners in formative emergency medicine OSCE testing, but not necessarily in summative assessments.",2.1317375462116823e-07,0.2616517280119841,0.02775510204081633,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
226,0.1,10,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners appropriate substitutes for faculty in an undergraduate OSCE on medical emergencies? It appears justified and reasonable to encourage medical students to act as examiners in formative OSCEs for emergency medicine, but not necessarily in summative evaluations.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
227,0.1,1,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? Answer: At the gas flow rates examined, HFNC are not louder than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,0.1,2,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise level of high flow nasal cannulae greater than that of bubble CPAP for preterm infants? Answer: Based on the gas flows studied, HFNC are not noisier than BCPAP in preterm infants.",1.658018091497971e-07,0.333212129805899,0.07359999999999998,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
227,0.1,3,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae noisier compared to bubble CPAP for preterm infants? Answer: At the studied gas flow rates, HFNC do not generate more noise than BCPAP for preterm infants.",9.47438909427412e-08,0.19611963673553268,0.041377777777777784,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,0.1,4,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae create more noise than bubble CPAP in preterm infants? Answer: Considering the gas flows analyzed, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.17414743517621023,0.07359999999999998,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.1,5,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise produced by high flow nasal cannulae higher than that of bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not louder than BCPAP for preterm infants.",1.421158364141118e-07,0.26135024662228146,0.043326562499999985,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
227,0.1,6,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae louder than bubble CPAP for preterm infants? Answer: At the gas flow rates studied, HFNC are not noisier than BCPAP for preterm infants.",2.36859727356853e-08,0.08954560246780208,0.03793470507544581,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.1,7,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae emit more noise than bubble CPAP in preterm infants? Answer: At the gas flows examined, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.17414743517621023,0.07359999999999998,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
227,0.1,8,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise level of high flow nasal cannulae higher than bubble CPAP for preterm infants? Answer: Based on the gas flow rates studied, HFNC are not noisier than BCPAP for preterm infants.",1.421158364141118e-07,0.26135024662228146,0.043326562499999985,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
227,0.1,9,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae noisier than bubble CPAP in preterm infants? Answer: At the gas flow rates studied, HFNC are not louder than BCPAP for preterm infants.",2.36859727356853e-08,0.13905611536494122,0.07359999999999998,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,0.1,10,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP for preterm infants? Answer: Considering the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",4.73719454713706e-08,0.1263441813444901,0.03916122448979589,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
228,0.1,1,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Does having both major depression and alcohol use disorder during adolescence result in worse depression outcomes? The findings indicate that adolescents with both conditions tend to have longer and more severe depressive episodes than those with only depression.,8.763809912203597e-07,0.45879271370349883,0.27110103300579474,0.06709677919692936,0.5335144846066266,0.20023668639053252,0.06699965701525608,0.5912588567731905,0.1432506887052342,8.7638099122036e-07,0.6508485694921391,0.08598797059478724
228,0.1,2,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Are depression outcomes poorer in adolescents with comorbid major depression and alcohol use disorder? Analysis shows that comorbidity is linked to prolonged and intensified depressive symptoms compared to depression alone.,1.0658687731058422e-06,0.7024147963612513,0.27110103300579474,0.0816041909151844,0.7848289128875328,0.20023668639053252,0.08148606934287907,0.8507700522582744,0.1432506887052342,1.0658687731058433e-06,0.9191125560868185,0.08598797059478724
228,0.1,3,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Does the coexistence of major depression and alcohol use disorder in adolescence lead to more severe depression outcomes? Results suggest that adolescents with both disorders experience longer and more severe depressive symptoms than those with just depression.,9.00066963956045e-07,0.524699864589389,0.24334593096497842,0.06891020566171123,0.5616853615733235,0.20023668639053252,0.06881045855620896,0.620246393646442,0.1432506887052342,9.000669639560454e-07,0.6807015326418209,0.08598797059478724
228,0.1,4,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Is depression outcome worse when major depression and alcohol use disorder occur together in adolescence? The data imply that comorbid cases have extended duration and greater severity of depressive symptoms relative to depression-only cases.,9.71124882163101e-07,0.5732030648812443,0.27110103300579474,0.07435048505605688,0.6512975202630105,0.20023668639053252,0.07424286317906757,0.7126197137774573,0.1432506887052342,9.711248821631017e-07,0.7760117124461461,0.08598797059478724
228,0.1,5,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Does comorbidity of major depression and alcohol use disorder during adolescence contribute to poorer depression outcomes? Findings reveal that individuals with both conditions suffer from longer-lasting and more intense depressive symptoms than those with depression alone.,9.237529366917303e-07,0.514362564858311,0.27110103300579474,0.0707236321264931,0.590672898446575,0.20023668639053252,0.07062126009716183,0.6500993567961237,0.1432506887052342,9.237529366917308e-07,0.7114731913085746,0.08598797059478724
228,0.1,6,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Are adolescents with both major depression and alcohol use disorder at risk for worse depression outcomes? The analyses suggest that comorbidity is associated with prolonged and more severe depressive episodes compared to having depression alone.,9.474389094274156e-07,0.5433501017315625,0.27110103300579474,0.07253705859127499,0.6205258615962568,0.20023668639053252,0.07243206163811469,0.6808710154628774,0.1432506887052342,9.474389094274162e-07,0.7432218896231544,0.08598797059478724
228,0.1,7,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Does having both major depression and alcohol use disorder in adolescence result in more severe depression? The results indicate that comorbid adolescents experience longer and more severe depressive symptoms than those with only depression.,9.71124882163101e-07,0.61521198491518,0.24082759550579474,0.07435048505605688,0.6512975202630105,0.20023668639053252,0.07424286317906757,0.7126197137774573,0.1432506887052342,9.711248821631017e-07,0.7760117124461461,0.08598797059478724
228,0.1,8,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Is the outcome of depression poorer in adolescents with comorbid major depression and alcohol use disorder? Evidence suggests that these individuals endure longer durations and increased severity of depressive symptoms compared to those with depression alone.,9.237529366917303e-07,0.514362564858311,0.27110103300579474,0.0707236321264931,0.590672898446575,0.20023668639053252,0.07062126009716183,0.6500993567961237,0.1432506887052342,9.237529366917308e-07,0.7114731913085746,0.08598797059478724
228,0.1,9,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Does the presence of both major depression and alcohol use disorder in adolescence lead to worse depression outcomes? The findings suggest that comorbidity is linked to longer and more severe depressive symptoms than depression alone.,9.474389094274156e-07,0.5433501017315625,0.27110103300579474,0.07253705859127499,0.6205258615962568,0.20023668639053252,0.07243206163811469,0.6808710154628774,0.1432506887052342,9.474389094274162e-07,0.7432218896231544,0.08598797059478724
228,0.1,10,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? 
Answer: The results of these analyses suggest that comorbidity of major depression and alcohol use disorder in adolescence may be associated with poorer depression outcomes. Specifically, individuals with comorbid depression and alcohol use disorder were more likely to have a longer duration of depressive symptoms and to experience more severe depressive symptoms compared to those with depression alone. 
",Are depression outcomes negatively impacted by comorbid major depression and alcohol use disorder in adolescence? The analyses indicate that individuals with both disorders have longer and more severe depressive symptoms than those with depression only.,9.474389094274156e-07,0.5433501017315625,0.27110103300579474,0.07253705859127499,0.6205258615962568,0.20023668639053252,0.07243206163811469,0.6808710154628774,0.1432506887052342,9.474389094274162e-07,0.7432218896231544,0.08598797059478724
229,0.1,1,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","In patients with coronary artery disease, severe hypotension can markedly decrease coronary blood flow, which may result in myocardial ischemia due to reduced oxygen delivery to the heart muscle.",5.447773729207631e-07,0.49089215304952116,0.07786328655500228,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6337237600891443,0.0,5.447773729207643e-07,0.652325186039691,0.0
229,0.1,2,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
",Profound hypotensive episodes in individuals with ischemic heart disease can lower coronary perfusion pressure enough to cause myocardial ischemic events by limiting oxygenated blood supply to the myocardium.,5.684633456564484e-07,0.5272597972203958,0.07786328655500228,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6729444732424268,0.0,5.684633456564497e-07,0.6931471805599458,0.0
229,0.1,3,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","Severe drops in blood pressure in patients suffering from coronary disease can lead to decreased coronary perfusion, increasing the risk of myocardial ischemia because the heart muscle receives less oxygenated blood.",4.974054274493925e-07,0.4218992815625704,0.07786328655500228,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5596157879354227,0.0,4.974054274493935e-07,0.5753641449035616,0.0
229,0.1,4,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","In those with ischemic heart conditions, significant hypotensive events can cause a reduction in coronary perfusion pressure, potentially triggering myocardial ischemia by diminishing oxygen supply to the heart tissue.",5.447773729207631e-07,0.49089215304952116,0.07786328655500228,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6337237600891443,0.0,5.447773729207643e-07,0.652325186039691,0.0
229,0.1,5,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","Profound hypotension in patients with coronary artery disease can reduce the pressure driving coronary blood flow, which may induce myocardial ischemia due to insufficient oxygen delivery to the heart muscle.",5.210914001850778e-07,0.45580083323825216,0.07786328655500228,0.03989538222520125,0.5243667208081457,0.039930555555555566,0.03983763390096312,0.5959834321062973,0.0,5.210914001850789e-07,0.6131044728864086,0.0
229,0.1,6,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","Patients with ischemic heart disease experiencing severe hypotensive episodes may suffer from decreased coronary perfusion pressure, leading to myocardial ischemia as the heart muscle gets less oxygenated blood.",5.684633456564484e-07,0.5272597972203958,0.07786328655500228,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6729444732424268,0.0,5.684633456564497e-07,0.6931471805599458,0.0
229,0.1,7,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","In coronary disease patients, profound hypotensive events can significantly lower coronary perfusion pressure, potentially causing myocardial ischemia by reducing oxygenated blood flow to the myocardium.",6.395212638635043e-07,0.6450428328767801,0.07786328655500228,0.048962514549110644,0.7210770150542003,0.039930555555555566,0.04889164160572749,0.8007778447523113,0.0,6.39521263863506e-07,0.8266785731844695,0.0
229,0.1,8,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","Severe hypotension in individuals with ischemic heart disease can cause a marked drop in coronary perfusion pressure, which may result in myocardial ischemic events due to decreased oxygen supply to the heart muscle.",4.5003348197802187e-07,0.35736076042499887,0.07786328655500228,0.03445510283085561,0.42258402649820326,0.039930555555555566,0.0344052292781045,0.4906229164484719,0.0,4.500334819780227e-07,0.5039051809214179,0.0
229,0.1,9,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","Profound hypotensive episodes in patients with coronary artery disease can diminish coronary perfusion pressure, increasing the likelihood of myocardial ischemia by limiting oxygenated blood reaching the heart.",5.921493183921337e-07,0.5650001252032428,0.07786328655500228,0.045335661619546885,0.6376954061151499,0.039930555555555566,0.04527003852382174,0.7137664677626816,0.0,5.921493183921352e-07,0.7357067949787415,0.0
229,0.1,10,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease, profound hypotensive events can significantly reduce coronary perfusion pressure, potentially leading to myocardial ischemia. This is because low blood pressure reduces the amount of oxygenated blood reaching the heart muscle. 
","In patients with ischemic heart disease, significant hypotensive events can reduce coronary perfusion pressure enough to cause myocardial ischemia by lowering the oxygenated blood flow to the myocardium.",5.684633456564484e-07,0.5272597972203958,0.07786328655500228,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6729444732424268,0.0,5.684633456564497e-07,0.6931471805599458,0.0
230,0.1,1,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should male HIV-infected patients over 52 years old with at least two additional cardiovascular risk factors be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening in this group was about four times more likely to yield positive results compared to the general population, suggesting that physicians might consider recommending more systematic SMI screening for these patients.",1.8948778188548325e-07,0.0451938914121337,0.060353798126951096,0.014507411718254981,0.08868079094970582,0.03073822121441168,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
230,0.1,2,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Is it advisable to screen HIV-infected males older than 52 years who have at least two other cardiovascular risk factors for silent myocardial ischemia with gated myocardial perfusion SPECT? The likelihood of a positive SMI screening in this group was approximately four times higher than in the general population, which could encourage physicians to recommend more routine SMI screening.",1.8948778188548325e-07,0.0451938914121337,0.060353798126951096,0.014507411718254981,0.08868079094970582,0.03073822121441168,0.014486412327622933,0.11187054323202528,0.015621063240110858,1.8948778188548325e-07,0.13580154115906407,0.0
230,0.1,3,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should screening for silent myocardial ischemia using gated myocardial perfusion SPECT be performed in male HIV-infected patients above 52 years old with two or more cardiovascular risk factors? These patients were about four times more likely to test positive for SMI than the general population, potentially prompting physicians to suggest more systematic screening.",3.316036182995957e-07,0.15439318337712482,0.060353798126951096,0.025387970506946217,0.1999064260599308,0.03073822121441168,0.025351221573340132,0.2251992285390294,0.015621063240110858,3.316036182995957e-07,0.25131442828090833,0.0
230,0.1,4,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","In male HIV-infected patients older than 52 years with at least two cardiovascular risk factors, is screening for silent myocardial ischemia via gated myocardial perfusion SPECT justified? The positive screening rate was roughly four times higher than in the general population, which may lead physicians to advocate for more consistent SMI screening.",3.552895910352811e-07,0.17381126923422752,0.060353798126951096,0.02720139697172809,0.21970905335611057,0.03073822121441168,0.027162023114293,0.24540193585654801,0.015621063240110858,3.552895910352811e-07,0.2719337154836441,0.0
230,0.1,5,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Is screening for silent myocardial ischemia using gated myocardial perfusion SPECT recommended for male HIV-infected patients over 52 years old who have at least two other cardiovascular risk factors? This group showed about a fourfold increase in positive SMI screening compared to the general population, possibly motivating physicians to encourage more systematic screening.",3.316036182995957e-07,0.15439318337712482,0.060353798126951096,0.025387970506946217,0.1999064260599308,0.03073822121441168,0.025351221573340132,0.2251992285390294,0.015621063240110858,3.316036182995957e-07,0.25131442828090833,0.0
230,0.1,6,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should male HIV-infected patients aged over 52 with two or more cardiovascular risk factors be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? The chance of a positive screening was nearly four times greater than in the general population, which might prompt physicians to advise more regular SMI screening.",3.789755637709665e-07,0.19361389653040728,0.060353798126951096,0.029014823436509962,0.23991176067362918,0.03073822121441168,0.028972824655245866,0.2660212230592838,0.015621063240110858,3.789755637709665e-07,0.29298712468147725,0.0
230,0.1,7,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Is it beneficial to screen male HIV-infected patients older than 52 years with at least two additional cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening was about four times more likely to be positive in this group than in the general population, potentially motivating physicians to recommend systematic screening.",3.079176455639103e-07,0.13534498840643172,0.060353798126951096,0.023574544042164344,0.1804883402028281,0.03073822121441168,0.023540420032387266,0.20539660124284964,0.015621063240110858,3.079176455639103e-07,0.23111172096338972,0.0
230,0.1,8,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","For male HIV-infected patients over 52 years old with two or more cardiovascular risk factors, should silent myocardial ischemia screening with gated myocardial perfusion SPECT be conducted? The likelihood of positive results was approximately four times higher than in the general population, which may encourage physicians to suggest more systematic screening.",3.789755637709665e-07,0.19361389653040728,0.060353798126951096,0.029014823436509962,0.23991176067362918,0.03073822121441168,0.028972824655245866,0.2660212230592838,0.015621063240110858,3.789755637709665e-07,0.29298712468147725,0.0
230,0.1,9,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Should physicians consider screening male HIV-infected patients older than 52 years with at least two other cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? Positive screening was about four times more frequent in this group compared to the general population, possibly motivating more systematic screening recommendations.",4.026615365066519e-07,0.2138166038479259,0.060353798126951096,0.030828249901291835,0.26053104787636494,0.03073822121441168,0.030783626196198732,0.28707463225711694,0.015621063240110858,4.026615365066519e-07,0.3144933299024406,0.0
230,0.1,10,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Is it appropriate to screen male HIV-infected patients above 52 years old with two or more cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? The screening positivity rate was roughly four times higher than in the general population, which might lead physicians to promote more systematic screening.",3.789755637709665e-07,0.19361389653040728,0.060353798126951096,0.029014823436509962,0.23991176067362918,0.03073822121441168,0.028972824655245866,0.2660212230592838,0.015621063240110858,3.789755637709665e-07,0.29298712468147725,0.0
231,0.1,1,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is robot-assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This research demonstrated for the first time that robot-assisted laparoscopic radical prostatectomy results in reduced blood loss and fewer transfusions compared to retropubic radical prostatectomy, indicating a less invasive method.",7.105791820705622e-08,0.049188666328096264,0.013303884405755584,0.005440279394345618,0.043721612314176816,0.01916457323037659,0.0054324046228586,0.042499213113674106,0.021417388369294285,7.105791820705622e-08,0.041100963555631864,0.023795359904818555
231,0.1,2,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Does robotically assisted laparoscopic radical prostatectomy offer a less invasive alternative to retropubic radical prostatectomy? Answer: The study revealed that robotically assisted laparoscopic radical prostatectomy is linked to decreased blood loss and a lower need for transfusions than retropubic radical prostatectomy, implying it is less invasive.",2.3685972735685406e-08,0.05613398518114998,0.023098395221215928,0.0018134264647818726,0.024573301853755503,0.0014902451164880426,0.0018108015409528666,0.0244549456677432,0.0010494778914937122,2.3685972735685406e-08,0.024298102261311794,0.0005527295193310314
231,0.1,3,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? Answer: Findings from this study indicate that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive procedure.",4.737194547137081e-08,0.08084623656566503,0.025302231346187434,0.0036268529295637453,0.04856133083502323,0.002916829812021182,0.003621603081905733,0.048328098854266255,0.0020526554379765236,4.737194547137081e-08,0.04802033420753293,0.0010803788339694455
231,0.1,4,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: How does robotically assisted laparoscopic radical prostatectomy compare in invasiveness to retropubic radical prostatectomy? Answer: This study found that robotically assisted laparoscopic radical prostatectomy leads to less blood loss and fewer transfusions than retropubic radical prostatectomy, pointing to a less invasive technique.",7.105791820705622e-08,0.049188666328096264,0.013303884405755584,0.005440279394345618,0.07753366990246713,0.004897905711710296,0.0054324046228586,0.07715657214167182,0.003460544030479129,7.105791820705622e-08,0.07664697281511579,0.0018279087932423985
231,0.1,5,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is robotically assisted laparoscopic radical prostatectomy a less invasive option than retropubic radical prostatectomy? Answer: According to this study, robotically assisted laparoscopic radical prostatectomy is connected with reduced blood loss and fewer transfusions relative to retropubic radical prostatectomy, indicating a less invasive approach.",4.737194547137081e-08,0.0862989521562576,0.026458287676236314,0.0036268529295637453,0.08402797995090827,0.026366049756031587,0.003621603081905733,0.05077335667188576,0.002251250683960135,4.737194547137081e-08,0.05044051459933652,0.0011882035402833654
231,0.1,6,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Does robotically assisted laparoscopic radical prostatectomy reduce invasiveness compared to retropubic radical prostatectomy? Answer: The study showed for the first time that robotically assisted laparoscopic radical prostatectomy is linked to less blood loss and fewer transfusions than retropubic radical prostatectomy, suggesting it is less invasive.",0.0,0.030806541358220585,0.020802514792899462,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
231,0.1,7,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is robotically assisted laparoscopic radical prostatectomy associated with less invasiveness than retropubic radical prostatectomy? Answer: This research demonstrated that robotically assisted laparoscopic radical prostatectomy results in lower blood loss and fewer transfusions compared to retropubic radical prostatectomy, implying a less invasive procedure.",7.105791820705622e-08,0.049188666328096264,0.013303884405755598,0.005440279394345618,0.07753366990246713,0.004897905711710296,0.0054324046228586,0.07715657214167182,0.003460544030479129,7.105791820705622e-08,0.07664697281511579,0.0018279087932423985
231,0.1,8,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Compared to retropubic radical prostatectomy, is robotically assisted laparoscopic radical prostatectomy less invasive? Answer: The study revealed that robotically assisted laparoscopic radical prostatectomy is associated with decreased blood loss and fewer transfusions, suggesting a less invasive approach.",1.8948778188548293e-07,0.16077498963838588,0.02365777190952023,0.014507411718254981,0.2216751554791192,0.014827852370440611,0.014486412327622933,0.22059006734562248,0.010532014209478899,1.8948778188548325e-07,0.2190754486314641,0.005589396752665381
231,0.1,9,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Is the robotically assisted laparoscopic radical prostatectomy procedure less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy involves less blood loss and fewer transfusions than retropubic radical prostatectomy, indicating a less invasive method.",2.3685972735685406e-08,0.05818043788090321,0.02321912509022689,0.0018134264647818726,0.05742706313623902,0.024227931700589914,0.0018108015409528666,0.025065707112430058,0.0010990481856038084,2.3685972735685406e-08,0.024902600569258304,0.0005796400951814454
231,0.1,10,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? 

Answer: This study showed for the first time that robotically assisted laparoscopic radical prostatectomy is associated with less blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive approach. 
","Question: Does robotically assisted laparoscopic radical prostatectomy present a less invasive alternative to retropubic radical prostatectomy? Answer: Findings from this study indicate that robotically assisted laparoscopic radical prostatectomy is linked to reduced blood loss and fewer transfusions compared to retropubic radical prostatectomy, suggesting a less invasive technique.",2.3685972735685406e-08,0.03427651663101727,0.03602747135668499,0.0018134264647818726,0.03703978086268389,0.04155822427126707,0.0018108015409528666,0.0244549456677432,0.0010494778914937122,2.3685972735685406e-08,0.024298102261311794,0.0005527295193310314
232,0.1,1,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
","This research introduces a new technique to deliver paclitaxel to the brain by temporarily disrupting the blood-brain barrier using Nd:YAG laser-induced thermo therapy, aiming to improve treatment outcomes for brain tumors.",6.632072365991903e-07,0.5636391212208229,0.06858710562414265,0.050775941013892475,0.627113530440361,0.035041322314049606,0.050702443146680314,0.6683919241113756,0.017851239669421492,6.632072365991914e-07,0.7114963192281416,0.0
232,0.1,2,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
","The study presents a novel method for enhancing paclitaxel delivery to the brain by locally opening the blood-brain barrier through Nd:YAG laser-induced thermo therapy, potentially increasing the effectiveness of brain tumor treatments.",6.39521263863505e-07,0.5308492983978312,0.06858710562414265,0.048962514549110596,0.5932119787646792,0.035041322314049606,0.04889164160572744,0.6333006043001066,0.017851239669421492,6.39521263863506e-07,0.6751286750572669,0.0
232,0.1,3,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
","A new concept is proposed in this study involving the use of Nd:YAG laser-induced thermo therapy to transiently open the blood-brain barrier, facilitating improved paclitaxel delivery for brain tumor therapy.",6.868932093348756e-07,0.5975406728965047,0.06858710562414265,0.052589367478674355,0.66220485025163,0.035041322314049606,0.05251324468763319,0.7047595682822503,0.017851239669421492,6.868932093348768e-07,0.7492366472109886,0.0
232,0.1,4,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",This investigation suggests a pioneering approach to temporarily breach the blood-brain barrier with Nd:YAG laser-induced thermo therapy to boost paclitaxel transport into the brain for better tumor treatment.,7.342651548062462e-07,0.6689996368786484,0.06858710562414265,0.056216220408238114,0.7363128224053517,0.035041322314049606,0.056134847769538934,0.7817206094183797,0.017851239669421492,7.342651548062476e-07,0.8292793548845259,0.0
232,0.1,5,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",The study explores a novel strategy to enhance paclitaxel delivery to brain tumors by using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier.,8.053230730133021e-07,0.7867826725350326,0.06858710562414265,0.06165649980258375,0.8589151444976846,0.035041322314049606,0.061567252392397555,0.9095539809282642,0.017851239669421492,8.053230730133038e-07,0.9628107475090495,0.0
232,0.1,6,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
","Researchers propose a new method to improve chemotherapy for brain tumors by using Nd:YAG laser-induced thermo therapy to transiently open the blood-brain barrier, allowing better paclitaxel penetration.",7.579511275419315e-07,0.7067399648614954,0.06858710562414265,0.058029646873019994,0.7755335355586341,0.035041322314049606,0.05794564931049181,0.8225426039386345,0.017851239669421492,7.57951127541933e-07,0.8718389693033215,0.0
232,0.1,7,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
","This work introduces a novel concept of using Nd:YAG laser-induced thermo therapy to temporarily disrupt the blood-brain barrier, thereby enhancing paclitaxel delivery to brain tumors.",8.053230730133021e-07,0.7867826725350326,0.06858710562414265,0.06165649980258375,0.8589151444976846,0.035041322314049606,0.061567252392397555,0.9095539809282642,0.017851239669421492,8.053230730133038e-07,0.9628107475090495,0.0
232,0.1,8,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",The study presents an innovative approach to increase paclitaxel delivery to the brain by locally opening the blood-brain barrier with Nd:YAG laser-induced thermo therapy for improved tumor treatment.,7.342651548062462e-07,0.6689996368786484,0.06858710562414265,0.056216220408238114,0.7363128224053517,0.035041322314049606,0.056134847769538934,0.7817206094183797,0.017851239669421492,7.342651548062476e-07,0.8292793548845259,0.0
232,0.1,9,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
","A new technique is proposed that uses Nd:YAG laser-induced thermo therapy to transiently open the blood-brain barrier, aiming to improve the efficacy of paclitaxel chemotherapy for brain tumors.",7.342651548062462e-07,0.6689996368786484,0.06858710562414265,0.056216220408238114,0.7363128224053517,0.035041322314049606,0.056134847769538934,0.7817206094183797,0.017851239669421492,7.342651548062476e-07,0.8292793548845259,0.0
232,0.1,10,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept.

Answer: This study proposes a novel approach for delivering paclitaxel, a chemotherapy drug, to the brain by temporarily opening the blood-brain barrier (BBB) using Nd:YAG laser-induced thermo therapy. The method aims to enhance paclitaxel delivery and treatment efficacy for brain tumors. 
",This research proposes a novel concept of locoregionally opening the blood-brain barrier using Nd:YAG laser-induced thermo therapy to facilitate enhanced delivery of paclitaxel for brain tumor treatment.,7.579511275419315e-07,0.7067399648614954,0.06858710562414265,0.058029646873019994,0.7755335355586341,0.035041322314049606,0.05794564931049181,0.8225426039386345,0.017851239669421492,7.57951127541933e-07,0.8718389693033215,0.0
233,0.1,1,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Is colorectal cancer in young patients a unique clinical entity?,1.4211583641411216e-06,1.9766082593862628,0.04338842975206611,0.10880558788691251,2.119679481715098,0.014702606371129419,0.10864809245717219,2.258782470335651,0.0,1.4211583641411235e-06,2.3978952727983693,0.0
233,0.1,2,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Could colorectal cancer in younger individuals represent a distinct clinical condition?,1.3974723914054364e-06,1.871247743728437,0.04338842975206611,0.10699216142213064,2.0018964460587143,0.014702606371129419,0.10683729091621931,2.125251077711129,0.0,1.3974723914054383e-06,2.2437445929711104,0.0
233,0.1,3,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Is colorectal cancer among young patients considered a separate clinical entity?,1.3974723914054364e-06,1.871247743728437,0.04338842975206611,0.10699216142213064,2.0018964460587143,0.014702606371129419,0.10683729091621931,2.125251077711129,0.0,1.3974723914054383e-06,2.2437445929711104,0.0
233,0.1,4,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Does colorectal cancer in young people constitute a distinct clinical syndrome?,1.3974723914054364e-06,1.871247743728437,0.04338842975206611,0.10699216142213064,2.0018964460587143,0.014702606371129419,0.10683729091621931,2.125251077711129,0.0,1.3974723914054383e-06,2.2437445929711104,0.0
233,0.1,5,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Is colorectal cancer in younger patients characterized as a unique clinical entity?,1.373786418669751e-06,1.7759375639241117,0.04338842975206611,0.10517873495734875,1.8965359304008884,0.014702606371129419,0.10502648937526644,2.0074680420547453,0.0,1.373786418669753e-06,2.1102132003465885,0.0
233,0.1,6,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Might colorectal cancer in young patients be a distinct clinical form?,1.3974723914054364e-06,1.871247743728437,0.04338842975206611,0.10699216142213064,2.0018964460587143,0.014702606371129419,0.10683729091621931,2.125251077711129,0.0,1.3974723914054383e-06,2.2437445929711104,0.0
233,0.1,7,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Is colorectal cancer in young individuals a different clinical entity?,1.4211583641411216e-06,1.9766082593862628,0.04338842975206611,0.10880558788691251,2.119679481715098,0.014702606371129419,0.10864809245717219,2.258782470335651,0.0,1.4211583641411235e-06,2.3978952727983693,0.0
233,0.1,8,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Could colorectal cancer in young patients be classified as a distinct clinical entity?,1.3501004459340656e-06,1.6889261869344816,0.04338842975206611,0.10336530849256688,1.8012257505965632,0.014702606371129419,0.10321568783431356,1.9021075263969194,0.0,1.3501004459340675e-06,1.9924301646902047,0.0
233,0.1,9,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Is colorectal cancer in young adults a separate clinical entity?,1.4211583641411216e-06,1.9766082593862628,0.04338842975206611,0.10880558788691251,2.119679481715098,0.014702606371129419,0.10864809245717219,2.258782470335651,0.0,1.4211583641411235e-06,2.3978952727983693,0.0
233,0.1,10,ai,"Question: Colorectal cancer in young patients: is it a distinct clinical entity? 
Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Emerging evidence suggests that these tumors possess unique molecular and genetic characteristics, often exhibiting a more aggressive biology and distinct response to treatment compared to their counterparts in older patients. Further research is crucial to understand this heterogeneity and develop targeted therapies for this growing population. 
",Does colorectal cancer in young patients represent a unique clinical entity?,1.3974723914054364e-06,1.871247743728437,0.04338842975206611,0.10699216142213064,2.0018964460587143,0.014702606371129419,0.10683729091621931,2.125251077711129,0.0,1.3974723914054383e-06,2.2437445929711104,0.0
234,0.1,1,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Can analyzing APC mutations aid in making treatment decisions for familial adenomatous polyposis? Since the age of onset and disease progression can be affected by the particular APC mutation, genetic testing can inform therapeutic approaches. For instance, individuals with truncating mutations might require earlier monitoring and possibly more intensive treatments.",9.474389094274162e-08,0.07847161544149417,0.0,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
234,0.1,2,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Is APC mutation analysis useful for guiding therapy in familial adenomatous polyposis? Because the specific APC mutation can influence when symptoms appear and how the disease progresses, genetic testing can assist in tailoring treatment plans. Patients with truncating mutations may need earlier surveillance and potentially more aggressive therapy.",1.4211583641411244e-07,0.14963993654674157,0.0212665406427221,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
234,0.1,3,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Does APC mutation testing help in therapeutic decision-making for familial adenomatous polyposis? Given that the disease's onset age and progression can depend on the APC mutation type, genetic analysis can support treatment choices. For example, those with truncating mutations could benefit from earlier screening and more intensive interventions.",1.4211583641411244e-07,0.14963993654674157,0.0212665406427221,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
234,0.1,4,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Can therapeutic decisions in familial adenomatous polyposis be informed by APC mutation analysis? Since the particular APC mutation can affect the age at which the disease manifests and its course, genetic testing can guide treatment strategies. Patients harboring truncating mutations may require earlier surveillance and possibly more aggressive treatment.",1.1842986367842703e-07,0.12797203516756062,0.020823902218198284,0.009067132323909363,0.10109611687136999,0.0,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
234,0.1,5,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Is genetic testing for APC mutations valuable in managing familial adenomatous polyposis therapy? Because the specific mutation influences disease onset and progression, analyzing APC mutations can help direct therapeutic decisions. For example, patients with truncating mutations might benefit from earlier and more rigorous monitoring and treatment.",1.8948778188548325e-07,0.19443596514002115,0.02221074380165289,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
234,0.1,6,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Can APC mutation analysis influence treatment strategies in familial adenomatous polyposis? As the age of disease manifestation and progression may vary with the APC mutation type, genetic testing can aid in therapeutic planning. Individuals with truncating mutations may need earlier surveillance and potentially more aggressive interventions.",1.8948778188548325e-07,0.19443596514002115,0.02221074380165289,0.014507411718254981,0.16705408466316607,0.0,0.014486412327622933,0.1706255170307629,0.0,1.8948778188548325e-07,0.17435338714477755,0.0
234,0.1,7,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Does analyzing APC mutations contribute to therapeutic choices in familial adenomatous polyposis? Since the specific mutation can impact the disease's onset and course, genetic testing can help tailor treatment. Patients with truncating mutations might require earlier monitoring and more intensive therapy.",3.079176455639103e-07,0.2814124594381848,0.0,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
234,0.1,8,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Can APC mutation testing guide therapeutic decisions in familial adenomatous polyposis? Because the disease's manifestation age and progression can be mutation-dependent, genetic analysis can inform treatment strategies. Those with truncating mutations may benefit from earlier surveillance and possibly more aggressive interventions.",3.079176455639103e-07,0.2814124594381848,0.0,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
234,0.1,9,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Is APC mutation analysis helpful for therapeutic decision-making in familial adenomatous polyposis? Given that the specific mutation can influence when the disease appears and how it progresses, genetic testing can assist in treatment planning. Patients with truncating mutations may need earlier and more intensive monitoring and treatment.",1.6580180914979784e-07,0.14165051706302645,0.0,0.012693985253473108,0.14458122881110835,0.0,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
234,0.1,10,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? 
Answer: As age at manifestation and course of the disease may be influenced by the specific APC mutation, genetic testing can help guide therapeutic strategies. For example, patients with truncating mutations may benefit from earlier surveillance and potentially more aggressive interventions. 
","Can genetic testing for APC mutations assist in therapeutic decisions for familial adenomatous polyposis? Since the age at disease onset and its progression may be affected by the APC mutation, such testing can guide therapy. For example, patients with truncating mutations could benefit from earlier surveillance and more aggressive interventions.",9.474389094274162e-08,0.07847161544149417,0.0,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
235,0.1,1,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Older adults participating in PICT who have more symptoms might trade quality of life for experimental therapies.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
235,0.1,2,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptoms be considered when choosing patients for phase I clinical trials? Answer: Older adults enrolled in PICT with a higher symptom burden may compromise their quality of life for experimental treatment.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,0.1,3,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms influence patient selection in phase I clinical trials? Answer: Older adults in PICT experiencing more symptoms may accept reduced quality of life in exchange for experimental treatment.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
235,0.1,4,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom presence relevant when evaluating patients for phase I clinical trials? Answer: Older adults with more symptoms enrolled in PICT might sacrifice quality of life to undergo experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.1,5,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms a factor in considering patients for phase I clinical trials? Answer: Older adults in PICT who have more symptoms may give up quality of life for the sake of experimental treatment.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
235,0.1,6,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Does symptom severity matter when enrolling patients in phase I clinical trials? Answer: Older adults with greater symptom burden in PICT may trade off quality of life for experimental therapies.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.1,7,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptom levels be taken into account for phase I clinical trial patient selection? Answer: Older adults enrolled in PICT with increased symptoms might sacrifice quality of life for experimental treatment.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,0.1,8,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms play a role in selecting patients for phase I clinical trials? Answer: Older adults in PICT with more symptoms may accept a decline in quality of life to receive experimental treatment.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
235,0.1,9,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom assessment important when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT who have more symptoms might compromise quality of life for experimental treatment.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,0.1,10,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms significant when deciding on patients for phase I clinical trials? Answer: Older adults participating in PICT with a higher number of symptoms may sacrifice quality of life for experimental treatment.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
236,0.1,1,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is a surgeon's prior experience a factor in their ability to perform transurethral resection of the prostate? The senior urologist was able to resect tissue at a rate four times greater than less experienced surgeons, suggesting that experience may help lower the risk of needing a secondary TURP due to recurring adenomas.",9.474389094274162e-08,0.07550755250814589,0.0,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
236,0.1,2,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does previous surgical experience affect the proficiency in performing transurethral resection of the prostate? The senior urologist resected tissue four times faster than inexperienced surgeons, indicating that experience might be crucial in minimizing the chance of secondary TURP from recurring adenomas.",3.552895910352811e-07,0.3184537311185349,0.0,0.02720139697172809,0.3254224004346309,0.0,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
236,0.1,3,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the skill to carry out transurethral resection of the prostate dependent on the surgeon's experience? The senior urologist removed tissue at a rate four times higher than that of less experienced surgeons, implying that experience could be key to reducing secondary TURP risk caused by recurring adenomas.",1.8948778188548325e-07,0.15718558352241319,0.0,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
236,0.1,4,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the surgeon's experience influence their ability to perform transurethral resection of the prostate? The senior urologist resected four times more tissue per unit time compared to inexperienced surgeons, suggesting that experience may be important to decrease the likelihood of secondary TURP due to adenoma recurrence.",2.3685972735685406e-07,0.20067069546215155,0.0,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
236,0.1,5,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the capability to perform transurethral resection of the prostate affected by the surgeon's previous experience? The senior urologist was able to resect tissue four times faster than less experienced surgeons, indicating that experience might be vital in lowering the risk of secondary TURP from recurring adenomas.",2.1317375462116866e-07,0.17869178874337655,0.0,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
236,0.1,6,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does prior experience impact a surgeon's ability to perform transurethral resection of the prostate? The senior urologist resected tissue at a rate four times greater than inexperienced surgeons, which suggests that experience may help reduce the risk of secondary TURP caused by recurring adenomas.",2.8423167282822487e-07,0.2461330695389088,0.0,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
236,0.1,7,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the ability to conduct transurethral resection of the prostate influenced by the surgeon's experience level? The senior urologist resected tissue four times more quickly than less experienced surgeons, implying that experience could be important in preventing secondary TURP due to recurring adenomas.",3.079176455639103e-07,0.2696635669491032,0.0,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
236,0.1,8,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the surgeon's previous experience affect their proficiency in transurethral resection of the prostate? The senior urologist was capable of resecting tissue four times faster than inexperienced surgeons, suggesting that experience may be crucial to reduce the risk of secondary TURP from recurring adenomas.",2.8423167282822487e-07,0.2461330695389088,0.0,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
236,0.1,9,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the skill in performing transurethral resection of the prostate dependent on the surgeon's prior experience? The senior urologist resected four times more tissue per time unit than less experienced surgeons, indicating that experience might be significant in lowering the risk of secondary TURP due to adenoma recurrence.",1.8948778188548325e-07,0.15718558352241319,0.0,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
236,0.1,10,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the surgeon's experience influence their ability to perform transurethral resection of the prostate? The senior urologist resected tissue at a rate four times higher than inexperienced surgeons, suggesting that experience may be important to minimize the risk of secondary TURP caused by recurring adenomas.",2.6054570009253947e-07,0.22314355131420927,0.0,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
237,0.1,1,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Does pretreatment with estradiol and antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not seem to enhance IVF results in the microdose leuprolide protocol versus the standard OCP in poor responders. Randomized trials with sufficient power are needed.,4.737194547137081e-08,0.01601776676871758,0.015239599241057,0.0036268529295637453,0.013846713931445542,0.03767781622452902,0.003621603081905733,0.012561206208669073,0.01922337562475971,4.737194547137081e-08,0.04000533461369837,0.0
237,0.1,2,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Is estradiol and antagonist pretreatment prior to microdose leuprolide beneficial for IVF outcomes in poor responders compared to oral contraceptive pills? Answer: E2 plus antagonist pretreatment does not improve IVF outcomes in the microdose leuprolide protocol compared to the standard oral contraceptive pill in poor responders. Well-powered randomized trials are required.,7.105791820705622e-08,0.11907352147166561,0.04215250360559132,0.005440279394345618,0.033681800587132216,0.01768614608708629,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
237,0.1,3,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Does using estradiol and antagonist pretreatment before microdose leuprolide improve IVF success in poor responders compared to oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not appear to improve IVF outcomes in the microdose leuprolide protocol relative to the standard OCP in poor responders. Adequately powered randomized trials are necessary.,4.737194547137081e-08,0.01601776676871758,0.015239599241057,0.0036268529295637453,0.013846713931445542,0.03767781622452902,0.003621603081905733,0.012561206208669073,0.01922337562475971,4.737194547137081e-08,0.04000533461369837,0.0
237,0.1,4,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Estradiol and antagonist pretreatment before microdose leuprolide: does it enhance IVF outcomes in poor responders compared to oral contraceptive pills? Answer: E2 plus antagonist pretreatment does not seem to improve IVF outcomes in poor responders undergoing the microdose leuprolide protocol versus the standard OCP. Randomized trials with adequate sample size are needed.,4.737194547137081e-08,0.04267727371333008,0.0034371524313941137,0.0036268529295637453,0.06770001319325347,0.020915933775470977,0.003621603081905733,0.06801298065346462,0.020707179930795856,4.737194547137081e-08,0.06829705626920646,0.020399305555555556
237,0.1,5,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Does pretreatment with estradiol and antagonist prior to microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not improve IVF outcomes in the microdose leuprolide protocol compared to the standard oral contraceptive pill in poor responders. Further randomized trials with sufficient power are warranted.,2.3685972735685406e-08,0.08013844052247565,0.06574391262619773,0.0018134264647818726,0.019660892174361955,0.0006955677038189695,0.0018108015409528666,0.019551204535685596,0.0003624288791975773,2.3685972735685406e-08,0.019418085857102696,0.0
237,0.1,6,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Is estradiol and antagonist pretreatment effective before microdose leuprolide in improving IVF outcomes for poor responders compared to oral contraceptive pills? Answer: E2 plus antagonist pretreatment does not appear to enhance IVF outcomes in poor responders using the microdose leuprolide protocol compared to the standard OCP. Randomized controlled trials with adequate power are needed.,0.0,0.0,1.3877787807814457e-17,0.0,0.05231299475924134,0.03767781622452902,0.0,0.026659506944613387,0.01922337562475971,0.0,0.0,0.0
237,0.1,7,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Does estradiol and antagonist pretreatment prior to microdose leuprolide improve IVF outcomes in poor responders versus oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not improve IVF outcomes in poor responders undergoing the microdose leuprolide protocol compared to the standard OCP. Well-powered randomized trials are necessary.,1.4211583641411244e-07,0.19159037432711834,0.04995390330372458,0.010880558788691236,0.18581381590153567,0.04669211346719623,0.0108648092457172,0.18635331695988677,0.04567657029195204,1.4211583641411244e-07,0.18677622567044505,0.04434829637641968
237,0.1,8,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Estradiol and antagonist pretreatment before microdose leuprolide: does it improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: E2 plus antagonist pretreatment does not seem to improve IVF outcomes in poor responders relative to the standard oral contraceptive pill in the microdose leuprolide protocol. Adequate randomized trials are required.,4.737194547137081e-08,0.09599628760255685,0.03972953656141211,0.0036268529295637453,0.09488225556815433,0.04018547033047326,0.003621603081905733,0.09573886787586217,0.04053216987093972,4.737194547137081e-08,0.0965887779247141,0.040742417383431435
237,0.1,9,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Does pretreatment with estradiol and antagonist before microdose leuprolide improve IVF outcomes in poor responders compared to oral contraceptive pills? Answer: Pretreatment with E2 and antagonist does not appear to improve IVF outcomes in poor responders using the microdose leuprolide protocol versus the standard OCP. Randomized trials with sufficient power are needed.,4.737194547137081e-08,0.12265579454717024,0.05713184244856649,0.0036268529295637453,0.09488225556815433,0.04018547033047326,0.003621603081905733,0.09573886787586217,0.04053216987093972,4.737194547137081e-08,0.0965887779247141,0.040742417383431435
237,0.1,10,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Question: Is estradiol and antagonist pretreatment prior to microdose leuprolide beneficial for IVF outcomes in poor responders compared to oral contraceptive pills? Answer: E2 plus antagonist pretreatment does not improve IVF outcomes in poor responders undergoing the microdose leuprolide protocol compared to the standard oral contraceptive pill. Further randomized trials with adequate power are warranted.,0.0,0.0770163533955488,0.0520388086564436,0.0,0.026156497379620447,0.018722183775471003,0.0,0.026659506944613387,0.0191766243752403,0.0,0.027182242374899523,0.019599999999999992
238,0.1,1,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Does minimal access major surgery cause less pain in newborns?,9.474389094274136e-07,1.6663039991188993,0.020399305555555556,0.07253705859127506,1.7917594692280554,0.0,0.07243206163811486,1.904237452654744,0.0,9.474389094274154e-07,2.0368819272610397,0.0
238,0.1,2,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Is pain reduced in newborns undergoing minimal access major surgery?,9.474389094274136e-07,1.6663039991188993,0.020399305555555556,0.07253705859127506,1.7917594692280554,0.0,0.07243206163811486,1.904237452654744,0.0,9.474389094274154e-07,2.0368819272610397,0.0
238,0.1,3,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Does minimal access surgery lead to less pain for newborns?,9.474389094274136e-07,1.6663039991188993,0.020399305555555556,0.07253705859127506,1.7917594692280554,0.0,0.07243206163811486,1.904237452654744,0.0,9.474389094274154e-07,2.0368819272610397,0.0
238,0.1,4,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Is there less pain with minimal access major surgery in newborns?,9.237529366917282e-07,1.5609434834610734,0.020399305555555556,0.07072363212649319,1.6739764335716716,0.0,0.07062126009716198,1.7707060600302222,0.0,9.237529366917301e-07,1.8827312474337807,0.0
238,0.1,5,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Do newborns experience less pain with minimal access major surgery?,9.474389094274136e-07,1.6663039991188993,0.020399305555555556,0.07253705859127506,1.7917594692280554,0.0,0.07243206163811486,1.904237452654744,0.0,9.474389094274154e-07,2.0368819272610397,0.0
238,0.1,6,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Is minimal access surgery less painful for newborns?,9.948108548987843e-07,1.917618427399805,0.020399305555555556,0.07616391152083882,2.079441541679836,0.0,0.0760536647200206,2.2407096892759575,0.0,9.948108548987862e-07,2.4423470353692043,0.0
238,0.1,7,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Does minimal access surgery result in reduced pain in newborns?,9.474389094274136e-07,1.6663039991188993,0.020399305555555556,0.07253705859127506,1.7917594692280554,0.0,0.07243206163811486,1.904237452654744,0.0,9.474389094274154e-07,2.0368819272610397,0.0
238,0.1,8,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Are newborns less hurt by minimal access major surgery?,9.71124882163099e-07,1.784087034775283,0.020399305555555556,0.07435048505605693,1.9252908618525773,0.0,0.07424286317906773,2.058388132482003,0.0,9.711248821631008e-07,2.219203484054994,0.0
238,0.1,9,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Does minimal access major surgery cause less discomfort in newborns?,9.474389094274136e-07,1.6663039991188993,0.020399305555555556,0.07253705859127506,1.7917594692280554,0.0,0.07243206163811486,1.904237452654744,0.0,9.474389094274154e-07,2.0368819272610397,0.0
238,0.1,10,ai,"Question: Does minimal access major surgery in the newborn hurt less? 

Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia in newborns is less invasive, potentially resulting in less pain. However, pain management protocols are crucial for all newborns undergoing surgery, regardless of the approach. 
",Is pain less severe in newborns after minimal access major surgery?,9.237529366917282e-07,1.5609434834610734,0.020399305555555556,0.07072363212649319,1.6739764335716716,0.0,0.07062126009716198,1.7707060600302222,0.0,9.237529366917301e-07,1.8827312474337807,0.0
239,0.1,1,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Does the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism contribute to chronic kidney disease in patients with hypertension? This is a complex topic under active investigation. Some research indicates a possible connection, especially concerning the insertion/deletion (I/D) polymorphism, but other studies find no correlation. Further studies are required to reach a conclusive answer.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
239,0.1,2,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Is there a relationship between ACE-1 gene polymorphism and chronic kidney disease in hypertensive individuals? The issue is complicated and currently being studied extensively. Certain studies point to a link, notably with the insertion/deletion (I/D) polymorphism, while others do not support this association. More research is necessary to clarify this matter.",2.3685972735685406e-08,0.02020270731751861,0.0,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
239,0.1,3,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Does polymorphism in the angiotensin-converting enzyme-1 (ACE-1) gene cause chronic kidney disease among patients with hypertension? This question is complex and actively researched. Some evidence suggests a connection, particularly involving the insertion/deletion (I/D) polymorphism, but other findings show no association. Additional research is needed for a definitive conclusion.",4.737194547137081e-08,0.04167269640056892,0.0,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
239,0.1,4,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Can the ACE-1 gene polymorphism lead to chronic kidney disease in hypertensive patients? This is a complex and ongoing area of research. Some studies have found a link, especially with the insertion/deletion (I/D) polymorphism, whereas others have not observed any association. More investigation is required to provide a clear answer.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
239,0.1,5,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Is chronic kidney disease in hypertensive patients linked to angiotensin-converting enzyme-1 (ACE-1) gene polymorphism? The topic is complex and under active study. While some research supports a connection, particularly with the insertion/deletion (I/D) polymorphism, other studies do not. Further research is essential to definitively resolve this question.",7.105791820705622e-08,0.06317890162153228,0.0,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
239,0.1,6,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Does the polymorphism of the ACE-1 gene influence the development of chronic kidney disease in hypertensive individuals? This is a complicated and actively researched subject. Some studies suggest an association, especially with the insertion/deletion (I/D) polymorphism, but others find no link. More research is needed to conclusively answer this question.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
239,0.1,7,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Is there an association between ACE-1 gene polymorphism and chronic kidney disease among patients with hypertension? This is a complex and actively investigated area. Some studies indicate a relationship, particularly for the insertion/deletion (I/D) polymorphism, while others do not. Additional research is necessary to reach a definitive conclusion.",4.737194547137081e-08,0.04167269640056892,0.0,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
239,0.1,8,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Does the angiotensin-converting enzyme-1 (ACE-1) gene polymorphism contribute to chronic kidney disease in hypertensive patients? This is a complex topic with ongoing research. Some studies suggest a link, especially involving the insertion/deletion (I/D) polymorphism, but others show no association. More research is needed to provide a definitive answer.",4.737194547137081e-08,0.04167269640056892,0.0,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
239,0.1,9,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Is the ACE-1 gene polymorphism a factor in chronic kidney disease among hypertensive patients? This area is complex and under active investigation. Some research points to a connection, particularly with the insertion/deletion (I/D) polymorphism, while other studies do not find an association. Further research is required to clarify this issue.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
239,0.1,10,ai,"Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is a complex and actively researched area.  While some studies suggest a link, particularly for the insertion/deletion (I/D) polymorphism, others have shown no association. More research is needed to definitively answer this question. 
","Does the presence of ACE-1 gene polymorphism lead to chronic kidney disease in patients with hypertension? This is a complex and actively researched question. Some studies suggest a link, especially concerning the insertion/deletion (I/D) polymorphism, but others have found no association. More research is needed to definitively answer this question.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
240,0.1,1,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Does receiving care at a birth center during a woman's first pregnancy affect her future reproductive outcomes?,9.948108548987847e-07,1.2161494075590564,0.051570247933884296,0.07616391152083878,1.3350010667323398,0.0,0.07605366472002054,1.3862943611198912,0.0,9.948108548987866e-07,1.442383827770934,0.0
240,0.1,2,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Is there any effect of birth center care during a woman's initial pregnancy on her later reproductive health?,9.711248821630993e-07,1.1555247857426214,0.051570247933884296,0.0743504850560569,1.2704625455947691,0.0,0.07424286317906767,1.3173014896329391,0.0,9.711248821631012e-07,1.3682758556172128,0.0
240,0.1,3,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Can care at a birth center during a first pregnancy influence a woman's future reproduction?,1.0421828003701555e-06,1.3496808001835792,0.051570247933884296,0.07979076445040253,1.478101910373013,0.0,0.07967526780192628,1.5404450409471488,0.0,1.0421828003701574e-06,1.6094379124341005,0.0
240,0.1,4,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
","Does the type of care during a first pregnancy, such as birth center care, impact future reproductive health?",9.711248821630993e-07,1.1555247857426214,0.051570247933884296,0.0743504850560569,1.2704625455947691,0.0,0.07424286317906767,1.3173014896329391,0.0,9.711248821631012e-07,1.3682758556172128,0.0
240,0.1,5,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Is a woman's future reproductive health affected by receiving birth center care in her first pregnancy?,1.0184968276344701e-06,1.280687928696627,0.051570247933884296,0.07797733798562065,1.4039939382192919,0.0,0.07786446626097342,1.4604023332736125,0.0,1.018496827634472e-06,1.5224265354444704,0.0
240,0.1,6,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Does birth center care in a woman's first pregnancy have any bearing on her subsequent reproductive health?,9.948108548987847e-07,1.2161494075590564,0.051570247933884296,0.07616391152083878,1.3350010667323398,0.0,0.07605366472002054,1.3862943611198912,0.0,9.948108548987866e-07,1.442383827770934,0.0
240,0.1,7,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Is there an impact on future reproduction from birth center care during a woman's first pregnancy?,1.0184968276344701e-06,1.280687928696627,0.051570247933884296,0.07797733798562065,1.4039939382192919,0.0,0.07786446626097342,1.4604023332736125,0.0,1.018496827634472e-06,1.5224265354444704,0.0
240,0.1,8,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
","Does the model of care, including birth center care, during a first pregnancy affect future reproductive outcomes?",9.948108548987847e-07,1.2161494075590564,0.051570247933884296,0.07616391152083878,1.3350010667323398,0.0,0.07605366472002054,1.3862943611198912,0.0,9.948108548987866e-07,1.442383827770934,0.0
240,0.1,9,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Does care at a birth center during a woman's first pregnancy influence her reproductive health later on?,9.948108548987847e-07,1.2161494075590564,0.051570247933884296,0.07616391152083878,1.3350010667323398,0.0,0.07605366472002054,1.3862943611198912,0.0,9.948108548987866e-07,1.442383827770934,0.0
240,0.1,10,ai,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? 
Answer: A woman's model of care during her first pregnancy, whether in a hospital, birth center, or at home, does not inherently influence her future reproductive health. Factors like overall health, lifestyle choices, and genetics play a larger role in subsequent pregnancies. 
",Does receiving birth center care in the first pregnancy affect a woman's future reproductive health?,1.0421828003701555e-06,1.3496808001835792,0.051570247933884296,0.07979076445040253,1.478101910373013,0.0,0.07967526780192628,1.5404450409471488,0.0,1.0421828003701574e-06,1.6094379124341005,0.0
241,0.1,1,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Is there a connection between the CYP2D6*4 allele and breast cancer risk? This allele may cause decreased activation of procarcinogens due to reduced enzyme activity, resulting in slower metabolism of some substances. Although some research indicates a potential association with lower breast cancer risk, more studies are required to confirm this link.",7.105791820705622e-08,0.03299642061781638,0.017382248520710075,0.005440279394345618,0.05826890812397556,0.0,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
241,0.1,2,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Does the CYP2D6*4 allele influence breast cancer risk? The allele is linked to diminished enzyme function, which might slow the metabolism of certain compounds and reduce procarcinogen activation. Some evidence points to a possible decreased risk of breast cancer, but additional research is necessary to verify this.",1.8948778188548325e-07,0.10899841447814751,0.03698224852071007,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
241,0.1,3,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","What is the relationship between the CYP2D6*4 allele and breast cancer risk? This allele is known for reduced enzyme activity, possibly leading to slower metabolism of procarcinogens. Some studies suggest it may be associated with a lower risk of breast cancer, though further investigation is needed to confirm this.",1.4211583641411244e-07,0.06643880005935099,0.03698224852071007,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
241,0.1,4,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Is there any association between the CYP2D6*4 allele and breast cancer risk? The allele causes reduced enzyme activity, potentially resulting in decreased transformation of procarcinogens and slower metabolism of certain compounds. While some studies hint at a reduced breast cancer risk, more research is required to establish a clear link.",1.1842986367842703e-07,0.07411123451212331,0.01658294296515451,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
241,0.1,5,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","How does the CYP2D6*4 allele relate to breast cancer risk? It is associated with decreased enzyme activity, which may slow the metabolism of procarcinogens. Some research suggests a possible reduced risk of breast cancer, but definitive conclusions await further studies.",3.55289591035281e-07,0.2740781648375976,0.03698224852071007,0.02720139697172809,0.33270575382573453,0.0,0.027162023114293,0.3403258059372023,0.0,3.552895910352811e-07,0.3483066942682149,0.0
241,0.1,6,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Can the CYP2D6*4 allele affect breast cancer risk? This allele leads to lower enzyme activity, potentially causing slower metabolism of certain compounds and decreased procarcinogen transformation. Some studies indicate a possible link to reduced breast cancer risk, though more research is needed.",3.079176455639103e-07,0.25787980185122406,0.012607248520710067,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
241,0.1,7,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Is the CYP2D6*4 allele linked to breast cancer risk? Due to its association with reduced enzyme activity, this allele may slow the metabolism of procarcinogens. Some evidence suggests a potential decrease in breast cancer risk, but further research is necessary to confirm this association.",2.6054570009253947e-07,0.20867909902065396,0.013739618135222544,0.0199476911126006,0.2326222952687531,0.0,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
241,0.1,8,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Does carrying the CYP2D6*4 allele impact breast cancer risk? The allele is connected to diminished enzyme function, which might reduce procarcinogen activation and slow metabolism. Some studies propose a possible reduced risk of breast cancer, yet more research is essential to establish this.",2.8423167282822487e-07,0.19997019268387417,0.03698224852071007,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
241,0.1,9,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","What impact does the CYP2D6*4 allele have on breast cancer risk? It is associated with reduced enzyme activity that may lead to slower metabolism of procarcinogens. Some findings suggest a potential link to lower breast cancer risk, but additional research is needed for confirmation.",2.6054570009253947e-07,0.20867909902065396,0.013739618135222544,0.0199476911126006,0.2326222952687531,0.0,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
241,0.1,10,ai,"Question: CYP2D6*4 allele and breast cancer risk: is there any association? 
Answer: A possible decreased transformation of procarcinogens. This allele is associated with reduced enzyme activity, potentially leading to slower metabolism of certain compounds. While some studies suggest a possible link to reduced breast cancer risk, further research is needed to establish a definitive connection. 
","Is there a potential association between the CYP2D6*4 allele and breast cancer risk? This allele results in decreased enzyme activity, possibly causing slower metabolism of certain compounds and reduced procarcinogen transformation. Some studies suggest a decreased breast cancer risk, but further investigation is required.",2.6054570009253947e-07,0.20867909902065396,0.013739618135222544,0.0199476911126006,0.2326222952687531,0.0,0.019918816950481533,0.23767165187712003,0.0,2.6054570009253947e-07,0.24294617861038903,0.0
242,0.1,1,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean individuals? Both hsCRP levels and carotid intima-media thickness (IMT) were notably elevated in subjects with carotid atherosclerosis compared to those without, indicating a significant association between hsCRP and carotid atherosclerosis development in healthy Koreans.",0.0,0.018362685475644458,0.026407251379631735,0.0,0.06027366787477817,0.04317155085498335,0.0,0.030806541358219697,0.02221074380165289,0.0,0.0,0.0
242,0.1,2,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Does high-sensitivity C-reactive protein correlate with carotid atherosclerosis among healthy Koreans? Subjects with carotid atherosclerosis showed significantly higher hsCRP levels and carotid IMT than those without, suggesting a strong relationship between hsCRP and carotid atherosclerosis in this population.",2.3685972735685374e-07,0.21513450399370626,0.006580323815735645,0.018134264647818726,0.1932201329185923,0.03714484387589542,0.018108015409528666,0.2205078869226864,0.02221074380165289,2.3685972735685406e-07,0.2578291093020999,0.0
242,0.1,3,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Korean people? The study found that both hsCRP and carotid IMT were significantly increased in individuals with carotid atherosclerosis, implying a strong connection between hsCRP and carotid atherosclerosis in healthy Koreans.",1.6580180914979784e-07,0.14644825527900407,0.05125714771333875,0.012693985253473108,0.1813072763257355,0.011488942972177146,0.012675610786670066,0.17475121924149972,0.004085823035454482,1.6580180914979784e-07,0.17327172127403623,0.0
242,0.1,4,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Are elevated hsCRP levels associated with carotid atherosclerosis in healthy Koreans? Findings revealed that subjects with carotid atherosclerosis had significantly higher hsCRP and carotid IMT values than those without, indicating a strong correlation between hsCRP and carotid atherosclerosis in healthy Korean individuals.",1.4211583641411244e-07,0.19791540051459267,0.04861221179517053,0.010880558788691236,0.18798087667497976,0.033865486182053706,0.0108648092457172,0.14784031154193933,0.0034125248964080625,1.4211583641411244e-07,0.14660347419187536,0.0
242,0.1,5,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Does carotid atherosclerosis in healthy Koreans relate to high-sensitivity C-reactive protein levels? Both hsCRP and carotid IMT were significantly greater in subjects with carotid atherosclerosis, suggesting a strong association between hsCRP and carotid atherosclerosis in this group.",2.6054570009253904e-07,0.23255468258794387,0.06433112730517548,0.0199476911126006,0.2620996538229363,0.007966979892836644,0.01991881695048154,0.24949542379593792,0.02221074380165289,2.6054570009253947e-07,0.2876820724517817,0.0
242,0.1,6,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is there an association between hsCRP and carotid atherosclerosis in healthy Korean subjects? The data showed significantly elevated hsCRP and carotid IMT in those with carotid atherosclerosis compared to those without, indicating a strong link between hsCRP and carotid atherosclerosis in healthy Koreans.",1.1842986367842703e-07,0.25880924076417333,0.20645916195102282,0.009067132323909363,0.24029332335027576,0.134283727552676,0.009054007704764333,0.22560593041015187,0.07655468829711257,1.1842986367842703e-07,0.2272660155670696,0.0763888888888889
242,0.1,7,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is high-sensitivity C-reactive protein connected to carotid atherosclerosis in healthy Koreans? Subjects with carotid atherosclerosis had significantly higher hsCRP levels and carotid IMT than those without, suggesting a strong correlation between hsCRP and carotid atherosclerosis in this population.",2.3685972735685374e-07,0.21513450399370626,0.0065803238157356725,0.018134264647818726,0.1932201329185923,0.03714484387589542,0.018108015409528666,0.2205078869226864,0.02221074380165289,2.3685972735685406e-07,0.2578291093020999,0.0
242,0.1,8,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Does high-sensitivity C-reactive protein have a relationship with carotid atherosclerosis in healthy Koreans? Both hsCRP and carotid IMT were significantly elevated in individuals with carotid atherosclerosis, indicating a strong association between hsCRP and carotid atherosclerosis in healthy Korean subjects.",2.1317375462116844e-07,0.2433433378612886,0.021362377305175484,0.016320838183036854,0.23971522752891072,0.015549881072907598,0.0162972138685758,0.2308451866537644,0.005544358239163438,2.1317375462116866e-07,0.2288415724288484,0.0
242,0.1,9,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Is there a significant correlation between hsCRP and carotid atherosclerosis in healthy Koreans? The study found that subjects with carotid atherosclerosis had significantly higher hsCRP levels and carotid IMT than those without, suggesting a strong link between hsCRP and carotid atherosclerosis in healthy Koreans.",9.474389094274162e-08,0.18309315150097927,0.11690611759278385,0.0072537058591274906,0.16559631938402353,0.05197368447043213,0.007243206163811466,0.19753211206095145,0.07421000126774085,9.474389094274162e-08,0.19928225688831658,0.07450693937180423
242,0.1,10,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? 

Answer: Both hsCRP levels and the carotid IMT were significantly higher in subjects with carotid atherosclerosis than in those without.  This suggests a strong correlation between hsCRP and the development of carotid atherosclerosis in healthy Koreans. 
","Are hsCRP levels associated with carotid atherosclerosis in healthy Korean individuals? Both hsCRP and carotid IMT were significantly higher in subjects with carotid atherosclerosis compared to those without, indicating a strong correlation between hsCRP and carotid atherosclerosis in healthy Koreans.",1.8948778188548314e-07,0.2607179520105847,0.059692310194824516,0.014507411718254981,0.24657045717368842,0.03890628245699068,0.014486412327622933,0.20240545093327666,0.004795429037853273,1.8948778188548325e-07,0.20067069546215155,0.0
243,0.1,1,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is the fragility of the esophageal mucosa a definitive endoscopic indicator of primary eosinophilic esophagitis? Primary eosinophilic esophagitis features a delicate esophageal lining that easily tears with minimal trauma during routine diagnostic endoscopy. This 'crpe-paper' appearance can help endoscopists recognize the disease even when other signs are absent.,7.105791820705622e-08,0.03591925397797047,0.018664014912833465,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
243,0.1,2,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other","Does fragile esophageal mucosa serve as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? In primary eosinophilic esophagitis, the esophageal mucosa is notably fragile and tears easily during minor trauma in diagnostic endoscopy. This 'crpe-paper' sign may help endoscopists identify the condition when other indicators are not evident.",7.105791820705622e-08,0.06541487868264895,0.0025385802469135646,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
243,0.1,3,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other","Is the fragile nature of the esophageal mucosa a hallmark endoscopic feature of primary eosinophilic esophagitis? The disease is marked by an esophageal mucosa that tears easily under slight trauma during diagnostic endoscopy, producing a 'crpe-paper' sign that can alert endoscopists to its presence even if other signs are missing.",2.3685972735685406e-08,0.00695734547176885,0.01953125000000001,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
243,0.1,4,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other",Can fragility of the esophageal mucosa be considered a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis is distinguished by a fragile esophageal lining that tears readily with minor trauma during diagnostic endoscopy. This 'crpe-paper' sign may signal the disease to endoscopists when other signs are not apparent.,2.3685972735685406e-08,0.00695734547176885,0.01953125000000001,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
243,0.1,5,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other","Is fragile esophageal mucosa an endoscopic hallmark of primary eosinophilic esophagitis? The condition is characterized by an esophageal mucosa that is easily torn by minor trauma during diagnostic endoscopy, producing a 'crpe-paper' sign that can alert endoscopists to the disease even in the absence of other signs.",9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
243,0.1,6,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other","Does the fragility of the esophageal mucosa indicate primary eosinophilic esophagitis during endoscopy? In this disease, the esophageal mucosa is fragile and tears easily with slight trauma during diagnostic endoscopy. This 'crpe-paper' sign may help endoscopists detect the disease when other signs are lacking.",1.6580180914979784e-07,0.159849922783736,0.00647039625884064,0.012693985253473108,0.18715768842535052,0.023795359904818555,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
243,0.1,7,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other","Is the fragile esophageal mucosa a diagnostic endoscopic sign pathognomonic for primary eosinophilic esophagitis? Primary eosinophilic esophagitis presents with an esophageal mucosa that tears easily under minor trauma during diagnostic endoscopy, creating a 'crpe-paper' sign that may alert endoscopists to the disease even when other signs are absent.",7.105791820705622e-08,0.06541487868264895,0.0025385802469135785,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
243,0.1,8,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other","Can the fragility of the esophageal mucosa be used as a pathognomonic endoscopic sign for primary eosinophilic esophagitis? This condition is characterized by a delicate esophageal mucosa that tears easily during minor trauma in diagnostic endoscopy, producing a 'crpe-paper' sign that may help endoscopists identify the disease when other signs are not visible.",4.737194547137081e-08,0.06801298065346462,0.020707179930795856,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
243,0.1,9,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is fragile esophageal mucosa a pathognomonic sign seen during endoscopy in primary eosinophilic esophagitis? The disease features an esophageal mucosa that is fragile and tears easily with minor trauma during diagnostic endoscopy. This 'crpe-paper' sign can alert endoscopists to the presence of the disease even if other signs are missing.,2.3685972735685406e-08,0.049626097839246874,0.021033527620247808,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
243,0.1,10,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crpe-paper"" sign may alert endoscopists to the presence of the disease when other","Does primary eosinophilic esophagitis cause fragility of the esophageal mucosa that serves as a pathognomonic endoscopic sign? The disease is marked by an esophageal mucosa that tears easily with minor trauma during diagnostic endoscopy, producing a 'crpe-paper' sign that may help endoscopists recognize the disease when other signs are absent.",2.3685972735685406e-08,0.049626097839246874,0.021033527620247815,0.0018134264647818726,0.04950041972606645,0.020823902218198284,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
244,0.1,1,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
","Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Enhancing hospital efficiency by reducing length of stay does not inherently harm patient care. Properly designed discharge planning programs, coupled with suitable support services, can guarantee patients receive timely and safe care despite shorter hospital stays.",2.1317375462116866e-07,0.17185025692665912,0.0,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
244,0.1,2,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
","Does earlier discharge from Winnipeg hospitals compromise care quality? Increasing hospital efficiency by shortening stays does not automatically reduce patient care quality. Effective discharge planning and adequate support services ensure patients get necessary care promptly and safely, even with shorter hospital stays.",3.789755637709665e-07,0.3294792011302423,0.0,0.029014823436509962,0.3364722366212134,0.0,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
244,0.1,3,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
",Is the quality of care affected by earlier patient discharge from Winnipeg hospitals? Improving hospital efficiency through shorter stays does not necessarily diminish patient care. Well-structured discharge planning programs with proper support can provide timely and safe care despite reduced hospital time.,3.789755637709665e-07,0.3294792011302423,0.0,0.029014823436509962,0.3364722366212134,0.0,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
244,0.1,4,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
",Does discharging patients sooner from Winnipeg hospitals adversely affect care quality? Streamlining hospital efficiency by decreasing length of stay does not inevitably compromise patient care. Thoughtful discharge planning and appropriate support services help maintain timely and safe patient care with shorter hospital stays.,3.552895910352811e-07,0.3053816495511823,0.0,0.02720139697172809,0.3117796240308417,0.0,0.027162023114293,0.3184537311185349,0.0,3.552895910352811e-07,0.3254224004346309,0.0
244,0.1,5,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
","Does earlier discharge from Winnipeg hospitals lead to poorer quality of care? Enhancing hospital efficiency by reducing length of stay does not always jeopardize patient care. Comprehensive discharge planning programs and adequate support services ensure patients receive necessary care safely and promptly, even with shorter stays.",2.8423167282822487e-07,0.23638877806423064,0.0,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
244,0.1,6,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
",Does releasing patients earlier from Winnipeg hospitals harm the quality of care? Improving hospital efficiency by shortening stays does not necessarily affect patient care negatively. Well-planned discharge programs and proper support services can ensure timely and safe care despite shorter hospital stays.,3.789755637709665e-07,0.3294792011302423,0.0,0.029014823436509962,0.3364722366212134,0.0,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
244,0.1,7,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
",Is patient care quality compromised by earlier discharge from Winnipeg hospitals? Increasing hospital efficiency by reducing length of stay does not inherently reduce care quality. Effective discharge planning combined with suitable support services ensures patients receive timely and safe care even with shorter hospital stays.,3.079176455639103e-07,0.25886163391628836,0.0,0.023574544042164344,0.26415157504158726,0.0,0.023540420032387266,0.2696635669491032,0.0,3.079176455639103e-07,0.27541197985996746,0.0
244,0.1,8,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
",Does earlier discharge from Winnipeg hospitals negatively impact patient care quality? Enhancing hospital efficiency by shortening length of stay does not automatically compromise care. Properly designed discharge planning and support services can maintain timely and safe patient care despite shorter hospital stays.,3.789755637709665e-07,0.3632912587185322,0.024375,0.029014823436509962,0.3364722366212134,0.0,0.028972824655245866,0.34377153910282665,0.0,3.789755637709665e-07,0.35139788683788886,0.0
244,0.1,9,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
",Does discharging patients earlier from Winnipeg hospitals affect the quality of care? Improving hospital efficiency by reducing length of stay does not necessarily compromise patient care. Well-designed discharge planning programs with appropriate support services ensure patients receive timely and safe care even with shorter hospital stays.,2.8423167282822487e-07,0.23638877806423064,0.0,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
244,0.1,10,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not necessarily compromise patient care.  Well-designed discharge planning programs, with appropriate support services, can ensure patients receive the care they need in a timely and safe manner, even when their hospital stay is shorter. 
",Does earlier discharge from Winnipeg hospitals adversely affect care quality? Streamlining hospital efficiency by shortening stays does not inherently compromise patient care. Thoughtful discharge planning and adequate support services can guarantee timely and safe care despite shorter hospital stays.,4.500334819780225e-07,0.4054651081081637,0.0,0.03445510283085558,0.41443377809092397,0.0,0.034405229278104466,0.4238142467763608,0.0,4.500334819780227e-07,0.4336359850748619,0.0
245,0.1,1,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a link between androgens and sexual desire in women? The current study found that FT and androstenedione were significantly correlated with sexual desire across the entire group of women. ADT-G did not show a stronger correlation than circulating androgens and thus is not a better measure than mass spectrometry of circulating androgens.,7.105791820705622e-08,0.05050248360208576,0.10792218377547103,0.005440279394345618,0.005678762610319854,0.036311854752580995,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
245,0.1,2,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Does a relationship exist between androgens and sexual desire in women? This study demonstrated that FT and androstenedione had a statistically significant correlation with sexual desire in the full cohort of women. ADT-G was not more strongly correlated than circulating androgens and therefore is not superior to measuring circulating androgens via mass spectrometry.,9.474389094274162e-08,0.022870744387819553,0.06921111111111115,0.0072537058591274906,0.052279090842322073,0.016711854752581003,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
245,0.1,3,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there an association between androgens and sexual desire in women? The present research showed that FT and androstenedione were significantly linked to sexual desire in the total female cohort. ADT-G did not correlate more strongly than circulating androgens and is thus not better than measuring circulating androgens by mass spectrometry.,1.4211583641411244e-07,0.06635697865223955,0.06620491493383746,0.010880558788691236,0.09339390473662901,0.01591254919702544,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
245,0.1,4,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Are androgens correlated with sexual desire in women? In this study, FT and androstenedione were found to have a statistically significant correlation with sexual desire among all women studied. ADT-G did not have a stronger correlation than circulating androgens and is therefore not superior to mass spectrometry measurement of circulating androgens.",1.4211583641411244e-07,0.03863109142984156,0.0858444545043006,0.010880558788691236,0.09339390473662901,0.01591254919702544,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
245,0.1,5,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a connection between androgens and sexual desire in women? The study revealed that FT and androstenedione were significantly correlated with sexual desire in the entire cohort of women. ADT-G did not correlate more strongly than circulating androgens and is not a better method than measuring circulating androgens by mass spectrometry.,1.1842986367842703e-07,0.044379771966069015,0.06773671344499775,0.009067132323909363,0.07262536298600031,0.01632018461513826,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,0.1,6,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Does androgen level relate to sexual desire in women? Findings from this study indicate that FT and androstenedione were statistically significantly correlated with sexual desire in the total group of women. ADT-G did not show a stronger correlation than circulating androgens and is thus not superior to mass spectrometry measurement of circulating androgens.,9.474389094274162e-08,0.03044826950140722,0.10720000000000002,0.0072537058591274906,0.052279090842322073,0.016711854752581003,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
245,0.1,7,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is sexual desire in women associated with androgens? The current study found a significant correlation between FT and androstenedione and sexual desire in the full cohort of women. ADT-G did not correlate more strongly than circulating androgens and is therefore not better than measuring circulating androgens by mass spectrometry.,1.8948778188548325e-07,0.08291882185289579,0.08337777777777783,0.014507411718254981,0.13627050418636832,0.015045314109858893,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
245,0.1,8,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Are circulating androgens linked to sexual desire in women? This study demonstrated that FT and androstenedione had a statistically significant correlation with sexual desire in the entire female cohort. ADT-G did not correlate more strongly than circulating androgens and is not superior to measuring circulating androgens via mass spectrometry.,1.8948778188548325e-07,0.1227009573713218,0.01750082644628101,0.014507411718254981,0.13627050418636832,0.015045314109858893,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
245,0.1,9,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a statistical correlation between androgens and sexual desire in women? The present study showed that FT and androstenedione were significantly correlated with sexual desire in the total cohort of women. ADT-G did not have a stronger correlation than circulating androgens and is therefore not superior to mass spectrometry measurement of circulating androgens.,7.105791820705622e-08,0.02434598622246531,0.0892,0.005440279394345618,0.03233826955493324,0.017088479127821285,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
245,0.1,10,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Does sexual desire in women correlate with androgen levels? The study found that FT and androstenedione were statistically significantly correlated with sexual desire in the entire cohort of women. ADT-G did not correlate more strongly than circulating androgens and is not a better measure than measuring circulating androgens by mass spectrometry.,1.4211583641411244e-07,0.03863109142984156,0.0858444545043006,0.010880558788691236,0.09339390473662901,0.01591254919702544,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
246,0.1,1,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does a medically supervised weight loss program before surgery enhance the results of bariatric surgery? MSWM seems to offer no extra advantage over standard preoperative care. Although certain studies indicate possible benefits in weight loss and metabolic health, these results are not consistently confirmed. More research is necessary to clearly determine MSWM's effectiveness in improving bariatric surgery outcomes.",9.474389094274162e-08,0.04669127590753952,0.015210944691004816,0.0072537058591274906,0.06899287148694988,0.0,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
246,0.1,2,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Is there an improvement in bariatric surgery outcomes with a preoperative medically supervised weight loss program? MSWM does not show additional benefits compared to usual preoperative care. Some research points to potential gains in weight loss and metabolic measures, but these are not reliably replicated. Further studies are required to conclusively evaluate MSWM's role in optimizing bariatric surgery results.",7.105791820705622e-08,0.052781833323533256,0.0016895655130768003,0.005440279394345618,0.05129329438754926,0.0,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
246,0.1,3,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does undergoing a medically supervised weight loss program before bariatric surgery improve surgical outcomes? Evidence suggests MSWM does not provide added benefits beyond standard preoperative care. While some studies report improvements in weight loss and metabolic factors, these findings lack consistent replication. Additional research is needed to definitively assess MSWM's impact on bariatric surgery outcomes.",1.6580180914979784e-07,0.12778177907099053,0.004233038523582783,0.012693985253473108,0.12405264866997845,0.0,0.012675610786670066,0.12629372532429084,0.0,1.6580180914979784e-07,0.12861737782209381,0.0
246,0.1,4,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Can a preoperative medically supervised weight loss program enhance the outcomes of bariatric surgery? MSWM appears to offer no significant advantage over standard preoperative protocols. Although some studies show potential improvements in weight loss and metabolic parameters, these results are not consistently observed. More research is necessary to firmly establish the role of MSWM in bariatric surgery success.",9.474389094274162e-08,0.04669127590753952,0.015210944691004816,0.0072537058591274906,0.06899287148694988,0.0,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
246,0.1,5,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does participation in a medically supervised weight loss program before surgery improve bariatric surgery results? MSWM does not seem to provide extra benefits compared to standard preoperative care. Some studies suggest possible improvements in weight loss and metabolic health, but these findings are not consistently replicated. Further investigation is needed to clarify MSWM's effectiveness in optimizing bariatric surgery outcomes.",7.105791820705622e-08,0.052781833323533256,0.0016895655130768211,0.005440279394345618,0.05129329438754926,0.0,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
246,0.1,6,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Is a preoperative medically supervised weight loss program beneficial for improving bariatric surgery outcomes? MSWM does not appear to offer additional benefits over standard preoperative care. While some research indicates potential improvements in weight loss and metabolic parameters, these results are not consistently confirmed. More studies are required to definitively determine MSWM's role in enhancing bariatric surgery outcomes.",9.474389094274162e-08,0.07101222961139797,0.0022921123169223345,0.0072537058591274906,0.06899287148694988,0.0,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
246,0.1,7,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does a medically supervised weight loss program before bariatric surgery improve the surgery's outcomes? MSWM does not seem to confer extra benefits compared to usual preoperative care. Although some studies suggest improvements in weight loss and metabolic factors, these findings are not consistently replicated. Further research is needed to conclusively assess MSWM's impact on bariatric surgery results.",1.1842986367842703e-07,0.08958041220022217,0.0029160849274268985,0.009067132323909363,0.08701137698962835,0.0,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
246,0.1,8,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Can a preoperative medically supervised weight loss program improve outcomes after bariatric surgery? MSWM does not appear to provide additional benefits beyond standard preoperative care. Some studies indicate potential improvements in weight loss and metabolic parameters, but these findings are not consistently observed. Additional research is necessary to definitively evaluate MSWM's role in bariatric surgery outcomes.",1.4211583641411244e-07,0.08329375682612294,0.01457362700672947,0.010880558788691236,0.10536051565782412,0.0,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
246,0.1,9,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Does engaging in a medically supervised weight loss program before bariatric surgery improve surgical outcomes? MSWM does not show added benefits compared to standard preoperative care. While some studies report possible improvements in weight loss and metabolic health, these results are not consistently replicated. More research is needed to clearly determine MSWM's effectiveness in optimizing bariatric surgery outcomes.",9.474389094274162e-08,0.07101222961139797,0.0022921123169223345,0.0072537058591274906,0.06899287148694988,0.0,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
246,0.1,10,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? 
Answer: MSWM does not appear to confer additional benefit as compared to standard preoperative care. While some studies suggest potential improvements in weight loss and metabolic parameters, these findings are not consistently replicated. Further research is needed to definitively assess the role of MSWM in optimizing bariatric surgery outcomes. 
","Is a preoperative medically supervised weight loss program effective in enhancing bariatric surgery outcomes? MSWM does not seem to offer additional benefits over standard preoperative care. Although some studies suggest improvements in weight loss and metabolic parameters, these findings are not consistently confirmed. Further studies are required to definitively assess MSWM's role in improving bariatric surgery results.",1.1842986367842703e-07,0.08958041220022217,0.0029160849274268985,0.009067132323909363,0.08701137698962835,0.0,0.009054007704764333,0.08855339734144341,0.0,1.1842986367842703e-07,0.09015109699429802,0.0
247,0.1,1,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
","What are the diagnostic features of child bipolar I disorder, and can the 'Treatment of Early Age Mania (TEAM)' sample be generalized?",7.57951127541931e-07,0.9257694758286994,0.0,0.05802964687302003,0.9555114450274376,0.0,0.05794564931049184,0.987386653557885,0.0,7.579511275419328e-07,1.0216512475319806,0.0
247,0.1,2,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Do the diagnostic characteristics of child bipolar I disorder in the 'Treatment of Early Age Mania (TEAM)' sample apply broadly?,8.053230730133017e-07,1.0258529343856808,0.0,0.06165649980258379,1.060871960685263,0.0,0.06156725239239759,1.0986122886681091,0.0,8.053230730133036e-07,1.1394342831883644,0.0
247,0.1,3,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Is the 'Treatment of Early Age Mania (TEAM)' sample representative for diagnosing child bipolar I disorder?,9.000669639560431e-07,1.2622417124499106,0.0,0.0689102056617113,1.3121863889661696,0.0,0.06881045855620908,1.366876275262788,0.0,9.00066963956045e-07,1.4271163556401447,0.0
247,0.1,4,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Can findings from the 'Treatment of Early Age Mania (TEAM)' sample be generalized to child bipolar I disorder diagnosis?,8.290090457489871e-07,1.0799201556559561,0.0,0.06346992626736567,1.1180303745252118,0.0,0.06337805393335046,1.1592369104845441,0.0,8.290090457489889e-07,1.203972804325935,0.0
247,0.1,5,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",How well do the diagnostic traits of child bipolar I disorder from the TEAM study generalize?,9.000669639560431e-07,1.2622417124499106,0.0,0.0689102056617113,1.3121863889661696,0.0,0.06881045855620908,1.366876275262788,0.0,9.00066963956045e-07,1.4271163556401447,0.0
247,0.1,6,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Does the 'Treatment of Early Age Mania (TEAM)' sample reflect the broader population for child bipolar I disorder diagnosis?,8.290090457489871e-07,1.0799201556559561,0.0,0.06346992626736567,1.1180303745252118,0.0,0.06337805393335046,1.1592369104845441,0.0,8.290090457489889e-07,1.203972804325935,0.0
247,0.1,7,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Are the diagnostic characteristics of child bipolar I disorder in the TEAM sample widely applicable?,9.237529366917285e-07,1.3312345839368627,0.0,0.07072363212649317,1.3862943611198908,0.0,0.07062126009716195,1.4469189829363245,0.0,9.237529366917303e-07,1.5141277326297748,0.0
247,0.1,8,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",To what extent does the 'Treatment of Early Age Mania (TEAM)' sample generalize for child bipolar I disorder diagnosis?,8.290090457489871e-07,1.0799201556559561,0.0,0.06346992626736567,1.1180303745252118,0.0,0.06337805393335046,1.1592369104845441,0.0,8.290090457489889e-07,1.203972804325935,0.0
247,0.1,9,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Is the 'Treatment of Early Age Mania (TEAM)' sample generalizable for understanding child bipolar I disorder?,9.000669639560431e-07,1.2622417124499106,0.0,0.0689102056617113,1.3121863889661696,0.0,0.06881045855620908,1.366876275262788,0.0,9.00066963956045e-07,1.4271163556401447,0.0
247,0.1,10,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (TEAM)"" sample generalize? 
Answer: Generalization of the TEAM sample findings is limited due to its specific inclusion criteria, focusing on children with severe mania. Further research with more diverse samples is needed to determine the generalizability of these findings. 
",Can the diagnostic findings from the TEAM sample be generalized to all children with bipolar I disorder?,8.763809912203577e-07,1.19770319131234,0.0,0.06709677919692941,1.2431935174792175,0.0,0.0669996570152562,1.2927683031090669,0.0,8.763809912203596e-07,1.3470736479666083,0.0
248,0.1,1,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular issues in young obese men? Our findings imply that reduced vessel compliance, shown by increased carotid artery pulsatility and resistance indexes, could signal early vascular dysfunction in young obese males, even in the absence of clear cardiovascular disease.",7.105791820705622e-08,0.015897694846942922,0.028695430632595678,0.005440279394345618,0.04023794003525882,0.014236279273227195,0.0054324046228586,0.0376889914602514,0.017286409693230302,7.105791820705622e-08,0.036732292247905196,0.019014022321703038
248,0.1,2,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Do increased carotid artery pulsatility and resistance indexes serve as early markers of vascular abnormalities in young obese males? The results indicate that decreased vessel compliance, reflected by higher carotid artery pulsatility and resistance indexes, may represent early vascular dysfunction in young obese men without obvious cardiovascular disease.",1.1842986367842703e-07,0.06479380954253466,0.023834691078214912,0.009067132323909363,0.08782036011028671,0.010713106918886009,0.009054007704764333,0.0837959367070722,0.01540724911927975,1.1842986367842703e-07,0.08255391090680186,0.018027436312582325
248,0.1,3,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Is an increase in carotid artery pulsatility and resistance indexes an early sign of vascular problems in young obese males? Our study suggests that impaired vessel compliance, demonstrated by elevated carotid artery pulsatility and resistance indexes, might be an early indicator of vascular dysfunction in young obese males, even when cardiovascular disease is not apparent.",4.737194547137081e-08,0.04563944115162144,0.005093033792122892,0.0036268529295637453,0.06975150318381296,0.02191214435699053,0.003621603081905733,0.06907936093124878,0.021355545495699423,4.737194547137081e-08,0.06940653554981457,0.021142417383431443
248,0.1,4,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Can increased carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese men? The data suggest that reduced vessel compliance, as evidenced by increased carotid artery pulsatility and resistance indexes, may indicate early vascular dysfunction in young obese males without overt cardiovascular disease.",1.1842986367842703e-07,0.09428943424721314,0.00438533057851237,0.009067132323909363,0.11795719404767535,0.010198212199282769,0.009054007704764333,0.11460247806529189,0.006570985116545455,1.1842986367842703e-07,0.11406060093225401,0.004609056539471058
248,0.1,5,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Are higher carotid artery pulsatility and resistance indexes early signs of vascular dysfunction in young obese males? Our findings suggest that diminished vessel compliance, indicated by increased carotid artery pulsatility and resistance indexes, could be an early marker of vascular abnormalities in young obese men, even without manifest cardiovascular disease.",7.105791820705622e-08,0.04418941650245101,0.009871441689623478,0.005440279394345618,0.04023794003525882,0.014236279273227195,0.0054324046228586,0.0376889914602514,0.017286409693230302,7.105791820705622e-08,0.036732292247905196,0.019014022321703038
248,0.1,6,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Do increased carotid artery pulsatility and resistance indexes indicate early vascular abnormalities in young obese males? The results suggest that decreased vessel compliance, as shown by elevated carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese men, even in the absence of overt cardiovascular disease.",0.0,0.053319013889226774,0.03533878048399437,0.0,0.027182242374899523,0.01901762081739848,0.0,0.02772588722239755,0.019824989940143867,0.0,0.02829172165550764,0.02034311182787588
248,0.1,7,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Is increased carotid artery pulsatility and resistance indexes an early indicator of vascular dysfunction in young obese males? Our findings imply that reduced vessel compliance, reflected by increased carotid artery pulsatility and resistance indexes, might be an early sign of vascular abnormalities in young obese men without clear cardiovascular disease.",7.105791820705622e-08,0.10077285981346673,0.02561466942148763,0.005440279394345618,0.06911907255858996,0.005877340329059455,0.0054324046228586,0.06718461616492988,0.003777512355540219,7.105791820705622e-08,0.06686912618529428,0.0026460123686346884
248,0.1,8,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Are elevated carotid artery pulsatility and resistance indexes early markers of vascular dysfunction in young obese males? The study suggests that impaired vessel compliance, indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular abnormalities in young obese men, even without evident cardiovascular disease.",7.105791820705622e-08,0.04418941650245101,0.009871441689623478,0.005440279394345618,0.04023794003525882,0.014236279273227195,0.0054324046228586,0.0376889914602514,0.017286409693230302,7.105791820705622e-08,0.036732292247905196,0.019014022321703038
248,0.1,9,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Can increased carotid artery pulsatility and resistance indexes be considered early signs of vascular dysfunction in young obese males? Our results indicate that decreased vessel compliance, as evidenced by increased carotid artery pulsatility and resistance indexes, might represent early vascular abnormalities in young obese men without overt cardiovascular disease.",9.474389094274162e-08,0.0689345797799481,0.0071779391448419105,0.0072537058591274906,0.0932449426631603,0.007994376074311263,0.007243206163811466,0.09061444908402416,0.005144400421012316,9.474389094274162e-08,0.09018744774573095,0.003605878992988247
248,0.1,10,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? 
Answer: Our results suggest that depressed vessel compliance, as indicated by increased carotid artery pulsatility and resistance indexes, may be an early sign of vascular dysfunction in young obese males, even without overt cardiovascular disease. 
","Are increased carotid artery pulsatility and resistance indexes early indicators of vascular dysfunction in young obese males? The findings suggest that reduced vessel compliance, shown by elevated carotid artery pulsatility and resistance indexes, may be an early sign of vascular abnormalities in young obese men, even in the absence of manifest cardiovascular disease.",0.0,0.026659506944613387,0.017402305887154385,0.0,0.027182242374899523,0.01901762081739848,0.0,0.02772588722239755,0.019824989940143867,0.0,0.02829172165550764,0.02034311182787588
249,0.1,1,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection necessary for metastatic carcinoma to the cervical nodes when the primary head and neck site is unknown? Answer: Based on our experience, definitive radiotherapy targeting the neck and possible mucosal sites, with or without prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. The role of neck dissection, especially in early nodal cases, is considered accordingly.",1.4211583641411244e-07,0.11502721129295335,0.019102570838475018,0.010880558788691264,0.1329338574746819,0.031217481789802295,0.0108648092457172,0.11297645060445483,0.01586888657648284,1.4211583641411244e-07,0.09237332013101707,0.0
249,0.1,2,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Should neck dissection be performed for metastatic carcinoma in cervical nodes from an unknown primary head and neck tumor? Answer: Our experience shows that definitive radiotherapy to the neck and potential mucosal areas, whether or not preceded by neck dissection, provides effective local control in unknown primary head and neck cancers. Neck dissection indications, particularly for early nodal involvement, are evaluated carefully.",2.1317375462116866e-07,0.18876760626911615,0.03785334268409447,0.01632083818303688,0.20579978907866536,0.049048751486325794,0.0162972138685758,0.18597175441249192,0.033293697978596916,2.1317375462116866e-07,0.1654667758656423,0.01694411414982164
249,0.1,3,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection required for metastatic carcinoma to cervical lymph nodes when the primary head and neck tumor is unknown? Answer: We have found that definitive radiotherapy to the neck and possible mucosal sites, regardless of prior neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. The decision for neck dissection, especially in early nodal disease, is made based on specific indications.",4.737194547137081e-08,0.050362444868271794,0.015580199013124234,0.003626852929563773,0.06976090043560035,0.029384756657483944,0.003621603081905733,0.05010484582002661,0.014921946740128552,4.737194547137081e-08,0.02985296314968444,0.0
249,0.1,4,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: For metastatic carcinoma in cervical nodes from an unknown head and neck primary, is neck dissection necessary? Answer: Our experience indicates that definitive radiotherapy to the neck and potential mucosal sites, whether preceded by neck dissection or not, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection is considered particularly for early nodal cases.",2.8423167282822487e-07,0.22942128604729728,0.06163037261574542,0.0217611175773825,0.21195385841879943,0.017236072637734686,0.0217296184914344,0.19105523676271208,0.0,2.8423167282822487e-07,0.1941560144409591,0.0
249,0.1,5,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Does metastatic carcinoma to cervical nodes from an unknown head and neck primary require neck dissection? Answer: According to our experience, definitive radiotherapy to the neck and possible mucosal sites, with or without neck dissection beforehand, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection is indicated especially in early nodal involvement.",3.316036182995957e-07,0.23401565224285203,0.010297855525652516,0.025387970506946245,0.24789880776277862,0.017851239669421492,0.025351221573340132,0.22677331936479117,0.0,3.316036182995957e-07,0.23052365861183333,0.0
249,0.1,6,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection indicated for metastatic carcinoma to cervical nodes from an unknown primary site in the head and neck? Answer: In our experience, definitive radiotherapy targeting the neck and potential mucosal sites, whether or not preceded by neck dissection, is effective for good local control in unknown primary head and neck cancers. Neck dissection is particularly considered for early nodal disease.",2.1317375462116866e-07,0.1440484333297647,0.006090713403160412,0.01632083818303688,0.137621377876048,0.0,0.0162972138685758,0.13976194237516282,0.0,2.1317375462116866e-07,0.14197026127038992,0.0
249,0.1,7,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Should patients with metastatic carcinoma to cervical nodes from an unknown head and neck primary undergo neck dissection? Answer: Our experience suggests that definitive radiotherapy to the neck and possible mucosal sites, regardless of prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection is especially indicated in early nodal cases.",3.079176455639103e-07,0.19146430225112976,0.007732504766612504,0.023574544042164372,0.22976492791866576,0.017538265306122455,0.023540420032387266,0.2087548138621127,0.0,3.079176455639103e-07,0.21217451994363756,0.0
249,0.1,8,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection necessary for metastatic carcinoma involving cervical nodes from an unknown head and neck primary tumor? Answer: We have observed that definitive radiotherapy to the neck and potential mucosal sites, whether or not preceded by neck dissection, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection is particularly indicated for early nodal involvement.",2.6054570009253947e-07,0.17907421479972285,0.007690215568058739,0.019947691112600627,0.19445431273889202,0.01694411414982164,0.019918816950481533,0.17366349405084325,0.0,2.6054570009253947e-07,0.17645643734155847,0.0
249,0.1,9,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: For metastatic carcinoma to cervical lymph nodes from an unknown head and neck primary, is neck dissection needed? Answer: Our experience shows that definitive radiotherapy to the neck and possible mucosal sites, with or without prior neck dissection, is effective in achieving good local control in unknown primary head and neck cancers. Neck dissection is especially considered for early nodal disease.",2.3685972735685406e-07,0.16140860599513562,0.006877471209509198,0.018134264647818754,0.1772555858459235,0.016661878770468257,0.018108015409528666,0.15656906069154353,0.0,2.3685972735685406e-07,0.15906469462968964,0.0
249,0.1,10,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection required in cases of metastatic carcinoma to cervical nodes from an unknown primary site in the head and neck? Answer: Based on our experience, definitive radiotherapy to the neck and potential mucosal sites, whether preceded by neck dissection or not, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection is particularly indicated for early nodal involvement.",1.6580180914979784e-07,0.14004012542247057,0.05338427527873894,0.012693985253473136,0.10536051565782323,0.0,0.012675610786670066,0.10697211955217067,0.0,1.6580180914979784e-07,0.10863384100279827,0.0
250,0.1,1,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy affect the activity of peri-sinusoidal cells? Laparoscopic surgery results in measurable injury to Kupffer and endothelial cells, indicated by increased post-operative HA serum levels. However, the harm to liver hepatocytes and perisinusoidal cells is clinically insignificant.",2.36859727356853e-08,0.00957052285622595,0.025623268698060954,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,0.1,2,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Laparoscopic techniques cause detectable damage to Kupffer and endothelial cells, as shown by elevated HA serum levels after surgery. The injury to liver hepatocytes and perisinusoidal cells does not have clinical consequences.",0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
250,0.1,3,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does undergoing laparoscopic cholecystectomy impact peri-sinusoidal cell function? The procedure leads to observable damage in Kupffer and endothelial cells, evidenced by raised post-operative HA serum levels. This damage to liver hepatocytes and perisinusoidal cells lacks clinical significance.",7.10579182070559e-08,0.04449669841405024,0.025623268698060954,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
250,0.1,4,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Can laparoscopic cholecystectomy alter peri-sinusoidal cell activity? Laparoscopic operations induce measurable harm to Kupffer and endothelial cells, reflected by increased HA serum levels post-surgery. The resulting damage to liver hepatocytes and perisinusoidal cells is not clinically relevant.",7.10579182070559e-08,0.04449669841405024,0.025623268698060954,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
250,0.1,5,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy cause changes in peri-sinusoidal cell activity? The laparoscopic approach causes detectable injury to Kupffer and endothelial cells, as indicated by elevated HA serum levels after the operation. The damage to liver hepatocytes and perisinusoidal cells has no clinical impact.",4.7371945471370706e-08,0.08555642983414735,0.025623268698060954,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
250,0.1,6,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is there an effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Laparoscopic procedures produce measurable damage to Kupffer and endothelial cells, demonstrated by increased post-operative HA serum levels. The injury to liver hepatocytes and perisinusoidal cells is clinically insignificant.",2.36859727356853e-08,0.00957052285622595,0.025623268698060954,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,0.1,7,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy influence the function of peri-sinusoidal cells? The surgery causes detectable damage to Kupffer and endothelial cells, shown by elevated HA serum levels post-operation. Damage to liver hepatocytes and perisinusoidal cells does not have clinical relevance.",4.73719454713706e-08,0.054565139391337336,0.0013829041414452105,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
250,0.1,8,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Laparoscopic surgery results in measurable injury to Kupffer and endothelial cells, as reflected by increased HA serum levels after surgery. The damage to liver hepatocytes and perisinusoidal cells is clinically insignificant.",4.73719454713706e-08,0.017097724225934918,0.025623268698060954,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
250,0.1,9,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is peri-sinusoidal cell activity affected by laparoscopic cholecystectomy? Laparoscopic procedures cause detectable damage to Kupffer and endothelial cells, indicated by elevated post-operative HA serum levels. The injury to liver hepatocytes and perisinusoidal cells has no clinical significance.",7.10579182070559e-08,0.04449669841405024,0.025623268698060954,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
250,0.1,10,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy impact peri-sinusoidal cell activity? The laparoscopic method causes measurable damage to Kupffer and endothelial cells, as evidenced by increased HA serum levels post-operation. The damage to liver hepatocytes and perisinusoidal cells lacks clinical importance.",7.10579182070559e-08,0.08300487511182508,0.002131833342755376,0.005440279394345618,0.08223809823697303,0.0,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
251,0.1,1,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does losing consciousness indicate neuropsychological decline following a concussion? The findings of this research question the significance of LOC as a predictor of neuropsychological test outcomes in the early recovery period after mild traumatic brain injury. Neuropsychological testing,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
251,0.1,2,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness a predictor of neuropsychological impairments after a concussion? This study's results challenge the role of LOC in forecasting neuropsychological test performance during the acute recovery phase from mild traumatic brain injury. Neuropsychological testing,1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
251,0.1,3,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Can loss of consciousness predict neuropsychological deficits post-concussion? The study's findings undermine the importance of LOC as an indicator of neuropsychological test results in the acute phase of mild traumatic brain injury recovery. Neuropsychological testing,1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
251,0.1,4,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness serve as a predictor for neuropsychological decline after concussion? The study suggests that LOC may not be a reliable predictor of neuropsychological test performance during the early recovery from mild traumatic brain injury. Neuropsychological testing,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
251,0.1,5,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness a reliable predictor of neuropsychological impairments following concussion? The results cast doubt on LOC's predictive value for neuropsychological test performance in the acute phase of mild traumatic brain injury recovery. Neuropsychological testing,1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
251,0.1,6,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does experiencing loss of consciousness predict neuropsychological deficits after a concussion? Findings from this study question the relevance of LOC as a predictor of neuropsychological test outcomes during the acute recovery phase of mild traumatic brain injury. Neuropsychological testing,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
251,0.1,7,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Can loss of consciousness forecast neuropsychological decrements after concussion? The study's results challenge the predictive importance of LOC for neuropsychological test performance in the acute phase following mild traumatic brain injury. Neuropsychological testing,2.3685972735685321e-07,0.2719337154836414,0.0,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
251,0.1,8,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness an effective predictor of neuropsychological decline after concussion? This research casts doubt on the significance of LOC in predicting neuropsychological test results during the early recovery from mild traumatic brain injury. Neuropsychological testing,1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
251,0.1,9,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness predict neuropsychological impairments after concussion? The findings question the role of LOC as a predictor of neuropsychological test performance in the acute phase of mild traumatic brain injury recovery. Neuropsychological testing,1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
251,0.1,10,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness a significant predictor of neuropsychological deficits following concussion? The study's results suggest that LOC may not be a key predictor of neuropsychological test outcomes during the acute recovery phase of mild traumatic brain injury. Neuropsychological testing,7.105791820705611e-08,0.14519999067269174,0.05113221329437545,0.005440279394345618,0.11246733753370775,0.026296566837107373,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
252,0.1,1,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Preoperative staging of patients with liver metastases from colorectal carcinoma. Does PET/CT provide additional value over multidetector CT? Answer: PET/CT plays a limited role in the hepatic staging of liver metastases from colorectal carcinoma. While PET/CT shows higher sensitivity in detecting extrahepatic disease in certain anatomical sites, its findings are",7.105791820705622e-08,0.04725840768922307,0.07749889145604336,0.005440279394345618,0.02169626334499153,0.060964083175803374,0.0054324046228586,0.006776256090909705,0.04158790170132326,7.105791820705622e-08,0.0364623430871176,0.0212665406427221
252,0.1,2,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In preoperative staging of liver metastases in colorectal cancer patients, does PET/CT offer benefits beyond multidetector CT? Answer: PET/CT has a restricted role in staging liver metastases from colorectal carcinoma. Although it is more sensitive in identifying extrahepatic disease in some locations, its results are",4.737194547137081e-08,0.04479602859327958,0.0009442031589307898,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
252,0.1,3,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: For preoperative staging of colorectal carcinoma liver metastases, does PET/CT add value compared to multidetector CT? Answer: PET/CT is of limited use in hepatic staging of liver metastases from colorectal cancer. It has higher sensitivity for detecting extrahepatic disease in certain anatomical areas, but its results are",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
252,0.1,4,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT improve preoperative staging of liver metastases in colorectal carcinoma patients compared to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of colorectal liver metastases. It offers greater sensitivity for detecting extrahepatic disease in some anatomical regions, yet its results are",4.737194547137081e-08,0.04479602859327958,0.0009442031589307898,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
252,0.1,5,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In patients with liver metastases from colorectal carcinoma, does PET/CT enhance preoperative staging beyond multidetector CT? Answer: PET/CT's role in hepatic staging of liver metastases from colorectal cancer is limited. It demonstrates higher sensitivity for extrahepatic disease detection in certain anatomical sites, but its results are",2.3685972735685406e-08,0.08242108232845125,0.04363340527398965,0.0018134264647818726,0.0835919894352144,0.04434829637641968,0.0018108015409528666,0.053979545877510304,0.02271498107084911,2.3685972735685406e-08,0.022989518224699523,0.0
252,0.1,6,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Preoperative staging of colorectal carcinoma liver metastases: does PET/CT add value over multidetector CT? Answer: PET/CT has a limited role in hepatic staging of liver metastases from colorectal carcinoma. Although it is more sensitive in detecting extrahepatic disease in some anatomical locations, its results are",4.737194547137081e-08,0.04479602859327958,0.0009442031589307898,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
252,0.1,7,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT contribute additional information to multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? Answer: PET/CT plays a limited role in hepatic staging of colorectal liver metastases. It shows higher sensitivity for detecting extrahepatic disease in certain anatomical areas, but its results are",2.3685972735685406e-08,0.02214741445367352,0.00046185441900629606,0.0018134264647818726,0.021978906718775004,0.0,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
252,0.1,8,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: For preoperative staging of liver metastases in colorectal carcinoma patients, is PET/CT superior to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of liver metastases from colorectal cancer. While it has greater sensitivity for extrahepatic disease detection in some anatomical locations, its results are",0.0,0.05899124940935696,0.042266517208517554,0.0,0.060273667874777725,0.043388429752066124,0.0,0.030806541358219697,0.02221074380165289,0.0,0.0,0.0
252,0.1,9,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In the preoperative staging of colorectal carcinoma liver metastases, does PET/CT offer advantages over multidetector CT? Answer: PET/CT is limited in its role for hepatic staging of liver metastases from colorectal carcinoma. It provides higher sensitivity for detecting extrahepatic disease in certain anatomical sites, but its results are",2.3685972735685406e-08,0.021667901379180954,0.00044263842452381755,0.0018134264647818726,0.02150620522096336,0.0,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
252,0.1,10,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does PET/CT add significant value to multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? Answer: PET/CT has a limited role in hepatic staging of colorectal liver metastases. Although it detects extrahepatic disease with higher sensitivity in some anatomical regions, its results are",4.737194547137081e-08,0.04479602859327958,0.0009442031589307898,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
253,0.1,1,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease in high-risk groups warranted? Long-term adherence to diet among those detected through screening was satisfactory. Their quality of life and bone mineral density matched those of non-coeliac individuals and the general population. Therefore, active screening in coeliac disease risk groups appears to be beneficial rather than detrimental.",4.737194547137081e-08,0.09769825720532266,0.04136408317580338,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.1,2,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Does screening for coeliac disease in at-risk populations make sense? Patients identified through screening maintained good long-term dietary compliance. Their quality of life and bone mineral density were similar to non-coeliac subjects and the general population. Hence, proactive screening in coeliac disease risk groups seems justified and not harmful.",2.3685972735685406e-08,0.03537474524045736,0.04014018095760509,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.1,3,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it justified to screen for coeliac disease in risk groups? Screen-detected patients showed good long-term adherence to dietary guidelines. Their quality of life and bone mineral density were comparable to those without coeliac disease and to the general population. Active screening in these risk groups appears reasonable and not harmful.,2.3685972735685406e-08,0.07735198506164442,0.04097241303836064,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
253,0.1,4,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should coeliac disease screening be conducted in risk groups? Those diagnosed via screening adhered well to dietary recommendations over the long term. Their quality of life and bone mineral density were on par with non-coeliac individuals and the general population. Thus, active screening in coeliac disease risk groups seems appropriate rather than harmful.",7.105791820705622e-08,0.11763907849271149,0.041740707551043664,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
253,0.1,5,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening justified in populations at risk? Patients detected through screening demonstrated good long-term dietary compliance. Their quality of life and bone mineral density were comparable to non-coeliac subjects and the general population. Active screening in these risk groups appears to be a reasonable approach rather than a harmful one.,4.737194547137081e-08,0.12488049958022218,0.060964083175803374,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.1,6,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it reasonable to screen for coeliac disease in risk groups? Screen-detected patients maintained good long-term dietary compliance. Their quality of life and bone mineral density were similar to those of non-coeliac individuals and the general population. Therefore, active screening in coeliac disease risk groups seems justified and not harmful.",0.0,0.056583443311015724,0.04056477762024782,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
253,0.1,7,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Does screening for coeliac disease in risk groups have justification? Patients identified by screening adhered well to dietary restrictions over the long term. Their quality of life and bone mineral density were comparable to non-coeliac subjects and the general population. Active screening in these risk groups appears to be a sensible and safe strategy.,9.474389094274162e-08,0.1371902830283971,0.042103136430241245,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
253,0.1,8,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is screening for coeliac disease in at-risk groups justified? Long-term dietary adherence among screen-detected patients was good. Their quality of life and bone mineral density were similar to those without coeliac disease and to the general population. Active screening in coeliac disease risk groups seems reasonable and not harmful.,2.3685972735685406e-08,0.004407390277968659,0.024102079395085046,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
253,0.1,9,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it appropriate to screen for coeliac disease in risk groups? Patients detected through screening showed good long-term compliance with dietary recommendations. Their quality of life and bone mineral density were comparable to non-coeliac individuals and the general population. Active screening in these risk groups appears to be justified rather than harmful.,4.737194547137081e-08,0.12488049958022218,0.060964083175803374,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,0.1,10,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening in risk groups warranted? Screen-detected patients maintained good long-term dietary compliance. Their quality of life and bone mineral density were on par with non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be a reasonable and safe approach.,4.737194547137081e-08,0.04528440554808055,0.002568974675436278,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
254,0.1,1,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: We conclude that the heightened cardiovascular risk associated with the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. However, we observe increased sensitivity in NIDDM patients carrying the ACE DD genotype.",2.3685972735685406e-08,0.048072159366075784,0.020330555555555574,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
254,0.1,2,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? Answer: Our findings indicate that the elevated cardiovascular risk in individuals with the DD genotype is not caused by insulin resistance or fibrinolytic dysfunction. On the other hand, NIDDM subjects with the ACE DD genotype show increased sensitivity.",7.105791820705622e-08,0.03525119042990932,0.016469444444444446,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
254,0.1,3,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele a potential gene for insulin resistance? Answer: We determine that the increased cardiovascular risk of the DD genotype does not arise from insulin resistance or fibrinolysis issues. Conversely, NIDDM patients with the ACE DD genotype exhibit heightened sensitivity.",9.474389094274162e-08,0.08820350236903352,0.0034578741965105575,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,0.1,4,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: We conclude that the cardiovascular risk elevation in DD genotype carriers is not mediated by insulin resistance or fibrinolytic abnormalities. In contrast, NIDDM individuals with the ACE DD genotype demonstrate increased sensitivity.",2.3685972735685406e-08,0.020889916991175816,0.0007802015363968726,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
254,0.1,5,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele associated with insulin resistance? Answer: Our conclusion is that the increased cardiovascular risk linked to the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. Conversely, NIDDM subjects with the ACE DD genotype show greater sensitivity.",9.474389094274162e-08,0.08820350236903352,0.0034578741965105575,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,0.1,6,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the insertion allele of the ACE gene I/D polymorphism be a candidate gene for insulin resistance? Answer: We find that the increased cardiovascular risk in DD genotype individuals is not mediated by insulin resistance or fibrinolytic dysfunction. However, NIDDM patients with the ACE DD genotype have increased sensitivity.",2.3685972735685406e-08,0.02133437618373879,0.0008118618278758691,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
254,0.1,7,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism implicated as a candidate gene for insulin resistance? Answer: We conclude that the DD genotype's increased cardiovascular risk is not caused by insulin resistance or fibrinolysis abnormalities. Conversely, NIDDM subjects with the ACE DD genotype display increased sensitivity.",4.737194547137081e-08,0.014251352598789513,0.019106653337357282,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
254,0.1,8,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism insertion allele a candidate gene for insulin resistance? Answer: Our results show that the elevated cardiovascular risk in DD genotype carriers is not mediated through insulin resistance or fibrinolytic abnormalities. On the other hand, NIDDM individuals with the ACE DD genotype exhibit increased sensitivity.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
254,0.1,9,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism represent a candidate gene for insulin resistance? Answer: We conclude that the increased cardiovascular risk associated with the DD genotype is not due to insulin resistance or fibrinolysis abnormalities. Conversely, NIDDM patients with the ACE DD genotype demonstrate heightened sensitivity.",0.0,0.02772588722239755,0.019824989940143867,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
254,0.1,10,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a potential candidate gene for insulin resistance? Answer: We determine that the increased cardiovascular risk seen in the DD genotype is not mediated by insulin resistance or fibrinolytic abnormalities. However, NIDDM subjects with the ACE DD genotype show increased sensitivity.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
255,0.1,1,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical","Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? In this study, employing an endoscope during VPS surgeries did not raise the infection risk.",1.894877818854824e-07,0.2274906230323297,0.029384756657483937,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
255,0.1,2,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is the simultaneous use of a neuroendoscope linked to higher ventriculoperitoneal shunt infection rates? Our study found that endoscope use during VPS procedures did not increase infection risk.,1.658018091497971e-07,0.1897502950494827,0.029384756657483937,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
255,0.1,3,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does simultaneous neuroendoscope use impact ventriculoperitoneal shunt infection incidence? The current study showed no increased infection risk with endoscope use in VPS operations.,2.842316728282236e-07,0.39454470769549665,0.029384756657483937,0.021761117577382555,0.45198512374305855,0.0,0.021729618491434483,0.47000362924573613,0.0,2.8423167282822477e-07,0.48954822531870645,0.0
255,0.1,4,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the concurrent use of a neuroendoscope influence ventriculoperitoneal shunt infection occurrence? Findings indicate that endoscope use during VPS did not elevate infection risk.,2.605457000925383e-07,0.3500929451246626,0.029384756657483937,0.019947691112600675,0.4054651081081646,0.0,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
255,0.1,5,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is there an effect of simultaneous neuroendoscope use on ventriculoperitoneal shunt infection rates? This study demonstrated no increased risk when an endoscope was used during VPS.,2.131737546211677e-07,0.26671133618561216,0.029384756657483937,0.016320838183036916,0.3184537311185349,0.0,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
255,0.1,6,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the use of a neuroendoscope at the same time affect the frequency of ventriculoperitoneal shunt infections? The present research found no higher infection risk with endoscope use in VPS procedures.,9.47438909427412e-08,0.08438977939165726,0.029384756657483937,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
255,0.1,7,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does simultaneous neuroendoscope application alter the incidence of ventriculoperitoneal shunt infections? Our findings reveal no increased infection risk during VPS with endoscope use.,2.842316728282236e-07,0.39454470769549665,0.029384756657483937,0.021761117577382555,0.45198512374305855,0.0,0.021729618491434483,0.47000362924573613,0.0,2.8423167282822477e-07,0.48954822531870645,0.0
255,0.1,8,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is the incidence of ventriculoperitoneal shunt infection affected by simultaneous neuroendoscope use? The study concluded that endoscope use during VPS does not increase infection risk.,2.36859727356853e-07,0.30753333070586697,0.029384756657483937,0.018134264647818796,0.36101334553733055,0.0,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
255,0.1,9,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does using a neuroendoscope simultaneously change the likelihood of ventriculoperitoneal shunt infections? Results show no increased infection risk with endoscope use in VPS surgeries.,2.605457000925383e-07,0.3500929451246626,0.029384756657483937,0.019947691112600675,0.4054651081081646,0.0,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
255,0.1,10,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the simultaneous employment of a neuroendoscope impact ventriculoperitoneal shunt infection rates? The study found no rise in infection risk when an endoscope was used during VPS.,1.894877818854824e-07,0.2274906230323297,0.029384756657483937,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
256,0.1,1,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation analysis aid in making therapeutic decisions for familial adenomatous polyposis? Answer: Since the age of onset and disease progression can vary significantly even among carriers of the same germline mutations, treatment choices should rely on colonoscopic observations in each patient rather than the mutation location. Nevertheless, in patients with mutations",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
256,0.1,2,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is APC mutation analysis useful for guiding therapy in familial adenomatous polyposis? Answer: Because the age at which symptoms appear and the disease course can differ widely, even among individuals with identical germline mutations, therapeutic decisions should be informed by colonoscopy results in each patient instead of the mutation site. However, in patients with mutations",2.3685972735685406e-08,0.006736750945891323,0.017851239669421492,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
256,0.1,3,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Does APC mutation analysis influence therapeutic decisions in familial adenomatous polyposis? Answer: Given that the age of disease manifestation and progression may vary considerably, even among carriers of the same germline mutations, treatment decisions should be based on colonoscopic findings for each patient rather than the mutation's location. Still, in patients with mutations",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
256,0.1,4,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can analysis of APC mutations impact treatment choices in familial adenomatous polyposis? Answer: Since the age at which the disease appears and its progression can be quite variable, even among those with identical germline mutations, therapy decisions should depend on colonoscopy findings in individual patients rather than mutation site. However, in patients with mutations",4.737194547137081e-08,0.01161238772230444,0.017851239669421492,0.0036268529295637453,0.037041271680350096,0.0,0.003621603081905733,0.03774032798284743,0.0,4.737194547137081e-08,0.038466280827795796,0.0
256,0.1,5,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is APC mutation testing helpful for therapeutic decision-making in familial adenomatous polyposis? Answer: Because the age of onset and disease course may vary even among carriers of the same germline mutations, treatment should be guided by colonoscopic findings in each patient rather than the mutation location. Nonetheless, in patients with mutations",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,0.1,6,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation analysis guide therapy in familial adenomatous polyposis? Answer: As the age at disease onset and progression can differ widely, even in individuals with identical germline mutations, therapeutic decisions should be based on colonoscopic findings in each patient rather than mutation site. However, in patients with mutations",1.6580180914979784e-07,0.10877613617595294,0.017851239669421492,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
256,0.1,7,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Does analyzing APC mutations help in therapeutic decisions for familial adenomatous polyposis? Answer: Since the age of manifestation and disease progression may vary, even among carriers of identical germline mutations, treatment choices should be based on colonoscopic findings in individual patients rather than mutation location. However, in patients with mutations",1.4211583641411244e-07,0.08857342885843433,0.017851239669421492,0.010880558788691236,0.11551288712184427,0.0,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
256,0.1,8,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation analysis be used to inform treatment decisions in familial adenomatous polyposis? Answer: Because the age at which symptoms appear and the disease course can be variable, even among those with the same germline mutations, therapy should be guided by colonoscopic findings in each patient rather than mutation site. However, in patients with mutations",0.0,0.024755256448569796,0.017851239669421492,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
256,0.1,9,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is APC mutation analysis relevant for therapeutic decisions in familial adenomatous polyposis? Answer: Given that the age of onset and disease progression may vary even among carriers of identical germline mutations, treatment decisions should rely on colonoscopic findings in individual patients rather than the mutation location. However, in patients with mutations",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,0.1,10,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation analysis affect therapeutic decision-making in familial adenomatous polyposis? Answer: Since the age at manifestation and disease course can be quite variable, even among carriers of the same germline mutations, therapy decisions should be based on colonoscopic findings in each patient rather than mutation site. However, in patients with mutations",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
257,0.1,1,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Are general practice features linked to the adoption of an IT innovation in primary care? Answer: The analysis indicates that the structural traits of a practice do not correlate with the adoption of a new IT tool, but usage might be affected by post-graduate training in the specific clinical area. For this diabetes system, the involvement of practice nurses was essential.",2.3685972735685406e-08,0.039719759135047106,0.0168265292641036,0.0018134264647818726,0.03963420796987549,0.016661878770468257,0.0018108015409528666,0.01680711831638071,0.0,2.3685972735685406e-08,0.01709443335929972,0.0
257,0.1,2,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Do characteristics of general practices affect the uptake of IT innovations in primary care? Answer: Findings reveal that structural aspects of a practice are not related to the adoption of new IT facilities, though usage may be influenced by post-graduate education in the relevant clinical field. In the case of this diabetes system, practice nurse participation was crucial.",9.474389094274162e-08,0.04587382847518118,0.014986149584487515,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
257,0.1,3,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Does the nature of general practice impact the adoption of IT innovations in primary care? Answer: The study shows that structural features of a practice are not linked to the uptake of new IT technology, but its use could be influenced by advanced education in the pertinent clinical condition. For this diabetes system, the role of practice nurses was vital.",4.737194547137081e-08,0.011929350116359316,0.0322222222222222,0.0036268529295637453,0.03333642026759165,0.0,0.003621603081905733,0.03390155167568043,0.0,4.737194547137081e-08,0.03448617607116855,0.0
257,0.1,4,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Are general practice characteristics determinants of IT innovation uptake in primary care? Answer: Analyses demonstrate that structural characteristics of a practice do not affect the adoption of new IT facilities, but usage may depend on post-graduate education related to the clinical condition. For this diabetes system, practice nurse involvement was key.",2.6054570009253947e-07,0.15058957938141493,0.0322222222222222,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
257,0.1,5,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Do the features of general practices influence the adoption of IT innovations in primary care? Answer: The data show that structural characteristics of a practice are not associated with the uptake of new IT tools, but usage might be shaped by post-graduate education in the relevant clinical area. Practice nurse use was critical for this diabetes system.",1.1842986367842703e-07,0.03936394427118994,0.0322222222222222,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
257,0.1,6,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Does the structure of general practices affect the uptake of IT innovations in primary care? Answer: Results indicate that structural aspects of a practice are not linked to the adoption of new IT facilities, but usage may be influenced by post-graduate education in the specific clinical condition. Practice nurse involvement was essential for this diabetes system.",1.4211583641411244e-07,0.057063521370590564,0.0322222222222222,0.010880558788691236,0.10354067894083929,0.0,0.0108648092457172,0.10536051565782412,0.0,1.4211583641411244e-07,0.10724553035359774,0.0
257,0.1,7,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Are general practice structural characteristics related to IT innovation adoption in primary care? Answer: The analyses reveal no association between practice structure and uptake of new IT tools, but usage might be influenced by post-graduate education in the relevant clinical field. Practice nurse use was critical for this diabetes system.",2.8423167282822487e-07,0.1703922066775947,0.0322222222222222,0.02176111757738247,0.21905356606268356,0.0,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
257,0.1,8,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Do general practice attributes impact the uptake of IT innovations in primary care? Answer: Findings suggest that structural characteristics of a practice do not determine adoption of new IT facilities, but usage may be affected by post-graduate education in the clinical condition concerned. Practice nurse involvement was vital for this diabetes system.",2.3685972735685406e-07,0.13117149352431223,0.0322222222222222,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
257,0.1,9,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Is the uptake of IT innovations in primary care influenced by general practice characteristics? Answer: The study finds no link between structural features of a practice and adoption of new IT tools, but usage could be influenced by post-graduate education in the relevant clinical area. Practice nurse use was crucial for this diabetes system.",1.8948778188548325e-07,0.11910328333998166,0.01371029626992602,0.014507411718254981,0.1405819506211894,0.0,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
257,0.1,10,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Question: Do general practice traits affect the adoption of IT innovations in primary care? Answer: Analysis shows that structural characteristics of a practice are not associated with uptake of new IT facilities, but usage may be influenced by post-graduate education in the relevant clinical condition. Practice nurse involvement was key for this diabetes system.",2.1317375462116866e-07,0.11212329855361913,0.0322222222222222,0.016320838183036854,0.1596301455918825,0.0,0.0162972138685758,0.16251892949777424,0.0,2.1317375462116866e-07,0.1655144384775733,0.0
258,0.1,1,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","How does living in an urban environment affect the risk of non-communicable diseases in Thailand, and does the timing of urban exposure matter? Urban living is linked to higher rates of non-communicable diseases, especially among individuals who relocate to cities later in life. This indicates that early life exposure to urban settings might offer some protection against these diseases, emphasizing the need to study the long-term health effects of urbanization.",1.4211583641411244e-07,0.09288522797952403,0.0013792671993201975,0.010880558788691236,0.09237332013101707,0.0,0.0108648092457172,0.09381875521765437,0.0,1.4211583641411244e-07,0.09531017980432477,0.0
258,0.1,2,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","What is the relationship between urban living and non-communicable disease risk in Thailand, and does the timing of moving to urban areas influence this risk? Increased urbanicity correlates with a higher prevalence of non-communicable diseases, particularly for those who move to urban areas later in life. This implies that early exposure to urban environments could be protective against such diseases, underscoring the importance of examining urbanization's long-term health consequences.",1.1842986367842703e-07,0.02952278019617971,0.05892401283180118,0.009067132323909363,0.056867273732144064,0.014921946740128554,0.009054007704764333,0.07878087785311383,0.0,1.1842986367842703e-07,0.08004270767353727,0.0
258,0.1,3,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","Does the timing of living in an urban environment impact the risk of non-communicable diseases in Thailand? Urban living is associated with a rise in non-communicable diseases, especially among people who migrate to cities later in life. This suggests that early urban exposure may help reduce the risk of these diseases, highlighting the significance of understanding urbanization's long-term health effects.",9.474389094274162e-08,0.09058563927759344,0.01798768467621029,0.0072537058591274906,0.09059300141453264,0.017236072637734686,0.007243206163811466,0.0678225963387602,0.0,9.474389094274162e-08,0.06899287148694988,0.0
258,0.1,4,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","In Thailand, how does living in urban areas influence the risk of non-communicable diseases, and does the timing of urban exposure matter? Urbanicity is linked to increased non-communicable disease prevalence, particularly in those who move to urban areas later in life. This suggests early urban exposure might offer some protection, pointing to the importance of studying the long-term health impacts of urbanization.",4.737194547137081e-08,0.055708463954575294,0.016880323420644435,0.0036268529295637453,0.03278982282299214,0.0,0.003621603081905733,0.03333642026759165,0.0,4.737194547137081e-08,0.03390155167568043,0.0
258,0.1,5,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","What role does the timing of urban living play in the risk of non-communicable diseases in Thailand? Living in urban environments is associated with higher rates of non-communicable diseases, especially for individuals who relocate to cities later in life. This indicates that early exposure to urban settings may provide protective effects, emphasizing the need to understand the long-term health outcomes of urbanization.",4.737194547137081e-08,0.03298232688703617,0.0005200023124060614,0.0036268529295637453,0.03278982282299214,0.0,0.003621603081905733,0.03333642026759165,0.0,4.737194547137081e-08,0.03390155167568043,0.0
258,0.1,6,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","How does the timing of moving to urban areas affect non-communicable disease risk in Thailand? Urban living correlates with increased prevalence of non-communicable diseases, particularly among those who move later in life. This suggests early urban exposure may confer some protection, highlighting the importance of understanding urbanization's long-term health impacts.",3.316036182995957e-07,0.2293097558821806,0.015868886576482836,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
258,0.1,7,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","Does the timing of urban exposure influence non-communicable disease risk in Thailand? Urbanicity is associated with higher non-communicable disease rates, especially in individuals who migrate to urban areas later in life. This implies that early urban exposure might be protective, underscoring the importance of studying the long-term health effects of urbanization.",3.079176455639103e-07,0.26455882300945754,0.02406166897907273,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
258,0.1,8,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","What is the impact of living in urban environments on non-communicable disease risk in Thailand, considering the timing of urban exposure? Increased urbanicity is linked to higher non-communicable disease prevalence, particularly among those who move to urban areas later in life. This suggests early exposure to urban settings may offer protection, highlighting the need to understand urbanization's long-term health consequences.",9.474389094274162e-08,0.09058563927759344,0.017987684676210296,0.0072537058591274906,0.06669137449867257,0.0,0.007243206163811466,0.0678225963387602,0.0,9.474389094274162e-08,0.06899287148694988,0.0
258,0.1,9,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","How does the timing of residence in urban areas affect the risk of non-communicable diseases in Thailand? Urban living is associated with increased non-communicable disease prevalence, especially for those who relocate later in life. This indicates that early urban exposure may provide some protective benefits, emphasizing the importance of understanding the long-term health impacts of urbanization.",1.8948778188548325e-07,0.11379686876033634,0.015868886576482836,0.014507411718254981,0.13815033848081626,0.0,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
258,0.1,10,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? 

Answer: Urbanicity was associated with increases in the prevalence of non-communicable diseases (NCDs), particularly in those who moved to urban areas later in life. This suggests that early exposure to urban environments may provide some protection against NCDs, highlighting the importance of understanding the long-term health impacts of urbanization. 
","In Thailand, does the timing of living in urban environments affect non-communicable disease risk? Urbanicity correlates with higher rates of non-communicable diseases, particularly among individuals who move to urban areas later in life. This suggests that early exposure to urban environments might protect against these diseases, highlighting the importance of studying the long-term health effects of urbanization.",1.6580180914979784e-07,0.14528887615479746,0.019796408348071334,0.012693985253473108,0.1198011998126205,0.0,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
259,0.1,1,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is anxiety caused by withdrawal in alcoholism linked to a deficiency in beta-endorphin? Our findings provide initial proof that reduced beta-endorphin levels during alcohol withdrawal might play a role in the anxiety commonly experienced in this condition.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,0.1,2,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Our results offer the first evidence that decreased beta-endorphin during alcohol withdrawal could contribute to the anxiety frequently observed in this state.,9.47438909427412e-08,0.12921173148000697,0.0,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
259,0.1,3,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is the anxiety seen during alcohol withdrawal in alcoholism due to a lack of beta-endorphin? Our study presents the first indication that lowered beta-endorphin levels during withdrawal may be a factor in the anxiety commonly associated with this phase.,1.184298636784265e-07,0.10459716770411998,0.026296566837107373,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
259,0.1,4,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is withdrawal-related anxiety in alcoholism caused by beta-endorphin deficiency? Our data provide initial evidence that diminished beta-endorphin during alcohol withdrawal may be linked to the anxiety often present during this period.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
259,0.1,5,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Does a deficiency in beta-endorphin cause anxiety during alcohol withdrawal in alcoholism? Our findings give the first evidence that reduced beta-endorphin levels during withdrawal might contribute to the anxiety commonly experienced.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
259,0.1,6,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is the anxiety induced by withdrawal in alcoholism based on a beta-endorphin shortage? Our results offer the first proof that lowered beta-endorphin during alcohol withdrawal may be involved in the anxiety frequently occurring in this state.,4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
259,0.1,7,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is withdrawal-induced anxiety in alcoholism related to beta-endorphin deficiency? Our findings provide initial evidence that decreased beta-endorphin during alcohol withdrawal could be a factor in the anxiety commonly seen during this condition.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
259,0.1,8,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is the anxiety during alcohol withdrawal in alcoholism caused by a beta-endorphin deficit? Our study provides the first evidence that reduced beta-endorphin levels during withdrawal may contribute to the anxiety often observed in this state.,2.36859727356853e-08,0.010920400412667952,0.029384756657483937,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
259,0.1,9,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is anxiety during withdrawal in alcoholism due to beta-endorphin deficiency? Our results give the first indication that lowered beta-endorphin during alcohol withdrawal might play a role in the anxiety commonly experienced during this phase.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,0.1,10,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Is withdrawal-induced anxiety in alcoholism a result of beta-endorphin deficiency? Our data provide the first evidence that decreased beta-endorphin during alcohol withdrawal may contribute to the anxiety frequently present in this condition.,4.73719454713706e-08,0.06252035698133351,0.0,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
260,0.1,1,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts a real entity? Answer: Based on our study findings and international literature, the concept of the globulomaxillary cyst is no longer supported.",7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,0.1,2,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts truly exist? Answer: Our research and global literature indicate that the term globulomaxillary cyst is no longer valid.,1.658018091497971e-07,0.28768207245178257,0.0,0.012693985253473157,0.30010459245033916,0.0,0.012675610786670115,0.3136575588550423,0.0,1.6580180914979768e-07,0.32850406697203516,0.0
260,0.1,3,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the globulomaxillary cyst a genuine condition? Answer: According to our study and worldwide data, the existence of the globulomaxillary cyst is not justified.",9.47438909427412e-08,0.2696752099205817,0.08264462809917354,0.007253705859127518,0.22061631794995806,0.04338842975206613,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.1,4,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts an actual pathological entity? Answer: The results from our study and international sources suggest that the globulomaxillary cyst is no longer a justified diagnosis.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
260,0.1,5,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts really exist? Answer: Our findings and international literature confirm that the globulomaxillary cyst entity is no longer warranted.,1.658018091497971e-07,0.28768207245178257,0.0,0.012693985253473157,0.30010459245033916,0.0,0.012675610786670115,0.3136575588550423,0.0,1.6580180914979768e-07,0.32850406697203516,0.0
260,0.1,6,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is there evidence supporting the existence of globulomaxillary cysts? Answer: Both our study and international literature show that the globulomaxillary cyst is no longer a valid entity.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
260,0.1,7,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts recognized as a distinct entity? Answer: The data from our research and global literature indicate that the globulomaxillary cyst is no longer justified.,4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
260,0.1,8,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Does the globulomaxillary cyst exist as a clinical entity? Answer: According to our study and international literature, the globulomaxillary cyst is no longer a justified concept.",4.73719454713706e-08,0.18074599993217522,0.07638888888888888,0.003626852929563759,0.13241281558092455,0.03993055555555556,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
260,0.1,9,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Are globulomaxillary cysts considered a real pathological entity? Answer: Our study results and international data demonstrate that the globulomaxillary cyst is no longer justified.,9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,0.1,10,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the globulomaxillary cyst a valid diagnosis? Answer: Based on our research and international literature, the globulomaxillary cyst entity is no longer supported.",1.184298636784265e-07,0.31725762999561047,0.08616780045351473,0.009067132323909398,0.26780779269691823,0.04535147392290251,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
261,0.1,1,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea impact aerobic fitness? In a US Air Force cohort, OSA generally does not lead to reduced aerobic fitness based on cycle ergometry tests. Yet, individuals with an apnea-hypopnea index above 20 show a significant decline in aerobic fitness relative to the normal population. This study",1.4211583641411244e-07,0.06964781478416526,0.034539419581109676,0.010880558788691236,0.06783131708282175,0.03767781622452902,0.0108648092457172,0.09594281514771996,0.01922337562475971,1.4211583641411244e-07,0.12516314295400566,0.0
261,0.1,2,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Is aerobic fitness affected by obstructive sleep apnea? Among US Air Force members, OSA does not typically predict lower aerobic fitness as measured by cycle ergometry. However, those with an apnea-hypopnea index exceeding 20 exhibit a statistically significant reduction in aerobic fitness compared to normal individuals. This study",1.6580180914979784e-07,0.13194428009705783,0.03155025844760563,0.012693985253473108,0.08933752230378511,0.03767781622452902,0.012675610786670066,0.11792172186649497,0.01922337562475971,1.6580180914979784e-07,0.14763599880606337,0.0
261,0.1,3,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea influence aerobic fitness levels? In a study of the US Air Force population, OSA was not associated with decreased aerobic fitness measured via cycle ergometry. Nevertheless, patients with an apnea-hypopnea index over 20 demonstrated a significant drop in aerobic fitness relative to the normal population. This study",9.474389094274162e-08,0.06586142506066661,0.026233900422914264,0.0072537058591274906,0.02615862068225283,0.03767781622452902,0.007243206163811466,0.05338320072892344,0.01922337562475971,9.474389094274162e-08,0.0816780310142673,0.0
261,0.1,4,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","How does obstructive sleep apnea affect aerobic fitness? Research in a US Air Force group shows that OSA does not generally predict lower aerobic fitness as assessed by cycle ergometry. Still, those with an apnea-hypopnea index greater than 20 have a statistically significant decrease in aerobic fitness compared to normal controls. This study",4.737194547137081e-08,0.012616518468088866,0.03613994617454825,0.0036268529295637453,0.013846713931445542,0.03767781622452902,0.003621603081905733,0.012561206208669073,0.01922337562475971,4.737194547137081e-08,0.04000533461369837,0.0
261,0.1,5,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea reduce aerobic fitness? In a US Air Force population, OSA overall does not predict diminished aerobic fitness measured by cycle ergometry. However, individuals with an apnea-hypopnea index above 20 have a significant decrease in aerobic fitness compared to the normal population. This study",1.8948778188548325e-07,0.11346313061701974,0.03363492673757956,0.014507411718254981,0.11131642902256011,0.03767781622452902,0.014486412327622933,0.14039457771855268,0.01922337562475971,1.8948778188548325e-07,0.1706255170307629,0.0
261,0.1,6,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Is there an effect of obstructive sleep apnea on aerobic fitness? Among US Air Force personnel, OSA does not typically cause a decline in aerobic fitness as measured by cycle ergometry. Yet, patients with an apnea-hypopnea index higher than 20 show a statistically significant reduction in aerobic fitness compared to normal subjects. This study",2.3685972735685406e-08,0.006011225624154015,0.017685505574778937,0.0018134264647818726,0.006605292843934851,0.018454440599769313,0.0018108015409528666,0.007241421087510691,0.01922337562475971,2.3685972735685406e-08,0.019802627296179764,0.0
261,0.1,7,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea impact aerobic capacity? In a US Air Force cohort, OSA does not generally predict reduced aerobic fitness based on cycle ergometry results. However, those with an apnea-hypopnea index greater than 20 experience a significant decrease in aerobic fitness relative to the normal population. This study",1.4211583641411244e-07,0.06964781478416526,0.034539419581109676,0.010880558788691236,0.06783131708282175,0.03767781622452902,0.0108648092457172,0.09594281514771996,0.01922337562475971,1.4211583641411244e-07,0.12516314295400566,0.0
261,0.1,8,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","How is aerobic fitness affected by obstructive sleep apnea? Research involving US Air Force members indicates that OSA does not usually predict lower aerobic fitness measured by cycle ergometry. Nonetheless, patients with an apnea-hypopnea index exceeding 20 have a statistically significant reduction in aerobic fitness compared to normal individuals. This study",9.474389094274162e-08,0.06586142506066661,0.026233900422914264,0.0072537058591274906,0.02615862068225283,0.03767781622452902,0.007243206163811466,0.05338320072892344,0.01922337562475971,9.474389094274162e-08,0.0816780310142673,0.0
261,0.1,9,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Does obstructive sleep apnea influence aerobic fitness? In a US Air Force population, OSA overall does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index over 20 show a significant decline in aerobic fitness compared to the normal population. This study",1.1842986367842703e-07,0.07673083836911454,0.014620904415876532,0.009067132323909363,0.07565904040831928,0.01685391400633074,0.009054007704764333,0.0744366099267566,0.01922337562475971,1.1842986367842703e-07,0.10318423623523065,0.0
261,0.1,10,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","What is the effect of obstructive sleep apnea on aerobic fitness? Among US Air Force personnel, OSA does not generally predict reduced aerobic fitness measured by cycle ergometry. Still, those with an apnea-hypopnea index greater than 20 have a statistically significant decrease in aerobic fitness compared to normal controls. This study",9.474389094274162e-08,0.0276705749629782,0.035371651661865226,0.0072537058591274906,0.02615862068225283,0.03767781622452902,0.007243206163811466,0.05338320072892344,0.01922337562475971,9.474389094274162e-08,0.0816780310142673,0.0
262,0.1,1,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
","Question: Are globulomaxillary cysts a real entity? Answer: Based on our study findings and international literature, the term globulomaxillary cyst is probably incorrect. Our research indicates these lesions are actually lateral periodontal cysts or radicular cysts originating from the maxillary canine or lateral incisor.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999996,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
262,0.1,2,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
",Question: Do globulomaxillary cysts truly exist? Answer: Our study results and global literature suggest that the so-called globulomaxillary cyst is a misnomer. These lesions are more likely lateral periodontal cysts or radicular cysts from the maxillary canine or lateral incisor.,2.8423167282822477e-07,0.24108174421978124,0.019599999999999996,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
262,0.1,3,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
","Question: Is the globulomaxillary cyst a genuine diagnosis? Answer: According to our research and international data, the globulomaxillary cyst is likely a misnamed condition. The lesions are probably lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor.",2.3685972735685406e-07,0.25869543882169754,0.029052202498356345,0.018134264647818726,0.25780091034220565,0.02498356344510192,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
262,0.1,4,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
",Question: Are globulomaxillary cysts real? Answer: The findings from our study and worldwide literature imply that the term globulomaxillary cyst is misleading. These lesions appear to be lateral periodontal cysts or radicular cysts linked to the maxillary canine or lateral incisor.,2.6054570009253947e-07,0.2157639362354895,0.019599999999999996,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
262,0.1,5,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
",Question: Do globulomaxillary cysts actually exist? Answer: Our study and international literature data indicate that the globulomaxillary cyst is a misnomer. The lesions are likely lateral periodontal cysts or radicular cysts originating from the maxillary canine or lateral incisor.,3.0791764556391007e-07,0.2670572306230392,0.019599999999999996,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
262,0.1,6,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
","Question: Is the globulomaxillary cyst a valid clinical entity? Answer: Based on our research and global literature, the so-called globulomaxillary cyst is probably a misnomer. These lesions are more accurately lateral periodontal cysts or radicular cysts from the maxillary canine or lateral incisor.",2.1317375462116866e-07,0.19998078066414937,0.0041953599048185596,0.016320838183036854,0.19845093872383757,0.0,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
262,0.1,7,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
","Question: Are globulomaxillary cysts a true pathological condition? Answer: According to our study and international literature, the globulomaxillary cyst is likely misnamed. The lesions are actually lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor.",2.8423167282822477e-07,0.24108174421978124,0.019599999999999996,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
262,0.1,8,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
",Question: Do globulomaxillary cysts exist as a distinct entity? Answer: Our research and international data suggest that the globulomaxillary cyst is a misnomer. These lesions are probably lateral periodontal cysts or radicular cysts originating from the maxillary canine or lateral incisor.,2.6054570009253947e-07,0.2157639362354895,0.019599999999999996,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
262,0.1,9,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
",Question: Is the globulomaxillary cyst a real pathological lesion? Answer: The results of our study and international literature indicate that the globulomaxillary cyst is likely a misnomer. These lesions are lateral periodontal cysts or radicular cysts from the maxillary canine or lateral incisor.,2.1317375462116866e-07,0.23298778926224184,0.02790000000000002,0.016320838183036854,0.23226299631212743,0.024375,0.0162972138685758,0.20294084399669066,0.0,2.1317375462116866e-07,0.20763936477824663,0.0
262,0.1,10,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the so-called globulomaxillary cyst is likely a misnomer.  Our research suggests that these lesions are actually either lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor. 
","Question: Are globulomaxillary cysts genuine lesions? Answer: Based on our study and data from international literature, the so-called globulomaxillary cyst is probably a misnomer. Our research shows these lesions are lateral periodontal cysts or radicular cysts arising from the maxillary canine or lateral incisor.",1.8948778188548325e-07,0.14344327465586337,0.019599999999999996,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
263,0.1,1,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Answer: For patients undergoing MMT and receiving medical care at various locations, opioid dependence and MMT are documented in the medical record for most, but some records lack this information.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
263,0.1,2,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Answer: Among patients treated with MMT and medical care at different sites, the majority have opioid dependence and MMT documented in their medical records, though some do not.",4.737194547137081e-08,0.013705450822062204,0.043392504930966504,0.0036268529295637453,0.017433506001244048,0.02251643655489808,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
263,0.1,3,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Answer: For patients receiving MMT and medical care across multiple sites, opioid dependence and MMT are recorded in most medical records, but some are missing this documentation.",2.3685972735685406e-08,0.03941310038151791,0.04454470742932283,0.0018134264647818726,0.008104408028834165,0.023125,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
263,0.1,4,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) included in the medical record? Answer: Among patients on MMT and receiving medical care at various sites, most have opioid dependence and MMT documented in their medical records, though some records lack this information.",2.3685972735685406e-08,0.03941310038151791,0.04454470742932283,0.0018134264647818726,0.008104408028834165,0.023125,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
263,0.1,5,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is opioid dependence and methadone maintenance treatment (MMT) documented in medical records? Answer: For patients receiving MMT and medical care at different locations, opioid dependence and MMT are documented in the majority of medical records, but some are missing this information.",4.737194547137081e-08,0.020106606766227664,0.019330025988879618,0.0036268529295637453,0.017433506001244048,0.02251643655489808,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
263,0.1,6,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Answer: Among patients undergoing MMT and medical care at various sites, most have documentation of opioid dependence and MMT in their medical records, but some records do not include this.",0.0,0.06447880749394796,0.04564375561492664,0.0,0.03300700859809247,0.023704640095181445,0.0,0.0,0.0,0.0,0.0,0.0
263,0.1,7,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Answer: For patients receiving MMT and medical care at different sites, opioid dependence and MMT are documented in most medical records, though some are missing this information.",2.3685972735685406e-08,0.03941310038151791,0.04454470742932283,0.0018134264647818726,0.008104408028834165,0.023125,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
263,0.1,8,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical record? Answer: Among patients treated with MMT and medical care at various locations, the majority have opioid dependence and MMT documented in their medical records, but some records lack this documentation.",0.0,0.06447880749394796,0.04564375561492664,0.0,0.03300700859809247,0.023704640095181445,0.0,0.0,0.0,0.0,0.0,0.0
263,0.1,9,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is opioid dependence and methadone maintenance treatment (MMT) included in the medical record? Answer: For patients receiving MMT and medical care at different sites, opioid dependence and MMT are documented in most medical records, but some are missing this information.",7.105791820705622e-08,0.012677764647723855,0.04218321158444751,0.005440279394345618,0.04363996421702332,0.021876731301939047,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
263,0.1,10,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients on MMT and receiving medical care at various sites, the majority have opioid dependence and MMT recorded in their medical records, though some records do not have this documentation.",4.737194547137081e-08,0.11280690634821422,0.04769641105290316,0.0036268529295637453,0.0810273428056254,0.02478501892915089,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
264,0.1,1,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the quantity of needles used in acupuncture affect neck pain treatment? Answer: For this condition, whether 5 or 11 needles are used does not appear to significantly influence the therapeutic outcome, provided the stimulation duration is equal in both groups.",1.1842986367842703e-07,0.05479566191000895,0.043388429752066124,0.009067132323909363,0.08697649429816368,0.02221074380165289,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
264,0.1,2,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In acupuncture for neck pain, is the number of needles significant? Answer: The number of needles, either 5 or 11, does not seem to be a critical factor in the treatment effect when both groups receive the same stimulation time.",1.4211583641411244e-07,0.14880299255637475,0.006473066092809211,0.010880558788691236,0.14784031154193933,0.0034125248964080625,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
264,0.1,3,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the number of acupuncture needles impact neck pain therapy? Answer: For this condition, using 5 or 11 needles does not seem to affect the therapeutic results if the stimulation time is consistent across groups.",2.6054570009253894e-07,0.2130196671249034,0.043388429752066124,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
264,0.1,4,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Is needle count important in acupuncture treatment for neck pain? Answer: The therapeutic effect appears unaffected by whether 5 or 11 needles are used, as long as the stimulation time remains the same in both groups.",2.3685972735685364e-07,0.18484879015820654,0.043388429752066124,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
264,0.1,5,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does the number of needles used in acupuncture influence neck pain relief? Answer: For this pathology, the therapeutic effect does not seem to depend on using 5 versus 11 needles when the stimulation time is identical in both groups.",1.6580180914979774e-07,0.10480608248467238,0.043388429752066124,0.012693985253473108,0.13826978868571338,0.02221074380165289,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
264,0.1,6,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In treating neck pain with acupuncture, does needle quantity matter? Answer: The number of needles, 5 or 11, does not appear to be a significant variable in determining treatment efficacy when stimulation time is equal.",2.6054570009253894e-07,0.2130196671249034,0.043388429752066124,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
264,0.1,7,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.",Question: Does the amount of needles used in acupuncture affect neck pain outcomes? Answer: Using either 5 or 11 needles seems not to impact the therapeutic effect if the stimulation duration is the same for both groups.,2.3685972735685364e-07,0.18484879015820654,0.043388429752066124,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
264,0.1,8,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Is the number of needles a factor in acupuncture treatment for neck pain? Answer: For this condition, the therapeutic effect seems independent of whether 5 or 11 needles are applied, given equal stimulation times.",2.8423167282822424e-07,0.2420072039981549,0.043388429752066124,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
264,0.1,9,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: Does needle count influence acupuncture effectiveness for neck pain? Answer: The number of needles, whether 5 or 11, does not appear to be important for therapeutic results when stimulation time is consistent.",3.3160361829959484e-07,0.30263182581459036,0.043388429752066124,0.025387970506946245,0.3418687439269532,0.02221074380165289,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
264,0.1,10,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Question: In acupuncture for neck pain, does the number of needles used affect treatment? Answer: The therapeutic effect seems unaffected by the use of 5 or 11 needles, provided the stimulation time is the same in both groups.",2.1317375462116834e-07,0.15744981597009122,0.043388429752066124,0.016320838183036854,0.19233700995598957,0.02221074380165289,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
265,0.1,1,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
",Is the formation of endometrial polyps linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1?,9.711248821630995e-07,1.0226900838427873,0.11649408284023667,0.0743504850560569,1.1316231588267618,0.06858710562414265,0.07424286317906766,1.2461415918909116,0.017538265306122455,9.711248821631014e-07,1.3173014896329391,0.0
265,0.1,2,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
",Does endometrial polyp development correlate with increased expression of VEGF and TGF-1?,1.136926691312897e-06,1.5151665689405815,0.11649408284023667,0.08704447030953003,1.6622514098889325,0.06858710562414265,0.08691847396573778,1.8215057367944731,0.017538265306122455,1.1369266913128989e-06,1.945910149055314,0.0
265,0.1,3,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
",Are higher expressions of vascular endothelial growth factor and transforming growth factor-beta1 associated with the formation of endometrial polyps?,9.711248821630995e-07,1.0226900838427873,0.11649408284023667,0.0743504850560569,1.1316231588267618,0.06858710562414265,0.07424286317906766,1.2461415918909116,0.017538265306122455,9.711248821631014e-07,1.3173014896329391,0.0
265,0.1,4,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
",Is there an association between endometrial polyp formation and elevated vascular endothelial growth factor and transforming growth factor-beta1 levels?,9.711248821630995e-07,1.0226900838427873,0.11649408284023667,0.0743504850560569,1.1316231588267618,0.06858710562414265,0.07424286317906766,1.2461415918909116,0.017538265306122455,9.711248821631014e-07,1.3173014896329391,0.0
265,0.1,5,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
",Does the presence of endometrial polyps coincide with increased levels of VEGF and TGF-1?,1.0895547458415261e-06,1.348112484277415,0.11649408284023667,0.08341761737996628,1.4799298530949772,0.06858710562414265,0.08329687088383203,1.620835041332322,0.017538265306122455,1.089554745841528e-06,1.7227665977411042,0.0
265,0.1,6,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
",Is the growth of endometrial polyps related to enhanced expression of vascular endothelial growth factor and transforming growth factor-beta1?,9.711248821630995e-07,1.0226900838427873,0.11649408284023667,0.0743504850560569,1.1316231588267618,0.06858710562414265,0.07424286317906766,1.2461415918909116,0.017538265306122455,9.711248821631014e-07,1.3173014896329391,0.0
265,0.1,7,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
",Are vascular endothelial growth factor and transforming growth factor-beta1 expressed more in endometrial polyps than in normal endometrium?,9.94810854898785e-07,1.079848497682736,0.11649408284023667,0.07616391152083878,1.1922477806431968,0.06858710562414265,0.07605366472002054,1.3106801130284822,0.017538265306122455,9.948108548987866e-07,1.3862943611198912,0.0
265,0.1,8,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
",Is increased expression of VEGF and TGF-1 observed in endometrial polyps compared to normal endometrial tissue?,1.0421828003701555e-06,1.2050116406367417,0.11649408284023667,0.07979076445040253,1.3257791732677195,0.06858710562414265,0.07967526780192628,1.4537809566691555,0.017538265306122455,1.0421828003701574e-06,1.5404450409471488,0.0
265,0.1,9,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
",Do endometrial polyps show higher levels of vascular endothelial growth factor and transforming growth factor-beta1 than normal endometrium?,9.94810854898785e-07,1.079848497682736,0.11649408284023667,0.07616391152083878,1.1922477806431968,0.06858710562414265,0.07605366472002054,1.3106801130284822,0.017538265306122455,9.948108548987866e-07,1.3862943611198912,0.0
265,0.1,10,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? 

Answer: There was increased expression of both vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-1) in endometrial polyps compared to normal endometrium. This suggests that these growth factors may play a role in the development and growth of endometrial polyps. 
",Is the development of endometrial polyps associated with upregulated expression of VEGF and TGF-1?,1.0895547458415261e-06,1.348112484277415,0.11649408284023667,0.08341761737996628,1.4799298530949772,0.06858710562414265,0.08329687088383203,1.620835041332322,0.017538265306122455,1.089554745841528e-06,1.7227665977411042,0.0
266,0.1,1,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Is gestational age misclassification responsible for the birthweight differences between Australian Aborigines and whites? It is unlikely that gestational age misclassification accounts for the birthweight differences observed. Research indicates that gestational age is accurately measured in both groups, and factors like socioeconomic status and maternal health are more probable causes of the disparity.",1.4211583641411244e-07,0.20125027749692714,0.07017832647462274,0.010880558788691236,0.1956336509059673,0.060325021248879826,0.0108648092457172,0.14105457252940212,0.019991670137442734,1.4211583641411244e-07,0.11551288712184427,0.0
266,0.1,2,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Does misclassification of gestational age explain the birthweight differences between Australian Aborigines and white populations? Gestational age misclassification is an improbable reason for the birthweight differences seen. Studies confirm accurate gestational age assessment in both populations, with socioeconomic and maternal health factors being more significant contributors.",3.079176455639103e-07,0.2840063953535581,0.03119917679152706,0.023574544042164344,0.2660473702378834,0.005176715764726655,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
266,0.1,3,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Can the difference in birthweights between Australian Aborigines and whites be explained by gestational age misclassification? Gestational age misclassification is unlikely to explain the birthweight differences. Evidence shows gestational age is reliably determined in both groups, and other influences such as socioeconomic conditions and maternal health likely play a larger role.",1.8948778188548325e-07,0.10970871505483881,0.024026920438957447,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
266,0.1,4,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? It is unlikely that gestational age misclassification explains the birthweight disparity. Research demonstrates accurate gestational age assessment in both populations, with socioeconomic status and maternal health being more influential factors.",3.316036182995957e-07,0.2465307325629169,0.012653621119229574,0.025387970506946217,0.2575301984371303,0.017538265306122455,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
266,0.1,5,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Does gestational age misclassification account for the birthweight differences between Australian Aborigines and whites? Gestational age misclassification is an unlikely cause of the observed birthweight differences. Studies have found gestational age to be accurately assessed in both groups, suggesting socioeconomic and maternal health factors are more relevant.",2.8423167282822487e-07,0.22895904813302526,0.005787431162508835,0.02176111757738247,0.24287436571859278,0.004672478495530437,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
266,0.1,6,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Could gestational age misclassification explain the birthweight differences between Australian Aborigines and whites? It is improbable that gestational age misclassification explains the birthweight variation. Research shows accurate gestational age measurement in both populations, with other factors like socioeconomic status and maternal health contributing more.",3.552895910352811e-07,0.33574104394012805,0.0377026160501944,0.02720139697172809,0.3140677044454163,0.006257094598696101,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
266,0.1,7,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Is gestational age misclassification the reason for birthweight differences between Australian Aborigines and whites? Gestational age misclassification is unlikely to be the reason for the birthweight differences. Studies indicate accurate gestational age assessment in both groups, with socioeconomic and maternal health factors playing a larger role.",3.079176455639103e-07,0.3148129367117778,0.05375085733882032,0.023574544042164344,0.29755406026333553,0.02781320861678004,0.023540420032387266,0.26415157504158726,0.0,3.079176455639103e-07,0.2696635669491032,0.0
266,0.1,8,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Does the misclassification of gestational age explain the birthweight disparity between Australian Aborigines and whites? Misclassification of gestational age is an unlikely explanation for the birthweight disparity. Research confirms accurate gestational age assessment in both populations, with socioeconomic status and maternal health being more significant contributors.",3.079176455639103e-07,0.3148129367117778,0.05375085733882032,0.023574544042164344,0.29755406026333553,0.02781320861678004,0.023540420032387266,0.29639097878856147,0.023242630385487524,3.079176455639103e-07,0.2696635669491032,0.0
266,0.1,9,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Is the birthweight difference between Australian Aborigines and whites due to gestational age misclassification? Gestational age misclassification is unlikely to explain the birthweight difference. Studies show gestational age is accurately assessed in both groups, and other factors such as socioeconomic status and maternal health are more likely causes.",2.6054570009253947e-07,0.2052871947959085,0.003363460644605437,0.0199476911126006,0.19008891764159808,0.017538265306122455,0.019918816950481533,0.21868920096483002,0.0,2.6054570009253947e-07,0.22314355131420927,0.0
266,0.1,10,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the observed difference in birthweights. Studies have shown that gestational age is accurately assessed in both populations, and other factors, such as socioeconomic status and maternal health, are more likely to contribute to the disparity. 
","Can gestational age misclassification clarify the birthweight differences between Australian Aborigines and whites? Gestational age misclassification is an unlikely explanation for the birthweight differences observed. Research indicates accurate gestational age assessment in both populations, with socioeconomic and maternal health factors being more probable causes.",3.552895910352811e-07,0.3679804476871027,0.061273364264028046,0.02720139697172809,0.3470747130435088,0.02996173469387756,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
267,0.1,1,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does Kenya's health care benefits distribution align with universal coverage principles? Universal coverage means everyone should receive health care based on need. Kenya's health sector is inequitable, with benefits not allocated by need. Focused efforts are needed to restructure the Kenyan health system.",4.263475092423373e-07,0.3170665336210221,0.027759514939002153,0.03264167636607371,0.29347583341565375,0.0507015306122449,0.0325944277371516,0.3476619295166228,0.017236072637734686,4.263475092423373e-07,0.37948962170490574,0.0
267,0.1,2,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Universal coverage demands health care access according to need. Kenya's health sector is unequal, and benefits are not distributed by need. Intentional reforms should target restructuring the health system in Kenya.",3.789755637709665e-07,0.23453887224275416,0.05341395817586296,0.029014823436509962,0.24584778442639932,0.0507015306122449,0.028972824655245866,0.29887176534719107,0.017236072637734686,3.789755637709665e-07,0.3294792011302423,0.0
267,0.1,3,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does Kenya's health care benefits distribution fulfill the principles of universal coverage? Universal coverage requires that health care benefits be allocated according to need. The Kenyan health sector is clearly unequal, with benefits not based on need. There should be deliberate efforts to reform the Kenyan health system.",3.079176455639103e-07,0.22355002321876727,0.014395502407040198,0.023574544042164344,0.2386801715056448,0.007313100860178785,0.023540420032387266,0.2298788938602394,0.017236072637734686,3.079176455639103e-07,0.25886163391628836,0.0
267,0.1,4,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Are health care benefits in Kenya distributed in line with universal coverage principles? Universal coverage means all individuals should receive health care based on their needs. Kenya's health sector is inequitable, and benefits are not allocated by need. Focused restructuring of the Kenyan health system is necessary.",3.316036182995957e-07,0.18734739749579443,0.05537700234669933,0.025387970506946217,0.20038541034964208,0.0507015306122449,0.025351221573340132,0.2523517497122971,0.017236072637734686,3.316036182995957e-07,0.2818511521409879,0.0
267,0.1,5,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does the Kenyan health care benefits distribution meet universal coverage standards? Universal coverage entails that everyone benefits from health care according to their needs. Kenya's health sector is inequitable, with benefits not distributed by need. Deliberate restructuring efforts are required for the Kenyan health system.",3.789755637709665e-07,0.29755225229365845,0.008765432098765458,0.029014823436509962,0.2780871881733735,0.027458900226757378,0.028972824655245866,0.29887176534719107,0.017236072637734686,3.789755637709665e-07,0.3294792011302423,0.0
267,0.1,6,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is the distribution of health care benefits in Kenya aligned with the principles of universal coverage? Universal coverage requires health care benefits to be provided based on need. Kenya's health sector is inequitable, and benefits are not allocated according to need. Targeted efforts should be made to restructure the Kenyan health system.",2.1317375462116866e-07,0.07825397813558554,0.05961507807960676,0.016320838183036854,0.12275078191421418,0.03070986047480217,0.0162972138685758,0.14472108551993212,0.017236072637734686,2.1317375462116866e-07,0.17185025692665912,0.0
267,0.1,7,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does the distribution of health care benefits in Kenya adhere to universal coverage principles? Universal coverage means all should receive health care benefits according to need. Kenya's health sector is clearly inequitable, with benefits not distributed by need. Intentional efforts are needed to restructure the health system in Kenya.",2.8423167282822487e-07,0.17115751277221314,0.036543209876543234,0.02176111757738247,0.1863959231145822,0.0294349899695228,0.0217296184914344,0.2078999871414644,0.017236072637734686,2.8423167282822487e-07,0.23638877806423064,0.0
267,0.1,8,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is Kenya's distribution of health care benefits consistent with universal coverage principles? Universal coverage requires that health care benefits be distributed based on need. Kenya's health sector is inequitable, and benefits are not allocated by need. Deliberate restructuring of the Kenyan health system is necessary.",3.789755637709665e-07,0.2660455622682063,0.030948656370032523,0.029014823436509962,0.2780871881733735,0.027458900226757378,0.028972824655245866,0.29887176534719107,0.017236072637734686,3.789755637709665e-07,0.3294792011302423,0.0
267,0.1,9,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does Kenya's health care benefits distribution conform to the principles of universal coverage? Universal coverage demands that all individuals benefit from health care according to need. Kenya's health sector is inequitable, with benefits not distributed based on need. Focused efforts should be directed towards restructuring the Kenyan health system.",2.8423167282822487e-07,0.142276380248882,0.057177530397442194,0.02176111757738247,0.15690029840990372,0.0507015306122449,0.0217296184914344,0.2078999871414644,0.017236072637734686,2.8423167282822487e-07,0.23638877806423064,0.0
267,0.1,10,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is the distribution of health care benefits in Kenya in accordance with universal coverage principles? Universal coverage requires that everyone benefits from health care according to need. Kenya's health sector is inequitable, and benefits are not allocated by need. Deliberate efforts must be made to restructure the Kenyan health system.",2.6054570009253947e-07,0.12047827131050015,0.058023014715334026,0.0199476911126006,0.13584688921207055,0.0507015306122449,0.019918816950481533,0.18639378192050104,0.017236072637734686,2.6054570009253947e-07,0.21440987134545564,0.0
268,0.1,1,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Does a history of postictal psychotic episodes (PIPE) reliably predict interictal psychotic episodes? Not conclusively, but those with PIPE might face a higher risk of psychosis, especially with a family history or other risk factors.",4.974054274493929e-07,0.38015125253486204,0.07227989234909649,0.03808195576041934,0.44113224950076146,0.036982248520710054,0.03802683236001022,0.47839951337277364,0.018860946745562133,4.974054274493935e-07,0.5172565140962813,0.0
268,0.1,2,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Are postictal psychotic episodes (PIPE) indicative of future interictal psychotic episodes? While not definitively predictive, individuals with PIPE could have an elevated risk of psychosis, particularly if they possess a family history or additional risk factors.",4.737194547137076e-07,0.35116371566161053,0.07227989234909649,0.03626852929563746,0.4112792863510797,0.036982248520710054,0.036216030819057346,0.44762785470601996,0.018860946745562133,4.737194547137081e-07,0.48550781578170144,0.0
268,0.1,3,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Is there a long-term link between postictal psychotic episodes and interictal psychotic episodes? A history of PIPE does not guarantee interictal episodes, but it may increase psychosis risk, especially with familial or other risk factors.",4.974054274493929e-07,0.38015125253486204,0.07227989234909649,0.03808195576041934,0.44113224950076146,0.036982248520710054,0.03802683236001022,0.47839951337277364,0.018860946745562133,4.974054274493935e-07,0.5172565140962813,0.0
268,0.1,4,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Do postictal psychotic episodes predict interictal psychotic episodes? A history of PIPE is not a certain predictor, though it may raise the likelihood of psychosis, particularly in those with family history or other risks.",5.210914001850782e-07,0.4100042156845438,0.07227989234909649,0.03989538222520122,0.47190390816751515,0.036982248520710054,0.03983763390096309,0.5101482116873535,0.018860946745562133,5.210914001850789e-07,0.550046336919273,0.0
268,0.1,5,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Can postictal psychotic episodes forecast interictal psychotic episodes? Not definitively, but individuals with PIPE might be more prone to psychosis if they have family history or other contributing factors.",6.395212638635047e-07,0.5743072669758198,0.07227989234909649,0.04896251454911062,0.6418029449629121,0.036982248520710054,0.04889164160572746,0.6860388781510176,0.018860946745562133,6.39521263863506e-07,0.7323678937132279,0.0
268,0.1,6,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Is the occurrence of postictal psychotic episodes a predictor for interictal psychotic episodes? No definitive prediction exists, but PIPE history may heighten psychosis risk, especially with familial or other risk factors.",5.921493183921341e-07,0.505314395488869,0.07227989234909649,0.04533566161954686,0.5703439809807684,0.036982248520710054,0.045270038523821714,0.6119309059972959,0.018860946745562133,5.921493183921352e-07,0.6554068525770984,0.0
268,0.1,7,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Are postictal psychotic episodes a reliable indicator of interictal psychotic episodes? They are not definitively predictive, yet those with PIPE may have increased psychosis risk, particularly if family history or other risks are present.",5.210914001850782e-07,0.4100042156845438,0.07227989234909649,0.03989538222520122,0.47190390816751515,0.036982248520710054,0.03983763390096309,0.5101482116873535,0.018860946745562133,5.210914001850789e-07,0.550046336919273,0.0
268,0.1,8,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Does experiencing postictal psychotic episodes suggest future interictal psychotic episodes? While not certain, PIPE may increase the risk of psychosis, especially with family history or other risk factors.",6.6320723659919e-07,0.6106749111466945,0.07227989234909649,0.050775941013892496,0.6795432729457591,0.036982248520710054,0.050702443146680334,0.7252595913043001,0.018860946745562133,6.632072365991914e-07,0.7731898882334827,0.0
268,0.1,9,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Is there a predictive relationship between postictal psychotic episodes and interictal psychotic episodes? A history of PIPE is not a definitive predictor but may raise psychosis risk, particularly with family history or other risk factors.",4.974054274493929e-07,0.38015125253486204,0.07227989234909649,0.03808195576041934,0.44113224950076146,0.036982248520710054,0.03802683236001022,0.47839951337277364,0.018860946745562133,4.974054274493935e-07,0.5172565140962813,0.0
268,0.1,10,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? 

Answer: A history of PIPE (postictal psychotic episodes) is not definitively predictive of interictal psychotic episodes. However, individuals with PIPE may have an increased risk of developing psychosis, particularly if they have a family history of psychosis or other risk factors. 
","Are individuals with postictal psychotic episodes more likely to develop interictal psychotic episodes? Not definitively, but they may have a higher risk of psychosis, especially if family history or other risk factors exist.",5.447773729207635e-07,0.4407758743512975,0.07227989234909649,0.0417088086899831,0.503652606482095,0.036982248520710054,0.04164843544191597,0.5429380345103452,0.018860946745562133,5.447773729207643e-07,0.5839478885949547,0.0
269,0.1,1,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
",Does aerobic fitness affect microvascular function in healthy adults who are at risk for Type 2 diabetes?,7.105791820705599e-07,0.9053685045623694,0.10707911957168353,0.054402793943456304,1.00619266459345,0.06632653061224489,0.05432404622858614,1.0821189242520988,0.045351473922902494,7.105791820705618e-07,1.164011354485051,0.023242630385487524
269,0.1,2,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","In healthy adults at risk of Type 2 diabetes, does aerobic fitness influence microvascular function?",7.579511275419307e-07,1.0388998971868921,0.10707911957168353,0.05802964687302006,1.1492935082341234,0.06632653061224489,0.057945649310491884,1.2362696040793564,0.045351473922902494,7.579511275419325e-07,1.3310654391482175,0.023242630385487524
269,0.1,3,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
",Is there an effect of aerobic fitness on microvascular function in adults at risk of developing Type 2 diabetes?,6.632072365991893e-07,0.7875854689059856,0.10707911957168353,0.05077594101389256,0.8810295216394444,0.06632653061224489,0.05070244314668039,0.948587531627576,0.045351473922902494,6.632072365991911e-07,1.0209105108443777,0.023242630385487524
269,0.1,4,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
",How does aerobic fitness impact microvascular function in healthy individuals at risk for Type 2 diabetes?,7.342651548062453e-07,0.96990702569994,0.10707911957168353,0.056216220408238184,1.0751855360804021,0.06632653061224489,0.05613484776953902,1.15622689640582,0.045351473922902494,7.342651548062472e-07,1.2440540621585874,0.023242630385487524
269,0.1,5,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
",Does aerobic fitness play a role in microvascular function among healthy adults at risk of Type 2 diabetes?,6.868932093348746e-07,0.8447438827459344,0.10707911957168353,0.05258936747867443,0.9416541434558794,0.06632653061224489,0.05251324468763327,1.0131260527651467,0.045351473922902494,6.868932093348764e-07,1.0899033823313298,0.023242630385487524
269,0.1,6,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
","In adults at risk of Type 2 diabetes, does aerobic fitness affect microvascular function?",7.81637100277616e-07,1.1130078693406134,0.10707911957168353,0.059843073337801936,1.2293362159076597,0.06632653061224489,0.059756450851444765,1.3232809810689865,0.045351473922902494,7.816371002776178e-07,1.4263756189525427,0.023242630385487524
269,0.1,7,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
",What is the influence of aerobic fitness on microvascular function in healthy adults at risk of Type 2 diabetes?,6.632072365991893e-07,0.7875854689059856,0.10707911957168353,0.05077594101389256,0.8810295216394444,0.06632653061224489,0.05070244314668039,0.948587531627576,0.045351473922902494,6.632072365991911e-07,1.0209105108443777,0.023242630385487524
269,0.1,8,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
",Does aerobic fitness contribute to microvascular function in healthy adults who may develop Type 2 diabetes?,7.342651548062453e-07,0.96990702569994,0.10707911957168353,0.056216220408238184,1.0751855360804021,0.06632653061224489,0.05613484776953902,1.15622689640582,0.045351473922902494,7.342651548062472e-07,1.2440540621585874,0.023242630385487524
269,0.1,9,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
",Is microvascular function in at-risk healthy adults affected by aerobic fitness?,8.52695018484672e-07,1.375372133808105,0.10707911957168353,0.06528335273214757,1.517018288359441,0.06632653061224489,0.06518885547430338,1.6417347121875214,0.045351473922902494,8.526950184846739e-07,1.7830505628912743,0.023242630385487524
269,0.1,10,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? 
Answer: In this 'at-risk' population, aerobic fitness has a significant positive impact on microvascular function, improving blood flow and endothelial function, thus mitigating the risk of developing Type 2 diabetes.  
",How does aerobic fitness influence microvascular function in healthy adults at risk of Type 2 diabetes?,7.342651548062453e-07,0.96990702569994,0.10707911957168353,0.056216220408238184,1.0751855360804021,0.06632653061224489,0.05613484776953902,1.15622689640582,0.045351473922902494,7.342651548062472e-07,1.2440540621585874,0.023242630385487524
270,0.1,1,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does initiating migraine treatment early reduce the time to reach headache peak and lessen its intensity? Early intervention and triptan use might shorten the interval from migraine onset to peak but do not diminish headache severity.,4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
270,0.1,2,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Can early migraine therapy decrease the time until headache peak and lower its severity? Starting treatment early and using triptans may shorten the duration from migraine start to peak but do not relieve the headache.,7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
270,0.1,3,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is early treatment of migraines effective in shortening the time to headache peak and reducing headache severity? Early treatment with triptans can lead to a quicker peak after migraine onset but does not reduce headache pain.,4.73719454713706e-08,0.0951782614725234,0.02854671280276816,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
270,0.1,4,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does treating migraines early shorten the time to headache peak and reduce how severe it is? Early use of triptans may speed up the time from migraine onset to peak but does not ease the headache.,4.73719454713706e-08,0.0951782614725234,0.02854671280276816,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
270,0.1,5,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Will early migraine treatment shorten the time to headache peak and lessen its severity? Early intervention and triptan administration may reduce the time from migraine onset to peak but do not alleviate headache pain.,9.47438909427412e-08,0.1564192712116812,0.0302734375,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
270,0.1,6,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early intervention in migraine cases reduce the time to headache peak and decrease its severity? Early treatment and triptan use might shorten the duration from migraine onset to peak but do not relieve headache symptoms.,4.73719454713706e-08,0.055569851154812167,0.0,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
270,0.1,7,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is early migraine treatment associated with a shorter time to headache peak and reduced severity? Early use of triptans may lead to a faster peak after migraine onset but does not lessen headache intensity.,9.47438909427412e-08,0.11441035117774545,0.0,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
270,0.1,8,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Can early treatment of migraines shorten the time to headache peak and reduce severity? Early administration of triptans may shorten the interval from migraine onset to peak but does not alleviate headache discomfort.,1.184298636784265e-07,0.18850370862949672,0.031217481789802305,0.009067132323909391,0.14953173397096364,0.0,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
270,0.1,9,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early migraine therapy shorten the time to headache peak and reduce headache severity? Early treatment and triptan use may lead to a shorter duration from migraine onset to peak but do not reduce headache pain.,4.73719454713706e-08,0.0951782614725234,0.02854671280276816,0.003626852929563752,0.05715841383994835,0.0,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
270,0.1,10,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is early treatment for migraines effective in reducing the time to headache peak and its severity? Early use of triptans might shorten the time from migraine onset to peak but does not relieve headache symptoms.,7.10579182070559e-08,0.1253307515904134,0.029384756657483937,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
271,0.1,1,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation change the cancer treatment plan for elderly patients? The consultation resulted in changes to the treatment plan in over one third of cases. Additional research is required to assess if these changes enhance outcomes for older patients.,2.1317375462116866e-07,0.09363356020013835,0.07439043209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,0.1,2,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients altered by a geriatric oncology consultation? More than one third of cases saw modifications to the treatment plan following the consultation. Further studies are necessary to evaluate whether these adjustments improve patient outcomes.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.1,3,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation influence the cancer treatment plan in elderly patients? The consultation led to treatment plan changes in over one third of cases. More research is needed to determine if these changes benefit older patients.,3.0791764556390996e-07,0.19994307183733318,0.07175925925925929,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
271,0.1,4,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Does consulting a geriatric oncologist lead to changes in cancer treatment plans for elderly patients? In more than one third of cases, the treatment plan was modified after the consultation. Further investigation is required to see if these modifications improve outcomes.",2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.1,5,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment approach for elderly patients modified after a geriatric oncology consultation? The consultation resulted in treatment plan changes in over one third of cases. Additional studies are needed to confirm if these changes improve patient outcomes.,2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.1,6,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation result in alterations to the cancer treatment plan for elderly patients? Treatment plans were changed in more than one third of cases following the consultation. Further research is necessary to determine if these changes lead to better outcomes.,1.8948778188548325e-07,0.03572395103278847,0.09876543209876545,0.014507411718254981,0.09337306643979515,0.060964083175803374,0.014486412327622933,0.1534404242706242,0.020823902218198284,1.8948778188548325e-07,0.18658595558041347,0.0
271,0.1,7,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Can a geriatric oncology consultation modify the cancer treatment strategy for elderly patients? More than one third of cases had their treatment plans altered after the consultation. Further studies are needed to assess whether these modifications improve outcomes.,3.0791764556390996e-07,0.16247565667193076,0.09876543209876545,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.28697181689514695,0.020823902218198284,3.079176455639103e-07,0.323787077093896,0.0
271,0.1,8,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does the involvement of a geriatric oncology consultation change cancer treatment plans for elderly patients? The consultation led to modifications in treatment plans in over one third of cases. Additional research is required to evaluate if these changes improve patient outcomes.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,0.1,9,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients adjusted following a geriatric oncology consultation? Over one third of cases experienced changes to their treatment plans after the consultation. Further studies are needed to determine if these adjustments improve outcomes.,2.8423167282822466e-07,0.1358074095897699,0.09876543209876545,0.02176111757738247,0.19602722049987742,0.060964083175803374,0.0217296184914344,0.2588009399284501,0.020823902218198284,2.8423167282822487e-07,0.2947995402206445,0.0
271,0.1,10,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a geriatric oncology consultation impact the cancer treatment plan for elderly patients? The consultation caused modifications in the treatment plan in more than one third of cases. Further research is necessary to establish if these changes enhance patient outcomes.,2.6054570009253936e-07,0.14537793244599584,0.07314216340070451,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.23140196574033478,0.020823902218198284,2.6054570009253947e-07,0.26662866325394763,0.0
272,0.1,1,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Can computerized tomography serve as a substitute for bone scintigraphy in identifying bone metastases in breast cancer patients? Our results indicate that routine bone scintigraphy might not be essential for patients newly diagnosed with high-risk breast cancer. CT scans, due to their higher sensitivity in detecting certain bone lesions, could offer a more effective option for initial screening.",1.4211583641411244e-07,0.11408692378126695,0.002061734693877538,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
272,0.1,2,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Is it possible for computerized tomography to replace bone scintigraphy when detecting bone metastases from breast cancer? Our study suggests that routine bone scintigraphy for patients with newly diagnosed high-risk breast cancer may be unnecessary. CT scans, being more sensitive to specific bone lesions, might be a better choice for initial screening.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
272,0.1,3,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Can CT scans replace bone scintigraphy in the detection of bone metastases in breast cancer? Our findings imply that routine bone scintigraphy may not be required for patients newly diagnosed with high-risk breast cancer. CT imaging, with its greater sensitivity to particular bone lesions, could be a more efficient initial screening tool.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
272,0.1,4,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Could computerized tomography be used instead of bone scintigraphy to detect bone metastases from breast cancer? Our data suggest that routine bone scintigraphy might not be needed for patients presenting with newly diagnosed high-risk breast cancer. CT scans, which are more sensitive to certain bone lesions, may be a more effective screening method initially.",4.737194547137081e-08,0.03949202582307443,0.0007390532544378596,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
272,0.1,5,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Is computerized tomography a viable alternative to bone scintigraphy for detecting bone metastases in breast cancer? Our findings indicate that routine bone scintigraphy may not be necessary for newly diagnosed high-risk breast cancer patients. CT scans, being more sensitive to specific bone lesions, could serve as a more efficient initial screening approach.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
272,0.1,6,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Can CT imaging replace bone scintigraphy in identifying bone metastases from breast cancer? Our results suggest that routine bone scintigraphy might not be essential for patients with newly diagnosed high-risk breast cancer. CT scans, due to their higher sensitivity to certain bone lesions, could be a more effective initial screening option.",2.3685972735685406e-08,0.020346272143678235,0.00039167013744274143,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
272,0.1,7,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Is it feasible for computerized tomography to substitute bone scintigraphy in detecting bone metastases from breast cancer? Our findings suggest that routine bone scintigraphy may not be required for patients newly diagnosed with high-risk breast cancer. CT scans, being more sensitive to specific bone lesions, could provide a more efficient initial screening alternative.",2.3685972735685406e-08,0.019940821287388832,0.0003766243752402823,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
272,0.1,8,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Can computerized tomography be used in place of bone scintigraphy for detecting bone metastases in breast cancer patients? Our study suggests that routine bone scintigraphy might not be necessary for patients newly diagnosed with high-risk breast cancer. CT scans, which are more sensitive to certain bone lesions, could be a more efficient option for initial screening.",9.474389094274162e-08,0.07748444286268352,0.0014244170096021913,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
272,0.1,9,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Could CT scans replace bone scintigraphy in the detection of bone metastases from breast cancer? Our findings indicate that routine bone scintigraphy may not be needed for patients presenting with newly diagnosed high-risk breast cancer. CT imaging, with its greater sensitivity to specific bone lesions, might be a more effective initial screening tool.",2.3685972735685406e-08,0.019940821287388832,0.0003766243752402823,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
272,0.1,10,ai,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with newly diagnosed, high-risk breast cancer may not be necessary. CT scans, being more sensitive in detecting specific bone lesions,  could be a more efficient alternative for initial screening. 
","Is it possible to replace bone scintigraphy with computerized tomography for detecting bone metastases in breast cancer? Our results suggest that routine bone scintigraphy might not be necessary for patients newly diagnosed with high-risk breast cancer. CT scans, being more sensitive to particular bone lesions, could be a more efficient method for initial screening.",4.737194547137081e-08,0.03949202582307443,0.0007390532544378596,0.0036268529295637453,0.03922071315328246,0.0,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
273,0.1,1,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Should male HIV-infected patients over 50 with at least one cardiovascular risk factor be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Screening in this group may help detect silent myocardial ischemia and lower cardiovascular events.,3.0791764556390996e-07,0.23741048700273648,0.044887881078357283,0.023574544042164344,0.29022609304127567,0.012987315342615106,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
273,0.1,2,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Is it advisable to screen HIV-positive men older than 50 who have one or more cardiovascular risk factors for silent myocardial ischemia via gated myocardial perfusion SPECT? Such screening might identify silent ischemia and reduce cardiovascular incidents.,3.3160361829959526e-07,0.18987463086004608,0.09876543209876545,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
273,0.1,3,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
","For male HIV-infected patients above 50 years with additional cardiovascular risks, is gated myocardial perfusion SPECT screening for silent myocardial ischemia recommended? This approach could help detect silent ischemia and decrease cardiovascular events.",4.2634750924233646e-07,0.3076576665164299,0.09876543209876545,0.032641676366073735,0.40124965031446447,0.040742417383431435,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
273,0.1,4,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Should silent myocardial ischemia be screened using gated myocardial perfusion SPECT in HIV-infected men over 50 with at least one cardiovascular risk factor? Screening may be useful to find silent ischemia and prevent cardiovascular complications.,3.7897556377096586e-07,0.24703304469999443,0.09876543209876545,0.029014823436509976,0.33872929333313095,0.040742417383431435,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
273,0.1,5,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Is screening for silent myocardial ischemia with gated myocardial perfusion SPECT beneficial in male HIV patients older than 50 who have one or more cardiovascular risk factors? It may help identify silent ischemia and reduce cardiovascular risks.,3.3160361829959526e-07,0.18987463086004608,0.09876543209876545,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
273,0.1,6,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
","In male HIV-infected patients aged over 50 with at least one cardiovascular risk factor, does screening with gated myocardial perfusion SPECT help detect silent myocardial ischemia and reduce cardiovascular events?",4.974054274493924e-07,0.4060977393296832,0.09876543209876545,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
273,0.1,7,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Should gated myocardial perfusion SPECT be used to screen for silent myocardial ischemia in HIV-positive men older than 50 with additional cardiovascular risk factors? This screening might identify silent ischemia and lower the risk of cardiovascular events.,3.3160361829959526e-07,0.18987463086004608,0.09876543209876545,0.025387970506946217,0.27988879331019767,0.040742417383431435,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
273,0.1,8,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Is it beneficial to screen male HIV-infected patients over 50 with one or more cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? Such screening may detect silent ischemia and reduce cardiovascular events.,3.5528959103528056e-07,0.21804550782674292,0.09876543209876545,0.027201396971728097,0.3088763301834492,0.040742417383431435,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
273,0.1,9,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
","For HIV-infected men older than 50 who have at least one cardiovascular risk factor, is gated myocardial perfusion SPECT screening for silent myocardial ischemia advisable? This may help identify silent ischemia and decrease cardiovascular events.",3.7897556377096586e-07,0.24703304469999443,0.09876543209876545,0.029014823436509976,0.33872929333313095,0.040742417383431435,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
273,0.1,10,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years with at least one additional cardiovascular risk factor, screening with gated myocardial perfusion SPECT may be beneficial to identify silent myocardial ischemia and potentially reduce cardiovascular events. 
",Should male HIV-positive patients above 50 years with additional cardiovascular risk factors undergo gated myocardial perfusion SPECT screening to detect silent myocardial ischemia? This could potentially reduce cardiovascular events.,5.210914001850777e-07,0.4411890591409522,0.09876543209876545,0.039895382225201254,0.5393999887952816,0.040742417383431435,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
274,0.1,1,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Is there a link between crime and over-the-counter pharmacy syringe sales? Our research shows that OTC pharmacy syringe sales do not correlate with higher crime rates. The study examined data across various regions and found no connection between syringe access and crime levels.,0.0,0.03300700859809247,0.02370464009518146,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
274,0.1,2,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Does crime relate to over-the-counter pharmacy syringe sales? Our results indicate that OTC syringe sales at pharmacies are not linked to increased crime. Analysis of data from multiple areas revealed no association between syringe availability and criminal incidents.,1.1842986367842671e-07,0.06073768844295824,0.047500000000000014,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
274,0.1,3,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Are over-the-counter pharmacy syringe sales connected to crime? Findings from our study reveal no association between OTC syringe sales and crime rate increases. Data from several jurisdictions showed no correlation between syringe sales and criminal activity.,1.6580180914979731e-07,0.25008271751560507,0.09996093749999999,0.012693985253473115,0.22798490565049567,0.029384756657483933,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
274,0.1,4,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Is there an association between crime and the sale of syringes over the counter at pharmacies? Our study found no evidence that OTC pharmacy syringe sales lead to higher crime rates. Data from multiple locations indicated no link between syringe availability and crime.,0.0,0.06601401719618405,0.047500000000000014,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
274,0.1,5,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Do over-the-counter pharmacy syringe sales impact crime rates? Our findings demonstrate no relationship between OTC syringe sales and crime increases. The study analyzed data from various jurisdictions and found no correlation between syringe sales and criminal behavior.,1.42115836414112e-07,0.218195863384524,0.09575068870523415,0.010880558788691236,0.19783241553260567,0.02854671280276816,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
274,0.1,6,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Is crime linked to the sale of syringes over the counter in pharmacies? Our research indicates that OTC pharmacy syringe sales are not associated with a rise in crime rates. Data from multiple regions showed no connection between syringe availability and crime.,2.3685972735685406e-08,0.04191646561712403,0.047500000000000014,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
274,0.1,7,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Are crime rates affected by over-the-counter pharmacy syringe sales? Our study results show no association between OTC syringe sales and increased crime. Analysis across multiple jurisdictions found no correlation between syringe access and criminal activity.,1.8948778188548261e-07,0.1452950764710219,0.047500000000000014,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
274,0.1,8,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Does the sale of syringes over the counter at pharmacies correlate with crime? Our findings reveal no link between OTC pharmacy syringe sales and crime rate increases. Data from several jurisdictions showed no association between syringe availability and crime.,9.474389094274141e-08,0.03406944136079737,0.047500000000000014,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
274,0.1,9,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Is there a connection between crime and over-the-counter syringe sales at pharmacies? Our research found no evidence that OTC pharmacy syringe sales contribute to higher crime rates. The study reviewed data from multiple areas and found no correlation between syringe sales and criminal activity.,2.3685972735685406e-08,0.019342258117440725,0.07187500000000002,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
274,0.1,10,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? 
Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in crime rates.  The study analyzed data from multiple jurisdictions and found no correlation between syringe availability and criminal activity. 
",Are over-the-counter pharmacy syringe sales related to crime? Our findings demonstrate that OTC syringe sales at pharmacies do not lead to increased crime rates. Data from various jurisdictions showed no association between syringe availability and crime.,1.6580180914979731e-07,0.15591594991548163,0.018953287197231855,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
275,0.1,1,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Can D-dimer serve as a novel diagnostic marker for acute appendicitis? Elevated D-dimer levels should not be used as a definitive diagnostic tool for acute appendicitis. Although D-dimer may be raised in some instances, it is not specific to appendicitis and can be elevated due to other conditions. Using D-dimer alone for diagnosis risks misdiagnosis and improper treatment.",7.105791820705622e-08,0.05372538975793617,0.0017476243354526896,0.005440279394345618,0.05218575317056917,0.0,0.0054324046228586,0.05310982531394792,0.0,7.105791820705622e-08,0.05406722127027486,0.0
275,0.1,2,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Is D-dimer a viable new diagnostic parameter for acute appendicitis? Increased D-dimer levels are not reliable for diagnosing acute appendicitis. While they may be elevated in certain cases, these levels are not unique to appendicitis and can result from various other medical issues. Diagnosing based solely on D-dimer can cause errors and inappropriate care.",1.6580180914979784e-07,0.1301558313918907,0.0043841182459321,0.012693985253473108,0.15295323226890423,0.01922337562475971,0.012675610786670066,0.12861737782209381,0.0,1.6580180914979784e-07,0.13102826240640475,0.0
275,0.1,3,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Could D-dimer be introduced as a new diagnostic criterion for acute appendicitis? Elevated D-dimer should not be considered a diagnostic indicator for acute appendicitis. Although D-dimer levels might rise in some patients, they lack specificity for appendicitis and may be elevated due to other conditions. Relying only on D-dimer can lead to incorrect diagnosis and treatment.",1.1842986367842703e-07,0.06600691697266114,0.015118114988199115,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
275,0.1,4,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Is it possible for D-dimer to become a new diagnostic marker for acute appendicitis? Increased D-dimer levels should not be used as a diagnostic measure for acute appendicitis. While D-dimer can be elevated in some cases, it is not specific to appendicitis and can be influenced by other diseases. Sole reliance on D-dimer may result in misdiagnosis and inappropriate therapy.",2.3685972735685406e-08,0.01759033546955635,0.0005628732740962164,0.0018134264647818726,0.01709443335929972,0.0,0.0018108015409528666,0.01739174271186883,0.0,2.3685972735685406e-08,0.01769957709940062,0.0
275,0.1,5,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Can D-dimer be considered a new diagnostic parameter for acute appendicitis? Elevated D-dimer levels are not a reliable diagnostic tool for acute appendicitis. Although these levels may rise in some cases, they are not specific to appendicitis and can be caused by other conditions. Using D-dimer alone for diagnosis can lead to misdiagnosis and improper treatment.",1.1842986367842703e-07,0.0912122689930226,0.0030181567739840723,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
275,0.1,6,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Is D-dimer a potential new diagnostic marker for acute appendicitis? Increased D-dimer levels should not be regarded as diagnostic for acute appendicitis. While D-dimer may be elevated in some instances, it is not specific to appendicitis and can be elevated due to other causes. Relying solely on D-dimer can cause misdiagnosis and inappropriate management.",1.6580180914979784e-07,0.1301558313918907,0.004384118245932107,0.012693985253473108,0.12629372532429084,0.0,0.012675610786670066,0.12861737782209381,0.0,1.6580180914979784e-07,0.13102826240640475,0.0
275,0.1,7,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Could D-dimer serve as a new diagnostic parameter for acute appendicitis? Elevated D-dimer levels should not be used as a diagnostic criterion for acute appendicitis. Although D-dimer may increase in some cases, it is not specific to appendicitis and can be elevated by other conditions. Diagnosing based only on D-dimer can lead to errors and improper treatment.",9.474389094274162e-08,0.07229357234676037,0.0023715969459572536,0.0072537058591274906,0.07020425867324764,0.0,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
275,0.1,8,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Is D-dimer suitable as a new diagnostic marker for acute appendicitis? Increased D-dimer levels should not be considered diagnostic for acute appendicitis. While D-dimer can be elevated in some cases, it is not specific to appendicitis and may be raised due to other conditions. Sole reliance on D-dimer can result in misdiagnosis and inappropriate care.",1.4211583641411244e-07,0.11049493921752873,0.003688550542113138,0.010880558788691236,0.10724553035359774,0.0,0.0108648092457172,0.10919929196499112,0.0,1.4211583641411244e-07,0.11122563511022499,0.0
275,0.1,9,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Can D-dimer be used as a new diagnostic parameter for acute appendicitis? Elevated D-dimer levels should not be taken as a diagnostic sign for acute appendicitis. Although D-dimer may be elevated in some cases, it is not specific to appendicitis and can be caused by other diseases. Using D-dimer alone for diagnosis risks misdiagnosis and improper treatment.",9.474389094274162e-08,0.07229357234676037,0.0023715969459572536,0.0072537058591274906,0.07020425867324764,0.0,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
275,0.1,10,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? 
Answer: Increased D-dimer levels should not be considered as a diagnostic for acute appendicitis. While elevated D-dimer levels may occur in some cases, they are not specific to appendicitis and can be caused by various other conditions. Relying solely on D-dimer for diagnosis can lead to misdiagnosis and inappropriate treatment. 
","Is D-dimer an effective new diagnostic marker for acute appendicitis? Increased D-dimer levels should not be used as a diagnostic tool for acute appendicitis. While D-dimer may rise in some cases, it is not specific to appendicitis and can be elevated due to other conditions. Relying solely on D-dimer can lead to misdiagnosis and inappropriate treatment.",1.1842986367842703e-07,0.06600691697266114,0.015118114988199115,0.009067132323909363,0.08855339734144341,0.0,0.009054007704764333,0.09015109699429802,0.0,1.1842986367842703e-07,0.09180754925312229,0.0
276,0.1,1,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Does the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, prevent colon cancer in patients with coronary artery disease?",9.000669639560433e-07,1.1102246763904149,0.017851239669421492,0.06891020566171129,1.174119841176255,0.0,0.06881045855620906,1.2163953243244943,0.0,9.000669639560451e-07,1.2622417124499106,0.0
276,0.1,2,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Can bezafibrate, which lowers lipids and activates peroxisome proliferator-activated receptors, help prevent colon cancer in those with coronary artery disease?",8.763809912203579e-07,1.0561574551201396,0.017851239669421492,0.06709677919692941,1.1169614273363062,0.0,0.06699965701525619,1.1557707025080592,0.0,8.763809912203598e-07,1.19770319131234,0.0
276,0.1,3,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Is bezafibrate, a peroxisome proliferator-activated receptor ligand used to lower lipids, effective in preventing colon cancer among coronary artery disease patients?",8.526950184846725e-07,1.0048641607325894,0.017851239669421492,0.06528335273214753,1.062894206066031,0.0,0.06518885547430331,1.0986122886681104,0.0,8.526950184846744e-07,1.137078569495905,0.0
276,0.1,4,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Does the use of bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, reduce the risk of colon cancer in patients with coronary artery disease?",8.053230730133019e-07,0.9095539809282642,0.017851239669421492,0.06165649980258377,0.9628107475090495,0.0,0.06156725239239757,0.993251773010285,0.0,8.053230730133037e-07,1.0258529343856808,0.0
276,0.1,5,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Can the lipid-lowering drug bezafibrate, which targets peroxisome proliferator-activated receptors, prevent colon cancer in individuals with coronary artery disease?",9.000669639560433e-07,1.1102246763904149,0.017851239669421492,0.06891020566171129,1.174119841176255,0.0,0.06881045855620906,1.2163953243244943,0.0,9.000669639560451e-07,1.2622417124499106,0.0
276,0.1,6,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Is there evidence that bezafibrate, a peroxisome proliferator-activated receptor ligand with lipid-lowering effects, prevents colon cancer in coronary artery disease patients?",8.526950184846725e-07,1.0048641607325894,0.017851239669421492,0.06528335273214753,1.062894206066031,0.0,0.06518885547430331,1.0986122886681104,0.0,8.526950184846744e-07,1.137078569495905,0.0
276,0.1,7,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Does bezafibrate, known for lowering lipids and activating peroxisome proliferator-activated receptors, have a preventive effect on colon cancer in patients with coronary artery disease?",7.816371002776166e-07,0.8651022183574302,0.017851239669421492,0.05984307333780189,0.9162907318741556,0.0,0.059756450851444695,0.9444616088408537,0.0,7.816371002776184e-07,0.9745596399981307,0.0
276,0.1,8,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Can bezafibrate, a lipid-lowering agent acting on peroxisome proliferator-activated receptors, be used to prevent colon cancer in coronary artery disease patients?",8.526950184846725e-07,1.0048641607325894,0.017851239669421492,0.06528335273214753,1.062894206066031,0.0,0.06518885547430331,1.0986122886681104,0.0,8.526950184846744e-07,1.137078569495905,0.0
276,0.1,9,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
",Is the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate effective in colon cancer prevention among patients with coronary artery disease?,9.000669639560433e-07,1.1102246763904149,0.017851239669421492,0.06891020566171129,1.174119841176255,0.0,0.06881045855620906,1.2163953243244943,0.0,9.000669639560451e-07,1.2622417124499106,0.0
276,0.1,10,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?**

Answer: This is a complex question with no definitive answer.  While bezafibrate is known to have anti-inflammatory properties, its role in preventing colon cancer remains under investigation. Further research is needed to assess its potential benefits in this context. 
","Does treatment with bezafibrate, a peroxisome proliferator-activated receptor ligand that lowers lipids, prevent colon cancer in patients suffering from coronary artery disease?",8.290090457489872e-07,0.9560739965631582,0.017851239669421492,0.06346992626736564,1.0116009116784808,0.0,0.06337805393335044,1.0445450673978351,0.0,8.29009045748989e-07,1.0799201556559561,0.0
277,0.1,1,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
277,0.1,2,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Is the stretch-sensitive KCNQ1 mutation a connection between genetic and environmental contributors to atrial fibrillation? Answer: The findings indicate that the R14C KCNQ1 mutation by itself does not cause AF. Instead, we propose a model where a ""second hit,"" such as an environmental factor like hypertension that induces atrial stretch, plays a role.",2.3685972735685406e-08,0.019176512593258366,0.0003490207932659514,0.0018134264647818726,0.0190481949706931,0.0,0.0018108015409528666,0.019418085857102696,0.0,2.3685972735685406e-08,0.019802627296179764,0.0
277,0.1,3,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Does the stretch-sensitive KCNQ1 mutation link genetic and environmental factors in atrial fibrillation development? Answer: The data imply that the R14C KCNQ1 mutation alone cannot cause AF. We propose a model where a ""second hit,"" for example, an environmental factor like hypertension causing atrial stretch, is necessary.",1.6580180914979784e-07,0.14265995176037904,0.0027546146904259203,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
277,0.1,4,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Stretch-sensitive KCNQ1 mutation: Is there a connection between genetics and environment in atrial fibrillation? Answer: Evidence suggests the R14C KCNQ1 mutation alone is not enough to trigger AF. Instead, a model involving a ""second hit,"" such as hypertension leading to atrial stretch, is suggested.",2.3685972735685406e-07,0.17912229484749664,0.01851192595229618,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
277,0.1,5,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Could the stretch-sensitive KCNQ1 mutation represent a genetic and environmental interplay in atrial fibrillation? Answer: Data show that the R14C KCNQ1 mutation alone does not cause AF. We propose a model where a ""second hit,"" like an environmental factor such as hypertension that causes atrial stretch, contributes.",1.6580180914979784e-07,0.14265995176037904,0.0027546146904259203,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
277,0.1,6,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Is the stretch-sensitive KCNQ1 mutation a factor linking genetics and environment in atrial fibrillation? Answer: The results indicate that the R14C KCNQ1 mutation alone is insufficient to cause AF. Instead, a model is proposed where a ""second hit,"" such as hypertension promoting atrial stretch, is involved.",1.8948778188548325e-07,0.16480736621405256,0.0032164691094322163,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
277,0.1,7,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Does the stretch-sensitive KCNQ1 mutation connect genetic and environmental causes in atrial fibrillation? Answer: Findings suggest the R14C KCNQ1 mutation alone cannot cause AF. A model is proposed where a ""second hit,"" like an environmental factor such as hypertension causing atrial stretch, is necessary.",2.3685972735685406e-07,0.21062898487294923,0.004203055118552929,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
277,0.1,8,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Stretch-sensitive KCNQ1 mutation: linking genetic and environmental factors in atrial fibrillation pathogenesis? Answer: The data suggest that the R14C KCNQ1 mutation alone is not enough to cause AF. Instead, a model involving a ""second hit,"" such as hypertension that promotes atrial stretch, is proposed.",2.3685972735685406e-07,0.17912229484749664,0.01851192595229618,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
277,0.1,9,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Is there a link between the stretch-sensitive KCNQ1 mutation and genetic-environmental factors in atrial fibrillation? Answer: These findings indicate that the R14C KCNQ1 mutation alone does not cause AF. We suggest a model where a ""second hit,"" like an environmental factor such as hypertension causing atrial stretch, is required.",1.1842986367842703e-07,0.09978335231063973,0.0018873796032593745,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
277,0.1,10,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Does the stretch-sensitive KCNQ1 mutation indicate a genetic and environmental interaction in atrial fibrillation? Answer: The evidence suggests that the R14C KCNQ1 mutation alone is insufficient to cause AF. Instead, a model is proposed where a ""second hit,"" such as hypertension leading to atrial stretch, plays a role.",1.4211583641411244e-07,0.12099205038119809,0.0023119762659021027,0.010880558788691236,0.12014431184206309,0.0,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
278,0.1,1,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient for assessing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for evaluating the cervical spine in elderly trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.1,2,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,"Question: In geriatric blunt trauma patients with low-energy mechanisms, are clinical predictors reliable for cervical spine fracture assessment? Answer: Clinical predictors are inadequate for assessing cervical spine injuries in elderly trauma patients with low-energy mechanisms.",0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.1,3,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors effectively evaluate cervical spine fractures in elderly patients with blunt trauma from low-energy mechanisms? Answer: Clinical predictors do not adequately assess cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,0.0,0.12232009068704963,0.08095839792732915,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,0.1,4,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors adequate for identifying cervical spine fractures in geriatric blunt trauma cases involving low-energy mechanisms? Answer: Clinical predictors appear insufficient for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.13076937815654377,0.10801354881182448,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
278,0.1,5,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors provide reliable evaluation of cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors are inadequate for evaluating cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.07558566665879374,0.02947845804988669,0.0018134264647818796,0.03232407609285426,0.0017600481269510818,0.0018108015409528735,0.032084437417815526,0.0009440442898023052,2.3685972735685406e-08,0.031748698314579826,0.0
278,0.1,6,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the use of clinical predictors adequate for cervical spine fracture assessment in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem inadequate for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,4.73719454713706e-08,0.07074953502739767,0.008367346938775527,0.003626852929563759,0.024033109137671982,0.024607139373048918,0.003621603081905747,0.06317295703908332,0.0018327251323183719,4.737194547137081e-08,0.06252035698133351,0.0
278,0.1,7,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors effective in assessing cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors appear insufficient for evaluating cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,0.1,8,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors adequately evaluate cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors are inadequate for cervical spine assessment in elderly trauma patients with low-energy mechanisms.,4.73719454713706e-08,0.032592934367321025,0.01747571456566166,0.003626852929563759,0.0679408627921636,0.0038554765460572307,0.003621603081905747,0.06742663438990348,0.0020762161887946107,4.737194547137081e-08,0.06669137449867346,0.0
278,0.1,9,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient for the evaluation of cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem inadequate for assessing cervical spine injuries in geriatric trauma patients with low-energy mechanisms.,4.73719454713706e-08,0.10925771172517296,0.03309159251629898,0.003626852929563759,0.06364151945538365,0.00342083210307597,0.003621603081905747,0.06317295703908332,0.0018327251323183684,4.737194547137081e-08,0.06252035698133351,0.0
278,0.1,10,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the evaluation of cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms adequately supported by clinical predictors? Answer: Clinical predictors appear inadequate for cervical spine evaluation in elderly trauma patients with low-energy mechanisms.,4.73719454713706e-08,0.14776588842294647,0.05899234693877556,0.003626852929563759,0.06364151945538365,0.003420832103075977,0.003621603081905747,0.06317295703908332,0.0018327251323183684,4.737194547137081e-08,0.06252035698133351,0.0
279,0.1,1,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","This research examines interfractional motion in the prostate bed using RTOG consensus guidelines and daily CT on rails, aiming to find out whether motion varies between the superior and inferior regions.",7.816371002776173e-07,0.4998859483433664,0.16678994082840226,0.05984307333780184,0.6256810362405636,0.09566326530612247,0.05975645085144465,0.6877648057279497,0.06525084641428129,7.816371002776184e-07,0.7291929781617763,0.049861495844875335
279,0.1,2,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
",The study focuses on interfractional motion in the prostate bed by applying RTOG consensus definitions and daily CT on rails to assess if there is a difference in motion between the upper and lower parts.,6.868932093348761e-07,0.3747228053893594,0.16678994082840226,0.05258936747867432,0.4964693047605566,0.09566326530612247,0.05251324468763315,0.5542334131034274,0.06525084641428129,6.868932093348768e-07,0.5910426396809592,0.049861495844875335
279,0.1,3,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","Using RTOG consensus criteria and daily CT on rails, this investigation explores whether the prostate bed's superior and inferior sections exhibit different interfractional motion.",9.474389094274144e-07,0.7655891140763718,0.16678994082840226,0.07253705859127499,0.9019344128687212,0.09566326530612247,0.07243206163811476,0.9754468781797323,0.06525084641428129,9.474389094274162e-07,1.0292975706121155,0.049861495844875335
279,0.1,4,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
",This analysis evaluates interfractional motion in the prostate bed with RTOG consensus standards and daily CT on rails to determine if motion differs between its superior and inferior portions.,8.290090457489879e-07,0.5688788198303172,0.16678994082840226,0.0634699262673656,0.6971400002227073,0.09566326530612247,0.06337805393335039,0.7618727778816714,0.06525084641428129,8.290090457489892e-07,0.8061540192979058,0.049861495844875335
279,0.1,5,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","The objective of this study is to assess interfractional motion in the prostate bed, employing RTOG consensus definitions and daily CT on rails, to see if target motion varies between the top and bottom areas.",6.868932093348761e-07,0.3747228053893594,0.16678994082840226,0.05258936747867432,0.4964693047605566,0.09566326530612247,0.05251324468763315,0.5542334131034274,0.06525084641428129,6.868932093348768e-07,0.5910426396809592,0.049861495844875335
279,0.1,6,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","By utilizing RTOG consensus definitions and daily CT on rails, this study investigates whether interfractional motion in the prostate bed differs between its superior and inferior parts.",8.763809912203585e-07,0.6429867919840389,0.16678994082840226,0.06709677919692936,0.7741010413588367,0.09566326530612247,0.06699965701525615,0.8419154855552087,0.06525084641428129,8.7638099122036e-07,0.8895356282369562,0.049861495844875335
279,0.1,7,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","This research aims to determine if there is a significant difference in interfractional motion between the superior and inferior portions of the prostate bed, using RTOG consensus definitions and daily CT on rails.",7.342651548062467e-07,0.4353474272057949,0.16678994082840226,0.05621622040823808,0.5589896617418901,0.09566326530612247,0.0561348477695389,0.618771934240999,0.06525084641428129,7.342651548062476e-07,0.6577340141796326,0.049861495844875335
279,0.1,8,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","The study investigates whether the interfractional motion of the prostate bed varies between its superior and inferior regions, based on RTOG consensus definitions and daily CT on rails.",8.526950184846732e-07,0.6052464640011919,0.16678994082840226,0.06528335273214747,0.7348803282055543,0.09566326530612247,0.06518885547430327,0.8010934910349539,0.06525084641428129,8.526950184846746e-07,0.8469760138181606,0.049861495844875335
279,0.1,9,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","Using daily CT on rails and RTOG consensus definitions, this study examines interfractional motion in the prostate bed to identify differences between its superior and inferior sections.",8.763809912203585e-07,0.6429867919840389,0.16678994082840226,0.06709677919692936,0.7741010413588367,0.09566326530612247,0.06699965701525615,0.8419154855552087,0.06525084641428129,8.7638099122036e-07,0.8895356282369562,0.049861495844875335
279,0.1,10,ai,"Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails: Does target motion differ between superior and inferior portions?

Answer: This study investigates interfractional motion in the prostate bed, utilizing RTOG consensus definitions and daily CT on rails.  The primary objective is to determine if target motion differs significantly between the superior and inferior portions of the prostate bed. 
","This study explores interfractional motion in the prostate bed with the help of RTOG consensus definitions and daily CT on rails, focusing on whether motion differs between the superior and inferior portions.",7.57951127541932e-07,0.4670961255203747,0.16678994082840226,0.05802964687301996,0.5917794845648818,0.09566326530612247,0.05794564931049177,0.6526734859166807,0.06525084641428129,7.57951127541933e-07,0.6928253339909016,0.049861495844875335
280,0.1,1,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
","Can mental imagery functional magnetic resonance imaging forecast recovery in patients with consciousness disorders? The fMRI mental imagery paradigm aligns closely with clinical outcomes, indicating its potential to predict recovery in such patients. This method could greatly enhance patient care and rehabilitation approaches.",2.1317375462116866e-07,0.097076577387742,0.06805555555555555,0.016320838183036854,0.08754738983424648,0.07939508506616257,0.0162972138685758,0.11806567903016685,0.060964083175803374,2.1317375462116866e-07,0.1498770997315848,0.04158790170132326
280,0.1,2,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
","Is it possible for mental imagery fMRI to predict recovery in patients suffering from disorders of consciousness? The mental imagery fMRI paradigm shows strong agreement with clinical results, suggesting it may be useful in forecasting recovery. This technique offers valuable prospects for advancing patient treatment and rehabilitation.",1.1842986367842703e-07,0.0003644498606090174,0.07216712580348944,0.009067132323909363,0.025263508126454504,0.05718434126450968,0.009054007704764333,0.02275549922584119,0.060964083175803374,1.1842986367842703e-07,0.052238630167666944,0.04158790170132326
280,0.1,3,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
","Does mental imagery functional MRI have the ability to predict recovery in patients with disorders of consciousness? The fMRI mental imagery approach demonstrates high consistency with clinical outcomes, making it promising for recovery prediction. This method could significantly improve patient management and rehabilitation strategies.",1.8948778188548325e-07,0.03977146652833774,0.09231292517006803,0.014507411718254981,0.06344983825518646,0.07939508506616257,0.014486412327622933,0.09337306643979515,0.060964083175803374,1.8948778188548325e-07,0.12455929174729308,0.04158790170132326
280,0.1,4,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
","Can functional magnetic resonance imaging using mental imagery predict recovery in patients with consciousness disorders? The mental imagery fMRI paradigm exhibits a strong correlation with clinical outcomes, showing promise for recovery prediction. This technique holds considerable potential for enhancing patient care and rehabilitation.",2.1317375462116866e-07,0.06406956878964953,0.09176019565073701,0.016320838183036854,0.08754738983424648,0.07939508506616257,0.0162972138685758,0.11806567903016685,0.060964083175803374,2.1317375462116866e-07,0.1498770997315848,0.04158790170132326
280,0.1,5,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
","Is mental imagery fMRI effective in predicting recovery for patients with disorders of consciousness? The mental imagery paradigm in fMRI shows high concordance with clinical outcomes, indicating its promise in recovery prediction. This approach could improve patient care and rehabilitation methods.",2.6054570009253947e-07,0.11451008338898605,0.09057199211045364,0.0199476911126006,0.1375578104089099,0.07939508506616257,0.019918816950481533,0.16935897341771655,0.060964083175803374,2.6054570009253947e-07,0.20252083321700365,0.04158790170132326
280,0.1,6,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
","Can recovery in patients with disorders of consciousness be predicted by mental imagery functional MRI? The fMRI mental imagery paradigm aligns well with clinical outcomes, suggesting it is promising for predicting recovery. This technique has significant potential to improve patient care and rehabilitation.",2.1317375462116866e-07,0.06406956878964953,0.09176019565073701,0.016320838183036854,0.08754738983424648,0.07939508506616257,0.0162972138685758,0.11806567903016685,0.060964083175803374,2.1317375462116866e-07,0.1498770997315848,0.04158790170132326
280,0.1,7,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
","Does mental imagery fMRI predict recovery in patients with consciousness disorders? The mental imagery fMRI paradigm shows strong agreement with clinical outcomes, indicating promise for recovery prediction. This method could enhance patient care and rehabilitation strategies.",3.7897556377096597e-07,0.2926009376209344,0.05862258953168046,0.02901482343650997,0.31553229548474215,0.050010328408678625,0.02897282465524588,0.31043757167762287,0.060964083175803374,3.789755637709665e-07,0.3477028430615028,0.04158790170132326
280,0.1,8,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
","Is it feasible for mental imagery functional MRI to forecast recovery in patients with disorders of consciousness? The fMRI mental imagery paradigm demonstrates high concordance with clinical outcomes, suggesting its usefulness in predicting recovery. This technique offers potential improvements in patient care and rehabilitation.",1.8948778188548325e-07,0.03977146652833774,0.09231292517006803,0.014507411718254981,0.06344983825518646,0.07939508506616257,0.014486412327622933,0.09337306643979515,0.060964083175803374,1.8948778188548325e-07,0.12455929174729308,0.04158790170132326
280,0.1,9,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
","Can mental imagery fMRI serve as a predictor of recovery in patients with disorders of consciousness? The mental imagery paradigm in fMRI shows a strong correlation with clinical outcomes, making it promising for recovery prediction. This approach could significantly benefit patient care and rehabilitation.",1.8948778188548325e-07,0.03977146652833774,0.09231292517006803,0.014507411718254981,0.06344983825518646,0.07939508506616257,0.014486412327622933,0.09337306643979515,0.060964083175803374,1.8948778188548325e-07,0.12455929174729308,0.04158790170132326
280,0.1,10,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? 

Answer: The fMRI paradigm mental imagery displays a high concordance with clinical outcomes, showing promise for predicting recovery in patients with disorders of consciousness. This technique holds significant potential for improving patient care and rehabilitation strategies. 
","Is mental imagery functional MRI a reliable tool for predicting recovery in patients with disorders of consciousness? The fMRI mental imagery paradigm exhibits high consistency with clinical outcomes, indicating its promise for recovery prediction. This technique holds great potential for enhancing patient care and rehabilitation.",1.6580180914979784e-07,0.0160492345821166,0.09284057448470645,0.012693985253473108,0.039919340844992046,0.07939508506616257,0.012675610786670066,0.06927551486073513,0.060964083175803374,1.6580180914979784e-07,0.09986667915692138,0.04158790170132326
281,0.1,1,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? This study shows that hospital management can promote the creation of care programs by integrating case-mix reimbursement into hospital budgeting. Further research is suggested to validate this result and to assess if the formation of care programs will eventually result in more...,1.8948778188548325e-07,0.08089532743657513,0.044244628099173504,0.014507411718254981,0.10240450977053595,0.031101530612244906,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
281,0.1,2,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is process-oriented care delivery fostered by case-mix based reimbursement? The study indicates that hospital management can drive the development of care programs through the implementation of case-mix reimbursement in hospital budgets. Additional studies are needed to confirm these findings and to explore whether care programs will ultimately lead to more...,2.6054570009253947e-07,0.1152914556736575,0.06224532254361796,0.0199476911126006,0.13584688921207055,0.0507015306122449,0.019918816950481533,0.18639378192050104,0.017236072637734686,2.6054570009253947e-07,0.21440987134545564,0.0
281,0.1,3,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does the use of case-mix based reimbursement promote the growth of process-oriented care delivery? Findings reveal that hospital management can encourage care program development by adopting case-mix reimbursement within budgeting procedures. Future investigations are advised to verify this outcome and to determine if care programs will eventually produce more...,2.8423167282822487e-07,0.10761902122088518,0.08264462809917351,0.02176111757738247,0.15690029840990372,0.0507015306122449,0.0217296184914344,0.2078999871414644,0.017236072637734686,2.8423167282822487e-07,0.23638877806423064,0.0
281,0.1,4,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Can case-mix based reimbursement stimulate the evolution of process-oriented care delivery? This research demonstrates that hospital management can foster care program development by incorporating case-mix reimbursement into hospital budgeting. Further research is recommended to confirm this and to see if care programs will in time lead to more...,3.079176455639103e-07,0.12867243041871834,0.08264462809917351,0.023574544042164344,0.17840650363086707,0.0507015306122449,0.023540420032387266,0.2298788938602394,0.017236072637734686,3.079176455639103e-07,0.25886163391628836,0.0
281,0.1,5,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix reimbursement encourage the advancement of process-oriented care delivery? The study finds that hospital management can stimulate care program development by adopting case-mix reimbursement in budgeting processes. Future studies should confirm this and examine whether care programs will eventually result in more...,4.263475092423373e-07,0.27415742244349994,0.05884926819435496,0.03264167636607371,0.29347583341565375,0.0507015306122449,0.0325944277371516,0.3476619295166228,0.017236072637734686,4.263475092423373e-07,0.37948962170490574,0.0
281,0.1,6,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is the development of process-oriented care delivery driven by case-mix based reimbursement? This study shows hospital management can promote care programs by integrating case-mix reimbursement into budgeting. Further research is needed to validate this and to determine if care programs will ultimately lead to more...,3.789755637709665e-07,0.226137088235967,0.0599296470283244,0.029014823436509962,0.24584778442639932,0.0507015306122449,0.028972824655245866,0.29887176534719107,0.017236072637734686,3.789755637709665e-07,0.3294792011302423,0.0
281,0.1,7,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement drive the development of process-oriented care delivery? The study demonstrates that hospital management can encourage care program creation by adopting case-mix reimbursement within budgeting. Additional research is suggested to confirm this and to assess whether care programs will eventually lead to more...,3.552895910352811e-07,0.1721575423584567,0.08264462809917351,0.02720139697172809,0.2228582662016998,0.0507015306122449,0.027162023114293,0.27534126793699665,0.017236072637734686,3.552895910352811e-07,0.3053816495511823,0.0
281,0.1,8,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Can the adoption of case-mix based reimbursement stimulate process-oriented care delivery development? This study indicates hospital management can foster care programs by integrating case-mix reimbursement into budgets. Future research is recommended to verify this and to determine if care programs will in time lead to more...,3.552895910352811e-07,0.2029640837166764,0.060433884297520626,0.02720139697172809,0.2228582662016998,0.0507015306122449,0.027162023114293,0.27534126793699665,0.017236072637734686,3.552895910352811e-07,0.3053816495511823,0.0
281,0.1,9,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement promote the development of process-oriented care delivery? Findings suggest hospital management can stimulate care programs by adopting case-mix reimbursement in budgeting processes. Further studies are needed to confirm this and to explore whether care programs will eventually lead to more...,4.026615365066519e-07,0.24985932018218815,0.05940199771368599,0.030828249901291835,0.26937828183659374,0.0507015306122449,0.030783626196198732,0.3229693169262511,0.017236072637734686,4.026615365066519e-07,0.354171813720614,0.0
281,0.1,10,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is process-oriented care delivery development encouraged by case-mix based reimbursement? This study demonstrates hospital management can promote care programs through case-mix reimbursement adoption in budgeting. Future research is advised to confirm this and to determine if care programs will ultimately result in more...,4.263475092423373e-07,0.27415742244349994,0.05884926819435496,0.03264167636607371,0.29347583341565375,0.0507015306122449,0.0325944277371516,0.3476619295166228,0.017236072637734686,4.263475092423373e-07,0.37948962170490574,0.0
282,0.1,1,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
",Does glomerular hyperfiltration in pregnancy cause kidney damage in women with multiple pregnancies?,9.237529366917283e-07,1.3381900134367246,0.07786328655500228,0.07072363212649317,1.4864018454073769,0.019991670137442734,0.07062126009716196,1.5892352051165815,0.0,9.237529366917302e-07,1.6739764335716716,0.0
282,0.1,2,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
",Is kidney damage linked to glomerular hyperfiltration during pregnancy in women who have had several births?,8.526950184846723e-07,1.115046462122515,0.07786328655500228,0.06528335273214755,1.2452397885904891,0.019991670137442734,0.06518885547430335,1.3268709406490897,0.0,8.526950184846742e-07,1.3862943611198904,0.0
282,0.1,3,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
",Can glomerular hyperfiltration during pregnancy harm the kidneys of women with many parities?,9.237529366917283e-07,1.3381900134367246,0.07786328655500228,0.07072363212649317,1.4864018454073769,0.019991670137442734,0.07062126009716196,1.5892352051165815,0.0,9.237529366917302e-07,1.6739764335716716,0.0
282,0.1,4,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
",Does experiencing glomerular hyperfiltration in pregnancy lead to kidney damage in women with multiple pregnancies?,8.763809912203577e-07,1.184039333609467,0.07786328655500228,0.06709677919692943,1.3193477607442103,0.019991670137442734,0.06699965701525622,1.406913648322626,0.0,8.763809912203595e-07,1.4733057381095205,0.0
282,0.1,5,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
",Is there kidney damage from glomerular hyperfiltration in pregnant women with higher parity?,9.237529366917283e-07,1.3381900134367246,0.07786328655500228,0.07072363212649317,1.4864018454073769,0.019991670137442734,0.07062126009716196,1.5892352051165815,0.0,9.237529366917302e-07,1.6739764335716716,0.0
282,0.1,6,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
",Does glomerular hyperfiltration during pregnancy result in kidney injury in women with several pregnancies?,9.00066963956043e-07,1.2581473057631882,0.07786328655500228,0.0689102056617113,1.3993904684177467,0.019991670137442734,0.0688104585562091,1.4939250253122562,0.0,9.000669639560448e-07,1.5686159179138457,0.0
282,0.1,7,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
",Are kidneys damaged by glomerular hyperfiltration in women who have had multiple pregnancies?,9.237529366917283e-07,1.3381900134367246,0.07786328655500228,0.07072363212649317,1.4864018454073769,0.019991670137442734,0.07062126009716196,1.5892352051165815,0.0,9.237529366917302e-07,1.6739764335716716,0.0
282,0.1,8,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
",Does glomerular hyperfiltration in pregnancy affect kidney health in women with more than one parity?,8.763809912203577e-07,1.184039333609467,0.07786328655500228,0.06709677919692943,1.3193477607442103,0.019991670137442734,0.06699965701525622,1.406913648322626,0.0,8.763809912203595e-07,1.4733057381095205,0.0
282,0.1,9,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
",Is kidney damage caused by glomerular hyperfiltration during pregnancy in women with multiple births?,9.00066963956043e-07,1.2581473057631882,0.07786328655500228,0.0689102056617113,1.3993904684177467,0.019991670137442734,0.0688104585562091,1.4939250253122562,0.0,9.000669639560448e-07,1.5686159179138457,0.0
282,0.1,10,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? 

Answer: In our study, we suggest that glomerular hyperfiltration during pregnancy may not be associated with long-term kidney damage, even in women with multiple pregnancies. This finding supports the notion that physiological adaptations during pregnancy are generally reversible. 
",Does glomerular hyperfiltration in pregnancy contribute to kidney damage in women with increased parity?,9.00066963956043e-07,1.2581473057631882,0.07786328655500228,0.0689102056617113,1.3993904684177467,0.019991670137442734,0.0688104585562091,1.4939250253122562,0.0,9.000669639560448e-07,1.5686159179138457,0.0
283,0.1,1,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? The current study indicates that septoplasty does not significantly impact the compensatory hypertrophy of the middle turbinate. The middle turbinate's dimensions stayed mostly the same post-surgery, suggesting that this hypertrophy is independent of septal deviation.",2.6054570009253947e-07,0.04544641977849295,0.18374460544294785,0.0199476911126006,0.06081394542047436,0.14560000000000003,0.019918816950481533,0.14752749525312403,0.05436390532544381,2.6054570009253947e-07,0.20211181307219617,0.01851192595229618
283,0.1,2,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Is there a change in the dimensions of compensatory hypertrophy of the middle turbinate after septoplasty? Findings from this study show that septoplasty does not notably affect the compensatory hypertrophy of the middle turbinate. The size of the middle turbinate remained fairly constant following the operation, implying that the hypertrophy is distinct from the septal deviation.",4.737194547137081e-08,0.039566161053771864,0.08725687371108076,0.0036268529295637453,0.01654275805918637,0.013155185339441933,0.003621603081905733,0.039894707758126646,0.0020360946745562186,4.737194547137081e-08,0.03872771712894396,0.0007114496724635287
283,0.1,3,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty influence the size of compensatory hypertrophy in the middle turbinate? According to the study, compensatory hypertrophy of the middle turbinate is not significantly altered by septoplasty. The middle turbinate's dimensions remained largely unchanged after the procedure, indicating that this hypertrophy is likely separate from the septal deviation.",2.1317375462116866e-07,0.0013542555344376872,0.1884895125999697,0.016320838183036854,0.017328833480735994,0.14560000000000003,0.0162972138685758,0.10307573268229131,0.05436390532544381,2.1317375462116866e-07,0.15664943899543893,0.01851192595229618
283,0.1,4,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty modify the dimensions of compensatory hypertrophy of the middle turbinate? The study's results suggest that septoplasty does not significantly change the compensatory hypertrophy of the middle turbinate. The size of the middle turbinate stayed relatively stable post-septoplasty, indicating that the hypertrophy is probably independent of septal deviation.",2.1317375462116866e-07,0.0961901450306506,0.07746910443670438,0.016320838183036854,0.14644427152848305,0.01471844240129802,0.0162972138685758,0.16334940055706904,0.010975475573377684,2.1317375462116866e-07,0.18745598035365862,0.00369881784935671
283,0.1,5,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Is compensatory hypertrophy of the middle turbinate affected dimensionally by septoplasty? The findings suggest that septoplasty does not significantly impact the size of compensatory hypertrophy in the middle turbinate. The dimensions remained mostly unchanged after surgery, implying the hypertrophy is a separate condition from septal deviation.",2.8423167282822487e-07,0.02725294775448539,0.25080788289021666,0.02176111757738247,0.08328680127253207,0.14560000000000003,0.0217296184914344,0.17051701347782355,0.05436390532544381,2.8423167282822487e-07,0.22564231048239058,0.01851192595229618
283,0.1,6,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty cause changes in the size of compensatory hypertrophy of the middle turbinate? The current research indicates that septoplasty does not significantly affect the compensatory hypertrophy of the middle turbinate. The middle turbinate's dimensions remained fairly consistent after the procedure, suggesting the hypertrophy is distinct from septal deviation.",2.1317375462116866e-07,0.05640800951222458,0.14588630365819935,0.016320838183036854,0.10581570759477144,0.08206694214876038,0.0162972138685758,0.16334940055706904,0.010975475573377684,2.1317375462116866e-07,0.18745598035365862,0.00369881784935671
283,0.1,7,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty impact the dimensions of compensatory hypertrophy in the middle turbinate? The study findings indicate that septoplasty does not significantly alter the compensatory hypertrophy of the middle turbinate. The size of the middle turbinate remained relatively unchanged post-procedure, suggesting the hypertrophy is separate from septal deviation.",2.6054570009253947e-07,0.07558325371588204,0.16136933119407398,0.0199476911126006,0.09162048677869405,0.12338925619834715,0.019918816950481533,0.14752749525312403,0.05436390532544381,2.6054570009253947e-07,0.20211181307219617,0.01851192595229618
283,0.1,8,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty alter the size of the middle turbinate's compensatory hypertrophy? According to the study, septoplasty does not significantly affect the compensatory hypertrophy of the middle turbinate. The dimensions of the middle turbinate remained stable after surgery, indicating that the hypertrophy is likely independent of septal deviation.",2.6054570009253947e-07,0.08695821336293719,0.11375028357502637,0.0199476911126006,0.13405476466501476,0.054740075716603595,0.019918816950481533,0.14752749525312403,0.05436390532544381,2.6054570009253947e-07,0.20211181307219617,0.01851192595229618
283,0.1,9,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Is there a dimensional change in compensatory hypertrophy of the middle turbinate following septoplasty? The study suggests that septoplasty does not significantly influence the compensatory hypertrophy of the middle turbinate. The middle turbinate's size remained largely unchanged after the procedure, implying the hypertrophy is a separate entity from septal deviation.",1.8948778188548325e-07,0.032619198521493864,0.14897849331622312,0.014507411718254981,0.08291882185289579,0.08337777777777781,0.014486412327622933,0.1405607768706849,0.011894769522974677,1.8948778188548325e-07,0.16480736621405256,0.0032164691094322163
283,0.1,10,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? 

Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not significantly affected by septoplasty. The dimensions of the middle turbinate remained relatively unchanged after the procedure, indicating that the compensatory hypertrophy is likely a separate entity from the septal deviation. 
","Does septoplasty affect the size of compensatory hypertrophy in the middle turbinate? The findings from this study suggest that septoplasty does not significantly impact the compensatory hypertrophy of the middle turbinate. The dimensions of the middle turbinate remained relatively stable post-surgery, indicating that the hypertrophy is likely independent of septal deviation.",1.6580180914979784e-07,0.018352138854897504,0.17228283333090855,0.012693985253473108,0.003947858735675158,0.12520069444444448,0.012675610786670066,0.06051611826349479,0.05436390532544381,1.6580180914979784e-07,0.11316432705570056,0.01851192595229618
284,0.1,1,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Does premature aging occur among Indigenous Australians? The notion that Indigenous Australians age prematurely is not strongly supported by this study focusing on specific conditions. Although some Indigenous communities experience higher rates of chronic diseases, these are mainly attributed to social and environmental influences rather than accelerated aging. More research is necessary to explore the intricate link between aging and health inequalities in Indigenous Australians.",1.1842986367842703e-07,0.07522342123759085,0.0,0.009067132323909363,0.0763729787845735,0.0,0.009054007704764333,0.07755823434587317,0.0,1.1842986367842703e-07,0.07878087785311383,0.0
284,0.1,2,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Is premature aging a characteristic of Indigenous Australians? This study on various discrete conditions does not provide strong evidence that Indigenous Australians age prematurely. While chronic disease rates are elevated in certain Indigenous populations, these are primarily caused by social and environmental factors instead of a quicker aging process. Additional studies are required to better understand the complex interplay between aging and health disparities among Indigenous Australians.",7.105791820705622e-08,0.04445176257083805,0.0,0.005440279394345618,0.04512043528047194,0.0,0.0054324046228586,0.04580953603129334,0.0,7.105791820705622e-08,0.046520015634889056,0.0
284,0.1,3,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Do Indigenous Australians experience premature aging? The concept that Indigenous Australians age prematurely lacks strong support from this study examining specific conditions. Higher chronic disease prevalence in some Indigenous communities is mostly due to social and environmental causes, not accelerated aging. Further investigation is needed to clarify the complex relationship between aging and health disparities in Indigenous Australians.",2.8423167282822487e-07,0.21537619046656964,0.017538265306122455,0.02176111757738247,0.1941560144409591,0.0,0.0217296184914344,0.19735943415849366,0.0,2.8423167282822487e-07,0.20067069546214888,0.0
284,0.1,4,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
",Is there evidence that Indigenous Australians age prematurely? This study of discrete health conditions does not strongly support the idea that Indigenous Australians undergo premature aging. Elevated chronic disease rates in some Indigenous groups are largely linked to social and environmental factors rather than a faster aging process. More research is essential to understand the complex connection between aging and health disparities in Indigenous Australians.,1.1842986367842703e-07,0.11854512002258577,0.031217481789802295,0.009067132323909363,0.09837765118330122,0.01586888657648284,0.009054007704764333,0.07755823434587317,0.0,1.1842986367842703e-07,0.07878087785311383,0.0
284,0.1,5,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Are Indigenous Australians prone to premature aging? The study of various discrete conditions does not strongly back the claim that Indigenous Australians age prematurely. Although chronic diseases are more common in some Indigenous communities, these are mainly due to social and environmental influences, not accelerated aging. Further research is needed to unravel the complex relationship between aging and health disparities in Indigenous Australians.",1.6580180914979784e-07,0.12933170602184685,0.016124697661918846,0.012693985253473108,0.10863384100279827,0.0,0.012675610786670066,0.11034805716886531,0.0,1.6580180914979784e-07,0.11211729812070548,0.0
284,0.1,6,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
",Does premature aging affect Indigenous Australians? The evidence from this study on discrete conditions does not strongly support the idea that Indigenous Australians age prematurely. Higher rates of chronic illness in some Indigenous populations are primarily caused by social and environmental factors rather than a faster aging process. Additional research is required to understand the complex dynamics between aging and health disparities in Indigenous Australians.,1.1842986367842703e-07,0.07522342123759085,0.0,0.009067132323909363,0.0763729787845735,0.0,0.009054007704764333,0.07755823434587317,0.0,1.1842986367842703e-07,0.07878087785311383,0.0
284,0.1,7,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Is premature aging observed in Indigenous Australians? This study focusing on specific conditions does not provide strong support for the notion that Indigenous Australians age prematurely. Increased chronic disease rates in some Indigenous communities are mostly due to social and environmental factors, not accelerated aging. More research is necessary to explore the complex relationship between aging and health disparities in Indigenous Australians.",1.8948778188548325e-07,0.145958777491491,0.016388888888888897,0.014507411718254981,0.1251631429540092,0.0,0.014486412327622933,0.12715517548524602,0.0,1.8948778188548325e-07,0.1292117314800052,0.0
284,0.1,8,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Do Indigenous Australians show signs of premature aging? The study of discrete conditions does not strongly support the idea that Indigenous Australians age prematurely. While some Indigenous communities have higher chronic disease rates, these are largely attributed to social and environmental factors rather than a faster aging process. Further research is needed to better understand the complex link between aging and health disparities in Indigenous Australians.",9.474389094274162e-08,0.08104684025731679,0.015380859375,0.0072537058591274906,0.06062462181643724,0.0,0.007243206163811466,0.0615578929994296,0.0,9.474389094274162e-08,0.06252035698133263,0.0
284,0.1,9,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
","Is premature aging a phenomenon among Indigenous Australians? This study on various discrete conditions does not strongly back the claim that Indigenous Australians age prematurely. Although chronic diseases are more prevalent in some Indigenous populations, these are mainly due to social and environmental causes, not accelerated aging. Additional research is essential to clarify the complex relationship between aging and health disparities in Indigenous Australians.",1.4211583641411244e-07,0.0909717782057271,0.0,0.010880558788691236,0.09237332013101707,0.0,0.0108648092457172,0.09381875521765437,0.0,1.4211583641411244e-07,0.09531017980432477,0.0
284,0.1,10,ai,"Question: Do Indigenous Australians age prematurely? 

Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions.  While there are higher rates of chronic disease in some Indigenous communities, these are largely due to social and environmental factors, not a faster aging process.  Further research is needed to understand the complex relationship between aging and health disparities in Indigenous Australians. 
",Are Indigenous Australians subject to premature aging? The idea that Indigenous Australians age prematurely is not well supported by this study of discrete conditions. Higher chronic disease rates in some Indigenous communities are largely due to social and environmental factors rather than a faster aging process. Further research is needed to understand the complex interplay between aging and health disparities in Indigenous Australians.,1.6580180914979784e-07,0.12933170602184685,0.016124697661918846,0.012693985253473108,0.10863384100279827,0.0,0.012675610786670066,0.11034805716886531,0.0,1.6580180914979784e-07,0.11211729812070548,0.0
285,0.1,1,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Are there discrepancies between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Significant differences exist regarding the clinical importance of red blood cell morphology between clinical pathologists and clinicians, which may result in misinterpretations and improper patient care.",2.3685972735685406e-08,0.02812279653004568,0.002725135044954946,0.0018134264647818726,0.027228516909492573,0.0017922579313609938,0.0018108015409528666,0.02620645821577927,0.000639705252959033,2.3685972735685406e-08,0.025975486403257975,0.0
285,0.1,2,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Is there a mismatch between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology? Clinical pathologists and clinicians differ notably in their views on the clinical relevance of red blood cell morphology, potentially causing misinterpretations and incorrect patient management.",4.737194547137081e-08,0.05402160849809823,0.005105057080109013,0.0036268529295637453,0.052346010513201424,0.0033396814404432484,0.003621603081905733,0.05044051459933652,0.0011882035402833654,4.737194547137081e-08,0.05001042057466343,0.0
285,0.1,3,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Do clinical pathologists and clinicians disagree on reporting and interpreting red blood cell morphology? There are important differences in how clinical pathologists and clinicians perceive the clinical significance of red blood cell morphology, which can lead to misinterpretation and inappropriate management of patients.",0.0,0.0,0.0,0.0,4.440892098500626e-16,1.3877787807814457e-17,0.0,0.0,0.0,0.0,0.0,0.0
285,0.1,4,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Is there discordance between clinical pathologists and clinicians in the reporting and interpretation of red blood cell morphology? Clinical pathologists and clinicians hold differing opinions on the clinical relevance of red blood cell morphology, which may cause misinterpretations and unsuitable patient treatment.",2.3685972735685406e-08,0.06193485411833599,0.025167185939386785,0.0018134264647818726,0.06188587593748984,0.026050750658322214,0.0018108015409528666,0.06175246747526364,0.02614864984927353,2.3685972735685406e-08,0.025975486403257975,0.0
285,0.1,5,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Are clinical pathologists and clinicians aligned in their reporting and interpretation of red blood cell morphology? Significant differences in understanding the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians, potentially leading to misinterpretations and improper patient management.",2.3685972735685406e-08,0.02812279653004568,0.002725135044954946,0.0018134264647818726,0.027228516909492573,0.0017922579313609938,0.0018108015409528666,0.02620645821577927,0.000639705252959033,2.3685972735685406e-08,0.025975486403257975,0.0
285,0.1,6,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Is there a difference between clinical pathologists and clinicians in how red blood cell morphology is reported and interpreted? Important discrepancies about the clinical significance of red blood cell morphology exist between clinical pathologists and clinicians, which can result in misinterpretations and inappropriate patient care.",4.737194547137081e-08,0.022514918472646528,0.01609035853252376,0.0036268529295637453,0.020106606766228108,0.019330025988879604,0.003621603081905733,0.017433506001244048,0.022516436554898094,4.737194547137081e-08,0.05001042057466343,0.0
285,0.1,7,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Do clinical pathologists and clinicians have conflicting views on reporting and interpreting red blood cell morphology? There are notable differences in the clinical relevance attributed to red blood cell morphology by clinical pathologists and clinicians, possibly causing misinterpretations and incorrect patient management.",2.3685972735685406e-08,0.005689261058244188,0.020452885317750122,0.0018134264647818726,0.007428842118504253,0.022853185595567906,0.0018108015409528666,0.009339551043704652,0.02498356344510192,2.3685972735685406e-08,0.025975486403257975,0.0
285,0.1,8,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Is there a lack of agreement between clinical pathologists and clinicians regarding red blood cell morphology reporting and interpretation? Clinical pathologists and clinicians differ significantly in their assessment of the clinical importance of red blood cell morphology, which can lead to misinterpretations and unsuitable patient management.",7.105791820705622e-08,0.07999520768631685,0.007498630387143865,0.005440279394345618,0.07753366990246713,0.00489790571171031,0.0054324046228586,0.07473861686064831,0.0017409330596143968,7.105791820705622e-08,0.07410797215372344,0.0
285,0.1,9,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Are there contrasting perspectives between clinical pathologists and clinicians on red blood cell morphology reporting and interpretation? Important differences exist between clinical pathologists and clinicians about the clinical relevance of red blood cell morphology, potentially resulting in misinterpretations and inappropriate patient care.",2.3685972735685406e-08,0.06193485411833599,0.025167185939386785,0.0018134264647818726,0.06188587593748984,0.026050750658322228,0.0018108015409528666,0.06175246747526364,0.02614864984927353,2.3685972735685406e-08,0.06245691695904432,0.026296566837107373
285,0.1,10,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of red blood cell morphology exist between clinical pathologists and clinicians. This can lead to misinterpretations and inappropriate patient management. 
","Is there inconsistency between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Clinical pathologists and clinicians have differing views on the clinical significance of red blood cell morphology, which may lead to misinterpretations and improper management of patients.",2.3685972735685406e-08,0.028122796530046124,0.002725135044954946,0.0018134264647818726,0.027228516909492573,0.0017922579313609938,0.0018108015409528666,0.02620645821577927,0.000639705252959033,2.3685972735685406e-08,0.025975486403257975,0.0
286,0.1,1,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better health outcomes? Individuals diagnosed with type 2 diabetes exhibiting lower initial blood sugar levels, possibly indicating an earlier disease stage, experienced fewer negative clinical events despite comparable glycemic progression. Because most of these individuals show no symptoms at diagnosis, proactive screening programs are necessary to detect them.",2.3685972735685406e-08,0.016436002980598552,0.0004944236119714222,0.0018134264647818726,0.016355255417392023,0.0002558110854360071,0.0018108015409528666,0.016260520871781203,0.0,2.3685972735685406e-08,0.01652930195121094,0.0
286,0.1,2,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there a connection between lower fasting plasma glucose at type 2 diabetes diagnosis and improved patient outcomes? Patients with type 2 diabetes who have lower initial glucose levels, suggesting an earlier phase of the disease, tend to have fewer adverse clinical outcomes even though their glycemic progression is similar. Since most are asymptomatic when diagnosed, active case-finding initiatives are needed to identify these patients.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
286,0.1,3,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Do lower fasting plasma glucose levels at the diagnosis of type 2 diabetes correlate with better clinical outcomes? People diagnosed with type 2 diabetes who present with lower initial glycemia, possibly indicating an earlier disease stage, show fewer negative clinical outcomes despite similar progression of blood sugar levels. Because most are asymptomatic at diagnosis, active detection programs are essential to find them.",7.105791820705622e-08,0.05013979453644435,0.0015317282073249762,0.005440279394345618,0.04989039778937254,0.0007929921939854173,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
286,0.1,4,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are lower fasting plasma glucose readings at type 2 diabetes diagnosis associated with improved outcomes? Individuals with type 2 diabetes who have lower initial blood glucose, potentially reflecting an earlier disease course, experience fewer adverse clinical events despite similar glycemic progression. Since most are symptom-free at diagnosis, active screening programs are required to identify these cases.",2.1317375462116866e-07,0.15863890338292874,0.005094372962778693,0.016320838183036854,0.15781812522704897,0.002643039375813342,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
286,0.1,5,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is a lower fasting plasma glucose level at the time of type 2 diabetes diagnosis linked to better outcomes? Patients presenting with type 2 diabetes with lower initial glycemia, possibly earlier in their disease, had fewer adverse clinical outcomes despite similar glycemic progression. Because most are asymptomatic at diagnosis, active case detection is necessary to identify them.",1.8948778188548325e-07,0.13972020673666652,0.004447813134751875,0.014507411718254981,0.13900222078069824,0.0023066964139149618,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
286,0.1,6,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Does having lower fasting plasma glucose at diagnosis of type 2 diabetes relate to improved clinical outcomes? Those diagnosed with type 2 diabetes who have lower initial blood sugar levels, indicating an earlier stage of disease, tend to have fewer adverse outcomes despite similar glycemic progression. Since most are asymptomatic at diagnosis, active screening programs are needed to detect them.",1.1842986367842703e-07,0.0850169698594625,0.0026390894628908305,0.009067132323909363,0.08458867036224849,0.0013671860612518467,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
286,0.1,7,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are improved outcomes associated with lower fasting plasma glucose levels at type 2 diabetes diagnosis? Individuals with type 2 diabetes presenting with lower initial glycemia, possibly earlier in the disease course, experience fewer adverse clinical outcomes despite similar glycemic progression. Because most are asymptomatic at diagnosis, active case detection programs are essential.",3.079176455639103e-07,0.2652824789750503,0.027376268210197705,0.023574544042164344,0.23683293578706,0.0041227835609598945,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
286,0.1,8,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there an association between lower fasting plasma glucose at type 2 diabetes diagnosis and better outcomes? People with type 2 diabetes who have lower initial blood glucose, suggesting an earlier disease stage, have fewer adverse clinical outcomes despite similar glycemic progression. Since most are asymptomatic at diagnosis, active detection programs are required to identify them.",2.1317375462116866e-07,0.15863890338292874,0.005094372962778693,0.016320838183036854,0.15781812522704897,0.002643039375813342,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
286,0.1,9,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes linked to better clinical outcomes? Patients presenting with type 2 diabetes with lower initial glycemia, possibly earlier in their disease, had fewer adverse outcomes despite similar glycemic progression. Because most are asymptomatic at diagnosis, active case detection programs would be necessary to find them.",2.1317375462116866e-07,0.15863890338292874,0.005094372962778693,0.016320838183036854,0.15781812522704897,0.002643039375813342,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
286,0.1,10,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Do lower fasting plasma glucose levels at type 2 diabetes diagnosis correspond to improved outcomes? Individuals diagnosed with type 2 diabetes who have lower initial blood sugar levels, potentially indicating an earlier stage of disease, experience fewer adverse clinical outcomes despite similar glycemic progression. Since most are asymptomatic at diagnosis, active screening programs are needed to identify these individuals.",1.4211583641411244e-07,0.1029216278599776,0.0032212937204017973,0.010880558788691236,0.10239973986211481,0.0016693787296396152,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
287,0.1,1,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.1,2,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do parents, their children, and the children's doctors differ in perceiving body image? Answer: A significant number of children underestimated how overweight they were. This misperception was also common among their parents and the doctors who cared for them. The study highlights the importance of improving physician education to better identify obesity and overweight, enabling them to advise children and their families effectively.",2.1317375462116866e-07,0.15509440075506564,0.0025545197502869436,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
287,0.1,3,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, children, and pediatricians view body image differently? Answer: Many children did not accurately perceive their overweight status. Their parents and even their physicians often shared this inaccurate view. The findings suggest a need for enhanced training for physicians to recognize overweight and obesity to provide better guidance to children and their families.",2.3685972735685406e-08,0.0068562133521661295,0.0181755829903978,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
287,0.1,4,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are there differences in body image perception among parents, their children, and the children's doctors? Answer: Numerous children underestimated their overweight condition, a misjudgment also held by their parents and attending physicians. This research underscores the necessity to educate physicians more thoroughly to identify obesity and overweight and to counsel affected children and families.",2.3685972735685406e-08,0.0068562133521661295,0.0181755829903978,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
287,0.1,5,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do perceptions of body image vary between children, their parents, and their doctors? Answer: Many children underestimated how overweight they were, and this misunderstanding was also present among their parents and doctors. The study indicates a critical need to train physicians better in recognizing obesity and overweight to support children and their families.",2.3685972735685406e-08,0.01881590444635073,0.0003363429618983803,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
287,0.1,6,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do children, their parents, and their physicians perceive body image differently? Answer: A large number of children underestimated their overweight status, a misconception shared by their parents and physicians. This study points to the importance of educating physicians to accurately identify obesity and overweight to counsel children and families effectively.",1.1842986367842703e-07,0.07010482778396376,0.0181755829903978,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
287,0.1,7,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Is there a difference in body image perception among children, their parents, and their doctors? Answer: Many children underestimated their overweight level, and this misperception was common among their parents and attending physicians. The study highlights the need for improved physician education to recognize obesity and overweight and to provide counseling to children and families.",0.0,0.025205352020361893,0.0181755829903978,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
287,0.1,8,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do children, parents, and physicians differ in perceiving body image? Answer: Many children underestimated their overweight status, and this misperception was also shared by their parents and physicians. The study emphasizes the need to better educate physicians to identify obesity and overweight and to counsel children and their families.",1.1842986367842703e-07,0.07010482778396376,0.0181755829903978,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
287,0.1,9,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are perceptions of body image different among children, their parents, and their doctors? Answer: Many children underestimated their overweight condition, a misperception also held by their parents and physicians. This study stresses the importance of educating physicians to recognize obesity and overweight to effectively counsel children and families.",1.6580180914979784e-07,0.11092682230421813,0.0181755829903978,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
287,0.1,10,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, children, and their physicians have different views on body image? Answer: Many children underestimated their overweight status, and this was a shared misperception among their parents and doctors. The study demonstrates the need for enhanced physician education to identify obesity and overweight and to provide counseling to children and their families.",4.737194547137081e-08,0.037992417039609094,0.0006853637551643317,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
288,0.1,1,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is screening for coeliac disease in high-risk groups warranted? Long-term adherence to diet among patients identified through screening was strong. Those diagnosed via screening showed significant improvements in quality of life and health outcomes compared to undiagnosed individuals. These results indicate that screening at-risk populations for coeliac disease is advantageous.,0.0,0.02829172165550764,0.02034311182787588,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0
288,0.1,2,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Does screening for coeliac disease in risk groups make sense? Patients detected by screening maintained good long-term dietary compliance. Quality of life and health-related measures improved notably in screened patients versus those undiagnosed. This evidence supports the benefit of screening at-risk groups for coeliac disease.,1.1842986367842703e-07,0.1108456325623095,0.002315675515293554,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
288,0.1,3,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is it justified to screen risk groups for coeliac disease? Screen-detected patients demonstrated good long-term adherence to dietary recommendations. Their quality of life and health outcomes improved significantly compared to undiagnosed patients. These findings imply that screening at-risk individuals for coeliac disease is beneficial.,1.4211583641411244e-07,0.13456786450853064,0.002843324829931968,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
288,0.1,4,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Should coeliac disease screening be conducted in risk groups? Patients identified through screening adhered well to dietary guidelines over the long term. Those diagnosed by screening experienced significant improvements in quality of life and health outcomes relative to undiagnosed patients. This suggests that screening at-risk groups for coeliac disease is justified.,2.3685972735685406e-08,0.0207685417506287,0.0004076354181128221,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
288,0.1,5,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is coeliac disease screening justified in populations at risk? Long-term dietary compliance was high among patients detected by screening. Quality of life and health-related outcomes improved markedly in those diagnosed through screening compared to those undiagnosed. These findings support the benefit of screening at-risk individuals.,1.1842986367842703e-07,0.07933894253685692,0.020399305555555556,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
288,0.1,6,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is screening for coeliac disease in risk groups appropriate? Patients found through screening showed good long-term dietary adherence. Their quality of life and health outcomes improved significantly compared to undiagnosed patients. This evidence suggests that screening at-risk groups for coeliac disease is worthwhile.,1.6580180914979784e-07,0.1918729753679349,0.02710069444444446,0.012693985253473108,0.19144100179187307,0.024375,0.012675610786670066,0.16126814759612174,0.0,1.6580180914979784e-07,0.1650797503594501,0.0
288,0.1,7,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is it reasonable to screen risk groups for coeliac disease? Screen-detected patients maintained strong long-term dietary compliance. Quality of life and health-related outcomes were significantly better in those diagnosed via screening than in undiagnosed individuals. These results indicate that screening at-risk populations is beneficial.,1.4211583641411244e-07,0.10232846076155644,0.020399305555555556,0.010880558788691236,0.13353139262452318,0.0,0.0108648092457172,0.13657553500575004,0.0,1.4211583641411244e-07,0.13976194237515838,0.0
288,0.1,8,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Does screening for coeliac disease in at-risk groups have justification? Patients identified by screening adhered well to dietary restrictions over time. Those diagnosed through screening had significantly improved quality of life and health outcomes compared to undiagnosed patients. This supports the value of screening at-risk individuals.,9.474389094274162e-08,0.0568660866847992,0.020399305555555556,0.0072537058591274906,0.08701137698962924,0.0,0.007243206163811466,0.0889474860164956,0.0,9.474389094274162e-08,0.09097177820572666,0.0
288,0.1,9,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is coeliac disease screening in risk groups warranted? Long-term dietary compliance among screen-detected patients was good. Quality of life and health outcomes improved significantly in those diagnosed through screening versus those undiagnosed. These findings suggest screening at-risk groups is beneficial.,2.3685972735685396e-07,0.1999669303254743,0.020399305555555556,0.018134264647818726,0.2336148511815046,0.0,0.018108015409528666,0.2392296890658323,0.0,2.3685972735685406e-07,0.24512245803298427,0.0
288,0.1,10,ai,"Question: Is coeliac disease screening in risk groups justified? 
Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and health-related outcomes improved significantly in those diagnosed through screening, compared to those who remained undiagnosed. These findings suggest that screening for coeliac disease in at-risk individuals is beneficial. 
",Is screening for coeliac disease justified in risk groups? Patients detected by screening showed good long-term adherence to diet. Their quality of life and health-related outcomes improved significantly compared to undiagnosed individuals. This evidence indicates that screening at-risk populations is advantageous.,2.1317375462116866e-07,0.17464912234118257,0.020399305555555556,0.016320838183036854,0.20763936477824663,0.0,0.0162972138685758,0.21256144198367144,0.0,2.1317375462116866e-07,0.21772348384486895,0.0
289,0.1,1,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites mirror community practice? The residency training locations of the Northeastern Ohio Universities College of Medicine offer patient care experiences comparable to those reported in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.1,2,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites representative of community practice? The residency training sites at Northeastern Ohio Universities College of Medicine deliver patient care opportunities akin to those identified in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.1,3,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do residency teaching sites for family practice reflect the nature of community practice? The Northeastern Ohio Universities College of Medicines residency training sites provide patient care experiences similar to those found in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.1,4,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites align with community practice? The residency training locations at Northeastern Ohio Universities College of Medicine offer patient care opportunities that resemble those in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.1,5,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is the family practice at residency teaching sites consistent with community practice? The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care opportunities comparable to those in a national survey of family and general practitioners.,4.73719454713706e-08,0.051293294387549704,0.0,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
289,0.1,6,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do family practice residency teaching sites reflect the practices seen in the community? The residency training sites at Northeastern Ohio Universities College of Medicine offer patient care experiences similar to those documented in a national survey of family and general practitioners.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
289,0.1,7,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Are family practice residency teaching sites indicative of community practice? The residency training sites of Northeastern Ohio Universities College of Medicine provide patient care opportunities that are similar to those found in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.1,8,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does the family practice at residency teaching sites correspond to community practice? The residency training sites at Northeastern Ohio Universities College of Medicine provide patient care opportunities comparable to those reported in a national survey of family and general practitioners.,2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,0.1,9,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is family practice at residency teaching sites reflective of community practice? The residency training sites of Northeastern Ohio Universities College of Medicine offer patient care experiences similar to those in a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,0.1,10,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do residency teaching sites for family practice offer patient care opportunities that reflect community practice? The residency training sites at Northeastern Ohio Universities College of Medicine provide experiences akin to those found in a national survey of family and general practitioners.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
290,0.1,1,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants during their first week? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. Monitoring end-tidal CO2 is useful for tracking trends.,2.3685972735685406e-08,0.03285545717155136,0.03723853486973019,0.0018134264647818726,0.007379615078719759,0.019599999999999996,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
290,0.1,2,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Is there a correlation between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants within the first week of life? Yes, end-tidal CO2 and arterial CO2 show good correlation and agreement in ELBW infants with EtCO2 levels between 30 and 50 mmHg. End-tidal CO2 monitoring aids in trend observation.",0.0,0.026659506944613387,0.01891283724374103,0.0,0.027182242374899523,0.019599999999999996,0.0,0.0,0.0,0.0,0.0,0.0
290,0.1,3,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does measuring end-tidal carbon dioxide correspond with arterial carbon dioxide levels in extremely low birth weight infants during their initial week? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 is between 30 and 50 mmHg. End-tidal CO2 monitoring helps in tracking changes.,2.3685972735685406e-08,0.03285545717155136,0.03723853486973019,0.0018134264647818726,0.007379615078719759,0.019599999999999996,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
290,0.1,4,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is there a relationship between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week? A good correlation and agreement exist between end-tidal CO2 and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. Monitoring end-tidal CO2 can assist in trend analysis.,0.0,0.0,0.0,0.0,0.027182242374899523,0.019599999999999996,0.0,0.0,0.0,0.0,0.0,0.0
290,0.1,5,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal CO2 measurement correlate with arterial CO2 in extremely low birth weight infants during their first week of life? There is a strong correlation and agreement between end-tidal and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. End-tidal CO2 monitoring is beneficial for trend tracking.,4.737194547137081e-08,0.015760347042022005,0.016633343393189448,0.0036268529295637453,0.041114813894306934,0.00079930555555556,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
290,0.1,6,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Is there a correlation between end-tidal CO2 and arterial CO2 in extremely low birth weight infants in the first week? Yes, end-tidal CO2 and arterial CO2 correlate well and agree in ELBW infants with EtCO2 levels from 30 to 50 mmHg. End-tidal CO2 monitoring can be useful for observing trends.",7.105791820705622e-08,0.10492253451610267,0.06978879706152431,0.005440279394345618,0.12008577701152756,0.04262222222222223,0.0054324046228586,0.12086665312744449,0.04246913580246913,7.105791820705622e-08,0.09331573555892092,0.021728395061728398
290,0.1,7,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does end-tidal carbon dioxide measurement align with arterial carbon dioxide in extremely low birth weight infants during their first week? There is good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring aids in trend monitoring.,9.474389094274162e-08,0.03116694494174599,0.03480098718756562,0.0072537058591274906,0.05449578863936777,0.019599999999999996,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
290,0.1,8,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Is there a correlation between end-tidal carbon dioxide and arterial carbon dioxide in extremely low birth weight infants in the first week of life? Yes, end-tidal CO2 and arterial CO2 show strong correlation and agreement in ELBW infants when EtCO2 is between 30 and 50 mmHg. Monitoring end-tidal CO2 helps in tracking trends.",0.0,0.026659506944613387,0.01891283724374103,0.0,0.027182242374899523,0.019599999999999996,0.0,0.0,0.0,0.0,0.0,0.0
290,0.1,9,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does measuring end-tidal CO2 correspond with arterial CO2 levels in extremely low birth weight infants during their first week? There is a good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants within the EtCO2 range of 30-50 mmHg. End-tidal CO2 monitoring can be helpful for trend observation.,4.737194547137081e-08,0.02622530991731331,0.025919848096172274,0.0036268529295637453,0.01282309223879885,0.019599999999999996,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
290,0.1,10,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Is there a relationship between end-tidal CO2 measurement and arterial CO2 in extremely low birth weight infants in their first week? A strong correlation and agreement exist between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 ranges from 30 to 50 mmHg. End-tidal CO2 monitoring is useful for tracking trends.,2.3685972735685406e-08,0.08613327985284336,0.08361111111111115,0.0018134264647818726,0.07579804658847333,0.04015554549569944,0.0018108015409528666,0.04849442897302669,0.020399305555555556,2.3685972735685406e-08,0.02061928720273576,0.0
291,0.1,1,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Is antral follicle assessment a superior predictor of IVF outcomes compared to age and FSH? Answer: IVF success depends on multiple factors. Although age and FSH are common predictors, antral follicle count (AFC) is gaining recognition as a valuable indicator. AFC measures ovarian reserve and correlates strongly with IVF results, possibly outperforming age and FSH in forecasting success.",2.8423167282822487e-07,0.18618425960983087,0.0038489947321855705,0.021761117577382486,0.19528496784163885,0.003048645928959816,0.0217296184914344,0.1941560144409591,0.0,2.8423167282822487e-07,0.19735943415849366,0.0
291,0.1,2,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Can antral follicle count better predict IVF outcomes than age and FSH? Answer: IVF success rates are affected by several factors. While age and FSH are traditional predictors, AFC has emerged as a reliable marker. It reflects ovarian reserve and shows a strong association with IVF success, potentially making it a better predictor than age and FSH.",3.079176455639103e-07,0.18109062804562281,0.01226897508948796,0.023574544042164358,0.2134188476857517,0.003361620292258857,0.023540420032387266,0.21217451994363756,0.0,3.079176455639103e-07,0.21570857282668943,0.0
291,0.1,3,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Does antral follicle assessment provide a more accurate prediction of IVF success than age and FSH? Answer: Various factors influence IVF outcomes. Age and FSH are commonly used predictors, but AFC, which indicates ovarian reserve, has demonstrated a strong correlation with IVF success and may be a superior predictor.",4.974054274493935e-07,0.30676238797311894,0.061032730545562665,0.03808195576041934,0.3428142710644404,0.014489619377162635,0.0380268323600102,0.36936010346605075,0.0,4.974054274493935e-07,0.3760512229018702,0.0
291,0.1,4,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Is AFC a better predictor of IVF success compared to age and FSH levels? Answer: IVF outcomes are influenced by many variables. Although age and FSH are widely used, AFC has become a promising tool as it reflects ovarian reserve and correlates well with IVF results, potentially outperforming the other two.",4.500334819780227e-07,0.26453809479820434,0.06262479390983541,0.034455102830855594,0.329718163766584,0.005502050760280099,0.034405229278104466,0.32768740706548183,0.0,4.500334819780227e-07,0.3334916084830737,0.0
291,0.1,5,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: How does antral follicle count compare to age and FSH in predicting IVF outcomes? Answer: IVF success is determined by multiple factors. Age and FSH are standard predictors, but AFC, which measures ovarian reserve, has shown a strong link to IVF success and might be a better predictor.",5.210914001850789e-07,0.35744162943483193,0.039552925706771894,0.03989538222520121,0.39336330496695204,0.006776921265559467,0.039837633900963065,0.3908663086870141,0.0,5.210914001850789e-07,0.3980301296206452,0.0
291,0.1,6,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Is antral follicle count a more effective predictor of IVF outcomes than age and FSH? Answer: Success in IVF depends on various factors. While age and FSH are traditional markers, AFC has emerged as a strong indicator of ovarian reserve and correlates closely with IVF success, possibly surpassing age and FSH.",4.500334819780227e-07,0.27479786232299963,0.021808467379223165,0.034455102830855594,0.30199227654418603,0.014489619377162635,0.034405229278104466,0.32768740706548183,0.0,4.500334819780227e-07,0.3334916084830737,0.0
291,0.1,7,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Can AFC outperform age and FSH in predicting IVF success? Answer: IVF success rates are influenced by several factors. Age and FSH are common predictors, but AFC, reflecting ovarian reserve, has shown a strong correlation with IVF outcomes and may be a better predictor.",6.158352911278206e-07,0.42082298890537295,0.056423674006091606,0.0471490880843287,0.48505457002574337,0.00875301100832489,0.04708084006477453,0.48183808689274077,0.0,6.158352911278206e-07,0.4911205526866569,0.0
291,0.1,8,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Does assessing antral follicles provide better IVF outcome predictions than age and FSH? Answer: Multiple factors affect IVF success. Age and FSH are widely used predictors, yet AFC, which indicates ovarian reserve, has demonstrated a strong relationship with IVF success and could be superior.",6.158352911278206e-07,0.3893162988799208,0.07906016685814499,0.0471490880843287,0.45281516627876917,0.014489619377162635,0.04708084006477453,0.48183808689274077,0.0,6.158352911278206e-07,0.4911205526866569,0.0
291,0.1,9,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: Is antral follicle assessment a more reliable predictor of IVF success than age and FSH? Answer: IVF outcomes depend on various factors. Although age and FSH are standard predictors, AFC has emerged as a promising tool reflecting ovarian reserve and correlating strongly with IVF success, potentially outperforming them.",5.210914001850789e-07,0.29967936438816967,0.08095124571079582,0.03989538222520121,0.36386768026227356,0.014489619377162635,0.039837633900963065,0.3908663086870141,0.0,5.210914001850789e-07,0.3980301296206452,0.0
291,0.1,10,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? 

Answer: In vitro fertilization (IVF) success rates are influenced by various factors. While age and FSH levels are widely used predictors, antral follicle count (AFC) has emerged as a promising tool. AFC reflects ovarian reserve and has shown strong correlation with IVF outcomes, potentially surpassing age and FSH in predicting success. 
","Question: How effective is antral follicle count compared to age and FSH in forecasting IVF outcomes? Answer: IVF success is influenced by many factors. While age and FSH are commonly used, AFC, which measures ovarian reserve, has shown a strong correlation with IVF success and may be a better predictor.",4.974054274493935e-07,0.33505410962862703,0.04081106475319072,0.03808195576041934,0.3716954035877711,0.006334282841035649,0.0380268323600102,0.36936010346605075,0.0,4.974054274493935e-07,0.3760512229018702,0.0
292,0.1,1,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a suitable alternative to thrombolysis? Patients and their carers found the reorganization of care to provide a primary angioplasty service acceptable. Satisfaction was generally high regardless of the care type, except for discharge and aftercare.",1.4211583641411212e-07,0.12327081072079071,0.01939477897489004,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
292,0.1,2,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty be considered an acceptable alternative to thrombolysis? The restructuring of care to include primary angioplasty was well accepted by patients and their carers. Satisfaction levels remained high across care types, except in discharge and aftercare.",1.4211583641411212e-07,0.12327081072079071,0.01939477897489004,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
292,0.1,3,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is it acceptable to use primary angioplasty instead of thrombolysis? Patients and carers accepted the care reorganization to offer primary angioplasty. Satisfaction was high regardless of care type, except for discharge and aftercare.",2.605457000925386e-07,0.23098540539988743,0.046400951814396206,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.1,4,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Does primary angioplasty serve as an acceptable alternative to thrombolysis? Patients and carers accepted the reorganization of care to provide primary angioplasty services. Satisfaction was high across care types, with the exception of discharge and aftercare.",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
292,0.1,5,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable substitute for thrombolysis? The care reorganization to offer primary angioplasty was accepted by patients and carers. Satisfaction levels were high regardless of care type, except for discharge and aftercare.",2.3685972735685332e-07,0.2422226667670695,0.016127514314396206,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
292,0.1,6,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Can primary angioplasty replace thrombolysis acceptably? Patients and carers found the reorganization to provide primary angioplasty acceptable. Satisfaction was high regardless of care type, except for discharge and aftercare.",3.552895910352798e-07,0.4140273109215489,0.01073565688984203,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
292,0.1,7,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a viable alternative to thrombolysis? Patients and carers accepted the care changes to offer primary angioplasty. Satisfaction was high across care types, except for discharge and aftercare.",3.316036182995945e-07,0.3294254782131407,0.046400951814396206,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
292,0.1,8,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty an acceptable option instead of thrombolysis? The reorganization of care to provide primary angioplasty was accepted by patients and carers. Satisfaction was high regardless of care type, except for discharge and aftercare.",2.1317375462116802e-07,0.25190751070815187,0.012192798185603794,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,0.1,9,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty considered an acceptable alternative to thrombolysis? Patients and carers accepted the care reorganization to offer primary angioplasty. Satisfaction levels were high regardless of care type, except for discharge and aftercare.",2.605457000925386e-07,0.23098540539988743,0.046400951814396206,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
292,0.1,10,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Is primary angioplasty a preferred alternative to thrombolysis? Patients and carers accepted the reorganization of care to provide primary angioplasty. Satisfaction was high across care types, except for discharge and aftercare.",3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
293,0.1,1,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Are reduced fasting plasma glucose levels at the time of type 2 diabetes diagnosis linked to better health outcomes?,8.526950184846725e-07,0.8578734480413774,0.2044444444444444,0.06528335273214754,0.9801395852181809,0.11136260751471248,0.06518885547430332,1.0720169685631933,0.07638888888888888,8.526950184846743e-07,1.1422287044974158,0.05859375
293,0.1,2,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Do individuals diagnosed with type 2 diabetes who have lower fasting plasma glucose levels tend to have improved prognoses?,8.526950184846725e-07,0.8578734480413774,0.2044444444444444,0.06528335273214754,0.9801395852181809,0.11136260751471248,0.06518885547430332,1.0720169685631933,0.07638888888888888,8.526950184846743e-07,1.1422287044974158,0.05859375
293,0.1,3,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Is there a connection between lower fasting plasma glucose at type 2 diabetes diagnosis and enhanced patient outcomes?,8.763809912203578e-07,0.9150318618813262,0.2044444444444444,0.06709677919692941,1.040764207034616,0.11136260751471248,0.0669996570152562,1.136555489700764,0.07638888888888888,8.763809912203596e-07,1.2112215759843679,0.05859375
293,0.1,4,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Can lower fasting plasma glucose levels at the diagnosis of type 2 diabetes predict better clinical results?,9.000669639560431e-07,0.9756564836977613,0.2044444444444444,0.06891020566171129,1.1053027281721866,0.11136260751471248,0.06881045855620907,1.205548361187716,0.07638888888888888,9.00066963956045e-07,1.285329548138089,0.05859375
293,0.1,5,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Are improved outcomes observed in type 2 diabetes patients presenting with lower fasting plasma glucose levels at diagnosis?,8.763809912203578e-07,0.9150318618813262,0.2044444444444444,0.06709677919692941,1.040764207034616,0.11136260751471248,0.0669996570152562,1.136555489700764,0.07638888888888888,8.763809912203596e-07,1.2112215759843679,0.05859375
293,0.1,6,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Does having a lower fasting plasma glucose level when diagnosed with type 2 diabetes correlate with fewer complications?,8.763809912203578e-07,0.9150318618813262,0.2044444444444444,0.06709677919692941,1.040764207034616,0.11136260751471248,0.0669996570152562,1.136555489700764,0.07638888888888888,8.763809912203596e-07,1.2112215759843679,0.05859375
293,0.1,7,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Are people with type 2 diabetes who show lower fasting plasma glucose at diagnosis more likely to experience better health outcomes?,8.053230730133017e-07,0.752512932383552,0.2044444444444444,0.06165649980258378,0.8689139501079568,0.11136260751471248,0.06156725239239758,0.9542339329068095,0.07638888888888888,8.053230730133036e-07,1.01706556154341,0.05859375
293,0.1,8,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Is a lower fasting plasma glucose level at the time of type 2 diabetes diagnosis associated with a decreased risk of complications?,7.816371002776164e-07,0.7037227682141207,0.2044444444444444,0.0598430733378019,0.8176206557204067,0.11136260751471248,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,0.9599071477034613,0.05859375
293,0.1,9,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Do lower fasting plasma glucose levels at diagnosis in type 2 diabetes patients relate to reduced cardiovascular and neuropathic risks?,8.290090457489871e-07,0.8038062267711021,0.2044444444444444,0.06346992626736567,0.9229811713782321,0.11136260751471248,0.06337805393335046,1.0113923467467583,0.07638888888888888,8.29009045748989e-07,1.0776901833598451,0.05859375
293,0.1,10,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? 
Answer: People presenting with type 2 diabetes with lower fasting plasma glucose levels at diagnosis may experience improved outcomes. Studies have shown an association between lower glucose levels and reduced risk of complications, including cardiovascular disease and neuropathy. 
",Are improved clinical outcomes linked to lower fasting plasma glucose levels at the initial diagnosis of type 2 diabetes?,8.526950184846725e-07,0.8578734480413774,0.2044444444444444,0.06528335273214754,0.9801395852181809,0.11136260751471248,0.06518885547430332,1.0720169685631933,0.07638888888888888,8.526950184846743e-07,1.1422287044974158,0.05859375
294,0.1,1,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Is anterior chamber depth affected by head positioning in pseudoexfoliation syndrome? Answer: In patients with clinically evident unilateral pseudoexfoliation, the lens appears to be more mobile in the affected eye, leading to a shallower anterior chamber when the head is positioned prone.",7.105791820705622e-08,0.040386797368603844,0.020552936471601127,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
294,0.1,2,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Does the position of the head impact anterior chamber depth in pseudoexfoliation syndrome? Answer: In cases of clinically obvious unilateral pseudoexfoliation, the lens tends to be more mobile in the affected eye, causing the anterior chamber to become shallower when the head is placed prone.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
294,0.1,3,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: How does head positioning affect anterior chamber depth in pseudoexfoliation syndrome? Answer: For patients with clinically apparent unilateral pseudoexfoliation, the lens shows increased mobility in the affected eye, resulting in a reduced anterior chamber depth when the head is in a prone position.",4.737194547137081e-08,0.0805675026012409,0.02502670362358031,0.0036268529295637453,0.07952702423298552,0.023795359904818555,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
294,0.1,4,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Is anterior chamber depth influenced by head position in pseudoexfoliation syndrome? Answer: In patients with unilateral pseudoexfoliation that is clinically evident, the lens is more mobile in the affected eye, which causes the anterior chamber to be shallower when the head is prone.",4.737194547137081e-08,0.01608869510729205,0.02110566599093216,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
294,0.1,5,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Does head posture alter anterior chamber depth in pseudoexfoliation syndrome? Answer: Among patients with clinically apparent unilateral pseudoexfoliation, the lens exhibits greater mobility in the affected eye, leading to a shallower anterior chamber when the head is placed in a prone position.",7.105791820705622e-08,0.040386797368603844,0.020552936471601127,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
294,0.1,6,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Can head positioning change anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically evident unilateral pseudoexfoliation, the lens is more mobile in the affected eye, resulting in a shallower anterior chamber when the head is positioned prone.",1.4211583641411233e-07,0.11703377018371963,0.01872502767835873,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
294,0.1,7,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Does the anterior chamber depth vary with head position in pseudoexfoliation syndrome? Answer: In clinically apparent unilateral pseudoexfoliation patients, the lens tends to be more mobile in the affected eye, causing the anterior chamber to become shallower when the head is prone.",7.105791820705622e-08,0.07339380596669631,0.003151703623580332,0.005440279394345618,0.10442962480224383,0.024375,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
294,0.1,8,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: How does the position of the head influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically evident unilateral pseudoexfoliation, the lens is more mobile in the affected eye, which leads to a shallower anterior chamber when the head is placed prone.",2.3685972735685406e-08,0.023873153186523055,0.0010031775464828113,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
294,0.1,9,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Is there an effect of head positioning on anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens shows increased mobility in the affected eye, resulting in a shallower anterior chamber when the head is prone.",7.105791820705622e-08,0.040386797368603844,0.020552936471601127,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
294,0.1,10,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Question: Does placing the head in different positions affect anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically evident unilateral pseudoexfoliation, the lens is more mobile in the affected eye, causing the anterior chamber to be shallower when the head is positioned prone.",2.3685972735685406e-08,0.023873153186523055,0.0010031775464828113,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
295,0.1,1,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Does using an automatic transmission enhance driving habits in elderly drivers? Switching to an automatic transmission is often advised for older drivers to help sustain safe driving. Without the need for manual gear changes, cognitive demands are lowered and the chance of stalling is removed, enabling drivers to concentrate better on traffic and road conditions.",7.105791820705622e-08,0.007324302819299522,0.03576332179930797,0.005440279394345618,0.03211241074435467,0.018860946745562133,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
295,0.1,2,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Can automatic transmissions improve the driving behavior of senior drivers? It is suggested that older drivers switch to automatic transmissions to promote safer driving. This change reduces mental effort and removes the possibility of stalling, allowing drivers to pay more attention to the road and surrounding traffic.",1.1842986367842703e-07,0.10613882779771977,0.0021283950617284053,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
295,0.1,3,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Is driving behavior improved in older adults by using automatic transmissions? Older drivers may benefit from switching to automatic transmissions as it supports safer driving. The lack of manual gear shifting decreases cognitive strain and prevents stalling, helping drivers focus more on traffic and road safety.",1.4211583641411244e-07,0.09798090057910613,0.019599999999999992,0.010880558788691236,0.1278333715098836,0.0,0.0108648092457172,0.13062018241706452,0.0,1.4211583641411244e-07,0.13353139262452318,0.0
295,0.1,4,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Do automatic transmissions help older drivers drive more safely? Recommending automatic transmissions for elderly drivers can aid in maintaining safe driving habits. By eliminating manual shifting, cognitive load is reduced and stalling risks are avoided, allowing better focus on the driving environment.",2.3685972735685406e-07,0.22488338123340768,0.004775000000000008,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
295,0.1,5,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Does an automatic transmission contribute to better driving behavior in older drivers? For older drivers, switching to automatic transmissions can be beneficial for safe driving. The removal of manual gear changes lowers mental workload and eliminates stalling risks, enabling drivers to concentrate on traffic and road conditions.",1.1842986367842703e-07,0.07600199386033113,0.019599999999999992,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
295,0.1,6,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Can older drivers improve their driving by using automatic transmissions? It is often recommended that older drivers use automatic transmissions to keep driving safely. This reduces the cognitive demands of shifting gears manually and removes the risk of stalling, so drivers can focus more on the road.",1.1842986367842703e-07,0.10613882779771977,0.0021283950617284053,0.009067132323909363,0.10536051565782589,0.0,0.009054007704764333,0.107630664192365,0.0,1.1842986367842703e-07,0.11000089521432876,0.0
295,0.1,7,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Is it advisable for older drivers to switch to automatic transmissions to improve driving behavior? Switching to automatic transmission is suggested for older drivers to maintain safety. The absence of manual shifting lessens cognitive load and prevents stalling, allowing drivers to better attend to traffic and road conditions.",9.474389094274162e-08,0.2131068513917933,0.13289433106575965,0.0072537058591274906,0.14365527681382861,0.043388429752066124,0.007243206163811466,0.11596434969852698,0.02221074380165289,9.474389094274162e-08,0.08701137698962924,0.0
295,0.1,8,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Does automatic transmission use lead to safer driving in elderly drivers? Older drivers may be advised to use automatic transmissions as a way to enhance driving safety. Without manual gear shifting, cognitive effort is reduced and stalling is avoided, helping drivers focus on the road.",1.6580180914979784e-07,0.12045375643116385,0.019599999999999992,0.012693985253473108,0.15082288973458313,0.0,0.012675610786670066,0.15415067982725894,0.0,1.6580180914979784e-07,0.1576289442035832,0.0
295,0.1,9,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Are automatic transmissions beneficial for improving driving in older adults? Switching to automatic transmissions is recommended for older drivers to support safe driving. This change reduces the mental effort required for manual shifting and eliminates stalling risks, allowing better attention to traffic.",2.3685972735685406e-07,0.22488338123340768,0.004775000000000008,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
295,0.1,10,ai,"Question: Does automatic transmission improve driving behavior in older drivers? 
Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving practices. The absence of manual shifting reduces cognitive load and eliminates the risk of stalling, allowing drivers to focus on road conditions and traffic. 
","Can the use of automatic transmissions improve driving safety for older drivers? It is recommended that older drivers switch to automatic transmissions to maintain safe driving practices. The lack of manual gear changes decreases cognitive load and removes the risk of stalling, enabling drivers to focus on road and traffic conditions.",2.3685972735685406e-08,0.020346272143678235,0.00039167013744274143,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
296,0.1,1,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Question: Do provider service networks lead to reduced costs compared to HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida seems to lower PMPM expenditures. Demonstration PSNs achieved slightly larger expenditure reductions than Demonstration HMOs. PSNs seem to be an effective model for providing care to Medicaid enrollees.,9.474389094274162e-08,0.0002459167654373928,0.05157024793388431,0.0072537058591274906,0.04843840057857163,0.017538265306122455,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
296,0.1,2,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Question: Are provider service networks associated with lower spending than HMOs or primary care case management in Florida's Medicaid program? Answer: Florida's Medicaid Demonstration appears to reduce PMPM expenditures. Demonstration PSNs showed marginally greater cost reductions compared to Demonstration HMOs. PSNs seem to offer a promising approach for Medicaid care delivery.,1.8948778188548325e-07,0.1044410115930905,0.031578577796441576,0.014507411718254981,0.1269100160200658,0.017538265306122455,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
296,0.1,3,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Question: Do provider service networks reduce expenditures more than HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida results in decreased PMPM expenditures. Demonstration PSNs produced slightly higher expenditure reductions than Demonstration HMOs. PSNs appear to be a viable model for Medicaid care.,2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,0.1,4,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Question: Are expenditures lower with provider service networks compared to HMOs or primary care case management in Florida's Medicaid program? Answer: The Florida Medicaid Demonstration shows lower PMPM expenditures. Demonstration PSNs generated somewhat greater reductions in costs than Demonstration HMOs. PSNs seem to be a promising care delivery model for Medicaid enrollees.,1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,0.1,5,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Question: Do provider service networks lead to cost savings compared to HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to lower PMPM costs. Demonstration PSNs achieved slightly more expenditure reductions than Demonstration HMOs. PSNs seem to be an effective model for delivering Medicaid care.,1.4211583641411244e-07,0.03749441121741004,0.05157024793388431,0.010880558788691236,0.08690468140636742,0.017538265306122455,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
296,0.1,6,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Question: Are provider service networks more cost-effective than HMOs or primary care case management in Florida's Medicaid program? Answer: Florida's Medicaid Demonstration results in reduced PMPM expenditures. Demonstration PSNs showed marginally greater cost savings compared to Demonstration HMOs. PSNs appear to be a promising model for Medicaid service delivery.,2.3685972735685406e-07,0.14641825141427756,0.030746345715686026,0.018134264647818726,0.16858271242063472,0.017538265306122455,0.018108015409528666,0.19671029424605502,0.0,2.3685972735685406e-07,0.20067069546215155,0.0
296,0.1,7,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Question: Do provider service networks result in lower Medicaid expenditures compared to HMOs or primary care case management in Florida? Answer: The Medicaid Demonstration in Florida leads to decreased PMPM expenditures. Demonstration PSNs produced slightly greater reductions in spending than Demonstration HMOs. PSNs seem to be a promising approach for Medicaid care.,1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,0.1,8,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Question: Are provider service networks associated with cost reductions compared to HMOs or primary care case management in Florida's Medicaid program? Answer: The Florida Medicaid Demonstration appears to reduce PMPM expenditures. Demonstration PSNs generated somewhat larger expenditure reductions than Demonstration HMOs. PSNs seem to be an effective model for Medicaid care delivery.,1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,0.1,9,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Question: Do provider service networks help lower expenditures compared to HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida results in lower PMPM expenditures. Demonstration PSNs achieved slightly greater cost reductions than Demonstration HMOs. PSNs appear to be a promising model for providing care to Medicaid enrollees.,1.1842986367842703e-07,0.01844621624671694,0.05157024793388431,0.009067132323909363,0.06748659554926473,0.017538265306122455,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
296,0.1,10,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Question: Are provider service networks effective in reducing expenditures compared to HMOs or primary care case management in Florida's Medicaid program? Answer: Florida's Medicaid Demonstration shows reduced PMPM expenditures. Demonstration PSNs produced marginally greater expenditure reductions than Demonstration HMOs. PSNs seem to be a promising model for Medicaid care delivery.,2.1317375462116866e-07,0.1252095533437192,0.031170942378328754,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
297,0.1,1,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers release GABA? Answer: We have presented strong evidence indicating the presence of a GABAergic signal from mossy fibers. The physiological function of this mossy fiber GABAergic signal remains unclear, though it might play a role in development. Additional data supports that this",7.105791820705622e-08,0.10420034732491601,0.025289256198347116,0.005440279394345618,0.10442962480224383,0.024375,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,0.1,2,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers capable of releasing GABA? Answer: Our findings strongly support the existence of a GABAergic signal originating from mossy fibers. The exact physiological purpose of this mossy fiber GABAergic signal is not well understood but could be important during development. Further evidence indicates that this,1.1842986367842703e-07,0.1489963759181956,0.026233459357277902,0.009067132323909363,0.14888138737307655,0.024375,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
297,0.1,3,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Is GABA released by mossy fibers? Answer: We have demonstrated convincing evidence for a GABAergic signal associated with mossy fibers. The physiological significance of this mossy fiber GABAergic signal is uncertain, yet it may have developmental relevance. Other studies suggest that this",0.0,0.03300700859809247,0.023704640095181452,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0,0.0,0.0,0.0
297,0.1,4,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Do mossy fibers emit GABA? Answer: Compelling evidence has been provided showing a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal is not fully known but might be crucial for development. Additional findings imply that this,0.0,0.03300700859809247,0.023704640095181452,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0,0.0,0.0,0.0
297,0.1,5,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers a source of GABA release? Answer: We have supplied strong evidence that mossy fibers generate a GABAergic signal. The physiological role of this mossy fiber GABAergic signal is unclear but could be significant in developmental processes. Other research suggests that this,4.737194547137081e-08,0.0810273428056254,0.024785018929150898,0.0036268529295637453,0.0814401065775443,0.024375,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
297,0.1,6,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Can mossy fibers release GABA? Answer: Evidence strongly indicates the presence of a GABAergic signal from mossy fibers. The physiological function of this mossy fiber GABAergic signal is uncertain, though it may be important for development. Other data supports that this",2.3685972735685406e-08,0.008104408028834165,0.023125000000000007,0.0018134264647818726,0.009119444997918169,0.024375,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
297,0.1,7,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Do mossy fibers discharge GABA? Answer: We have provided convincing evidence for a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal remains uncertain but might be developmentally significant. Additional evidence suggests that this,7.105791820705611e-08,0.04363996421702332,0.021876731301939054,0.005440279394345618,0.042173849389631535,0.024375,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
297,0.1,8,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Is there GABA release from mossy fibers? Answer: Our data provide compelling evidence of a GABAergic signal in mossy fibers. The physiological role of this mossy fiber GABAergic signal is not clear but may have developmental importance. Other evidence indicates that this,0.0,0.03300700859809247,0.023704640095181452,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0,0.0,0.0,0.0
297,0.1,9,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Do mossy fibers secrete GABA? Answer: We have presented strong evidence supporting a GABAergic signal from mossy fibers. The physiological role of this mossy fiber GABAergic signal is uncertain but could be important during development. Further evidence suggests that this,4.737194547137081e-08,0.017433506001244048,0.022516436554898087,0.0036268529295637453,0.01619836298637356,0.024375,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
297,0.1,10,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers involved in GABA release? Answer: We have demonstrated compelling evidence for a GABAergic signal associated with mossy fibers. The physiological role of this mossy fiber GABAergic signal is unclear but may be significant in developmental stages. Other evidence suggests that this,4.737194547137081e-08,0.0810273428056254,0.024785018929150898,0.0036268529295637453,0.0814401065775443,0.024375,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
298,0.1,1,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","What is the prognosis for low-tone sudden deafnessdoes it always develop into Meniere's disease? We find that low-tone sudden deafness does not necessarily evolve into Meniere's disease. Although some symptoms may overlap, fluctuating hearing loss, tinnitus, and vertigo are key indicators for diagnosing Meniere's disease.",4.737194547137081e-08,0.04856133083502279,0.002916829812021182,0.0036268529295637453,0.014655832718537543,0.02221074380165289,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
298,0.1,2,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Does low-tone sudden deafness inevitably lead to Meniere's disease? Our conclusion is that not every case of low-tone sudden deafness progresses to Meniere's disease. The diagnosis of Meniere's requires the presence of fluctuating hearing loss, tinnitus, and vertigo, which are not always present.",9.474389094274162e-08,0.09958230218783859,0.006105971243051553,0.0072537058591274906,0.09609593929608184,0.0021642561983471094,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
298,0.1,3,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Is the prognosis of low-tone sudden deafness such that it always progresses to Meniere's disease? We conclude that progression to Meniere's disease is not inevitable in low-tone sudden deafness. The diagnosis depends on symptoms like fluctuating hearing loss, tinnitus, and vertigo, which are essential for Meniere's disease.",0.0,0.030136833937389085,0.02151151616464564,0.0,0.030806541358219697,0.02221074380165289,0.0,0.0,0.0,0.0,0.0,0.0
298,0.1,4,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Does low-tone sudden deafness inevitably develop into Meniere's disease? Our findings indicate that not all cases of low-tone sudden deafness advance to Meniere's disease. The hallmark symptoms for Meniere's include fluctuating hearing loss, tinnitus, and vertigo, which are critical for diagnosis.",1.4211583641411244e-07,0.11866615861898566,0.015038450071836414,0.010880558788691236,0.14784031154193933,0.0034125248964080625,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
298,0.1,5,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Is progression to Meniere's disease unavoidable in low-tone sudden deafness? We conclude that low-tone sudden deafness does not always progress to Meniere's disease. The diagnosis of Meniere's disease requires fluctuating hearing loss, tinnitus, and vertigo, which are not present in all cases.",1.1842986367842703e-07,0.12609500073748992,0.007814735523731478,0.009067132323909363,0.08697649429816368,0.02221074380165289,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
298,0.1,6,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","What is the likelihood that low-tone sudden deafness will progress to Meniere's disease? Our conclusion is that not all low-tone sudden deafness cases develop into Meniere's disease. The presence of fluctuating hearing loss, tinnitus, and vertigo is essential for diagnosing Meniere's disease.",1.1842986367842703e-07,0.12609500073748947,0.007814735523731478,0.009067132323909363,0.12163385332616006,0.0027728196434490295,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
298,0.1,7,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Does low-tone sudden deafness always lead to Meniere's disease? We conclude that it does not necessarily progress to Meniere's disease. Key diagnostic features of Meniere's include fluctuating hearing loss, tinnitus, and vertigo, which may not be present in all low-tone sudden deafness cases.",9.474389094274162e-08,0.09958230218783859,0.006105971243051553,0.0072537058591274906,0.09609593929608184,0.0021642561983471094,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
298,0.1,8,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Is Meniere's disease an inevitable outcome of low-tone sudden deafness? Our conclusion is that low-tone sudden deafness does not inevitably progress to Meniere's disease. The diagnosis depends on symptoms such as fluctuating hearing loss, tinnitus, and vertigo.",2.3685972735685364e-07,0.1932201329185923,0.03714484387589542,0.018134264647818726,0.2205078869226864,0.02221074380165289,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
298,0.1,9,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Does low-tone sudden deafness inevitably result in Meniere's disease? We conclude that progression to Meniere's disease is not guaranteed in low-tone sudden deafness. The diagnosis requires fluctuating hearing loss, tinnitus, and vertigo, which are critical symptoms for Meniere's disease.",1.8948778188548304e-07,0.1371261655063276,0.03860337907960437,0.014507411718254981,0.16493803576787425,0.02221074380165289,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
298,0.1,10,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? 
Answer: We conclude that not all low-tone sudden deafness progresses to Meniere's disease. While some cases may share characteristics, the presence of fluctuating hearing loss, tinnitus, and vertigo are crucial for Meniere's diagnosis.  
","Is the progression from low-tone sudden deafness to Meniere's disease certain? We conclude that not all cases of low-tone sudden deafness evolve into Meniere's disease. The presence of fluctuating hearing loss, tinnitus, and vertigo is essential for diagnosing Meniere's disease.",1.6580180914979774e-07,0.18130727632573596,0.011488942972177146,0.012693985253473108,0.17475121924149972,0.004085823035454482,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
299,0.1,1,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Is it possible to use mental imagery functional magnetic resonance imaging to forecast recovery in patients with consciousness disorders? Answer: The fMRI mental imagery paradigm shows strong agreement with the subsequent clinical progression of patients in a vegetative state. All five patients in a vegetative state who exhibited significant activation in regions of interest experienced a positive clinical course through the observation period. Hence, we",9.474389094274162e-08,0.04638139470218228,0.01222509962896582,0.0072537058591274906,0.0443217283712416,0.014555603019334031,0.007243206163811466,0.0435926100870887,0.015868886576482836,9.474389094274162e-08,0.06669137449867257,0.0
299,0.1,2,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can mental imagery fMRI predict recovery outcomes in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm demonstrates high consistency with the later clinical trajectory of patients in a vegetative state. Each of the five patients in a vegetative state who showed notable activation in regions of interest had a favorable clinical progression by the end of the observation period. Therefore, we",7.105791820705622e-08,0.013777465966010816,0.043697978596908466,0.005440279394345618,0.005881052991914437,0.03083812122953175,0.0054324046228586,0.02723735466969668,0.016124697661918843,7.105791820705622e-08,0.05043085362689137,0.0
299,0.1,3,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Does mental imagery functional MRI have predictive value for recovery in patients with consciousness disorders? Answer: The mental imagery fMRI paradigm correlates strongly with the subsequent clinical outcomes of patients in a vegetative state. All five vegetative state patients with significant ROI activation experienced a positive clinical course until the observation period ended. Thus, we",1.4211583641411244e-07,0.08577297177894527,0.012736896733744812,0.010880558788691236,0.08225560963915957,0.016661878770468257,0.0108648092457172,0.10724553035359774,0.0,1.4211583641411244e-07,0.10919929196499112,0.0
299,0.1,4,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can mental imagery fMRI be used to predict recovery in patients suffering from disorders of consciousness? Answer: The mental imagery fMRI paradigm aligns closely with the future clinical course of patients in a vegetative state. All five patients in a vegetative state who showed significant activation in regions of interest had a favorable clinical outcome by the end of the observation period. Consequently, we",7.105791820705622e-08,0.007883383426487534,0.028515166927922983,0.005440279394345618,0.005881052991914437,0.03083812122953175,0.0054324046228586,0.02723735466969668,0.016124697661918843,7.105791820705622e-08,0.05043085362689137,0.0
299,0.1,5,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Is mental imagery functional magnetic resonance imaging effective in predicting recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm exhibits a strong correlation with the subsequent clinical progression of patients in a vegetative state. All five patients in a vegetative state who demonstrated significant ROI activation had a positive clinical course through the observation period. Therefore, we",0.0,0.02272613706753912,0.016202094927955504,0.0,0.02310490601866455,0.01663181920812866,0.0,0.02349651459525237,0.01694411414982164,0.0,0.0,0.0
299,0.1,6,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can mental imagery fMRI serve as a predictor for recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm shows a high level of agreement with the later clinical course of patients in a vegetative state. All five vegetative state patients with significant activation in regions of interest had a favorable clinical progression by the end of the observation period. Hence, we",9.474389094274162e-08,0.06770900025787263,0.003002965846367417,0.0072537058591274906,0.06598257776373995,0.0010408155303573991,0.007243206163811466,0.06559728248581642,0.0,9.474389094274162e-08,0.06669137449867257,0.0
299,0.1,7,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Does mental imagery functional MRI predict recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm is highly concordant with the subsequent clinical course of patients in a vegetative state. All five patients in a vegetative state who exhibited significant ROI activation experienced a positive clinical outcome until the observation period concluded. Thus, we",9.474389094274162e-08,0.09692799995157442,0.020726969410790608,0.0072537058591274906,0.09539847836542492,0.01900341615408592,0.007243206163811466,0.09540961069360954,0.0181755829903978,9.474389094274162e-08,0.07145896398214369,0.0
299,0.1,8,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can mental imagery fMRI predict clinical recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm demonstrates strong concordance with the future clinical course of patients in a vegetative state. All five patients in a vegetative state who showed significant activation in regions of interest had a favorable clinical outcome by the end of the observation period. Therefore, we",2.3685972735685406e-08,0.027359000273980527,0.030975871474585248,0.0018134264647818726,0.02854420323274187,0.03238687271585754,0.0018108015409528666,0.006297787702283841,0.016661878770468257,2.3685972735685406e-08,0.01709443335929972,0.0
299,0.1,9,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Is mental imagery functional MRI a reliable predictor of recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm correlates highly with the subsequent clinical progression of patients in a vegetative state. All five patients in a vegetative state who showed significant ROI activation had a positive clinical course through the observation period. Consequently, we",7.105791820705622e-08,0.07785895008771515,0.01953835413781685,0.005440279394345618,0.07683029577660072,0.018379443543581335,0.0054324046228586,0.07694100961913897,0.017851239669421492,7.105791820705622e-08,0.05310982531394792,0.0
299,0.1,10,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Question: Can mental imagery functional magnetic resonance imaging forecast recovery in patients with disorders of consciousness? Answer: The mental imagery fMRI paradigm exhibits strong agreement with the later clinical course of patients in a vegetative state. All five patients in a vegetative state who demonstrated significant activation in regions of interest experienced a favorable clinical progression by the end of the observation period. Hence, we",7.105791820705622e-08,0.029544232818985883,0.01317347073589642,0.005440279394345618,0.027885725390643046,0.01505002663130546,0.0054324046228586,0.02723735466969668,0.016124697661918843,7.105791820705622e-08,0.05043085362689137,0.0
